Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Behavioral & Substance Use Disorder Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:arsenous acid
go back to main search page
Accession:CHEBI:49900 term browser browse the term
Definition:An arsenic oxoacid consisting of three hydroxy groups attached to a central arsenic atom.
Synonyms:related_synonym: Arsenic trioxide;   As(OH)3;   H3AsO3;   TRIHYDROXYARSENITE(III);   arsorous acid;   trihydrogen trioxoarsenate(3-);   trihydroxidoarsenic;   trioxoarsenic acid
 alt_id: CHEBI:22635;   CHEBI:49899
 xref: CAS:1327-53-3;   CAS:13464-58-9;   DrugBank:DB04456;   Gmelin:1397624
 xref_mesh: MESH:C032793
 xref: kegg.compound:C06697;   kegg.compound:C13619;   kegg.drug:D02106;   pdb-ccd:TAS;   umbbd.compound:c0532
 chemrof_inchikey: GCPXMJHSNVMWNM-UHFFFAOYSA-N
 chemrof_formula: H3AsO3
 chemrof_inchi: InChI=1S/AsH3O3/c2-1(3)4/h2-4H
 chemrof_smiles: O[As](O)O
 cyclic_relationship: is_conjugate_acid_of CHEBI:29242


show annotations for term's descendants           Sort by:
arsenous acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G A1cf APOBEC1 complementation factor multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to A1CF protein] CTD PMID:26598702 NCBI chr 1:239,149,436...239,242,460
Ensembl chr 1:239,149,493...239,236,817 		JBrowse link
G A2m alpha-2-macroglobulin decreases expression ISO Arsenic Trioxide results in decreased expression of A2M protein CTD PMID:30093655 NCBI chr 4:156,570,163...156,619,870
Ensembl chr 4:156,569,860...156,619,868 		JBrowse link
G A2ml1 alpha-2-macroglobulin-like 1 decreases expression ISO Arsenic Trioxide results in decreased expression of OVOS2P mRNA CTD PMID:26705709 NCBI chr 4:163,501,210...163,543,419
Ensembl chr 4:163,501,585...163,543,506 		JBrowse link
G Aaas aladin WD repeat nucleoporin decreases expression ISO Arsenic Trioxide results in decreased expression of AAAS mRNA CTD PMID:39716349 NCBI chr 7:135,342,901...135,362,545
Ensembl chr 7:135,342,901...135,362,545 		JBrowse link
G Aamp angio-associated, migratory cell protein multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to AAMP protein] CTD PMID:26598702 NCBI chr 9:83,312,519...83,318,325
Ensembl chr 9:83,312,519...83,318,325 		JBrowse link
G Aars1 alanyl-tRNA synthetase 1 decreases expression ISO Arsenic Trioxide results in decreased expression of AARS1 protein CTD PMID:19364129 NCBI chr19:55,906,694...55,930,499
Ensembl chr19:55,906,702...55,930,497 		JBrowse link
G Abat 4-aminobutyrate aminotransferase decreases expression ISO Arsenic Trioxide results in decreased expression of ABAT mRNA CTD PMID:39716349 NCBI chr10:7,503,351...7,599,474
Ensembl chr10:7,492,022...7,599,474 		JBrowse link
G Abca1 ATP binding cassette subfamily A member 1 increases expression
decreases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of ABCA1 mRNA
Arsenic Trioxide results in decreased expression of ABCA1 mRNA; Arsenic Trioxide results in decreased expression of ABCA1 protein
Arsenic Trioxide inhibits the reaction [[Alitretinoin co-treated with 22-hydroxycholesterol] results in increased expression of ABCA1 mRNA]; Arsenic Trioxide inhibits the reaction [[Alitretinoin co-treated with 22-hydroxycholesterol] results in increased expression of ABCA1 protein] 		CTD PMID:16184197 PMID:20339114 PMID:20458559 PMID:25424538 NCBI chr 5:72,473,676...72,596,563
Ensembl chr 5:72,473,676...72,596,473 		JBrowse link
G Abca3 ATP binding cassette subfamily A member 3 increases expression ISO Arsenic Trioxide results in increased expression of ABCA3 mRNA CTD PMID:20458559 NCBI chr10:13,886,948...13,944,286
Ensembl chr10:13,887,083...13,944,285 		JBrowse link
G Abca9 ATP binding cassette subfamily A member 9 increases expression
affects expression 		ISO Arsenic Trioxide results in increased expression of ABCA9 mRNA
Arsenic Trioxide affects the expression of ABCA10 mRNA 		CTD PMID:20458559 PMID:39716349 NCBI chr10:95,577,079...95,638,706
Ensembl chr10:95,578,350...95,636,405 		JBrowse link
G Abcb1a ATP binding cassette subfamily B member 1A decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of ABCB1 mRNA; Arsenic Trioxide results in decreased expression of ABCB1 protein
Arsenic Trioxide results in increased expression of ABCB1 mRNA; Arsenic Trioxide results in increased expression of ABCB1 protein 		CTD PMID:14642128 PMID:15634520 PMID:15844663 PMID:15979894 PMID:21945491 More... NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135 		JBrowse link
G Abcb4 ATP binding cassette subfamily B member 4 increases expression ISO Arsenic Trioxide results in increased expression of ABCB4 mRNA CTD PMID:27829220 NCBI chr 4:26,106,895...26,164,440 JBrowse link
G Abcc1 ATP binding cassette subfamily C member 1 decreases response to substance
increases expression
increases secretion
increases response to substance
increases transport
multiple interactions
decreases expression 		ISO ABCC1 protein results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in increased expression of ABCC1 mRNA; Arsenic Trioxide results in increased expression of ABCC1 protein
ABCC1 protein results in increased secretion of Arsenic Trioxide
ABCC1 gene mutant form results in increased susceptibility to Arsenic Trioxide
ABCC1 protein results in increased transport of Arsenic Trioxide
[verlukast results in decreased activity of ABCC1 protein] which results in increased susceptibility to Arsenic Trioxide; ABCC1 protein results in decreased uptake of and results in decreased susceptibility to Arsenic Trioxide; Glutathione affects the reaction [ABCC1 protein results in increased secretion of Arsenic Trioxide]; Proanthocyanidins inhibits the reaction [Arsenic Trioxide results in decreased expression of ABCC1 protein]; verlukast inhibits the reaction [ABCC1 protein results in decreased susceptibility to Arsenic Trioxide]; verlukast inhibits the reaction [ABCC1 protein results in decreased uptake of and results in decreased susceptibility to Arsenic Trioxide]
Arsenic Trioxide results in decreased expression of ABCC1 mRNA 		CTD PMID:11331074 PMID:12018890 PMID:18633430 PMID:19100828 PMID:20707922 More... NCBI chr10:1,022,041...1,162,431
Ensembl chr10:1,038,947...1,162,404 		JBrowse link
G Abcc2 ATP binding cassette subfamily C member 2 increases expression
decreases expression
decreases response to substance 		ISO Arsenic Trioxide results in increased expression of ABCC2 mRNA; Arsenic Trioxide results in increased expression of ABCC2 protein
Arsenic Trioxide results in decreased expression of ABCC2 mRNA; Arsenic Trioxide results in decreased expression of ABCC2 protein
ABCC2 protein results in decreased susceptibility to Arsenic Trioxide 		CTD PMID:21783896 PMID:21945491 PMID:22214486 PMID:27736728 PMID:38758479 More... NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:252,614,017...252,673,471 		JBrowse link
G Abcc3 ATP binding cassette subfamily C member 3 decreases expression
decreases response to substance 		ISO Arsenic Trioxide results in decreased expression of ABCC3 mRNA
ABCC3 protein results in decreased susceptibility to Arsenic Trioxide 		CTD PMID:20707922 PMID:22214486 NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,793,583...79,839,494 		JBrowse link
G Abcc4 ATP binding cassette subfamily C member 4 decreases expression
increases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of ABCC4 mRNA
Arsenic Trioxide results in increased expression of ABCC4 mRNA
[Arsenic Trioxide co-treated with Torsemide] results in decreased expression of ABCC4 mRNA; ABCC4 promotes the reaction [[Arsenic Trioxide co-treated with Torsemide] results in increased abundance of arsenite]; ABCC4 promotes the reaction [[Arsenic Trioxide co-treated with Torsemide] results in increased abundance of Cacodylic Acid]; ABCC4 promotes the reaction [[Arsenic Trioxide co-treated with Torsemide] results in increased abundance of monomethylarsonic acid] 		CTD PMID:19142964 PMID:35676786 PMID:37172335 PMID:38758479 NCBI chr15:101,948,387...102,182,912
Ensembl chr15:101,949,433...102,181,375 		JBrowse link
G Abcc5 ATP binding cassette subfamily C member 5 multiple interactions
decreases expression
increases expression 		ISO Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of ABCC5 mRNA]
Arsenic Trioxide results in increased expression of ABCC5 mRNA 		CTD PMID:20458559 PMID:29095437 PMID:38758479 NCBI chr11:93,975,579...94,071,659
Ensembl chr11:93,978,274...94,071,655 		JBrowse link
G Abcc6 ATP binding cassette subfamily C member 6 increases expression ISO Arsenic Trioxide results in increased expression of ABCC6 mRNA CTD PMID:38758479 NCBI chr 1:105,583,681...105,637,895
Ensembl chr 1:105,583,682...105,637,895 		JBrowse link
G Abcg1 ATP binding cassette subfamily G member 1 decreases expression ISO Arsenic Trioxide results in decreased expression of ABCG1 mRNA CTD PMID:39716349 NCBI chr20:9,128,056...9,184,312
Ensembl chr20:9,127,803...9,186,563 		JBrowse link
G Abcg2 ATP binding cassette subfamily G member 2 increases expression
multiple interactions
affects expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of ABCG2 mRNA; Arsenic Trioxide results in increased expression of ABCG2 protein
prolinedithiocarbamate inhibits the reaction [Arsenic Trioxide results in increased expression of ABCG2 mRNA]; prolinedithiocarbamate inhibits the reaction [Arsenic Trioxide results in increased expression of ABCG2 protein]; TNF protein promotes the reaction [Arsenic Trioxide results in increased expression of ABCG2 mRNA]; TNF protein promotes the reaction [Arsenic Trioxide results in increased expression of ABCG2 protein]
Arsenic Trioxide affects the expression of ABCG2 mRNA
Arsenic Trioxide results in decreased expression of ABCG2 mRNA; Arsenic Trioxide results in decreased expression of ABCG2 protein 		CTD PMID:17547211 PMID:22214486 PMID:22521957 PMID:29274627 PMID:33634982 NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:89,005,969...89,132,493 		JBrowse link
G Abhd1 abhydrolase domain containing 1 increases expression ISO Arsenic Trioxide results in increased expression of ABHD1 mRNA CTD PMID:20458559 NCBI chr 6:31,142,476...31,147,464
Ensembl chr 6:31,142,476...31,147,464 		JBrowse link
G Abhd12b abhydrolase domain containing 12B multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ABHD12B protein] CTD PMID:26598702 NCBI chr 6:94,404,594...94,432,395
Ensembl chr 6:94,404,594...94,432,395 		JBrowse link
G Abhd3 abhydrolase domain containing 3, phospholipase increases expression ISO Arsenic Trioxide results in increased expression of ABHD3 mRNA CTD PMID:27829220 NCBI chr18:1,996,010...2,051,311
Ensembl chr18:1,993,525...2,075,492 		JBrowse link
G Abhd5 abhydrolase domain containing 5, lysophosphatidic acid acyltransferase multiple interactions
increases expression 		ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ABHD5 protein]
Arsenic Trioxide results in increased expression of ABHD5 mRNA 		CTD PMID:26598702 PMID:39716349 NCBI chr 8:130,877,834...130,903,947
Ensembl chr 8:130,877,703...130,903,947 		JBrowse link
G Abi2 abl-interactor 2 increases expression ISO Arsenic Trioxide results in increased expression of ABI2 mRNA CTD PMID:22521957 NCBI chr 9:69,321,072...69,490,630
Ensembl chr 9:69,321,150...69,490,597 		JBrowse link
G Abl1 ABL proto-oncogene 1, non-receptor tyrosine kinase decreases expression
multiple interactions
affects response to substance 		ISO Arsenic Trioxide results in decreased expression of ABL1 mRNA; Arsenic Trioxide results in decreased expression of ABL1 protein; Arsenic Trioxide results in decreased expression of ABL1 protein mutant form
[Arsenic Trioxide co-treated with Bortezomib] results in decreased expression of ABL1 protein; [nilotinib co-treated with Arsenic Trioxide] results in decreased phosphorylation of ABL1 protein; [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of ABL1 mRNA; Arsenic Trioxide promotes the reaction [ABL1 protein mutant form binds to BECN1 protein]; Arsenic Trioxide promotes the reaction [ABL1 protein mutant form binds to YWHAQ protein]; Arsenic Trioxide results in decreased expression of [BCR protein mutant form binds to ABL1 protein mutant form]; Arsenic Trioxide results in decreased expression of and affects the localization of ABL1 protein mutant form
ABL1 protein affects the susceptibility to Arsenic Trioxide 		CTD PMID:10648417 PMID:14633726 PMID:15894607 PMID:17495969 PMID:20458559 More... NCBI chr 3:35,377,587...35,480,843
Ensembl chr 3:35,377,391...35,480,846 		JBrowse link
G Ablim1 actin-binding LIM protein 1 decreases response to substance
increases expression 		ISO ABLIM1 protein results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in increased expression of ABLIM1 mRNA 		CTD PMID:20458559 PMID:20707922 NCBI chr 1:266,088,868...266,377,169
Ensembl chr 1:266,088,870...266,377,098 		JBrowse link
G Acaa2 acetyl-CoA acyltransferase 2 increases expression ISO Arsenic Trioxide results in increased expression of ACAA2 mRNA CTD PMID:15761015 NCBI chr18:70,620,310...70,648,417
Ensembl chr18:70,620,110...70,648,420 		JBrowse link
G Acaca acetyl-CoA carboxylase alpha decreases expression ISO Arsenic Trioxide results in decreased expression of ACACA mRNA CTD PMID:30237538 NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,511,857...69,773,888 		JBrowse link
G Acacb acetyl-CoA carboxylase beta multiple interactions ISO [Arsenic Trioxide co-treated with Tretinoin] results in increased expression of ACACB mRNA CTD PMID:38179723 NCBI chr12:48,026,394...48,138,214
Ensembl chr12:48,026,394...48,138,214 		JBrowse link
G Acadl acyl-CoA dehydrogenase, long chain increases expression ISO Arsenic Trioxide results in increased expression of ACADL mRNA CTD PMID:35676786 NCBI chr 9:75,783,689...75,822,077
Ensembl chr 9:75,783,689...75,822,164 		JBrowse link
G Acat1 acetyl-CoA acetyltransferase 1 increases expression ISO Arsenic Trioxide results in increased expression of ACAT1 mRNA CTD PMID:22521957 NCBI chr 8:62,876,003...62,905,080
Ensembl chr 8:62,876,003...62,905,042 		JBrowse link
G Acat2 acetyl-CoA acetyltransferase 2 decreases expression ISO Arsenic Trioxide results in decreased expression of ACAT2 mRNA CTD PMID:19128835 NCBI chr 1:50,100,840...50,118,886
Ensembl chr 1:50,100,817...50,135,095 		JBrowse link
G Ache acetylcholinesterase decreases activity EXP Arsenic Trioxide results in decreased activity of ACHE protein CTD PMID:16705804 NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410 		JBrowse link
G Ackr1 atypical chemokine receptor 1 decreases expression ISO Arsenic Trioxide results in decreased expression of ACKR1 mRNA CTD PMID:20458559 NCBI chr13:88,314,735...88,316,354
Ensembl chr13:88,293,188...88,317,807 		JBrowse link
G Acly ATP citrate lyase increases expression ISO Arsenic Trioxide results in increased expression of ACLY mRNA CTD PMID:39716349 NCBI chr10:85,912,402...85,964,605
Ensembl chr10:85,912,402...85,963,631 		JBrowse link
G Aco1 aconitase 1 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of ACO1 mRNA
Arsenic Trioxide results in decreased expression of ACO1 protein 		CTD PMID:19364129 PMID:20458559 NCBI chr 5:60,055,895...60,111,920
Ensembl chr 5:60,055,866...60,112,600 		JBrowse link
G Aco2 aconitase 2 decreases expression ISO Arsenic Trioxide results in decreased expression of ACO2 protein CTD PMID:19364129 NCBI chr 7:115,265,816...115,308,931
Ensembl chr 7:115,265,791...115,308,892 		JBrowse link
G Acot4 acyl-CoA thioesterase 4 increases expression ISO Arsenic Trioxide results in increased expression of ACOT4 mRNA CTD PMID:34108876 NCBI chr 6:109,399,032...109,405,138
Ensembl chr 6:109,399,578...109,405,138 		JBrowse link
G Acot9 acyl-CoA thioesterase 9 increases expression ISO Arsenic Trioxide results in increased expression of ACOT9 mRNA CTD PMID:22521957 NCBI chr  X:43,922,943...43,973,311
Ensembl chr  X:43,914,923...43,973,205 		JBrowse link
G Acox1 acyl-CoA oxidase 1 multiple interactions
increases expression 		ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ACOX1 protein]
Arsenic Trioxide results in increased expression of ACOX1 mRNA 		CTD PMID:26598702 PMID:35676786 NCBI chr10:101,905,083...101,930,136
Ensembl chr10:101,905,083...101,930,136 		JBrowse link
G Acox2 acyl-CoA oxidase 2 increases expression ISO Arsenic Trioxide results in increased expression of ACOX2 mRNA CTD PMID:35676786 NCBI chr15:19,090,820...19,122,392
Ensembl chr15:19,090,926...19,122,392 		JBrowse link
G Acsbg1 acyl-CoA synthetase bubblegum family member 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ACSBG1 protein] CTD PMID:26598702 NCBI chr 8:63,887,433...63,943,486
Ensembl chr 8:63,887,435...63,984,178 		JBrowse link
G Acsf3 acyl-CoA synthetase family member 3 increases expression ISO Arsenic Trioxide results in increased expression of ACSF3 mRNA CTD PMID:35676786 NCBI chr19:67,743,660...67,784,109
Ensembl chr19:67,743,490...67,784,084 		JBrowse link
G Acsl1 acyl-CoA synthetase long-chain family member 1 multiple interactions
increases expression 		ISO Dasatinib inhibits the reaction [Arsenic Trioxide results in increased expression of ACSL1 mRNA] CTD PMID:29266867 NCBI chr16:52,487,870...52,554,110
Ensembl chr16:52,487,870...52,554,023 		JBrowse link
G Acss2 acyl-CoA synthetase short-chain family member 2 decreases expression ISO Arsenic Trioxide results in decreased expression of ACSS2 mRNA CTD PMID:27829220 NCBI chr 3:164,464,124...164,507,607
Ensembl chr 3:164,464,055...164,519,830 		JBrowse link
G Acta2 actin alpha 2, smooth muscle multiple interactions
increases expression
decreases expression 		ISO
EXP 		3-methyladenine inhibits the reaction [Arsenic Trioxide results in increased expression of ACTA2 protein]; Arsenic Trioxide inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA]; Arsenic Trioxide inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]; Diosgenin inhibits the reaction [Arsenic Trioxide results in increased expression of ACTA2 protein]; MK-886 inhibits the reaction [Arsenic Trioxide results in increased expression of ACTA2 protein]; NFE2L2 protein affects the reaction [Arsenic Trioxide results in decreased expression of ACTA2 protein]; NR3C1 promotes the reaction [Diosgenin inhibits the reaction [Arsenic Trioxide results in increased expression of ACTA2 protein]]; PML protein affects the reaction [Arsenic Trioxide results in increased expression of ACTA2 protein]; RNF4 protein affects the reaction [Arsenic Trioxide results in increased expression of ACTA2 mRNA]; Taurine inhibits the reaction [Arsenic Trioxide results in increased expression of ACTA2 protein]; UBE2I protein affects the reaction [Arsenic Trioxide results in increased expression of ACTA2 mRNA]
Arsenic Trioxide results in increased expression of ACTA2 mRNA; Arsenic Trioxide results in increased expression of ACTA2 protein
[Arsenic Trioxide co-treated with Bleomycin] results in decreased expression of ACTA2 mRNA; Taurine inhibits the reaction [Arsenic Trioxide results in increased expression of ACTA2 protein]
Arsenic Trioxide results in decreased expression of ACTA2 mRNA; Arsenic Trioxide results in decreased expression of ACTA2 protein
[Arsenic Trioxide co-treated with Curcumin] inhibits the reaction [Cisplatin results in increased expression of ACTA2 mRNA]; Arsenic Trioxide inhibits the reaction [Cisplatin results in increased expression of ACTA2 mRNA]; Arsenic Trioxide inhibits the reaction [Cisplatin results in increased expression of ACTA2 protein]; Arsenic Trioxide promotes the reaction [Curcumin inhibits the reaction [Cisplatin results in increased expression of ACTA2 protein]]; Curcumin promotes the reaction [Arsenic Trioxide inhibits the reaction [Cisplatin results in increased expression of ACTA2 protein]]; Diosgenin inhibits the reaction [Arsenic Trioxide results in increased expression of ACTA2 protein] 		CTD PMID:24762191 PMID:30317545 PMID:30677399 PMID:31612257 PMID:32240679 More... NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:241,159,724...241,172,503 		JBrowse link
G Actb actin, beta decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of ACTB mRNA; Arsenic Trioxide results in decreased expression of ACTB protein
Arsenic Trioxide results in increased expression of ACTB mRNA 		CTD PMID:11940349 PMID:20452446 PMID:20458559 NCBI chr12:16,776,664...16,779,634
Ensembl chr12:16,776,661...16,780,242 		JBrowse link
G Actg1 actin, gamma 1 decreases expression ISO Arsenic Trioxide results in decreased expression of ACTG1 mRNA CTD PMID:20458559 NCBI chr10:106,118,106...106,120,951
Ensembl chr10:106,118,108...106,120,951 		JBrowse link
G Actg2 actin gamma 2, smooth muscle multiple interactions
increases expression 		ISO [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of ACTG2 mRNA
Arsenic Trioxide results in increased expression of ACTG2 mRNA 		CTD PMID:15894607 NCBI chr 4:117,579,513...117,604,379
Ensembl chr 4:117,579,514...117,604,295 		JBrowse link
G Actl6b actin-like 6B increases expression ISO Arsenic Trioxide results in increased expression of ACTL6B mRNA CTD PMID:20458559 NCBI chr12:24,761,660...24,778,193
Ensembl chr12:24,761,693...24,778,151 		JBrowse link
G Actn3 actinin alpha 3 decreases expression ISO Arsenic Trioxide results in decreased expression of ACTN3 mRNA CTD PMID:20458559 NCBI chr 1:211,588,473...211,604,401
Ensembl chr 1:211,588,474...211,604,401 		JBrowse link
G Actr1b actin related protein 1B decreases expression ISO Arsenic Trioxide results in decreased expression of ACTR1B mRNA CTD PMID:27829220 NCBI chr 9:46,424,677...46,434,341
Ensembl chr 9:46,424,678...46,434,341 		JBrowse link
G Actr3 actin related protein 3 multiple interactions
increases expression 		ISO [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of ACTR3 protein
Arsenic Trioxide results in increased expression of ACTR3 mRNA; Arsenic Trioxide results in increased expression of ACTR3 protein 		CTD PMID:15894607 PMID:22521957 PMID:25419056 NCBI chr13:39,353,413...39,396,509
Ensembl chr13:39,353,079...39,396,711 		JBrowse link
G Acvrl1 activin A receptor like type 1 decreases expression ISO Arsenic Trioxide results in decreased expression of ACVRL1 mRNA CTD PMID:18231732 NCBI chr 7:134,117,917...134,135,306
Ensembl chr 7:134,118,024...134,135,305 		JBrowse link
G Acy1 aminoacylase 1 decreases expression ISO Arsenic Trioxide results in decreased expression of ACY1 protein CTD PMID:19364129 NCBI chr 8:115,951,068...115,956,471
Ensembl chr 8:115,951,068...115,956,405 		JBrowse link
G Acyp1 acylphosphatase 1 decreases expression ISO Arsenic Trioxide results in decreased expression of ACYP1 mRNA CTD PMID:26705709 NCBI chr 6:110,650,213...110,663,404
Ensembl chr 6:110,650,213...110,663,612 		JBrowse link
G Acyp2 acylphosphatase 2 increases expression ISO Arsenic Trioxide results in increased expression of ACYP2 mRNA CTD PMID:27829220 NCBI chr14:108,402,837...108,572,367
Ensembl chr14:108,402,544...108,633,318 		JBrowse link
G Adam10 ADAM metallopeptidase domain 10 decreases expression ISO Arsenic Trioxide results in decreased expression of ADAM10 mRNA CTD PMID:39716349 NCBI chr 8:80,226,862...80,358,728
Ensembl chr 8:80,226,674...80,361,600 		JBrowse link
G Adam17 ADAM metallopeptidase domain 17 increases expression ISO Arsenic Trioxide results in increased expression of ADAM17 mRNA CTD PMID:35676786 NCBI chr 6:46,601,583...46,663,690
Ensembl chr 6:46,601,583...46,649,344 		JBrowse link
G Adam19 ADAM metallopeptidase domain 19 increases expression ISO Arsenic Trioxide results in increased expression of ADAM19 mRNA CTD PMID:39716349 NCBI chr10:30,992,713...31,084,455
Ensembl chr10:30,992,754...31,084,455 		JBrowse link
G Adam24 ADAM metallopeptidase domain 24 increases expression ISO Arsenic Trioxide results in increased expression of ADAM29 mRNA
Arsenic Trioxide results in increased expression of NPIPB11 mRNA 		CTD PMID:20458559 PMID:39716349 NCBI chr16:58,281,748...58,287,735
Ensembl chr16:58,281,748...58,287,735 		JBrowse link
G Adam8 ADAM metallopeptidase domain 8 decreases expression ISO Arsenic Trioxide results in decreased expression of ADAM8 mRNA CTD PMID:39716349 NCBI chr 1:204,206,206...204,218,988
Ensembl chr 1:204,206,199...204,218,485 		JBrowse link
G Adamdec1 ADAM-like, decysin 1 increases expression ISO Arsenic Trioxide results in increased expression of ADAMDEC1 mRNA CTD PMID:20458559 NCBI chr15:47,076,011...47,097,065
Ensembl chr15:47,076,019...47,097,065 		JBrowse link
G Adamts1 ADAM metallopeptidase with thrombospondin type 1 motif, 1 increases expression ISO Arsenic Trioxide results in increased expression of ADAMTS1 mRNA CTD PMID:22521957 NCBI chr11:38,418,565...38,427,384
Ensembl chr11:38,418,101...38,427,390 		JBrowse link
G Adamts15 ADAM metallopeptidase with thrombospondin type 1 motif, 15 decreases expression ISO Arsenic Trioxide results in decreased expression of ADAMTS15 mRNA CTD PMID:26705709 NCBI chr 8:37,566,064...37,589,446
Ensembl chr 8:37,566,065...37,589,446 		JBrowse link
G Adamts2 ADAM metallopeptidase with thrombospondin type 1 motif, 2 decreases expression ISO Arsenic Trioxide results in decreased expression of ADAMTS2 mRNA CTD PMID:20458559 NCBI chr10:35,422,030...35,627,483
Ensembl chr10:35,422,030...35,627,483 		JBrowse link
G Adamts4 ADAM metallopeptidase with thrombospondin type 1 motif, 4 multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of ADAMTS4 mRNA CTD PMID:15894607 NCBI chr13:86,203,011...86,212,500
Ensembl chr13:86,202,642...86,212,514 		JBrowse link
G Adamts5 ADAM metallopeptidase with thrombospondin type 1 motif, 5 decreases expression ISO Arsenic Trioxide results in decreased expression of ADAMTS5 mRNA CTD PMID:25258189 NCBI chr11:38,486,945...38,533,516
Ensembl chr11:38,486,955...38,533,516 		JBrowse link
G Adamtsl3 ADAMTS-like 3 decreases expression ISO Arsenic Trioxide results in decreased expression of ADAMTSL3 mRNA CTD PMID:26705709 NCBI chr 1:145,698,004...146,006,195
Ensembl chr 1:145,698,004...146,006,195 		JBrowse link
G Adap1 ArfGAP with dual PH domains 1 decreases response to substance ISO ADAP1 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr12:20,438,091...20,489,961
Ensembl chr12:20,438,063...20,495,020 		JBrowse link
G Adar adenosine deaminase, RNA-specific increases expression ISO Arsenic Trioxide results in increased expression of ADAR mRNA CTD PMID:20458559 NCBI chr 2:177,436,076...177,475,969
Ensembl chr 2:177,436,094...177,475,971 		JBrowse link
G Adat3 adenosine deaminase, tRNA-specific 3 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ADAT3 protein] CTD PMID:26598702 NCBI chr 7:9,759,758...9,761,127
Ensembl chr 7:9,758,671...9,764,582 		JBrowse link
G Adcy1 adenylate cyclase 1 decreases expression ISO Arsenic Trioxide results in decreased expression of ADCY1 mRNA CTD PMID:24831965 NCBI chr14:86,125,119...86,234,459
Ensembl chr14:86,124,850...86,261,075 		JBrowse link
G Adcy9 adenylate cyclase 9 decreases expression ISO Arsenic Trioxide results in decreased expression of ADCY9 mRNA CTD PMID:15761015 NCBI chr10:11,645,373...11,768,462
Ensembl chr10:11,645,282...11,765,792 		JBrowse link
G Adgre1 adhesion G protein-coupled receptor E1 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of ADGRE1 protein
Taurine inhibits the reaction [Arsenic Trioxide results in increased expression of ADGRE1 protein] 		CTD PMID:30237538 NCBI chr 9:2,329,398...2,484,959
Ensembl chr 9:2,329,438...2,484,959 		JBrowse link
G Adgre5 adhesion G protein-coupled receptor E5 decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of ADGRE5 mRNA
Arsenic Trioxide results in increased expression of ADGRE5 mRNA 		CTD PMID:19128835 PMID:39716349 NCBI chr19:41,302,687...41,332,183
Ensembl chr19:41,303,213...41,324,641 		JBrowse link
G Adgrf5 adhesion G protein-coupled receptor F5 decreases expression ISO Arsenic Trioxide results in decreased expression of ADGRF5 mRNA CTD PMID:26705709 NCBI chr 9:25,014,861...25,128,045
Ensembl chr 9:25,018,277...25,121,237 		JBrowse link
G Adgrg2 adhesion G protein-coupled receptor G2 decreases expression ISO Arsenic Trioxide results in decreased expression of ADGRG2 mRNA CTD PMID:26705709 NCBI chr  X:38,106,067...38,231,286
Ensembl chr  X:38,106,067...38,231,331 		JBrowse link
G Adh5 alcohol dehydrogenase 5 (class III), chi polypeptide multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ADH5 protein] CTD PMID:26598702 NCBI chr 2:229,648,557...229,660,964
Ensembl chr 2:229,648,501...229,665,232 		JBrowse link
G Adh6 alcohol dehydrogenase 6 (class V) decreases expression ISO Arsenic Trioxide results in decreased expression of ADH6 mRNA CTD PMID:39716349 NCBI chr 2:229,576,612...229,608,359
Ensembl chr 2:229,576,636...229,607,914 		JBrowse link
G Adipoq adiponectin, C1Q and collagen domain containing decreases expression
increases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of ADIPOQ mRNA; Arsenic Trioxide results in decreased expression of ADIPOQ protein
Arsenic Trioxide results in increased expression of ADIPOQ mRNA
RNF4 protein affects the reaction [Arsenic Trioxide results in increased expression of ADIPOQ mRNA]; UBE2I protein affects the reaction [Arsenic Trioxide results in increased expression of ADIPOQ mRNA] 		CTD PMID:25859628 PMID:32240679 PMID:35676786 NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169 		JBrowse link
G Adk adenosine kinase decreases expression ISO Arsenic Trioxide results in decreased expression of ADK protein CTD PMID:25419056 NCBI chr15:2,912,543...3,295,745
Ensembl chr15:2,912,544...3,295,745 		JBrowse link
G Adm adrenomedullin multiple interactions
increases expression
decreases expression 		ISO Bortezomib inhibits the reaction [Arsenic Trioxide results in decreased expression of ADM mRNA]
Arsenic Trioxide results in increased expression of ADM mRNA 		CTD PMID:19128835 PMID:20471514 NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:174,178,773...174,182,371 		JBrowse link
G Adprs ADP-ribosylserine hydrolase increases expression ISO Arsenic Trioxide results in increased expression of ADPRS mRNA CTD PMID:35676786 NCBI chr 5:143,898,542...143,903,816
Ensembl chr 5:143,898,542...143,903,816 		JBrowse link
G Adra2a adrenoceptor alpha 2A decreases expression ISO Arsenic Trioxide results in decreased expression of ADRA2A mRNA CTD PMID:26705709 NCBI chr 1:263,066,780...263,069,580
Ensembl chr 1:263,065,278...263,069,871 		JBrowse link
G Adra2b adrenoceptor alpha 2B decreases expression ISO Arsenic Trioxide results in decreased expression of ADRA2B mRNA CTD PMID:19128835 NCBI chr 3:135,038,481...135,042,527
Ensembl chr 3:135,038,474...135,042,525 		JBrowse link
G Adsl adenylosuccinate lyase multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ADSL protein] CTD PMID:26598702 NCBI chr 7:114,359,440...114,383,618
Ensembl chr 7:114,359,440...114,384,872 		JBrowse link
G Adss2 adenylosuccinate synthase 2 decreases expression ISO Arsenic Trioxide results in decreased expression of ADSS2 protein CTD PMID:19364129 NCBI chr13:92,301,302...92,331,638
Ensembl chr13:92,301,302...92,331,638 		JBrowse link
G Aen apoptosis enhancing nuclease multiple interactions
increases expression 		ISO Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of AEN mRNA] CTD PMID:29095437 NCBI chr 1:142,224,499...142,233,902
Ensembl chr 1:142,224,493...142,233,898 		JBrowse link
G Afap1 actin filament associated protein 1 increases expression ISO Arsenic Trioxide results in increased expression of AFAP1 mRNA CTD PMID:15761015 NCBI chr14:78,967,961...79,081,032
Ensembl chr14:78,967,961...79,080,939 		JBrowse link
G Afdn afadin, adherens junction formation factor multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of AFDN mRNA CTD PMID:15894607 NCBI chr 1:58,041,065...58,170,505
Ensembl chr 1:58,041,641...58,170,505 		JBrowse link
G Aff4 ALF transcription elongation factor 4 decreases expression ISO Arsenic Trioxide results in decreased expression of AFF4 mRNA CTD PMID:20458559 NCBI chr10:37,998,319...38,080,580
Ensembl chr10:37,999,579...38,080,580 		JBrowse link
G Afp alpha-fetoprotein increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of AFP mRNA
Arsenic Trioxide results in decreased expression of AFP mRNA; Arsenic Trioxide results in decreased expression of AFP protein 		CTD PMID:23382965 PMID:29767511 PMID:33634982 NCBI chr14:17,857,584...17,875,645
Ensembl chr14:17,857,584...17,875,649 		JBrowse link
G Aftph aftiphilin decreases response to substance
increases expression 		ISO AFTPH protein results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in increased expression of AFTPH mRNA 		CTD PMID:20458559 PMID:20707922 NCBI chr14:99,072,761...99,127,006
Ensembl chr14:99,072,761...99,126,727 		JBrowse link
G Agl amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase increases expression ISO Arsenic Trioxide results in increased expression of AGL protein
Arsenic Trioxide results in increased expression of AGL mRNA 		CTD PMID:25419056 PMID:39716349 NCBI chr 2:207,389,949...207,445,959
Ensembl chr 2:207,389,949...207,445,724 		JBrowse link
G Ago2 argonaute RISC catalytic component 2 multiple interactions
decreases expression 		ISO Arsenic Trioxide inhibits the reaction [AGO2 protein binds to SESN2 mRNA]
Arsenic Trioxide results in decreased expression of AGO2 protein 		CTD PMID:25419056 PMID:29662624 NCBI chr 7:106,907,209...106,994,124
Ensembl chr 7:106,918,125...106,993,980 		JBrowse link
G Agpat2 1-acylglycerol-3-phosphate O-acyltransferase 2 decreases response to substance ISO AGPAT2 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 3:29,814,924...29,826,569
Ensembl chr 3:29,814,924...29,826,581 		JBrowse link
G Agpat4 1-acylglycerol-3-phosphate O-acyltransferase 4 increases expression ISO Arsenic Trioxide results in increased expression of AGPAT4 mRNA CTD PMID:21461292 NCBI chr 1:51,075,081...51,181,548
Ensembl chr 1:51,075,081...51,180,976 		JBrowse link
G Agpat5 1-acylglycerol-3-phosphate O-acyltransferase 5 decreases expression ISO Arsenic Trioxide results in decreased expression of AGPAT5 mRNA CTD PMID:26705709 NCBI chr16:77,641,887...77,688,148
Ensembl chr16:77,641,887...77,688,148 		JBrowse link
G Agps alkylglycerone phosphate synthase multiple interactions
decreases expression 		ISO Arsenic Trioxide inhibits the reaction [Dasatinib results in increased expression of AGPS mRNA]
Arsenic Trioxide results in decreased expression of AGPS mRNA 		CTD PMID:29266867 PMID:39716349 NCBI chr 3:81,154,599...81,253,099
Ensembl chr 3:81,154,604...81,258,277 		JBrowse link
G Agr2 anterior gradient 2, protein disulphide isomerase family member decreases response to substance
increases expression 		ISO AGR2 protein results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in increased expression of AGR2 mRNA 		CTD PMID:20707922 PMID:22521957 NCBI chr 6:58,435,908...58,456,678
Ensembl chr 6:58,435,908...58,456,677 		JBrowse link
G Agrn agrin multiple interactions ISO [Arsenic Trioxide co-treated with apatinib] results in decreased expression of AGRN mRNA CTD PMID:39223679 NCBI chr 5:172,031,528...172,064,429
Ensembl chr 5:172,031,528...172,064,539 		JBrowse link
G Agtpbp1 ATP/GTP binding carboxypeptidase 1 increases expression ISO Arsenic Trioxide results in increased expression of AGTPBP1 mRNA CTD PMID:39716349 NCBI chr17:5,092,108...5,244,414
Ensembl chr17:5,126,146...5,244,420 		JBrowse link
G Agtr1a angiotensin II receptor, type 1a decreases expression ISO Arsenic Trioxide results in decreased expression of AGTR1 mRNA CTD PMID:26705709 NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,381,467...34,435,660 		JBrowse link
G Ahcy adenosylhomocysteinase increases expression ISO Arsenic Trioxide results in increased expression of AHCY mRNA CTD PMID:22521957 NCBI chr 3:164,029,338...164,044,562
Ensembl chr 3:164,029,338...164,044,587 		JBrowse link
G Ahcyl1 adenosylhomocysteinase-like 1 increases expression ISO Arsenic Trioxide results in increased expression of AHCYL1 mRNA CTD PMID:22521957 NCBI chr 2:197,982,335...198,016,770
Ensembl chr 2:197,982,344...198,033,930 		JBrowse link
G Ahcyl2 adenosylhomocysteinase-like 2 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to AHCYL2 protein] CTD PMID:26598702 NCBI chr 4:59,348,747...59,498,503
Ensembl chr 4:59,348,217...59,498,502 		JBrowse link
G Ahr aryl hydrocarbon receptor affects localization
multiple interactions 		ISO Arsenic Trioxide affects the localization of AHR protein
AHR protein promotes the reaction [Arsenic Trioxide results in increased expression of NQO1 protein]; Arsenic Trioxide results in increased expression of and results in increased localization of AHR protein 		CTD PMID:37423394 PMID:39630573 NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901 		JBrowse link
G Ahsa2 activator of HSP90 ATPase homolog 2 increases expression ISO Arsenic Trioxide results in increased expression of AHSA2P mRNA CTD PMID:20458559 PMID:39716349 NCBI chr14:101,677,447...101,688,706
Ensembl chr14:101,677,447...101,686,923 		JBrowse link
G Aicda activation-induced cytidine deaminase multiple interactions
decreases expression 		ISO Imatinib Mesylate promotes the reaction [Arsenic Trioxide results in decreased expression of AICDA protein] CTD PMID:21570118 NCBI chr 4:157,446,120...157,455,958
Ensembl chr 4:157,444,697...157,456,356 		JBrowse link
G Aif1 allograft inflammatory factor 1 decreases expression ISO Arsenic Trioxide results in decreased expression of AIF1 mRNA CTD PMID:19128835 NCBI chr20:3,651,435...3,657,341
Ensembl chr20:3,652,243...3,657,339 		JBrowse link
G Aifm1 apoptosis inducing factor, mitochondria associated 1 multiple interactions
affects localization
affects expression 		ISO
EXP 		2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole inhibits the reaction [Arsenic Trioxide affects the localization of AIFM1 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide affects the localization of AIFM1 protein]; BAX mutant form inhibits the reaction [Arsenic Trioxide affects the localization of AIFM1 protein]; pyrazolanthrone inhibits the reaction [Arsenic Trioxide affects the localization of AIFM1 protein]
Arsenic Trioxide affects the expression of AIFM1 protein 		CTD PMID:15131059 PMID:18412143 PMID:18618274 NCBI chr  X:132,528,107...132,567,237
Ensembl chr  X:132,528,107...132,567,237 		JBrowse link
G Akap12 A-kinase anchoring protein 12 increases expression ISO Arsenic Trioxide results in increased expression of AKAP12 mRNA CTD PMID:17547211 PMID:26705709 NCBI chr 1:43,135,515...43,225,245
Ensembl chr 1:43,199,008...43,225,557 		JBrowse link
G Akap13 A-kinase anchoring protein 13 increases expression ISO Arsenic Trioxide results in increased expression of AKAP13 mRNA CTD PMID:20458559 NCBI chr 1:138,722,445...139,029,401
Ensembl chr 1:138,724,150...139,029,401 		JBrowse link
G Akap3 A-kinase anchoring protein 3 increases expression ISO Arsenic Trioxide results in increased expression of AKAP3 mRNA CTD PMID:20458559 NCBI chr 4:161,374,198...161,400,062
Ensembl chr 4:161,374,407...161,400,230 		JBrowse link
G Akap8 A-kinase anchoring protein 8 decreases expression ISO Arsenic Trioxide results in decreased expression of AKAP8 mRNA CTD PMID:35676786 NCBI chr 7:11,966,769...11,983,056
Ensembl chr 7:11,966,772...11,982,900 		JBrowse link
G Akap8l A-kinase anchoring protein 8 like increases expression ISO Arsenic Trioxide results in increased expression of AKAP8L mRNA CTD PMID:20458559 NCBI chr 7:11,983,215...12,012,843
Ensembl chr 7:11,982,721...12,012,811 		JBrowse link
G Akap9 A-kinase anchoring protein 9 multiple interactions
increases expression
affects expression 		ISO [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of AKAP9 protein
Arsenic Trioxide results in increased expression of AKAP9 mRNA
Arsenic Trioxide affects the expression of AKAP9 protein 		CTD PMID:15894607 PMID:20458559 NCBI chr 4:31,011,475...31,147,338
Ensembl chr 4:31,011,475...31,147,338 		JBrowse link
G Akirin2 akirin 2 increases expression ISO Arsenic Trioxide results in increased expression of AKIRIN2 mRNA CTD PMID:22521957 NCBI chr 5:53,897,792...53,918,873
Ensembl chr 5:53,904,285...53,918,934 		JBrowse link
G Akna AT-hook transcription factor decreases expression ISO Arsenic Trioxide results in decreased expression of AKNA mRNA CTD PMID:25258189 NCBI chr 5:81,792,928...81,839,936
Ensembl chr 5:81,792,929...81,831,528 		JBrowse link
G Akr1a1 aldo-keto reductase family 1 member A1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to AKR1A1 protein] CTD PMID:26598702 NCBI chr 5:135,329,605...135,367,037
Ensembl chr 5:135,329,606...135,367,035 		JBrowse link
G Akr1b1 aldo-keto reductase family 1 member B1 decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of AKR1B1 mRNA
Arsenic Trioxide results in increased expression of AKR1B1 mRNA 		CTD PMID:17547211 PMID:36801614 NCBI chr 4:63,899,222...63,913,315
Ensembl chr 4:63,899,222...63,913,315 		JBrowse link
G Akr1b10 aldo-keto reductase family 1 member B10 decreases response to substance ISO AKR1B10 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 4:64,005,632...64,027,860
Ensembl chr 4:64,007,420...64,020,847 		JBrowse link
G Akr1c1 aldo-keto reductase family 1, member C1 decreases response to substance
multiple interactions 		ISO AKR1C1 protein results in decreased susceptibility to Arsenic Trioxide
[Arsenic Trioxide co-treated with Bortezomib] results in increased expression of AKR1C1 mRNA; Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to AKR1C1 protein] 		CTD PMID:20707922 PMID:25913414 PMID:26598702 NCBI chr17:70,720,397...70,747,285
Ensembl chr17:70,720,398...70,747,247 		JBrowse link
G Akr1c2 aldo-keto reductase family 1, member C2 increases expression
decreases response to substance
multiple interactions 		ISO Arsenic Trioxide results in increased expression of AKR1C2 mRNA
AKR1C2 protein results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to AKR1C2 protein] 		CTD PMID:20707922 PMID:21461292 PMID:26598702 PMID:26705709 PMID:39716349 NCBI chr17:70,669,684...70,717,935
Ensembl chr17:70,669,710...70,685,686 		JBrowse link
G Akr1c3 aldo-keto reductase family 1, member C3 multiple interactions
decreases response to substance
increases expression 		ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to AKR1C3 protein]
AKR1C3 protein results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in increased expression of AKR1C3 mRNA 		CTD PMID:19128835 PMID:20707922 PMID:21461292 PMID:26598702 PMID:26705709 More... NCBI chr17:71,020,884...71,037,779
Ensembl chr17:70,970,900...71,048,438 		JBrowse link
G Akr7a3 aldo-keto reductase family 7 member A3 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to AKR7A3 protein] CTD PMID:26598702 NCBI chr 5:156,876,721...156,884,599
Ensembl chr 5:156,874,086...156,885,153 		JBrowse link
G Akt1 AKT serine/threonine kinase 1 increases phosphorylation
decreases phosphorylation
decreases expression
increases activity
affects stability
multiple interactions
decreases response to substance 		ISO
EXP 		Arsenic Trioxide results in increased phosphorylation of AKT1 protein
Arsenic Trioxide results in decreased phosphorylation of AKT1 protein
Arsenic Trioxide results in decreased expression of AKT1 mRNA; Arsenic Trioxide results in decreased expression of AKT1 protein
Arsenic Trioxide results in increased activity of AKT1 protein
Arsenic Trioxide affects the stability of AKT1 protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Arsenic Trioxide results in decreased phosphorylation of AKT1 protein]; 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of AKT1 protein]; [AKT1 protein co-treated with 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole] inhibits the reaction [Arsenic Trioxide results in decreased expression of MCL1 protein]; [Arsenic Trioxide co-treated with IFNA2 protein co-treated with Docosahexaenoic Acids co-treated with Emodin] results in decreased expression of AKT1 protein; [Arsenic Trioxide results in increased expression of BCL2L11 protein] which results in decreased phosphorylation of AKT1 protein; [aspartyl-glutamyl-valyl-aspartal results in decreased activity of CASP3 protein] inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of AKT1 protein]; [Bortezomib results in decreased activity of CBL protein] promotes the reaction [Arsenic Trioxide results in increased activity of AKT1 protein]; [Sirolimus co-treated with Arsenic Trioxide] results in decreased phosphorylation of AKT1 protein; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased activity of AKT1 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of AKT1 protein]; AKT1 mutant form promotes the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; AKT1 mutant form promotes the reaction [Arsenic Trioxide results in increased cleavage of CASP9 protein]; AKT1 protein affects the reaction [Arsenic Trioxide affects the localization of SLC2A1 protein]; AKT1 protein affects the reaction [Arsenic Trioxide results in increased expression of CCND1 protein]; AKT1 protein affects the reaction [Arsenic Trioxide results in increased expression of CDC6 protein]; AKT1 protein inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of GSK3B protein]; AKT1 protein inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK1 protein]; AKT1 protein inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK3 protein]; AKT1 protein promotes the reaction [Arsenic Trioxide results in increased expression of TGIF1 mRNA]; Arsenic Trioxide affects the reaction [temsirolimus results in increased phosphorylation of AKT1 protein]; Arsenic Trioxide inhibits the reaction [AKT1 protein binds to MAPK8IP1 protein]; Arsenic Trioxide inhibits the reaction [lonidamine results in increased phosphorylation of AKT1 protein]; Arsenic Trioxide inhibits the reaction [Sirolimus results in increased phosphorylation of AKT1 protein]; Arsenic Trioxide inhibits the reaction [TGFB1 protein results in increased phosphorylation of AKT1 protein]; Arsenic Trioxide promotes the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of AKT1 protein]; Arsenic Trioxide promotes the reaction [AKT1 protein binds to PPP2CA protein]; Arsenic Trioxide promotes the reaction [Curcumin results in decreased phosphorylation of AKT1 protein]; Arsenic Trioxide promotes the reaction [tanespimycin results in decreased expression of AKT1 protein]; Arsenic Trioxide promotes the reaction [Tretinoin results in decreased expression of AKT1 protein]; Arsenic Trioxide results in decreased activity of and results in decreased expression of AKT1 protein; Arsenic Trioxide results in decreased phosphorylation of and results in decreased activity of AKT1 protein; Arsenic Trioxide results in increased phosphorylation of and results in increased activity of AKT1 protein; aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Arsenic Trioxide promotes the reaction [AKT1 protein binds to PPP2CA protein]]; benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [Arsenic Trioxide results in decreased expression of AKT1 protein]; Gemcitabine promotes the reaction [Arsenic Trioxide results in decreased phosphorylation of AKT1 protein]; Genistein inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of AKT1 protein]; MAPK8 protein affects the reaction [Arsenic Trioxide results in decreased phosphorylation of and results in decreased activity of AKT1 protein]; NSC 680410 promotes the reaction [Arsenic Trioxide results in decreased phosphorylation of AKT1 protein]; Okadaic Acid inhibits the reaction [Arsenic Trioxide promotes the reaction [AKT1 protein binds to PPP2CA protein]]; Okadaic Acid inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of AKT1 protein]; Palmitic Acid inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of AKT1 protein]; pyrazolanthrone inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of and results in decreased activity of AKT1 protein]; Rosiglitazone inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of AKT1 protein]; setanaxib inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of AKT1 protein]; tanespimycin promotes the reaction [Arsenic Trioxide results in decreased expression of AKT1 protein]; Taurine inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of AKT1 protein]; Tretinoin promotes the reaction [Arsenic Trioxide results in decreased expression of AKT1 protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Arsenic Trioxide results in decreased phosphorylation of AKT1 protein]; Arsenic Trioxide inhibits the reaction [AKT1 protein binds to PPARG protein]; Arsenic Trioxide inhibits the reaction [Glycerol results in increased phosphorylation of AKT1 protein]; Arsenic Trioxide promotes the reaction [Reserpine results in decreased phosphorylation of AKT1 protein]; Arsenic Trioxide results in increased expression of and results in increased phosphorylation of AKT1 protein; Genistein inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of AKT1 protein]; Taurine inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of AKT1 protein]
AKT1 protein results in decreased susceptibility to Arsenic Trioxide; AKT1 results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in decreased expression of and results in decreased phosphorylation of AKT1 protein; dapagliflozin inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of AKT1 protein]; Phloretin inhibits the reaction [Arsenic Trioxide results in decreased expression of AKT1 mRNA]; trans-sodium crocetinate inhibits the reaction [Arsenic Trioxide results in decreased expression of and results in decreased phosphorylation of AKT1 protein] 		CTD PMID:12168106 PMID:15688020 PMID:15916724 PMID:16115127 PMID:16434995 More... NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610 		JBrowse link
G Akt2 AKT serine/threonine kinase 2 decreases response to substance ISO AKT2 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:18048359 NCBI chr 1:92,004,705...92,061,420
Ensembl chr 1:92,014,859...92,061,420 		JBrowse link
G Alad aminolevulinate dehydratase multiple interactions
decreases expression 		ISO beta Carotene inhibits the reaction [Arsenic Trioxide results in decreased expression of ALAD protein] CTD PMID:25542264 NCBI chr 5:80,977,562...80,987,901
Ensembl chr 5:80,977,562...80,988,041 		JBrowse link
G Alas1 5'-aminolevulinate synthase 1 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of ALAS1 mRNA
[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of ALAS1 mRNA 		CTD PMID:15725085 PMID:15894607 PMID:29633893 NCBI chr 8:115,755,238...115,768,642
Ensembl chr 8:115,755,238...115,768,642 		JBrowse link
G Alas2 5'-aminolevulinate synthase 2 increases expression ISO Arsenic Trioxide results in increased expression of ALAS2 mRNA CTD PMID:20458559 NCBI chr  X:22,890,650...22,914,046
Ensembl chr  X:22,890,689...22,914,043 		JBrowse link
G Alb albumin multiple interactions
decreases expression 		ISO
EXP 		Arsenic Trioxide binds to and affects the folding of ALB protein
Arsenic Trioxide results in decreased expression of ALB protein
baicalin inhibits the reaction [Arsenic Trioxide results in decreased expression of ALB protein]
dapagliflozin inhibits the reaction [Arsenic Trioxide results in decreased expression of ALB protein] 		CTD PMID:25863441 PMID:35088608 PMID:38070468 NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865 		JBrowse link
G Aldh18a1 aldehyde dehydrogenase 18 family, member A1 increases expression ISO Arsenic Trioxide results in increased expression of ALDH18A1 mRNA CTD PMID:39716349 NCBI chr 1:249,325,082...249,357,383
Ensembl chr 1:249,325,082...249,357,383 		JBrowse link
G Aldh1a1 aldehyde dehydrogenase 1 family, member A1 multiple interactions
decreases expression 		ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ALDH1A1 protein]
Arsenic Trioxide results in decreased expression of ALDH1A1 mRNA 		CTD PMID:24061648 PMID:26598702 PMID:29633893 NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:227,427,070...227,579,500 		JBrowse link
G Aldh1a3 aldehyde dehydrogenase 1 family, member A3 increases expression
multiple interactions
decreases expression 		ISO Arsenic Trioxide results in increased expression of ALDH1A3 protein
Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ALDH1A3 protein]
Arsenic Trioxide results in decreased expression of ALDH1A3 mRNA 		CTD PMID:25419056 PMID:26598702 PMID:26705709 NCBI chr 1:129,392,516...129,436,552
Ensembl chr 1:129,392,516...129,427,777 		JBrowse link
G Aldh1b1 aldehyde dehydrogenase 1 family, member B1 increases expression ISO Arsenic Trioxide results in increased expression of ALDH1B1 mRNA CTD PMID:22521957 NCBI chr 5:64,859,000...64,864,008
Ensembl chr 5:64,858,934...64,864,365 		JBrowse link
G Aldh3a1 aldehyde dehydrogenase 3 family, member A1 multiple interactions
decreases response to substance
decreases expression
increases expression 		ISO ALDH3A1 protein inhibits the reaction [PML mutant form results in increased susceptibility to Arsenic Trioxide]
ALDH3A1 protein results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in decreased expression of ALDH3A1 mRNA
Arsenic Trioxide results in increased expression of ALDH3A1 mRNA 		CTD PMID:20707922 PMID:26118777 PMID:35676786 PMID:39716349 NCBI chr10:46,392,464...46,402,151
Ensembl chr10:46,392,411...46,402,151 		JBrowse link
G Aldh3a2 aldehyde dehydrogenase 3 family, member A2 increases expression
decreases response to substance 		ISO Arsenic Trioxide results in increased expression of ALDH3A2 mRNA
ALDH3A2 protein results in decreased susceptibility to Arsenic Trioxide 		CTD PMID:20458559 PMID:20707922 NCBI chr10:46,427,789...46,448,449
Ensembl chr10:46,407,993...46,448,648 		JBrowse link
G Aldh3b1 aldehyde dehydrogenase 3 family, member B1 decreases response to substance ISO ALDH3B1 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 1:210,574,545...210,605,188
Ensembl chr 1:210,573,661...210,610,538 		JBrowse link
G Aldh4a1 aldehyde dehydrogenase 4 family, member A1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ALDH4A1 protein] CTD PMID:26598702 NCBI chr 5:157,163,189...157,188,673
Ensembl chr 5:157,162,945...157,188,673 		JBrowse link
G Aldh6a1 aldehyde dehydrogenase 6 family, member A1 decreases expression ISO Arsenic Trioxide results in decreased expression of ALDH6A1 mRNA CTD PMID:17547211 NCBI chr 6:109,809,092...109,829,725
Ensembl chr 6:109,809,122...109,829,743 		JBrowse link
G Aldh7a1 aldehyde dehydrogenase 7 family, member A1 decreases expression ISO Arsenic Trioxide results in decreased expression of ALDH7A1 mRNA CTD PMID:26705709 PMID:39716349 NCBI chr18:52,208,035...52,240,293
Ensembl chr18:52,204,161...52,240,467 		JBrowse link
G Aldh8a1 aldehyde dehydrogenase 8 family, member A1 decreases expression ISO Arsenic Trioxide results in decreased expression of ALDH8A1 mRNA CTD PMID:25424538 NCBI chr 1:18,003,507...18,022,952
Ensembl chr 1:18,003,514...18,023,883 		JBrowse link
G Aldoa aldolase, fructose-bisphosphate A multiple interactions
decreases expression 		ISO [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of ALDOA mRNA
Arsenic Trioxide results in decreased expression of ALDOA protein 		CTD PMID:15894607 NCBI chr 1:190,832,820...190,838,021
Ensembl chr 1:190,832,820...190,838,211 		JBrowse link
G Aldoc aldolase, fructose-bisphosphate C decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of ALDOC mRNA
Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ALDOC protein] 		CTD PMID:15725085 PMID:26598702 NCBI chr10:63,715,544...63,719,133
Ensembl chr10:63,715,489...63,719,133 		JBrowse link
G Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit increases expression ISO Arsenic Trioxide results in increased expression of ALG13 mRNA CTD PMID:15761015 NCBI chr  X:112,703,015...112,764,924
Ensembl chr  X:112,702,796...112,739,356 		JBrowse link
G Alkbh4 alkB homolog 4, lysine demethylase multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ALKBH4 protein] CTD PMID:26598702 NCBI chr12:26,160,643...26,166,560
Ensembl chr12:26,160,643...26,166,560 		JBrowse link
G Alkbh5 alkB homolog 5, RNA demethylase increases expression ISO Arsenic Trioxide results in increased expression of ALKBH5 protein CTD PMID:35226250 NCBI chr10:45,844,411...45,865,853
Ensembl chr10:45,843,656...45,869,658 		JBrowse link
G Alox15 arachidonate 15-lipoxygenase decreases expression ISO Arsenic Trioxide results in decreased expression of ALOX15 mRNA CTD PMID:35676786 PMID:38758479 NCBI chr10:55,559,060...55,567,535
Ensembl chr10:55,559,061...55,567,723 		JBrowse link
G Alox5 arachidonate 5-lipoxygenase decreases expression ISO Arsenic Trioxide results in decreased expression of ALOX5 mRNA CTD PMID:38758479 NCBI chr 4:151,203,948...151,251,126
Ensembl chr 4:151,203,949...151,251,126 		JBrowse link
G Alox5ap arachidonate 5-lipoxygenase activating protein increases expression
decreases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of ALOX5AP mRNA
Arsenic Trioxide results in decreased expression of ALOX5AP mRNA
[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of ALOX5AP mRNA 		CTD PMID:15070760 PMID:15761015 PMID:15894607 PMID:19128835 NCBI chr12:10,785,254...10,809,295
Ensembl chr12:10,785,257...10,817,038 		JBrowse link
G Alpk2 alpha-kinase 2 decreases expression ISO Arsenic Trioxide results in decreased expression of ALPK2 mRNA CTD PMID:35676786 NCBI chr18:61,045,717...61,161,703
Ensembl chr18:61,045,380...61,175,985 		JBrowse link
G Alpl alkaline phosphatase, biomineralization associated decreases expression EXP Arsenic Trioxide results in decreased expression of ALPL mRNA CTD PMID:22465848 NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:155,234,775...155,254,167 		JBrowse link
G Alpp alkaline phosphatase, placental decreases expression ISO Arsenic Trioxide results in decreased expression of ALPP protein CTD PMID:30093655 NCBI chr 9:95,213,763...95,216,509
Ensembl chr 9:95,213,374...95,219,451 		JBrowse link
G Als2 alsin Rho guanine nucleotide exchange factor ALS2 decreases expression ISO Arsenic Trioxide results in decreased expression of ALS2 mRNA CTD PMID:24831965 NCBI chr 9:68,107,310...68,180,192
Ensembl chr 9:68,107,528...68,179,660 		JBrowse link
G Als2cl ALS2 C-terminal like increases expression ISO Arsenic Trioxide results in increased expression of ALS2CL mRNA CTD PMID:39716349 NCBI chr 8:119,746,498...119,762,824
Ensembl chr 8:119,743,248...119,762,843 		JBrowse link
G Alx4 ALX homeobox 4 increases expression ISO Arsenic Trioxide results in increased expression of ALX4 mRNA CTD PMID:20458559 NCBI chr 3:100,067,052...100,103,624
Ensembl chr 3:100,067,052...100,103,624 		JBrowse link
G Amacr alpha-methylacyl-CoA racemase decreases expression ISO Arsenic Trioxide results in decreased expression of AMACR mRNA CTD PMID:26705709 PMID:39716349 NCBI chr 2:61,673,291...61,685,381
Ensembl chr 2:61,670,475...61,685,379 		JBrowse link
G Ambp alpha-1-microglobulin/bikunin precursor increases expression ISO Arsenic Trioxide results in increased expression of AMBP mRNA CTD PMID:27829220 NCBI chr 5:81,583,621...81,593,938
Ensembl chr 5:81,583,622...81,593,850 		JBrowse link
G Amd1 adenosylmethionine decarboxylase 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to AMD1 protein] CTD PMID:26598702 NCBI chr20:45,250,289...45,324,939
Ensembl chr20:45,250,289...45,265,982 		JBrowse link
G Amfr autocrine motility factor receptor decreases response to substance ISO AMFR protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr19:11,002,451...11,038,182
Ensembl chr19:11,002,101...11,038,364 		JBrowse link
G Amot angiomotin decreases expression ISO Arsenic Trioxide results in decreased expression of AMOT mRNA CTD PMID:26705709 NCBI chr  X:113,778,990...113,837,846
Ensembl chr  X:113,781,526...113,837,482 		JBrowse link
G Anapc5 anaphase-promoting complex subunit 5 decreases expression ISO Arsenic Trioxide results in decreased expression of ANAPC5 mRNA CTD PMID:39716349 NCBI chr12:39,409,519...39,442,518
Ensembl chr12:39,385,399...39,442,762 		JBrowse link
G Angpt1 angiopoietin 1 decreases expression ISO Arsenic Trioxide results in decreased expression of ANGPT1 mRNA CTD PMID:20458559 NCBI chr 7:75,415,959...75,668,696
Ensembl chr 7:75,418,218...75,668,696 		JBrowse link
G Angpt2 angiopoietin 2 increases expression ISO Arsenic Trioxide results in increased expression of ANGPT2 mRNA CTD PMID:20458559 PMID:36801614 NCBI chr16:77,790,760...77,841,241
Ensembl chr16:77,790,563...77,841,239 		JBrowse link
G Angptl1 angiopoietin-like 1 decreases expression ISO Arsenic Trioxide results in decreased expression of ANGPTL1 mRNA CTD PMID:26705709 NCBI chr13:71,463,913...71,531,810
Ensembl chr13:71,511,727...71,531,818 		JBrowse link
G Angptl7 angiopoietin like 7 decreases expression ISO Arsenic Trioxide results in decreased expression of ANGPTL7 mRNA CTD PMID:35676786 NCBI chr 5:164,215,223...164,220,408
Ensembl chr 5:164,215,223...164,220,584 		JBrowse link
G Ank3 ankyrin 3 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of ANK3 mRNA
Arsenic Trioxide results in decreased expression of ANK3 mRNA 		CTD PMID:15761015 NCBI chr20:18,601,307...19,224,790
Ensembl chr20:18,601,826...19,084,879 		JBrowse link
G Ankhd1 ankyrin repeat and KH domain containing 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ANKHD1 protein] CTD PMID:26598702 NCBI chr18:28,436,296...28,534,954
Ensembl chr18:28,436,394...28,534,954 		JBrowse link
G Ankib1 ankyrin repeat and IBR domain containing 1 increases expression ISO Arsenic Trioxide results in increased expression of ANKIB1 mRNA CTD PMID:20458559 NCBI chr 4:31,288,393...31,412,500
Ensembl chr 4:31,288,142...31,412,504 		JBrowse link
G Ankrd11 ankyrin repeat domain containing 11 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of ANKRD11 mRNA
Arsenic Trioxide results in decreased expression of ANKRD11 mRNA 		CTD PMID:20458559 PMID:22521957 NCBI chr19:67,848,836...68,007,491
Ensembl chr19:67,848,844...68,007,491 		JBrowse link
G Ankrd12 ankyrin repeat domain 12 increases expression ISO Arsenic Trioxide results in increased expression of ANKRD12 mRNA CTD PMID:15761015 NCBI chr 9:113,030,127...113,134,816
Ensembl chr 9:113,030,919...113,134,762 		JBrowse link
G Ankrd2 ankyrin repeat domain 2 decreases response to substance ISO ANKRD2 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 1:250,796,419...250,805,867
Ensembl chr 1:250,796,409...250,805,870 		JBrowse link
G Ankrd23 ankyrin repeat domain 23 increases expression ISO Arsenic Trioxide results in increased expression of ANKRD23 mRNA CTD PMID:39716349 NCBI chr 9:46,269,107...46,274,578
Ensembl chr 9:46,269,107...46,274,510 		JBrowse link
G Ankrd28 ankyrin repeat domain 28 increases expression ISO Arsenic Trioxide results in increased expression of ANKRD28 mRNA CTD PMID:39716349 NCBI chr16:6,924,868...7,056,593
Ensembl chr16:6,924,882...7,056,593 		JBrowse link
G Ankrd29 ankyrin repeat domain 29 decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of ANKRD29 mRNA
Arsenic Trioxide results in increased expression of ANKRD29 mRNA 		CTD PMID:20458559 PMID:35676786 NCBI chr18:3,711,052...3,768,997
Ensembl chr18:3,711,059...3,769,098 		JBrowse link
G Ankrd39 ankyrin repeat domain 39 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ANKRD39 protein] CTD PMID:26598702 NCBI chr 9:46,277,659...46,286,050
Ensembl chr 9:46,279,952...46,286,043 		JBrowse link
G Ankrd40 ankyrin repeat domain 40 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ANKRD40 protein] CTD PMID:26598702 NCBI chr10:79,778,966...79,792,212
Ensembl chr10:56,415,260...56,416,345
Ensembl chr10:56,415,260...56,416,345 		JBrowse link
G Ankrd54 ankyrin repeat domain 54 increases expression ISO Arsenic Trioxide results in increased expression of ANKRD54 mRNA CTD PMID:39716349 NCBI chr 7:112,495,396...112,508,186
Ensembl chr 7:112,495,462...112,508,128 		JBrowse link
G Ankrd6 ankyrin repeat domain 6 increases expression ISO Arsenic Trioxide results in increased expression of ANKRD6 mRNA CTD PMID:27829220 NCBI chr 5:51,999,225...52,139,623
Ensembl chr 5:51,999,221...52,139,594 		JBrowse link
G Anks1a ankyrin repeat and sterile alpha motif domain containing 1A multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ANKS1A protein] CTD PMID:26598702 NCBI chr20:5,965,421...6,118,875
Ensembl chr20:5,965,028...6,118,875 		JBrowse link
G Anks1b ankyrin repeat and sterile alpha motif domain containing 1B decreases expression ISO Arsenic Trioxide results in decreased expression of ANKS1B mRNA CTD PMID:24831965 NCBI chr 7:26,200,649...27,366,552
Ensembl chr 7:26,201,240...27,364,943 		JBrowse link
G Ano3 anoctamin 3 decreases expression ISO Arsenic Trioxide results in decreased expression of ANO3 mRNA CTD PMID:26705709 PMID:39716349 NCBI chr 3:117,690,242...118,004,695
Ensembl chr 3:117,692,103...118,004,675 		JBrowse link
G Ano4 anoctamin 4 decreases expression ISO Arsenic Trioxide results in decreased expression of ANO4 mRNA CTD PMID:35676786 NCBI chr 7:25,216,389...25,625,811
Ensembl chr 7:25,216,389...25,625,746 		JBrowse link
G Anp32b acidic nuclear phosphoprotein 32 family member B increases expression ISO Arsenic Trioxide results in increased expression of ANP32B mRNA CTD PMID:20458559 NCBI chr 5:65,538,872...65,561,305
Ensembl chr 5:65,538,535...65,561,437 		JBrowse link
G Anpep alanyl aminopeptidase, membrane decreases expression ISO Arsenic Trioxide results in decreased expression of ANPEP mRNA CTD PMID:15949261 NCBI chr 1:143,176,645...143,219,447
Ensembl chr 1:143,176,645...143,195,101 		JBrowse link
G Antxr1 ANTXR cell adhesion molecule 1 increases expression ISO Arsenic Trioxide results in increased expression of ANTXR1 mRNA CTD PMID:22521957 NCBI chr 4:121,148,102...121,335,549
Ensembl chr 4:121,148,103...121,336,892 		JBrowse link
G Anxa1 annexin A1 decreases expression
increases response to substance
increases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of ANXA1 protein
ANXA1 mutant form results in increased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in increased expression of ANXA1 mRNA; Arsenic Trioxide results in increased expression of ANXA1 protein
Arsenic Trioxide results in increased expression of and results in increased secretion of ANXA1 protein 		CTD PMID:18081892 PMID:22521957 PMID:25258189 PMID:25983101 NCBI chr 1:227,287,713...227,306,739
Ensembl chr 1:227,287,717...227,306,831 		JBrowse link
G Anxa11 annexin A11 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ANXA11 protein] CTD PMID:26598702 NCBI chr16:1,419,627...1,464,590
Ensembl chr16:1,418,351...1,464,839 		JBrowse link
G Anxa2 annexin A2 multiple interactions
increases expression
decreases response to substance
decreases expression 		ISO Arsenic Trioxide affects the localization of and results in decreased expression of ANXA2 protein; Arsenic Trioxide results in decreased expression of and results in increased degradation of ANXA2 mRNA
Arsenic Trioxide results in increased expression of ANXA2 mRNA
ANXA2 protein results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in decreased expression of ANXA2 mRNA; Arsenic Trioxide results in decreased expression of ANXA2 protein 		CTD PMID:12165291 PMID:17547211 PMID:19642359 PMID:19781379 PMID:20707922 More... NCBI chr 8:78,986,252...79,022,638
Ensembl chr 8:78,986,242...79,022,631 		JBrowse link
G Anxa3 annexin A3 decreases response to substance ISO ANXA3 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr14:13,031,675...13,085,678
Ensembl chr14:13,023,762...13,085,849 		JBrowse link
G Anxa9 annexin A9 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ANXA9 protein] CTD PMID:26598702 NCBI chr 2:185,562,174...185,572,560
Ensembl chr 2:185,562,174...185,572,560 		JBrowse link
G Aoc3 amine oxidase, copper containing 3 increases expression ISO Arsenic Trioxide results in increased expression of AOC3 mRNA CTD PMID:25258189 NCBI chr10:86,773,018...86,780,961 JBrowse link
G Aopep aminopeptidase O increases expression ISO Arsenic Trioxide results in increased expression of AOPEP mRNA CTD PMID:22521957 NCBI chr17:1,817,001...2,133,008
Ensembl chr17:1,817,001...2,133,104 		JBrowse link
G Ap1s1 adaptor related protein complex 1 subunit sigma 1 increases expression ISO Arsenic Trioxide results in increased expression of AP1S1 mRNA CTD PMID:17258074 NCBI chr12:25,261,958...25,272,483
Ensembl chr12:25,262,036...25,272,483 		JBrowse link
G Ap2b1 adaptor related protein complex 2 subunit beta 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to AP2B1 protein] CTD PMID:26598702 NCBI chr10:68,596,925...68,702,547
Ensembl chr10:68,597,093...68,702,539 		JBrowse link
G Ap2m1 adaptor related protein complex 2 subunit mu 1 multiple interactions ISO [Arsenic Trioxide co-treated with nilotinib] affects the expression of AP2M1 mRNA CTD PMID:28786057 NCBI chr11:93,859,690...93,868,600
Ensembl chr11:93,859,690...93,868,480 		JBrowse link
G Ap3s1 adaptor related protein complex 3 subunit sigma 1 decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of AP3S1 mRNA
Arsenic Trioxide results in increased expression of AP3S1 mRNA 		CTD PMID:15761015 PMID:20458559 NCBI chr18:41,649,321...41,718,221
Ensembl chr18:41,648,796...41,767,641 		JBrowse link
G Apaf1 apoptotic peptidase activating factor 1 increases expression
multiple interactions 		ISO
EXP 		Arsenic Trioxide results in increased expression of APAF1 protein
Arsenic Trioxide results in increased expression of APAF1 mRNA
[Erlotinib Hydrochloride co-treated with Arsenic Trioxide] results in increased expression of APAF1 mRNA; [ruxolitinib co-treated with Arsenic Trioxide] results in increased expression of APAF1 mRNA 		CTD PMID:19730151 PMID:25258189 PMID:29274334 PMID:30012499 NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:27,381,855...27,466,772 		JBrowse link
G Apbb1 amyloid beta precursor protein binding family B member 1 decreases expression ISO Arsenic Trioxide results in decreased expression of APBB1 mRNA CTD PMID:19128835 PMID:22521957 NCBI chr 1:169,308,719...169,332,372
Ensembl chr 1:169,308,720...169,332,552 		JBrowse link
G Apbb1ip amyloid beta precursor protein binding family B member 1 interacting protein increases expression ISO Arsenic Trioxide results in increased expression of APBB1IP mRNA CTD PMID:20458559 NCBI chr17:89,849,474...89,941,099
Ensembl chr17:89,671,716...89,941,089 		JBrowse link
G Apbb2 amyloid beta precursor protein binding family B member 2 increases expression ISO Arsenic Trioxide results in increased expression of APBB2 mRNA CTD PMID:26705709 PMID:35676786 NCBI chr14:41,849,638...42,232,930
Ensembl chr14:41,911,785...42,232,280 		JBrowse link
G Aplp1 amyloid beta precursor like protein 1 decreases expression ISO Arsenic Trioxide results in decreased expression of APLP1 mRNA CTD PMID:39716349 NCBI chr 1:94,824,330...94,834,705
Ensembl chr 1:94,824,072...94,834,610 		JBrowse link
G Aplp2 amyloid beta precursor like protein 2 multiple interactions
increases expression 		ISO [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of APLP2 mRNA
Arsenic Trioxide results in increased expression of APLP2 mRNA 		CTD PMID:15894607 PMID:27829220 NCBI chr 8:37,857,407...37,920,487
Ensembl chr 8:37,857,407...37,920,031 		JBrowse link
G Apoe apolipoprotein E multiple interactions
decreases expression 		ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to APOE protein]
Arsenic Trioxide results in decreased expression of APOE mRNA
Arsenic Trioxide affects the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the cleavage of CASP3 protein]; Arsenic Trioxide affects the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the cleavage of IL1B protein]; Arsenic Trioxide affects the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of CD36 mRNA]; Arsenic Trioxide affects the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of CD36 protein]; Arsenic Trioxide affects the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of IL10 mRNA]; Arsenic Trioxide affects the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of IL10 protein]; Arsenic Trioxide affects the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of IL1B mRNA]; Arsenic Trioxide affects the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of IL6 mRNA]; Arsenic Trioxide affects the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of IL6 protein]; Arsenic Trioxide affects the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of NLRP3 mRNA]; Arsenic Trioxide affects the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of NLRP3 protein]; Arsenic Trioxide affects the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of TNF mRNA] 		CTD PMID:22521957 PMID:26598702 PMID:38237221 NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:88,481,385...88,485,855 		JBrowse link
G App amyloid beta precursor protein increases expression ISO Arsenic Trioxide results in increased expression of APP mRNA CTD PMID:20458559 NCBI chr11:37,506,207...37,724,351
Ensembl chr11:37,506,408...37,722,971 		JBrowse link
G Aptx aprataxin multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to APTX protein] CTD PMID:26598702 NCBI chr 5:60,593,338...60,618,946
Ensembl chr 5:60,597,648...60,618,790 		JBrowse link
G Aqp1 aquaporin 1 decreases expression ISO Arsenic Trioxide results in decreased expression of AQP1 mRNA CTD PMID:26705709 NCBI chr 4:85,812,784...85,824,964
Ensembl chr 4:85,812,784...85,830,504 		JBrowse link
G Aqp10 aquaporin 10 increases expression ISO Arsenic Trioxide results in increased expression of AQP10 mRNA CTD PMID:22214486 NCBI chr 2:177,699,717...177,704,620
Ensembl chr 2:177,700,943...177,704,495 		JBrowse link
G Aqp3 aquaporin 3 (Gill blood group) increases expression
affects response to substance 		ISO Arsenic Trioxide results in increased expression of AQP3 mRNA
AQP3 gene mutant form affects the susceptibility to Arsenic Trioxide 		CTD PMID:22214486 PMID:30815697 PMID:38758479 NCBI chr 5:61,035,165...61,040,683
Ensembl chr 5:61,035,166...61,040,685 		JBrowse link
G Aqp4 aquaporin 4 increases expression ISO Arsenic Trioxide results in increased expression of AQP4 mRNA CTD PMID:22214486 NCBI chr18:6,782,389...6,799,034
Ensembl chr18:6,782,389...6,799,098 		JBrowse link
G Aqp7 aquaporin 7 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of AQP7 mRNA
[Arsenic Trioxide co-treated with Glucose] results in increased expression of AQP7 mRNA; [Arsenic Trioxide co-treated with Glucose] results in increased expression of AQP7 protein; INS protein inhibits the reaction [[Arsenic Trioxide co-treated with Glucose] results in increased expression of AQP7 mRNA]; INS protein inhibits the reaction [[Arsenic Trioxide co-treated with Glucose] results in increased expression of AQP7 protein] 		CTD PMID:37146668 PMID:38758479 NCBI chr 5:60,968,495...60,982,618
Ensembl chr 5:60,967,558...60,982,618 		JBrowse link
G Aqp9 aquaporin 9 increases response to substance
increases uptake
affects expression
increases expression
increases import
multiple interactions 		ISO AQP9 protein results in increased susceptibility to Arsenic Trioxide
AQP9 protein results in increased uptake of Arsenic Trioxide
Arsenic Trioxide affects the expression of AQP9 protein
Arsenic Trioxide results in increased expression of AQP9 protein
AQP9 protein results in increased import of Arsenic Trioxide
[Azacitidine results in increased expression of AQP9 mRNA] which results in increased uptake of Arsenic Trioxide; [CSF3 protein results in increased expression of AQP9 mRNA] which results in increased uptake of Arsenic Trioxide; [CSF3 protein results in increased expression of AQP9 protein] which results in increased uptake of Arsenic Trioxide; [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of AQP9 mRNA; [Tretinoin results in increased expression of AQP9 mRNA] which results in increased import of Arsenic Trioxide; [Tretinoin results in increased expression of AQP9 mRNA] which results in increased susceptibility to Arsenic Trioxide; AQP9 protein affects the reaction [Arsenic Trioxide promotes the reaction [Tretinoin results in decreased expression of and results in increased degradation of PIN1 protein]]; AQP9 protein affects the reaction [PIN1 protein affects the susceptibility to Arsenic Trioxide]; AQP9 protein affects the reaction [Tretinoin promotes the reaction [Arsenic Trioxide results in decreased expression of and results in increased degradation of PIN1 protein]]; AQP9 protein affects the uptake of and affects the susceptibility to Arsenic Trioxide; AQP9 protein promotes the reaction [CSF3 protein results in increased uptake of Arsenic Trioxide]; AQP9 protein results in increased uptake of and results in increased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in increased expression of AQP9 mRNA 		CTD PMID:15336539 PMID:16968895 PMID:19100828 PMID:19225113 PMID:21945491 More... NCBI chr 8:80,678,027...80,718,273
Ensembl chr 8:80,678,030...80,717,240 		JBrowse link
G Ar androgen receptor decreases expression
multiple interactions
decreases activity 		ISO Arsenic Trioxide results in decreased expression of AR mRNA
Arsenic Trioxide results in decreased expression of AR protein
Arsenic Trioxide inhibits the reaction [Metribolone promotes the reaction [AR protein binds to KLK3 promoter]]
Arsenic Trioxide results in decreased activity of AR protein 		CTD PMID:19131511 PMID:19769630 PMID:28956719 NCBI chr  X:67,135,317...67,304,476
Ensembl chr  X:67,135,317...67,304,467 		JBrowse link
G Arc activity-regulated cytoskeleton-associated protein decreases expression EXP Arsenic Trioxide results in decreased expression of ARC mRNA CTD PMID:29223816 NCBI chr 7:108,444,959...108,448,413
Ensembl chr 7:108,444,692...108,451,220 		JBrowse link
G Arf1 ARF GTPase 1 increases expression ISO Arsenic Trioxide results in increased expression of ARF1 mRNA CTD PMID:20458559 PMID:39716349 NCBI chr10:44,497,543...44,513,994 JBrowse link
G Arfgap3 ARF GTPase activating protein 3 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ARFGAP3 protein] CTD PMID:26598702 NCBI chr 7:116,312,996...116,359,300
Ensembl chr 7:116,313,001...116,359,592 		JBrowse link
G Arfip1 ARF interacting protein 1 increases expression ISO Arsenic Trioxide results in increased expression of ARFIP1 mRNA CTD PMID:20458559 NCBI chr 2:172,141,862...172,224,464
Ensembl chr 2:172,141,859...172,221,280 		JBrowse link
G Arfip2 ARF interacting protein 2 increases expression ISO Arsenic Trioxide results in increased expression of ARFIP2 mRNA CTD PMID:25258189 NCBI chr 1:169,387,484...169,392,290
Ensembl chr 1:169,387,485...169,392,166 		JBrowse link
G Arg1 arginase 1 decreases expression ISO Arsenic Trioxide results in decreased expression of ARG1 mRNA CTD PMID:28454374 NCBI chr 1:22,295,093...22,307,720
Ensembl chr 1:22,295,322...22,307,713 		JBrowse link
G Arhgap1 Rho GTPase activating protein 1 increases expression ISO Arsenic Trioxide results in increased expression of ARHGAP1 protein CTD PMID:25419056 NCBI chr 3:98,077,064...98,099,163
Ensembl chr 3:98,077,150...98,099,154 		JBrowse link
G Arhgap18 Rho GTPase activating protein 18 decreases expression ISO Arsenic Trioxide results in decreased expression of ARHGAP18 mRNA CTD PMID:27829220 NCBI chr 1:20,222,948...20,456,827
Ensembl chr 1:20,222,954...20,456,670 		JBrowse link
G Arhgap19 Rho GTPase activating protein 19 increases response to substance ISO ARHGAP19 protein results in increased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 1:250,519,703...250,566,705
Ensembl chr 1:250,530,214...250,580,190 		JBrowse link
G Arhgap21 Rho GTPase activating protein 21 increases expression ISO Arsenic Trioxide results in increased expression of ARHGAP21 mRNA CTD PMID:20458559 NCBI chr17:88,256,961...88,380,478
Ensembl chr17:88,256,961...88,380,797 		JBrowse link
G Arhgap26 Rho GTPase activating protein 26 multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of ARHGAP26 mRNA CTD PMID:15894607 NCBI chr18:30,702,602...31,489,047
Ensembl chr18:31,089,787...31,489,047 		JBrowse link
G Arhgap39 Rho GTPase activating protein 39 increases expression ISO Arsenic Trioxide results in increased expression of ARHGAP39 mRNA CTD PMID:39716349 NCBI chr 7:110,326,918...110,419,500
Ensembl chr 7:110,326,918...110,419,460 		JBrowse link
G Arhgap5 Rho GTPase activating protein 5 increases expression ISO Arsenic Trioxide results in increased expression of ARHGAP5 mRNA CTD PMID:20458559 NCBI chr 6:75,711,199...75,774,636
Ensembl chr 6:75,711,515...75,774,636 		JBrowse link
G Arhgap9 Rho GTPase activating protein 9 multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of ARHGAP9 mRNA CTD PMID:15894607 NCBI chr 7:65,034,023...65,042,336
Ensembl chr 7:65,034,144...65,042,336 		JBrowse link
G Arhgdib Rho GDP dissociation inhibitor beta increases expression ISO Arsenic Trioxide results in increased expression of ARHGDIB mRNA CTD PMID:20458559 NCBI chr 4:171,554,139...171,573,057
Ensembl chr 4:171,554,140...171,573,068 		JBrowse link
G Arhgef11 Rho guanine nucleotide exchange factor 11 increases expression ISO Arsenic Trioxide results in increased expression of ARHGEF11 mRNA CTD PMID:39716349 NCBI chr 2:175,372,269...175,493,852
Ensembl chr 2:175,372,290...175,493,852 		JBrowse link
G Arid1a AT-rich interaction domain 1A increases sumoylation
increases response to substance 		ISO Arsenic Trioxide results in increased sumoylation of ARID1A protein
ARID1A protein results in increased susceptibility to Arsenic Trioxide 		CTD PMID:20707922 PMID:28318385 NCBI chr 5:151,192,014...151,269,291
Ensembl chr 5:151,192,014...151,265,386 		JBrowse link
G Arid1b AT-rich interaction domain 1B decreases expression ISO Arsenic Trioxide results in decreased expression of ARID1B mRNA CTD PMID:20458559 NCBI chr 1:47,973,199...48,328,793
Ensembl chr 1:47,973,997...48,328,793 		JBrowse link
G Arid2 AT-rich interaction domain 2 increases expression ISO Arsenic Trioxide results in increased expression of ARID2 mRNA CTD PMID:39716349 NCBI chr 7:129,326,371...129,443,813
Ensembl chr 7:129,324,137...129,443,187 		JBrowse link
G Arid4a AT-rich interaction domain 4A increases expression ISO Arsenic Trioxide results in increased expression of ARID4A mRNA CTD PMID:35676786 NCBI chr 6:95,258,429...95,335,987
Ensembl chr 6:95,258,429...95,329,840 		JBrowse link
G Arid4b AT-rich interaction domain 4B increases response to substance ISO ARID4B protein results in increased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr17:55,833,908...55,958,382
Ensembl chr17:55,833,908...55,958,382 		JBrowse link
G Arid5b AT-rich interaction domain 5B decreases expression ISO Arsenic Trioxide results in decreased expression of ARID5B mRNA CTD PMID:27829220 NCBI chr20:20,305,693...20,489,689
Ensembl chr20:20,306,712...20,489,686 		JBrowse link
G Arl13b ARF like GTPase 13B decreases expression ISO Arsenic Trioxide results in decreased expression of ARL13B mRNA CTD PMID:39716349 NCBI chr11:13,597,538...13,663,681
Ensembl chr11:13,597,538...13,663,546 		JBrowse link
G Arl3 ARF like GTPase 3 decreases expression ISO Arsenic Trioxide results in decreased expression of ARL3 mRNA CTD PMID:35676786 NCBI chr 1:255,342,078...255,388,087
Ensembl chr 1:255,342,076...255,388,279 		JBrowse link
G Arl4c ARF like GTPase 4C decreases expression ISO Arsenic Trioxide results in decreased expression of ARL4C mRNA CTD PMID:15725085 NCBI chr 9:96,748,075...96,751,510
Ensembl chr 9:96,745,069...96,752,772 		JBrowse link
G Arl5b ARF like GTPase 5B increases expression ISO Arsenic Trioxide results in increased expression of ARL5B mRNA CTD PMID:22521957 NCBI chr17:82,864,315...82,888,458
Ensembl chr17:82,864,287...82,890,646 		JBrowse link
G Arl6ip1 ARL6 interacting reticulophagy regulator 1 increases expression ISO Arsenic Trioxide results in increased expression of ARL6IP1 mRNA CTD PMID:14703492 NCBI chr 1:181,864,717...181,874,232
Ensembl chr 1:181,864,746...181,874,232 		JBrowse link
G Arl6ip5 ARF like GTPase 6 interacting protein 5 increases response to substance
increases expression
multiple interactions 		ISO ARL6IP5 protein results in increased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in increased expression of ARL6IP5 protein
[Arsenic Trioxide results in increased abundance of Hydrogen Peroxide] which results in increased expression of ARL6IP5 protein; [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of ARL6IP5 mRNA; ARL6IP5 protein promotes the reaction [Arsenic Trioxide results in increased cleavage of CASP9 protein]; ARL6IP5 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK1 protein]; ARL6IP5 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK3 protein]; CAT protein inhibits the reaction [[Arsenic Trioxide results in increased abundance of Hydrogen Peroxide] which results in increased expression of ARL6IP5 protein] 		CTD PMID:16430862 PMID:16468075 PMID:18387645 NCBI chr 4:131,365,320...131,395,311
Ensembl chr 4:131,367,289...131,400,130 		JBrowse link
G Arl8b ARF like GTPase 8B multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ARL8B protein] CTD PMID:26598702 NCBI chr 4:143,304,597...143,348,580
Ensembl chr 4:143,304,621...143,349,068 		JBrowse link
G Armc8 armadillo repeat containing 8 increases expression ISO Arsenic Trioxide results in increased expression of ARMC8 mRNA CTD PMID:20458559 NCBI chr 8:108,916,274...109,010,877
Ensembl chr 8:108,916,274...109,010,717 		JBrowse link
G Armc9 armadillo repeat containing 9 decreases expression ISO Arsenic Trioxide results in decreased expression of ARMC9 mRNA CTD PMID:15761015 NCBI chr 9:94,250,492...94,376,589
Ensembl chr 9:94,250,859...94,376,589 		JBrowse link
G Armcx3 armadillo repeat containing, X-linked 3 increases expression ISO Arsenic Trioxide results in increased expression of ARMCX3 protein CTD PMID:30093655 NCBI chr  X:102,230,464...102,234,017
Ensembl chr  X:102,219,848...102,263,297 		JBrowse link
G Arnt2 aryl hydrocarbon receptor nuclear translocator 2 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of ARNT2 mRNA
Arsenic Trioxide results in decreased expression of ARNT2 mRNA 		CTD PMID:20458559 PMID:35676786 NCBI chr 1:147,645,354...147,801,986
Ensembl chr 1:147,599,058...147,801,997 		JBrowse link
G Arpc1b actin related protein 2/3 complex, subunit 1B multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of ARPC1B mRNA CTD PMID:15894607 NCBI chr12:14,595,939...14,609,501
Ensembl chr12:14,595,678...14,609,504 		JBrowse link
G Arpc3 actin related protein 2/3 complex, subunit 3 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of ARPC3 protein
Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ARPC3 protein] 		CTD PMID:25419056 PMID:26598702 NCBI chr12:39,833,569...39,847,436
Ensembl chr12:39,833,569...39,847,436 		JBrowse link
G Arpc5l actin related protein 2/3 complex, subunit 5-like multiple interactions
decreases expression 		ISO Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of ARPC5L mRNA] CTD PMID:29095437 NCBI chr 3:43,169,518...43,177,224
Ensembl chr 3:43,169,462...43,177,240
Ensembl chr 9:43,169,462...43,177,240 		JBrowse link
G Arpp19 cAMP-regulated phosphoprotein 19 multiple interactions
increases expression 		ISO [Dasatinib co-treated with Arsenic Trioxide] results in decreased expression of ARPP19 mRNA; Arsenic Trioxide inhibits the reaction [Dasatinib results in increased expression of ARPP19 mRNA]
Arsenic Trioxide results in increased expression of ARPP19 mRNA 		CTD PMID:29266867 NCBI chr 8:84,660,166...84,683,012
Ensembl chr 8:119,691,942...119,692,385
Ensembl chr 8:119,691,942...119,692,385 		JBrowse link
G Arrdc2 arrestin domain containing 2 increases expression ISO Arsenic Trioxide results in increased expression of ARRDC2 mRNA CTD PMID:35676786 NCBI chr16:18,635,883...18,640,019
Ensembl chr16:18,635,883...18,640,158 		JBrowse link
G Arrdc3 arrestin domain containing 3 increases expression ISO Arsenic Trioxide results in increased expression of ARRDC3 mRNA CTD PMID:20458559 PMID:24356939 NCBI chr 2:12,873,202...12,885,716
Ensembl chr 2:12,873,202...12,885,875 		JBrowse link
G Arxes1 adipocyte-related X-chromosome expressed sequence 1 decreases expression ISO Arsenic Trioxide results in decreased expression of ARXES1 mRNA CTD PMID:35676786 NCBI chr  X:103,742,157...103,743,676 JBrowse link
G As3mt arsenite methyltransferase multiple interactions
affects metabolic processing
affects response to substance
increases expression 		EXP
ISO 		Glutathione affects the reaction [AS3MT protein affects the metabolism of arsenous acid]
AS3MT gene polymorphism affects the susceptibility to Arsenic Trioxide
Arsenic Trioxide promotes the reaction [AS3MT protein binds to NLRP3 protein]; AS3MT mRNA promotes the reaction [Arsenic Trioxide inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]]; AS3MT mRNA promotes the reaction [Arsenic Trioxide promotes the reaction [METTL14 protein binds to NLRP3 mRNA]]; AS3MT mRNA promotes the reaction [Arsenic Trioxide results in increased expression of CASP1 protein modified form]; AS3MT mRNA promotes the reaction [Arsenic Trioxide results in increased expression of IL1B protein]; AS3MT mRNA promotes the reaction [Arsenic Trioxide results in increased expression of NLRP3 protein]; AS3MT mRNA promotes the reaction [Arsenic Trioxide results in increased stability of NLRP3 mRNA]; Proanthocyanidins promotes the reaction [Arsenic Trioxide results in increased expression of AS3MT protein]
Arsenic Trioxide results in increased expression of AS3MT mRNA; Arsenic Trioxide results in increased expression of AS3MT protein 		CTD PMID:15606138 PMID:30376134 PMID:31355259 PMID:35226250 PMID:36399430 NCBI chr 1:255,536,879...255,569,245
Ensembl chr 1:255,537,109...255,569,249 		JBrowse link
G Asah1 N-acylsphingosine amidohydrolase 1 increases expression ISO Arsenic Trioxide results in increased expression of ASAH1 mRNA CTD PMID:20458559 PMID:27829220 NCBI chr16:57,669,927...57,701,349
Ensembl chr16:57,669,750...57,718,305 		JBrowse link
G Asah2 N-acylsphingosine amidohydrolase 2 increases expression ISO Arsenic Trioxide results in increased expression of ASAH2 mRNA CTD PMID:25258189 NCBI chr 1:239,278,994...239,386,598
Ensembl chr 1:239,278,994...239,382,024 		JBrowse link
G Asb11 ankyrin repeat and SOCS box containing 11 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ASB11 protein] CTD PMID:26598702 NCBI chr  X:33,646,389...33,669,790
Ensembl chr  X:33,624,394...33,669,934 		JBrowse link
G Asb5 ankyrin repeat and SOCS box-containing 5 decreases expression ISO Arsenic Trioxide results in decreased expression of ASB5 mRNA CTD PMID:20458559 NCBI chr16:43,970,940...44,038,318
Ensembl chr16:43,970,940...44,010,437 		JBrowse link
G Asb8 ankyrin repeat and SOCS box-containing 8 increases expression ISO Arsenic Trioxide results in increased expression of ASB8 mRNA CTD PMID:39716349 NCBI chr 7:131,140,455...131,176,648
Ensembl chr 7:131,141,406...131,150,633 		JBrowse link
G Asb9 ankyrin repeat and SOCS box-containing 9 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ASB9 protein] CTD PMID:26598702 NCBI chr  X:33,588,484...33,633,285
Ensembl chr  X:33,588,484...33,624,397 		JBrowse link
G Asic1 acid sensing ion channel subunit 1 decreases expression ISO Arsenic Trioxide results in decreased expression of ASIC1 mRNA CTD PMID:26705709 NCBI chr 7:132,677,158...132,707,379
Ensembl chr 7:132,698,723...132,707,832 		JBrowse link
G Asl argininosuccinate lyase decreases response to substance
increases expression 		ISO ASL protein results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in increased expression of ASL mRNA 		CTD PMID:20458559 PMID:20707922 NCBI chr12:32,295,779...32,313,257
Ensembl chr12:32,295,633...32,317,261 		JBrowse link
G Asns asparagine synthetase (glutamine-hydrolyzing) decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of ASNS mRNA; Arsenic Trioxide results in decreased expression of ASNS protein
Arsenic Trioxide results in increased expression of ASNS mRNA 		CTD PMID:17547211 PMID:24356939 PMID:25419056 NCBI chr 4:36,752,061...36,769,970
Ensembl chr 4:36,751,802...36,776,050 		JBrowse link
G Asph aspartate-beta-hydroxylase decreases response to substance ISO ASPH protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 5:27,398,933...27,611,519
Ensembl chr 5:27,398,949...27,611,215 		JBrowse link
G Aspm assembly factor for spindle microtubules increases expression ISO Arsenic Trioxide results in increased expression of ASPM mRNA CTD PMID:20458559 NCBI chr13:53,625,584...53,674,489
Ensembl chr13:53,625,584...53,674,489 		JBrowse link
G Asrgl1 asparaginase and isoaspartyl peptidase 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ASRGL1 protein] CTD PMID:26598702 NCBI chr 1:215,436,180...215,456,188
Ensembl chr 1:215,435,218...215,456,198 		JBrowse link
G Ass1 argininosuccinate synthase 1 multiple interactions
decreases expression
increases expression 		ISO [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of ASS1 mRNA
Arsenic Trioxide results in decreased expression of ASS1 mRNA
Arsenic Trioxide results in increased expression of ASS1 mRNA 		CTD PMID:15070760 PMID:15761015 PMID:15894607 PMID:27829220 NCBI chr 3:35,144,765...35,194,632
Ensembl chr 3:35,144,999...35,194,627 		JBrowse link
G Asxl2 ASXL transcriptional regulator 2 increases expression ISO Arsenic Trioxide results in increased expression of ASXL2 mRNA CTD PMID:20458559 NCBI chr 6:32,090,497...32,234,487
Ensembl chr 6:32,145,607...32,227,851 		JBrowse link
G Atad2 ATPase family, AAA domain containing 2 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of ATAD2 mRNA
[Dasatinib co-treated with Arsenic Trioxide] results in decreased expression of ATAD2 mRNA 		CTD PMID:29266867 NCBI chr 7:91,523,626...91,566,238
Ensembl chr 7:91,523,626...91,566,238 		JBrowse link
G Atad3a ATPase family, AAA domain containing 3A decreases expression ISO Arsenic Trioxide results in decreased expression of ATAD3A protein CTD PMID:25419056 NCBI chr 5:171,632,545...171,652,725
Ensembl chr 5:171,632,547...171,652,725 		JBrowse link
G Atat1 alpha tubulin acetyltransferase 1 decreases expression ISO Arsenic Trioxide results in decreased expression of ATAT1 mRNA CTD PMID:39716349 NCBI chr20:2,849,399...2,862,614
Ensembl chr20:2,849,421...2,862,389 		JBrowse link
G Atf2 activating transcription factor 2 increases phosphorylation
multiple interactions 		ISO Arsenic Trioxide results in increased phosphorylation of ATF2 protein
Arsenic Trioxide results in increased expression of and results in increased phosphorylation of ATF2 protein; Dasatinib promotes the reaction [Arsenic Trioxide results in increased phosphorylation of ATF2 protein] 		CTD PMID:24934751 PMID:29266867 NCBI chr 3:79,125,814...79,202,896
Ensembl chr 3:79,126,705...79,202,745 		JBrowse link
G Atf3 activating transcription factor 3 decreases methylation
decreases expression
increases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased methylation of ATF3 promoter
Arsenic Trioxide results in decreased expression of ATF3 mRNA
Arsenic Trioxide results in increased expression of ATF3 mRNA
ATF3 promotes the reaction [Arsenic Trioxide results in increased expression of MIR21 protein] 		CTD PMID:20458559 PMID:26046465 PMID:36801614 PMID:38295932 NCBI chr13:105,274,103...105,331,653
Ensembl chr13:105,282,440...105,295,750 		JBrowse link
G Atf4 activating transcription factor 4 multiple interactions
increases expression 		ISO Dasatinib inhibits the reaction [Arsenic Trioxide results in increased expression of ATF4 protein]
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Arsenic Trioxide results in increased expression of ATF4 protein]; 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid inhibits the reaction [Arsenic Trioxide results in increased expression of ATF4 protein]; [Arsenic Trioxide results in increased abundance of Reactive Oxygen Species] which results in increased expression of ATF4 protein; Arsenic Trioxide results in increased expression of and affects the localization of ATF4 protein; ATF4 protein affects the reaction [Arsenic Trioxide results in decreased expression of IL1B mRNA]; ATF4 protein affects the reaction [Arsenic Trioxide results in decreased expression of ITGAM protein]; ATF4 protein affects the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; ATF4 protein affects the reaction [Arsenic Trioxide results in increased expression of IL10 mRNA]; ATF4 protein affects the reaction [Arsenic Trioxide results in increased expression of TGFB1 mRNA]; ATF4 protein affects the reaction [Arsenic Trioxide results in increased expression of TNF mRNA]; ATF4 protein promotes the reaction [Arsenic Trioxide affects the expression of DNM1L protein modified form]; ATF4 protein promotes the reaction [Arsenic Trioxide results in increased expression of and affects the localization of BAX protein]; ATF4 protein promotes the reaction [Arsenic Trioxide results in increased expression of and affects the localization of CYCS protein]; ATF4 protein promotes the reaction [Arsenic Trioxide results in increased expression of and affects the localization of RAC1 protein]; ATF4 protein promotes the reaction [Arsenic Trioxide results in increased expression of CAPN1 protein]; ATF4 protein promotes the reaction [Arsenic Trioxide results in increased expression of CASP12 protein modified form]; ATF4 protein promotes the reaction [Arsenic Trioxide results in increased expression of CASP3 protein modified form]; ATF4 protein promotes the reaction [Arsenic Trioxide results in increased expression of DDIT3 protein]; ATF4 protein promotes the reaction [Arsenic Trioxide results in increased expression of EIF2AK3 protein modified form]; ATF4 protein promotes the reaction [Arsenic Trioxide results in increased expression of HSP90B1 protein]; ATF4 protein promotes the reaction [Arsenic Trioxide results in increased expression of HSPA5 protein]; ATF4 protein promotes the reaction [Arsenic Trioxide results in increased expression of HSPA9 protein]; ATF4 protein promotes the reaction [Arsenic Trioxide results in increased expression of ITPR1 protein modified form]; ATF4 protein promotes the reaction [Arsenic Trioxide results in increased expression of NCF1 protein]; ATF4 protein promotes the reaction [Arsenic Trioxide results in increased expression of NCF2 protein]; ATF4 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of TP53 protein]; Thioctic Acid inhibits the reaction [Arsenic Trioxide results in increased expression of ATF4 mRNA]; Thioctic Acid inhibits the reaction [Arsenic Trioxide results in increased expression of ATF4 protein]
Arsenic Trioxide results in increased expression of ATF4 mRNA; Arsenic Trioxide results in increased expression of ATF4 protein 		CTD PMID:23892647 PMID:27461142 PMID:27638049 PMID:29266867 NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:113,684,681...113,686,739 		JBrowse link
G Atf6 activating transcription factor 6 increases expression
multiple interactions
decreases expression
increases phosphorylation 		ISO Arsenic Trioxide results in increased expression of ATF6 mRNA; Arsenic Trioxide results in increased expression of ATF6 protein
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Arsenic Trioxide results in increased expression of and results in increased cleavage of ATF6 protein]; [Arsenic Trioxide co-treated with antimony trichloride] results in increased expression of ATF6 mRNA; [Arsenic Trioxide results in increased abundance of Reactive Oxygen Species] which results in increased expression of and results in increased cleavage of ATF6 protein; Arsenic Trioxide results in increased expression of and results in increased cleavage of ATF6 protein; Thioctic Acid inhibits the reaction [Arsenic Trioxide results in increased expression of and results in increased cleavage of ATF6 protein]; Thioctic Acid inhibits the reaction [Arsenic Trioxide results in increased expression of ATF6 mRNA]
Arsenic Trioxide results in decreased expression of ATF6 protein
Arsenic Trioxide promotes the reaction [nilotinib results in decreased expression of ATF6 protein]; Resveratrol inhibits the reaction [Arsenic Trioxide results in increased expression of ATF6 protein]
Arsenic Trioxide results in increased phosphorylation of ATF6 protein 		CTD PMID:17963750 PMID:19176121 PMID:23883479 PMID:23892647 PMID:25107562 More... NCBI chr13:85,460,312...85,639,959
Ensembl chr13:85,462,840...85,640,033 		JBrowse link
G Atf6b activating transcription factor 6 beta increases expression ISO Arsenic Trioxide results in increased expression of ATF6B protein CTD PMID:25258189 NCBI chr20:4,095,534...4,103,534
Ensembl chr20:4,095,534...4,106,032 		JBrowse link
G Atg12 autophagy related 12 multiple interactions
increases expression 		ISO Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG12 mRNA]; Arsenic Trioxide promotes the reaction [ATG5 protein binds to ATG12 protein]; TFEB protein affects the reaction [Arsenic Trioxide results in increased expression of ATG12 mRNA]
Arsenic Trioxide results in increased expression of ATG12 mRNA; Arsenic Trioxide results in increased expression of ATG12 protein
TFEB protein affects the reaction [Arsenic Trioxide results in increased expression of ATG12 protein] 		CTD PMID:28978663 PMID:29307831 PMID:30032600 PMID:30225639 PMID:32112876 More... NCBI chr18:41,638,841...41,649,311
Ensembl chr18:41,635,835...41,649,261 		JBrowse link
G Atg13 autophagy related 13 increases expression ISO Arsenic Trioxide results in increased expression of ATG13 mRNA CTD PMID:32112876 NCBI chr 3:98,102,831...98,136,741
Ensembl chr 3:98,101,552...98,136,743 		JBrowse link
G Atg3 autophagy related 3 increases expression ISO Arsenic Trioxide results in increased expression of ATG3 mRNA CTD PMID:31846860 PMID:32112876 PMID:32781346 NCBI chr11:69,130,948...69,159,280
Ensembl chr11:69,121,952...69,159,280 		JBrowse link
G Atg5 autophagy related 5 multiple interactions
increases expression
decreases expression 		ISO
EXP 		Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG5 mRNA]; Arsenic Trioxide promotes the reaction [ATG5 protein binds to ATG12 protein]; ATG5 protein promotes the reaction [Arsenic Trioxide results in increased degradation of FLT3 protein mutant form]; Chloroquine promotes the reaction [Arsenic Trioxide results in increased expression of ATG5 protein]; TFEB protein affects the reaction [Arsenic Trioxide results in increased expression of ATG5 mRNA]
Arsenic Trioxide results in increased expression of ATG5 mRNA; Arsenic Trioxide results in increased expression of ATG5 protein
3-methyladenine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG5 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG5 mRNA]
Arsenic Trioxide results in decreased expression of ATG5 protein
ferrostatin-1 inhibits the reaction [Arsenic Trioxide results in decreased expression of ATG5 protein] 		CTD PMID:21594580 PMID:28978663 PMID:29307831 PMID:30032600 PMID:30225639 More... NCBI chr20:49,380,835...49,471,826
Ensembl chr20:49,380,813...49,471,821 		JBrowse link
G Atg7 autophagy related 7 multiple interactions
increases expression 		ISO Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG7 mRNA]; ATG7 protein promotes the reaction [Arsenic Trioxide results in increased degradation of BCR protein mutant form]; ATG7 protein promotes the reaction [Arsenic Trioxide results in increased degradation of FLT3 protein mutant form]; TFEB protein affects the reaction [Arsenic Trioxide results in increased expression of ATG7 mRNA]
Arsenic Trioxide results in increased expression of ATG7 mRNA; Arsenic Trioxide results in increased expression of ATG7 protein
3-methyladenine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG7 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG7 mRNA] 		CTD PMID:22898604 PMID:29307831 PMID:32284743 PMID:32781346 PMID:33462182 NCBI chr 4:149,390,000...149,597,534
Ensembl chr 4:149,391,390...149,598,319 		JBrowse link
G Atic 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase increases expression ISO Arsenic Trioxide results in increased expression of ATIC mRNA CTD PMID:29633893 NCBI chr 9:80,614,311...80,634,360
Ensembl chr 9:80,614,283...80,635,756 		JBrowse link
G Atm ATM serine/threonine kinase decreases expression
increases expression
increases phosphorylation
multiple interactions
decreases phosphorylation 		ISO
EXP 		Arsenic Trioxide results in decreased expression of ATM mRNA; Arsenic Trioxide results in decreased expression of ATM protein modified form
Arsenic Trioxide results in increased expression of ATM mRNA
Arsenic Trioxide results in increased phosphorylation of ATM protein
[ruxolitinib co-treated with Arsenic Trioxide] results in increased phosphorylation of ATM protein; Erlotinib Hydrochloride promotes the reaction [Arsenic Trioxide results in increased expression of ATM mRNA]
Arsenic Trioxide results in decreased phosphorylation of ATM protein 		CTD PMID:19730151 PMID:19763917 PMID:20471514 PMID:23337567 PMID:28318385 More... NCBI chr 8:62,724,939...62,829,040
Ensembl chr 8:62,727,291...62,828,629 		JBrowse link
G Atn1 atrophin 1 increases sumoylation ISO Arsenic Trioxide results in increased sumoylation of ATN1 protein CTD PMID:28318385 NCBI chr 4:159,240,573...159,254,378
Ensembl chr 4:159,237,562...159,254,418 		JBrowse link
G Atoh1 atonal bHLH transcription factor 1 decreases expression ISO Arsenic Trioxide results in decreased expression of ATOH1 mRNA CTD PMID:39716349 NCBI chr 4:95,241,933...95,244,028
Ensembl chr 4:95,241,933...95,244,019 		JBrowse link
G Atp11c ATPase phospholipid transporting 11C decreases expression ISO Arsenic Trioxide results in decreased expression of ATP11C mRNA CTD PMID:39716349 NCBI chr  X:143,600,763...143,788,407
Ensembl chr  X:143,600,767...143,788,432 		JBrowse link
G Atp1b1 ATPase Na+/K+ transporting subunit beta 1 decreases response to substance
decreases expression 		ISO ATP1B1 protein results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in decreased expression of ATP1B1 mRNA; Arsenic Trioxide results in decreased expression of ATP1B1 protein 		CTD PMID:15761015 PMID:20707922 PMID:25419056 NCBI chr13:79,319,708...79,340,226
Ensembl chr13:79,319,706...79,340,549 		JBrowse link
G Atp2a2 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of ATP2A2 mRNA
[Arsenic Trioxide co-treated with antimony trichloride] results in decreased expression of ATP2A2 mRNA; Arsenic Trioxide promotes the reaction [antimony trichloride results in decreased expression of ATP2A2 protein]
Arsenic Trioxide results in decreased expression of ATP2A2 mRNA; Arsenic Trioxide results in decreased expression of ATP2A2 protein 		CTD PMID:20458559 PMID:34091186 NCBI chr12:39,733,519...39,782,942
Ensembl chr12:39,733,458...39,782,934 		JBrowse link
G Atp2b1 ATPase plasma membrane Ca2+ transporting 1 decreases expression ISO Arsenic Trioxide results in decreased expression of ATP2B1 mRNA CTD PMID:12852829 PMID:17547211 NCBI chr 7:35,622,267...35,731,904
Ensembl chr 7:35,622,461...35,731,904 		JBrowse link
G Atp5f1a ATP synthase F1 subunit alpha decreases expression ISO Arsenic Trioxide results in decreased expression of ATP5F1A mRNA CTD PMID:15949261 PMID:19422848 NCBI chr18:73,567,537...73,575,473
Ensembl chr18:73,567,526...73,575,922 		JBrowse link
G Atp5f1c ATP synthase F1 subunit gamma increases expression ISO Arsenic Trioxide results in increased expression of ATP5F1C mRNA CTD PMID:22521957 NCBI chr17:73,333,584...73,355,872
Ensembl chr17:73,333,588...73,383,073 		JBrowse link
G Atp5if1 ATP synthase inhibitory factor subunit 1 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of ATP5IF1 mRNA
Arsenic Trioxide results in decreased expression of ATP5IF1 mRNA 		CTD PMID:19422848 PMID:20458559 NCBI chr 5:150,022,960...150,026,677
Ensembl chr 5:150,022,960...150,026,677 		JBrowse link
G Atp5mc1 ATP synthase membrane subunit c locus 1 decreases expression ISO Arsenic Trioxide results in decreased expression of ATP5MC1 mRNA CTD PMID:19422848 NCBI chr10:81,520,762...81,523,735
Ensembl chr10:81,520,765...81,523,363 		JBrowse link
G Atp5mc2 ATP synthase membrane subunit c locus 2 multiple interactions
decreases expression 		ISO Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of ATP5MC2 mRNA] CTD PMID:29095437 NCBI chr 7:135,669,847...135,680,839
Ensembl chr 7:135,669,848...135,678,231 		JBrowse link
G Atp5me ATP synthase membrane subunit e increases expression ISO Arsenic Trioxide results in increased expression of ATP5ME mRNA CTD PMID:20458559 NCBI chr14:1,464,788...1,465,989
Ensembl chr14:1,464,800...1,465,988 		JBrowse link
G Atp6v0b ATPase H+ transporting V0 subunit B increases expression ISO Arsenic Trioxide results in increased expression of ATP6V0B mRNA CTD PMID:29633893 NCBI chr 5:136,708,823...136,710,339
Ensembl chr 5:136,708,823...136,716,828 		JBrowse link
G Atp6v0d1 ATPase H+ transporting V0 subunit D1 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of ATP6V0D1 mRNA
[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of ATP6V0D1 mRNA; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATP6V0D1 mRNA]; TFEB protein affects the reaction [Arsenic Trioxide results in increased expression of ATP6V0D1 mRNA] 		CTD PMID:15894607 PMID:29307831 NCBI chr19:50,313,268...50,357,248
Ensembl chr19:50,313,273...50,357,395 		JBrowse link
G Atp6v1a ATPase H+ transporting V1 subunit A increases expression ISO Arsenic Trioxide results in increased expression of ATP6V1A mRNA CTD PMID:20458559 NCBI chr11:70,066,800...70,120,603
Ensembl chr11:70,035,134...70,120,603 		JBrowse link
G Atp6v1e1 ATPase H+ transporting V1 subunit E1 multiple interactions
increases expression 		ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ATP6V1E1 protein]
Arsenic Trioxide results in increased expression of ATP6V1E1 mRNA 		CTD PMID:26598702 PMID:39716349 NCBI chr 4:155,694,534...155,716,660
Ensembl chr 4:155,694,534...155,716,678 		JBrowse link
G Atp6v1g1 ATPase H+ transporting V1 subunit G1 increases expression ISO Arsenic Trioxide results in increased expression of ATP6V1G1 mRNA CTD PMID:20458559 NCBI chr 5:81,976,959...81,983,139
Ensembl chr 5:81,977,015...81,985,930 		JBrowse link
G Atp6v1h ATPase H+ transporting V1 subunit H multiple interactions ISO [Arsenic Trioxide co-treated with apatinib] results in increased expression of ATP6V1H mRNA CTD PMID:39223679 NCBI chr 5:19,176,849...19,282,516
Ensembl chr 5:19,176,849...19,282,516 		JBrowse link
G Atp7a ATPase copper transporting alpha decreases expression ISO Arsenic Trioxide results in decreased expression of ATP7A mRNA CTD PMID:35676786 NCBI chr  X:75,159,635...75,267,094
Ensembl chr  X:75,159,782...75,267,093 		JBrowse link
G Atp8a1 ATPase phospholipid transporting 8A1 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of ATP8A1 mRNA
Arsenic Trioxide results in decreased expression of ATP8A1 mRNA 		CTD PMID:15761015 PMID:35676786 NCBI chr14:40,668,932...40,911,465
Ensembl chr14:40,731,846...40,911,463 		JBrowse link
G Atr ATR serine/threonine kinase increases expression
increases activity
multiple interactions 		ISO Arsenic Trioxide results in increased expression of ATR mRNA
Arsenic Trioxide results in increased activity of ATR protein
Erlotinib Hydrochloride promotes the reaction [Arsenic Trioxide results in increased expression of ATR mRNA] 		CTD PMID:16891316 PMID:29274334 NCBI chr 8:105,306,299...105,403,742
Ensembl chr 8:105,306,305...105,403,718 		JBrowse link
G Atxn7 ataxin 7 increases expression ISO Arsenic Trioxide results in increased expression of ATXN7 mRNA CTD PMID:39716349 NCBI chr15:13,547,859...13,693,311
Ensembl chr15:13,547,862...13,693,526 		JBrowse link
G Aurka aurora kinase A increases expression ISO Arsenic Trioxide results in increased expression of AURKA protein CTD PMID:16338065 NCBI chr 3:181,546,742...181,562,890
Ensembl chr 3:181,546,742...181,562,771 		JBrowse link
G Aurkc aurora kinase C multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to AURKC protein] CTD PMID:26598702 NCBI chr 1:75,876,773...75,882,893
Ensembl chr 1:75,876,773...75,897,426 		JBrowse link
G Auts2 activator of transcription and developmental regulator AUTS2 increases expression ISO Arsenic Trioxide results in increased expression of AUTS2 mRNA CTD PMID:25555879 NCBI chr12:29,739,138...30,830,386
Ensembl chr12:29,740,523...30,830,386 		JBrowse link
G Avil advillin increases expression ISO Arsenic Trioxide results in increased expression of AVIL mRNA CTD PMID:20458559 NCBI chr 7:64,711,294...64,729,436
Ensembl chr 7:64,711,403...64,729,436 		JBrowse link
G Axin2 axin 2 decreases expression ISO Arsenic Trioxide results in decreased expression of AXIN2 mRNA CTD PMID:29633893 PMID:35676786 NCBI chr10:94,393,379...94,426,579
Ensembl chr10:94,395,909...94,426,575 		JBrowse link
G Azgp1 alpha-2-glycoprotein 1, zinc-binding decreases expression ISO Arsenic Trioxide results in decreased expression of AZGP1 mRNA CTD PMID:17547211 NCBI chr12:22,044,685...22,051,248
Ensembl chr12:22,044,751...22,053,020 		JBrowse link
G B3galt5 Beta-1,3-galactosyltransferase 5 decreases expression ISO Arsenic Trioxide results in decreased expression of B3GALT5 mRNA CTD PMID:39716349 NCBI chr11:49,053,959...49,100,398
Ensembl chr11:49,006,560...49,101,283 		JBrowse link
G B3gat3 beta-1,3-glucuronyltransferase 3 multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of B3GAT3 mRNA CTD PMID:15894607 NCBI chr 1:215,246,453...215,253,033
Ensembl chr 1:215,246,482...215,266,876 		JBrowse link
G B3gnt3 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 decreases response to substance ISO B3GNT3 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr16:18,434,114...18,444,851
Ensembl chr16:18,435,378...18,444,738 		JBrowse link
G B3gnt6 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 decreases expression ISO Arsenic Trioxide results in decreased expression of B3GNT6 mRNA CTD PMID:20458559 NCBI chr 1:161,897,504...161,915,046
Ensembl chr 1:161,898,323...161,903,354 		JBrowse link
G B3gntl1 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like 1 increases expression ISO Arsenic Trioxide results in increased expression of B3GNTL1 mRNA CTD PMID:39716349 NCBI chr10:107,363,036...107,431,988
Ensembl chr10:107,371,442...107,431,908 		JBrowse link
G B4galnt1 beta-1,4-N-acetyl-galactosaminyl transferase 1 increases expression ISO Arsenic Trioxide results in increased expression of B4GALNT1 mRNA CTD PMID:22521957 NCBI chr 7:64,873,909...64,881,512
Ensembl chr 7:64,874,022...64,881,516 		JBrowse link
G B4galt3 beta-1,4-galactosyltransferase 3 increases expression ISO Arsenic Trioxide results in increased expression of B4GALT3 mRNA CTD PMID:39716349 NCBI chr13:86,223,827...86,229,886
Ensembl chr13:86,223,899...86,229,888 		JBrowse link
G B4galt5 beta-1,4-galactosyltransferase 5 decreases expression
decreases response to substance 		ISO Arsenic Trioxide results in decreased expression of B4GALT5 protein
B4GALT5 protein results in decreased susceptibility to Arsenic Trioxide 		CTD PMID:18439752 NCBI chr 3:176,437,073...176,453,001
Ensembl chr 3:176,437,073...176,488,978 		JBrowse link
G Baalc BAALC binder of MAP3K1 and KLF4 decreases expression ISO Arsenic Trioxide results in decreased expression of BAALC mRNA CTD PMID:19128835 PMID:26705709 NCBI chr 7:71,803,640...71,877,608
Ensembl chr 7:71,774,898...71,879,261 		JBrowse link
G Babam1 BRISC and BRCA1 A complex member 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to BABAM1 protein] CTD PMID:26598702 NCBI chr16:18,102,885...18,108,916
Ensembl chr16:18,102,815...18,108,932 		JBrowse link
G Bace1 beta-secretase 1 decreases expression ISO Arsenic Trioxide results in decreased expression of BACE1 mRNA CTD PMID:22521957 NCBI chr 8:55,038,842...55,061,138
Ensembl chr 8:55,038,823...55,064,918 		JBrowse link
G Bach1 BTB domain and CNC homolog 1 affects localization
multiple interactions
increases expression 		ISO Arsenic Trioxide affects the localization of BACH1 protein
[Arsenic Trioxide results in increased abundance of Arsenic] which results in increased expression of and affects the localization of BACH1 protein; [Arsenic Trioxide results in increased abundance of Arsenic] which results in increased expression of BACH1 mRNA; Acetylcysteine inhibits the reaction [Arsenic Trioxide affects the localization of BACH1 protein]; MIR155 mRNA inhibits the reaction [Arsenic Trioxide results in increased expression of BACH1 protein] 		CTD PMID:19350554 PMID:29260515 PMID:33434570 NCBI chr11:40,425,721...40,461,118
Ensembl chr11:40,425,664...40,461,277 		JBrowse link
G Bach2 BTB domain and CNC homolog 2 decreases expression ISO Arsenic Trioxide results in decreased expression of BACH2 mRNA CTD PMID:15725085 NCBI chr 5:51,428,802...51,779,030
Ensembl chr 5:51,434,870...51,774,234 		JBrowse link
G Bad BCL2-associated agonist of cell death multiple interactions
decreases phosphorylation
decreases expression
increases expression
affects expression 		EXP
ISO 		salvianolic acid A inhibits the reaction [Arsenic Trioxide results in increased expression of BAD protein]
Arsenic Trioxide results in decreased phosphorylation of BAD protein
Arsenic Trioxide results in decreased expression of BAD protein
Arsenic Trioxide results in decreased expression of BAD mRNA
Arsenic Trioxide results in increased expression of BAD mRNA; Arsenic Trioxide results in increased expression of BAD protein
Arsenic Trioxide affects the expression of BAD protein
[Arsenic Trioxide co-treated with Curcumin] results in increased expression of BAD protein; [Arsenic Trioxide co-treated with NVP-BKM120] results in increased expression of BAD mRNA; Arsenic Trioxide promotes the reaction [Aprepitant results in increased expression of BAD mRNA]; Arsenic Trioxide results in increased phosphorylation of and results in increased activity of BAD protein; Erlotinib Hydrochloride promotes the reaction [Arsenic Trioxide results in increased expression of BAD mRNA]; NVP-BKM120 promotes the reaction [Arsenic Trioxide results in increased expression of BAD mRNA]; salvin promotes the reaction [Arsenic Trioxide results in decreased phosphorylation of BAD protein] 		CTD PMID:15073043 PMID:17530438 PMID:18349030 PMID:18387645 PMID:18618274 More... NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:213,562,187...213,572,034 		JBrowse link
G Bag1 BAG cochaperone 1 decreases expression ISO Arsenic Trioxide results in decreased expression of BAG1 mRNA CTD PMID:17530438 NCBI chr 5:60,864,476...60,877,059
Ensembl chr 5:60,864,476...60,878,161 		JBrowse link
G Bag3 BAG cochaperone 3 affects expression ISO Arsenic Trioxide affects the expression of BAG3 mRNA CTD PMID:17530438 NCBI chr 1:192,533,460...192,557,281
Ensembl chr 1:192,475,828...192,557,280 		JBrowse link
G Baiap2l1 BAR/IMD domain containing adaptor protein 2 like 1 increases expression ISO Arsenic Trioxide results in increased expression of BAIAP2L1 mRNA CTD PMID:26705709 NCBI chr12:15,364,090...15,453,602
Ensembl chr12:15,364,109...15,453,605 		JBrowse link
G Bak1 BCL2-antagonist/killer 1 increases expression
decreases expression
multiple interactions
affects response to substance 		ISO
EXP 		Arsenic Trioxide results in increased expression of BAK1 protein
Arsenic Trioxide results in decreased expression of BAK1 mRNA
[Arsenic Trioxide co-treated with apatinib] results in increased expression of BAK1 protein; [Arsenic Trioxide co-treated with Ascorbic Acid co-treated with Disulfiram] results in decreased expression of BAK1 protein
BAK1 protein affects the susceptibility to Arsenic Trioxide
Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of BAK1 mRNA]; Arsenic Trioxide promotes the reaction [Drugs, Chinese Herbal results in increased expression of BAK1 protein] 		CTD PMID:11940349 PMID:15979664 PMID:17530438 PMID:19695276 PMID:19730151 More... NCBI chr20:5,102,334...5,111,615
Ensembl chr20:5,102,335...5,110,974 		JBrowse link
G Bambi BMP and activin membrane-bound inhibitor decreases expression ISO Arsenic Trioxide results in decreased expression of BAMBI mRNA CTD PMID:15725085 NCBI chr17:58,816,438...58,821,003
Ensembl chr17:58,816,442...58,821,247 		JBrowse link
G Banf1 barrier to autointegration nuclear assembly factor 1 decreases expression ISO Arsenic Trioxide results in decreased expression of BANF1 protein CTD PMID:25419056 NCBI chr 1:212,101,523...212,103,568
Ensembl chr 1:212,101,523...212,103,552 		JBrowse link
G Bap1 BRCA1 associated deubiquitinase 1 affects expression ISO Arsenic Trioxide affects the expression of BAP1 mRNA CTD PMID:17530438 NCBI chr16:6,453,126...6,461,952
Ensembl chr16:6,452,974...6,461,952 		JBrowse link
G Basp1 brain abundant, membrane attached signal protein 1 increases expression ISO Arsenic Trioxide results in increased expression of BASP1 mRNA CTD PMID:20458559 NCBI chr 2:77,546,628...77,594,297
Ensembl chr 2:77,546,092...77,597,178 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator increases activity
affects localization
increases expression
increases response to substance
multiple interactions
affects expression
decreases expression
affects response to substance
increases cleavage 		ISO
EXP 		Arsenic Trioxide results in increased activity of BAX protein
Arsenic Trioxide affects the localization of BAX protein
Arsenic Trioxide results in increased expression of BAX mRNA; Arsenic Trioxide results in increased expression of BAX protein
BAX results in increased susceptibility to Arsenic Trioxide
18alpha,20beta-hydroxy-11-oxo-norolean-12-en-3beta-yl-2-O-beta-D-glucopyranurosyl-alpha-D-glucopyranosiduronate magnesium tetrahydrate inhibits the reaction [Arsenic Trioxide results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of BAX mRNA]; Arsenic Trioxide results in increased expression of and affects the localization of BAX protein; ATF4 protein promotes the reaction [Arsenic Trioxide results in increased expression of and affects the localization of BAX protein]; baicalin inhibits the reaction [Arsenic Trioxide results in increased expression of BAX mRNA]; baicalin inhibits the reaction [Arsenic Trioxide results in increased expression of BAX protein]; MIR34A affects the reaction [Arsenic Trioxide results in increased expression of BAX protein]; Propranolol inhibits the reaction [Arsenic Trioxide results in increased expression of BAX protein]; Thioctic Acid inhibits the reaction [Arsenic Trioxide results in increased expression of BAX mRNA]
Arsenic Trioxide affects the expression of BAX; Arsenic Trioxide affects the expression of BAX protein
Arsenic Trioxide results in decreased expression of BAX protein
Arsenic Trioxide results in decreased expression of BAX mRNA; Arsenic Trioxide results in decreased expression of BAX protein
BAX protein affects the susceptibility to Arsenic Trioxide
Arsenic Trioxide results in increased expression of BAX; Arsenic Trioxide results in increased expression of BAX mRNA; Arsenic Trioxide results in increased expression of BAX protein
2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole inhibits the reaction [Arsenic Trioxide affects the localization of BAX protein]; 3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone inhibits the reaction [[Arsenic Trioxide co-treated with phytosphingosine] results in increased localization of BAX protein]; [Arsenic Trioxide co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] results in increased activity of BAX protein; [Arsenic Trioxide co-treated with Ascorbic Acid co-treated with Disulfiram] results in increased expression of BAX protein; [Arsenic Trioxide co-treated with Calcitriol] results in increased expression of BAX mRNA; [Arsenic Trioxide co-treated with Calcitriol] results in increased expression of BAX protein; [Arsenic Trioxide co-treated with Curcumin] results in increased expression of BAX protein; [Arsenic Trioxide co-treated with Doxorubicin co-treated with Magnetite Nanoparticles analog] affects the expression of BAX mRNA; [Arsenic Trioxide co-treated with Doxorubicin co-treated with Magnetite Nanoparticles analog] affects the expression of BAX protein; [Arsenic Trioxide co-treated with NVP-BKM120] results in increased expression of BAX mRNA; [Arsenic Trioxide co-treated with phytosphingosine] results in increased localization of BAX protein; [Arsenic Trioxide results in increased phosphorylation of BCL2 protein] inhibits the reaction [BCL2 protein binds to BAX protein]; [Arsenic Trioxide results in increased susceptibility to Ascorbic Acid] which results in increased expression of BAX protein; [Bortezomib co-treated with Arsenic Trioxide] affects the expression of BAX protein; [CpG ODN 2216 co-treated with Arsenic Trioxide] results in increased expression of BAX protein; [Curcumin co-treated with Arsenic Trioxide] results in increased expression of BAX protein; [Docosahexaenoic Acids co-treated with Arsenic Trioxide] results in increased expression of BAX protein; [MARVELD1 protein results in decreased susceptibility to Arsenic Trioxide] which results in decreased expression of BAX protein; [NVP-BKM120 co-treated with Arsenic Trioxide] results in increased expression of BAX mRNA; [ruxolitinib co-treated with Arsenic Trioxide] results in increased expression of BAX mRNA; [tetraarsenic tetrasulfide co-treated with Arsenic Trioxide] results in increased expression of BAX mRNA; [tetraarsenic tetrasulfide co-treated with Arsenic Trioxide] results in increased expression of BAX protein; [Valproic Acid co-treated with Arsenic Trioxide] results in increased expression of BAX mRNA; [Valproic Acid co-treated with Arsenic Trioxide] results in increased expression of BAX protein; Acetylcysteine inhibits the reaction [[Arsenic Trioxide co-treated with phytosphingosine] results in increased localization of BAX protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide affects the localization of BAX protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of BAX protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased localization of BAX protein]; Acetylcysteine inhibits the reaction [Resveratrol promotes the reaction [Arsenic Trioxide results in increased expression of BAX protein]]; allicin inhibits the reaction [Arsenic Trioxide results in increased expression of BAX protein]; Arsenic Trioxide inhibits the reaction [BCL2 protein binds to BAX protein binds to VDAC1 protein]; Arsenic Trioxide inhibits the reaction [BCL2 protein binds to BAX protein]; Arsenic Trioxide promotes the reaction [Aprepitant results in increased expression of BAX mRNA]; Arsenic Trioxide promotes the reaction [BAX protein binds to BAX protein]; Arsenic Trioxide promotes the reaction [Curcumin affects the localization of BAX protein]; Arsenic Trioxide promotes the reaction [Genistein results in increased expression of BAX protein]; Arsenic Trioxide promotes the reaction [Quercetin results in increased activity of BAX protein]; Arsenic Trioxide results in increased activity of and affects the localization of BAX protein; Arsenic Trioxide results in increased cleavage of and results in increased expression of BAX protein; Arsenic Trioxide results in increased localization of and results in increased activity of BAX protein; BAX mutant form inhibits the reaction [Arsenic Trioxide affects the localization of AIFM1 protein]; BCL2 protein inhibits the reaction [Arsenic Trioxide inhibits the reaction [BCL2 protein binds to BAX protein]]; BCL2 protein inhibits the reaction [Arsenic Trioxide results in increased activity of BAX protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [Arsenic Trioxide results in increased cleavage of BAX protein]; calpeptin inhibits the reaction [Arsenic Trioxide results in increased cleavage of BAX protein]; Curcumin promotes the reaction [Arsenic Trioxide affects the localization of BAX protein]; Deoxyglucose promotes the reaction [Arsenic Trioxide results in increased localization of and results in increased activity of BAX protein]; Erlotinib Hydrochloride promotes the reaction [Arsenic Trioxide results in increased expression of BAX mRNA]; Gemcitabine promotes the reaction [Arsenic Trioxide results in increased expression of BAX protein]; Genistein promotes the reaction [Arsenic Trioxide results in increased expression of BAX protein]; GH1 protein promotes the reaction [Arsenic Trioxide results in increased expression of BAX mRNA]; GRB10 protein promotes the reaction [[Arsenic Trioxide co-treated with apatinib] results in increased expression of BAX protein]; Hydrogen Peroxide inhibits the reaction [Arsenic Trioxide results in increased expression of BAX protein]; ID1 protein inhibits the reaction [Arsenic Trioxide results in increased expression of BAX protein]; MAPK14 mutant form inhibits the reaction [Arsenic Trioxide affects the localization of BAX protein]; MARVELD1 protein inhibits the reaction [Arsenic Trioxide results in increased expression of BAX protein]; MMP9 protein inhibits the reaction [Arsenic Trioxide results in increased expression of BAX protein]; MT2A protein inhibits the reaction [Arsenic Trioxide results in increased expression of BAX protein]; pyrazolanthrone promotes the reaction [Arsenic Trioxide results in increased activity of and results in increased localization of BAX protein]; Quercetin promotes the reaction [Arsenic Trioxide results in increased activity of BAX protein]; Resveratrol promotes the reaction [Arsenic Trioxide results in increased expression of BAX protein]; SB 203580 inhibits the reaction [[Arsenic Trioxide co-treated with phytosphingosine] results in increased localization of BAX protein]; Thioctic Acid inhibits the reaction [Arsenic Trioxide results in increased localization of BAX protein]; TNF protein promotes the reaction [Arsenic Trioxide affects the localization of BAX protein]; U 0126 promotes the reaction [Arsenic Trioxide results in increased activity of and results in increased localization of BAX protein]; Wortmannin inhibits the reaction [Hydrogen Peroxide inhibits the reaction [Arsenic Trioxide results in increased expression of BAX protein]]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [salvianolic acid B inhibits the reaction [Arsenic Trioxide results in increased expression of BAX protein]]; [Arsenic Trioxide results in increased abundance of Arsenic] which results in increased expression of BAX protein; Apigenin inhibits the reaction [[Arsenic Trioxide results in increased abundance of Arsenic] which results in increased expression of BAX protein]; crocin inhibits the reaction [Arsenic Trioxide results in increased expression of BAX mRNA]; crocin inhibits the reaction [Arsenic Trioxide results in increased expression of BAX protein]; ferrostatin-1 inhibits the reaction [Arsenic Trioxide results in increased expression of BAX protein]; HTS 466284 inhibits the reaction [Arsenic Trioxide results in increased expression of BAX protein]; Phloretin inhibits the reaction [Arsenic Trioxide results in increased expression of BAX mRNA]; salvianolic acid A inhibits the reaction [Arsenic Trioxide results in increased expression of BAX protein]; salvianolic acid B inhibits the reaction [Arsenic Trioxide results in increased expression of BAX protein]; trans-sodium crocetinate inhibits the reaction [Arsenic Trioxide results in increased expression of BAX protein] 		CTD PMID:10712780 PMID:11135700 PMID:11775218 PMID:11940349 PMID:12429934 More... NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429 		JBrowse link
G Bbc3 Bcl-2 binding component 3 multiple interactions
increases expression
decreases expression 		ISO [Arsenic Trioxide co-treated with VS-5584] results in increased expression of BBC3 mRNA; [Erlotinib Hydrochloride co-treated with Arsenic Trioxide] results in increased expression of BBC3 mRNA; [ruxolitinib co-treated with Arsenic Trioxide] results in increased expression of BBC3 mRNA; [sanguinarine co-treated with Arsenic Trioxide] results in increased expression of BBC3 mRNA; Dasatinib promotes the reaction [Arsenic Trioxide results in increased expression of BBC3 protein]; pyrazolanthrone inhibits the reaction [Arsenic Trioxide results in increased expression of BBC3 protein]
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Arsenic Trioxide results in increased expression of BBC3 mRNA]; Thioctic Acid inhibits the reaction [Arsenic Trioxide results in increased expression of BBC3 mRNA]
Arsenic Trioxide results in increased expression of BBC3 mRNA; Arsenic Trioxide results in increased expression of BBC3 protein
Arsenic Trioxide results in decreased expression of BBC3 protein 		CTD PMID:17374990 PMID:20723298 PMID:21454520 PMID:23892647 PMID:24345465 More... NCBI chr 1:86,141,450...86,150,666
Ensembl chr 1:86,141,603...86,150,666 		JBrowse link
G Bbs4 Bardet-Biedl syndrome 4 decreases expression ISO Arsenic Trioxide results in decreased expression of BBS4 mRNA CTD PMID:39716349 NCBI chr 8:68,627,739...68,661,232
Ensembl chr 8:68,627,656...68,661,358 		JBrowse link
G Bbs9 Bardet-Biedl syndrome 9 increases expression ISO Arsenic Trioxide results in increased expression of BBS9 mRNA CTD PMID:20458559 NCBI chr 8:29,288,846...29,713,889
Ensembl chr 8:29,289,997...29,713,880 		JBrowse link
G Bcar1 BCAR1 scaffold protein, Cas family member multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to BCAR1 protein] CTD PMID:26598702 NCBI chr19:56,588,500...56,623,190
Ensembl chr19:56,588,500...56,623,190 		JBrowse link
G Bcat2 branched chain amino acid transaminase 2 increases expression ISO Arsenic Trioxide results in increased expression of BCAT2 mRNA CTD PMID:25258189 NCBI chr 1:105,175,157...105,196,474
Ensembl chr 1:105,176,977...105,196,463 		JBrowse link
G Bccip BRCA2 and CDKN1A interacting protein multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to BCCIP protein] CTD PMID:26598702 NCBI chr 1:197,942,535...197,954,948
Ensembl chr 1:197,942,190...197,956,378 		JBrowse link
G Bche butyrylcholinesterase increases expression ISO Arsenic Trioxide results in increased expression of BCHE mRNA CTD PMID:20458559 NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:160,606,288...160,699,760 		JBrowse link
G Bcl10 BCL10, immune signaling adaptor increases expression ISO Arsenic Trioxide results in increased expression of BCL10 mRNA CTD PMID:17530438 NCBI chr 2:237,501,181...237,510,821
Ensembl chr 2:237,501,134...237,511,829 		JBrowse link
G Bcl2 BCL2, apoptosis regulator increases cleavage
multiple interactions
decreases expression
affects response to substance
affects folding
affects expression
decreases response to substance
increases expression
increases phosphorylation
increases degradation
increases response to substance 		ISO
EXP 		Arsenic Trioxide results in increased cleavage of BCL2 protein
2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of BCL2 protein]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Arsenic Trioxide affects the localization of BCL2 protein]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Arsenic Trioxide results in increased expression of BCL2 mRNA]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Arsenic Trioxide results in increased expression of BCL2 protein]; 3-methyladenine inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2]; 4-amino-1,8-naphthalimide inhibits the reaction [Arsenic Trioxide results in increased expression of BCL2 protein]; [Arsenic Trioxide co-treated with apatinib] results in decreased expression of BCL2 protein; [Arsenic Trioxide co-treated with Aprepitant] results in decreased expression of BCL2 mRNA; [Arsenic Trioxide co-treated with Ascorbic Acid co-treated with Disulfiram] results in decreased expression of BCL2 protein; [Arsenic Trioxide co-treated with BCL2 mutant form] results in increased expression of BCL2 protein; [Arsenic Trioxide co-treated with Bortezomib] results in decreased expression of BCL2 mRNA; [Arsenic Trioxide co-treated with Calcitriol] results in decreased expression of BCL2 mRNA; [Arsenic Trioxide co-treated with Calcitriol] results in decreased expression of BCL2 protein; [Arsenic Trioxide co-treated with Curcumin] affects the expression of BCL2 protein; [Arsenic Trioxide co-treated with Doxorubicin co-treated with Magnetite Nanoparticles analog] affects the expression of BCL2 mRNA; [Arsenic Trioxide co-treated with Doxorubicin co-treated with Magnetite Nanoparticles analog] affects the expression of BCL2 protein; [Arsenic Trioxide co-treated with epigallocatechin gallate] results in decreased expression of BCL2 protein; [Arsenic Trioxide co-treated with NVP-BKM120] results in decreased expression of BCL2 mRNA; [Arsenic Trioxide co-treated with PML protein] results in decreased expression of BCL2; [Arsenic Trioxide results in increased phosphorylation of BCL2 protein] inhibits the reaction [BCL2 protein binds to BAX protein]; [BIBR 1532 co-treated with Arsenic Trioxide] affects the expression of BCL2 mRNA; [Bortezomib co-treated with Arsenic Trioxide] affects the expression of BCL2 protein; [Bortezomib co-treated with Arsenic Trioxide] results in decreased expression of BCL2 protein; [Curcumin co-treated with Arsenic Trioxide] results in decreased expression of BCL2 protein; [Erlotinib Hydrochloride co-treated with Arsenic Trioxide] results in decreased expression of BCL2 mRNA; [Genistein co-treated with Arsenic Trioxide] results in decreased expression of BCL2 protein; [Hydrogen Peroxide co-treated with Arsenic Trioxide] results in decreased expression of BCL2 protein; [MARVELD1 protein results in decreased susceptibility to Arsenic Trioxide] which results in increased expression of BCL2 protein; [paricalcitol co-treated with Arsenic Trioxide] results in decreased expression of BCL2; [pifithrin co-treated with Arsenic Trioxide] results in decreased expression of BCL2 protein; [ruxolitinib co-treated with Arsenic Trioxide] results in decreased expression of BCL2 mRNA; [Silybin co-treated with Arsenic Trioxide] results in decreased expression of BCL2 mRNA; [tetraarsenic tetrasulfide co-treated with Arsenic Trioxide] results in decreased expression of BCL2 mRNA; [tetraarsenic tetrasulfide co-treated with Arsenic Trioxide] results in decreased expression of BCL2 protein; [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of BCL2 mRNA; [Valproic Acid co-treated with Arsenic Trioxide] results in decreased expression of BCL2 mRNA; [Valproic Acid co-treated with Arsenic Trioxide] results in decreased expression of BCL2 protein; [Vorinostat co-treated with Arsenic Trioxide] results in decreased expression of BCL2 protein; Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [Resveratrol results in decreased expression of BCL2 protein]]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of and affects the localization of BCL2 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of BCL2 protein]; Acetylcysteine inhibits the reaction [Resveratrol promotes the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]]; Arsenic Trioxide inhibits the reaction [BCL2 protein binds to BAX protein binds to VDAC1 protein]; Arsenic Trioxide inhibits the reaction [BCL2 protein binds to BAX protein]; Arsenic Trioxide promotes the reaction [Genistein results in decreased expression of BCL2 protein]; Arsenic Trioxide promotes the reaction [Matrines results in decreased expression of BCL2 protein]; Arsenic Trioxide promotes the reaction [puerarin results in decreased expression of BCL2 mRNA]; Arsenic Trioxide promotes the reaction [Resveratrol results in decreased expression of BCL2 protein]; Arsenic Trioxide promotes the reaction [TGFB1 protein results in decreased expression of BCL2 protein]; Arsenic Trioxide results in decreased expression of and affects the localization of BCL2 protein; Arsenic Trioxide results in increased expression of and affects the localization of BCL2 protein; BCL2 inhibits the reaction [[Arsenic Trioxide co-treated with TNF protein] results in decreased expression of CFLAR protein]; BCL2 inhibits the reaction [[Arsenic Trioxide co-treated with TNF protein] results in increased activity of CASP8 protein]; BCL2 protein inhibits the reaction [[Arsenic Trioxide co-treated with lonidamine] results in increased cleavage of and results in increased activity of CASP8 protein]; BCL2 protein inhibits the reaction [[Arsenic Trioxide co-treated with Quercetin] results in increased cleavage of and results in increased activity of CASP8 protein]; BCL2 protein inhibits the reaction [Arsenic Trioxide inhibits the reaction [BCL2 protein binds to BAX protein]]; BCL2 protein inhibits the reaction [Arsenic Trioxide promotes the reaction [lonidamine results in increased cleavage of and results in increased activity of CASP9 protein]]; BCL2 protein inhibits the reaction [Arsenic Trioxide results in decreased expression of MYC mRNA]; BCL2 protein inhibits the reaction [Arsenic Trioxide results in increased activity of BAX protein]; BCL2 protein inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; BCL2 protein inhibits the reaction [lonidamine promotes the reaction [Arsenic Trioxide results in increased cleavage of and results in increased activity of CASP9 protein]]; Cycloheximide inhibits the reaction [Arsenic Trioxide results in increased expression of BCL2 protein]; Dactinomycin inhibits the reaction [Arsenic Trioxide results in increased expression of BCL2 protein]; Dithiothreitol inhibits the reaction [Arsenic Trioxide results in increased expression of BCL2 protein]; Gemcitabine promotes the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]; Genistein promotes the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]; GH1 protein promotes the reaction [Arsenic Trioxide results in decreased expression of BCL2 mRNA]; GRB10 protein promotes the reaction [[Arsenic Trioxide co-treated with apatinib] results in decreased expression of BCL2 protein]; HOMER3 protein affects the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]; ID1 protein inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]; MAPK14 mutant form inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of BCL2 protein]; MAPK8 mutant form inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of BCL2 protein]; MAPK9 mutant form inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of BCL2 protein]; MARVELD1 protein inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]; Matrines promotes the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]; NVP-BKM120 promotes the reaction [Arsenic Trioxide results in decreased expression of BCL2 mRNA]; pyrazolanthrone inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]; pyrazolanthrone inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of BCL2 protein]; Resveratrol promotes the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]; SB 203580 inhibits the reaction [Arsenic Trioxide affects the localization of BCL2 protein]; SB 203580 inhibits the reaction [Arsenic Trioxide results in increased expression of BCL2 mRNA]; SB 203580 inhibits the reaction [Arsenic Trioxide results in increased expression of BCL2 protein]; SB 203580 promotes the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]; Wortmannin inhibits the reaction [[Hydrogen Peroxide co-treated with Arsenic Trioxide] results in decreased expression of BCL2 protein]
Arsenic Trioxide results in decreased expression of BCL2 mRNA; Arsenic Trioxide results in decreased expression of BCL2 protein
BCL2 protein affects the susceptibility to Arsenic Trioxide
Arsenic Trioxide affects the folding of BCL2 protein
Arsenic Trioxide affects the expression of BCL2 mRNA; Arsenic Trioxide affects the expression of BCL2 protein
BCL2 protein results in decreased susceptibility to Arsenic Trioxide; BCL2 results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in increased expression of BCL2 mRNA; Arsenic Trioxide results in increased expression of BCL2 protein
Arsenic Trioxide results in increased degradation of BCL2 protein
18alpha,20beta-hydroxy-11-oxo-norolean-12-en-3beta-yl-2-O-beta-D-glucopyranurosyl-alpha-D-glucopyranosiduronate magnesium tetrahydrate inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]; [Genistein co-treated with Arsenic Trioxide] results in decreased expression of BCL2 protein; Arsenic Trioxide promotes the reaction [Drugs, Chinese Herbal results in decreased expression of BCL2 protein]; baicalin inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 mRNA]; baicalin inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]; Drugs, Chinese Herbal promotes the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]; MIR34A affects the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]; Propranolol inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]
BCL2 mutant form results in increased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in decreased expression of BCL2; Arsenic Trioxide results in decreased expression of BCL2 mRNA; Arsenic Trioxide results in decreased expression of BCL2 protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [salvianolic acid B inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]]; [alpha-Tocopherol co-treated with Ascorbic Acid] inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 mRNA]; [Arsenic Trioxide results in increased abundance of Arsenic] which results in decreased expression of BCL2 protein; Apigenin inhibits the reaction [[Arsenic Trioxide results in increased abundance of Arsenic] which results in decreased expression of BCL2 protein]; crocin inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 mRNA]; crocin inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]; Febuxostat inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]; ferrostatin-1 inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]; HTS 466284 inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]; Phloretin inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 mRNA]; pifithrin inhibits the reaction [Arsenic Trioxide results in increased expression of BCL2 mRNA]; salvianolic acid A inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]; salvianolic acid B inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]; Taurine inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]; trans-sodium crocetinate inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein] 		CTD PMID:8704214 PMID:9129041 PMID:9716575 PMID:9734658 PMID:10340400 More... NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900 		JBrowse link
G Bcl2a1 BCL2-related protein A1 decreases expression
multiple interactions
increases expression 		ISO
EXP 		Arsenic Trioxide results in decreased expression of BCL2A1 mRNA
[Tretinoin co-treated with Arsenic Trioxide co-treated with Butyrates] results in increased expression of BCL2A1 mRNA; [Tretinoin co-treated with Arsenic Trioxide co-treated with hexamethylene bisacetamide] results in increased expression of BCL2A1 mRNA; [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of BCL2A1 mRNA; Arsenic Trioxide inhibits the reaction [Tretinoin results in increased expression of BCL2A1A protein]
Arsenic Trioxide results in increased expression of BCL2A1 mRNA
Arsenic Trioxide results in decreased expression of BCL2A1D mRNA 		CTD PMID:10673743 PMID:11133770 PMID:12130515 PMID:15894607 PMID:17530438 More... NCBI chr 8:98,596,806...98,604,890
Ensembl chr 8:98,596,650...98,604,890 		JBrowse link
G Bcl2l1 Bcl2-like 1 affects expression
affects response to substance
multiple interactions
increases expression
decreases expression 		EXP
ISO 		Arsenic Trioxide affects the expression of BCL2L1 protein
BCL2L1 protein affects the susceptibility to Arsenic Trioxide
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [salvianolic acid B inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2L1 protein]]; salvianolic acid A inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2L1 protein]; salvianolic acid B inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2L1 protein]
Arsenic Trioxide results in increased expression of BCL2L1 mRNA; Arsenic Trioxide results in increased expression of BCL2L1 protein
[Genistein co-treated with Arsenic Trioxide] results in decreased expression of BCL2L1 protein; Arsenic Trioxide promotes the reaction [Drugs, Chinese Herbal results in decreased expression of BCL2L1 protein]; Drugs, Chinese Herbal promotes the reaction [Arsenic Trioxide results in decreased expression of BCL2L1 protein]
Arsenic Trioxide results in decreased expression of BCL2L1 mRNA; Arsenic Trioxide results in decreased expression of BCL2L1 protein
[Arsenic Trioxide co-treated with epigallocatechin gallate] results in decreased expression of BCL2L1 protein; [Arsenic Trioxide co-treated with Ethacrynic Acid] results in increased expression of BCL2L1 protein; [Arsenic Trioxide co-treated with IL24 protein] results in decreased expression of BCL2L1; [Arsenic Trioxide co-treated with Quercetin] results in decreased expression of BCL2L1 protein; [BIBR 1532 co-treated with Arsenic Trioxide] affects the expression of BCL2L1 mRNA; [Genistein co-treated with Arsenic Trioxide] results in decreased expression of BCL2L1 protein; [paricalcitol co-treated with Arsenic Trioxide] results in decreased expression of BCL2L1; [Sulindac co-treated with Arsenic Trioxide] results in increased phosphorylation of BCL2L1 protein; Acetylcysteine inhibits the reaction [[Sulindac co-treated with Arsenic Trioxide] results in increased phosphorylation of BCL2L1 protein]; allicin inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2L1 protein]; Genistein promotes the reaction [Arsenic Trioxide results in decreased expression of BCL2L1 protein]; Hydrogen Peroxide inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2L1 protein]; MAPK8 affects the reaction [[Sulindac co-treated with Arsenic Trioxide] results in increased phosphorylation of BCL2L1 protein]; MMP9 protein inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2L1 protein]; pyrazolanthrone inhibits the reaction [[Sulindac co-treated with Arsenic Trioxide] results in increased phosphorylation of BCL2L1 protein]; Wortmannin inhibits the reaction [Hydrogen Peroxide inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2L1 protein]] 		CTD PMID:10648417 PMID:11468182 PMID:11739184 PMID:12480548 PMID:12883035 More... NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907
Ensembl chr 1:161,745,540...161,764,907 		JBrowse link
G Bcl2l10 Bcl2-like 10 decreases expression EXP Arsenic Trioxide results in decreased expression of BCL2L10 mRNA CTD PMID:19730151 NCBI chr 8:84,987,833...84,993,878
Ensembl chr 8:84,987,833...84,993,872 		JBrowse link
G Bcl2l11 Bcl2-like 11 increases expression
multiple interactions
increases degradation
affects expression 		ISO Arsenic Trioxide results in increased expression of BCL2L11 mRNA; Arsenic Trioxide results in increased expression of BCL2L11 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased degradation of BCL2L11 protein]; [Arsenic Trioxide co-treated with Curcumin] results in increased expression of BCL2L11 protein; [Arsenic Trioxide co-treated with VS-5584] results in increased expression of BCL2L11 mRNA; [Arsenic Trioxide results in increased expression of BCL2L11 protein] which results in decreased phosphorylation of AKT1 protein; Arsenic Trioxide inhibits the reaction [BCL2L11 protein binds to MCL1 protein]; Arsenic Trioxide inhibits the reaction [Tunicamycin results in increased expression of BCL2L11 protein]; Arsenic Trioxide promotes the reaction [Matrines results in increased expression of BCL2L11 protein]; BCL2L11 mutant form inhibits the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; BCL2L11 mutant form inhibits the reaction [Arsenic Trioxide results in increased cleavage of CASP9 protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Arsenic Trioxide results in increased degradation of BCL2L11 protein]; Bortezomib inhibits the reaction [Arsenic Trioxide results in increased degradation of BCL2L11 protein]; Matrines promotes the reaction [Arsenic Trioxide results in increased expression of BCL2L11 protein]; MMP9 protein inhibits the reaction [Arsenic Trioxide inhibits the reaction [BCL2L11 protein binds to MCL1 protein]]; MMP9 protein inhibits the reaction [Arsenic Trioxide results in increased expression of BCL2L11 protein]
Arsenic Trioxide affects the expression of BCL2L11 protein 		CTD PMID:17203211 PMID:17530438 PMID:21655183 PMID:23700110 PMID:24956101 More... NCBI chr 3:135,820,042...135,857,330
Ensembl chr 3:135,817,562...135,960,695 		JBrowse link
G Bcl2l12 Bcl2 like 12 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to BCL2L12 protein] CTD PMID:26598702 NCBI chr 1:104,608,753...104,617,472
Ensembl chr 1:104,608,753...104,617,472 		JBrowse link
G Bcl2l14 Bcl2-like 14 increases expression
decreases response to substance
multiple interactions 		ISO Arsenic Trioxide results in increased expression of BCL2L14 mRNA
BCL2L14 protein results in decreased susceptibility to Arsenic Trioxide
[sanguinarine co-treated with Arsenic Trioxide] results in increased expression of BCL2L14 mRNA 		CTD PMID:20458559 PMID:20707922 PMID:24345465 NCBI chr 4:168,948,919...168,989,450
Ensembl chr 4:168,948,946...168,990,079 		JBrowse link
G Bcl2l2 Bcl2-like 2 increases expression
decreases expression
multiple interactions 		ISO
EXP 		Arsenic Trioxide results in increased expression of BCL2L2 protein
Arsenic Trioxide results in decreased expression of BCL2L2 mRNA
[Arsenic Trioxide co-treated with Curcumin] affects the expression of BCL2L2 protein 		CTD PMID:19730151 PMID:27430728 NCBI chr15:32,326,686...32,337,834
Ensembl chr15:32,326,020...32,335,379 		JBrowse link
G Bcl3 BCL3, transcription coactivator multiple interactions ISO [Arsenic Trioxide co-treated with Bortezomib] results in decreased expression of BCL3 mRNA CTD PMID:20471514 NCBI chr 1:88,599,321...88,613,555
Ensembl chr 1:88,599,321...88,614,368 		JBrowse link
G Bcl6 BCL6, transcription repressor increases expression ISO Arsenic Trioxide results in increased expression of BCL6 mRNA CTD PMID:24356939 NCBI chr11:90,358,753...90,382,049
Ensembl chr11:90,358,753...90,382,047 		JBrowse link
G Bcl7a BAF chromatin remodeling complex subunit BCL7A increases expression ISO Arsenic Trioxide results in increased expression of BCL7A mRNA CTD PMID:20458559 NCBI chr12:38,872,851...38,904,770
Ensembl chr12:38,872,851...38,904,770 		JBrowse link
G Bcl7b BAF chromatin remodeling complex subunit BCL7B increases expression ISO Arsenic Trioxide results in increased expression of BCL7B mRNA CTD PMID:39716349 NCBI chr12:27,133,412...27,146,631
Ensembl chr12:27,133,412...27,146,636 		JBrowse link
G Bco1 beta-carotene oxygenase 1 decreases expression ISO Arsenic Trioxide results in decreased expression of BCO1 mRNA CTD PMID:15761015 NCBI chr19:62,058,061...62,094,923
Ensembl chr19:62,058,089...62,094,917 		JBrowse link
G Bcr BCR activator of RhoGEF and GTPase multiple interactions
increases degradation
increases expression
decreases expression 		ISO Arsenic Trioxide promotes the reaction [CTSB protein results in increased degradation of BCR protein mutant form]; Arsenic Trioxide promotes the reaction [SQSTM1 protein results in increased localization of BCR protein mutant form]; Arsenic Trioxide results in decreased expression of [BCR protein mutant form binds to ABL1 protein mutant form]; ATG7 protein promotes the reaction [Arsenic Trioxide results in increased degradation of BCR protein mutant form]; BECN1 protein promotes the reaction [Arsenic Trioxide results in increased degradation of BCR protein mutant form]; SQSTM1 protein promotes the reaction [Arsenic Trioxide results in increased degradation of BCR protein mutant form]
Arsenic Trioxide results in increased expression of BCR mRNA
Arsenic Trioxide results in decreased expression of BCR mRNA; Arsenic Trioxide results in decreased expression of BCR protein mutant form 		CTD PMID:14633726 PMID:20458559 PMID:22330069 PMID:22521957 PMID:22898604 More... NCBI chr20:13,468,732...13,596,333
Ensembl chr20:13,468,732...13,596,333 		JBrowse link
G Bdh1 3-hydroxybutyrate dehydrogenase 1 decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of BDH1 mRNA
Arsenic Trioxide results in increased expression of BDH1 mRNA 		CTD PMID:22521957 PMID:39716349 NCBI chr11:82,806,125...82,848,133
Ensembl chr11:82,807,503...82,842,636 		JBrowse link
G Bdh2 3-hydroxybutyrate dehydrogenase 2 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to BDH2 protein] CTD PMID:26598702 NCBI chr 2:226,376,346...226,397,010
Ensembl chr 2:226,376,356...226,397,006 		JBrowse link
G Bdkrb2 bradykinin receptor B2 increases expression ISO Arsenic Trioxide results in increased expression of BDKRB2 mRNA CTD PMID:37969188 NCBI chr 6:130,237,055...130,267,205
Ensembl chr 6:130,237,255...130,267,209 		JBrowse link
G Bdnf brain-derived neurotrophic factor decreases expression
multiple interactions 		ISO
EXP 		Arsenic Trioxide results in decreased expression of BDNF protein
Arsenic Trioxide promotes the reaction [Reserpine results in decreased expression of BDNF protein]; Resveratrol inhibits the reaction [Arsenic Trioxide results in decreased expression of BDNF protein]
Arsenic Trioxide results in decreased expression of BDNF mRNA 		CTD PMID:16711005 PMID:26114099 PMID:29223816 PMID:34050381 NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657 		JBrowse link
G Becn1 beclin 1 increases expression
multiple interactions
decreases expression 		ISO
EXP 		Arsenic Trioxide results in increased expression of BECN1; Arsenic Trioxide results in increased expression of BECN1 mRNA; Arsenic Trioxide results in increased expression of BECN1 protein
3-methyladenine inhibits the reaction [Arsenic Trioxide results in increased expression of BECN1]; Arsenic Trioxide promotes the reaction [ABL1 protein mutant form binds to BECN1 protein]; BECN1 protein promotes the reaction [Arsenic Trioxide results in increased degradation of BCR protein mutant form]; Cycloheximide inhibits the reaction [Arsenic Trioxide results in increased expression of BECN1 protein]
3-methyladenine inhibits the reaction [Arsenic Trioxide results in increased expression of BECN1 mRNA]; [Cisplatin co-treated with Arsenic Trioxide] results in increased expression of BECN1 protein
ferrostatin-1 inhibits the reaction [Arsenic Trioxide results in decreased expression of BECN1 protein] 		CTD PMID:16882451 PMID:20200477 PMID:21594580 PMID:22519831 PMID:22898604 More... NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,731,650...86,747,002 		JBrowse link
G Best1 bestrophin 1 increases expression ISO Arsenic Trioxide results in increased expression of BEST1 mRNA CTD PMID:39716349 NCBI chr 1:216,054,395...216,071,012
Ensembl chr 1:216,054,395...216,070,974 		JBrowse link
G Bfar bifunctional apoptosis regulator decreases expression
increases expression 		EXP
ISO 		Arsenic Trioxide results in decreased expression of BFAR mRNA
Arsenic Trioxide results in increased expression of BFAR mRNA 		CTD PMID:19730151 PMID:20458559 PMID:35676786 NCBI chr10:2,059,189...2,092,207
Ensembl chr10:2,059,058...2,094,183 		JBrowse link
G Bglap bone gamma-carboxyglutamate protein decreases expression
multiple interactions 		EXP Arsenic Trioxide results in decreased expression of BGLAP; Arsenic Trioxide results in decreased expression of BGLAP mRNA
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in decreased expression of BGLAP] 		CTD PMID:22465848 PMID:24531206 NCBI chr 2:176,136,341...176,137,318
Ensembl chr 2:176,136,341...176,137,318 		JBrowse link
G Bgn biglycan decreases expression ISO Arsenic Trioxide results in decreased expression of BGN mRNA CTD PMID:39716349 NCBI chr  X:156,348,633...156,360,797
Ensembl chr  X:156,348,615...156,360,799 		JBrowse link
G Bhlhe40 basic helix-loop-helix family, member e40 multiple interactions
increases expression 		ISO [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of BHLHE40 mRNA
Arsenic Trioxide results in increased expression of BHLHE40 mRNA 		CTD PMID:15761015 PMID:15894607 NCBI chr 4:143,174,450...143,180,150
Ensembl chr 4:143,174,048...143,180,783 		JBrowse link
G Bhlhe41 basic helix-loop-helix family, member e41 decreases expression ISO Arsenic Trioxide results in decreased expression of BHLHE41 mRNA CTD PMID:35676786 NCBI chr 4:180,565,003...180,569,415
Ensembl chr 4:180,565,003...180,569,355 		JBrowse link
G Bid BH3 interacting domain death agonist decreases expression
affects cleavage
multiple interactions
increases activity
increases cleavage
affects expression 		ISO
EXP 		Arsenic Trioxide results in decreased expression of BID protein
Arsenic Trioxide affects the cleavage of BID protein
[Arsenic Trioxide co-treated with apatinib] results in increased expression of BID protein; [Arsenic Trioxide co-treated with Aprepitant] results in increased expression of BID mRNA; [Arsenic Trioxide co-treated with Curcumin] results in decreased expression of BID protein; [Arsenic Trioxide co-treated with Curcumin] results in increased expression of BID protein; [Arsenic Trioxide co-treated with esculetin] results in increased cleavage of BID protein; [Arsenic Trioxide co-treated with lonidamine] results in increased cleavage of and results in increased activity of BID protein; [Arsenic Trioxide co-treated with NVP-BKM120] results in increased expression of BID mRNA; [Arsenic Trioxide co-treated with Quercetin] results in increased cleavage of BID protein; [Arsenic Trioxide co-treated with TNF protein] results in increased cleavage of and results in increased activity of BID protein; Arsenic Trioxide results in increased cleavage of and results in increased activity of BID protein; Curcumin promotes the reaction [Arsenic Trioxide results in increased activity of BID protein]; Deoxyglucose promotes the reaction [Arsenic Trioxide results in increased cleavage of and results in increased activity of BID protein]; Genistein promotes the reaction [Arsenic Trioxide results in increased cleavage of and results in increased activity of BID protein]; pyrazolanthrone promotes the reaction [Arsenic Trioxide results in increased cleavage of BID protein]; TP53 protein inhibits the reaction [Arsenic Trioxide results in increased cleavage of and results in increased activity of BID protein]; U 0126 promotes the reaction [Arsenic Trioxide results in increased cleavage of BID protein]
Arsenic Trioxide promotes the reaction [Drugs, Chinese Herbal results in increased cleavage of BID protein]
Arsenic Trioxide affects the expression of BID protein 		CTD PMID:10648417 PMID:12851490 PMID:15131059 PMID:15665116 PMID:16972261 More... NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:155,785,377...155,808,275 		JBrowse link
G Bik BCL2-interacting killer multiple interactions
increases expression 		ISO
EXP 		[sanguinarine co-treated with Arsenic Trioxide] results in increased expression of BIK mRNA
Arsenic Trioxide results in increased expression of BIK mRNA 		CTD PMID:19730151 PMID:24345465 NCBI chr 7:116,552,303...116,571,317
Ensembl chr 7:116,552,303...116,571,317 		JBrowse link
G Birc2 baculoviral IAP repeat-containing 2 multiple interactions
decreases expression 		ISO [Arsenic Trioxide co-treated with NVP-BKM120] results in decreased expression of BIRC2 mRNA; [NVP-BKM120 co-treated with Arsenic Trioxide] results in decreased expression of BIRC2 mRNA; Arsenic Trioxide promotes the reaction [Aprepitant results in decreased expression of BIRC2 mRNA]
Arsenic Trioxide results in decreased expression of BIRC2 mRNA 		CTD PMID:30145367 PMID:30316766 PMID:31539632 NCBI chr 8:13,253,697...13,273,672
Ensembl chr 8:13,253,706...13,271,911 		JBrowse link
G Birc3 baculoviral IAP repeat-containing 3 decreases expression
increases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of BIRC3 mRNA; Arsenic Trioxide results in decreased expression of BIRC3 protein
Arsenic Trioxide results in increased expression of BIRC3 mRNA
[Arsenic Trioxide co-treated with Curcumin] results in decreased expression of BIRC3 protein; [Arsenic Trioxide co-treated with VS-5584] results in decreased expression of BIRC3 mRNA; [BIBR 1532 co-treated with Arsenic Trioxide] affects the expression of BIRC3 mRNA; Arsenic Trioxide promotes the reaction [Aprepitant results in decreased expression of BIRC3 mRNA]; NVP-BKM120 promotes the reaction [Arsenic Trioxide results in decreased expression of BIRC3 mRNA] 		CTD PMID:19763917 PMID:24356939 PMID:27430728 PMID:29574283 PMID:30145367 More... NCBI chr 8:13,285,702...13,313,329
Ensembl chr 8:13,285,703...13,298,590 		JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 decreases expression
increases expression
affects response to substance
multiple interactions
affects expression
decreases response to substance 		ISO Arsenic Trioxide results in decreased expression of BIRC5 protein
Arsenic Trioxide results in decreased expression of BIRC5; Arsenic Trioxide results in decreased expression of BIRC5 mRNA; Arsenic Trioxide results in decreased expression of BIRC5 protein
Arsenic Trioxide results in increased expression of BIRC5 mRNA; Arsenic Trioxide results in increased expression of BIRC5 protein
BIRC5 protein affects the susceptibility to Arsenic Trioxide
Arsenic Trioxide promotes the reaction [Drugs, Chinese Herbal results in decreased expression of BIRC5 protein]; Drugs, Chinese Herbal promotes the reaction [Arsenic Trioxide results in decreased expression of BIRC5 protein]
Arsenic Trioxide affects the expression of BIRC5 mRNA
BIRC5 protein results in decreased susceptibility to Arsenic Trioxide
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Arsenic Trioxide results in decreased expression of BIRC5 protein]; [Arsenic Trioxide co-treated with Aprepitant] results in decreased expression of BIRC5 mRNA; [Arsenic Trioxide co-treated with Calcitriol] results in decreased expression of BIRC5 mRNA; [Arsenic Trioxide co-treated with Calcitriol] results in decreased expression of BIRC5 protein; [Arsenic Trioxide co-treated with Curcumin] results in decreased expression of BIRC5 protein; [Arsenic Trioxide co-treated with Doxorubicin co-treated with Magnetite Nanoparticles analog] affects the expression of BIRC5 mRNA; [Arsenic Trioxide co-treated with Doxorubicin co-treated with Magnetite Nanoparticles analog] affects the expression of BIRC5 protein; [Arsenic Trioxide co-treated with Ethacrynic Acid] results in decreased expression of BIRC5 protein; [Arsenic Trioxide co-treated with NVP-BKM120] results in decreased expression of BIRC5 mRNA; [Arsenic Trioxide co-treated with Oxygen deficiency] results in decreased expression of BIRC5 mRNA; [Arsenic Trioxide co-treated with Oxygen deficiency] results in decreased expression of BIRC5 protein; [Arsenic Trioxide co-treated with sepantronium] results in decreased expression of BIRC5 protein; [Arsenic Trioxide results in increased susceptibility to PD 173074] which results in decreased expression of BIRC5 protein; [BIBR 1532 co-treated with Arsenic Trioxide] affects the expression of BIRC5 mRNA; [Erlotinib Hydrochloride co-treated with Arsenic Trioxide] results in decreased expression of BIRC5 mRNA; [NVP-BKM120 co-treated with Arsenic Trioxide] results in decreased expression of BIRC5 mRNA; [ruxolitinib co-treated with Arsenic Trioxide] results in decreased expression of BIRC5 mRNA; [Silybin co-treated with Arsenic Trioxide] results in decreased expression of BIRC5 mRNA; [Sulindac co-treated with Arsenic Trioxide] results in decreased expression of BIRC5 protein; Arsenic Trioxide promotes the reaction [Matrines results in decreased expression of BIRC5 protein]; Arsenic Trioxide promotes the reaction [puerarin results in decreased expression of BIRC5 mRNA]; GH1 protein promotes the reaction [Arsenic Trioxide results in decreased expression of BIRC5 mRNA]; Matrines promotes the reaction [Arsenic Trioxide results in decreased expression of BIRC5 protein]; Poly I-C promotes the reaction [Arsenic Trioxide results in decreased expression of BIRC5 protein]; pyrazolanthrone inhibits the reaction [Arsenic Trioxide results in decreased expression of BIRC5 protein]; SB 203580 inhibits the reaction [Arsenic Trioxide results in decreased expression of BIRC5 protein]; U 0126 inhibits the reaction [Arsenic Trioxide results in decreased expression of BIRC5 protein] 		CTD PMID:15587394 PMID:16328441 PMID:16638212 PMID:17869043 PMID:18088464 More... NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,572,080...103,582,155 		JBrowse link
G Birc7 baculoviral IAP repeat-containing 7 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of BIRC7 protein
[Arsenic Trioxide co-treated with Curcumin] results in increased expression of BIRC7 protein; Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to BIRC7 protein]; Arsenic Trioxide promotes the reaction [Bortezomib results in decreased expression of BIRC7 mRNA]
Arsenic Trioxide results in increased expression of BIRC7 mRNA 		CTD PMID:21867610 PMID:26598702 PMID:27430728 PMID:39716349 NCBI chr 3:188,425,392...188,430,174
Ensembl chr 3:188,425,392...188,430,174 		JBrowse link
G Blvrb biliverdin reductase B increases expression ISO Arsenic Trioxide results in increased expression of BLVRB mRNA CTD PMID:15725085 PMID:27829220 PMID:29633893 NCBI chr 1:91,866,258...91,883,921
Ensembl chr 1:91,866,258...91,884,225 		JBrowse link
G Blzf1 basic leucine zipper nuclear factor 1 increases expression ISO Arsenic Trioxide results in increased expression of BLZF1 mRNA CTD PMID:15761015 NCBI chr13:79,174,898...79,190,116
Ensembl chr13:79,174,902...79,190,116 		JBrowse link
G Bmf Bcl2 modifying factor increases expression ISO Arsenic Trioxide results in increased expression of BMF mRNA CTD PMID:19417148 NCBI chr 3:125,953,466...125,974,087
Ensembl chr 3:125,953,466...125,974,258 		JBrowse link
G Bmi1 BMI1 proto-oncogene, polycomb ring finger decreases response to substance ISO BMI1 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:24571310 NCBI chr17:86,240,683...86,250,044
Ensembl chr17:86,243,491...86,250,024 		JBrowse link
G Bmp1 bone morphogenetic protein 1 multiple interactions ISO [Arsenic Trioxide co-treated with apatinib] results in decreased expression of BMP1 mRNA CTD PMID:39223679 NCBI chr15:51,961,310...52,005,597
Ensembl chr15:51,961,310...52,005,485 		JBrowse link
G Bmp2 bone morphogenetic protein 2 multiple interactions
decreases expression 		EXP 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in decreased expression of BMP2] CTD PMID:24531206 NCBI chr 3:141,264,648...141,275,416
Ensembl chr 3:141,264,646...141,274,760 		JBrowse link
G Bmpr1a bone morphogenetic protein receptor type 1A decreases expression ISO Arsenic Trioxide results in decreased expression of BMPR1A mRNA CTD PMID:39716349 NCBI chr16:9,740,751...9,786,861
Ensembl chr16:9,742,875...9,786,861 		JBrowse link
G Bmpr2 bone morphogenetic protein receptor type 2 increases expression ISO Arsenic Trioxide results in increased expression of BMPR2 mRNA CTD PMID:20458559 NCBI chr 9:68,685,942...68,801,353
Ensembl chr 9:68,685,988...68,801,350 		JBrowse link
G Bnc2 basonuclin zinc finger protein 2 decreases expression ISO Arsenic Trioxide results in decreased expression of BNC2 mRNA CTD PMID:26705709 NCBI chr 5:103,724,934...104,061,890
Ensembl chr 5:103,724,934...104,125,428 		JBrowse link
G Bnip3 BCL2 interacting protein 3 multiple interactions
increases expression
decreases expression
increases response to substance 		ISO
EXP 		[Arsenic Trioxide co-treated with benzyloxycarbonylleucyl-leucyl-leucine aldehyde] results in decreased expression of BNIP3 mRNA; Arsenic Trioxide inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of BNIP3 mRNA]
Arsenic Trioxide results in increased expression of BNIP3 mRNA; Arsenic Trioxide results in increased expression of BNIP3 protein
Arsenic Trioxide results in decreased expression of BNIP3 mRNA
BNIP3 protein results in increased susceptibility to Arsenic Trioxide 		CTD PMID:15592527 PMID:17530438 PMID:19730151 PMID:25446377 NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:203,137,778...203,154,962 		JBrowse link
G Bnip3l BCL2 interacting protein 3 like increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of BNIP3L mRNA; Arsenic Trioxide results in increased expression of BNIP3L protein
[sanguinarine co-treated with Arsenic Trioxide] results in increased expression of BNIP3L mRNA 		CTD PMID:15592527 PMID:24345465 NCBI chr15:45,350,081...45,373,213
Ensembl chr15:45,334,537...45,373,282 		JBrowse link
G Boc BOC cell adhesion associated, oncogene regulated decreases expression ISO Arsenic Trioxide results in decreased expression of BOC mRNA CTD PMID:26705709 NCBI chr11:69,628,703...69,704,009
Ensembl chr11:69,628,660...69,704,004 		JBrowse link
G Bod1l1 biorientation of chromosomes in cell division 1-like 1 increases expression ISO Arsenic Trioxide results in increased expression of BOD1L1 mRNA CTD PMID:26705709 NCBI chr14:73,320,880...73,375,662
Ensembl chr14:73,320,832...73,375,658 		JBrowse link
G Bop1 BOP1 ribosomal biogenesis factor decreases expression ISO Arsenic Trioxide results in decreased expression of BOP1 mRNA CTD PMID:20458559 NCBI chr 7:110,052,716...110,076,529
Ensembl chr 7:110,052,720...110,076,529 		JBrowse link
G Bpi bactericidal/permeability-increasing protein increases expression ISO Arsenic Trioxide results in increased expression of BPI mRNA CTD PMID:15761015 PMID:20458559 NCBI chr 3:167,329,513...167,356,217
Ensembl chr 3:167,329,530...167,356,396 		JBrowse link
G Braf B-Raf proto-oncogene, serine/threonine kinase decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of BRAF mRNA
Arsenic Trioxide results in increased expression of BRAF mRNA 		CTD PMID:24831965 PMID:29633893 NCBI chr 4:69,329,772...69,476,931
Ensembl chr 4:69,342,813...69,476,931 		JBrowse link
G Brca1 BRCA1, DNA repair associated increases expression ISO Arsenic Trioxide results in increased expression of BRCA1 mRNA CTD PMID:20458559 NCBI chr10:86,917,693...86,978,012
Ensembl chr10:86,917,693...86,977,763 		JBrowse link
G Brca2 BRCA2, DNA repair associated multiple interactions
decreases expression 		ISO [Arsenic Trioxide co-treated with Bortezomib] results in increased expression of BRCA2 mRNA
Arsenic Trioxide results in decreased expression of BRCA2 mRNA 		CTD PMID:20471514 PMID:25913414 NCBI chr12:4,895,092...4,939,340
Ensembl chr12:4,895,447...4,936,194 		JBrowse link
G Brd8 bromodomain containing 8 increases expression ISO Arsenic Trioxide results in increased expression of BRD8 mRNA CTD PMID:39716349 NCBI chr18:26,455,824...26,504,106
Ensembl chr18:26,455,512...26,504,006 		JBrowse link
G Brinp1 BMP/retinoic acid inducible neural specific 1 increases expression ISO Arsenic Trioxide results in increased expression of BRINP1 mRNA CTD PMID:15761015 NCBI chr 5:87,363,621...87,565,580
Ensembl chr 5:87,364,050...87,508,256 		JBrowse link
G Brpf1 bromodomain and PHD finger containing, 1 increases expression ISO Arsenic Trioxide results in increased expression of BRPF1 mRNA CTD PMID:29633893 NCBI chr 4:148,011,977...148,028,431
Ensembl chr 4:148,011,931...148,028,424 		JBrowse link
G Bsg basigin decreases expression ISO Arsenic Trioxide results in decreased expression of BSG mRNA; Arsenic Trioxide results in decreased expression of BSG protein CTD PMID:23232515 NCBI chr 7:10,643,788...10,651,005
Ensembl chr 7:10,643,789...10,651,005 		JBrowse link
G Bst2 bone marrow stromal cell antigen 2 multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of BST2 mRNA CTD PMID:15894607 NCBI chr16:18,250,593...18,254,967
Ensembl chr16:18,251,847...18,254,967 		JBrowse link
G Btaf1 B-TFIID TATA-box binding protein associated factor 1 increases expression ISO Arsenic Trioxide results in increased expression of BTAF1 mRNA CTD PMID:39716349 NCBI chr 1:244,065,728...244,156,457
Ensembl chr 1:244,065,743...244,156,457 		JBrowse link
G Btbd2 BTB domain containing 2 decreases expression ISO Arsenic Trioxide results in decreased expression of BTBD2 mRNA CTD PMID:15725085 NCBI chr 7:9,710,392...9,726,032
Ensembl chr 7:9,712,269...9,726,032 		JBrowse link
G Btbd3 BTB domain containing 3 decreases expression ISO Arsenic Trioxide results in decreased expression of BTBD3 mRNA CTD PMID:15725085 NCBI chr 3:146,044,053...146,074,189
Ensembl chr 3:146,044,096...146,074,635 		JBrowse link
G Btf3 basic transcription factor 3 increases expression ISO Arsenic Trioxide results in increased expression of BTF3 mRNA CTD PMID:20458559 NCBI chr 2:31,394,010...31,401,138
Ensembl chr 2:31,394,011...31,401,125
Ensembl chr13:31,394,011...31,401,125 		JBrowse link
G Btg1 BTG anti-proliferation factor 1 increases expression ISO Arsenic Trioxide results in increased expression of BTG1 mRNA CTD PMID:18231732 NCBI chr 7:33,228,149...33,230,406
Ensembl chr 7:33,227,833...33,230,406 		JBrowse link
G Btg2 BTG anti-proliferation factor 2 increases expression ISO Arsenic Trioxide results in increased expression of BTG2 mRNA CTD PMID:20458559 PMID:22521957 NCBI chr13:48,083,931...48,087,690
Ensembl chr13:48,083,931...48,087,690 		JBrowse link
G Btk Bruton tyrosine kinase increases expression ISO Arsenic Trioxide results in increased expression of BTK mRNA CTD PMID:23911876 NCBI chr  X:102,016,070...102,055,448
Ensembl chr  X:102,016,074...102,055,143 		JBrowse link
G Bub1b BUB1 mitotic checkpoint serine/threonine kinase B increases phosphorylation
multiple interactions 		ISO Arsenic Trioxide results in increased phosphorylation of BUB1B protein
17-(dimethylaminoethylamino)-17-demethoxygeldanamycin promotes the reaction [Arsenic Trioxide results in increased phosphorylation of BUB1B protein]; [Arsenic Trioxide co-treated with Paclitaxel] promotes the reaction [BUB1B protein binds to CDC20 protein]; [Arsenic Trioxide co-treated with Paclitaxel] results in increased expression of BUB1B protein modified form; KNK 437 promotes the reaction [Arsenic Trioxide results in increased phosphorylation of BUB1B protein] 		CTD PMID:19371599 PMID:19781537 NCBI chr 3:126,017,019...126,069,470
Ensembl chr 3:126,017,045...126,069,796 		JBrowse link
G Bzw1 basic leucine zipper and W2 domains 1 increases expression ISO Arsenic Trioxide results in increased expression of BZW1 mRNA CTD PMID:22521957 NCBI chr 9:67,424,860...67,438,656
Ensembl chr 9:67,424,866...67,439,684 		JBrowse link
G Bzw2 basic leucine zipper and W2 domains 2 decreases expression ISO Arsenic Trioxide results in decreased expression of BZW2 mRNA CTD PMID:27829220 NCBI chr 6:58,555,362...58,615,921
Ensembl chr 6:58,554,961...58,615,912 		JBrowse link
G C10h17orf78 similar to human chromosome 17 open reading frame 78 decreases expression ISO Arsenic Trioxide results in decreased expression of C17ORF78 mRNA CTD PMID:39716349 NCBI chr10:69,537,701...69,552,358
Ensembl chr10:69,535,160...69,583,661 		JBrowse link
G C10h5orf58 similar to human chromosome 5 open reading frame 58 decreases expression ISO Arsenic Trioxide results in decreased expression of C5ORF58 mRNA CTD PMID:26705709 NCBI chr10:19,195,306...19,203,013
Ensembl chr10:19,193,035...19,205,380 		JBrowse link
G C1qb complement C1q B chain increases expression ISO Arsenic Trioxide results in increased expression of C1QB mRNA CTD PMID:19128835 NCBI chr 5:154,402,276...154,407,827
Ensembl chr 5:154,402,279...154,407,840 		JBrowse link
G C1qtnf4 C1q and TNF related 4 decreases expression ISO Arsenic Trioxide results in decreased expression of C1QTNF4 mRNA CTD PMID:26705709 NCBI chr 3:97,310,220...97,328,818
Ensembl chr 3:97,327,670...97,342,587 		JBrowse link
G C1qtnf7 C1q and TNF related 7 decreases expression ISO Arsenic Trioxide results in decreased expression of C1QTNF7 mRNA CTD PMID:26705709 NCBI chr14:71,680,415...71,792,931
Ensembl chr14:71,680,479...71,792,865 		JBrowse link
G C1r complement C1r increases expression ISO Arsenic Trioxide results in increased expression of C1R mRNA CTD PMID:20458559 NCBI chr 4:159,099,013...159,109,770
Ensembl chr 4:159,098,918...159,109,714 		JBrowse link
G C2cd3 C2 domain containing 3 centriole elongation regulator increases expression ISO Arsenic Trioxide results in increased expression of C2CD3 mRNA CTD PMID:39716349 NCBI chr 1:164,127,304...164,225,088
Ensembl chr 1:164,127,281...164,225,086 		JBrowse link
G C2h3orf80 similar to human chromosome 3 open reading frame 80 decreases expression ISO Arsenic Trioxide results in decreased expression of C3ORF80 mRNA CTD PMID:26705709 NCBI chr 2:155,435,287...155,438,099
Ensembl chr 2:155,434,073...155,437,507 		JBrowse link
G C3 complement C3 decreases expression ISO Arsenic Trioxide results in decreased expression of C3 mRNA CTD PMID:29633893 NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,174,412...2,201,339 		JBrowse link
G C3h15orf48 similar to human chromosome 15 open reading frame 48 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of NMES1 mRNA
Arsenic Trioxide results in decreased expression of COXFA4L3 mRNA 		CTD PMID:19128835 PMID:20458559 PMID:39716349 NCBI chr 3:130,173,535...130,177,088
Ensembl chr 3:130,173,416...130,177,089 		JBrowse link
G C4b complement C4B decreases expression ISO Arsenic Trioxide results in decreased expression of C4B mRNA CTD PMID:29633893 NCBI chr20:4,201,979...4,216,292
Ensembl chr20:4,201,961...4,216,289 		JBrowse link
G C4bpa complement component 4 binding protein, alpha increases expression ISO Arsenic Trioxide results in increased expression of C4BPA mRNA CTD PMID:39716349 NCBI chr13:44,627,959...44,663,552
Ensembl chr13:44,627,982...44,663,471 		JBrowse link
G C5 complement C5 decreases expression ISO Arsenic Trioxide results in decreased expression of C5 mRNA CTD PMID:27829220 PMID:29633893 NCBI chr 3:38,668,174...38,759,468
Ensembl chr 3:38,668,174...38,759,468 		JBrowse link
G C8h11orf54 similar to human chromosome 11 open reading frame 54 multiple interactions
decreases expression 		ISO [Arsenic Trioxide co-treated with Ascorbic Acid] results in decreased expression of BKGD mRNA
Arsenic Trioxide results in decreased expression of BKGD mRNA 		CTD PMID:25555879 NCBI chr 8:20,405,240...20,427,811
Ensembl chr 8:20,405,241...20,427,811 		JBrowse link
G C8h11orf87 similar to human chromosome 11 open reading frame 87 decreases expression ISO Arsenic Trioxide results in decreased expression of C11ORF87 mRNA CTD PMID:26705709 NCBI chr 8:61,958,626...61,966,119
Ensembl chr 8:61,957,676...61,968,365 		JBrowse link
G Ca3 carbonic anhydrase 3 multiple interactions
decreases expression 		ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CA3 protein]
Arsenic Trioxide results in decreased expression of CAR3 mRNA 		CTD PMID:26598702 PMID:35676786 NCBI chr 2:88,491,666...88,501,299
Ensembl chr 2:88,491,670...88,500,524 		JBrowse link
G Ca9 carbonic anhydrase 9 multiple interactions
decreases expression 		ISO Arsenic Trioxide promotes the reaction [Silybin results in decreased expression of CA9 mRNA]
Arsenic Trioxide results in decreased expression of CA9 mRNA 		CTD PMID:21969006 NCBI chr 5:62,559,024...62,565,626
Ensembl chr 5:62,558,823...62,565,626 		JBrowse link
G Cab39l calcium binding protein 39-like increases expression
decreases response to substance
decreases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of CAB39L mRNA
CAB39L protein alternative form results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in decreased expression of CAB39L protein alternative form
CAB39L protein alternative form inhibits the reaction [Arsenic Trioxide results in decreased expression of CCNB1 protein]; CAB39L protein alternative form inhibits the reaction [Arsenic Trioxide results in decreased expression of CCND1 protein]; CAB39L protein alternative form inhibits the reaction [Arsenic Trioxide results in decreased expression of CTNNB1 mRNA]; CAB39L protein alternative form inhibits the reaction [Arsenic Trioxide results in decreased expression of CTNNB1 protein]; CAB39L protein alternative form inhibits the reaction [Arsenic Trioxide results in decreased expression of MYC protein] 		CTD PMID:27829220 PMID:29059232 NCBI chr15:37,782,778...37,885,191
Ensembl chr15:37,782,870...37,919,742 		JBrowse link
G Cabin1 calcineurin binding protein 1 decreases expression ISO Arsenic Trioxide results in decreased expression of CABIN1 mRNA CTD PMID:20458559 NCBI chr20:12,892,750...13,014,801
Ensembl chr20:12,892,771...13,014,800 		JBrowse link
G Cabp1 calcium binding protein 1 decreases expression ISO Arsenic Trioxide results in decreased expression of CABP1 mRNA CTD PMID:35676786 NCBI chr12:47,045,914...47,109,614
Ensembl chr12:47,085,292...47,109,611 		JBrowse link
G Cacna1a calcium voltage-gated channel subunit alpha1 A decreases expression ISO Arsenic Trioxide results in decreased expression of CACNA1A mRNA CTD PMID:24831965 NCBI chr19:40,425,560...40,724,810
Ensembl chr19:40,425,560...40,724,599 		JBrowse link
G Cacna1c calcium voltage-gated channel subunit alpha1 C decreases expression ISO Arsenic Trioxide results in decreased expression of CACNA1C mRNA CTD PMID:24831965 NCBI chr 4:153,431,169...154,051,932
Ensembl chr 4:153,436,427...154,051,762 		JBrowse link
G Cacna1e calcium voltage-gated channel subunit alpha1 E increases expression ISO Arsenic Trioxide results in increased expression of CACNA1E mRNA CTD PMID:27829220 NCBI chr13:69,125,048...69,613,795
Ensembl chr13:69,132,305...69,612,983 		JBrowse link
G Cacna2d1 calcium voltage-gated channel auxiliary subunit alpha2delta 1 increases expression ISO Arsenic Trioxide results in increased expression of CACNA2D1 mRNA CTD PMID:20458559 NCBI chr 4:19,902,324...20,330,287
Ensembl chr 4:19,905,764...20,330,147 		JBrowse link
G Cacna2d2 calcium voltage-gated channel auxiliary subunit alpha2delta 2 increases expression ISO Arsenic Trioxide results in increased expression of CACNA2D2 mRNA CTD PMID:15761015 NCBI chr 8:116,950,860...117,082,159
Ensembl chr 8:116,950,907...117,081,759 		JBrowse link
G Cacnb2 calcium voltage-gated channel auxiliary subunit beta 2 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of CACNB2 mRNA
Arsenic Trioxide results in decreased expression of CACNB2 mRNA 		CTD PMID:20458559 PMID:35676786 NCBI chr17:82,473,097...82,818,564
Ensembl chr17:82,473,129...82,818,564 		JBrowse link
G Cacng3 calcium voltage-gated channel auxiliary subunit gamma 3 increases expression ISO Arsenic Trioxide results in increased expression of CACNG3 mRNA CTD PMID:20458559 NCBI chr 1:186,632,334...186,728,220
Ensembl chr 1:186,632,323...186,728,214 		JBrowse link
G Cacng5 calcium voltage-gated channel auxiliary subunit gamma 5 increases expression ISO Arsenic Trioxide results in increased expression of CACNG5 mRNA CTD PMID:20458559 NCBI chr10:93,327,142...93,369,244
Ensembl chr10:93,327,150...93,336,667 		JBrowse link
G Cad carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase decreases expression ISO Arsenic Trioxide results in decreased expression of CAD mRNA CTD PMID:20458559 NCBI chr 6:31,012,091...31,035,098
Ensembl chr 6:31,012,091...31,035,297 		JBrowse link
G Cadm1 cell adhesion molecule 1 decreases expression ISO Arsenic Trioxide results in decreased expression of CADM1 mRNA CTD PMID:27829220 NCBI chr 8:56,744,374...57,075,264
Ensembl chr 8:56,744,372...57,080,192 		JBrowse link
G Calb2 calbindin 2 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CALB2 protein] CTD PMID:26598702 NCBI chr19:55,023,849...55,050,858
Ensembl chr19:55,023,838...55,057,952 		JBrowse link
G Cald1 caldesmon 1 increases expression ISO Arsenic Trioxide results in increased expression of CALD1 mRNA CTD PMID:22535156 NCBI chr 4:64,232,906...64,414,085
Ensembl chr 4:64,233,171...64,414,085 		JBrowse link
G Calr calreticulin increases expression
decreases expression
multiple interactions
increases localization 		ISO Arsenic Trioxide results in increased expression of CALR protein
Arsenic Trioxide results in decreased expression of CALR mRNA
Resveratrol inhibits the reaction [Arsenic Trioxide results in increased expression of CALR protein]
Arsenic Trioxide results in increased localization of CALR protein 		CTD PMID:20458559 PMID:25107562 PMID:38684648 NCBI chr19:40,213,367...40,218,262
Ensembl chr19:40,213,239...40,219,236 		JBrowse link
G Camk2a calcium/calmodulin-dependent protein kinase II alpha decreases expression ISO Arsenic Trioxide results in decreased expression of CAMK2A protein CTD PMID:24831965 NCBI chr18:56,648,779...56,711,505
Ensembl chr18:56,649,025...56,711,504 		JBrowse link
G Camk2d calcium/calmodulin-dependent protein kinase II delta decreases expression ISO Arsenic Trioxide results in decreased expression of CAMK2D mRNA CTD PMID:24831965 NCBI chr 2:217,698,324...217,961,898
Ensembl chr 2:217,698,551...217,960,276 		JBrowse link
G Camk2g calcium/calmodulin-dependent protein kinase II gamma increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of CAMK2G mRNA
[Arsenic Trioxide co-treated with antimony trichloride] results in increased expression of CAMK2G mRNA 		CTD PMID:20458559 PMID:34091186 NCBI chr15:3,553,238...3,612,310
Ensembl chr15:3,553,294...3,612,310 		JBrowse link
G Camk4 calcium/calmodulin-dependent protein kinase IV decreases expression ISO Arsenic Trioxide results in decreased expression of CAMK4 mRNA; Arsenic Trioxide results in decreased expression of CAMK4 protein CTD PMID:19410645 PMID:24831965 PMID:26821021 NCBI chr18:24,857,152...25,076,054
Ensembl chr18:24,857,146...25,077,193 		JBrowse link
G Camp cathelicidin antimicrobial peptide decreases expression ISO Arsenic Trioxide results in decreased expression of CAMP mRNA CTD PMID:19128835 NCBI chr 8:118,720,184...118,721,998
Ensembl chr 8:118,720,184...118,721,998 		JBrowse link
G Canx calnexin increases expression
decreases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of CANX mRNA; Arsenic Trioxide results in increased expression of CANX protein
Arsenic Trioxide results in decreased expression of CANX protein
Resveratrol inhibits the reaction [Arsenic Trioxide results in increased expression of CANX protein] 		CTD PMID:20458559 PMID:25107562 PMID:25419056 NCBI chr10:35,124,941...35,157,954
Ensembl chr10:35,124,941...35,157,857 		JBrowse link
G Capg capping actin protein, gelsolin like increases expression ISO Arsenic Trioxide results in increased expression of CAPG mRNA CTD PMID:22521957 NCBI chr 4:106,152,912...106,170,010
Ensembl chr 4:106,152,890...106,170,672 		JBrowse link
G Capn1 calpain 1 increases cleavage
increases expression
multiple interactions 		ISO
EXP 		Arsenic Trioxide results in increased cleavage of CAPN1 protein
Arsenic Trioxide results in increased expression of CAPN1 mRNA; Arsenic Trioxide results in increased expression of CAPN1 protein
2-aminoethoxydiphenyl borate inhibits the reaction [Arsenic Trioxide results in increased expression of CAPN1 protein]; 2-aminoethyl diphenylborinate inhibits the reaction [Arsenic Trioxide results in increased expression of CAPN1 protein]; ATF4 protein promotes the reaction [Arsenic Trioxide results in increased expression of CAPN1 protein]; PD 150606 inhibits the reaction [Arsenic Trioxide results in increased expression of CAPN1 protein]; Quin2 inhibits the reaction [Arsenic Trioxide results in increased expression of CAPN1 protein]
fexofenadine inhibits the reaction [Arsenic Trioxide results in increased expression of CAPN1 protein]; tanshinone inhibits the reaction [Arsenic Trioxide results in increased expression of CAPN1 protein] 		CTD PMID:19695276 PMID:24641850 PMID:25258189 PMID:25419056 PMID:27461142 More... NCBI chr 1:212,705,219...212,736,134
Ensembl chr 1:212,705,222...212,729,445 		JBrowse link
G Capn10 calpain 10 increases expression ISO Arsenic Trioxide results in increased expression of CAPN10 mRNA CTD PMID:15761015 NCBI chr 9:100,943,665...100,957,910
Ensembl chr 9:100,945,551...100,957,912 		JBrowse link
G Capn2 calpain 2 increases expression ISO Arsenic Trioxide results in increased expression of CAPN2 mRNA; Arsenic Trioxide results in increased expression of CAPN2 protein CTD PMID:19695276 PMID:36801614 NCBI chr13:96,681,902...96,732,625
Ensembl chr13:96,681,848...96,732,625 		JBrowse link
G Capn6 calpain 6 decreases expression ISO Arsenic Trioxide results in decreased expression of CAPN6 mRNA CTD PMID:26705709 NCBI chr  X:112,177,467...112,202,178
Ensembl chr  X:112,177,467...112,202,178 		JBrowse link
G Capns1 calpain, small subunit 1 increases expression
decreases response to substance 		ISO Arsenic Trioxide results in increased expression of CAPNS1 protein
CAPNS1 protein results in decreased susceptibility to Arsenic Trioxide 		CTD PMID:20707922 PMID:25419056 NCBI chr 1:94,572,083...94,582,332
Ensembl chr 1:94,572,083...94,583,368 		JBrowse link
G Capza2 capping actin protein of muscle Z-line subunit alpha 2 increases expression ISO Arsenic Trioxide results in increased expression of CAPZA2 mRNA CTD PMID:20458559 NCBI chr 4:46,944,040...46,979,930
Ensembl chr 4:46,895,701...46,979,938 		JBrowse link
G Capzb capping actin protein of muscle Z-line subunit beta increases expression ISO Arsenic Trioxide results in increased expression of CAPZB mRNA CTD PMID:12852829 NCBI chr 5:156,718,619...156,818,623
Ensembl chr 5:156,650,432...156,818,619 		JBrowse link
G Car2 carbonic anhydrase 2 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of CAR2 protein
Arsenic Trioxide results in decreased expression of CA2 mRNA 		CTD PMID:25419056 PMID:39716349 NCBI chr 2:88,462,883...88,478,012
Ensembl chr 2:88,462,872...88,478,064 		JBrowse link
G Card6 caspase recruitment domain family, member 6 multiple interactions ISO [sanguinarine co-treated with Arsenic Trioxide] results in increased expression of CARD6 mRNA CTD PMID:24345465 NCBI chr 2:55,921,832...55,934,388
Ensembl chr 2:55,921,832...55,934,363 		JBrowse link
G Card9 caspase recruitment domain family, member 9 multiple interactions ISO [Arsenic Trioxide co-treated with Bortezomib] results in increased expression of CARD9 mRNA CTD PMID:20471514 NCBI chr 3:29,569,907...29,578,402
Ensembl chr 3:29,569,959...29,578,402 		JBrowse link
G Carm1 coactivator-associated arginine methyltransferase 1 increases expression ISO Arsenic Trioxide results in increased expression of CARM1 protein CTD PMID:25419056 NCBI chr 8:28,373,370...28,418,056
Ensembl chr 8:28,373,362...28,418,056 		JBrowse link
G Cars1 cysteinyl-tRNA synthetase 1 multiple interactions
increases expression
decreases expression 		ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CARS1 protein]
Arsenic Trioxide results in increased expression of CARS1 mRNA
Arsenic Trioxide results in decreased expression of CARS1 mRNA 		CTD PMID:12852829 PMID:24356939 PMID:26598702 NCBI chr 1:208,183,092...208,225,425
Ensembl chr 1:208,182,788...208,225,407 		JBrowse link
G Cask calcium/calmodulin dependent serine protein kinase increases expression ISO Arsenic Trioxide results in increased expression of CASK mRNA CTD PMID:20458559 NCBI chr  X:11,572,328...11,915,831
Ensembl chr  X:11,572,636...11,911,948 		JBrowse link
G Caskin2 cask-interacting protein 2 increases expression ISO Arsenic Trioxide results in increased expression of CASKIN2 mRNA CTD PMID:20458559 NCBI chr10:101,526,131...101,540,362
Ensembl chr10:101,526,195...101,540,349 		JBrowse link
G Casp1 caspase 1 increases expression
multiple interactions
increases activity
increases cleavage
decreases expression 		ISO
EXP 		Arsenic Trioxide results in increased expression of CASP1 mRNA; Arsenic Trioxide results in increased expression of CASP1 protein modified form
[Arsenic Trioxide co-treated with Lipopolysaccharides] results in increased cleavage of CASP1 protein; Febuxostat inhibits the reaction [Arsenic Trioxide results in increased expression of CASP1 protein]; Lenalidomide inhibits the reaction [[Arsenic Trioxide co-treated with Lipopolysaccharides] results in increased cleavage of CASP1 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[Arsenic Trioxide co-treated with Lipopolysaccharides] results in increased cleavage of CASP1 protein]; Taurine inhibits the reaction [[Arsenic Trioxide co-treated with Lipopolysaccharides] results in increased cleavage of CASP1 protein]
Arsenic Trioxide results in increased activity of CASP1 protein
Arsenic Trioxide results in increased cleavage of CASP1 protein
3-methyladenine inhibits the reaction [[Arsenic Trioxide co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased cleavage of CASP1 protein]; [sanguinarine co-treated with Arsenic Trioxide] results in increased expression of CASP1 mRNA; AS3MT mRNA promotes the reaction [Arsenic Trioxide results in increased expression of CASP1 protein modified form]; CA 074 methyl ester inhibits the reaction [[Arsenic Trioxide co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased cleavage of CASP1 protein]; IGF2BP2 protein promotes the reaction [Arsenic Trioxide results in increased expression of CASP1 protein modified form]; METTL14 protein promotes the reaction [Arsenic Trioxide results in increased expression of CASP1 protein modified form]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[Arsenic Trioxide co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased cleavage of CASP1 protein]; Taurine inhibits the reaction [[Arsenic Trioxide co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased cleavage of CASP1 protein]
Acetylcysteine inhibits the reaction [Arsenic Trioxide inhibits the reaction [anthrax toxin results in increased cleavage of CASP1 protein]]; Arsenic Trioxide inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased activity of CASP1 protein]; Arsenic Trioxide inhibits the reaction [anthrax toxin results in increased cleavage of CASP1 protein]; Arsenic Trioxide inhibits the reaction [Nigericin results in increased cleavage of CASP1 protein]; Arsenic Trioxide results in increased activity of and results in increased cleavage of CASP1 protein; Taurine inhibits the reaction [Arsenic Trioxide results in increased activity of and results in increased cleavage of CASP1 protein]
Arsenic Trioxide results in decreased expression of CASP1 mRNA
Arsenic Trioxide results in increased expression of CASP1 protein; Arsenic Trioxide results in increased expression of CASP1 protein modified form 		CTD PMID:9734658 PMID:9801394 PMID:15073043 PMID:23430110 PMID:24337744 More... NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:10,746,333...10,882,275 		JBrowse link
G Casp12 caspase 12 increases expression
multiple interactions
increases cleavage
increases degradation 		EXP
ISO 		Arsenic Trioxide results in increased expression of CASP12 mRNA; Arsenic Trioxide results in increased expression of CASP12 protein modified form
2-aminoethoxydiphenyl borate inhibits the reaction [Arsenic Trioxide results in increased cleavage of CASP12 protein]; 2-aminoethyl diphenylborinate inhibits the reaction [Arsenic Trioxide results in increased expression of CASP12 protein modified form]; 4-phenylbutyric acid inhibits the reaction [Arsenic Trioxide results in increased expression of CASP12 protein modified form]; ATF4 protein promotes the reaction [Arsenic Trioxide results in increased expression of CASP12 protein modified form]; DDIT3 mutant form inhibits the reaction [Arsenic Trioxide results in increased degradation of CASP12 protein]; HSPA5 mutant form inhibits the reaction [Arsenic Trioxide results in increased degradation of CASP12 protein]; PD 150606 inhibits the reaction [Arsenic Trioxide results in increased cleavage of CASP12 protein]; Quin2 inhibits the reaction [Arsenic Trioxide results in increased cleavage of CASP12 protein]; Thapsigargin promotes the reaction [Arsenic Trioxide results in increased expression of CASP12 protein modified form]
Arsenic Trioxide promotes the reaction [tetraarsenic tetrasulfide results in increased cleavage of CASP12 protein]; Arsenic Trioxide results in increased expression of and results in increased activity of CASP12 protein; MT2A protein inhibits the reaction [Arsenic Trioxide results in increased expression of CASP12 protein modified form]; tetraarsenic tetrasulfide promotes the reaction [Arsenic Trioxide results in increased cleavage of CASP12 protein]
Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased cleavage of CASP12 protein] 		CTD PMID:19695276 PMID:19730151 PMID:21145380 PMID:22959511 PMID:23664956 More... NCBI chr 8:10,927,188...10,954,442
Ensembl chr 8:10,926,994...10,954,442 		JBrowse link
G Casp2 caspase 2 decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of CASP2 mRNA
Arsenic Trioxide results in increased expression of CASP2; Arsenic Trioxide results in increased expression of CASP2 mRNA 		CTD PMID:9801394 PMID:15073043 PMID:17530438 NCBI chr 4:72,116,265...72,134,023
Ensembl chr 4:72,116,246...72,134,022 		JBrowse link
G Casp3 caspase 3 increases activity
increases cleavage
increases expression
increases degradation
affects activity
multiple interactions
affects expression
decreases expression 		ISO
EXP 		Arsenic Trioxide analog results in increased activity of CASP3 protein; Arsenic Trioxide results in increased activity of CASP3 protein
Arsenic Trioxide results in increased cleavage of CASP3 protein
Arsenic Trioxide results in increased expression of CASP3; Arsenic Trioxide results in increased expression of CASP3 mRNA; Arsenic Trioxide results in increased expression of CASP3 protein; Arsenic Trioxide results in increased expression of CASP3 protein modified form
Arsenic Trioxide results in increased degradation of CASP3 protein
Arsenic Trioxide affects the activity of CASP3 protein
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; 18alpha,20beta-hydroxy-11-oxo-norolean-12-en-3beta-yl-2-O-beta-D-glucopyranurosyl-alpha-D-glucopyranosiduronate magnesium tetrahydrate inhibits the reaction [Arsenic Trioxide results in increased expression of and results in increased cleavage of CASP3 protein]; 18alpha,20beta-hydroxy-11-oxo-norolean-12-en-3beta-yl-2-O-beta-D-glucopyranurosyl-alpha-D-glucopyranosiduronate magnesium tetrahydrate inhibits the reaction [Arsenic Trioxide results in increased expression of CASP3 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; 2-aminoethoxydiphenyl borate inhibits the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; 2-aminoethyl diphenylborinate inhibits the reaction [Arsenic Trioxide results in increased expression of CASP3 protein modified form]; 4-phenylbutyric acid inhibits the reaction [Arsenic Trioxide results in increased expression of CASP3 protein modified form]; [Genistein co-treated with Arsenic Trioxide] results in decreased expression of CASP3 protein; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased cleavage of and results in increased activity of CASP3 protein]; Arsenic Trioxide affects the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the cleavage of CASP3 protein]; Arsenic Trioxide affects the reaction [lipopolysaccharide, E coli O55-B5 affects the cleavage of CASP3 protein]; Arsenic Trioxide promotes the reaction [CDKN1A protein binds to CASP3 protein]; Arsenic Trioxide promotes the reaction [Drugs, Chinese Herbal results in decreased expression of CASP3 protein]; Arsenic Trioxide results in increased activity of and results in increased cleavage of CASP3 protein; Arsenic Trioxide results in increased cleavage of and results in increased activity of CASP3 protein; Arsenic Trioxide results in increased expression of and results in increased cleavage of CASP3 protein; aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Arsenic Trioxide results in increased cleavage of and results in increased activity of CASP3 protein]; ATF4 protein affects the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; ATF4 protein promotes the reaction [Arsenic Trioxide results in increased expression of CASP3 protein modified form]; baicalin inhibits the reaction [Arsenic Trioxide results in increased expression of CASP3 mRNA]; baicalin inhibits the reaction [Arsenic Trioxide results in increased expression of CASP3 protein]; DDIT3 mutant form inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; Deoxyglucose promotes the reaction [Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of CASP3 protein modified form]]; Glucose deficiency inhibits the reaction [Arsenic Trioxide results in increased expression of CASP3 protein modified form]; HSPA5 mutant form inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of CASP3 protein modified form]; PD 150606 inhibits the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; pyrazolanthrone inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; Quin2 inhibits the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; Resveratrol inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; Rotenone inhibits the reaction [Arsenic Trioxide results in increased expression of CASP3 protein modified form]; Thapsigargin promotes the reaction [Arsenic Trioxide results in increased expression of CASP3 protein modified form]; Thioctic Acid inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; Tretinoin promotes the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; 3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone inhibits the reaction [[Arsenic Trioxide co-treated with phytosphingosine] results in increased activity of CASP3 protein]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; 4-amino-1,8-naphthalimide promotes the reaction [Arsenic Trioxide results in increased expression of CASP3 protein]; [Arsenic Trioxide co-treated with apatinib] results in increased cleavage of CASP3 protein; [Arsenic Trioxide co-treated with benzyloxycarbonylleucyl-leucyl-leucine aldehyde] results in increased cleavage of CASP3 protein; [Arsenic Trioxide co-treated with BIBR 1532] results in increased activity of CASP3 protein; [Arsenic Trioxide co-treated with Bortezomib] results in increased activity of CASP3 protein; [Arsenic Trioxide co-treated with Bortezomib] results in increased cleavage of CASP3 protein; [Arsenic Trioxide co-treated with Curcumin] results in increased expression of CASP3 protein; [Arsenic Trioxide co-treated with Doxorubicin co-treated with Magnetite Nanoparticles analog] affects the expression of CASP3 mRNA; [Arsenic Trioxide co-treated with Doxorubicin co-treated with Magnetite Nanoparticles analog] affects the expression of CASP3 protein; [Arsenic Trioxide co-treated with epigallocatechin gallate] results in increased activity of CASP3 protein; [Arsenic Trioxide co-treated with Ethacrynic Acid] results in increased cleavage of CASP3 protein; [Arsenic Trioxide co-treated with IL24 protein] results in decreased expression of CASP3; [Arsenic Trioxide co-treated with Indomethacin] results in increased activity of CASP3 protein; [Arsenic Trioxide co-treated with lonidamine] results in increased cleavage of and results in increased activity of CASP3 protein; [Arsenic Trioxide co-treated with MIR15A protein co-treated with MIR16-1 protein] results in increased activity of CASP3 protein; [Arsenic Trioxide co-treated with phytosphingosine] results in increased activity of CASP3 protein; [Arsenic Trioxide co-treated with Plant Extracts] results in increased cleavage of CASP3 protein; [Arsenic Trioxide co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP3 protein; [Arsenic Trioxide results in decreased expression of MIR376A1 mRNA] which results in increased expression of CASP3 protein; [Arsenic Trioxide results in increased susceptibility to Ascorbic Acid] which results in increased cleavage of CASP3 protein; [aspartyl-glutamyl-valyl-aspartal results in decreased activity of CASP3 protein] inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of AKT1 protein]; [Bortezomib co-treated with Arsenic Trioxide] affects the expression of CASP3 protein; [Bortezomib co-treated with Arsenic Trioxide] results in increased activity of CASP3 protein; [Bortezomib co-treated with Arsenic Trioxide] results in increased expression of CASP3 protein; [CSF2 protein co-treated with Arsenic Trioxide] affects the activity of CASP3 protein; [CSF2 protein co-treated with Arsenic Trioxide] results in decreased expression of and results in increased cleavage of CASP3 protein; [Curcumin co-treated with Arsenic Trioxide] results in decreased expression of and results in increased cleavage of CASP3 protein; [Curcumin co-treated with Arsenic Trioxide] results in increased cleavage of CASP3 protein; [Dasatinib co-treated with Arsenic Trioxide] results in increased cleavage of CASP3 protein; [Docosahexaenoic Acids co-treated with Arsenic Trioxide] results in increased cleavage of CASP3 protein; [Genistein co-treated with Arsenic Trioxide] results in decreased expression of CASP3 protein; [MARVELD1 protein results in decreased susceptibility to Arsenic Trioxide] which results in decreased cleavage of CASP3 protein; [MCL1 mutant form results in increased susceptibility to [Ethacrynic Acid co-treated with Arsenic Trioxide]] which results in increased cleavage of CASP3 protein; [monomethylarsonous acid co-treated with dimethylarsinous acid co-treated with Arsenic Trioxide] results in increased activity of and results in increased cleavage of CASP3 protein; [sanguinarine co-treated with Arsenic Trioxide co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP3 protein; [sanguinarine co-treated with Arsenic Trioxide] results in increased activity of CASP3 protein; [sulforaphane co-treated with Arsenic Trioxide] results in increased cleavage of CASP3 protein; [Sulindac co-treated with Arsenic Trioxide] results in increased activity of CASP3 protein; [Vitamin K 2 co-treated with Arsenic Trioxide] results in increased expression of CASP3; [Zoledronic Acid co-treated with Arsenic Trioxide] results in increased cleavage of CASP3 protein; Acetylcysteine inhibits the reaction [[monomethylarsonous acid co-treated with dimethylarsinous acid co-treated with Arsenic Trioxide] results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [[sulforaphane co-treated with Arsenic Trioxide] results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [[Sulindac co-treated with Arsenic Trioxide] results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [[Vitamin K 2 co-treated with Arsenic Trioxide] results in increased expression of CASP3]; Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [Cisplatin results in increased cleavage of CASP3 protein]]; Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [Poly I-C results in increased activity of CASP3 protein]]; Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [Resveratrol results in increased expression of CASP3 protein]]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of CASP3 protein]; Acetylcysteine inhibits the reaction [Cisplatin promotes the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]]; Acetylcysteine inhibits the reaction [Poly I-C promotes the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]]; Acetylcysteine inhibits the reaction [Resveratrol promotes the reaction [Arsenic Trioxide results in increased expression of CASP3 protein]]; Acetylcysteine inhibits the reaction [sulforaphane promotes the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]]; AKT1 mutant form promotes the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; Aprepitant promotes the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; Arsenic Trioxide inhibits the reaction [Tunicamycin results in increased cleavage of CASP3 protein]; Arsenic Trioxide promotes the reaction [2-Methoxyestradiol results in increased expression of CASP3 protein modified form]; Arsenic Trioxide promotes the reaction [Aprepitant results in increased activity of CASP3 protein]; Arsenic Trioxide promotes the reaction [Cisplatin results in increased cleavage of CASP3 protein]; Arsenic Trioxide promotes the reaction [Curcumin results in increased expression of CASP3 protein modified form]; Arsenic Trioxide promotes the reaction [Dasatinib results in increased cleavage of CASP3 protein]; Arsenic Trioxide promotes the reaction [Deferoxamine results in increased expression of CASP3 mRNA]; Arsenic Trioxide promotes the reaction [Genistein results in increased activity of CASP3 protein]; Arsenic Trioxide promotes the reaction [Imatinib Mesylate results in increased activity of CASP3 protein]; Arsenic Trioxide promotes the reaction [Matrines results in increased cleavage of CASP3 protein]; Arsenic Trioxide promotes the reaction [Poly I-C results in increased activity of CASP3 protein]; Arsenic Trioxide promotes the reaction [puerarin results in increased expression of CASP3 protein]; Arsenic Trioxide promotes the reaction [Resveratrol results in increased expression of CASP3 protein]; Arsenic Trioxide promotes the reaction [Silybin results in increased activity of CASP3 protein]; Arsenic Trioxide promotes the reaction [Sorafenib results in decreased expression of CASP3 protein]; Arsenic Trioxide promotes the reaction [Sorafenib results in increased activity of CASP3 protein]; Arsenic Trioxide promotes the reaction [tetraarsenic tetrasulfide results in decreased expression of CASP3 mRNA]; Arsenic Trioxide promotes the reaction [tetraarsenic tetrasulfide results in increased cleavage of CASP3 protein]; Arsenic Trioxide promotes the reaction [VS-5584 results in increased cleavage of CASP3 protein]; Arsenic Trioxide results in decreased expression of and affects the cleavage of CASP3 protein; Arsenic Trioxide results in increased cleavage of and results in increased activity of CASP3 protein; Arsenic Trioxide results in increased expression of and results in increased activity of CASP3 protein; Arsenic Trioxide results in increased expression of and results in increased cleavage of CASP3 protein; Ascorbic Acid promotes the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; Ascorbic Acid promotes the reaction [Arsenic Trioxide results in increased cleavage of and results in increased activity of CASP3 protein]; BCL2 protein inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; BCL2L11 mutant form inhibits the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[monomethylarsonous acid co-treated with dimethylarsinous acid co-treated with Arsenic Trioxide] results in increased cleavage of CASP3 protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; buthionine analog promotes the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; Buthionine Sulfoximine promotes the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; CASP3 protein promotes the reaction [Arsenic Trioxide results in increased activity of IFNG protein]; Chloroquine promotes the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; Cisplatin promotes the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; Curcumin promotes the reaction [Arsenic Trioxide results in increased expression of CASP3 protein modified form]; Cycloheximide inhibits the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; Dactinomycin inhibits the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; DAPK2 protein affects the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; Dasatinib promotes the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; Dehydroascorbic Acid promotes the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; Deoxyglucose promotes the reaction [Arsenic Trioxide results in increased cleavage of and results in increased activity of CASP3 protein]; diphenyleneiodonium inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; Dithiothreitol inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; FAS protein affects the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; Genistein promotes the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; GRB10 protein promotes the reaction [[Arsenic Trioxide co-treated with apatinib] results in increased cleavage of CASP3 protein]; GSTP1 mutant form promotes the reaction [[Arsenic Trioxide co-treated with Ethacrynic Acid] results in increased cleavage of CASP3 protein]; HMOX1 protein inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; Hydrogen Peroxide inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; ID1 protein inhibits the reaction [Arsenic Trioxide results in increased expression of CASP3 protein]; Imatinib Mesylate promotes the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; KNK 437 promotes the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; MAPK8 mutant form inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; MAPK8 protein affects the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; MAPK9 mutant form inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; MARVELD1 protein inhibits the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; Matrines promotes the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; MIR203A protein promotes the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; MSI1 protein inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; MT2A protein inhibits the reaction [Arsenic Trioxide results in increased expression of CASP3 protein modified form]; NVP-BKM120 promotes the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; PMAIP1 protein promotes the reaction [[Bortezomib co-treated with Arsenic Trioxide] results in increased activity of CASP3 protein]; PMAIP1 protein promotes the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; Poly I-C promotes the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; pyrazolanthrone inhibits the reaction [[Arsenic Trioxide co-treated with Ethacrynic Acid] results in increased cleavage of CASP3 protein]; pyrazolanthrone inhibits the reaction [[Sulindac co-treated with Arsenic Trioxide] results in increased activity of CASP3 protein]; RARA gene mutant form inhibits the reaction [Tretinoin promotes the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]]; Resveratrol promotes the reaction [Arsenic Trioxide results in increased expression of CASP3 protein]; SB 203580 inhibits the reaction [[Arsenic Trioxide co-treated with phytosphingosine] results in increased activity of CASP3 protein]; SB 203580 inhibits the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; Silybin promotes the reaction [Arsenic Trioxide results in increased expression of CASP3 mRNA]; Sorafenib promotes the reaction [Arsenic Trioxide results in decreased expression of CASP3 protein]; Sorafenib promotes the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; sulforaphane promotes the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; tetraarsenic tetrasulfide promotes the reaction [Arsenic Trioxide results in decreased expression of CASP3 mRNA]; tetraarsenic tetrasulfide promotes the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; Tetradecanoylphorbol Acetate inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; Tetradecanoylphorbol Acetate promotes the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; TNF protein promotes the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; TP53 protein inhibits the reaction [Arsenic Trioxide results in increased cleavage of and results in increased activity of CASP3 protein]; TP73 protein affects the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; Tretinoin promotes the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; venetoclax inhibits the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; Wortmannin inhibits the reaction [Hydrogen Peroxide inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]]; zinc protoporphyrin promotes the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]
Arsenic Trioxide affects the expression of CASP3 protein
Arsenic Trioxide results in decreased expression of CASP3 mRNA; Arsenic Trioxide results in decreased expression of CASP3 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased expression of CASP3 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [salvianolic acid B inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]]; [17-(dimethylaminoethylamino)-17-demethoxygeldanamycin co-treated with Arsenic Trioxide] results in increased activity of CASP3 protein; [Buthionine Sulfoximine co-treated with Arsenic Trioxide] results in increased activity of CASP3 protein; [Ditiocarb co-treated with Arsenic Trioxide] results in increased activity of CASP3 protein; [VER 155008 co-treated with Arsenic Trioxide] results in increased activity of CASP3 protein; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; Ascorbic Acid inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; crocin inhibits the reaction [Arsenic Trioxide results in increased expression of CASP3 mRNA]; crocin inhibits the reaction [Arsenic Trioxide results in increased expression of CASP3 protein]; ferrostatin-1 inhibits the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; Genistein inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; GSR protein inhibits the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; HTS 466284 inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; pyrazolanthrone inhibits the reaction [Arsenic Trioxide results in increased expression of CASP3 protein]; salvianolic acid A inhibits the reaction [Arsenic Trioxide results in increased expression of CASP3 protein]; salvianolic acid B inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; SB 203580 inhibits the reaction [Arsenic Trioxide results in increased expression of CASP3 protein]; trans-sodium crocetinate inhibits the reaction [Arsenic Trioxide results in increased expression of CASP3 protein] 		CTD PMID:9734658 PMID:9801394 PMID:10428472 PMID:10477740 PMID:10673743 More... NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732 		JBrowse link
G Casp4 caspase 4 increases expression
multiple interactions
increases cleavage
increases activity 		EXP
ISO 		Arsenic Trioxide results in increased expression of CASP4 mRNA
[sanguinarine co-treated with Arsenic Trioxide] results in increased expression of CASP4 mRNA; [sulforaphane co-treated with Arsenic Trioxide] results in increased cleavage of CASP4 protein; Acetylcysteine inhibits the reaction [[sulforaphane co-treated with Arsenic Trioxide] results in increased cleavage of CASP4 protein]; Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CASP4 protein]; isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [Arsenic Trioxide results in increased activity of CASP4 protein]
Arsenic Trioxide results in increased cleavage of CASP4 protein 		CTD PMID:11940349 PMID:19730151 PMID:20138156 PMID:22922937 PMID:24345465 More... NCBI chr 8:10,883,817...10,919,978
Ensembl chr 8:10,883,769...10,920,727 		JBrowse link
G Casp6 caspase 6 increases expression
increases activity
multiple interactions 		ISO Arsenic Trioxide results in increased expression of CASP6 mRNA
Arsenic Trioxide results in increased activity of CASP6 protein
Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased activity of CASP6 protein] 		CTD PMID:11940349 PMID:24157283 NCBI chr 2:221,140,287...221,152,727
Ensembl chr 2:221,140,256...221,152,726 		JBrowse link
G Casp7 caspase 7 multiple interactions
increases activity
increases cleavage 		ISO
EXP 		[Arsenic Trioxide co-treated with apatinib] results in increased cleavage of CASP7 protein; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased activity of CASP7 protein]; Arsenic Trioxide promotes the reaction [2-Methoxyestradiol results in increased expression of CASP7 protein modified form]
Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased activity of CASP7 protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [Arsenic Trioxide results in increased activity of CASP7 protein]
Arsenic Trioxide results in increased cleavage of CASP7 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased activity of CASP7 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased activity of CASP7 protein]; Arsenic Trioxide results in increased cleavage of and results in increased activity of CASP7 protein; DDIT3 mutant form inhibits the reaction [Arsenic Trioxide results in increased activity of CASP7 protein]; HSPA5 mutant form inhibits the reaction [Arsenic Trioxide results in increased activity of CASP7 protein]; pyrazolanthrone inhibits the reaction [Arsenic Trioxide results in increased activity of CASP7 protein]; Tretinoin promotes the reaction [Arsenic Trioxide results in increased cleavage of CASP7 protein] 		CTD PMID:12181429 PMID:12480548 PMID:12883267 PMID:15493360 PMID:15688020 More... NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:265,442,676...265,482,512 		JBrowse link
G Casp8 caspase 8 increases activity
increases cleavage
multiple interactions
increases expression
affects activity 		ISO Arsenic Trioxide results in increased activity of CASP8 protein
Arsenic Trioxide results in increased cleavage of CASP8 protein
[Arsenic Trioxide co-treated with Bortezomib] results in decreased expression of CASP8 mRNA; [Arsenic Trioxide co-treated with Curcumin] results in increased expression of CASP8 protein; [Arsenic Trioxide co-treated with Ethacrynic Acid] results in increased cleavage of CASP8 protein; [Arsenic Trioxide co-treated with lonidamine] results in increased cleavage of and results in increased activity of CASP8 protein; [Arsenic Trioxide co-treated with Quercetin] results in increased cleavage of and results in increased activity of CASP8 protein; [Arsenic Trioxide co-treated with TNF protein] results in increased cleavage of and results in increased activity of CASP8 protein; [Arsenic Trioxide co-treated with TNFSF10 protein] results in increased activity of CASP8 protein; [Bortezomib co-treated with Arsenic Trioxide] results in increased expression of CASP8 protein; [Buthionine Sulfoximine co-treated with Arsenic Trioxide] results in increased cleavage of CASP8 protein; [CSF2 protein co-treated with Arsenic Trioxide] results in decreased expression of and affects the activity of CASP8 protein; [sanguinarine co-treated with Arsenic Trioxide co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP8 protein; [sanguinarine co-treated with Arsenic Trioxide] results in increased activity of CASP8 protein; [Valproic Acid co-treated with Arsenic Trioxide] results in increased expression of CASP8 mRNA; [Valproic Acid co-treated with Arsenic Trioxide] results in increased expression of CASP8 protein; Arsenic Trioxide promotes the reaction [Poly I-C results in increased activity of CASP8 protein]; Arsenic Trioxide promotes the reaction [puerarin results in increased expression of CASP8 protein]; Arsenic Trioxide promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP8 protein]; Arsenic Trioxide results in increased cleavage of and results in increased activity of CASP8 protein; BCL2 inhibits the reaction [[Arsenic Trioxide co-treated with TNF protein] results in increased activity of CASP8 protein]; BCL2 protein inhibits the reaction [[Arsenic Trioxide co-treated with lonidamine] results in increased cleavage of and results in increased activity of CASP8 protein]; BCL2 protein inhibits the reaction [[Arsenic Trioxide co-treated with Quercetin] results in increased cleavage of and results in increased activity of CASP8 protein]; benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [[Arsenic Trioxide co-treated with TNF protein] results in increased cleavage of and results in increased activity of CASP8 protein]; Bortezomib promotes the reaction [Arsenic Trioxide results in increased activity of CASP8 protein]; FAS protein affects the reaction [Arsenic Trioxide results in increased cleavage of CASP8 protein]; Genistein promotes the reaction [Arsenic Trioxide results in increased cleavage of and results in increased activity of CASP8 protein]; isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [Arsenic Trioxide promotes the reaction [TNFSF10 protein results in increased cleavage of and results in increased activity of CASP8 protein]]; MAPK8 protein affects the reaction [Arsenic Trioxide results in increased activity of CASP8 protein]; Poly I-C promotes the reaction [Arsenic Trioxide results in increased activity of CASP8 protein]; pyrazolanthrone inhibits the reaction [[Buthionine Sulfoximine co-treated with Arsenic Trioxide] results in increased cleavage of CASP8 protein]; pyrazolanthrone promotes the reaction [Arsenic Trioxide results in increased activity of CASP8 protein]; U 0126 promotes the reaction [Arsenic Trioxide results in increased activity of CASP8 protein]
Arsenic Trioxide results in increased expression of CASP8 mRNA; Arsenic Trioxide results in increased expression of CASP8 protein; Arsenic Trioxide results in increased expression of CASP8 protein modified form
Arsenic Trioxide promotes the reaction [Drugs, Chinese Herbal results in increased cleavage of CASP8 protein]
Arsenic Trioxide affects the activity of CASP8 protein 		CTD PMID:10721769 PMID:12148893 PMID:12684647 PMID:12975549 PMID:16010437 More... NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699 		JBrowse link
G Casp8ap2 caspase 8 associated protein 2 increases expression
multiple interactions 		EXP
ISO 		Arsenic Trioxide results in increased expression of CASP8AP2 mRNA
Arsenic Trioxide results in increased localization of [CASP8AP2 protein co-treated with PML protein]; Arsenic Trioxide results in increased localization of and results in increased degradation of CASP8AP2 protein 		CTD PMID:19730151 PMID:23673342 NCBI chr 5:51,809,366...51,848,633
Ensembl chr 5:51,810,972...51,848,632 		JBrowse link
G Casp9 caspase 9 increases cleavage
multiple interactions
increases expression
decreases expression
increases activity 		ISO
EXP 		Arsenic Trioxide results in increased cleavage of CASP9 protein
Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [CASP9 protein binds to CYCS protein]]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased cleavage of CASP9 protein]; Arsenic Trioxide promotes the reaction [CYCS protein binds to CASP9 protein]
Arsenic Trioxide results in increased expression of CASP9 protein modified form
Arsenic Trioxide results in decreased expression of CASP9 protein
17-(dimethylaminoethylamino)-17-demethoxygeldanamycin promotes the reaction [Arsenic Trioxide results in increased cleavage of CASP9 protein]; 3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone inhibits the reaction [[Arsenic Trioxide co-treated with phytosphingosine] results in increased activity of CASP9 protein]; [Arsenic Trioxide co-treated with phytosphingosine] results in increased activity of CASP9 protein; [Arsenic Trioxide co-treated with Plant Extracts] results in increased cleavage of CASP9 protein; [Bortezomib co-treated with Arsenic Trioxide] results in increased activity of CASP9 protein; [Bortezomib co-treated with Arsenic Trioxide] results in increased expression of CASP9 protein; [Curcumin co-treated with Arsenic Trioxide] results in increased cleavage of CASP9 protein; [Dasatinib co-treated with Arsenic Trioxide] results in increased cleavage of CASP9 protein; [Sulindac co-treated with Arsenic Trioxide] results in increased activity of CASP9 protein; [Valproic Acid co-treated with Arsenic Trioxide] results in increased expression of CASP9 mRNA; [Valproic Acid co-treated with Arsenic Trioxide] results in increased expression of CASP9 protein; Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [Poly I-C results in increased activity of CASP9 protein]]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [Poly I-C promotes the reaction [Arsenic Trioxide results in increased activity of CASP9 protein]]; AKT1 mutant form promotes the reaction [Arsenic Trioxide results in increased cleavage of CASP9 protein]; ARL6IP5 protein promotes the reaction [Arsenic Trioxide results in increased cleavage of CASP9 protein]; Arsenic Trioxide analog results in increased cleavage of and results in increased activity of CASP9 protein; Arsenic Trioxide promotes the reaction [Dasatinib results in increased cleavage of CASP9 protein]; Arsenic Trioxide promotes the reaction [Ethacrynic Acid results in increased cleavage of CASP9 protein]; Arsenic Trioxide promotes the reaction [lonidamine results in increased cleavage of and results in increased activity of CASP9 protein]; Arsenic Trioxide promotes the reaction [Poly I-C results in increased activity of CASP9 protein]; Arsenic Trioxide promotes the reaction [Sorafenib results in increased activity of CASP9 protein]; Arsenic Trioxide results in increased cleavage of and results in increased activity of CASP9 protein; Arsenic Trioxide results in increased expression of and results in increased cleavage of CASP9 protein; BCL2 protein inhibits the reaction [Arsenic Trioxide promotes the reaction [lonidamine results in increased cleavage of and results in increased activity of CASP9 protein]]; BCL2 protein inhibits the reaction [lonidamine promotes the reaction [Arsenic Trioxide results in increased cleavage of and results in increased activity of CASP9 protein]]; BCL2L11 mutant form inhibits the reaction [Arsenic Trioxide results in increased cleavage of CASP9 protein]; Bortezomib promotes the reaction [Arsenic Trioxide results in increased activity of CASP9 protein]; Dasatinib promotes the reaction [Arsenic Trioxide results in increased cleavage of CASP9 protein]; Deoxyglucose promotes the reaction [Arsenic Trioxide results in increased cleavage of and results in increased activity of CASP9 protein]; Fluorouracil promotes the reaction [Arsenic Trioxide results in decreased expression of CASP9 protein]; Genistein promotes the reaction [Arsenic Trioxide results in increased activity of CASP9 protein]; GRB10 protein promotes the reaction [[Arsenic Trioxide co-treated with apatinib] results in increased cleavage of CASP9 protein]; GSTP1 mutant form promotes the reaction [[Arsenic Trioxide co-treated with Ethacrynic Acid] results in increased cleavage of CASP9 protein]; HSF1 protein affects the reaction [Arsenic Trioxide results in increased activity of CASP9 protein]; KNK 437 promotes the reaction [Arsenic Trioxide results in increased cleavage of CASP9 protein]; lonidamine promotes the reaction [Arsenic Trioxide results in increased cleavage of and results in increased activity of CASP9 protein]; MAPK8 protein affects the reaction [Arsenic Trioxide results in increased activity of CASP9 protein]; MCL1 mutant form promotes the reaction [[Arsenic Trioxide co-treated with Ethacrynic Acid] results in increased cleavage of CASP9 protein]; MIR203A protein promotes the reaction [Arsenic Trioxide results in increased activity of CASP9 protein]; Poly I-C promotes the reaction [Arsenic Trioxide results in increased activity of CASP9 protein]; salvin promotes the reaction [Arsenic Trioxide results in increased activity of CASP9 protein]; SB 203580 inhibits the reaction [[Arsenic Trioxide co-treated with phytosphingosine] results in increased activity of CASP9 protein]; Sorafenib promotes the reaction [Arsenic Trioxide results in increased activity of CASP9 protein]; STMN1 inhibits the reaction [Arsenic Trioxide results in increased cleavage of CASP9 protein]; TNF protein promotes the reaction [Arsenic Trioxide results in increased activity of CASP9 protein]
Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of CASP9 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased activity of CASP9 protein]; Arsenic Trioxide affects the reaction [lipopolysaccharide, E coli O55-B5 affects the cleavage of CASP9 protein]; Arsenic Trioxide promotes the reaction [Drugs, Chinese Herbal results in increased expression of CASP9 protein modified form]; Arsenic Trioxide results in increased cleavage of and results in increased activity of CASP9 protein; Drugs, Chinese Herbal promotes the reaction [Arsenic Trioxide results in increased expression of CASP9 protein modified form]
Arsenic Trioxide results in increased expression of CASP9 mRNA 		CTD PMID:12148893 PMID:12480548 PMID:12492118 PMID:12883267 PMID:12975549 More... Ensembl chr 5:159,391,188...159,409,648 JBrowse link
G Cat catalase increases response to substance
multiple interactions
decreases expression
decreases response to substance
decreases activity
increases activity 		ISO
EXP 		CAT results in increased susceptibility to Arsenic Trioxide
[Arsenic Trioxide results in increased abundance of Arsenic] which results in decreased activity of CAT protein; [Arsenic Trioxide results in increased abundance of Arsenic] which results in increased activity of CAT protein; [boric acid co-treated with Arsenic Trioxide] affects the activity of CAT protein; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of CAT mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of CAT protein]; Apigenin inhibits the reaction [[Arsenic Trioxide results in increased abundance of Arsenic] which results in decreased activity of CAT protein]; Apigenin inhibits the reaction [[Arsenic Trioxide results in increased abundance of Arsenic] which results in increased activity of CAT protein]; crocin inhibits the reaction [Arsenic Trioxide results in decreased activity of CAT protein]; eriodictyol inhibits the reaction [Arsenic Trioxide results in decreased activity of CAT protein]; Folic Acid inhibits the reaction [Arsenic Trioxide results in decreased activity of CAT protein]; Linseed Oil inhibits the reaction [Arsenic Trioxide results in decreased activity of CAT protein]; naringenin inhibits the reaction [Arsenic Trioxide results in decreased activity of CAT protein]; oxymatrine inhibits the reaction [Arsenic Trioxide results in decreased activity of CAT protein]; polydatin inhibits the reaction [Arsenic Trioxide results in decreased activity of CAT protein]; Resveratrol inhibits the reaction [Arsenic Trioxide results in decreased activity of CAT protein]; Riboflavin inhibits the reaction [Arsenic Trioxide results in decreased activity of CAT protein]; salvianolic acid A inhibits the reaction [Arsenic Trioxide results in decreased activity of CAT protein]; trans-sodium crocetinate inhibits the reaction [Arsenic Trioxide results in decreased activity of CAT protein]; trans-sodium crocetinate inhibits the reaction [Arsenic Trioxide results in decreased expression of CAT protein]; Vitamin B 12 promotes the reaction [Folic Acid inhibits the reaction [Arsenic Trioxide results in decreased activity of CAT protein]]
18alpha,20beta-hydroxy-11-oxo-norolean-12-en-3beta-yl-2-O-beta-D-glucopyranurosyl-alpha-D-glucopyranosiduronate magnesium tetrahydrate inhibits the reaction [Arsenic Trioxide results in decreased activity of CAT protein]; Arsenic Trioxide affects the reaction [1,2-Dimethylhydrazine results in decreased activity of CAT protein]; Ascorbic Acid inhibits the reaction [Arsenic Trioxide results in decreased activity of CAT protein]; baicalin inhibits the reaction [Arsenic Trioxide results in decreased activity of CAT protein]; beta Carotene inhibits the reaction [Arsenic Trioxide results in decreased activity of CAT protein]; CAT protein inhibits the reaction [Arsenic Trioxide results in decreased activity of TERT protein]; CAT protein inhibits the reaction [Arsenic Trioxide results in increased expression of HMOX1 protein]; Melatonin inhibits the reaction [Arsenic Trioxide results in decreased expression of CAT protein]; Resveratrol inhibits the reaction [Arsenic Trioxide results in decreased activity of CAT protein]
Arsenic Trioxide results in decreased expression of CAT mRNA; Arsenic Trioxide results in decreased expression of CAT protein
CAT protein results in decreased susceptibility to Arsenic Trioxide
[Cisplatin co-treated with Arsenic Trioxide] results in decreased activity of CAT protein; [Fluorouracil co-treated with Arsenic Trioxide] results in decreased activity of CAT protein; [ruxolitinib co-treated with Arsenic Trioxide] results in decreased expression of CAT mRNA; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of CAT protein]; CAT mutant form promotes the reaction [Arsenic Trioxide promotes the reaction [Ethacrynic Acid results in decreased expression of MCL1 protein]]; CAT protein inhibits the reaction [[Arsenic Trioxide results in increased abundance of Hydrogen Peroxide] which results in increased expression of ARL6IP5 protein]; CAT protein inhibits the reaction [Arsenic Trioxide results in increased expression of PTGS2 mRNA]; CAT protein results in decreased susceptibility to [Arsenic Trioxide co-treated with Ascorbic Acid]; Docosahexaenoic Acids inhibits the reaction [Arsenic Trioxide results in decreased activity of CAT protein]; Grape Seed Proanthocyanidins inhibits the reaction [Arsenic Trioxide results in decreased expression of CAT protein]; Pioglitazone inhibits the reaction [Arsenic Trioxide results in decreased expression of CAT protein]
Arsenic Trioxide results in increased activity of CAT protein 		CTD PMID:11749846 PMID:16214333 PMID:17258074 PMID:18332854 PMID:18336854 More... NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526 		JBrowse link
G Catsper4 cation channel, sperm associated 4 increases expression ISO Arsenic Trioxide results in increased expression of CATSPER4 mRNA CTD PMID:20458559 NCBI chr 5:151,711,415...151,731,083
Ensembl chr 5:151,711,194...151,730,750 		JBrowse link
G Cav1 caveolin 1 decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of CAV1 mRNA; Arsenic Trioxide results in decreased expression of CAV1 protein
Arsenic Trioxide results in increased expression of CAV1 mRNA; Arsenic Trioxide results in increased expression of CAV1 protein 		CTD PMID:15725085 PMID:17512576 PMID:22521957 PMID:26238599 PMID:28521025 NCBI chr 4:46,606,538...46,639,616
Ensembl chr 4:46,600,738...46,639,740 		JBrowse link
G Cav2 caveolin 2 increases expression
multiple interactions
decreases expression 		ISO Arsenic Trioxide results in increased expression of CAV2 mRNA
[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of CAV2 mRNA
Arsenic Trioxide results in decreased expression of CAV2 mRNA 		CTD PMID:15725085 PMID:15761015 PMID:15894607 NCBI chr 4:46,582,681...46,590,058
Ensembl chr 4:46,582,096...46,591,425 		JBrowse link
G Cav3 caveolin 3 increases expression
multiple interactions 		EXP Arsenic Trioxide results in increased expression of CAV3 mRNA
Phloretin inhibits the reaction [Arsenic Trioxide results in decreased expression of CAV3 mRNA] 		CTD PMID:34037972 NCBI chr 4:147,137,993...147,153,967
Ensembl chr 4:147,137,797...147,153,967 		JBrowse link
G Cavin2 caveolae associated protein 2 increases expression ISO Arsenic Trioxide results in increased expression of CAVIN2 mRNA CTD PMID:26705709 NCBI chr 9:57,794,007...57,806,024
Ensembl chr 9:57,794,019...57,806,024 		JBrowse link
G Cavin3 caveolae associated protein 3 decreases expression ISO Arsenic Trioxide results in decreased expression of CAVIN3 protein CTD PMID:25419056 NCBI chr 1:169,238,384...169,239,973
Ensembl chr 1:169,238,384...169,239,981 		JBrowse link
G Cbl Cbl proto-oncogene multiple interactions
increases expression 		ISO [Bortezomib results in decreased activity of CBL protein] promotes the reaction [Arsenic Trioxide results in increased activity of AKT1 protein]
Arsenic Trioxide results in increased expression of CBL protein 		CTD PMID:19457607 NCBI chr 8:53,384,656...53,468,067
Ensembl chr 8:53,384,656...53,468,067 		JBrowse link
G Cbln4 cerebellin 4 precursor multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CBLN4 protein] CTD PMID:26598702 NCBI chr 3:181,218,046...181,225,600
Ensembl chr 3:181,218,046...181,225,600 		JBrowse link
G Cbr1 carbonyl reductase 1 decreases response to substance
increases expression 		ISO CBR1 protein results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in increased expression of CBR1 mRNA 		CTD PMID:22719067 NCBI chr11:46,346,405...46,348,815
Ensembl chr11:46,378,411...46,381,104
Ensembl chr11:46,378,411...46,381,104 		JBrowse link
G Cbr4 carbonyl reductase 4 decreases expression ISO Arsenic Trioxide results in decreased expression of CBR4 mRNA CTD PMID:27829220 NCBI chr16:33,625,734...33,695,067
Ensembl chr16:33,617,399...33,656,832 		JBrowse link
G Cbx4 chromobox 4 increases sumoylation ISO Arsenic Trioxide results in increased sumoylation of CBX4 protein CTD PMID:28318385 NCBI chr10:104,835,685...104,841,727
Ensembl chr10:104,835,685...104,841,727 		JBrowse link
G Cbx7 chromobox 7 decreases expression ISO Arsenic Trioxide results in decreased expression of CBX7 mRNA CTD PMID:22521957 NCBI chr 7:113,341,030...113,358,716
Ensembl chr 7:113,341,030...113,358,346 		JBrowse link
G Cby1 chibby 1, beta catenin antagonist increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of CBY1 mRNA
Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of CBY1 mRNA] 		CTD PMID:29095437 NCBI chr 7:113,097,220...113,103,831 JBrowse link
G Cc2d2a coiled-coil and C2 domain containing 2A increases expression ISO Arsenic Trioxide results in increased expression of CC2D2A mRNA CTD PMID:35676786 NCBI chr14:71,563,835...71,648,352
Ensembl chr14:71,563,835...71,648,331 		JBrowse link
G Cc2d2b coiled-coil and C2 domain containing 2B multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CC2D2B protein] CTD PMID:26598702 NCBI chr 1:249,509,371...249,608,894
Ensembl chr 1:249,511,389...249,606,142 		JBrowse link
G Ccdc14 coiled-coil domain containing 14 increases expression ISO Arsenic Trioxide results in increased expression of CCDC14 mRNA CTD PMID:39716349 NCBI chr11:79,557,267...79,593,128
Ensembl chr11:79,557,274...79,593,285 		JBrowse link
G Ccdc150 coiled-coil domain containing 150 decreases expression ISO Arsenic Trioxide results in decreased expression of CCDC150 mRNA CTD PMID:21461292 NCBI chr 9:63,287,962...63,403,644
Ensembl chr 9:63,288,000...63,391,670 		JBrowse link
G Ccdc198 coiled-coil domain containing 198 increases expression ISO Arsenic Trioxide results in increased expression of CCDC198 mRNA CTD PMID:15761015 NCBI chr15:24,979,764...25,006,608
Ensembl chr15:24,979,531...25,006,542 		JBrowse link
G Ccdc28b coiled coil domain containing 28B increases response to substance ISO CCDC28B protein results in increased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 5:147,246,627...147,251,629
Ensembl chr 5:147,246,628...147,251,629 		JBrowse link
G Ccdc32 coiled-coil domain containing 32 decreases expression ISO Arsenic Trioxide results in decreased expression of CCDC32 mRNA CTD PMID:39716349 NCBI chr 3:126,452,293...126,464,845
Ensembl chr 3:126,452,304...126,472,778 		JBrowse link
G Ccdc47 coiled-coil domain containing 47 increases expression ISO Arsenic Trioxide results in increased expression of CCDC47 mRNA CTD PMID:20458559 NCBI chr10:91,630,101...91,648,626
Ensembl chr10:91,630,106...91,648,626 		JBrowse link
G Ccdc6 coiled-coil domain containing 6 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CCDC6 protein] CTD PMID:26598702 NCBI chr20:18,431,243...18,527,227
Ensembl chr20:18,431,243...18,527,227 		JBrowse link
G Ccdc85b coiled-coil domain containing 85B decreases expression ISO Arsenic Trioxide results in decreased expression of DIPA mRNA CTD PMID:20458559 NCBI chr 1:212,192,979...212,193,994
Ensembl chr 1:212,189,468...212,196,911 		JBrowse link
G Ccdc86 coiled-coil domain containing 86 decreases expression ISO Arsenic Trioxide results in decreased expression of CCDC86 mRNA CTD PMID:20458559 NCBI chr 1:217,015,059...217,021,439
Ensembl chr 1:217,014,848...217,021,468 		JBrowse link
G Ccdc92 coiled-coil domain containing 92 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CCDC92 protein] CTD PMID:26598702 NCBI chr12:37,457,676...37,484,080
Ensembl chr12:37,457,068...37,484,327 		JBrowse link
G Ccl1 C-C motif chemokine ligand 1 multiple interactions ISO [Arsenic Trioxide co-treated with Tretinoin] results in increased expression of CCL1 mRNA CTD PMID:19828696 NCBI chr10:67,625,962...67,628,740
Ensembl chr10:67,625,962...67,628,790 		JBrowse link
G Ccl11 C-C motif chemokine ligand 11 increases expression ISO Arsenic Trioxide results in increased expression of CCL11 protein CTD PMID:37166470 NCBI chr10:67,525,975...67,530,576
Ensembl chr10:67,525,862...67,530,575 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 multiple interactions
increases expression
affects expression 		ISO
EXP 		[Arsenic Trioxide co-treated with Tretinoin] results in increased expression of CCL2 mRNA; [Arsenic Trioxide co-treated with Tretinoin] results in increased expression of CCL2 protein; [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of CCL2 mRNA
Thioctic Acid inhibits the reaction [Arsenic Trioxide results in increased expression of CCL2 mRNA]
Arsenic Trioxide results in increased expression of CCL2 mRNA; Arsenic Trioxide results in increased expression of CCL2 protein
Arsenic Trioxide affects the expression of CCL2 mRNA
Phloretin inhibits the reaction [Arsenic Trioxide results in increased expression of CCL2 protein] 		CTD PMID:15761015 PMID:15894607 PMID:18231732 PMID:19828696 PMID:20458559 More... NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875 		JBrowse link
G Ccl20 C-C motif chemokine ligand 20 multiple interactions ISO [Arsenic Trioxide co-treated with Tretinoin] results in increased expression of CCL20 mRNA CTD PMID:19828696 NCBI chr 9:91,837,139...91,839,736
Ensembl chr 9:91,836,946...91,839,736 		JBrowse link
G Ccl22 C-C motif chemokine ligand 22 multiple interactions
decreases expression 		ISO [Arsenic Trioxide co-treated with Tretinoin] results in increased expression of CCL22 mRNA; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of CCL22 mRNA] CTD PMID:19128835 PMID:19350554 PMID:19828696 NCBI chr19:10,263,589...10,270,359
Ensembl chr19:10,263,589...10,270,359 		JBrowse link
G Ccl24 C-C motif chemokine ligand 24 multiple interactions
decreases expression 		ISO [Arsenic Trioxide co-treated with Tretinoin] results in increased expression of CCL24 mRNA
Arsenic Trioxide results in decreased expression of CCL24 mRNA 		CTD PMID:19828696 PMID:39716349 NCBI chr12:26,737,423...26,741,420
Ensembl chr12:26,737,439...26,750,924 		JBrowse link
G Ccl27 C-C motif chemokine ligand 27 decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of CCL27A mRNA
Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of CCL27A mRNA] 		CTD PMID:29095437 NCBI chr 5:61,737,261...61,744,375
Ensembl chr 5:61,737,261...61,743,522 		JBrowse link
G Ccl3 C-C motif chemokine ligand 3 decreases expression ISO Arsenic Trioxide results in decreased expression of CCL3 mRNA CTD PMID:19128835 NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,948,889...68,950,439 		JBrowse link
G Ccl4 C-C motif chemokine ligand 4 multiple interactions ISO [Arsenic Trioxide co-treated with Tretinoin] results in increased expression of CCL4 mRNA CTD PMID:19828696 NCBI chr10:68,963,893...68,965,728
Ensembl chr10:68,950,289...68,965,722 		JBrowse link
G Ccl5 C-C motif chemokine ligand 5 increases expression ISO Arsenic Trioxide results in increased expression of CCL5 protein CTD PMID:37166470 NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,738,651...68,824,884 		JBrowse link
G Ccl7 C-C motif chemokine ligand 7 multiple interactions
increases expression 		ISO [Arsenic Trioxide co-treated with Tretinoin] results in increased expression of CCL7 mRNA; [Arsenic Trioxide co-treated with Tretinoin] results in increased expression of CCL7 protein
Arsenic Trioxide results in increased expression of CCL7 mRNA; Arsenic Trioxide results in increased expression of CCL7 protein 		CTD PMID:19828696 PMID:37166470 NCBI chr10:67,514,095...67,515,945
Ensembl chr10:67,514,091...67,515,947 		JBrowse link
G Ccl9 C-C motif chemokine ligand 9 increases expression ISO Arsenic Trioxide results in increased expression of CCL15 mRNA CTD PMID:15761015 NCBI chr10:68,863,994...68,868,928
Ensembl chr10:68,863,995...68,868,877 		JBrowse link
G Ccn1 cellular communication network factor 1 decreases expression ISO Arsenic Trioxide results in decreased expression of CCN1 mRNA CTD PMID:20458559 NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:237,222,432...237,225,883 		JBrowse link
G Ccn2 cellular communication network factor 2 multiple interactions ISO Arsenic Trioxide inhibits the reaction [TGFB1 protein results in increased expression of CCN2 mRNA] CTD PMID:24762191 NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:22,621,501...22,624,976 		JBrowse link
G Ccn4 cellular communication network factor 4 decreases expression ISO Arsenic Trioxide results in decreased expression of CCN4 mRNA; Arsenic Trioxide results in decreased expression of WISP1 mRNA CTD PMID:20458559 PMID:26705709 PMID:39716349 NCBI chr 7:100,534,578...100,566,287
Ensembl chr 7:100,534,505...100,563,094 		JBrowse link
G Ccn5 cellular communication network factor 5 decreases response to substance ISO CCN5 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 3:172,910,670...172,922,064
Ensembl chr 3:172,910,681...172,922,062 		JBrowse link
G Ccna1 cyclin A1 decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of CCNA1 mRNA
Arsenic Trioxide inhibits the reaction [PDGFB protein results in increased expression of CCNA1 protein] 		CTD PMID:15761015 PMID:35276128 NCBI chr 2:141,383,352...141,428,205
Ensembl chr 2:141,382,468...141,393,300 		JBrowse link
G Ccna2 cyclin A2 affects expression
decreases expression 		ISO Arsenic Trioxide affects the expression of CCNA2 mRNA
Arsenic Trioxide results in decreased expression of CCNA2 mRNA; Arsenic Trioxide results in decreased expression of CCNA2 protein 		CTD PMID:12480548 PMID:20458559 PMID:25174355 PMID:28786057 NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:121,355,363...121,361,701 		JBrowse link
G Ccnb1 cyclin B1 decreases expression
multiple interactions
increases expression 		ISO
EXP 		Arsenic Trioxide results in decreased expression of CCNB1 mRNA; Arsenic Trioxide results in decreased expression of CCNB1 protein
4-amino-1,8-naphthalimide inhibits the reaction [Arsenic Trioxide results in decreased expression of CCNB1 mRNA]; 4-amino-1,8-naphthalimide inhibits the reaction [Arsenic Trioxide results in decreased expression of CCNB1 protein]; [Arsenic Trioxide co-treated with Oxygen deficiency] results in decreased expression of CCNB1 mRNA; [Arsenic Trioxide co-treated with Oxygen deficiency] results in decreased expression of CCNB1 protein; [Erlotinib Hydrochloride co-treated with Arsenic Trioxide] results in decreased expression of CCNB1 mRNA; CAB39L protein alternative form inhibits the reaction [Arsenic Trioxide results in decreased expression of CCNB1 protein]
Arsenic Trioxide results in increased expression of CCNB1 mRNA; Arsenic Trioxide results in increased expression of CCNB1 protein 		CTD PMID:12181429 PMID:12783709 PMID:12883267 PMID:17530438 PMID:19825857 More... NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:33,646,252...33,655,225 		JBrowse link
G Ccnb2 cyclin B2 increases expression ISO Arsenic Trioxide results in increased expression of CCNB2 mRNA CTD PMID:17547211 NCBI chr 8:79,968,459...79,981,717
Ensembl chr 8:79,968,465...79,981,682 		JBrowse link
G Ccnd1 cyclin D1 multiple interactions
decreases response to substance
increases expression
decreases activity
decreases expression
affects response to substance
decreases methylation 		ISO 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased expression of CCND1 protein]; 9-methoxy-2-methylellipticinium acetate inhibits the reaction [Arsenic Trioxide results in increased expression of CCND1 protein]; [Arsenic Trioxide co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CCND1 mRNA; [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of CHUK protein] which results in increased phosphorylation of and results in increased ubiquitination of and results in increased degradation of CCND1 protein; [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of GSK3B protein] which results in increased phosphorylation of and results in increased ubiquitination of and results in increased degradation of CCND1 protein; [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of IKBKB protein] which results in increased phosphorylation of and results in increased ubiquitination of and results in increased degradation of CCND1 protein; [BIBR 1532 co-treated with Arsenic Trioxide] affects the expression of CCND1 mRNA; [Genistein co-treated with Arsenic Trioxide] results in decreased expression of CCND1 protein; [ruxolitinib co-treated with Arsenic Trioxide] results in decreased expression of CCND1 mRNA; AKT1 protein affects the reaction [Arsenic Trioxide results in increased expression of CCND1 protein]; Arsenic Trioxide affects the reaction [KEAP1 protein results in increased expression of CCND1 protein]; Arsenic Trioxide promotes the reaction [Sorafenib results in decreased expression of CCND1 protein]; Arsenic Trioxide promotes the reaction [Tretinoin results in decreased expression of CCND1 protein]; CAB39L protein alternative form inhibits the reaction [Arsenic Trioxide results in decreased expression of CCND1 protein]; KEAP1 protein inhibits the reaction [Arsenic Trioxide results in decreased expression of CCND1 mRNA]; MAPK1 protein affects the reaction [Arsenic Trioxide results in increased expression of CCND1 protein]; MAPK3 protein affects the reaction [Arsenic Trioxide results in increased expression of CCND1 protein]; Sorafenib promotes the reaction [Arsenic Trioxide results in decreased expression of CCND1 protein]; Tretinoin promotes the reaction [Arsenic Trioxide results in decreased expression of CCND1 protein]
CCND1 mRNA results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in increased expression of CCND1 mRNA; Arsenic Trioxide results in increased expression of CCND1 protein
Arsenic Trioxide results in decreased activity of CCND1 promoter
Arsenic Trioxide results in decreased expression of CCND1 mRNA; Arsenic Trioxide results in decreased expression of CCND1 protein
CCND1 mRNA affects the susceptibility to Arsenic Trioxide
Arsenic Trioxide results in decreased methylation of CCND1 promoter 		CTD PMID:12480548 PMID:12883267 PMID:15073043 PMID:17530438 PMID:17617380 More... NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810 		JBrowse link
G Ccnd2 cyclin D2 increases expression ISO Arsenic Trioxide results in increased expression of CCND2 mRNA CTD PMID:15073043 NCBI chr 4:161,653,048...161,675,422
Ensembl chr 4:161,653,048...161,680,301
Ensembl chr 4:161,653,048...161,680,301 		JBrowse link
G Ccnd3 cyclin D3 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of CCND3 mRNA
Arsenic Trioxide results in decreased expression of CCND3 mRNA 		CTD PMID:20458559 PMID:29633893 PMID:39716349 NCBI chr 9:20,891,696...20,987,199
Ensembl chr 9:20,891,704...20,987,033 		JBrowse link
G Ccne1 cyclin E1 affects expression
multiple interactions
decreases methylation
decreases expression
increases expression 		ISO Arsenic Trioxide affects the expression of CCNE1 protein
Arsenic Trioxide promotes the reaction [CCNE1 protein binds to CDKN1A protein]; TP53 protein promotes the reaction [Arsenic Trioxide results in decreased expression of CCNE1 protein]
Arsenic Trioxide results in decreased methylation of CCNE1 promoter
Arsenic Trioxide results in decreased expression of CCNE1 mRNA; Arsenic Trioxide results in decreased expression of CCNE1 protein
Arsenic Trioxide results in increased expression of CCNE1 mRNA; Arsenic Trioxide results in increased expression of CCNE1 protein 		CTD PMID:10850458 PMID:12480548 PMID:12962562 PMID:19236751 PMID:29159499 More... NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:99,918,674...99,927,822 		JBrowse link
G Ccnf cyclin F increases expression
decreases methylation
decreases expression 		ISO Arsenic Trioxide results in increased expression of CCNF mRNA
Arsenic Trioxide results in decreased methylation of CCNF promoter
Arsenic Trioxide results in decreased expression of CCNF mRNA; Arsenic Trioxide results in decreased expression of CCNF protein 		CTD PMID:17530438 PMID:29159499 NCBI chr10:13,757,884...13,783,669
Ensembl chr10:13,758,421...13,783,837 		JBrowse link
G Ccng1 cyclin G1 increases expression
multiple interactions 		EXP Arsenic Trioxide results in increased expression of CCNG1 mRNA
pifithrin inhibits the reaction [Arsenic Trioxide results in increased expression of CCNG1 mRNA] 		CTD PMID:17487067 NCBI chr10:25,678,503...25,684,876
Ensembl chr10:25,677,885...25,683,766 		JBrowse link
G Ccng2 cyclin G2 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of CCNG2 mRNA
[pifithrin co-treated with Arsenic Trioxide] results in increased expression of CCNG2 mRNA 		CTD PMID:20458559 PMID:24356939 PMID:25424538 PMID:35030298 NCBI chr14:15,088,694...15,097,190
Ensembl chr14:15,088,695...15,096,206 		JBrowse link
G Ccnh cyclin H increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of CCNH mRNA
Arsenic Trioxide results in decreased expression of CCNH mRNA 		CTD PMID:11940349 PMID:17530438 NCBI chr 2:17,570,449...17,591,078
Ensembl chr 2:17,570,263...17,614,860 		JBrowse link
G Ccnjl cyclin J-like decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of CCNJL mRNA
Arsenic Trioxide results in increased expression of CCNJL mRNA 		CTD PMID:35676786 PMID:39716349 NCBI chr10:28,497,144...28,554,877
Ensembl chr10:28,496,990...28,554,877 		JBrowse link
G Ccno cyclin O decreases response to substance ISO CCNO protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 2:46,364,074...46,367,113
Ensembl chr 2:46,350,717...46,367,113 		JBrowse link
G Ccpg1 cell cycle progression 1 decreases expression ISO Arsenic Trioxide results in decreased expression of CCPG1 mRNA CTD PMID:20471514 NCBI chr 8:82,600,677...82,633,082
Ensembl chr 8:82,600,536...82,660,246 		JBrowse link
G Ccr1 C-C motif chemokine receptor 1 multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of CCR1 mRNA CTD PMID:15894607 NCBI chr 8:132,433,711...132,439,266
Ensembl chr 8:132,431,592...132,439,374 		JBrowse link
G Ccr6 C-C motif chemokine receptor 6 decreases expression ISO Arsenic Trioxide results in decreased expression of CCR6 mRNA; Arsenic Trioxide results in decreased expression of CCR6 protein CTD PMID:34108876 NCBI chr 1:55,022,037...55,055,857
Ensembl chr 1:55,021,833...55,046,059 		JBrowse link
G Ccr8 C-C motif chemokine receptor 8 decreases expression ISO Arsenic Trioxide results in decreased expression of CCR8 mRNA CTD PMID:27829220 NCBI chr 8:128,703,966...128,705,926
Ensembl chr 8:128,702,349...128,705,955 		JBrowse link
G Cct2 chaperonin containing TCP1 subunit 2 increases expression ISO Arsenic Trioxide results in increased expression of CCT2 protein CTD PMID:19364129 NCBI chr 7:54,578,654...54,591,428
Ensembl chr 7:54,578,663...54,592,977 		JBrowse link
G Cct3 chaperonin containing TCP1 subunit 3 increases expression ISO Arsenic Trioxide results in increased expression of CCT3 protein CTD PMID:19364129 NCBI chr 2:176,063,529...176,088,180
Ensembl chr 2:176,063,526...176,089,925 		JBrowse link
G Cct6a chaperonin containing TCP1 subunit 6A increases expression ISO Arsenic Trioxide results in increased expression of CCT6A protein CTD PMID:19364129 NCBI chr12:32,508,842...32,519,072
Ensembl chr12:32,508,675...32,519,119 		JBrowse link
G Cct7 chaperonin containing TCP1 subunit 7 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CCT7 protein] CTD PMID:26598702 NCBI chr 4:119,546,730...119,563,973
Ensembl chr 4:119,546,730...119,563,973 		JBrowse link
G Cct8 chaperonin containing TCP1 subunit 8 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of CCT8 mRNA
Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CCT8 protein] 		CTD PMID:20458559 PMID:26598702 NCBI chr11:40,196,619...40,208,328
Ensembl chr11:40,196,619...40,208,328 		JBrowse link
G Cd14 CD14 molecule multiple interactions
increases expression
decreases expression 		ISO 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Gefitinib promotes the reaction [Arsenic Trioxide results in increased expression of CD14 protein]]; [Gefitinib promotes the reaction Arsenic Trioxide] which results in increased expression of CD14 mRNA; Gefitinib promotes the reaction [Arsenic Trioxide results in increased expression of CD14 protein]; SB 203580 inhibits the reaction [Gefitinib promotes the reaction [Arsenic Trioxide results in increased expression of CD14 protein]]
Arsenic Trioxide results in increased expression of CD14 mRNA
Arsenic Trioxide results in decreased expression of CD14 mRNA
Arsenic Trioxide results in increased expression of CD14 mRNA; Arsenic Trioxide results in increased expression of CD14 protein 		CTD PMID:15073043 PMID:20226526 PMID:22521957 PMID:23911876 NCBI chr18:28,609,558...28,611,409
Ensembl chr18:28,608,883...28,611,292 		JBrowse link
G Cd164 CD164 molecule decreases expression ISO Arsenic Trioxide results in decreased expression of CD164 mRNA CTD PMID:19128835 NCBI chr20:46,606,439...46,618,015
Ensembl chr20:46,606,107...46,638,649 		JBrowse link
G Cd177 CD177 molecule increases expression ISO Arsenic Trioxide results in increased expression of CD177 mRNA CTD PMID:20458559 NCBI chr 1:89,467,926...89,488,490
Ensembl chr 1:89,467,926...89,488,443 		JBrowse link
G Cd1d1 CD1d1 molecule decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of CD1D mRNA
[Arsenic Trioxide co-treated with Tretinoin] results in increased expression of CD1D mRNA 		CTD PMID:15761015 PMID:38179723 NCBI chr 2:174,721,522...174,725,029
Ensembl chr 2:174,721,522...174,725,029 		JBrowse link
G Cd22 CD22 molecule increases expression ISO Arsenic Trioxide results in increased expression of CD22 mRNA CTD PMID:20458559 NCBI chr 1:95,243,785...95,270,430
Ensembl chr 1:95,244,868...95,259,730 		JBrowse link
G Cd24 CD24 molecule multiple interactions
increases expression 		ISO SOX2 protein affects the reaction [Arsenic Trioxide results in increased expression of CD24 protein]
Arsenic Trioxide results in increased expression of CD24 mRNA; Arsenic Trioxide results in increased expression of CD24 protein 		CTD PMID:29396848 NCBI chr20:48,655,549...48,661,786
Ensembl chr20:48,655,805...48,661,785 		JBrowse link
G Cd27 CD27 molecule increases expression ISO Arsenic Trioxide results in increased expression of CD27 mRNA CTD PMID:17530438 NCBI chr 4:159,716,932...159,721,823
Ensembl chr 4:159,716,935...159,721,823 		JBrowse link
G Cd274 CD274 molecule multiple interactions
increases phosphorylation 		ISO [CpG ODN 2216 co-treated with Arsenic Trioxide] results in increased expression of CD274 protein; Arsenic Trioxide promotes the reaction [CPG-oligonucleotide results in increased expression of CD274 protein]
Arsenic Trioxide results in increased phosphorylation of CD274 protein
STING1 promotes the reaction [Arsenic Trioxide results in increased phosphorylation of CD274 protein] 		CTD PMID:32642412 PMID:38684648 NCBI chr 1:236,526,215...236,549,956
Ensembl chr 1:236,496,463...236,549,951 		JBrowse link
G Cd28 Cd28 molecule increases expression ISO Arsenic Trioxide results in increased expression of CD28 mRNA CTD PMID:34108876 NCBI chr 9:69,660,316...69,689,192
Ensembl chr 9:69,545,326...69,689,192 		JBrowse link
G Cd34 CD34 molecule multiple interactions
decreases expression 		ISO [Tetradecanoylphorbol Acetate co-treated with Arsenic Trioxide] results in increased expression of CD34 mRNA; [Tetradecanoylphorbol Acetate co-treated with Arsenic Trioxide] results in increased expression of CD34 protein; Arsenic Trioxide promotes the reaction [Homoharringtonine results in decreased expression of CD34 mRNA]
Arsenic Trioxide results in decreased expression of CD34 mRNA 		CTD PMID:18922899 PMID:31307525 NCBI chr13:109,008,786...109,029,317
Ensembl chr13:109,008,623...109,029,315 		JBrowse link
G Cd36 CD36 molecule multiple interactions ISO Arsenic Trioxide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CD36 mRNA]; Thioctic Acid inhibits the reaction [Arsenic Trioxide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CD36 mRNA]]
Arsenic Trioxide affects the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of CD36 mRNA]; Arsenic Trioxide affects the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of CD36 protein] 		CTD PMID:21315065 PMID:38237221 NCBI chr 4:18,209,088...18,302,142 JBrowse link
G Cd38 CD38 molecule increases response to substance
increases expression
multiple interactions 		ISO CD38 results in increased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in increased expression of CD38 mRNA
[Arsenic Trioxide co-treated with Homoharringtonine] results in increased expression of CD38 mRNA; [Arsenic Trioxide co-treated with Tretinoin] results in increased expression of CD38 mRNA 		CTD PMID:18297255 PMID:31307525 PMID:38179723 NCBI chr14:71,384,532...71,424,794
Ensembl chr14:71,384,532...71,424,505 		JBrowse link
G Cd40 CD40 molecule multiple interactions
increases expression 		ISO [Arsenic Trioxide co-treated with Curcumin] results in increased expression of CD40 protein
Arsenic Trioxide results in increased expression of CD40 protein 		CTD PMID:27430728 NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:174,209,719...174,224,847 		JBrowse link
G Cd40lg CD40 ligand multiple interactions
increases expression 		ISO [Arsenic Trioxide co-treated with Curcumin] results in increased expression of CD40LG protein
Arsenic Trioxide results in increased expression of CD40LG protein 		CTD PMID:27430728 NCBI chr  X:140,164,341...140,176,057
Ensembl chr  X:140,164,302...140,176,475 		JBrowse link
G Cd44 CD44 molecule multiple interactions
decreases expression 		ISO [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of CD44 mRNA
Arsenic Trioxide results in decreased expression of CD44 mRNA; Arsenic Trioxide results in decreased expression of CD44 mRNA alternative form; Arsenic Trioxide results in decreased expression of CD44 protein; Arsenic Trioxide results in decreased expression of CD44 protein alternative form 		CTD PMID:15553829 PMID:15894607 PMID:19804631 PMID:22391160 PMID:23098472 NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:109,612,054...109,699,424 		JBrowse link
G Cd52 CD52 molecule decreases expression
multiple interactions
increases expression 		ISO Arsenic Trioxide results in decreased expression of CD52 mRNA
[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of CD52 mRNA
Arsenic Trioxide results in increased expression of CD52 mRNA 		CTD PMID:10673743 PMID:15761015 PMID:15894607 PMID:19128835 NCBI chr 5:151,603,537...151,605,096
Ensembl chr 5:151,603,524...151,605,086 		JBrowse link
G Cd53 Cd53 molecule multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of CD53 mRNA CTD PMID:15894607 NCBI chr 2:197,040,369...197,087,925
Ensembl chr 2:197,040,369...197,218,593 		JBrowse link
G Cd55 CD55 molecule (Cromer blood group) decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of CD55 mRNA
Arsenic Trioxide results in increased expression of CD55 mRNA 		CTD PMID:29633893 PMID:36801614 NCBI chr13:44,409,574...44,438,913
Ensembl chr13:44,409,587...44,438,107 		JBrowse link
G Cd5l Cd5 molecule-like decreases expression ISO Arsenic Trioxide results in decreased expression of CD5L mRNA CTD PMID:35676786 NCBI chr 2:175,088,915...175,099,928
Ensembl chr 2:175,088,884...175,099,926 		JBrowse link
G Cd70 Cd70 molecule increases expression
decreases expression 		ISO
EXP 		Arsenic Trioxide results in increased expression of CD70 mRNA
Arsenic Trioxide results in decreased expression of CD70 mRNA 		CTD PMID:15761015 PMID:17530438 PMID:19730151 NCBI chr 9:2,093,540...2,096,692
Ensembl chr 9:2,086,848...2,096,692 		JBrowse link
G Cd74 CD74 molecule increases expression ISO Arsenic Trioxide results in increased expression of CD74 mRNA CTD PMID:20458559 NCBI chr18:56,527,071...56,536,406
Ensembl chr18:56,527,132...56,536,410 		JBrowse link
G Cd80 Cd80 molecule multiple interactions ISO [CpG ODN 2216 co-treated with Arsenic Trioxide] results in decreased expression of CD80 protein; Arsenic Trioxide inhibits the reaction [CpG ODN 2216 results in increased expression of CD80 protein] CTD PMID:32642412 NCBI chr11:75,760,073...75,798,978
Ensembl chr11:75,760,147...75,797,540 		JBrowse link
G Cd84 CD84 molecule increases expression ISO Arsenic Trioxide results in increased expression of CD84 mRNA CTD PMID:24356939 NCBI chr13:86,859,979...86,899,984
Ensembl chr13:86,859,990...86,894,318 		JBrowse link
G Cd86 CD86 molecule increases expression
decreases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of CD86 mRNA
Arsenic Trioxide results in decreased expression of CD86 mRNA
[CpG ODN 2216 co-treated with Arsenic Trioxide] results in decreased expression of CD86 protein; Arsenic Trioxide inhibits the reaction [CpG ODN 2216 results in increased expression of CD86 protein] 		CTD PMID:15761015 PMID:20458559 PMID:32642412 NCBI chr11:77,647,565...77,706,178
Ensembl chr11:77,647,600...77,725,361 		JBrowse link
G Cd9 CD9 molecule decreases response to substance ISO CD9 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 4:159,942,553...159,975,463
Ensembl chr 4:159,942,560...159,975,444 		JBrowse link
G Cd96 CD96 molecule multiple interactions
decreases expression 		ISO [Arsenic Trioxide co-treated with Homoharringtonine] results in decreased expression of CD96 mRNA
Arsenic Trioxide results in decreased expression of CD96 mRNA 		CTD PMID:31307525 NCBI chr11:68,164,926...68,239,266
Ensembl chr11:68,164,872...68,241,937 		JBrowse link
G Cdc20 cell division cycle 20 decreases expression
multiple interactions
increases expression 		ISO Arsenic Trioxide results in decreased expression of CDC20 mRNA; Arsenic Trioxide results in decreased expression of CDC20 protein
[Arsenic Trioxide co-treated with Paclitaxel] promotes the reaction [BUB1B protein binds to CDC20 protein]
Arsenic Trioxide results in increased expression of CDC20 mRNA 		CTD PMID:19781537 PMID:20862710 PMID:29950208 NCBI chr 5:137,251,596...137,255,799
Ensembl chr 5:137,251,596...137,255,799 		JBrowse link
G Cdc23 cell division cycle 23 increases expression ISO Arsenic Trioxide results in increased expression of CDC23 mRNA CTD PMID:20862710 NCBI chr18:26,511,019...26,534,872
Ensembl chr18:26,510,355...26,532,646 		JBrowse link
G Cdc25a cell division cycle 25A increases expression ISO Arsenic Trioxide results in increased expression of CDC25A mRNA; Arsenic Trioxide results in increased expression of CDC25A protein CTD PMID:20862710 PMID:23255470 PMID:29633893 NCBI chr 8:118,742,824...118,761,190
Ensembl chr 8:118,742,426...118,761,188 		JBrowse link
G Cdc25b cell division cycle 25B decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of CDC25B protein
Arsenic Trioxide results in increased expression of CDC25B mRNA 		CTD PMID:10850458 PMID:39716349 NCBI chr 3:138,860,148...138,870,287
Ensembl chr 3:138,860,130...138,870,492 		JBrowse link
G Cdc25c cell division cycle 25C multiple interactions
decreases expression 		EXP
ISO 		Arsenic Trioxide affects the expression of and affects the phosphorylation of CDC25C protein
[Arsenic Trioxide co-treated with Paclitaxel] results in increased expression of CDC25C protein modified form; Arsenic Trioxide promotes the reaction [Docetaxel results in decreased expression of CDC25C mRNA]; Arsenic Trioxide promotes the reaction [Docetaxel results in decreased expression of CDC25C protein]; Arsenic Trioxide promotes the reaction [Oxaliplatin results in decreased expression of CDC25C mRNA]; Arsenic Trioxide promotes the reaction [Oxaliplatin results in decreased expression of CDC25C protein]
Arsenic Trioxide results in decreased expression of CDC25C mRNA; Arsenic Trioxide results in decreased expression of CDC25C protein 		CTD PMID:10850458 PMID:19781537 PMID:23337567 PMID:39903385 NCBI chr18:26,608,483...26,630,292
Ensembl chr18:26,609,959...26,630,292 		JBrowse link
G Cdc27 cell division cycle 27 multiple interactions ISO [Arsenic Trioxide co-treated with Paclitaxel] results in increased expression of CDC27 protein modified form CTD PMID:19781537 NCBI chr10:89,900,676...89,949,770
Ensembl chr10:89,900,684...89,949,770 		JBrowse link
G Cdc34 cell division cycle 34, ubiquitin conjugating enzyme decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of CDC34 mRNA
Arsenic Trioxide results in increased expression of CDC34 mRNA 		CTD PMID:17530438 PMID:20458559 NCBI chr 7:10,668,209...10,674,206
Ensembl chr 7:10,668,210...10,674,526 		JBrowse link
G Cdc37 cell division cycle 37, HSP90 cochaperone increases expression ISO Arsenic Trioxide results in increased expression of CDC37 mRNA CTD PMID:17530438 NCBI chr 8:27,954,292...27,966,935
Ensembl chr 8:27,948,016...27,983,931 		JBrowse link
G Cdc42 cell division cycle 42 increases expression ISO Arsenic Trioxide results in increased expression of CDC42 mRNA CTD PMID:20458559 NCBI chr 5:154,838,478...154,876,629
Ensembl chr 5:154,839,631...154,876,627 		JBrowse link
G Cdc42bpa CDC42 binding protein kinase alpha increases expression ISO Arsenic Trioxide results in increased expression of CDC42BPA mRNA CTD PMID:15761015 PMID:19128835 NCBI chr13:94,215,359...94,435,681
Ensembl chr13:94,215,959...94,435,681 		JBrowse link
G Cdc42ep3 CDC42 effector protein 3 multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of CDC42EP3 mRNA CTD PMID:15894607 NCBI chr 6:21,463,081...21,483,553
Ensembl chr 6:21,461,762...21,508,540 		JBrowse link
G Cdc45 cell division cycle 45 decreases expression ISO Arsenic Trioxide results in decreased expression of CDC45 mRNA CTD PMID:19128835 PMID:34413873 NCBI chr11:95,689,702...95,714,980
Ensembl chr11:95,689,919...95,714,981 		JBrowse link
G Cdc6 cell division cycle 6 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of CDC6 mRNA; Arsenic Trioxide results in increased expression of CDC6 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased expression of CDC6 protein]; 9-methoxy-2-methylellipticinium acetate inhibits the reaction [Arsenic Trioxide results in increased expression of CDC6 protein]; AKT1 protein affects the reaction [Arsenic Trioxide results in increased expression of CDC6 protein]; MAPK1 protein affects the reaction [Arsenic Trioxide results in increased expression of CDC6 protein]; MAPK3 protein affects the reaction [Arsenic Trioxide results in increased expression of CDC6 protein]; SB 203580 inhibits the reaction [Arsenic Trioxide results in increased expression of CDC6 protein] 		CTD PMID:20862710 PMID:23255470 NCBI chr10:84,360,361...84,374,239
Ensembl chr10:84,360,381...84,374,241 		JBrowse link
G Cdc7 cell division cycle 7 increases expression ISO Arsenic Trioxide results in increased expression of CDC7 mRNA CTD PMID:17530438 NCBI chr14:2,949,538...2,969,656
Ensembl chr14:2,949,539...2,969,656 		JBrowse link
G Cdc73 cell division cycle 73 increases expression ISO Arsenic Trioxide results in increased expression of CDC73 mRNA CTD PMID:15761015 NCBI chr13:57,897,924...58,000,031
Ensembl chr13:57,883,983...57,999,978 		JBrowse link
G Cdh1 cadherin 1 increases expression
decreases expression
multiple interactions
decreases methylation 		ISO Arsenic Trioxide results in increased expression of CDH1 mRNA; Arsenic Trioxide results in increased expression of CDH1 protein
Arsenic Trioxide results in decreased expression of CDH1 mRNA; Arsenic Trioxide results in decreased expression of CDH1 protein
[Arsenic Trioxide results in decreased methylation of CDH1 promoter] which results in increased expression of CDH1 mRNA; [Arsenic Trioxide results in decreased methylation of CDH1 promoter] which results in increased expression of CDH1 protein; [Curcumin co-treated with Arsenic Trioxide] results in increased expression of CDH1 mRNA; Arsenic Trioxide promotes the reaction [Decitabine results in increased expression of CDH1 mRNA]; Arsenic Trioxide promotes the reaction [Tretinoin results in increased expression of CDH1 mRNA]; Arsenic Trioxide results in increased expression of and affects the localization of CDH1 protein; Decitabine promotes the reaction [Arsenic Trioxide results in increased expression of CDH1 mRNA]; Gemcitabine promotes the reaction [Arsenic Trioxide results in increased expression of CDH1 protein]; GH1 protein promotes the reaction [Arsenic Trioxide results in decreased expression of CDH1 mRNA]; MEG3 protein affects the reaction [Arsenic Trioxide results in increased expression of CDH1 protein]; MIR491 mRNA affects the reaction [Arsenic Trioxide results in increased expression of CDH1 protein]; pervanadate inhibits the reaction [Arsenic Trioxide results in increased expression of CDH1 protein]; PKM protein inhibits the reaction [Arsenic Trioxide results in increased expression of CDH1 mRNA]; PKM protein inhibits the reaction [Arsenic Trioxide results in increased expression of CDH1 protein]; Tretinoin promotes the reaction [Arsenic Trioxide results in increased expression of CDH1 mRNA] 		CTD PMID:16613325 PMID:17512576 PMID:23104537 PMID:23851143 PMID:24680928 More... NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565 		JBrowse link
G Cdh2 cadherin 2 increases expression
multiple interactions
decreases expression 		ISO Arsenic Trioxide results in increased expression of CDH2 protein
Gemcitabine promotes the reaction [Arsenic Trioxide results in decreased expression of CDH2 protein]; MEG3 protein affects the reaction [Arsenic Trioxide results in decreased expression of CDH2 protein]; PKM protein inhibits the reaction [Arsenic Trioxide results in decreased expression of CDH2 mRNA]; PKM protein inhibits the reaction [Arsenic Trioxide results in decreased expression of CDH2 protein]
Arsenic Trioxide results in decreased expression of CDH2 mRNA; Arsenic Trioxide results in decreased expression of CDH2 protein 		CTD PMID:29396848 PMID:31003765 PMID:36400307 PMID:36442592 NCBI chr18:8,051,097...8,265,288
Ensembl chr18:8,051,097...8,265,288 		JBrowse link
G Cdh23 cadherin-related 23 increases expression ISO Arsenic Trioxide results in increased expression of CDH23 mRNA CTD PMID:20458559 NCBI chr20:28,783,124...29,165,624
Ensembl chr20:28,783,564...29,165,332 		JBrowse link
G Cdh5 cadherin 5 multiple interactions
decreases expression 		ISO
EXP 		Arsenic Trioxide results in increased degradation of and affects the localization of CDH5 protein; calpain inhibitor 2 inhibits the reaction [Arsenic Trioxide results in increased degradation of and affects the localization of CDH5 protein]; Diosgenin inhibits the reaction [Arsenic Trioxide results in decreased expression of CDH5 protein]; NR3C1 promotes the reaction [Diosgenin inhibits the reaction [Arsenic Trioxide results in decreased expression of CDH5 protein]] CTD PMID:31274337 PMID:39059093 NCBI chr19:821,875...860,931
Ensembl chr19:822,464...860,822 		JBrowse link
G Cdh8 cadherin 8 decreases expression ISO Arsenic Trioxide results in decreased expression of CDH8 mRNA CTD PMID:26705709 NCBI chr19:5,494,552...5,901,950
Ensembl chr19:5,500,221...5,902,627 		JBrowse link
G Cdhr3 cadherin-related family member 3 decreases expression ISO Arsenic Trioxide results in decreased expression of CDHR3 mRNA CTD PMID:39716349 NCBI chr 6:55,369,215...55,429,454
Ensembl chr 6:55,369,851...55,429,458 		JBrowse link
G Cdip1 cell death-inducing p53 target 1 multiple interactions
increases expression 		ISO Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of CDIP1 mRNA] CTD PMID:29095437 NCBI chr10:11,278,213...11,303,415
Ensembl chr10:11,293,827...11,303,415 		JBrowse link
G Cdk1 cyclin-dependent kinase 1 multiple interactions
decreases expression
increases expression
affects expression
decreases activity 		EXP
ISO 		Arsenic Trioxide results in increased expression of and results in increased phosphorylation of CDK1 protein
Arsenic Trioxide results in decreased expression of CDK1 protein modified form
[Arsenic Trioxide co-treated with Paclitaxel] results in increased activity of CDK1 protein; [Arsenic Trioxide co-treated with Paclitaxel] results in increased expression of CDK1 protein modified form; Arsenic Trioxide promotes the reaction [CDK1 protein binds to CDKN1A protein]; Arsenic Trioxide results in decreased expression of and results in increased phosphorylation of CDK1 protein; PTEN protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of CDK1 protein]
Arsenic Trioxide results in increased expression of CDK1 mRNA
Arsenic Trioxide affects the expression of CDK1 mRNA
Arsenic Trioxide results in decreased activity of CDK1 protein 		CTD PMID:10850458 PMID:18088464 PMID:19781537 PMID:19825857 PMID:20862710 More... NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,265,289...19,280,455 		JBrowse link
G Cdk10 cyclin-dependent kinase 10 increases expression ISO Arsenic Trioxide results in increased expression of CDK10 mRNA CTD PMID:39716349 NCBI chr19:68,168,040...68,184,923
Ensembl chr19:68,169,874...68,177,599 		JBrowse link
G Cdk11b cyclin-dependent kinase 11B decreases expression ISO Arsenic Trioxide results in decreased expression of CDK11B mRNA CTD PMID:22521957 NCBI chr 5:171,495,042...171,521,143
Ensembl chr 5:171,495,776...171,521,145 		JBrowse link
G Cdk2 cyclin dependent kinase 2 multiple interactions
decreases expression 		ISO [ruxolitinib co-treated with Arsenic Trioxide] results in decreased expression of CDK2 mRNA; Arsenic Trioxide inhibits the reaction [PDGFB protein results in increased expression of CDK2 protein]; Arsenic Trioxide promotes the reaction [CDK2 protein binds to CDKN1A protein]; Arsenic Trioxide results in decreased expression of and results in decreased activity of CDK2 protein
Arsenic Trioxide results in decreased expression of CDK2 mRNA 		CTD PMID:12480548 PMID:20458559 PMID:30012499 PMID:35276128 NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,714,392...1,721,878 		JBrowse link
G Cdk2ap2 cyclin-dependent kinase 2 associated protein 2 increases expression ISO Arsenic Trioxide results in increased expression of CDK2AP2 mRNA CTD PMID:35676786 NCBI chr 1:210,819,155...210,822,604
Ensembl chr 1:210,820,507...210,823,010 		JBrowse link
G Cdk4 cyclin-dependent kinase 4 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of CDK4 mRNA
Arsenic Trioxide inhibits the reaction [PDGFB protein results in increased expression of CDK4 protein] 		CTD PMID:17530438 PMID:19769630 PMID:20016248 PMID:35276128 NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:64,771,147...64,775,163 		JBrowse link
G Cdk5 cyclin-dependent kinase 5 increases expression EXP Arsenic Trioxide results in increased expression of CDK5 mRNA; Arsenic Trioxide results in increased expression of CDK5 protein CTD PMID:22801079 PMID:24641850 NCBI chr 4:11,647,098...11,651,606
Ensembl chr 4:11,647,141...11,652,777 		JBrowse link
G Cdk5r1 cyclin-dependent kinase 5 regulatory subunit 1 increases expression EXP Arsenic Trioxide results in increased expression of CDK5R1 mRNA; Arsenic Trioxide results in increased expression of CDK5R1 protein modified form CTD PMID:24641850 NCBI chr10:65,981,692...65,985,831
Ensembl chr10:65,978,911...65,989,272 		JBrowse link
G Cdk6 cyclin-dependent kinase 6 multiple interactions
decreases expression
decreases activity 		ISO [Arsenic Trioxide results in decreased activity of CDK6 protein] which results in decreased phosphorylation of RB1 protein; [BIBR 1532 co-treated with Arsenic Trioxide] affects the expression of CDK6 mRNA; [Dasatinib co-treated with Arsenic Trioxide] results in decreased expression of CDK6 mRNA; Arsenic Trioxide promotes the reaction [CDK6 protein binds to CDKN1A protein]; Arsenic Trioxide results in decreased expression of and results in decreased activity of CDK6 protein
Arsenic Trioxide results in decreased expression of CDK6 mRNA; Arsenic Trioxide results in decreased expression of CDK6 protein 		CTD PMID:10850458 PMID:12480548 PMID:29266867 PMID:32645343 NCBI chr 4:31,592,384...31,784,732
Ensembl chr 4:31,601,192...31,781,701 		JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A increases stability
increases sumoylation
decreases methylation
decreases expression
increases response to substance
increases expression
multiple interactions
affects expression 		ISO
EXP 		Arsenic Trioxide results in increased stability of CDKN1A protein
Arsenic Trioxide results in increased sumoylation of CDKN1A protein
Arsenic Trioxide results in decreased methylation of CDKN1A promoter
Arsenic Trioxide results in decreased expression of CDKN1A mRNA
CDKN1A protein results in increased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in increased expression of CDKN1A mRNA; Arsenic Trioxide results in increased expression of CDKN1A protein
2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [Arsenic Trioxide results in increased expression of CDKN1A protein]; pifithrin inhibits the reaction [Arsenic Trioxide results in increased expression of CDKN1A mRNA]
Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of CDKN1A protein]; Arsenic Trioxide promotes the reaction [CDKN1A protein binds to CASP3 protein]; Arsenic Trioxide promotes the reaction [CDKN1A protein binds to PCNA protein]
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Arsenic Trioxide results in increased expression of CDKN1A mRNA]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased expression of CDKN1A mRNA]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Arsenic Trioxide results in increased expression of CDKN1A mRNA]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Arsenic Trioxide results in increased expression of CDKN1A protein]; 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [Arsenic Trioxide results in increased expression of CDKN1A mRNA]; 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [Arsenic Trioxide results in increased expression of CDKN1A protein]; 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Arsenic Trioxide results in increased expression of CDKN1A mRNA]; 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Arsenic Trioxide results in increased expression of CDKN1A protein]; [[Arsenic Trioxide results in increased phosphorylation of JUN protein] which binds to HDAC1 protein] which binds to CDKN1A promoter; [Arsenic Trioxide co-treated with Aprepitant] results in increased expression of CDKN1A mRNA; [Arsenic Trioxide co-treated with Calcitriol] results in increased expression of CDKN1A mRNA; [Arsenic Trioxide co-treated with Calcitriol] results in increased expression of CDKN1A protein; [Arsenic Trioxide co-treated with Cisplatin] results in increased expression of CDKN1A mRNA; [Arsenic Trioxide co-treated with Curcumin] results in increased expression of CDKN1A protein; [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of FOS protein] promotes the reaction [FOS protein binds to CDKN1A promoter]; [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of FOS protein] promotes the reaction [FOS protein results in increased expression of CDKN1A mRNA]; [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of JUN protein] which results in decreased expression of CDKN1A mRNA; [Arsenic Trioxide results in increased phosphorylation of JUN protein] which results in decreased expression of CDKN1A; [Arsenic Trioxide results in increased phosphorylation of JUN protein] which results in decreased expression of CDKN1A mRNA; [NVP-BKM120 co-treated with Arsenic Trioxide] results in increased expression of CDKN1A mRNA; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of CDKN1A protein]; Arsenic Trioxide inhibits the reaction [Dasatinib results in decreased expression of CDKN1A protein]; Arsenic Trioxide promotes the reaction [[CREBBP protein binds to CDKN1A promoter] which results in increased expression of CDKN1A mRNA]; Arsenic Trioxide promotes the reaction [[FOS protein binds to JUN promoter] which binds to CDKN1A promoter]; Arsenic Trioxide promotes the reaction [[FOS protein binds to JUN protein] which results in increased expression of CDKN1A mRNA]; Arsenic Trioxide promotes the reaction [[JUN protein binds to CDKN1A promoter] which results in increased expression of CDKN1A protein]; Arsenic Trioxide promotes the reaction [[TGIF1 protein co-treated with HDAC1 protein] binds to CDKN1A promoter]; Arsenic Trioxide promotes the reaction [[TGIF1 protein co-treated with HDAC1 protein] results in decreased expression of CDKN1A mRNA]; Arsenic Trioxide promotes the reaction [CCNE1 protein binds to CDKN1A protein]; Arsenic Trioxide promotes the reaction [CDK1 protein binds to CDKN1A protein]; Arsenic Trioxide promotes the reaction [CDK2 protein binds to CDKN1A protein]; Arsenic Trioxide promotes the reaction [CDK6 protein binds to CDKN1A protein]; Arsenic Trioxide promotes the reaction [CREBBP protein binds to CDKN1A promoter]; Arsenic Trioxide promotes the reaction [FOS protein binds to CDKN1A promoter]; Arsenic Trioxide promotes the reaction [MAPK1 protein promotes the reaction [FOS protein binds to CDKN1A promoter]]; Arsenic Trioxide promotes the reaction [MAPK3 protein promotes the reaction [FOS protein binds to CDKN1A promoter]]; Erlotinib Hydrochloride promotes the reaction [Arsenic Trioxide results in increased expression of CDKN1A mRNA]; GSK3B protein modified form affects the reaction [Arsenic Trioxide results in increased expression of CDKN1A protein]; pyrazolanthrone inhibits the reaction [Arsenic Trioxide results in increased expression of CDKN1A protein]; pyrazolanthrone promotes the reaction [Arsenic Trioxide results in increased expression of CDKN1A mRNA]; pyrazolanthrone promotes the reaction [Arsenic Trioxide results in increased expression of CDKN1A protein]; RTKI cpd inhibits the reaction [Arsenic Trioxide results in increased expression of CDKN1A protein]; SMAD3 protein promotes the reaction [Arsenic Trioxide results in increased expression of CDKN1A mRNA]; SMAD3 protein promotes the reaction [Arsenic Trioxide results in increased expression of CDKN1A protein]; TGIF1 protein inhibits the reaction [Arsenic Trioxide results in increased expression of CDKN1A mRNA]; TGIF1 protein inhibits the reaction [Arsenic Trioxide results in increased expression of CDKN1A protein]; U 0126 inhibits the reaction [Arsenic Trioxide results in increased expression of CDKN1A protein]
Arsenic Trioxide affects the expression of CDKN1A mRNA; Arsenic Trioxide affects the expression of CDKN1A protein 		CTD PMID:10850458 PMID:12480548 PMID:12749819 PMID:12864950 PMID:15073043 More... NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969 		JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B decreases expression
multiple interactions
increases expression 		ISO Arsenic Trioxide results in decreased expression of CDKN1B mRNA
[Arsenic Trioxide co-treated with Calcitriol] results in increased expression of CDKN1B mRNA; [Arsenic Trioxide co-treated with Calcitriol] results in increased expression of CDKN1B protein; [Arsenic Trioxide co-treated with Curcumin] results in increased expression of CDKN1B protein; [Arsenic Trioxide co-treated with VS-5584] results in increased expression of CDKN1B mRNA; [Curcumin co-treated with Arsenic Trioxide] results in increased expression of CDKN1B protein; [NVP-BKM120 co-treated with Arsenic Trioxide] results in increased expression of CDKN1B mRNA; Arsenic Trioxide results in increased expression of and results in increased localization of CDKN1B protein; salvin promotes the reaction [Arsenic Trioxide results in increased expression of CDKN1B protein]
Arsenic Trioxide results in increased expression of CDKN1B gene; Arsenic Trioxide results in increased expression of CDKN1B mRNA; Arsenic Trioxide results in increased expression of CDKN1B protein 		CTD PMID:19236751 PMID:19769630 PMID:20458559 PMID:20698225 PMID:20953137 More... NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:169,490,876...169,496,498 		JBrowse link
G Cdkn1c cyclin-dependent kinase inhibitor 1C decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of CDKN1C protein
Arsenic Trioxide results in increased expression of CDKN1C mRNA 		CTD PMID:34413873 NCBI chr 1:208,084,801...208,087,680
Ensembl chr 1:208,084,787...208,087,498 		JBrowse link
G Cdkn2a cyclin-dependent kinase inhibitor 2A decreases methylation
multiple interactions
increases expression 		ISO
EXP 		Arsenic Trioxide results in decreased methylation of CDKN2A gene; Arsenic Trioxide results in decreased methylation of CDKN2A promoter
[Arsenic Trioxide co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CDKN2A mRNA; [Arsenic Trioxide results in decreased methylation of CDKN2A gene] which results in increased expression of CDKN2A mRNA; [Arsenic Trioxide results in decreased methylation of CDKN2A promoter] which results in increased expression of CDKN2A mRNA; Arsenic Trioxide promotes the reaction [Decitabine results in increased expression of CDKN2A mRNA]; Arsenic Trioxide results in increased expression of and affects the localization of CDKN2A protein; Decitabine promotes the reaction [Arsenic Trioxide results in increased expression of CDKN2A mRNA]; GH1 protein promotes the reaction [Arsenic Trioxide results in increased expression of CDKN2A mRNA]; SB 203580 inhibits the reaction [Arsenic Trioxide results in increased expression of CDKN2A protein]
Arsenic Trioxide results in increased expression of CDKN2A gene; Arsenic Trioxide results in increased expression of CDKN2A mRNA; Arsenic Trioxide results in increased expression of CDKN2A protein 		CTD PMID:12864950 PMID:15191659 PMID:16008847 PMID:16613325 PMID:18922899 More... NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:109,100,772...109,119,248 		JBrowse link
G Cdkn2b cyclin-dependent kinase inhibitor 2B decreases methylation
multiple interactions
increases expression 		ISO Arsenic Trioxide results in decreased methylation of CDKN2B gene
[Arsenic Trioxide results in decreased methylation of CDKN2B promoter] which results in increased expression of CDKN2B mRNA; [Valproic Acid co-treated with Arsenic Trioxide] results in increased expression of CDKN2B mRNA
Arsenic Trioxide results in increased expression of CDKN2B mRNA 		CTD PMID:11877046 PMID:12667347 PMID:12679007 PMID:12864950 PMID:17294728 More... NCBI chr 5:109,123,308...109,134,906
Ensembl chr 5:109,114,322...109,134,855 		JBrowse link
G Cdkn2c cyclin-dependent kinase inhibitor 2C increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of CDKN2C mRNA
Arsenic Trioxide results in decreased expression of CDKN2C mRNA 		CTD PMID:17530438 PMID:20862710 PMID:26705709 NCBI chr 5:129,639,736...129,645,564
Ensembl chr 5:129,639,736...129,644,891 		JBrowse link
G Cdkn2d cyclin dependent kinase inhibitor 2D increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of CDKN2D mRNA
[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of CDKN2D mRNA 		CTD PMID:15894607 PMID:19769630 PMID:20458559 NCBI chr 8:28,108,036...28,110,809
Ensembl chr 8:28,108,044...28,110,809 		JBrowse link
G Cdkn3 cyclin-dependent kinase inhibitor 3 increases expression ISO Arsenic Trioxide results in increased expression of CDKN3 mRNA CTD PMID:17547211 PMID:34108876 PMID:34413873 NCBI chr15:22,502,299...22,513,725
Ensembl chr15:22,502,382...22,513,722 		JBrowse link
G Cdnf cerebral dopamine neurotrophic factor multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CDNF protein] CTD PMID:26598702 NCBI chr17:79,623,728...79,637,800
Ensembl chr17:79,611,623...79,665,922 		JBrowse link
G Cdon cell adhesion associated, oncogene regulated decreases expression ISO Arsenic Trioxide results in decreased expression of CDON mRNA CTD PMID:39716349 NCBI chr 8:42,032,921...42,119,451
Ensembl chr 8:42,033,042...42,119,345 		JBrowse link
G Cdr2 cerebellar degeneration-related protein 2 increases expression ISO Arsenic Trioxide results in increased expression of CDR2 mRNA CTD PMID:39716349 NCBI chr 1:184,934,128...184,959,036
Ensembl chr 1:184,934,129...184,968,863 		JBrowse link
G Cds1 CDP-diacylglycerol synthase 1 increases expression ISO Arsenic Trioxide results in increased expression of CDS1 mRNA CTD PMID:29633893 NCBI chr14:8,126,678...8,187,243
Ensembl chr14:8,124,838...8,187,218 		JBrowse link
G Cdv3 carnitine deficiency-associated gene expressed in ventricle 3 increases expression ISO Arsenic Trioxide results in increased expression of CDV3 mRNA CTD PMID:17258074 NCBI chr 8:112,812,898...112,826,073
Ensembl chr 8:112,813,952...112,826,056 		JBrowse link
G Cdx1 caudal type homeo box 1 decreases expression ISO Arsenic Trioxide results in decreased expression of CDX1 mRNA CTD PMID:30748021 NCBI chr18:56,742,970...56,761,299
Ensembl chr18:56,742,984...56,761,299 		JBrowse link
G Cdx2 caudal type homeo box 2 decreases expression ISO Arsenic Trioxide results in decreased expression of CDX2 mRNA CTD PMID:30748021 PMID:39716349 NCBI chr12:12,762,769...12,769,246
Ensembl chr12:12,762,904...12,769,246 		JBrowse link
G Cebpa CCAAT/enhancer binding protein alpha decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of CEBPA mRNA; Arsenic Trioxide results in decreased expression of CEBPA protein
Arsenic Trioxide results in increased expression of CEBPA mRNA 		CTD PMID:15916724 PMID:19662097 PMID:20458559 PMID:21257625 NCBI chr 1:96,896,584...96,899,256
Ensembl chr 1:96,896,171...96,899,309 		JBrowse link
G Cebpb CCAAT/enhancer binding protein beta decreases methylation
increases expression
multiple interactions
decreases expression 		ISO Arsenic Trioxide results in decreased methylation of CEBPB promoter
Arsenic Trioxide results in increased expression of CEBPB mRNA; Arsenic Trioxide results in increased expression of CEBPB protein
[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of CEBPB mRNA; Arsenic Trioxide inhibits the reaction [DAXX protein binds to CEBPB protein]; Bortezomib inhibits the reaction [Arsenic Trioxide results in decreased expression of CEBPB mRNA] 		CTD PMID:15894607 PMID:19690170 PMID:20471514 PMID:24356939 PMID:25424538 More... NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:176,816,859...176,838,072 		JBrowse link
G Cebpd CCAAT/enhancer binding protein delta increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of CEBPD mRNA
[Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of CEBPD mRNA 		CTD PMID:15894607 PMID:26705709 NCBI chr11:98,268,856...98,269,994
Ensembl chr11:98,265,651...98,280,824 		JBrowse link
G Cebpe CCAAT/enhancer binding protein epsilon multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide co-treated with Butyrates] results in increased expression of CEBPE mRNA; [Tretinoin co-treated with Arsenic Trioxide co-treated with hexamethylene bisacetamide] results in increased expression of CEBPE mRNA; [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of CEBPE mRNA; Arsenic Trioxide inhibits the reaction [Tretinoin results in increased expression of CEBPE mRNA] CTD PMID:12130515 PMID:16184197 NCBI chr15:32,139,716...32,141,476
Ensembl chr15:32,139,716...32,141,476 		JBrowse link
G Cebpz CCAAT/enhancer binding protein zeta increases expression ISO Arsenic Trioxide results in increased expression of CEBPZ mRNA CTD PMID:20458559 NCBI chr 6:21,872,071...21,889,755
Ensembl chr 6:21,872,025...21,889,749 		JBrowse link
G Cela1 chymotrypsin like elastase 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CELA1 protein] CTD PMID:26598702 NCBI chr 7:133,651,939...133,665,136
Ensembl chr 7:133,651,941...133,665,061 		JBrowse link
G Cela2a chymotrypsin like elastase 2A increases expression ISO Arsenic Trioxide results in increased expression of CELA2A mRNA CTD PMID:15761015 NCBI chr 5:159,409,900...159,420,282
Ensembl chr 5:159,409,899...159,426,208 		JBrowse link
G Celsr1 cadherin, EGF LAG seven-pass G-type receptor 1 increases expression ISO Arsenic Trioxide results in increased expression of CELSR1 mRNA CTD PMID:20458559 NCBI chr 7:118,867,450...119,004,859
Ensembl chr 7:118,867,450...119,004,856 		JBrowse link
G Cenpc centromere protein C increases expression ISO Arsenic Trioxide results in increased expression of CENPC mRNA CTD PMID:20458559 NCBI chr14:22,342,910...22,401,522
Ensembl chr14:22,342,927...22,438,590 		JBrowse link
G Cenpp centromere protein P multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CENPP protein] CTD PMID:26598702 NCBI chr17:15,220,521...15,395,741
Ensembl chr17:15,220,291...15,395,739 		JBrowse link
G Cep112 centrosomal protein 112 decreases expression ISO Arsenic Trioxide results in decreased expression of CEP112 mRNA CTD PMID:35676786 PMID:39716349 NCBI chr10:93,865,630...94,332,679
Ensembl chr10:93,865,699...94,332,680 		JBrowse link
G Cep295nl CEP295 N-terminal like increases expression ISO Arsenic Trioxide results in increased expression of CEP295NL mRNA CTD PMID:36801614 NCBI chr10:104,066,652...104,079,787
Ensembl chr10:104,054,640...104,084,291 		JBrowse link
G Cep350 centrosomal protein 350 decreases expression ISO Arsenic Trioxide results in decreased expression of CEP350 mRNA CTD PMID:35676786 NCBI chr13:70,573,597...70,714,673
Ensembl chr13:70,573,597...70,714,673 		JBrowse link
G Cep55 centrosomal protein 55 increases expression ISO Arsenic Trioxide results in increased expression of CEP55 mRNA CTD PMID:20458559 NCBI chr 1:245,245,272...245,260,835
Ensembl chr 1:245,245,306...245,260,890 		JBrowse link
G Cep57 centrosomal protein 57 increases expression ISO Arsenic Trioxide results in increased expression of CEP57 mRNA CTD PMID:14703492 NCBI chr 8:18,951,179...18,971,205
Ensembl chr 8:18,932,808...18,970,890 		JBrowse link
G Cep70 centrosomal protein 70 increases expression ISO Arsenic Trioxide results in increased expression of CEP70 mRNA CTD PMID:20458559 NCBI chr 8:108,689,562...108,742,620
Ensembl chr 8:108,689,671...108,742,617 		JBrowse link
G Cers4 ceramide synthase 4 decreases expression ISO Arsenic Trioxide results in decreased expression of CERS4 mRNA CTD PMID:22521957 NCBI chr12:7,649,610...7,688,066
Ensembl chr12:7,649,610...7,688,070 		JBrowse link
G Ces2e carboxylesterase 2E increases expression ISO Arsenic Trioxide results in increased expression of CES2E mRNA CTD PMID:35676786 NCBI chr19:163,899...179,274
Ensembl chr19:163,859...179,308 		JBrowse link
G Cfap221 cilia and flagella associated protein 221 decreases expression ISO Arsenic Trioxide results in decreased expression of CFAP221 mRNA CTD PMID:39716349 NCBI chr13:33,599,322...33,669,721
Ensembl chr13:33,598,895...33,669,549 		JBrowse link
G Cfap36 cilia and flagella associated protein 36 increases expression ISO Arsenic Trioxide results in increased expression of CFAP36 mRNA CTD PMID:20458559 NCBI chr14:107,166,932...107,192,531
Ensembl chr14:107,166,947...107,192,406 		JBrowse link
G Cfap54 cilia and flagella associated protein 54 increases expression ISO Arsenic Trioxide results in increased expression of CFAP54 mRNA CTD PMID:35676786 NCBI chr 7:29,203,143...29,489,551
Ensembl chr 7:29,202,722...29,491,189 		JBrowse link
G Cfb complement factor B decreases expression ISO Arsenic Trioxide results in decreased expression of CFB mRNA CTD PMID:17547211 NCBI chr20:3,975,271...3,981,138
Ensembl chr20:3,955,776...3,981,740 		JBrowse link
G Cfd complement factor D decreases expression ISO Arsenic Trioxide results in decreased expression of CFD mRNA CTD PMID:29633893 PMID:35676786 NCBI chr 7:10,463,773...10,465,496
Ensembl chr 7:10,463,775...10,465,572 		JBrowse link
G Cfdp1 craniofacial development protein 1 increases expression ISO Arsenic Trioxide results in increased expression of CFDP1 mRNA CTD PMID:39716349 NCBI chr19:56,627,596...56,733,099
Ensembl chr19:56,626,963...56,733,098 		JBrowse link
G Cfi complement factor I decreases expression ISO Arsenic Trioxide results in decreased expression of CFI mRNA CTD PMID:29633893 NCBI chr 2:221,062,206...221,104,790
Ensembl chr 2:221,062,212...221,104,786 		JBrowse link
G Cfl1 cofilin 1 decreases expression ISO Arsenic Trioxide results in decreased expression of CFL1 protein CTD PMID:19364129 NCBI chr 1:212,227,124...212,230,656
Ensembl chr 1:212,226,121...212,231,353 		JBrowse link
G Cflar CASP8 and FADD-like apoptosis regulator multiple interactions
increases expression
decreases expression
decreases response to substance 		ISO [Arsenic Trioxide co-treated with TNF protein] results in decreased expression of CFLAR protein; Arsenic Trioxide promotes the reaction [Ethacrynic Acid results in decreased expression of CFLAR protein]; BCL2 inhibits the reaction [[Arsenic Trioxide co-treated with TNF protein] results in decreased expression of CFLAR protein]
Arsenic Trioxide results in increased expression of CFLAR mRNA
Arsenic Trioxide results in decreased expression of CFLAR mRNA; Arsenic Trioxide results in decreased expression of CFLAR protein; Arsenic Trioxide results in decreased expression of CFLAR protein alternative form
CFLAR protein results in decreased susceptibility to Arsenic Trioxide 		CTD PMID:16105982 PMID:16174796 PMID:16434995 PMID:17673311 PMID:22521957 More... NCBI chr 9:67,679,502...67,747,226
Ensembl chr 9:67,679,559...67,726,434 		JBrowse link
G Cga glycoprotein hormones, alpha polypeptide increases expression ISO Arsenic Trioxide results in increased expression of CGA mRNA CTD PMID:20458559 NCBI chr 5:54,283,109...54,295,464
Ensembl chr 5:54,235,019...54,295,464 		JBrowse link
G Cgnl1 cingulin-like 1 decreases expression ISO Arsenic Trioxide results in decreased expression of CGNL1 mRNA CTD PMID:26705709 NCBI chr 8:81,154,169...81,305,598
Ensembl chr 8:81,140,091...81,305,747 		JBrowse link
G Chac1 ChaC glutathione-specific gamma-glutamylcyclotransferase 1 increases expression ISO Arsenic Trioxide results in increased expression of CHAC1 mRNA CTD PMID:23824090 PMID:24356939 PMID:25424538 NCBI chr 3:126,796,131...126,799,352
Ensembl chr 3:126,796,024...126,799,361 		JBrowse link
G Chad chondroadherin decreases expression ISO Arsenic Trioxide results in decreased expression of CHAD mRNA CTD PMID:35676786 NCBI chr10:80,009,045...80,012,816
Ensembl chr10:80,008,767...80,012,816 		JBrowse link
G Chchd7 coiled-coil-helix-coiled-coil-helix domain containing 7 decreases expression ISO Arsenic Trioxide results in decreased expression of CHCHD7 mRNA CTD PMID:20458559 NCBI chr 5:21,754,719...21,759,274
Ensembl chr 5:21,754,719...21,759,274 		JBrowse link
G Chd2 chromodomain helicase DNA binding protein 2 affects methylation
increases expression 		ISO Arsenic Trioxide affects the methylation of CHD2 promoter
Arsenic Trioxide results in increased expression of CHD2 mRNA 		CTD PMID:26046465 PMID:39716349 NCBI chr 1:136,597,993...136,726,874
Ensembl chr 1:136,599,900...136,710,335 		JBrowse link
G Chek1 checkpoint kinase 1 increases phosphorylation
multiple interactions
decreases expression 		ISO
EXP 		Arsenic Trioxide results in increased phosphorylation of CHEK1 protein
2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of CHEK1 protein]
Arsenic Trioxide results in decreased expression of CHEK1 mRNA; Arsenic Trioxide results in decreased expression of CHEK1 protein
[Arsenic Trioxide co-treated with Oxaliplatin] results in decreased expression of CHEK1 protein; Arsenic Trioxide inhibits the reaction [Oxaliplatin results in increased expression of CHEK1 mRNA]; Arsenic Trioxide promotes the reaction [Docetaxel results in decreased expression of CHEK1 mRNA]; Arsenic Trioxide promotes the reaction [Docetaxel results in decreased expression of CHEK1 protein] 		CTD PMID:16891316 PMID:23337567 PMID:39903385 NCBI chr 8:44,609,417...44,629,867
Ensembl chr 8:44,609,417...44,629,359 		JBrowse link
G Chek2 checkpoint kinase 2 increases phosphorylation
multiple interactions
increases expression 		EXP
ISO 		Arsenic Trioxide results in increased phosphorylation of CHEK2 protein
[ruxolitinib co-treated with Arsenic Trioxide] results in increased phosphorylation of CHEK2 protein; Arsenic Trioxide results in increased phosphorylation of and results in increased activity of CHEK2 protein; PPM1D mutant form promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of CHEK2 protein]
2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of CHEK2 protein]
Arsenic Trioxide results in increased expression of CHEK2 mRNA 		CTD PMID:16891316 PMID:18482988 PMID:22521957 PMID:23337567 PMID:30012499 NCBI chr12:51,448,838...51,481,159
Ensembl chr12:51,449,140...51,480,667 		JBrowse link
G Chgb chromogranin B increases expression ISO Arsenic Trioxide results in increased expression of CHGB mRNA CTD PMID:15761015 NCBI chr 3:140,496,712...140,510,057
Ensembl chr 3:140,495,951...140,510,054 		JBrowse link
G Chi3l1 chitinase 3 like 1 multiple interactions
increases expression
decreases expression 		ISO [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of CHI3L1 mRNA
Arsenic Trioxide results in increased expression of CHI3L1 mRNA
Arsenic Trioxide results in decreased expression of CHI3L1 mRNA 		CTD PMID:15761015 PMID:15894607 PMID:19128835 PMID:35676786 NCBI chr13:48,193,839...48,201,822
Ensembl chr13:48,193,800...48,201,825 		JBrowse link
G Chia chitinase, acidic increases expression ISO Arsenic Trioxide results in increased expression of CHIA mRNA CTD PMID:20458559 NCBI chr 2:196,302,687...196,344,849
Ensembl chr 2:196,302,545...196,344,850 		JBrowse link
G Chit1 chitinase 1 decreases expression ISO Arsenic Trioxide results in decreased expression of CHIT1 mRNA CTD PMID:19128835 NCBI chr13:48,117,886...48,165,645
Ensembl chr13:48,145,893...48,165,639 		JBrowse link
G Chka choline kinase alpha increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of CHKA mRNA
Arsenic Trioxide results in decreased expression of CHKA mRNA 		CTD PMID:20458559 PMID:39716349 NCBI chr 1:210,506,069...210,554,753
Ensembl chr 1:210,506,056...210,554,752 		JBrowse link
G Chml CHM like Rab escort protein increases expression ISO Arsenic Trioxide results in increased expression of CHML mRNA CTD PMID:20458559 NCBI chr13:90,141,880...90,152,097
Ensembl chr13:90,131,514...90,151,265 		JBrowse link
G Chmp1a charged multivesicular body protein 1A decreases response to substance ISO CHMP1A protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr19:68,146,672...68,154,952
Ensembl chr19:68,146,672...68,154,952 		JBrowse link
G Chodl chondrolectin decreases expression ISO Arsenic Trioxide results in decreased expression of CHODL mRNA CTD PMID:26705709 NCBI chr11:31,141,030...31,163,342
Ensembl chr11:31,141,021...31,163,334 		JBrowse link
G Chordc1 cysteine and histidine rich domain containing 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CHORDC1 protein] CTD PMID:26598702 NCBI chr 8:23,650,721...23,674,786
Ensembl chr 8:23,650,865...23,677,696 		JBrowse link
G Chrdl1 chordin-like 1 decreases expression ISO Arsenic Trioxide results in decreased expression of CHRDL1 mRNA CTD PMID:26705709 PMID:35676786 NCBI chr  X:111,685,864...111,789,684
Ensembl chr  X:111,685,866...111,789,661 		JBrowse link
G Chrm3 cholinergic receptor, muscarinic 3 decreases expression ISO Arsenic Trioxide results in decreased expression of CHRM3 mRNA CTD PMID:26705709 NCBI chr17:64,696,549...65,158,622
Ensembl chr17:64,696,066...65,173,304 		JBrowse link
G Chrna6 cholinergic receptor nicotinic alpha 6 subunit decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of CHRNA6 mRNA
Arsenic Trioxide results in increased expression of CHRNA6 mRNA 		CTD PMID:20458559 PMID:27829220 NCBI chr16:71,400,615...71,407,315
Ensembl chr16:71,400,615...71,407,315 		JBrowse link
G Chrna7 cholinergic receptor nicotinic alpha 7 subunit decreases expression ISO Arsenic Trioxide results in decreased expression of CHRNA7 mRNA CTD PMID:39716349 NCBI chr 1:126,123,425...126,249,181
Ensembl chr 1:126,123,425...126,446,858 		JBrowse link
G Chst1 carbohydrate sulfotransferase 1 decreases expression ISO Arsenic Trioxide results in decreased expression of CHST1 mRNA CTD PMID:26705709 NCBI chr 3:99,003,987...99,030,214
Ensembl chr 3:99,009,958...99,031,262 		JBrowse link
G Chst6 carbohydrate sulfotransferase 6 increases expression ISO Arsenic Trioxide results in increased expression of CHST6 mRNA CTD PMID:15070760 PMID:15761015 NCBI chr19:56,769,991...56,790,276
Ensembl chr19:56,769,967...56,790,306 		JBrowse link
G Chtf18 chromosome transmission fidelity factor 18 increases sumoylation ISO Arsenic Trioxide results in increased sumoylation of CHTF18 protein CTD PMID:28318385 NCBI chr10:15,247,525...15,255,573
Ensembl chr10:15,246,362...15,255,685 		JBrowse link
G Chtop chromatin target of PRMT1 increases expression ISO Arsenic Trioxide results in increased expression of CHTOP mRNA CTD PMID:25258189 NCBI chr 2:178,278,848...178,291,142
Ensembl chr 2:178,278,848...178,290,348 		JBrowse link
G Chuk component of inhibitor of nuclear factor kappa B kinase complex decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of CHUK protein
[Arsenic Trioxide results in increased phosphorylation of and results in increased activity of CHUK protein] which results in increased phosphorylation of and results in increased ubiquitination of and results in increased degradation of CCND1 protein; Arsenic Trioxide inhibits the reaction [Homoharringtonine results in increased phosphorylation of CHUK protein]; Arsenic Trioxide results in increased phosphorylation of and results in increased activity of CHUK protein 		CTD PMID:22384180 PMID:23949314 PMID:31307525 NCBI chr 1:252,908,748...252,944,273
Ensembl chr 1:252,908,749...252,944,273 		JBrowse link
G Ciao1 cytosolic iron-sulfur assembly component 1 decreases expression ISO Arsenic Trioxide results in decreased expression of CIAO1 protein CTD PMID:30093655 NCBI chr 3:134,913,639...134,919,244
Ensembl chr 3:134,913,172...134,979,255 		JBrowse link
G Cib1 calcium and integrin binding 1 increases expression ISO Arsenic Trioxide results in increased expression of CIB1 mRNA CTD PMID:22521957 NCBI chr 1:143,587,591...143,593,153
Ensembl chr 1:143,587,021...143,593,326 		JBrowse link
G Cidea cell death-inducing DFFA-like effector a increases expression ISO Arsenic Trioxide results in increased expression of CIDEA mRNA CTD PMID:17530438 NCBI chr18:63,164,817...63,190,384
Ensembl chr18:63,164,099...63,190,382 		JBrowse link
G Cideb cell death-inducing DFFA-like effector b increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of CIDEB mRNA
Arsenic Trioxide results in decreased expression of CIDEB mRNA 		CTD PMID:17530438 PMID:17547211 NCBI chr15:33,222,135...33,226,407
Ensembl chr15:33,221,824...33,226,688 		JBrowse link
G Ciita class II, major histocompatibility complex, transactivator decreases expression ISO Arsenic Trioxide results in decreased expression of CIITA mRNA CTD PMID:20458559 NCBI chr10:5,646,854...5,694,393
Ensembl chr10:5,647,085...5,694,342 		JBrowse link
G Cilk1 ciliogenesis associated kinase 1 increases expression ISO Arsenic Trioxide results in increased expression of CILK1 mRNA CTD PMID:27829220 NCBI chr 8:87,868,294...87,922,995
Ensembl chr 8:87,868,156...87,922,995 		JBrowse link
G Cilp2 cartilage intermediate layer protein 2 decreases expression ISO Arsenic Trioxide results in decreased expression of CILP2 mRNA CTD PMID:35676786 NCBI chr16:19,573,821...19,581,100
Ensembl chr16:19,573,908...19,581,100 		JBrowse link
G Cited2 Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 decreases expression ISO Arsenic Trioxide results in decreased expression of CITED2 mRNA CTD PMID:15725085 NCBI chr 1:14,132,303...14,134,746
Ensembl chr 1:14,103,457...14,134,782 		JBrowse link
G Ckap2 cytoskeleton associated protein 2 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of CKAP2 mRNA
Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of CKAP2 mRNA] 		CTD PMID:29095437 NCBI chr16:76,542,114...76,567,297
Ensembl chr16:76,542,104...76,567,352 		JBrowse link
G Ckap4 cytoskeleton-associated protein 4 decreases expression ISO Arsenic Trioxide results in decreased expression of CKAP4 mRNA CTD PMID:12852829 NCBI chr 7:21,118,527...21,126,624
Ensembl chr 7:21,118,085...21,126,624 		JBrowse link
G Ckb creatine kinase B decreases expression ISO Arsenic Trioxide results in decreased expression of CKB protein CTD PMID:30093655 NCBI chr 6:136,550,583...136,553,464
Ensembl chr 6:136,549,844...136,553,478 		JBrowse link
G Ckm creatine kinase, M-type increases expression ISO Arsenic Trioxide results in increased expression of CKM mRNA CTD PMID:20458559 NCBI chr 1:88,189,382...88,199,717
Ensembl chr 1:88,189,485...88,199,719 		JBrowse link
G Clca2 chloride channel accessory 2 increases expression ISO Arsenic Trioxide results in increased expression of CLCA2 mRNA CTD PMID:26705709 NCBI chr 2:236,655,419...236,682,669
Ensembl chr 2:236,639,545...236,685,129 		JBrowse link
G Clcc1 chloride channel CLIC-like 1 decreases expression ISO Arsenic Trioxide results in decreased expression of CLCC1 mRNA CTD PMID:21461292 NCBI chr 2:198,984,455...199,015,015
Ensembl chr 2:198,984,495...199,015,014 		JBrowse link
G Clcf1 cardiotrophin-like cytokine factor 1 increases expression ISO Arsenic Trioxide results in increased expression of CLCF1 mRNA CTD PMID:39716349 NCBI chr 1:210,937,763...210,947,064
Ensembl chr 1:210,937,255...210,947,064 		JBrowse link
G Cldn1 claudin 1 multiple interactions
increases expression
decreases expression 		ISO Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of CLDN1 protein]
Arsenic Trioxide results in increased expression of CLDN1 mRNA
[Arsenic Trioxide results in increased abundance of arsenite] which results in decreased expression of CLDN1 mRNA 		CTD PMID:26705709 PMID:28115242 PMID:36791901 NCBI chr11:87,926,376...87,941,533
Ensembl chr11:87,926,337...87,941,529 		JBrowse link
G Cldn11 claudin 11 decreases expression ISO Arsenic Trioxide results in decreased expression of CLDN11 mRNA CTD PMID:22521957 NCBI chr 2:114,136,234...114,149,539
Ensembl chr 2:114,136,234...114,149,539 		JBrowse link
G Cldn14 claudin 14 decreases expression ISO Arsenic Trioxide results in decreased expression of CLDN14 mRNA CTD PMID:19128835 NCBI chr11:46,701,940...46,799,049
Ensembl chr11:46,701,940...46,799,096 		JBrowse link
G Cldn2 claudin 2 increases expression ISO Arsenic Trioxide results in increased expression of CLDN2 mRNA CTD PMID:39716349 NCBI chr  X:108,248,383...108,258,847
Ensembl chr  X:108,237,676...108,262,377 		JBrowse link
G Cldn4 claudin 4 decreases response to substance ISO CLDN4 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr12:27,388,160...27,389,958
Ensembl chr12:27,387,981...27,389,958 		JBrowse link
G Cldn5 claudin 5 decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of CLDN5 mRNA
Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of CLDN5 protein] 		CTD PMID:28115242 PMID:30032600 PMID:30225639 NCBI chr11:95,717,172...95,718,598
Ensembl chr11:95,717,176...95,719,322 		JBrowse link
G Cldn7 claudin 7 decreases response to substance ISO CLDN7 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr10:55,188,670...55,190,871
Ensembl chr10:55,188,684...55,190,905 		JBrowse link
G Cldn9 claudin 9 decreases expression ISO Arsenic Trioxide results in decreased expression of CLDN9 mRNA CTD PMID:20458559 NCBI chr10:13,218,728...13,220,159
Ensembl chr10:13,218,729...13,220,178 		JBrowse link
G Clec11a C-type lectin domain containing 11A decreases expression ISO Arsenic Trioxide results in decreased expression of CLEC11A mRNA CTD PMID:20458559 NCBI chr 1:103,938,029...103,941,170
Ensembl chr 1:103,935,185...103,946,784 		JBrowse link
G Clec2d C-type lectin domain family 2, member D increases expression ISO Arsenic Trioxide results in increased expression of CLEC2D mRNA CTD PMID:22521957 NCBI chr 4:163,902,124...163,925,587
Ensembl chr 4:163,902,547...163,925,587 		JBrowse link
G Clec3a C-type lectin domain family 3, member A decreases expression ISO Arsenic Trioxide results in decreased expression of CLEC3A mRNA CTD PMID:35676786 NCBI chr19:59,313,746...59,321,126
Ensembl chr19:59,313,570...59,321,126 		JBrowse link
G Clec7a C-type lectin domain containing 7A decreases expression ISO Arsenic Trioxide results in decreased expression of CLEC7A mRNA CTD PMID:15725085 NCBI chr 4:164,588,737...164,599,953
Ensembl chr 4:164,588,754...164,599,919 		JBrowse link
G Clgn calmegin decreases expression ISO Arsenic Trioxide results in decreased expression of CLGN mRNA CTD PMID:17547211 NCBI chr19:41,601,568...41,633,207
Ensembl chr19:41,601,568...41,633,325 		JBrowse link
G Clic2 chloride intracellular channel 2 increases expression ISO Arsenic Trioxide results in increased expression of CLIC2 mRNA CTD PMID:26705709 PMID:27829220 NCBI chr20:154,630...169,655
Ensembl chr20:154,255...169,648 		JBrowse link
G Clic3 chloride intracellular channel 3 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CLIC3 protein] CTD PMID:26598702 NCBI chr 3:28,670,176...28,672,166
Ensembl chr 3:28,670,229...28,675,723 		JBrowse link
G Clic4 chloride intracellular channel 4 increases expression ISO Arsenic Trioxide results in increased expression of CLIC4 mRNA; Arsenic Trioxide results in increased expression of CLIC4 protein CTD PMID:17258074 PMID:30093655 NCBI chr 5:152,737,371...152,797,118
Ensembl chr 5:152,737,371...152,797,118 		JBrowse link
G Clip4 CAP-GLY domain containing linker protein family, member 4 increases expression ISO Arsenic Trioxide results in increased expression of CLIP4 mRNA CTD PMID:39716349 NCBI chr 6:29,359,628...29,449,365
NCBI chr 6:29,349,245...29,351,890
Ensembl chr 6:29,348,918...29,449,271 		JBrowse link
G Clk1 CDC-like kinase 1 increases expression ISO Arsenic Trioxide results in increased expression of CLK1 mRNA CTD PMID:20458559 NCBI chr 9:67,441,962...67,453,180
Ensembl chr 9:67,441,952...67,451,187 		JBrowse link
G Clk3 CDC-like kinase 3 increases expression ISO Arsenic Trioxide results in increased expression of CLK3 mRNA CTD PMID:20458559 NCBI chr 8:67,048,121...67,063,192
Ensembl chr 8:67,048,123...67,062,881 		JBrowse link
G Clk4 CDC-like kinase 4 increases expression ISO Arsenic Trioxide results in increased expression of CLK4 mRNA CTD PMID:20458559 NCBI chr10:36,024,364...36,042,366
Ensembl chr10:36,024,427...36,042,372 		JBrowse link
G Cln3 CLN3 lysosomal/endosomal transmembrane protein, battenin decreases response to substance ISO CLN3 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 1:190,586,649...190,600,034
Ensembl chr 1:190,586,650...190,597,929 		JBrowse link
G Clpb ClpB family mitochondrial disaggregase increases expression ISO Arsenic Trioxide results in increased expression of CLPB mRNA CTD PMID:39716349 NCBI chr 1:165,440,705...165,563,514
Ensembl chr 1:165,440,861...165,583,815 		JBrowse link
G Clspn claspin decreases expression ISO Arsenic Trioxide results in decreased expression of CLSPN mRNA CTD PMID:26705709 NCBI chr 5:144,134,619...144,169,531
Ensembl chr 5:144,134,632...144,169,530 		JBrowse link
G Clstn1 calsyntenin 1 decreases expression ISO Arsenic Trioxide results in decreased expression of CLSTN1 mRNA CTD PMID:22521957 NCBI chr 5:165,314,128...165,377,627
Ensembl chr 5:165,314,309...165,377,625 		JBrowse link
G Clstn2 calsyntenin 2 multiple interactions ISO [Arsenic Trioxide co-treated with Tretinoin] results in decreased expression of CLSTN2 mRNA CTD PMID:38179723 NCBI chr 8:106,899,894...107,516,402
Ensembl chr 8:106,899,894...107,040,053 		JBrowse link
G Clta clathrin, light chain A increases expression ISO Arsenic Trioxide results in increased expression of CLTA mRNA CTD PMID:20458559 NCBI chr 5:63,022,046...63,059,223
Ensembl chr 5:63,041,184...63,059,215 		JBrowse link
G Cltb clathrin, light chain B increases expression ISO Arsenic Trioxide results in increased expression of CLTB mRNA CTD PMID:17258074 NCBI chr17:10,006,416...10,024,278
Ensembl chr17:10,006,656...10,024,915 		JBrowse link
G Cltc clathrin heavy chain decreases expression
multiple interactions
increases expression 		ISO Arsenic Trioxide results in decreased expression of CLTC mRNA
[Arsenic Trioxide co-treated with nilotinib] affects the expression of CLTC mRNA
Arsenic Trioxide results in increased expression of CLTC protein 		CTD PMID:20458559 PMID:25419056 PMID:28786057 NCBI chr10:72,014,984...72,073,308
Ensembl chr10:72,014,986...72,070,691 		JBrowse link
G Clu clusterin increases expression ISO Arsenic Trioxide results in increased expression of CLU mRNA CTD PMID:22521957 PMID:27829220 NCBI chr15:44,336,619...44,375,861
Ensembl chr15:44,359,914...44,375,860 		JBrowse link
G Cmip c-Maf-inducing protein multiple interactions
increases expression 		ISO [Arsenic Trioxide co-treated with Ascorbic Acid] results in increased expression of CMIP mRNA
Arsenic Trioxide results in increased expression of CMIP mRNA 		CTD PMID:25555879 NCBI chr19:62,213,402...62,419,443
Ensembl chr19:62,213,365...62,417,500 		JBrowse link
G Cmklr1 chemerin chemokine-like receptor 1 decreases expression ISO Arsenic Trioxide results in decreased expression of CMKLR1 mRNA CTD PMID:25258189 NCBI chr12:48,634,929...48,687,833
Ensembl chr12:48,634,003...48,691,458 		JBrowse link
G Cmss1 cms1 ribosomal small subunit homolog decreases expression ISO Arsenic Trioxide results in decreased expression of CMSS1 mRNA CTD PMID:39716349 NCBI chr11:56,403,620...56,701,751
Ensembl chr11:56,403,499...56,701,755 		JBrowse link
G Cmtm6 CKLF-like MARVEL transmembrane domain containing 6 increases expression ISO Arsenic Trioxide results in increased expression of CMTM6 mRNA CTD PMID:20458559 NCBI chr 8:123,301,131...123,319,230
Ensembl chr 8:123,300,918...123,319,230 		JBrowse link
G Cmtm8 CKLF-like MARVEL transmembrane domain containing 8 decreases expression ISO Arsenic Trioxide results in decreased expression of CMTM8 mRNA CTD PMID:15761015 NCBI chr 8:123,360,168...123,425,291
Ensembl chr 8:123,360,170...123,425,276 		JBrowse link
G Cnbp CCHC-type zinc finger, nucleic acid binding protein decreases expression ISO Arsenic Trioxide results in decreased expression of CNBP mRNA CTD PMID:20458559 NCBI chr 4:121,860,102...121,868,976
Ensembl chr 4:121,860,105...121,869,010 		JBrowse link
G Cnmd chondromodulin decreases expression ISO Arsenic Trioxide results in decreased expression of CNMD mRNA CTD PMID:18414637 NCBI chr15:61,450,617...61,475,382
Ensembl chr15:61,450,450...61,475,350 		JBrowse link
G Cnnm2 cyclin and CBS domain divalent metal cation transport mediator 2 increases expression ISO Arsenic Trioxide results in increased expression of CNNM2 mRNA CTD PMID:20458559 NCBI chr 1:255,585,063...255,709,455
Ensembl chr 1:255,585,095...255,704,849 		JBrowse link
G Cnnm4 cyclin and CBS domain divalent metal cation transport mediator 4 multiple interactions
decreases response to substance 		ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CNNM4 protein]
CNNM4 protein results in decreased susceptibility to Arsenic Trioxide 		CTD PMID:20707922 PMID:26598702 NCBI chr 9:46,207,602...46,246,817
Ensembl chr 9:46,207,551...46,246,817 		JBrowse link
G Cnot2 CCR4-NOT transcription complex, subunit 2 decreases expression ISO Arsenic Trioxide results in decreased expression of CNOT2 mRNA CTD PMID:15761015 NCBI chr 7:54,016,447...54,117,511
Ensembl chr 7:54,016,447...54,107,960 		JBrowse link
G Cnot6l CCR4-NOT transcription complex, subunit 6-like increases expression ISO Arsenic Trioxide results in increased expression of CNOT6L mRNA CTD PMID:20458559 NCBI chr14:13,714,475...13,806,481
Ensembl chr14:13,714,475...13,806,481 		JBrowse link
G Cnot9 CCR4-NOT transcription complex subunit 9 multiple interactions
decreases expression 		ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CNOT9 protein]
Arsenic Trioxide results in decreased expression of CNOT9 protein 		CTD PMID:25419056 PMID:26598702 NCBI chr 9:83,533,369...83,558,207
Ensembl chr 9:83,533,369...83,558,197 		JBrowse link
G Cntn1 contactin 1 decreases expression ISO Arsenic Trioxide results in decreased expression of CNTN1 mRNA CTD PMID:26705709 NCBI chr 7:125,142,638...125,440,397
Ensembl chr 7:125,142,696...125,440,391 		JBrowse link
G Cntn3 contactin 3 decreases expression ISO Arsenic Trioxide results in decreased expression of CNTN3 mRNA CTD PMID:26705709 NCBI chr 4:136,397,575...136,770,765
Ensembl chr 4:136,398,572...136,770,717 		JBrowse link
G Cntnap1 contactin associated protein 1 multiple interactions
decreases expression 		ISO [Arsenic Trioxide co-treated with Ascorbic Acid] results in increased expression of CNTNAP1 mRNA
Arsenic Trioxide results in decreased expression of CNTNAP1 mRNA 		CTD PMID:25555879 PMID:27829220 NCBI chr10:86,610,140...86,625,896
Ensembl chr10:86,611,890...86,631,730 		JBrowse link
G Coa7 cytochrome c oxidase assembly factor 7 decreases expression ISO Arsenic Trioxide results in decreased expression of COA7 mRNA CTD PMID:39716349 NCBI chr 5:128,298,084...128,308,935
Ensembl chr 5:128,298,093...128,309,664 		JBrowse link
G Coasy Coenzyme A synthase increases expression ISO Arsenic Trioxide results in increased expression of COASY protein CTD PMID:25419056 NCBI chr10:86,514,850...86,519,130
Ensembl chr10:86,514,874...86,519,130 		JBrowse link
G Cobll1 cordon-bleu WH2 repeat protein-like 1 increases expression ISO Arsenic Trioxide results in increased expression of COBLL1 mRNA CTD PMID:15761015 NCBI chr 3:70,161,369...70,324,844
Ensembl chr 3:70,161,372...70,323,460 		JBrowse link
G Cog5 component of oligomeric golgi complex 5 increases expression ISO Arsenic Trioxide results in increased expression of COG5 mRNA CTD PMID:20458559 NCBI chr 6:53,969,967...54,267,869
Ensembl chr 6:53,969,979...54,278,973 		JBrowse link
G Col12a1 collagen type XII alpha 1 chain decreases expression ISO Arsenic Trioxide results in decreased expression of COL12A1 mRNA CTD PMID:35676786 NCBI chr 8:89,427,834...89,545,886
Ensembl chr 8:89,427,834...89,545,711 		JBrowse link
G Col14a1 collagen type XIV alpha 1 chain increases expression ISO Arsenic Trioxide results in increased expression of COL14A1 mRNA CTD PMID:20458559 NCBI chr 7:88,611,827...88,826,939
Ensembl chr 7:88,611,828...88,826,938 		JBrowse link
G Col16a1 collagen type XVI alpha 1 chain increases expression ISO Arsenic Trioxide results in increased expression of COL16A1 mRNA CTD PMID:20458559 PMID:35676786 PMID:39716349 NCBI chr 5:147,672,559...147,727,007
Ensembl chr 5:147,672,601...147,727,011 		JBrowse link
G Col1a1 collagen type I alpha 1 chain multiple interactions
increases expression
decreases expression 		ISO
EXP 		Arsenic Trioxide inhibits the reaction [Bleomycin results in increased expression of COL1A1 mRNA]; Arsenic Trioxide inhibits the reaction [Bleomycin results in increased expression of COL1A1 protein]
Arsenic Trioxide results in increased expression of COL1A1 protein
Arsenic Trioxide inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 mRNA]; Arsenic Trioxide inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 protein]
Arsenic Trioxide results in decreased expression of COL1A1 mRNA
Arsenic Trioxide results in increased expression of COL1A1 mRNA
Diosgenin inhibits the reaction [Arsenic Trioxide results in increased expression of COL1A1 mRNA] 		CTD PMID:19364129 PMID:24762191 PMID:30317545 PMID:35276128 PMID:39059093 NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460 		JBrowse link
G Col1a2 collagen type I alpha 2 chain decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of COL1A2 mRNA
[Arsenic Trioxide co-treated with Ascorbic Acid] results in increased expression of COL1A2 mRNA; [Tetradecanoylphorbol Acetate co-treated with Arsenic Trioxide] results in increased expression of COL1A2 mRNA 		CTD PMID:18922899 PMID:20458559 PMID:25555879 NCBI chr 4:33,518,557...33,553,484
Ensembl chr 4:33,518,420...33,553,995 		JBrowse link
G Col3a1 collagen type III alpha 1 chain increases expression
multiple interactions 		EXP Arsenic Trioxide results in increased expression of COL3A1 mRNA
Diosgenin inhibits the reaction [Arsenic Trioxide results in increased expression of COL3A1 mRNA] 		CTD PMID:39059093 NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:54,866,632...54,903,232 		JBrowse link
G Col6a3 collagen type VI alpha 3 chain decreases expression ISO Arsenic Trioxide results in decreased expression of COL6A3 mRNA CTD PMID:20458559 NCBI chr 9:98,809,171...98,887,060
Ensembl chr 9:98,809,171...98,886,990 		JBrowse link
G Col7a1 collagen type VII alpha 1 chain decreases expression ISO Arsenic Trioxide results in decreased expression of COL7A1 mRNA CTD PMID:22521957 NCBI chr 8:118,483,364...118,515,736
Ensembl chr 8:118,483,364...118,517,439 		JBrowse link
G Col8a2 collagen type VIII alpha 2 chain decreases expression ISO Arsenic Trioxide results in decreased expression of COL8A2 mRNA CTD PMID:19128835 PMID:26705709 NCBI chr 5:143,870,754...143,897,372
Ensembl chr 5:143,870,742...143,897,884 		JBrowse link
G Colec10 collectin subfamily member 10 decreases expression ISO Arsenic Trioxide results in decreased expression of COLEC10 mRNA CTD PMID:15761015 NCBI chr 7:87,634,686...87,695,465
Ensembl chr 7:87,634,654...87,699,534 		JBrowse link
G Commd3 COMM domain containing 3 increases expression ISO Arsenic Trioxide results in increased expression of COMMD3 mRNA CTD PMID:35676786 NCBI chr17:86,235,863...86,239,610
Ensembl chr17:86,235,863...86,239,610 		JBrowse link
G Commd6 COMM domain containing 6 decreases expression ISO Arsenic Trioxide results in decreased expression of COMMD6 mRNA CTD PMID:39716349 NCBI chr15:84,882,069...84,889,124
Ensembl chr15:84,882,548...84,889,194 		JBrowse link
G Comp cartilage oligomeric matrix protein decreases expression ISO Arsenic Trioxide results in decreased expression of COMP mRNA CTD PMID:35676786 NCBI chr16:19,081,172...19,089,548
Ensembl chr16:19,081,172...19,089,605 		JBrowse link
G Comt catechol-O-methyltransferase decreases expression ISO Arsenic Trioxide results in decreased expression of COMT mRNA CTD PMID:39716349 NCBI chr11:96,072,371...96,091,956
Ensembl chr11:96,072,489...96,092,533 		JBrowse link
G Copb1 COPI coat complex subunit beta 1 increases expression ISO Arsenic Trioxide results in increased expression of COPB1 mRNA CTD PMID:20458559 NCBI chr 1:177,838,751...177,876,688
Ensembl chr 1:177,838,752...177,872,840 		JBrowse link
G Copb2 COPI coat complex subunit beta 2 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of COPB2 protein
Arsenic Trioxide results in decreased expression of COPB2 mRNA 		CTD PMID:25419056 PMID:39716349 NCBI chr 8:108,040,687...108,062,810
Ensembl chr 8:108,040,693...108,064,550 		JBrowse link
G Cops5 COP9 signalosome subunit 5 multiple interactions ISO [Arsenic Trioxide co-treated with IFNA2 protein co-treated with Docosahexaenoic Acids co-treated with Emodin] results in decreased expression of COPS5 protein; Arsenic Trioxide results in decreased expression of and results in increased localization of COPS5 protein CTD PMID:17077332 PMID:20698225 NCBI chr 5:13,975,198...13,993,391
Ensembl chr 5:13,975,052...13,993,387 		JBrowse link
G Cops6 COP9 signalosome subunit 6 increases expression ISO Arsenic Trioxide results in increased expression of COPS6 protein CTD PMID:25419056 NCBI chr12:22,152,688...22,155,527
Ensembl chr12:22,147,482...22,161,106 		JBrowse link
G Coq2 coenzyme Q2, polyprenyltransferase decreases expression ISO Arsenic Trioxide results in decreased expression of COQ2 mRNA CTD PMID:27829220 NCBI chr14:9,245,777...9,265,784
Ensembl chr14:9,245,803...9,265,783 		JBrowse link
G Corin corin, serine peptidase decreases expression ISO Arsenic Trioxide results in decreased expression of CORIN mRNA CTD PMID:26705709 NCBI chr14:36,034,613...36,264,671
Ensembl chr14:36,034,993...36,264,649 		JBrowse link
G Coro1a coronin 1A increases expression ISO Arsenic Trioxide results in increased expression of CORO1A protein CTD PMID:19364129 NCBI chr 1:190,726,129...190,731,133
Ensembl chr 1:190,726,130...190,731,102 		JBrowse link
G Coro2a coronin 2A decreases expression ISO Arsenic Trioxide results in decreased expression of CORO2A mRNA CTD PMID:26705709 NCBI chr 5:65,623,820...65,677,483
Ensembl chr 5:65,623,823...65,654,602 		JBrowse link
G Coro6 coronin 6 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CORO6 protein] CTD PMID:26598702 NCBI chr10:62,808,172...62,817,788
Ensembl chr10:62,809,689...62,817,787 		JBrowse link
G Cotl1 coactosin-like F-actin binding protein 1 multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of COTL1 mRNA CTD PMID:15894607 NCBI chr19:64,780,309...64,814,629
Ensembl chr19:64,780,322...64,814,840 		JBrowse link
G Cox10 cytochrome c oxidase assembly factor heme A:farnesyltransferase COX10 increases expression ISO Arsenic Trioxide results in increased expression of COX10 mRNA CTD PMID:22521957 PMID:35676786 NCBI chr10:49,130,209...49,242,009
Ensembl chr10:49,130,209...49,242,009 		JBrowse link
G Cox11 cytochrome c oxidase copper chaperone COX11 increases expression ISO Arsenic Trioxide results in increased expression of COX11 mRNA CTD PMID:22521957 NCBI chr10:75,955,825...75,962,398
Ensembl chr10:75,955,783...75,963,489 		JBrowse link
G Cox15 cytochrome c oxidase assembly homolog COX15 increases expression ISO Arsenic Trioxide results in increased expression of COX15 mRNA CTD PMID:22521957 NCBI chr 1:252,554,811...252,571,471
Ensembl chr 1:252,554,811...252,571,471 		JBrowse link
G Cox17 cytochrome c oxidase copper chaperone COX17 decreases expression ISO Arsenic Trioxide results in decreased expression of COX17 mRNA CTD PMID:19422848 NCBI chr11:75,906,245...75,912,036
Ensembl chr11:75,906,248...75,912,019 		JBrowse link
G Cox4i1 cytochrome c oxidase subunit 4i1 increases expression
decreases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of COX4I1 mRNA
Arsenic Trioxide results in decreased expression of COX4I1 protein
3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [Arsenic Trioxide results in decreased expression of COX4I1 protein]; Cyclosporine inhibits the reaction [Arsenic Trioxide results in decreased expression of COX4I1 protein] 		CTD PMID:20458559 PMID:27318970 NCBI chr19:65,630,383...65,636,623
Ensembl chr19:65,630,432...65,636,624 		JBrowse link
G Cox5a cytochrome c oxidase subunit 5A increases expression ISO Arsenic Trioxide results in increased expression of COX5A mRNA CTD PMID:22521957 NCBI chr 8:66,818,284...66,829,691
Ensembl chr 8:66,818,196...66,830,279 		JBrowse link
G Cox6a2 cytochrome c oxidase subunit 6A2 decreases expression ISO Arsenic Trioxide results in decreased expression of COX6A2 mRNA CTD PMID:19422848 NCBI chr 1:192,218,970...192,221,188
Ensembl chr 1:192,218,970...192,219,716 		JBrowse link
G Cox6b2 cytochrome c oxidase subunit 6B2 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to COX6B2 protein] CTD PMID:26598702 NCBI chr 1:78,122,871...78,124,096
Ensembl chr 1:78,122,453...78,124,094 		JBrowse link
G Cox6c cytochrome c oxidase subunit 6C increases expression ISO Arsenic Trioxide results in increased expression of COX6C mRNA CTD PMID:25258189 NCBI chr 7:69,014,410...69,027,145
Ensembl chr 7:69,014,417...69,027,166 		JBrowse link
G Cox7a2l cytochrome c oxidase subunit 7A2 like decreases expression ISO Arsenic Trioxide results in decreased expression of COX7A2L mRNA CTD PMID:39716349 NCBI chr 6:16,936,574...16,950,797
Ensembl chr 6:16,936,795...16,950,798 		JBrowse link
G Cox7b cytochrome c oxidase subunit 7B increases expression ISO Arsenic Trioxide results in increased expression of COX7B mRNA CTD PMID:25258189 NCBI chr  X:75,149,036...75,155,285
Ensembl chr  X:75,148,996...75,155,284 		JBrowse link
G Cp ceruloplasmin decreases expression ISO Arsenic Trioxide results in decreased expression of CP mRNA CTD PMID:20458559 NCBI chr 2:104,368,336...104,427,119
Ensembl chr 2:104,368,456...104,427,087 		JBrowse link
G Cpe carboxypeptidase E increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of CPE mRNA
Arsenic Trioxide results in decreased expression of CPE mRNA 		CTD PMID:19128835 PMID:22535156 NCBI chr16:29,796,707...29,908,647
Ensembl chr16:29,796,689...29,909,524 		JBrowse link
G Cpeb1 cytoplasmic polyadenylation element binding protein 1 increases expression ISO Arsenic Trioxide results in increased expression of CPEB1 mRNA CTD PMID:20458559 NCBI chr 1:144,709,278...144,817,388
Ensembl chr 1:144,709,691...144,815,880 		JBrowse link
G Cped1 cadherin-like and PC-esterase domain containing 1 decreases expression ISO Arsenic Trioxide results in decreased expression of CPED1 mRNA CTD PMID:35676786 NCBI chr 4:51,482,497...51,755,440
Ensembl chr 4:51,482,545...51,755,442 		JBrowse link
G Cpne1 copine 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CPNE1 protein] CTD PMID:26598702 NCBI chr 3:165,047,615...165,089,994 JBrowse link
G Cpne6 copine 6 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CPNE6 protein] CTD PMID:26598702 NCBI chr15:32,968,047...32,975,008
Ensembl chr15:32,968,046...32,975,007 		JBrowse link
G Cpne7 copine 7 increases expression ISO Arsenic Trioxide results in increased expression of CPNE7 mRNA CTD PMID:39716349 NCBI chr19:68,072,165...68,091,197
Ensembl chr19:68,074,545...68,091,197 		JBrowse link
G Cpt1a carnitine palmitoyltransferase 1A decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of CPT1A mRNA
Arsenic Trioxide results in increased expression of CPT1A mRNA 		CTD PMID:22521957 PMID:30237538 NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:209,993,875...210,056,326 		JBrowse link
G Cpt1b carnitine palmitoyltransferase 1B decreases expression ISO Arsenic Trioxide results in decreased expression of CPT1B mRNA CTD PMID:22521957 NCBI chr 7:122,370,974...122,380,473
Ensembl chr 7:122,370,444...122,380,036 		JBrowse link
G Cptp ceramide-1-phosphate transfer protein multiple interactions
increases expression 		ISO Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of CPTP mRNA] CTD PMID:29095437 NCBI chr 5:171,757,181...171,761,271
Ensembl chr 5:171,757,181...171,761,266 		JBrowse link
G Cpxm2 carboxypeptidase X (M14 family), member 2 decreases expression ISO Arsenic Trioxide results in decreased expression of CPXM2 mRNA CTD PMID:35676786 NCBI chr 1:196,266,930...196,377,350
Ensembl chr 1:196,266,930...196,377,347 		JBrowse link
G Crabp1 cellular retinoic acid binding protein 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CRABP1 protein] CTD PMID:26598702 NCBI chr 8:64,047,431...64,055,469
Ensembl chr 8:64,047,060...64,055,470 		JBrowse link
G Cracr2a calcium release activated channel regulator 2A increases expression ISO Arsenic Trioxide results in increased expression of CRACR2A mRNA CTD PMID:25258189 NCBI chr 4:162,094,247...162,207,926
Ensembl chr 4:162,110,929...162,221,529 		JBrowse link
G Crat carnitine O-acetyltransferase increases expression ISO Arsenic Trioxide results in increased expression of CRAT mRNA CTD PMID:34108876 NCBI chr 3:34,073,504...34,087,099
Ensembl chr 3:34,073,506...34,087,099 		JBrowse link
G Crbn cereblon multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CRBN protein] CTD PMID:26598702 NCBI chr 4:141,255,400...141,276,722
Ensembl chr 4:141,257,243...141,276,038 		JBrowse link
G Creb1 cAMP responsive element binding protein 1 decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of CREB1 mRNA
Arsenic Trioxide results in increased expression of CREB1 mRNA 		CTD PMID:24831965 PMID:39716349 NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:73,397,306...73,466,339 		JBrowse link
G Creb3l2 cAMP responsive element binding protein 3-like 2 multiple interactions
increases expression 		ISO Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of CREB3L2 mRNA] CTD PMID:29095437 NCBI chr 4:66,874,623...66,990,962
Ensembl chr 4:66,387,126...66,990,832 		JBrowse link
G Creb5 cAMP responsive element binding protein 5 increases expression ISO Arsenic Trioxide results in increased expression of CREB5 mRNA CTD PMID:15761015 NCBI chr 4:83,723,587...84,124,786
Ensembl chr 4:83,723,194...84,120,793 		JBrowse link
G Crebbp CREB binding protein multiple interactions
decreases expression 		ISO Arsenic Trioxide promotes the reaction [[CREBBP protein binds to CDKN1A promoter] which results in increased expression of CDKN1A mRNA]; Arsenic Trioxide promotes the reaction [CREBBP protein binds to CDKN1A promoter]; Arsenic Trioxide promotes the reaction [CREBBP protein results in increased expression of VCP mRNA]
Arsenic Trioxide results in decreased expression of CREBBP mRNA 		CTD PMID:18822310 PMID:24831965 NCBI chr10:11,842,307...11,968,266
Ensembl chr10:11,822,620...11,968,266 		JBrowse link
G Crem cAMP responsive element modulator increases expression ISO Arsenic Trioxide results in increased expression of CREM mRNA CTD PMID:20458559 NCBI chr17:58,932,011...59,001,160
Ensembl chr17:58,934,147...59,001,160 		JBrowse link
G Crh corticotropin releasing hormone decreases expression ISO Arsenic Trioxide results in decreased expression of CRH mRNA CTD PMID:15761015 NCBI chr 2:104,059,184...104,061,048
Ensembl chr 2:104,058,770...104,061,386 		JBrowse link
G Crim1 cysteine rich transmembrane BMP regulator 1 increases expression ISO Arsenic Trioxide results in increased expression of CRIM1 mRNA CTD PMID:15725085 PMID:15761015 PMID:24356939 PMID:25424538 NCBI chr 6:22,447,983...22,622,459
Ensembl chr 6:22,449,948...22,622,416 		JBrowse link
G Crip1 cysteine rich protein 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CRIP1 protein] CTD PMID:26598702 NCBI chr 6:138,047,801...138,055,672
Ensembl chr 6:138,047,801...138,055,672 		JBrowse link
G Crkl CRK like proto-oncogene, adaptor protein multiple interactions ISO [nilotinib co-treated with Arsenic Trioxide] results in decreased phosphorylation of CRKL protein CTD PMID:23883479 NCBI chr11:97,033,033...97,067,457
Ensembl chr11:97,024,782...97,067,457 		JBrowse link
G Crlf3 cytokine receptor-like factor 3 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CRLF3 protein] CTD PMID:26598702 NCBI chr10:65,521,296...65,559,162
Ensembl chr10:65,521,492...65,558,804 		JBrowse link
G Crls1 cardiolipin synthase 1 increases expression ISO Arsenic Trioxide results in increased expression of CRLS1 mRNA CTD PMID:39716349 NCBI chr 3:140,572,680...140,591,543
Ensembl chr 3:140,572,716...140,591,599 		JBrowse link
G Crp C-reactive protein increases expression EXP Arsenic Trioxide results in increased expression of CRP CTD PMID:21851829 NCBI chr13:87,694,062...87,695,978
Ensembl chr13:87,657,317...87,707,514 		JBrowse link
G Cry2 cryptochrome circadian regulator 2 increases expression ISO Arsenic Trioxide results in increased expression of CRY2 mRNA CTD PMID:20458559 NCBI chr 3:98,830,479...98,860,437
Ensembl chr 3:98,830,483...98,860,447 		JBrowse link
G Cryab crystallin, alpha B increases expression ISO Arsenic Trioxide results in increased expression of CRYAB mRNA CTD PMID:25258189 NCBI chr 8:59,989,885...59,995,532
Ensembl chr 8:59,989,814...59,995,528 		JBrowse link
G Crygn crystallin, gamma N multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CRYGN protein] CTD PMID:26598702 NCBI chr 4:11,286,475...11,294,002
Ensembl chr 4:11,286,475...11,294,002 		JBrowse link
G Cryzl2 crystallin zeta like 2 decreases expression ISO Arsenic Trioxide results in decreased expression of CRYZL2P mRNA CTD PMID:39716349 NCBI chr13:72,146,147...72,210,258
Ensembl chr13:72,144,307...72,188,560 		JBrowse link
G Csf1 colony stimulating factor 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [CSF1 protein results in increased expression of TGM2 mRNA]; Arsenic Trioxide inhibits the reaction [CSF1 protein results in increased expression of TGM2 protein] CTD PMID:37446117 NCBI chr 2:198,065,400...198,084,774
Ensembl chr 2:198,065,405...198,084,468 		JBrowse link
G Csf1r colony stimulating factor 1 receptor increases expression ISO Arsenic Trioxide results in increased expression of CSF1R gene mutant form CTD PMID:38746032 NCBI chr18:56,834,152...56,860,804
Ensembl chr18:56,817,049...56,860,806 		JBrowse link
G Csf2 colony stimulating factor 2 increases expression
decreases expression
multiple interactions 		EXP
ISO 		Arsenic Trioxide results in increased expression of CSF2 mRNA
Arsenic Trioxide results in decreased expression of CSF2 mRNA; Arsenic Trioxide results in decreased expression of CSF2 protein
[Arsenic Trioxide co-treated with CSF2] results in decreased activity of RELA protein; [CSF2 protein co-treated with Arsenic Trioxide] affects the activity of CASP3 protein; [CSF2 protein co-treated with Arsenic Trioxide] results in decreased expression of and affects the activity of CASP8 protein; [CSF2 protein co-treated with Arsenic Trioxide] results in decreased expression of and results in increased cleavage of CASP3 protein 		CTD PMID:16174796 PMID:22465848 PMID:29049341 NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,887,692...38,890,031 		JBrowse link
G Csf2rb colony stimulating factor 2 receptor subunit beta increases expression ISO Arsenic Trioxide results in increased expression of CSF2RB mRNA CTD PMID:15070760 NCBI chr 7:111,756,950...111,782,089
Ensembl chr 7:111,757,405...111,784,654 		JBrowse link
G Csf3 colony stimulating factor 3 multiple interactions
increases expression
increases response to substance
increases uptake 		ISO [CSF3 protein results in increased expression of AQP9 mRNA] which results in increased uptake of Arsenic Trioxide; [CSF3 protein results in increased expression of AQP9 protein] which results in increased uptake of Arsenic Trioxide; AQP9 protein promotes the reaction [CSF3 protein results in increased uptake of Arsenic Trioxide]; CSF3 protein inhibits the reaction [Tretinoin results in decreased uptake of Arsenic Trioxide]
Arsenic Trioxide results in increased expression of CSF3 protein
CSF3 protein results in increased susceptibility to Arsenic Trioxide 		CTD PMID:22940758 PMID:35590355 PMID:37166470 NCBI chr10:84,157,485...84,159,860
Ensembl chr10:84,157,211...84,159,860 		JBrowse link
G Csgalnact1 chondroitin sulfate N-acetylgalactosaminyltransferase 1 increases expression ISO Arsenic Trioxide results in increased expression of CSGALNACT1 mRNA CTD PMID:20458559 NCBI chr16:25,761,946...26,097,306
Ensembl chr16:26,002,530...26,096,065 		JBrowse link
G Csnk1d casein kinase 1, delta increases expression ISO Arsenic Trioxide results in increased expression of CSNK1D mRNA CTD PMID:20458559 NCBI chr10:106,713,497...106,754,953
Ensembl chr10:106,694,279...106,754,953 		JBrowse link
G Cspg5 chondroitin sulfate proteoglycan 5 decreases expression ISO Arsenic Trioxide results in decreased expression of CSPG5 mRNA CTD PMID:26705709 NCBI chr 8:119,098,932...119,113,191
Ensembl chr 8:119,098,925...119,143,907 		JBrowse link
G Cspp1 centrosome and spindle pole associated protein 1 decreases expression ISO Arsenic Trioxide results in decreased expression of CSPP1 mRNA CTD PMID:15761015 PMID:22521957 NCBI chr 5:13,860,072...13,975,299
Ensembl chr 5:13,860,072...13,975,321 		JBrowse link
G Csrp1 cysteine and glycine-rich protein 1 decreases expression ISO Arsenic Trioxide results in decreased expression of CSRP1 mRNA CTD PMID:21461292 NCBI chr13:49,709,928...49,731,141
Ensembl chr13:49,709,914...49,731,139 		JBrowse link
G Csrp2 cysteine and glycine-rich protein 2 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of CSRP2 mRNA
Arsenic Trioxide results in decreased expression of CSRP2 mRNA 		CTD PMID:19128835 PMID:25258189 NCBI chr 7:48,235,415...48,254,049
Ensembl chr 7:48,235,383...48,266,238 		JBrowse link
G Csrp3 cysteine and glycine rich protein 3 decreases expression ISO Arsenic Trioxide results in decreased expression of CSRP3 mRNA CTD PMID:15725085 NCBI chr 1:107,664,338...107,682,916
Ensembl chr 1:107,664,338...107,682,916 		JBrowse link
G Cst3 cystatin C decreases expression
increases expression
multiple interactions 		ISO
EXP 		Arsenic Trioxide results in decreased expression of CST3 mRNA
Arsenic Trioxide results in increased expression of CST3 protein
Febuxostat inhibits the reaction [Arsenic Trioxide results in increased expression of CST3 protein] 		CTD PMID:15725085 PMID:37689273 NCBI chr 3:156,790,061...156,794,116
Ensembl chr 3:156,790,079...156,793,937 		JBrowse link
G Csta cystatin A increases expression
affects expression 		ISO Arsenic Trioxide results in increased expression of CSTA mRNA
Arsenic Trioxide affects the expression of CSTA mRNA 		CTD PMID:20458559 PMID:24356939 PMID:26705709 PMID:27825931 NCBI chr11:78,125,813...78,136,818
Ensembl chr11:78,125,800...78,136,822 		JBrowse link
G Cstb cystatin B increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of CSTB protein
Arsenic Trioxide results in decreased expression of CSTB protein 		CTD PMID:19364129 PMID:30093655 NCBI chr20:10,245,157...10,247,199
Ensembl chr20:10,245,158...10,247,199 		JBrowse link
G Cstf2 cleavage stimulation factor subunit 2 increases expression ISO Arsenic Trioxide results in increased expression of CSTF2 protein CTD PMID:15894607 NCBI chr  X:101,546,809...101,572,760
Ensembl chr  X:101,546,819...101,572,764 		JBrowse link
G Cstl1 cystatin-like 1 increases expression ISO Arsenic Trioxide results in increased expression of CSTL1 mRNA CTD PMID:20458559 NCBI chr 3:156,652,967...156,658,049
Ensembl chr 3:156,653,052...156,658,049 		JBrowse link
G Ctbp1 C-terminal binding protein 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CTBP1 protein] CTD PMID:26598702 NCBI chr14:81,679,956...81,707,331
Ensembl chr14:81,679,765...81,707,554 		JBrowse link
G Ctbp2 C-terminal binding protein 2 decreases response to substance ISO CTBP2 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 1:197,208,536...197,348,802
Ensembl chr 1:197,212,133...197,254,261 		JBrowse link
G Ctcf CCCTC-binding factor affects methylation ISO Arsenic Trioxide affects the methylation of CTCF promoter CTD PMID:26046465 NCBI chr19:50,431,478...50,481,013
Ensembl chr19:50,431,689...50,481,012 		JBrowse link
G Ctdsp1 CTD small phosphatase 1 decreases expression ISO Arsenic Trioxide results in decreased expression of CTDSP1 mRNA CTD PMID:26705709 NCBI chr 9:83,422,755...83,428,411
Ensembl chr 9:83,423,051...83,428,412 		JBrowse link
G Ctdspl2 CTD small phosphatase like 2 increases expression ISO Arsenic Trioxide results in increased expression of CTDSPL2 mRNA CTD PMID:35676786 NCBI chr 3:129,365,709...129,424,232
Ensembl chr 3:129,368,938...129,424,232 		JBrowse link
G Ctf1 cardiotrophin 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CTF1 protein] CTD PMID:26598702 NCBI chr 1:191,758,512...191,771,259
Ensembl chr 1:191,757,477...191,776,395 		JBrowse link
G Cth cystathionine gamma-lyase increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of CTH mRNA
Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CTH protein] 		CTD PMID:19417148 PMID:26598702 PMID:26705709 NCBI chr 2:249,634,731...249,661,066
Ensembl chr 2:249,634,731...249,661,066 		JBrowse link
G Ctla4 cytotoxic T-lymphocyte-associated protein 4 increases expression ISO Arsenic Trioxide results in increased expression of CTLA4 mRNA CTD PMID:34108876 NCBI chr 9:69,812,859...69,819,959
Ensembl chr 9:69,813,265...69,819,973 		JBrowse link
G Ctnna1 catenin alpha 1 decreases expression ISO Arsenic Trioxide results in decreased expression of CTNNA1 mRNA CTD PMID:15761015 NCBI chr18:27,002,330...27,135,009
Ensembl chr18:26,999,820...27,135,007 		JBrowse link
G Ctnna2 catenin alpha 2 multiple interactions ISO [Arsenic Trioxide co-treated with apatinib] results in increased expression of CTNNA2 mRNA CTD PMID:39223679 NCBI chr 4:110,852,265...112,001,351
Ensembl chr 4:110,852,265...112,001,365 		JBrowse link
G Ctnnal1 catenin alpha-like 1 increases expression ISO Arsenic Trioxide results in increased expression of CTNNAL1 mRNA CTD PMID:22521957 NCBI chr 5:76,309,546...76,375,869
Ensembl chr 5:76,309,546...76,364,637 		JBrowse link
G Ctnnb1 catenin beta 1 decreases expression
increases expression
multiple interactions
increases cleavage
affects expression 		ISO Arsenic Trioxide results in decreased expression of CTNNB1 mRNA; Arsenic Trioxide results in decreased expression of CTNNB1 protein
Arsenic Trioxide results in increased expression of CTNNB1 mRNA
[Arsenic Trioxide binds to PIN1 protein] affects the reaction [Arsenic Trioxide results in decreased expression of CTNNB1 protein]; [Arsenic Trioxide co-treated with apatinib] results in decreased expression of CTNNB1 protein; Arsenic Trioxide inhibits the reaction [CTNNB1 protein results in decreased susceptibility to Bortezomib]; Arsenic Trioxide inhibits the reaction [Lithium Chloride results in increased expression of CTNNB1 protein]; Arsenic Trioxide promotes the reaction [Tretinoin results in decreased expression of CTNNB1 protein]; CAB39L protein alternative form inhibits the reaction [Arsenic Trioxide results in decreased expression of CTNNB1 mRNA]; CAB39L protein alternative form inhibits the reaction [Arsenic Trioxide results in decreased expression of CTNNB1 protein]; GRB10 protein promotes the reaction [[Arsenic Trioxide co-treated with apatinib] results in decreased expression of CTNNB1 protein]; ICG 001 affects the reaction [RORB protein affects the reaction [Arsenic Trioxide affects the expression of CTNNB1 protein]]; N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea inhibits the reaction [Arsenic Trioxide results in decreased expression of CTNNB1 protein]; PIN1 protein affects the reaction [Arsenic Trioxide results in decreased expression of CTNNB1 protein]; RORB protein affects the reaction [Arsenic Trioxide affects the expression of CTNNB1 protein]; Tretinoin promotes the reaction [Arsenic Trioxide results in decreased expression of CTNNB1 protein]
Arsenic Trioxide results in increased cleavage of CTNNB1 protein 		CTD PMID:12181429 PMID:17512576 PMID:18485479 PMID:20458559 PMID:26966376 More... NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:129,517,545...129,544,662 		JBrowse link
G Ctnnd1 catenin delta 1 decreases response to substance
increases expression 		ISO CTNND1 protein results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in increased expression of CTNND1 mRNA 		CTD PMID:20707922 PMID:35676786 NCBI chr 3:90,090,025...90,141,247
Ensembl chr 3:90,090,564...90,141,189 		JBrowse link
G Ctps1 CTP synthase 1 multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of CTPS1 mRNA CTD PMID:15894607 NCBI chr 5:139,372,349...139,440,441
Ensembl chr 5:139,410,249...139,440,465 		JBrowse link
G Ctps2 CTP synthase 2 decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of CTPS2 mRNA
[Arsenic Trioxide co-treated with Ascorbic Acid] results in decreased expression of CTPS2 mRNA 		CTD PMID:25555879 NCBI chr  X:35,277,658...35,418,505
Ensembl chr  X:35,277,658...35,418,505 		JBrowse link
G Ctsa cathepsin A increases expression ISO Arsenic Trioxide results in increased expression of CTSA mRNA CTD PMID:15725085 PMID:20458559 NCBI chr 3:173,988,443...173,994,320
Ensembl chr 3:173,988,460...173,995,539 		JBrowse link
G Ctsb cathepsin B increases expression
increases activity
multiple interactions
decreases activity
decreases expression 		ISO Arsenic Trioxide results in increased expression of CTSB mRNA
Arsenic Trioxide results in increased activity of CTSB protein
3-methyladenine inhibits the reaction [[Arsenic Trioxide co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of CTSB protein]; [Arsenic Trioxide co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of CTSB protein; [Arsenic Trioxide co-treated with Silybin] results in decreased expression of CTSB mRNA; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of CTSB mRNA]; Arsenic Trioxide promotes the reaction [CTSB protein results in increased degradation of BCR protein mutant form]; CA 074 methyl ester inhibits the reaction [[Arsenic Trioxide co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of CTSB protein]; Chloroquine inhibits the reaction [Arsenic Trioxide results in increased activity of CTSB protein]; Taurine inhibits the reaction [[Arsenic Trioxide co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of CTSB protein]; TFEB protein affects the reaction [Arsenic Trioxide results in increased expression of CTSB mRNA]
Taurine inhibits the reaction [Arsenic Trioxide results in increased expression of CTSB protein]
Arsenic Trioxide results in decreased activity of CTSB protein
Arsenic Trioxide results in decreased expression of CTSB mRNA 		CTD PMID:21969006 PMID:22898604 PMID:27039805 PMID:27829220 PMID:29307831 More... NCBI chr15:41,565,607...41,586,479
Ensembl chr15:41,565,611...41,586,478 		JBrowse link
G Ctsc cathepsin C decreases expression ISO Arsenic Trioxide results in decreased expression of CTSC mRNA CTD PMID:26705709 NCBI chr 1:151,440,860...151,472,430
Ensembl chr 1:151,441,032...151,474,082 		JBrowse link
G Ctsd cathepsin D increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of CTSD protein
Arsenic Trioxide promotes the reaction [AG 1879 results in increased expression of CTSD protein] 		CTD PMID:23864846 PMID:25419056 NCBI chr 1:206,956,945...206,968,821
Ensembl chr 1:206,956,944...206,968,821 		JBrowse link
G Ctsg cathepsin G multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of CTSG mRNA CTD PMID:15894607 NCBI chr15:33,901,230...33,907,596
Ensembl chr15:33,901,754...33,907,596 		JBrowse link
G Ctsh cathepsin H multiple interactions
decreases expression 		ISO [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of CTSH mRNA
Arsenic Trioxide results in decreased expression of CTSH mRNA 		CTD PMID:15761015 PMID:15894607 PMID:39716349 NCBI chr 8:99,488,756...99,507,639
Ensembl chr 8:99,488,874...99,509,181 		JBrowse link
G Ctsl cathepsin L multiple interactions ISO [CTSL protein affects the susceptibility to [Arsenic Trioxide results in increased abundance of arsenite]] which affects the expression of TP53 protein; Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CTSL protein]; CTSL protein affects the susceptibility to [Arsenic Trioxide results in increased abundance of arsenite] CTD PMID:23968587 PMID:26598702 NCBI chr17:770,104...776,266
Ensembl chr17:770,093...777,113 		JBrowse link
G Ctso cathepsin O decreases expression ISO Arsenic Trioxide results in decreased expression of CTSO mRNA CTD PMID:39716349 NCBI chr 2:169,528,468...169,551,975
Ensembl chr 2:169,528,511...169,554,995 		JBrowse link
G Ctss cathepsin S increases expression ISO Arsenic Trioxide results in increased expression of CTSS mRNA CTD PMID:19101991 NCBI chr 2:185,775,316...185,803,440
Ensembl chr 2:185,775,296...185,803,440 		JBrowse link
G Cttn cortactin multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of CTTN mRNA CTD PMID:15894607 NCBI chr 1:209,029,048...209,064,577
Ensembl chr 1:209,029,048...209,058,211 		JBrowse link
G Cttnbp2nl CTTNBP2 N-terminal like multiple interactions
decreases expression 		ISO Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of CTTNBP2NL mRNA] CTD PMID:29095437 NCBI chr 2:195,196,318...195,244,792
Ensembl chr 2:195,196,318...195,243,181 		JBrowse link
G Cul1 cullin 1 decreases expression ISO Arsenic Trioxide results in decreased expression of CUL1 mRNA CTD PMID:29633893 NCBI chr 4:77,551,781...77,634,210
Ensembl chr 4:77,551,787...77,621,760 		JBrowse link
G Cul2 cullin 2 increases expression ISO Arsenic Trioxide results in increased expression of CUL2 mRNA CTD PMID:20458559 NCBI chr17:58,864,274...58,905,447
Ensembl chr17:58,864,274...58,905,132 		JBrowse link
G Cul5 cullin 5 increases expression ISO Arsenic Trioxide results in increased expression of CUL5 mRNA CTD PMID:17530438 NCBI chr 8:62,909,150...62,974,641
Ensembl chr 8:62,912,193...62,965,463 		JBrowse link
G Cwf19l1 CWF19 like cell cycle control factor 1 decreases expression ISO Arsenic Trioxide results in decreased expression of CWF19L1 mRNA CTD PMID:20458559 NCBI chr 1:252,946,934...252,970,194
Ensembl chr 1:252,946,934...252,970,168 		JBrowse link
G Cx3cl1 C-X3-C motif chemokine ligand 1 decreases expression ISO Arsenic Trioxide results in decreased expression of CX3CL1 mRNA CTD PMID:17547211 NCBI chr19:10,233,326...10,244,856
Ensembl chr19:10,233,329...10,242,999 		JBrowse link
G Cxcl10 C-X-C motif chemokine ligand 10 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of CXCL10 mRNA
Arsenic Trioxide results in decreased expression of CXCL10 mRNA 		CTD PMID:17530438 PMID:27829220 PMID:38684648 NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261 		JBrowse link
G Cxcl11 C-X-C motif chemokine ligand 11 increases expression ISO Arsenic Trioxide results in increased expression of CXCL11 mRNA CTD PMID:38684648 NCBI chr14:15,973,728...15,976,503
Ensembl chr14:15,973,720...15,976,567 		JBrowse link
G Cxcl12 C-X-C motif chemokine ligand 12 multiple interactions
increases expression 		ISO Arsenic Trioxide inhibits the reaction [CXCL12 protein results in increased expression of CXCR4 protein]; Arsenic Trioxide inhibits the reaction [CXCL12 protein results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; RELA protein inhibits the reaction [Arsenic Trioxide inhibits the reaction [CXCL12 protein results in increased expression of CXCR4 protein]]
Arsenic Trioxide results in increased expression of CXCL12 mRNA 		CTD PMID:25047463 PMID:38684648 NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:152,060,780...152,073,627 		JBrowse link
G Cxcl14 C-X-C motif chemokine ligand 14 decreases expression ISO Arsenic Trioxide results in decreased expression of CXCL14 mRNA CTD PMID:26705709 NCBI chr17:8,323,150...8,331,176
Ensembl chr17:8,323,143...8,331,172 		JBrowse link
G Cxcl16 C-X-C motif chemokine ligand 16 increases expression ISO Arsenic Trioxide results in increased expression of CXCL16 mRNA CTD PMID:25258189 NCBI chr10:55,665,355...55,669,950
Ensembl chr10:55,664,742...55,670,226 		JBrowse link
G Cxcl2 C-X-C motif chemokine ligand 2 multiple interactions
increases expression 		ISO Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of CXCL2 mRNA] CTD PMID:19128835 PMID:19350554 NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255 		JBrowse link
G Cxcl3 C-X-C motif chemokine ligand 3 decreases expression ISO Arsenic Trioxide results in decreased expression of CXCL1 mRNA CTD PMID:39716349 NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,571,900...17,573,624 		JBrowse link
G Cxcl9 C-X-C motif chemokine ligand 9 decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of CXCL9 mRNA
Arsenic Trioxide results in increased expression of CXCL9 mRNA 		CTD PMID:18414637 PMID:38684648 NCBI chr14:16,007,166...16,012,077
Ensembl chr14:16,007,204...16,014,299 		JBrowse link
G Cxcr2 C-X-C motif chemokine receptor 2 increases expression ISO Arsenic Trioxide results in increased expression of CXCR2 mRNA CTD PMID:15761015 NCBI chr 9:83,178,645...83,185,017
Ensembl chr 9:83,183,808...83,188,602 		JBrowse link
G Cxcr3 C-X-C motif chemokine receptor 3 decreases expression ISO Arsenic Trioxide results in decreased expression of CXCR3 mRNA CTD PMID:34108876 NCBI chr  X:70,884,293...70,886,944
Ensembl chr  X:70,883,958...70,886,871 		JBrowse link
G Cxcr4 C-X-C motif chemokine receptor 4 multiple interactions
decreases expression
affects expression 		ISO Arsenic Trioxide inhibits the reaction [CXCL12 protein results in increased expression of CXCR4 protein]; Arsenic Trioxide inhibits the reaction [Oxygen deficiency results in increased expression of CXCR4 mRNA]; Arsenic Trioxide inhibits the reaction [Oxygen deficiency results in increased expression of CXCR4 protein]; PPP2CA protein affects the reaction [Arsenic Trioxide results in decreased expression of CXCR4 protein]; RELA protein inhibits the reaction [Arsenic Trioxide inhibits the reaction [CXCL12 protein results in increased expression of CXCR4 protein]]; RELA protein inhibits the reaction [Arsenic Trioxide results in decreased expression of CXCR4 protein]
Arsenic Trioxide results in decreased expression of CXCR4 mRNA; Arsenic Trioxide results in decreased expression of CXCR4 protein
Arsenic Trioxide affects the expression of CXCR4 mRNA 		CTD PMID:20458559 PMID:25047463 PMID:26705709 NCBI chr13:42,630,383...42,634,288
Ensembl chr13:42,630,104...42,634,459 		JBrowse link
G Cxxc5 CXXC finger protein 5 multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of CXXC5 mRNA CTD PMID:15894607 NCBI chr18:27,701,650...27,732,633
Ensembl chr18:27,701,188...27,732,635 		JBrowse link
G Cyb561d1 cytochrome b561 family, member D1 decreases expression ISO Arsenic Trioxide results in decreased expression of CYB561D1 mRNA CTD PMID:35676786 NCBI chr 2:198,523,031...198,525,671
Ensembl chr 2:198,523,031...198,525,676 		JBrowse link
G Cyb5r2 cytochrome b5 reductase 2 decreases expression ISO Arsenic Trioxide results in decreased expression of CYB5R2 mRNA CTD PMID:20458559 NCBI chr 1:171,062,083...171,076,183
Ensembl chr 1:171,067,614...171,075,904 		JBrowse link
G Cyb5r3 cytochrome b5 reductase 3 increases expression ISO Arsenic Trioxide results in increased expression of CYB5R3 mRNA CTD PMID:15725085 NCBI chr 7:116,186,729...116,204,290
Ensembl chr 7:116,186,729...116,204,306 		JBrowse link
G Cyba cytochrome b-245 alpha chain increases expression ISO Arsenic Trioxide results in increased expression of CYBA mRNA CTD PMID:15070760 PMID:27750169 NCBI chr19:67,396,143...67,404,214
Ensembl chr19:67,396,143...67,404,214 		JBrowse link
G Cybb cytochrome b-245 beta chain decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of CYBB mRNA
[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of CYBB mRNA 		CTD PMID:15894607 PMID:20458559 PMID:28454374 NCBI chr  X:16,030,596...16,065,065
Ensembl chr  X:16,030,596...16,065,065 		JBrowse link
G Cybrd1 cytochrome b reductase 1 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of CYBRD1 mRNA
Arsenic Trioxide results in decreased expression of CYBRD1 mRNA 		CTD PMID:15761015 PMID:39716349 NCBI chr 3:76,342,231...76,369,846
Ensembl chr 3:76,342,404...76,370,061 		JBrowse link
G Cyc1 cytochrome c-1 increases expression ISO Arsenic Trioxide results in increased expression of CYC1 mRNA CTD PMID:22521957 NCBI chr 7:109,947,750...109,950,142
Ensembl chr 7:109,947,766...109,950,657 		JBrowse link
G Cycs cytochrome c, somatic affects localization
multiple interactions
increases expression
increases secretion 		EXP
ISO 		Arsenic Trioxide affects the localization of CYCS protein
Acetylcysteine inhibits the reaction [Arsenic Trioxide affects the localization of CYCS protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [CASP9 protein binds to CYCS protein]]; Arsenic Trioxide promotes the reaction [CYCS protein binds to CASP9 protein]; salvianolic acid A inhibits the reaction [Arsenic Trioxide affects the localization of CYCS protein]; trans-sodium crocetinate inhibits the reaction [Arsenic Trioxide results in increased expression of CYCS protein]
Arsenic Trioxide results in increased expression of and affects the localization of CYCS protein; ATF4 protein promotes the reaction [Arsenic Trioxide results in increased expression of and affects the localization of CYCS protein]
[Arsenic Trioxide co-treated with Curcumin] results in increased expression of CYCS protein; [Arsenic Trioxide co-treated with esculetin] affects the localization of CYCS protein; pyrazolanthrone promotes the reaction [Arsenic Trioxide affects the localization of CYCS protein]; U 0126 promotes the reaction [Arsenic Trioxide affects the localization of CYCS protein]
Arsenic Trioxide results in increased expression of CYCS mRNA; Arsenic Trioxide results in increased expression of CYCS protein
Arsenic Trioxide results in increased secretion of CYCS protein 		CTD PMID:15979664 PMID:16972261 PMID:19428345 PMID:21145380 PMID:22521957 More... NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:80,982,668...80,984,816
Ensembl chr18:80,982,668...80,984,816 		JBrowse link
G Cyfip2 cytoplasmic FMR1 interacting protein 2 multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of CYFIP2 mRNA CTD PMID:15894607 NCBI chr10:31,122,653...31,242,440
Ensembl chr10:31,122,653...31,242,440 		JBrowse link
G Cygb cytoglobin multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CYGB protein] CTD PMID:26598702 NCBI chr10:102,376,506...102,386,272
Ensembl chr10:102,376,507...102,386,272 		JBrowse link
G Cyld CYLD lysine 63 deubiquitinase decreases expression ISO Arsenic Trioxide results in decreased expression of CYLD mRNA CTD PMID:15761015 NCBI chr19:34,487,491...34,547,311
Ensembl chr19:34,488,583...34,547,118 		JBrowse link
G Cyp11a1 cytochrome P450, family 11, subfamily a, polypeptide 1 decreases expression ISO Arsenic Trioxide results in decreased expression of CYP11A1 mRNA CTD PMID:18630931 NCBI chr 8:67,318,665...67,330,196
Ensembl chr 8:67,270,556...67,330,196 		JBrowse link
G Cyp17a1 cytochrome P450, family 17, subfamily a, polypeptide 1 decreases expression ISO Arsenic Trioxide results in decreased expression of CYP17A1 mRNA CTD PMID:18630931 NCBI chr 1:255,476,861...255,484,547
Ensembl chr 1:255,476,861...255,482,974 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 affects expression
multiple interactions
increases expression
decreases expression
increases stability 		ISO Arsenic Trioxide affects the expression of CYP1A1 mRNA
[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of CYP1A1 mRNA; Arsenic Trioxide inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A1 protein]; Arsenic Trioxide inhibits the reaction [Dioxins results in increased activity of CYP1A1 protein]; Arsenic Trioxide inhibits the reaction [Methylcholanthrene results in increased expression of and results in increased activity of CYP1A1 protein]; Arsenic Trioxide inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA]; Arsenic Trioxide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A1 protein]; Arsenic Trioxide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; verlukast promotes the reaction [Arsenic Trioxide results in decreased activity of CYP1A1 protein]
Arsenic Trioxide results in increased expression of CYP1A1 mRNA
[Arsenic Trioxide co-treated with Tetrachlorodibenzodioxin] results in increased stability of CYP1A1 mRNA; [Arsenic Trioxide co-treated with Tetrachlorodibenzodioxin] results in increased stability of CYP1A1 protein; Arsenic Trioxide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A1 protein]; Arsenic Trioxide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; Arsenic Trioxide promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A1 protein]; Arsenic Trioxide promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; Arsenic Trioxide promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 protein]
Arsenic Trioxide results in decreased expression of CYP1A1 mRNA
Arsenic Trioxide results in increased stability of CYP1A1 mRNA 		CTD PMID:11678611 PMID:12490585 PMID:15894607 PMID:17530438 PMID:27829220 More... NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 multiple interactions
increases expression 		ISO Arsenic Trioxide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A2 protein]; Arsenic Trioxide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]
Arsenic Trioxide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]; Arsenic Trioxide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 protein]; Arsenic Trioxide promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A2 protein]; Arsenic Trioxide promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]
Arsenic Trioxide results in increased expression of CYP1A2 mRNA; Arsenic Trioxide results in increased expression of CYP1A2 protein 		CTD PMID:35872050 PMID:37423394 NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149 		JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 affects expression
decreases expression
multiple interactions
increases expression 		ISO Arsenic Trioxide affects the expression of CYP1B1 mRNA
Arsenic Trioxide results in decreased expression of CYP1B1 protein
[Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of CYP1B1 mRNA; Resveratrol inhibits the reaction [Arsenic Trioxide results in decreased expression of CYP1B1 protein]
Arsenic Trioxide results in increased expression of CYP1B1 mRNA 		CTD PMID:15894607 PMID:17530438 PMID:29876539 PMID:38758479 NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142 		JBrowse link
G Cyp24a1 cytochrome P450, family 24, subfamily a, polypeptide 1 decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of CYP24A1
[Arsenic Trioxide results in decreased expression of CYP24A1] which results in increased activity of paricalcitol; Arsenic Trioxide inhibits the reaction [Cholecalciferol results in increased expression of CYP24A1 mRNA] 		CTD PMID:15781666 PMID:16184197 NCBI chr 3:179,694,647...179,709,083
Ensembl chr 3:179,694,647...179,709,083 		JBrowse link
G Cyp26a1 cytochrome P450, family 26, subfamily a, polypeptide 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [Tretinoin results in increased expression of CYP26A1 mRNA] CTD PMID:15688020 NCBI chr 1:244,883,822...244,887,657
Ensembl chr 1:244,883,752...244,887,657 		JBrowse link
G Cyp2a3 cytochrome P450, family 2, subfamily a, polypeptide 3 increases expression ISO Arsenic Trioxide results in increased expression of CYP2A4 mRNA CTD PMID:38758479 NCBI chr 1:91,299,584...91,307,650
Ensembl chr 1:91,299,561...91,307,649 		JBrowse link
G Cyp2b3 cytochrome P450, family 2, subfamily b, polypeptide 3 increases expression ISO Arsenic Trioxide results in increased expression of CYP2B10 mRNA CTD PMID:38758479 NCBI chr 1:90,780,468...90,859,852 JBrowse link
G Cyp2c11 cytochrome P450, subfamily 2, polypeptide 11 increases expression ISO Arsenic Trioxide results in increased expression of CYP2C18 mRNA CTD PMID:39716349 NCBI chr 1:246,175,216...246,211,445
Ensembl chr 1:246,174,711...246,211,853 		JBrowse link
G Cyp2c6 cytochrome P450, family 2, subfamily C, polypeptide 6 decreases expression ISO Arsenic Trioxide results in decreased expression of CYP2C29 mRNA CTD PMID:38758479 NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798 		JBrowse link
G Cyp2d4 cytochrome P450, family 2, subfamily d, polypeptide 4 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CYP2D6 protein] CTD PMID:26598702 NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:115,761,696...115,771,837 		JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 affects expression
decreases expression 		ISO Arsenic Trioxide affects the expression of CYP2E1 mRNA
Arsenic Trioxide results in decreased expression of CYP2E1 mRNA 		CTD PMID:17530438 PMID:35676786 PMID:38758479 NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495 		JBrowse link
G Cyp2j4 cytochrome P450, family 2, subfamily j, polypeptide 4 decreases response to substance
increases expression 		ISO CYP2J2 protein results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in increased expression of CYP2J9 mRNA 		CTD PMID:20707922 PMID:38758479 NCBI chr 5:116,295,691...116,323,219
Ensembl chr 5:116,295,694...116,323,042 		JBrowse link
G Cyp39a1 cytochrome P450, family 39, subfamily a, polypeptide 1 decreases expression ISO Arsenic Trioxide results in decreased expression of CYP39A1 mRNA CTD PMID:15761015 NCBI chr 9:24,727,817...24,804,060
Ensembl chr 9:24,727,817...24,804,060 		JBrowse link
G Cyp3a18 cytochrome P450, family 3, subfamily a, polypeptide 18 multiple interactions
increases expression 		ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CYP3A43 protein]
Arsenic Trioxide results in increased expression of CYP3A43 mRNA 		CTD PMID:15761015 PMID:26598702 NCBI chr12:13,994,312...14,044,185
Ensembl chr12:13,994,311...14,045,788 		JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 multiple interactions
increases expression 		ISO Arsenic Trioxide inhibits the reaction [Rifampin results in increased expression of CYP3A4 protein]
Arsenic Trioxide results in increased expression of CYP3A4 mRNA 		CTD PMID:16184197 PMID:20458559 NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857 		JBrowse link
G Cyp3a9 cytochrome P450, family 3, subfamily a, polypeptide 9 increases expression ISO Arsenic Trioxide results in increased expression of CYP3A13 mRNA CTD PMID:38758479 NCBI chr12:21,919,955...21,960,160
Ensembl chr12:21,919,940...21,960,154 		JBrowse link
G Cyp4f18 cytochrome P450, family 4, subfamily f, polypeptide 18 increases expression ISO Arsenic Trioxide results in increased expression of CYP4F18 mRNA CTD PMID:38758479 NCBI chr16:17,797,558...17,838,958
Ensembl chr16:17,740,001...17,838,958 		JBrowse link
G Cyp4f40 cytochrome P450, family 4, subfamily f, polypeptide 40 decreases expression ISO Arsenic Trioxide results in decreased expression of CYP4F11 mRNA CTD PMID:20458559 NCBI chr 7:12,342,121...12,357,974
Ensembl chr 7:12,342,590...12,356,733 		JBrowse link
G Cyp4f6 cytochrome P450, family 4, subfamily f, polypeptide 6 increases expression ISO Arsenic Trioxide results in increased expression of CYP4F16 mRNA CTD PMID:38758479 NCBI chr 7:12,680,799...12,708,378
Ensembl chr 7:12,680,806...12,708,402 		JBrowse link
G Cyp7b1 cytochrome P450 family 7 subfamily B member 1 increases expression ISO Arsenic Trioxide results in increased expression of CYP7B1 mRNA CTD PMID:17530438 PMID:26705709 NCBI chr 2:102,419,011...102,586,047
Ensembl chr 2:102,419,011...102,451,804 		JBrowse link
G Cystm1 cysteine-rich transmembrane module containing 1 decreases expression ISO Arsenic Trioxide results in decreased expression of CYSTM1 mRNA CTD PMID:39716349 NCBI chr18:28,219,861...28,287,574
Ensembl chr18:28,220,004...28,287,574 		JBrowse link
G Cytl1 cytokine like 1 multiple interactions
decreases expression 		ISO [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of CYTL1 mRNA; Arsenic Trioxide inhibits the reaction [SP1 protein binds to CYTL1 promoter]
Arsenic Trioxide results in decreased expression of CYTL1 mRNA 		CTD PMID:15070760 PMID:15761015 PMID:15894607 NCBI chr14:77,278,635...77,283,645
Ensembl chr14:77,278,636...77,283,645 		JBrowse link
G Czib CXXC motif containing zinc binding protein multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CZIB protein] CTD PMID:26598702 NCBI chr 5:127,875,408...127,885,100
Ensembl chr 5:127,877,173...127,886,538 		JBrowse link
G Dab2 DAB adaptor protein 2 affects expression
decreases expression 		ISO Arsenic Trioxide affects the expression of DAB2 mRNA
Arsenic Trioxide results in decreased expression of DAB2 mRNA 		CTD PMID:22521957 PMID:28786057 NCBI chr 2:57,241,947...57,294,893
Ensembl chr 2:57,242,064...57,294,888 		JBrowse link
G Dab2ip DAB2 interacting protein decreases expression ISO Arsenic Trioxide results in decreased expression of DAB2IP mRNA CTD PMID:22521957 NCBI chr 3:39,312,745...39,483,730
Ensembl chr 3:39,312,745...39,483,730 		JBrowse link
G Dach2 dachshund family transcription factor 2 increases expression ISO Arsenic Trioxide results in increased expression of DACH2 mRNA CTD PMID:20458559 NCBI chr  X:82,644,374...83,210,181
Ensembl chr  X:82,644,128...83,210,000 		JBrowse link
G Dact1 dishevelled-binding antagonist of beta-catenin 1 decreases methylation
decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased methylation of DACT1 promoter
Arsenic Trioxide results in decreased expression of DACT1 mRNA
[Arsenic Trioxide results in decreased methylation of DACT1 promoter] which results in increased expression of DACT1 mRNA 		CTD PMID:21176356 PMID:27829220 NCBI chr 6:95,526,645...95,538,625
Ensembl chr 6:95,526,690...95,551,053 		JBrowse link
G Dad1 defender against cell death 1 decreases expression ISO Arsenic Trioxide results in decreased expression of DAD1 protein CTD PMID:25419056 NCBI chr15:31,647,326...31,667,159
Ensembl chr15:31,647,326...31,667,287 		JBrowse link
G Dag1 dystroglycan 1 multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of DAG1 mRNA CTD PMID:15894607 NCBI chr 8:117,769,517...117,834,347
Ensembl chr 8:117,769,517...117,782,199 		JBrowse link
G Dapk2 death-associated protein kinase 2 multiple interactions
increases expression 		ISO DAPK2 protein affects the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; TP73 protein affects the reaction [Arsenic Trioxide results in increased expression of DAPK2 mRNA]; TP73 protein affects the reaction [Arsenic Trioxide results in increased expression of DAPK2 protein]
Arsenic Trioxide results in increased expression of DAPK2 mRNA; Arsenic Trioxide results in increased expression of DAPK2 protein 		CTD PMID:28978663 NCBI chr 8:75,601,621...75,720,619
Ensembl chr 8:75,601,634...75,720,617 		JBrowse link
G Dapp1 dual adaptor of phosphotyrosine and 3-phosphoinositides 1 increases expression ISO Arsenic Trioxide results in increased expression of DAPP1 mRNA CTD PMID:20458559 NCBI chr 2:229,099,319...229,148,868
Ensembl chr 2:229,099,319...229,148,843 		JBrowse link
G Dars1 aspartyl-tRNA synthetase 1 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of DARS1 protein
Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to DARS1 protein] 		CTD PMID:25419056 PMID:26598702 NCBI chr13:42,410,351...42,465,467
Ensembl chr13:42,379,162...42,465,467 		JBrowse link
G Daxx death-domain associated protein multiple interactions
decreases expression 		ISO Arsenic Trioxide affects the reaction [NR3C1 protein modified form binds to DAXX protein]; Arsenic Trioxide affects the reaction [PML protein modified form binds to DAXX protein]; Arsenic Trioxide inhibits the reaction [[DAXX protein binds to NR3C1 protein] which binds to TSC22D3 promoter]; Arsenic Trioxide inhibits the reaction [DAXX protein binds to CEBPB protein]
Arsenic Trioxide results in decreased expression of DAXX protein 		CTD PMID:17081986 PMID:19690170 NCBI chr20:4,971,973...4,978,062
Ensembl chr20:4,971,941...4,977,720 		JBrowse link
G Dazap1 DAZ associated protein 1 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of DAZAP1 mRNA
Arsenic Trioxide results in decreased expression of DAZAP1 mRNA 		CTD PMID:20458559 PMID:39716349 NCBI chr 7:10,074,342...10,098,810
Ensembl chr 7:10,074,849...10,095,599 		JBrowse link
G Dazap2 DAZ associated protein 2 increases expression ISO Arsenic Trioxide results in increased expression of DAZAP2 mRNA CTD PMID:20458559 NCBI chr 7:133,593,503...133,599,044
Ensembl chr 7:133,593,512...133,599,047 		JBrowse link
G Dbh dopamine beta-hydroxylase decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of DBH mRNA
Taurine inhibits the reaction [Arsenic Trioxide results in decreased expression of DBH mRNA] 		CTD PMID:23392890 PMID:23518225 NCBI chr 3:30,886,313...30,903,313
Ensembl chr 3:30,886,328...30,903,316 		JBrowse link
G Dbn1 drebrin 1 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of DBN1 mRNA
Arsenic Trioxide results in decreased expression of DBN1 mRNA 		CTD PMID:19128835 PMID:20458559 NCBI chr17:9,155,729...9,170,121
Ensembl chr17:9,155,787...9,170,122 		JBrowse link
G Dbnl drebrin-like multiple interactions
increases cleavage 		ISO benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [Arsenic Trioxide results in increased cleavage of DBNL protein] CTD PMID:15637062 NCBI chr14:84,880,085...84,895,122
Ensembl chr14:84,880,142...84,897,133 		JBrowse link
G Dbt dihydrolipoamide branched chain transacylase E2 increases expression ISO Arsenic Trioxide results in increased expression of DBT mRNA CTD PMID:20458559 NCBI chr 2:207,166,660...207,195,528
Ensembl chr 2:207,166,652...207,195,525 		JBrowse link
G Dcbld2 discoidin, CUB and LCCL domain containing 2 increases expression ISO Arsenic Trioxide results in increased expression of DCBLD2 mRNA CTD PMID:26705709 NCBI chr11:55,594,691...55,649,113
Ensembl chr11:55,594,691...55,649,085 		JBrowse link
G Dcc DCC netrin 1 receptor increases expression ISO Arsenic Trioxide results in increased expression of DCC mRNA CTD PMID:11940349 NCBI chr18:67,144,272...68,248,159
Ensembl chr18:67,149,179...68,247,541 		JBrowse link
G Dclk1 doublecortin-like kinase 1 decreases expression ISO Arsenic Trioxide results in decreased expression of DCLK1 mRNA CTD PMID:29633893 NCBI chr 2:141,567,215...141,861,088
Ensembl chr 2:141,571,983...141,861,090 		JBrowse link
G Dclre1c DNA cross-link repair 1C increases expression ISO Arsenic Trioxide results in increased expression of DCLRE1C mRNA CTD PMID:20458559 NCBI chr17:79,684,988...79,718,399
Ensembl chr17:79,678,698...79,718,734 		JBrowse link
G Dcn decorin decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of DCN mRNA
[Arsenic Trioxide co-treated with apatinib] results in decreased expression of DCN mRNA 		CTD PMID:26705709 PMID:39223679 NCBI chr 7:34,167,973...34,208,004
Ensembl chr 7:34,163,011...34,218,926 		JBrowse link
G Dcp2 decapping mRNA 2 increases response to substance ISO DCP2 protein results in increased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr18:37,001,615...37,037,949
Ensembl chr18:37,001,615...37,049,939 		JBrowse link
G Dctd dCMP deaminase multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to DCTD protein] CTD PMID:26598702 NCBI chr16:50,799,699...50,831,398
Ensembl chr16:50,787,875...50,831,186 		JBrowse link
G Dctn1 dynactin subunit 1 increases expression ISO Arsenic Trioxide results in increased expression of DCTN1 mRNA CTD PMID:39716349 NCBI chr 4:117,228,722...117,261,528
Ensembl chr 4:117,219,349...117,261,528 		JBrowse link
G Dcun1d3 defective in cullin neddylation 1 domain containing 3 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to DCUN1D3 protein] CTD PMID:26598702 NCBI chr 1:183,674,364...183,717,002
Ensembl chr 1:75,527,981...75,529,932
Ensembl chr 1:75,527,981...75,529,932 		JBrowse link
G Dcx doublecortin increases expression ISO Arsenic Trioxide results in increased expression of DCX mRNA CTD PMID:20458559 NCBI chr  X:112,227,455...112,370,291
Ensembl chr  X:112,227,455...112,304,161 		JBrowse link
G Ddb1 damage-specific DNA binding protein 1 increases expression ISO Arsenic Trioxide results in increased expression of DDB1 protein CTD PMID:25419056 NCBI chr 1:216,677,810...216,703,605
Ensembl chr 1:216,677,810...216,703,596 		JBrowse link
G Ddb2 damage specific DNA binding protein 2 affects expression ISO Arsenic Trioxide affects the expression of DDB2 mRNA CTD PMID:25873331 NCBI chr 3:97,640,923...97,667,617
Ensembl chr 3:97,640,579...97,664,066 		JBrowse link
G Ddc dopa decarboxylase decreases expression ISO Arsenic Trioxide results in decreased expression of DDC mRNA CTD PMID:39716349 NCBI chr14:90,592,304...90,682,830
Ensembl chr14:90,592,304...90,682,806 		JBrowse link
G Ddi2 DNA damage inducible 1 homolog 2 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to DDI2 protein] CTD PMID:26598702 NCBI chr 5:159,272,625...159,318,365
Ensembl chr 5:159,272,625...159,318,310 		JBrowse link
G Ddit3 DNA-damage inducible transcript 3 affects localization
increases expression
multiple interactions
affects expression
affects response to substance 		ISO
EXP 		Arsenic Trioxide affects the localization of DDIT3 protein
Arsenic Trioxide results in increased expression of DDIT3 protein
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Arsenic Trioxide results in increased expression of DDIT3 protein]; 2-(4-chlorophenoxy)-N-(4-(2-(4-chlorophenoxy)acetamido)cyclohexyl)acetamide inhibits the reaction [Arsenic Trioxide results in increased expression of DDIT3 protein]; 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid inhibits the reaction [Arsenic Trioxide results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [Arsenic Trioxide results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of DDIT3 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of DDIT3 protein]; ATF4 protein promotes the reaction [Arsenic Trioxide results in increased expression of DDIT3 protein]; DDIT3 mutant form inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; DDIT3 mutant form inhibits the reaction [Arsenic Trioxide results in increased activity of CASP7 protein]; DDIT3 mutant form inhibits the reaction [Arsenic Trioxide results in increased degradation of CASP12 protein]; Thapsigargin promotes the reaction [Arsenic Trioxide results in increased expression of DDIT3 protein]; Thioctic Acid inhibits the reaction [Arsenic Trioxide results in increased expression of DDIT3 protein]
Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of DDIT3 protein]; ferrostatin-1 inhibits the reaction [Arsenic Trioxide results in increased expression of DDIT3 protein]
Arsenic Trioxide results in increased expression of DDIT3 mRNA; Arsenic Trioxide results in increased expression of DDIT3 protein
Arsenic Trioxide affects the expression of DDIT3 mRNA
Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [Resveratrol results in increased expression of DDIT3 protein]]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [Resveratrol promotes the reaction [Arsenic Trioxide results in increased expression of DDIT3 protein]]; Arsenic Trioxide promotes the reaction [nilotinib results in increased expression of DDIT3 mRNA]; Arsenic Trioxide promotes the reaction [Resveratrol results in increased expression of DDIT3 protein]; Atrazine promotes the reaction [Arsenic Trioxide results in increased expression of DDIT3 mRNA]; DDIT3 affects the reaction [Arsenic Trioxide results in increased expression of TNFRSF10B]; DDIT3 mutant form inhibits the reaction [Arsenic Trioxide results in increased expression of TNFRSF10B protein]; DDIT3 results in increased susceptibility to [Arsenic Trioxide co-treated with TNFSF10]; MT2A protein promotes the reaction [Arsenic Trioxide results in increased expression of DDIT3 protein]; Resveratrol promotes the reaction [Arsenic Trioxide results in increased expression of DDIT3 protein]; sulforaphane promotes the reaction [Arsenic Trioxide results in increased expression of DDIT3 protein]
DDIT3 affects the susceptibility to Arsenic Trioxide 		CTD PMID:11678611 PMID:12749819 PMID:12883267 PMID:15493360 PMID:18172319 More... NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509 		JBrowse link
G Ddit4 DNA-damage-inducible transcript 4 increases expression ISO Arsenic Trioxide results in increased expression of DDIT4 mRNA CTD PMID:22521957 NCBI chr20:28,434,938...28,437,037
Ensembl chr20:28,434,944...28,437,037 		JBrowse link
G Ddr2 discoidin domain receptor tyrosine kinase 2 increases expression ISO Arsenic Trioxide results in increased expression of DDR2 protein CTD PMID:30093655 NCBI chr13:84,726,412...84,851,032
Ensembl chr13:84,731,180...84,850,288 		JBrowse link
G Ddt D-dopachrome tautomerase multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to DDT protein] CTD PMID:26598702 NCBI chr20:12,883,025...12,886,121 JBrowse link
G Ddx1 DEAD-box helicase 1 multiple interactions
decreases expression 		ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to DDX1 protein]
Arsenic Trioxide results in decreased expression of DDX1 protein 		CTD PMID:25419056 PMID:26598702 NCBI chr 6:41,725,365...41,756,236
Ensembl chr 6:41,725,367...41,758,302 		JBrowse link
G Ddx21 DExD-box helicase 21 decreases expression ISO Arsenic Trioxide results in decreased expression of DDX21 protein CTD PMID:25419056 NCBI chr20:31,077,044...31,097,238
Ensembl chr20:31,077,045...31,097,238 		JBrowse link
G Ddx39b DExD-box helicase 39B increases expression ISO Arsenic Trioxide results in increased expression of DDX39B protein CTD PMID:25419056 NCBI chr20:3,577,200...3,589,651
Ensembl chr20:3,576,734...3,589,651 		JBrowse link
G Ddx3y DEAD box helicase 3, Y-linked decreases expression ISO Arsenic Trioxide results in decreased expression of DDX3Y mRNA; Arsenic Trioxide results in decreased expression of DDX3Y protein CTD PMID:22581830 NCBI chr  Y:1,190,042...1,210,699
Ensembl chr  Y:1,191,242...1,210,650 		JBrowse link
G Ddx41 DEAD-box helicase 41 decreases expression ISO Arsenic Trioxide results in decreased expression of DDX41 mRNA CTD PMID:39716349 NCBI chr17:9,108,030...9,113,562
Ensembl chr17:9,108,074...9,113,561 		JBrowse link
G Ddx5 DEAD-box helicase 5 decreases expression ISO Arsenic Trioxide results in decreased expression of DDX5 protein CTD PMID:25419056 NCBI chr10:92,224,393...92,231,928
Ensembl chr10:92,224,395...92,231,300 		JBrowse link
G Decr1 2,4-dienoyl-CoA reductase 1 increases expression ISO Arsenic Trioxide results in increased expression of DECR1 mRNA CTD PMID:22521957 NCBI chr 5:34,208,195...34,236,074
Ensembl chr 5:34,208,195...34,236,033 		JBrowse link
G Dedd2 death effector domain containing 2 multiple interactions ISO [sanguinarine co-treated with Arsenic Trioxide] results in increased expression of DEDD2 mRNA CTD PMID:24345465 NCBI chr 1:89,916,906...89,934,663
Ensembl chr 1:89,919,524...89,936,804 		JBrowse link
G Dennd2b DENN domain containing 2B decreases expression ISO Arsenic Trioxide results in decreased expression of DENND2B mRNA CTD PMID:22521957 NCBI chr 1:172,978,895...173,129,623
Ensembl chr 1:172,978,895...173,129,810 		JBrowse link
G Denr density regulated reinitiation and release factor increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of DENR mRNA
Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of DENR mRNA] 		CTD PMID:29095437 NCBI chr12:38,323,433...38,346,207
Ensembl chr12:38,323,445...38,344,797 		JBrowse link
G Depdc1 DEP domain containing 1 decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of DEPDC1 mRNA
Arsenic Trioxide results in increased expression of DEPDC1 mRNA 		CTD PMID:22521957 PMID:26705709 NCBI chr 2:251,343,250...251,376,709
Ensembl chr 2:251,343,281...251,376,709 		JBrowse link
G Deptor DEP domain containing MTOR-interacting protein multiple interactions ISO [Arsenic Trioxide co-treated with apatinib] results in decreased expression of DEPTOR mRNA CTD PMID:39223679 NCBI chr 7:88,404,745...88,574,065
Ensembl chr 7:88,404,620...88,574,041 		JBrowse link
G Derl1 derlin 1 increases expression ISO Arsenic Trioxide results in increased expression of DERL1 mRNA CTD PMID:35676786 NCBI chr 7:91,293,963...91,316,639
Ensembl chr 7:91,258,382...91,316,678 		JBrowse link
G Des desmin decreases expression
multiple interactions 		EXP Arsenic Trioxide results in decreased expression of DES mRNA
Phloretin inhibits the reaction [Arsenic Trioxide results in decreased expression of DES mRNA] 		CTD PMID:34037972 NCBI chr 9:84,299,626...84,307,344
Ensembl chr 9:84,298,447...84,307,347 		JBrowse link
G Desi2 desumoylating isopeptidase 2 increases expression ISO Arsenic Trioxide results in increased expression of DESI2 mRNA CTD PMID:20458559 PMID:22521957 NCBI chr13:92,493,765...92,543,307
Ensembl chr13:92,493,989...92,564,981 		JBrowse link
G Dexi Dexi homolog decreases expression ISO Arsenic Trioxide results in decreased expression of DEXI mRNA CTD PMID:35676786 NCBI chr10:5,632,400...5,645,653
Ensembl chr10:5,632,961...5,645,648 		JBrowse link
G Dffa DNA fragmentation factor subunit alpha increases expression
multiple interactions 		ISO
EXP 		Arsenic Trioxide results in increased expression of DFFA mRNA
Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to DFFA protein] 		CTD PMID:17530438 PMID:19730151 PMID:26598702 NCBI chr 5:164,823,807...164,836,729
Ensembl chr 5:164,823,807...164,836,728 		JBrowse link
G Dffb DNA fragmentation factor subunit beta increases expression
multiple interactions
decreases expression 		ISO Arsenic Trioxide results in increased expression of DFFB mRNA
Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to DFFB protein]
Arsenic Trioxide results in decreased expression of DFFB mRNA 		CTD PMID:17530438 PMID:26598702 PMID:34108876 NCBI chr 5:169,804,873...169,817,157
Ensembl chr 5:169,804,889...169,817,225 		JBrowse link
G Dgcr8 DGCR8 microprocessor complex subunit decreases expression ISO Arsenic Trioxide results in decreased expression of DGCR8 mRNA CTD PMID:22521957 NCBI chr11:96,208,959...96,241,560
Ensembl chr11:96,209,038...96,241,551 		JBrowse link
G Dgki diacylglycerol kinase, iota increases expression ISO Arsenic Trioxide results in increased expression of DGKI mRNA CTD PMID:20458559 NCBI chr 4:66,377,897...66,839,790
Ensembl chr 4:66,387,126...66,990,832 		JBrowse link
G Dhrs1 dehydrogenase/reductase 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to DHRS1 protein] CTD PMID:26598702 NCBI chr15:33,206,449...33,213,776
Ensembl chr15:33,206,451...33,213,734 		JBrowse link
G Dhrs2 dehydrogenase/reductase 2 increases expression ISO Arsenic Trioxide results in increased expression of DHRS2 mRNA CTD PMID:26705709 NCBI chr15:32,658,855...32,673,591
Ensembl chr15:32,659,223...32,673,588 		JBrowse link
G Dhrs7 dehydrogenase/reductase 7 increases expression ISO Arsenic Trioxide results in increased expression of DHRS7 mRNA CTD PMID:27829220 NCBI chr 6:97,068,149...97,083,744
Ensembl chr 6:97,068,149...97,083,744 		JBrowse link
G Dhrs9 dehydrogenase/reductase 9 multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of DHRS9 mRNA CTD PMID:15894607 NCBI chr 3:74,553,357...74,579,535
Ensembl chr 3:74,555,606...74,581,376 		JBrowse link
G Dhrsx dehydrogenase/reductase X-linked increases expression ISO Arsenic Trioxide results in increased expression of DHRSX mRNA CTD PMID:26705709 NCBI chr12:21,413,563...21,418,319
Ensembl chr12:21,413,575...21,418,319 		JBrowse link
G Dhtkd1 dehydrogenase E1 and transketolase domain containing 1 increases expression ISO Arsenic Trioxide results in increased expression of DHTKD1 protein CTD PMID:25419056 NCBI chr17:77,242,512...77,316,074
Ensembl chr17:77,264,514...77,316,071 		JBrowse link
G Dhx15 DEAH-box helicase 15 decreases expression ISO Arsenic Trioxide results in decreased expression of DHX15 protein CTD PMID:29163777 NCBI chr14:62,999,886...63,037,829
Ensembl chr14:62,999,877...63,037,828 		JBrowse link
G Dhx9 DExH-box helicase 9 increases expression
multiple interactions
decreases expression 		ISO Arsenic Trioxide results in increased expression of DHX9 mRNA
Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of DHX9 mRNA]
Arsenic Trioxide results in decreased expression of DHX9 mRNA 		CTD PMID:29095437 PMID:39716349 NCBI chr13:68,152,813...68,189,580
Ensembl chr13:68,152,813...68,189,546 		JBrowse link
G Diablo diablo, IAP-binding mitochondrial protein multiple interactions ISO [Arsenic Trioxide co-treated with Curcumin] results in increased expression of DIABLO protein CTD PMID:27430728 NCBI chr12:38,716,668...38,731,285
Ensembl chr12:38,716,668...38,731,265 		JBrowse link
G Diaph1 diaphanous-related formin 1 decreases expression ISO Arsenic Trioxide results in decreased expression of DIAPH1 mRNA CTD PMID:19128835 NCBI chr18:29,920,889...30,020,280
Ensembl chr18:29,920,889...30,020,280 		JBrowse link
G Diaph3 diaphanous-related formin 3 increases expression ISO Arsenic Trioxide results in increased expression of DIAPH3 mRNA CTD PMID:20458559 NCBI chr15:68,951,992...69,421,623
Ensembl chr15:68,951,989...69,421,552 		JBrowse link
G Dip2b disco-interacting protein 2 homolog B increases expression ISO Arsenic Trioxide results in increased expression of DIP2B mRNA CTD PMID:35676786 NCBI chr 7:133,053,393...133,231,430
Ensembl chr 7:133,053,401...133,228,874 		JBrowse link
G Dipk1a divergent protein kinase domain 1A decreases expression ISO Arsenic Trioxide results in decreased expression of DIPK1A mRNA CTD PMID:39716349 NCBI chr14:1,917,353...1,988,188
Ensembl chr14:1,917,324...1,988,678 		JBrowse link
G Diras3 DIRAS family GTPase 3 decreases expression ISO Arsenic Trioxide results in decreased expression of DIRAS3 mRNA CTD PMID:26705709 NCBI chr 6:136,346,157...136,347,371
Ensembl chr 6:136,346,154...136,348,376 		JBrowse link
G Dkk1 dickkopf WNT signaling pathway inhibitor 1 increases expression ISO Arsenic Trioxide results in increased expression of DKK1 mRNA CTD PMID:17547211 NCBI chr 1:237,794,969...237,798,650
Ensembl chr 1:237,794,969...237,798,650 		JBrowse link
G Dkk3 dickkopf WNT signaling pathway inhibitor 3 increases expression ISO Arsenic Trioxide results in increased expression of DKK3 mRNA CTD PMID:20458559 NCBI chr 1:175,672,834...175,715,867
Ensembl chr 1:175,672,834...175,715,186 		JBrowse link
G Dlc1 DLC1 Rho GTPase activating protein decreases methylation
increases expression 		ISO Arsenic Trioxide results in decreased methylation of DLC1 gene
Arsenic Trioxide results in increased expression of DLC1 mRNA 		CTD PMID:25534098 NCBI chr16:61,954,177...62,374,819
Ensembl chr16:61,995,001...62,374,819 		JBrowse link
G Dlg1 discs large MAGUK scaffold protein 1 decreases expression ISO Arsenic Trioxide results in decreased expression of DLG1 mRNA CTD PMID:24831965 NCBI chr11:82,416,853...82,607,797
Ensembl chr11:82,416,853...82,607,797 		JBrowse link
G Dlg2 discs large MAGUK scaffold protein 2 decreases expression ISO Arsenic Trioxide results in decreased expression of DLG2 mRNA CTD PMID:24831965 NCBI chr 1:153,864,545...155,916,238
Ensembl chr 1:153,865,299...155,916,215 		JBrowse link
G Dlg3 discs large MAGUK scaffold protein 3 decreases expression ISO Arsenic Trioxide results in decreased expression of DLG3 mRNA CTD PMID:39716349 NCBI chr  X:69,899,694...69,951,928
Ensembl chr  X:69,900,003...69,950,696 		JBrowse link
G Dlgap4 DLG associated protein 4 decreases expression ISO Arsenic Trioxide results in decreased expression of DLGAP4 mRNA CTD PMID:22521957 NCBI chr 3:165,584,271...165,731,868
Ensembl chr 3:165,584,360...165,730,604 		JBrowse link
G Dlk1 delta like non-canonical Notch ligand 1 affects response to substance ISO DLK1 protein affects the susceptibility to Arsenic Trioxide CTD PMID:18575777 NCBI chr 6:134,192,491...134,199,779
Ensembl chr 6:134,192,518...134,200,529 		JBrowse link
G Dll4 delta like canonical Notch ligand 4 decreases expression ISO Arsenic Trioxide results in decreased expression of DLL4 CTD PMID:25088040 NCBI chr 3:126,770,945...126,780,769
Ensembl chr 3:126,770,794...126,780,763 		JBrowse link
G Dlx1 distal-less homeobox 1 decreases expression ISO Arsenic Trioxide results in decreased expression of DLX1 mRNA CTD PMID:26705709 NCBI chr 3:76,763,864...76,768,454
Ensembl chr 3:76,763,500...76,768,447 		JBrowse link
G Dlx3 distal-less homeobox 3 decreases expression ISO Arsenic Trioxide results in decreased expression of DLX3 mRNA CTD PMID:20458559 NCBI chr10:80,561,335...80,566,730
Ensembl chr10:80,561,335...80,566,711 		JBrowse link
G Dlx4 distal-less homeobox 4 decreases expression ISO Arsenic Trioxide results in decreased expression of DLX4 mRNA CTD PMID:22521957 NCBI chr10:80,581,878...80,587,272
Ensembl chr10:80,582,303...80,587,294 		JBrowse link
G Dmkn dermokine decreases expression ISO Arsenic Trioxide results in decreased expression of DMKN mRNA CTD PMID:39716349 NCBI chr 1:95,140,737...95,158,676
Ensembl chr 1:95,141,620...95,157,439 		JBrowse link
G Dmxl1 Dmx-like 1 decreases expression ISO Arsenic Trioxide results in decreased expression of DMXL1 protein CTD PMID:30093655 NCBI chr18:45,179,505...45,349,999
Ensembl chr18:45,179,551...45,356,406 		JBrowse link
G Dnaaf11 dynein axonemal assembly factor 11 decreases expression ISO Arsenic Trioxide results in decreased expression of LRRC6 mRNA CTD PMID:39716349 NCBI chr 7:100,033,843...100,134,979
Ensembl chr 7:100,034,202...100,135,179 		JBrowse link
G Dnah7 dynein, axonemal, heavy chain 7 increases expression ISO Arsenic Trioxide results in increased expression of DNAH7 mRNA CTD PMID:20458559 NCBI chr 9:62,454,838...62,760,504
Ensembl chr 9:62,454,838...62,756,730 		JBrowse link
G Dnai3 dynein axonemal intermediate chain 3 increases expression ISO Arsenic Trioxide results in increased expression of DNAI3 mRNA CTD PMID:26705709 NCBI chr 2:237,608,202...237,666,465
Ensembl chr 2:237,604,068...237,666,465 		JBrowse link
G Dnaja1 DnaJ heat shock protein family (Hsp40) member A1 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of DNAJA1 mRNA
Arsenic Trioxide results in decreased expression of DNAJA1 mRNA 		CTD PMID:19417148 PMID:27829220 PMID:35676786 NCBI chr 5:60,638,404...60,649,315
Ensembl chr 5:60,638,410...60,650,160 		JBrowse link
G Dnaja4 DnaJ heat shock protein family (Hsp40) member A4 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to DNAJA4 protein] CTD PMID:26598702 NCBI chr 8:63,975,177...63,998,836
Ensembl chr 8:63,981,559...63,998,836 		JBrowse link
G Dnajb1 DnaJ heat shock protein family (Hsp40) member B1 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of DNAJB1 mRNA; Arsenic Trioxide results in increased expression of DNAJB1 protein
KNK 437 inhibits the reaction [Arsenic Trioxide results in increased expression of DNAJB1 protein] 		CTD PMID:19417148 PMID:20458559 PMID:20724260 PMID:24356939 NCBI chr19:41,427,453...41,431,141
Ensembl chr19:41,427,453...41,431,416 		JBrowse link
G Dnajb11 DnaJ heat shock protein family (Hsp40) member B11 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to DNAJB11 protein] CTD PMID:26598702 NCBI chr11:91,656,334...91,672,800
Ensembl chr11:91,656,335...91,672,800 		JBrowse link
G Dnajb2 DnaJ heat shock protein family (Hsp40) member B2 increases expression ISO Arsenic Trioxide results in increased expression of DNAJB2 mRNA CTD PMID:19417148 NCBI chr 9:84,179,702...84,187,942
Ensembl chr 9:84,179,695...84,187,942 		JBrowse link
G Dnajb4 DnaJ heat shock protein family (Hsp40) member B4 increases expression ISO Arsenic Trioxide results in increased expression of DNAJB4 mRNA CTD PMID:15761015 PMID:19417148 PMID:24356939 PMID:25258189 NCBI chr 2:243,790,296...243,819,042
Ensembl chr 2:243,790,297...243,819,042 		JBrowse link
G Dnajb6 DnaJ heat shock protein family (Hsp40) member B6 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of DNAJB6 mRNA
Arsenic Trioxide results in decreased expression of DNAJB6 mRNA 		CTD PMID:19417148 PMID:39716349 NCBI chr 4:6,010,081...6,232,052
Ensembl chr 4:6,128,070...6,232,005 		JBrowse link
G Dnajb9 DnaJ heat shock protein family (Hsp40) member B9 multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of DNAJB9 mRNA CTD PMID:15894607 NCBI chr 6:66,997,842...67,007,371
Ensembl chr 6:66,997,842...67,009,344 		JBrowse link
G Dnajc10 DnaJ heat shock protein family (Hsp40) member C10 decreases expression ISO Arsenic Trioxide results in decreased expression of DNAJC10 protein CTD PMID:25419056 NCBI chr 3:85,636,890...85,679,620
Ensembl chr 3:85,639,589...85,689,368 		JBrowse link
G Dnajc7 DnaJ heat shock protein family (Hsp40) member C7 decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of DNAJC7 protein
Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to DNAJC7 protein] 		CTD PMID:25419056 PMID:26598702 NCBI chr10:86,018,977...86,055,419
Ensembl chr10:86,018,961...86,055,489 		JBrowse link
G Dnajc9 DnaJ heat shock protein family (Hsp40) member C9 increases expression ISO Arsenic Trioxide results in increased expression of DNAJC9 mRNA CTD PMID:15761015 NCBI chr15:3,970,843...4,003,009
Ensembl chr15:3,970,114...3,977,304 		JBrowse link
G Dnase1l1 deoxyribonuclease 1-like 1 increases expression ISO Arsenic Trioxide results in increased expression of DNASE1L1 mRNA CTD PMID:20458559 NCBI chr  X:157,208,230...157,216,812
Ensembl chr  X:157,208,230...157,216,711 		JBrowse link
G Dnm1l dynamin 1-like multiple interactions
decreases expression
affects expression 		ISO
EXP 		ATF4 protein promotes the reaction [Arsenic Trioxide affects the expression of DNM1L protein modified form]; salvianolic acid A inhibits the reaction [Arsenic Trioxide results in decreased expression of DNM1L protein] CTD PMID:27638049 PMID:29867492 NCBI chr11:98,084,049...98,135,663
Ensembl chr11:98,085,397...98,137,420 		JBrowse link
G Dnm2 dynamin 2 multiple interactions ISO [Arsenic Trioxide co-treated with nilotinib] affects the expression of DNM2 mRNA CTD PMID:28786057 NCBI chr 8:28,254,344...28,336,297
Ensembl chr 8:28,254,529...28,336,295 		JBrowse link
G Dnm3 dynamin 3 decreases expression ISO Arsenic Trioxide results in decreased expression of DNM3 mRNA CTD PMID:26705709 NCBI chr13:76,892,381...77,371,346
Ensembl chr13:76,892,171...77,371,350 		JBrowse link
G Dnmbp dynamin binding protein decreases expression ISO Arsenic Trioxide results in decreased expression of DNMBP mRNA CTD PMID:27829220 NCBI chr 1:252,685,406...252,778,642
Ensembl chr 1:252,685,406...252,778,688 		JBrowse link
G Dnmt1 DNA methyltransferase 1 decreases expression
increases expression
multiple interactions
decreases activity 		EXP
ISO 		Arsenic Trioxide results in decreased expression of DNMT1 mRNA
Arsenic Trioxide results in decreased expression of DNMT1 mRNA; Arsenic Trioxide results in decreased expression of DNMT1 protein
Arsenic Trioxide results in increased expression of DNMT1 mRNA
[Arsenic Trioxide co-treated with Tamoxifen] results in decreased expression of DNMT1 mRNA; [Arsenic Trioxide co-treated with Tamoxifen] results in decreased expression of DNMT1 protein
Arsenic Trioxide inhibits the reaction [DNMT1 protein binds to ESR1 promoter]; Arsenic Trioxide promotes the reaction [Azacitidine results in decreased expression of DNMT1 protein]; S-Adenosylmethionine inhibits the reaction [Arsenic Trioxide inhibits the reaction [DNMT1 protein binds to ESR1 promoter]]; S-Adenosylmethionine inhibits the reaction [Arsenic Trioxide results in decreased expression of DNMT1 protein]
Arsenic Trioxide results in decreased activity of DNMT1 protein 		CTD PMID:16613325 PMID:17490527 PMID:19679824 PMID:20596618 PMID:21176356 More... NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:27,716,797...27,763,119 		JBrowse link
G Dnmt3a DNA methyltransferase 3 alpha decreases expression
decreases activity
multiple interactions
increases expression 		EXP
ISO 		Arsenic Trioxide results in decreased expression of DNMT3A mRNA
Arsenic Trioxide results in decreased expression of DNMT3A; Arsenic Trioxide results in decreased expression of DNMT3A mRNA; Arsenic Trioxide results in decreased expression of DNMT3A protein
Arsenic Trioxide results in decreased activity of DNMT3A protein
[[Arsenic Trioxide results in increased expression of DNMT3A protein] which results in increased methylation of MEG3 promoter] which results in decreased expression of MEG3 protein; S-Adenosylmethionine inhibits the reaction [Arsenic Trioxide results in decreased expression of DNMT3A protein]
Arsenic Trioxide results in increased expression of DNMT3A mRNA; Arsenic Trioxide results in increased expression of DNMT3A protein 		CTD PMID:12667347 PMID:12679007 PMID:17490527 PMID:20416177 PMID:20596618 More... NCBI chr 6:32,507,316...32,621,678
Ensembl chr 6:32,512,070...32,614,970 		JBrowse link
G Dnmt3b DNA methyltransferase 3 beta decreases expression
decreases activity
increases expression 		ISO
EXP 		Arsenic Trioxide results in decreased expression of DNMT3B protein
Arsenic Trioxide results in decreased activity of DNMT3B protein
Arsenic Trioxide results in increased expression of DNMT3B mRNA
Arsenic Trioxide results in decreased expression of DNMT3B mRNA
Arsenic Trioxide results in decreased expression of DNMT3B; Arsenic Trioxide results in decreased expression of DNMT3B mRNA 		CTD PMID:12667347 PMID:12679007 PMID:17490527 PMID:19679824 PMID:20416177 More... NCBI chr 3:162,590,777...162,629,313
Ensembl chr 3:162,604,037...162,629,313 		JBrowse link
G Dnmt3l DNA methyltransferase 3 like multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to DNMT3L protein] CTD PMID:26598702 NCBI chr20:10,614,591...10,628,989
Ensembl chr20:10,614,591...10,629,168 		JBrowse link
G Dock3 dedicator of cyto-kinesis 3 increases expression ISO Arsenic Trioxide results in increased expression of DOCK3 mRNA CTD PMID:20458559 NCBI chr 8:116,431,158...116,782,218
Ensembl chr 8:116,431,159...116,782,195 		JBrowse link
G Dok3 docking protein 3 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to DOK3 protein] CTD PMID:26598702 NCBI chr17:9,114,763...9,121,781
Ensembl chr17:9,114,762...9,120,335 		JBrowse link
G Dok5 docking protein 5 increases expression ISO Arsenic Trioxide results in increased expression of DOK5 mRNA CTD PMID:20458559 NCBI chr 3:179,934,419...180,071,334
Ensembl chr 3:179,934,552...180,071,333 		JBrowse link
G Dok7 docking protein 7 increases expression ISO Arsenic Trioxide results in increased expression of DOK7 mRNA CTD PMID:39716349 NCBI chr14:79,890,051...79,924,081
Ensembl chr14:79,891,367...79,932,252 		JBrowse link
G Dpagt1 dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 increases expression ISO Arsenic Trioxide results in increased expression of DPAGT1 mRNA CTD PMID:22521957 NCBI chr 8:53,560,869...53,567,625
Ensembl chr 8:53,555,239...53,567,898 		JBrowse link
G Dpep1 dipeptidase 1 increases expression
multiple interactions
decreases expression 		ISO Arsenic Trioxide results in increased expression of DPEP1 mRNA
Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of DPEP1 mRNA]
Arsenic Trioxide results in decreased expression of DPEP1 mRNA 		CTD PMID:29095437 PMID:39716349 NCBI chr19:68,118,270...68,143,781
Ensembl chr19:68,118,453...68,143,775 		JBrowse link
G Dph2 diphthamide biosynthesis 2 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to DPH2 protein] CTD PMID:26598702 NCBI chr 5:136,713,868...136,716,828 JBrowse link
G Dpp4 dipeptidylpeptidase 4 decreases expression ISO Arsenic Trioxide results in decreased expression of DPP4 mRNA CTD PMID:26238599 PMID:29355690 NCBI chr 3:67,370,794...67,452,422
Ensembl chr 3:67,370,804...67,452,422 		JBrowse link
G Dpt dermatopontin decreases expression ISO Arsenic Trioxide results in decreased expression of DPT mRNA CTD PMID:39716349 NCBI chr13:79,656,341...79,684,759
Ensembl chr13:79,655,985...79,684,758 		JBrowse link
G Dpy19l1 dpy-19 like C-mannosyltransferase 1 decreases expression ISO Arsenic Trioxide results in decreased expression of DPY19L1 mRNA CTD PMID:39716349 NCBI chr 8:31,209,025...31,297,485
Ensembl chr 8:31,209,025...31,297,518 		JBrowse link
G Dpyd dihydropyrimidine dehydrogenase increases expression ISO Arsenic Trioxide results in increased expression of DPYD mRNA CTD PMID:22521957 NCBI chr 2:209,293,902...210,159,777
Ensembl chr 2:209,293,929...210,159,778 		JBrowse link
G Dpysl2 dihydropyrimidinase-like 2 increases expression
affects expression 		ISO Arsenic Trioxide results in increased expression of DPYSL2 mRNA
Arsenic Trioxide affects the expression of DPYSL2 protein 		CTD PMID:19364129 PMID:20458559 NCBI chr15:45,181,041...45,287,065
Ensembl chr15:45,181,041...45,287,065 		JBrowse link
G Dpysl3 dihydropyrimidinase-like 3 increases expression ISO Arsenic Trioxide results in increased expression of DPYSL3 protein CTD PMID:25419056 NCBI chr18:35,625,357...35,731,152
Ensembl chr18:35,625,357...35,731,152 		JBrowse link
G Dram1 DNA-damage regulated autophagy modulator 1 decreases expression ISO Arsenic Trioxide results in decreased expression of DRAM1 mRNA CTD PMID:39716349 NCBI chr 7:24,630,233...24,665,270
Ensembl chr 7:24,630,238...24,664,354 		JBrowse link
G Drg1 developmentally regulated GTP binding protein 1 increases expression ISO Arsenic Trioxide results in increased expression of DRG1 mRNA CTD PMID:39716349 NCBI chr14:82,328,320...82,344,416
Ensembl chr14:82,328,320...82,344,348 		JBrowse link
G Dsc2 desmocollin 2 decreases response to substance ISO DSC2 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr18:11,725,466...11,757,591
Ensembl chr18:11,725,466...11,757,466 		JBrowse link
G Dsg2 desmoglein 2 decreases response to substance ISO DSG2 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr18:12,121,287...12,179,590
Ensembl chr18:12,121,181...12,179,590 		JBrowse link
G Dsg4 desmoglein 4 increases expression ISO Arsenic Trioxide results in increased expression of DSG4 mRNA CTD PMID:20458559 NCBI chr18:11,995,902...12,032,908
Ensembl chr18:11,995,902...12,032,908 		JBrowse link
G Dsp desmoplakin increases expression ISO Arsenic Trioxide results in increased expression of DSP protein CTD PMID:25419056 NCBI chr17:26,829,153...26,877,419
Ensembl chr17:26,829,153...26,877,121 		JBrowse link
G Dst dystonin increases expression ISO Arsenic Trioxide results in increased expression of DST mRNA CTD PMID:22521957 NCBI chr 9:43,631,716...44,025,535
Ensembl chr 9:43,631,517...44,025,533 		JBrowse link
G Dtl denticleless E3 ubiquitin protein ligase homolog increases sumoylation ISO Arsenic Trioxide results in increased sumoylation of DTL protein CTD PMID:28318385 NCBI chr13:105,646,908...105,685,921
Ensembl chr13:105,646,908...105,686,174 		JBrowse link
G Dtymk deoxythymidylate kinase increases expression ISO Arsenic Trioxide results in increased expression of DTYMK mRNA CTD PMID:35676786 NCBI chr 9:101,762,899...101,771,733
Ensembl chr 9:101,762,899...101,774,504 		JBrowse link
G Duox2 dual oxidase 2 increases expression ISO Arsenic Trioxide results in increased expression of DUOX2 mRNA CTD PMID:20458559 NCBI chr 3:129,680,543...129,698,886
Ensembl chr 3:129,680,546...129,699,203 		JBrowse link
G Dus2 dihydrouridine synthase 2 decreases expression ISO Arsenic Trioxide results in decreased expression of DUS2 protein CTD PMID:30093655 NCBI chr19:50,816,306...50,864,559
Ensembl chr19:50,816,310...50,864,559 		JBrowse link
G Dusp10 dual specificity phosphatase 10 increases expression ISO Arsenic Trioxide results in increased expression of DUSP10 mRNA CTD PMID:24356939 NCBI chr13:98,145,317...98,183,304
Ensembl chr13:98,145,893...98,183,304 		JBrowse link
G Dusp16 dual specificity phosphatase 16 decreases expression ISO Arsenic Trioxide results in decreased expression of DUSP16 mRNA CTD PMID:20458559 NCBI chr 4:169,278,118...169,361,508
Ensembl chr 4:169,278,118...169,361,508 		JBrowse link
G Dusp2 dual specificity phosphatase 2 decreases expression ISO Arsenic Trioxide results in decreased expression of DUSP2 mRNA CTD PMID:20458559 NCBI chr 3:135,009,636...135,011,821
Ensembl chr 3:135,009,590...135,011,809 		JBrowse link
G Dusp4 dual specificity phosphatase 4 decreases expression ISO Arsenic Trioxide results in decreased expression of DUSP4 mRNA CTD PMID:15725085 NCBI chr16:64,079,893...64,101,396
Ensembl chr16:64,079,893...64,093,700 		JBrowse link
G Dusp5 dual specificity phosphatase 5 decreases expression ISO Arsenic Trioxide results in decreased expression of DUSP5 mRNA CTD PMID:20016248 NCBI chr 1:262,543,774...262,557,201
Ensembl chr 1:262,543,738...262,562,417 		JBrowse link
G Dusp7 dual specificity phosphatase 7 decreases expression ISO Arsenic Trioxide results in decreased expression of DUSP7 mRNA CTD PMID:20458559 NCBI chr 8:115,888,091...115,895,126
Ensembl chr 8:115,887,892...115,895,126 		JBrowse link
G Dusp8 dual specificity phosphatase 8 increases expression ISO Arsenic Trioxide results in increased expression of DUSP8 mRNA CTD PMID:20458559 PMID:39716349 NCBI chr 1:206,596,912...206,613,728
Ensembl chr 1:206,598,942...206,612,441 		JBrowse link
G Dync1h1 dynein cytoplasmic 1 heavy chain 1 increases expression ISO Arsenic Trioxide results in increased expression of DYNC1H1 mRNA CTD PMID:15725085 PMID:26705709 NCBI chr 6:135,436,375...135,502,117
Ensembl chr 6:135,430,750...135,502,116 		JBrowse link
G Dync1i2 dynein cytoplasmic 1 intermediate chain 2 decreases expression ISO Arsenic Trioxide results in decreased expression of DYNC1I2 mRNA CTD PMID:15894607 NCBI chr 3:76,441,621...76,492,782
Ensembl chr 3:76,424,469...76,492,782 		JBrowse link
G Dync2i2 dynein 2 intermediate chain 2 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to DYNC2I2 protein] CTD PMID:26598702 NCBI chr 3:33,703,882...33,719,960
Ensembl chr 3:33,703,882...33,719,960 		JBrowse link
G Dyrk1a dual specificity tyrosine phosphorylation regulated kinase 1A increases response to substance ISO DYRK1A protein results in increased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr11:47,360,824...47,479,033
Ensembl chr11:47,360,850...47,479,033 		JBrowse link
G Dyrk1b dual specificity tyrosine phosphorylation regulated kinase 1B increases expression ISO Arsenic Trioxide results in increased expression of DYRK1B mRNA CTD PMID:15070760 NCBI chr 1:92,606,743...92,624,089
Ensembl chr 1:92,607,303...92,614,744 		JBrowse link
G Dyrk2 dual specificity tyrosine phosphorylation regulated kinase 2 increases expression ISO Arsenic Trioxide results in increased expression of DYRK2 mRNA CTD PMID:20458559 NCBI chr 7:56,235,276...56,265,741
Ensembl chr 7:56,235,276...56,265,942 		JBrowse link
G E2f1 E2F transcription factor 1 decreases expression
affects methylation
increases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of E2F1 protein
Arsenic Trioxide affects the methylation of E2F1 promoter
Arsenic Trioxide results in increased expression of E2F1 mRNA
Arsenic Trioxide inhibits the reaction [TP53 protein binds to E2F1 protein]; Arsenic Trioxide promotes the reaction [RB1 protein binds to E2F1 protein]; TP53 protein promotes the reaction [Arsenic Trioxide results in decreased expression of E2F1 protein] 		CTD PMID:20016248 PMID:24691991 PMID:25174355 PMID:25335113 PMID:26046465 More... NCBI chr 3:163,524,739...163,535,563
Ensembl chr 3:163,524,739...163,535,563 		JBrowse link
G E2f2 E2F transcription factor 2 increases expression ISO Arsenic Trioxide results in increased expression of E2F2 mRNA CTD PMID:17530438 NCBI chr 5:153,682,789...153,706,087
Ensembl chr 5:153,682,789...153,706,087 		JBrowse link
G E2f3 E2F transcription factor 3 increases response to substance
increases expression 		ISO E2F3 protein results in increased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in increased expression of E2F3 mRNA 		CTD PMID:20707922 PMID:20862710 NCBI chr17:34,810,355...34,887,725
Ensembl chr17:34,809,998...34,887,725 		JBrowse link
G E2f4 E2F transcription factor 4 increases expression ISO Arsenic Trioxide results in increased expression of E2F4 mRNA CTD PMID:20458559 PMID:29633893 NCBI chr19:50,084,335...50,091,731
Ensembl chr19:50,084,335...50,091,834 		JBrowse link
G E2f5 E2F transcription factor 5 decreases expression ISO Arsenic Trioxide results in decreased expression of E2F5 mRNA CTD PMID:17530438 PMID:27829220 NCBI chr 2:88,718,567...88,734,143
Ensembl chr 2:88,718,567...88,734,143 		JBrowse link
G E2f6 E2F transcription factor 6 affects methylation ISO Arsenic Trioxide affects the methylation of E2F6 promoter CTD PMID:26046465 NCBI chr 6:45,320,993...45,337,437
Ensembl chr 6:45,320,996...45,337,428 		JBrowse link
G E2f8 E2F transcription factor 8 decreases expression ISO Arsenic Trioxide results in decreased expression of E2F8 mRNA CTD PMID:26705709 NCBI chr 1:107,701,985...107,720,538
Ensembl chr 1:107,701,985...107,720,009 		JBrowse link
G Ebna1bp2 EBNA1 binding protein 2 decreases expression ISO Arsenic Trioxide results in decreased expression of EBNA1BP2 mRNA CTD PMID:35676786 NCBI chr 5:137,433,534...137,438,100
Ensembl chr 5:137,433,226...137,438,637 		JBrowse link
G Ebpl EBP like decreases expression ISO Arsenic Trioxide results in decreased expression of EBPL mRNA CTD PMID:39716349 NCBI chr15:39,684,140...39,707,537
Ensembl chr15:39,684,140...39,707,537 		JBrowse link
G Ecd ecdysoneless cell cycle regulator decreases expression ISO Arsenic Trioxide results in decreased expression of ECD mRNA CTD PMID:15894607 NCBI chr15:4,016,411...4,047,899
Ensembl chr15:4,016,403...4,047,897 		JBrowse link
G Ech1 enoyl-CoA hydratase 1 increases expression ISO Arsenic Trioxide results in increased expression of ECH1 protein CTD PMID:19364129 NCBI chr 1:93,241,076...93,248,314
Ensembl chr 1:93,241,734...93,248,440 		JBrowse link
G Echs1 enoyl-CoA hydratase, short chain 1 increases expression ISO Arsenic Trioxide results in increased expression of ECHS1 protein CTD PMID:19364129 PMID:25419056 NCBI chr 1:204,324,679...204,333,506
Ensembl chr 1:204,324,682...204,333,506 		JBrowse link
G Eci1 enoyl-CoA delta isomerase 1 decreases response to substance ISO ECI1 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr10:13,961,250...13,974,595
Ensembl chr10:13,961,218...13,974,773 		JBrowse link
G Ecm1 extracellular matrix protein 1 increases expression ISO Arsenic Trioxide results in increased expression of ECM1 mRNA CTD PMID:20458559 NCBI chr 2:185,976,439...185,981,656
Ensembl chr 2:185,976,440...185,981,606 		JBrowse link
G Ecpas Ecm29 proteasome adaptor and scaffold increases expression ISO Arsenic Trioxide results in increased expression of ECPAS mRNA CTD PMID:20458559 NCBI chr 5:78,398,449...78,509,077
Ensembl chr 5:78,398,718...78,512,908 		JBrowse link
G Ecrg4 ECRG4 augurin precursor multiple interactions
decreases methylation
decreases expression 		ISO [Arsenic Trioxide results in decreased methylation of ECRG4 promoter] which results in increased expression of ECRG4 mRNA
Arsenic Trioxide results in decreased expression of ECRG4 mRNA 		CTD PMID:22325214 PMID:35676786 NCBI chr 9:53,485,040...53,504,691
Ensembl chr 9:53,485,040...53,504,703 		JBrowse link
G Ecscr endothelial cell surface expressed chemotaxis and apoptosis regulator decreases expression ISO Arsenic Trioxide results in decreased expression of ECSCR mRNA CTD PMID:26705709 NCBI chr18:27,583,791...27,593,184
Ensembl chr18:27,583,195...27,593,195 		JBrowse link
G Eda2r ectodysplasin A2 receptor increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of EDA2R mRNA
Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of EDA2R mRNA] 		CTD PMID:29095437 NCBI chr  X:66,225,557...66,280,674
Ensembl chr  X:66,236,111...66,280,663 		JBrowse link
G Edem1 ER degradation enhancing alpha-mannosidase like protein 1 multiple interactions
increases expression 		ISO Arsenic Trioxide promotes the reaction [nilotinib results in increased expression of EDEM1 mRNA]
Arsenic Trioxide results in increased expression of EDEM1 mRNA 		CTD PMID:23883479 NCBI chr 4:143,350,989...143,385,693
Ensembl chr 4:143,353,624...143,388,060 		JBrowse link
G Edn1 endothelin 1 increases expression ISO Arsenic Trioxide results in increased expression of EDN1 mRNA CTD PMID:26705709 NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687 		JBrowse link
G Edn3 endothelin 3 decreases expression ISO Arsenic Trioxide results in decreased expression of EDN3 mRNA CTD PMID:35676786 NCBI chr 3:183,980,458...184,004,958
Ensembl chr 3:183,980,668...184,005,329 		JBrowse link
G Ednrb endothelin receptor type B decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of EDNRB mRNA
Arsenic Trioxide results in increased expression of EDNRB mRNA alternative form 		CTD PMID:19128835 PMID:26705709 NCBI chr15:87,055,490...87,086,765
Ensembl chr15:87,057,691...87,086,765 		JBrowse link
G Edrf1 erythroid differentiation regulatory factor 1 decreases expression ISO Arsenic Trioxide results in decreased expression of EDRF1 mRNA CTD PMID:27829220 NCBI chr 1:197,869,873...197,908,693
Ensembl chr 1:197,870,962...197,908,731 		JBrowse link
G Eef1a1 eukaryotic translation elongation factor 1 alpha 1 multiple interactions
decreases expression 		ISO [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of EEF1A1 protein
Arsenic Trioxide results in decreased expression of EEF1A1 protein 		CTD PMID:15894607 PMID:25258189 NCBI chr 8:88,221,839...88,225,688
Ensembl chr 8:88,221,843...88,225,072 		JBrowse link
G Eef1a2 eukaryotic translation elongation factor 1 alpha 2 decreases response to substance
increases expression 		ISO EEF1A2 protein results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in increased expression of EEF1A2 mRNA 		CTD PMID:20707922 PMID:39716349 NCBI chr 3:188,643,455...188,652,633
Ensembl chr 3:188,643,458...188,677,712 		JBrowse link
G Eef1akmt1 EEF1A lysine methyltransferase 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to EEF1AKMT1 protein] CTD PMID:26598702 NCBI chr15:35,809,842...35,826,921
Ensembl chr15:35,809,842...35,827,129 		JBrowse link
G Eef1b2 eukaryotic translation elongation factor 1 beta 2 multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of EEF1B2 protein; Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to EEF1B2 protein] CTD PMID:15894607 PMID:26598702 NCBI chr 9:72,074,091...72,076,591
Ensembl chr 9:72,073,802...72,076,589 		JBrowse link
G Eef1d eukaryotic translation elongation factor 1 delta multiple interactions
decreases expression 		ISO [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of EEF1D protein; Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to EEF1D protein]
Arsenic Trioxide results in decreased expression of EEF1D protein 		CTD PMID:15894607 PMID:25419056 PMID:26598702 NCBI chr 7:109,462,645...109,478,021
Ensembl chr 7:109,462,646...109,489,531 		JBrowse link
G Eef1e1 eukaryotic translation elongation factor 1 epsilon 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to EEF1E1 protein] CTD PMID:26598702 NCBI chr17:26,354,247...26,364,953
Ensembl chr17:26,354,228...26,370,687 		JBrowse link
G Eef1g eukaryotic translation elongation factor 1 gamma decreases expression ISO Arsenic Trioxide results in decreased expression of EEF1G protein CTD PMID:15894607 NCBI chr 1:215,289,815...215,300,421
Ensembl chr 1:215,277,860...215,301,479 		JBrowse link
G Eef2 eukaryotic translation elongation factor 2 decreases expression ISO Arsenic Trioxide results in decreased expression of EEF2 protein CTD PMID:19364129 NCBI chr 7:9,183,836...9,196,255
Ensembl chr 7:9,183,961...9,189,544 		JBrowse link
G Eefsec eukaryotic elongation factor, selenocysteine-tRNA-specific decreases response to substance ISO EEFSEC gene mutant form results in decreased susceptibility to Arsenic Trioxide CTD PMID:30815697 NCBI chr 4:122,276,907...122,473,049
Ensembl chr 4:122,263,535...122,473,049 		JBrowse link
G Efna1 ephrin A1 increases expression ISO Arsenic Trioxide results in increased expression of EFNA1 mRNA CTD PMID:20458559 NCBI chr 2:176,979,434...176,988,675
Ensembl chr 2:176,979,434...176,988,726 		JBrowse link
G Egf epidermal growth factor increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of EGF mRNA
[Arsenic Trioxide co-treated with Pamidronate] promotes the reaction [EGF protein results in increased phosphorylation of EGFR protein]; Arsenic Trioxide promotes the reaction [EGF protein results in increased phosphorylation of EGFR protein] 		CTD PMID:15073043 PMID:26238599 PMID:32337366 NCBI chr 2:220,893,660...220,976,331
Ensembl chr 2:220,893,660...220,976,297 		JBrowse link
G Egfl6 EGF-like-domain, multiple 6 decreases expression ISO Arsenic Trioxide results in decreased expression of EGFL6 mRNA CTD PMID:26705709 NCBI chr  X:31,515,752...31,573,699
Ensembl chr  X:31,515,767...31,574,632 		JBrowse link
G Egfr epidermal growth factor receptor multiple interactions
decreases expression
increases phosphorylation
affects response to substance
increases expression 		ISO [Arsenic Trioxide co-treated with huachansu] results in decreased expression of EGFR protein
Arsenic Trioxide results in decreased expression of EGFR protein
Arsenic Trioxide results in increased phosphorylation of EGFR protein
4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of EGFR protein]; [Arsenic Trioxide co-treated with Pamidronate] promotes the reaction [EGF protein results in increased phosphorylation of EGFR protein]; Arsenic Trioxide promotes the reaction [EGF protein results in increased phosphorylation of EGFR protein]; Arsenic Trioxide promotes the reaction [EGFR protein mutant form binds to SQSTM1 protein]; Arsenic Trioxide results in decreased expression of and results in decreased phosphorylation of EGFR protein; Arsenic Trioxide results in increased phosphorylation of and results in increased activity of EGFR protein; bafilomycin A1 inhibits the reaction [Arsenic Trioxide results in decreased expression of EGFR protein]; Cycloheximide promotes the reaction [Arsenic Trioxide results in decreased expression of EGFR protein]; Erlotinib Hydrochloride inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of EGFR protein]; NCF2 mutant form inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of EGFR protein]; SQSTM1 protein affects the reaction [Arsenic Trioxide results in decreased expression of EGFR protein]; SQSTM1 protein inhibits the reaction [Arsenic Trioxide results in decreased expression of EGFR protein]
Arsenic Trioxide results in decreased expression of EGFR mRNA; Arsenic Trioxide results in decreased expression of EGFR protein
EGFR protein affects the susceptibility to Arsenic Trioxide; EGFR protein mutant form affects the susceptibility to Arsenic Trioxide
Arsenic Trioxide results in increased expression of EGFR mRNA 		CTD PMID:15961274 PMID:20435036 PMID:21434348 PMID:22521957 PMID:22532027 More... NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358 		JBrowse link
G Egr1 early growth response 1 affects methylation
increases expression
multiple interactions
decreases expression
affects expression 		ISO
EXP 		Arsenic Trioxide affects the methylation of EGR1 promoter
Arsenic Trioxide results in increased expression of EGR1 mRNA
[Zidovudine co-treated with Arsenic Trioxide] results in increased expression of EGR1 mRNA
Arsenic Trioxide results in decreased expression of EGR1 mRNA
Arsenic Trioxide affects the expression of EGR1 mRNA
pyrazolanthrone inhibits the reaction [Arsenic Trioxide results in increased expression of EGR1 mRNA]; Tretinoin promotes the reaction [Arsenic Trioxide results in increased expression of EGR1 mRNA] 		CTD PMID:12749819 PMID:15073043 PMID:15688020 PMID:20458559 PMID:22521957 More... NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843 		JBrowse link
G Egr2 early growth response 2 multiple interactions
decreases expression 		ISO Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of EGR2 mRNA] CTD PMID:19128835 PMID:19350554 NCBI chr20:21,050,149...21,055,201
Ensembl chr20:21,050,149...21,057,748 		JBrowse link
G Egr3 early growth response 3 decreases expression ISO Arsenic Trioxide results in decreased expression of EGR3 mRNA CTD PMID:26705709 NCBI chr15:51,560,482...51,565,778
Ensembl chr15:51,560,344...51,565,712 		JBrowse link
G Ehmt1 euchromatic histone lysine methyltransferase 1 increases expression ISO Arsenic Trioxide results in increased expression of EHMT1 mRNA CTD PMID:39716349 NCBI chr 3:27,978,888...28,127,178
Ensembl chr 3:27,978,888...28,127,349 		JBrowse link
G Ehmt2 euchromatic histone lysine methyltransferase 2 decreases expression ISO Arsenic Trioxide results in decreased expression of EHMT2 mRNA CTD PMID:22521957 NCBI chr20:3,924,263...3,941,238
Ensembl chr20:3,924,263...3,941,384 		JBrowse link
G Eid1 EP300 interacting inhibitor of differentiation 1 increases expression ISO Arsenic Trioxide results in increased expression of EID1 mRNA CTD PMID:20458559 NCBI chr 3:133,376,389...133,378,108
Ensembl chr 3:133,370,474...133,378,434 		JBrowse link
G Eid3 EP300 interacting inhibitor of differentiation 3 increases expression ISO Arsenic Trioxide results in increased expression of EID3 mRNA CTD PMID:39716349 NCBI chr 7:22,747,645...22,748,967
Ensembl chr 7:22,747,656...22,749,177 		JBrowse link
G Eif2a eukaryotic translation initiation factor 2A increases expression
increases phosphorylation
multiple interactions 		ISO Arsenic Trioxide results in increased expression of EIF2A mRNA
Arsenic Trioxide results in increased phosphorylation of EIF2A protein
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of EIF2A protein]; [Arsenic Trioxide results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of EIF2A protein; Thioctic Acid inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of EIF2A protein] 		CTD PMID:19176121 PMID:23892647 NCBI chr 2:144,911,247...144,944,705
Ensembl chr 2:144,911,153...144,945,201 		JBrowse link
G Eif2ak1 eukaryotic translation initiation factor 2 alpha kinase 1 decreases expression ISO Arsenic Trioxide results in decreased expression of EIF2AK1 mRNA CTD PMID:39716349 NCBI chr12:15,824,431...15,858,266
Ensembl chr12:15,825,124...15,858,281 		JBrowse link
G Eif2ak2 eukaryotic translation initiation factor 2-alpha kinase 2 multiple interactions
increases phosphorylation 		ISO Arsenic Trioxide promotes the reaction [MSI1 protein binds to EIF2AK2 protein modified form]; EIF2AK2 protein affects the reaction [Arsenic Trioxide promotes the reaction [MSI1 protein results in increased expression of KLF4 protein]]; EIF2AK2 protein affects the reaction [Arsenic Trioxide promotes the reaction [MSI1 protein results in increased expression of MYC protein]]; EIF2AK2 protein affects the reaction [Arsenic Trioxide promotes the reaction [MSI1 protein results in increased expression of POU5F1 protein]]; EIF2AK2 protein affects the reaction [Arsenic Trioxide promotes the reaction [MSI1 protein results in increased expression of SOX2 protein]]; EIF2AK2 protein affects the reaction [Arsenic Trioxide results in increased expression of KLF4 protein]; EIF2AK2 protein affects the reaction [Arsenic Trioxide results in increased expression of MYC protein]; EIF2AK2 protein affects the reaction [Arsenic Trioxide results in increased expression of POU5F1 protein]; EIF2AK2 protein affects the reaction [Arsenic Trioxide results in increased expression of SOX2 protein]; EIF2AK2 protein affects the reaction [MSI1 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of EIF2S1 protein]]; EIF2S1 protein affects the reaction [MSI1 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of EIF2AK2 protein]]; MSI1 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of EIF2AK2 protein] CTD PMID:29486283 NCBI chr 6:21,941,147...21,977,115
Ensembl chr 6:21,952,631...21,977,116 		JBrowse link
G Eif2ak3 eukaryotic translation initiation factor 2 alpha kinase 3 increases expression
multiple interactions
increases phosphorylation 		ISO
EXP 		Arsenic Trioxide results in increased expression of EIF2AK3 protein modified form
Arsenic Trioxide results in increased expression of EIF2AK3 mRNA; Arsenic Trioxide results in increased expression of EIF2AK3 protein modified form
2-(4-chlorophenoxy)-N-(4-(2-(4-chlorophenoxy)acetamido)cyclohexyl)acetamide inhibits the reaction [Arsenic Trioxide results in increased expression of EIF2AK3 protein modified form]; 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid inhibits the reaction [Arsenic Trioxide results in increased expression of EIF2AK3 protein modified form]; ATF4 protein promotes the reaction [Arsenic Trioxide results in increased expression of EIF2AK3 protein modified form]
Arsenic Trioxide results in increased phosphorylation of EIF2AK3 protein
sulforaphane promotes the reaction [Arsenic Trioxide results in increased expression of EIF2AK3 protein modified form] 		CTD PMID:17963750 PMID:22922937 PMID:27638049 PMID:29111283 NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:104,363,833...104,425,268 		JBrowse link
G Eif2s1 eukaryotic translation initiation factor 2 subunit alpha multiple interactions
increases phosphorylation
increases expression 		ISO 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of EIF2S1 protein]; 4-phenylbutyric acid inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of EIF2S1 protein]
Arsenic Trioxide results in increased expression of EIF2S1 protein modified form
7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of EIF2S1 protein]; Arsenic Trioxide promotes the reaction [MSI1 protein binds to EIF2S1 protein modified form]; EIF2AK2 protein affects the reaction [MSI1 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of EIF2S1 protein]]; EIF2S1 protein affects the reaction [Arsenic Trioxide promotes the reaction [MSI1 protein results in increased expression of KLF4 protein]]; EIF2S1 protein affects the reaction [Arsenic Trioxide promotes the reaction [MSI1 protein results in increased expression of MYC protein]]; EIF2S1 protein affects the reaction [Arsenic Trioxide promotes the reaction [MSI1 protein results in increased expression of POU5F1 protein]]; EIF2S1 protein affects the reaction [Arsenic Trioxide promotes the reaction [MSI1 protein results in increased expression of SOX2 protein]]; EIF2S1 protein affects the reaction [MSI1 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of EIF2AK2 protein]]; MSI1 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of EIF2S1 protein]; sulforaphane promotes the reaction [Arsenic Trioxide results in increased expression of EIF2S1 protein modified form] 		CTD PMID:22922937 PMID:25258189 PMID:27638049 PMID:29486283 PMID:34560123 NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:103,405,788...103,431,649 		JBrowse link
G Eif2s3y eukaryotic translation initiation factor 2, subunit 3, structural gene Y-linked multiple interactions ISO [Arsenic Trioxide co-treated with Tretinoin] results in decreased expression of EIF2S3B mRNA CTD PMID:38179723 NCBI chr  Y:944,653...964,303
Ensembl chr  Y:944,618...964,778 		JBrowse link
G Eif3c eukaryotic translation initiation factor 3, subunit C increases expression ISO Arsenic Trioxide results in increased expression of EIF3C mRNA CTD PMID:20458559 NCBI chr 1:190,565,183...190,583,067
Ensembl chr 1:190,565,184...190,583,067 		JBrowse link
G Eif3f eukaryotic translation initiation factor 3, subunit F increases expression ISO Arsenic Trioxide results in increased expression of EIF3F mRNA CTD PMID:20458559 NCBI chr 1:172,369,062...172,378,043
Ensembl chr 1:172,369,062...172,378,041 		JBrowse link
G Eif3g eukaryotic translation initiation factor 3, subunit G decreases expression ISO Arsenic Trioxide results in decreased expression of EIF3G protein CTD PMID:19364129 NCBI chr 8:27,705,914...27,709,946
Ensembl chr 8:27,705,915...27,709,987 		JBrowse link
G Eif3i eukaryotic translation initiation factor 3, subunit I decreases expression ISO Arsenic Trioxide results in decreased expression of EIF3I protein CTD PMID:19364129 NCBI chr 5:147,219,457...147,226,910
Ensembl chr 5:147,219,366...147,241,232 		JBrowse link
G Eif3m eukaryotic translation initiation factor 3, subunit M increases expression ISO Arsenic Trioxide results in increased expression of EIF3M mRNA CTD PMID:20458559 NCBI chr 3:111,879,589...111,897,193
Ensembl chr 3:111,870,925...111,897,193 		JBrowse link
G Eif4a1 eukaryotic translation initiation factor 4A1 multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of EIF4A1 protein CTD PMID:15894607 NCBI chr10:54,883,093...54,888,602
Ensembl chr10:54,883,093...54,888,602 		JBrowse link
G Eif4a3 eukaryotic translation initiation factor 4A3 increases expression ISO Arsenic Trioxide results in increased expression of EIF4A3 protein CTD PMID:19364129 NCBI chr10:105,047,567...105,057,561
Ensembl chr10:105,047,568...105,058,207 		JBrowse link
G Eif4b eukaryotic translation initiation factor 4B decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of EIF4B mRNA
Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to EIF4B protein] 		CTD PMID:23911876 PMID:26598702 NCBI chr 7:135,085,259...135,107,054
Ensembl chr 7:135,085,066...135,107,064 		JBrowse link
G Eif4e eukaryotic translation initiation factor 4E multiple interactions
affects expression
increases phosphorylation 		ISO [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MKNK1 protein] which results in increased phosphorylation of EIF4E protein; CGP 57380 inhibits the reaction [[Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MKNK1 protein] which results in increased phosphorylation of EIF4E protein]; CGP 57380 inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of EIF4E protein]; CGP 57380 inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of EIF4E protein]; MAPK14 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of EIF4E protein]; MKNK1 protein affects the reaction [Arsenic Trioxide results in increased phosphorylation of EIF4E protein]; MKNK1 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of EIF4E protein]; MKNK2 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of EIF4E protein]; U 0126 inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of EIF4E protein]
Arsenic Trioxide affects the expression of EIF4E mRNA 		CTD PMID:18299328 PMID:20458559 PMID:29042487 NCBI chr 2:229,736,309...229,772,628
Ensembl chr 2:229,739,897...229,774,105 		JBrowse link
G Eif4e1b eukaryotic translation initiation factor 4E family member 1B multiple interactions ISO [Arsenic Trioxide co-treated with apatinib] results in decreased expression of EIF4E1B mRNA CTD PMID:39223679 NCBI chr17:9,835,883...9,868,781
Ensembl chr17:9,836,362...9,860,681 		JBrowse link
G Eif4e3 eukaryotic translation initiation factor 4E family member 3 increases expression ISO Arsenic Trioxide results in increased expression of EIF4E3 mRNA CTD PMID:27829220 NCBI chr 4:133,709,802...133,858,398
Ensembl chr 4:133,625,768...133,885,647 		JBrowse link
G Eif4ebp1 eukaryotic translation initiation factor 4E binding protein 1 multiple interactions
increases phosphorylation
decreases phosphorylation 		ISO Arsenic Trioxide inhibits the reaction [Sorafenib results in increased phosphorylation of EIF4EBP1 protein]
Arsenic Trioxide results in increased phosphorylation of EIF4EBP1 protein
Arsenic Trioxide results in decreased phosphorylation of EIF4EBP1 protein 		CTD PMID:18048359 PMID:25416439 NCBI chr16:71,495,457...71,508,845
Ensembl chr16:71,487,930...71,508,874 		JBrowse link
G Eif4g1 eukaryotic translation initiation factor 4 gamma 1 increases expression
multiple interactions
decreases expression 		ISO Arsenic Trioxide results in increased expression of EIF4G1 mRNA
[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of EIF4G1 mRNA
Arsenic Trioxide results in decreased expression of EIF4G1 mRNA 		CTD PMID:15894607 PMID:23911876 NCBI chr11:93,726,322...93,746,387
Ensembl chr11:93,726,322...93,746,367 		JBrowse link
G Eif4g2 eukaryotic translation initiation factor 4, gamma 2 increases cleavage ISO Arsenic Trioxide results in increased cleavage of EIF4G2 protein CTD PMID:18491231 NCBI chr 1:174,616,102...174,628,252
Ensembl chr 1:174,616,103...174,628,252 		JBrowse link
G Eif5 eukaryotic translation initiation factor 5 increases expression ISO Arsenic Trioxide results in increased expression of EIF5 mRNA; Arsenic Trioxide results in increased expression of EIF5 protein CTD PMID:20458559 PMID:25419056 NCBI chr 6:136,410,333...136,418,827
Ensembl chr 6:136,407,440...136,418,821 		JBrowse link
G Eif5a eukaryotic translation initiation factor 5A decreases expression ISO Arsenic Trioxide results in decreased expression of EIF5A protein CTD PMID:25419056 NCBI chr10:55,138,821...55,143,272
Ensembl chr10:55,138,823...55,143,330 		JBrowse link
G Eif5a2 eukaryotic translation initiation factor 5A2 decreases expression ISO Arsenic Trioxide results in decreased expression of EIF5A2 mRNA CTD PMID:30983542 NCBI chr 2:113,656,748...113,674,598
Ensembl chr 2:113,657,797...113,674,594 		JBrowse link
G Elac2 elaC ribonuclease Z 2 decreases expression ISO Arsenic Trioxide results in decreased expression of ELAC2 mRNA CTD PMID:20458559 NCBI chr10:50,131,449...50,154,755
Ensembl chr10:50,131,521...50,155,069 		JBrowse link
G Elapor2 endosome-lysosome associated apoptosis and autophagy regulator family member 2 decreases expression ISO Arsenic Trioxide results in decreased expression of ELAPOR2 mRNA CTD PMID:39716349 NCBI chr 4:25,565,298...25,760,684
Ensembl chr 4:25,568,122...25,760,684 		JBrowse link
G Elavl1 ELAV like RNA binding protein 1 multiple interactions ISO [Arsenic Trioxide promotes the reaction [ELAVL1 protein binds to TGIF1 promoter]] which results in decreased degradation of TGIF1 promoter; Arsenic Trioxide promotes the reaction [ELAVL1 protein binds to TGIF1 promoter] CTD PMID:21649584 NCBI chr12:7,441,699...7,482,625
Ensembl chr12:7,441,699...7,482,631 		JBrowse link
G Elavl4 ELAV like RNA binding protein 4 decreases expression ISO Arsenic Trioxide results in decreased expression of ELAVL4 mRNA CTD PMID:39716349 NCBI chr 5:130,285,418...130,429,106
Ensembl chr 5:130,285,418...130,429,096 		JBrowse link
G Elf1 E74 like ETS transcription factor 1 affects methylation ISO Arsenic Trioxide affects the methylation of ELF1 promoter CTD PMID:26046465 NCBI chr15:61,354,026...61,395,762
Ensembl chr15:61,330,877...61,395,758 		JBrowse link
G Elf3 E74 like ETS transcription factor 3 decreases response to substance ISO ELF3 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr13:49,242,265...49,247,102
Ensembl chr13:49,242,267...49,247,380 		JBrowse link
G Elk1 ETS transcription factor ELK1 multiple interactions
increases phosphorylation 		ISO 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of ELK1 protein] CTD PMID:32683294 NCBI chr  X:3,692,367...3,709,252
Ensembl chr  X:3,693,293...3,709,249 		JBrowse link
G Elk4 ETS transcription factor ELK4 decreases methylation ISO Arsenic Trioxide results in decreased methylation of ELK4 promoter CTD PMID:26046465 NCBI chr13:46,004,145...46,027,206
Ensembl chr13:46,004,182...46,027,199 		JBrowse link
G Ell3 elongation factor for RNA polymerase II 3 increases expression ISO Arsenic Trioxide results in increased expression of ELL3 mRNA CTD PMID:39716349 NCBI chr 3:128,866,755...128,870,896
Ensembl chr 3:128,864,777...128,870,852 		JBrowse link
G Elmo1 engulfment and cell motility 1 increases expression ISO Arsenic Trioxide results in increased expression of ELMO1 mRNA CTD PMID:20458559 NCBI chr17:48,982,188...49,518,525
Ensembl chr17:48,982,188...49,518,159 		JBrowse link
G Elmod1 ELMO domain containing 1 decreases expression ISO Arsenic Trioxide results in decreased expression of ELMOD1 mRNA CTD PMID:26705709 NCBI chr 8:63,194,539...63,251,526
Ensembl chr 8:63,137,295...63,251,322 		JBrowse link
G Elovl2 ELOVL fatty acid elongase 2 decreases expression ISO Arsenic Trioxide results in decreased expression of ELOVL2 mRNA CTD PMID:26705709 NCBI chr17:23,750,350...23,790,601
Ensembl chr17:23,750,350...23,790,601 		JBrowse link
G Elovl5 ELOVL fatty acid elongase 5 decreases expression ISO Arsenic Trioxide results in decreased expression of ELOVL5 mRNA CTD PMID:19128835 NCBI chr 8:87,671,164...87,737,618
Ensembl chr 8:87,671,159...87,737,616 		JBrowse link
G Elp5 elongator acetyltransferase complex subunit 5 increases expression ISO Arsenic Trioxide results in increased expression of ELP5 mRNA CTD PMID:22521957 NCBI chr10:55,191,223...55,202,949
Ensembl chr10:55,191,227...55,203,617 		JBrowse link
G Elp6 elongator acetyltransferase complex subunit 6 multiple interactions
decreases expression 		ISO [Arsenic Trioxide co-treated with Ascorbic Acid] results in decreased expression of ELP6 mRNA
Arsenic Trioxide results in decreased expression of ELP6 mRNA 		CTD PMID:25555879 NCBI chr 8:119,158,380...119,173,483
Ensembl chr 8:119,158,396...119,174,244 		JBrowse link
G Emcn endomucin decreases expression ISO Arsenic Trioxide results in decreased expression of EMCN mRNA CTD PMID:26705709 NCBI chr 2:228,564,445...228,644,370
Ensembl chr 2:228,564,430...228,645,155 		JBrowse link
G Emd emerin increases expression ISO Arsenic Trioxide results in increased expression of EMD mRNA CTD PMID:25258189 NCBI chr  X:157,190,438...157,193,479
Ensembl chr  X:157,189,819...157,197,095 		JBrowse link
G Eml1 EMAP like 1 increases expression ISO Arsenic Trioxide results in increased expression of EML1 mRNA CTD PMID:35676786 NCBI chr 6:133,048,271...133,221,642
Ensembl chr 6:133,048,427...133,221,642 		JBrowse link
G Eml2 EMAP like 2 increases expression ISO Arsenic Trioxide results in increased expression of EML2 protein CTD PMID:25419056 NCBI chr 1:87,955,924...87,987,366
Ensembl chr 1:87,955,606...87,987,366 		JBrowse link
G Eml4 EMAP like 4 increases expression ISO Arsenic Trioxide results in increased expression of EML4 protein CTD PMID:25419056 NCBI chr 6:16,972,054...17,087,365
Ensembl chr 6:16,972,075...17,087,439 		JBrowse link
G Emp2 epithelial membrane protein 2 affects expression ISO Arsenic Trioxide affects the expression of EMP2 mRNA CTD PMID:28786057 NCBI chr10:5,866,869...5,901,533
Ensembl chr10:5,866,922...5,901,532 		JBrowse link
G Emp3 epithelial membrane protein 3 decreases expression ISO Arsenic Trioxide results in decreased expression of EMP3 mRNA CTD PMID:20458559 NCBI chr 1:105,525,086...105,528,370
Ensembl chr 1:105,525,088...105,528,265 		JBrowse link
G Enah ENAH, actin regulator increases expression ISO Arsenic Trioxide results in increased expression of ENAH mRNA CTD PMID:22521957 NCBI chr13:96,149,437...96,269,841
Ensembl chr13:96,149,437...96,269,796 		JBrowse link
G Enc1 ectodermal-neural cortex 1 decreases expression ISO Arsenic Trioxide results in decreased expression of ENC1 mRNA CTD PMID:22521957 NCBI chr 2:30,285,274...30,297,194
Ensembl chr 2:30,283,736...30,315,721 		JBrowse link
G Eng endoglin decreases expression ISO Arsenic Trioxide results in decreased expression of ENG mRNA CTD PMID:20458559 NCBI chr 3:36,332,190...36,370,324
Ensembl chr 3:36,326,202...36,370,933 		JBrowse link
G Eno1 enolase 1 multiple interactions
decreases expression 		ISO [Ascorbic Acid co-treated with Arsenic Trioxide] results in decreased expression of ENO1 protein; Arsenic Trioxide promotes the reaction [Ascorbic Acid results in decreased expression of ENO1 mRNA]; Arsenic Trioxide promotes the reaction [Ascorbic Acid results in decreased expression of ENO1 protein]; Ascorbic Acid promotes the reaction [Arsenic Trioxide results in decreased expression of ENO1 mRNA]; Ascorbic Acid promotes the reaction [Arsenic Trioxide results in decreased expression of ENO1 protein]
Arsenic Trioxide results in decreased expression of ENO1 mRNA; Arsenic Trioxide results in decreased expression of ENO1 protein 		CTD PMID:38160894 NCBI chr 5:166,002,867...166,014,252
Ensembl chr 3:77,946,261...77,986,003
Ensembl chr 5:77,946,261...77,986,003 		JBrowse link
G Enox2 ecto-NOX disulfide-thiol exchanger 2 increases expression ISO Arsenic Trioxide results in increased expression of ENOX2 mRNA CTD PMID:20458559 NCBI chr  X:133,148,813...133,470,914
Ensembl chr  X:133,148,813...133,470,891 		JBrowse link
G Enpp2 ectonucleotide pyrophosphatase/phosphodiesterase 2 increases expression ISO Arsenic Trioxide results in increased expression of ENPP2 mRNA CTD PMID:20458559 NCBI chr 7:88,092,140...88,214,758
Ensembl chr 7:88,092,140...88,214,957 		JBrowse link
G Ep300 E1A binding protein p300 increases expression
increases activity
multiple interactions 		ISO Arsenic Trioxide results in increased expression of EP300 mRNA
Arsenic Trioxide results in increased activity of EP300 protein
Arsenic Trioxide promotes the reaction [EP300 protein binds to and results in increased acetylation of TP73 protein] 		CTD PMID:15031205 PMID:20458559 NCBI chr 7:114,987,857...115,058,652
Ensembl chr 7:114,946,982...115,058,574 		JBrowse link
G Epb41 erythrocyte membrane protein band 4.1 decreases expression ISO Arsenic Trioxide results in decreased expression of EPB41 mRNA CTD PMID:35676786 NCBI chr 5:149,394,080...149,548,178
Ensembl chr 5:149,394,096...149,543,540 		JBrowse link
G Epb41l1 erythrocyte membrane protein band 4.1-like 1 decreases response to substance
increases expression 		ISO EPB41L1 protein results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in increased expression of EPB41L1 protein 		CTD PMID:20707922 PMID:30093655 NCBI chr 3:165,389,295...165,512,821
Ensembl chr 3:165,389,293...165,510,498 		JBrowse link
G Epb41l2 erythrocyte membrane protein band 4.1-like 2 decreases expression ISO Arsenic Trioxide results in decreased expression of EPB41L2 mRNA CTD PMID:15761015 NCBI chr 1:21,682,336...21,857,106
Ensembl chr 1:21,682,335...21,857,105 		JBrowse link
G Epb41l4b erythrocyte membrane protein band 4.1 like 4B increases expression ISO Arsenic Trioxide results in increased expression of EPB41L4B mRNA CTD PMID:22521957 NCBI chr 5:76,486,886...76,647,752
Ensembl chr 5:76,486,902...76,647,752 		JBrowse link
G Epb41l5 erythrocyte membrane protein band 4.1 like 5 increases expression ISO Arsenic Trioxide results in increased expression of EPB41L5 mRNA CTD PMID:35676786 NCBI chr13:33,221,705...33,321,400
Ensembl chr13:33,223,589...33,321,133 		JBrowse link
G Epcam epithelial cell adhesion molecule decreases response to substance ISO EPCAM protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 6:12,633,715...12,649,678
Ensembl chr 6:12,631,611...12,649,702 		JBrowse link
G Ephb4 EPH receptor B4 decreases expression ISO Arsenic Trioxide results in decreased expression of EPHB4 mRNA CTD PMID:39716349 NCBI chr12:24,963,174...24,988,473
Ensembl chr12:24,963,174...24,988,388 		JBrowse link
G Ephx1 epoxide hydrolase 1 decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of EPHX1 mRNA
Arsenic Trioxide results in increased expression of EPHX1 mRNA 		CTD PMID:17547211 PMID:39716349 NCBI chr13:95,246,079...95,275,852
Ensembl chr13:95,246,080...95,321,981 		JBrowse link
G Ephx2 epoxide hydrolase 2 increases expression ISO Arsenic Trioxide results in increased expression of EPHX2 mRNA CTD PMID:17530438 NCBI chr15:44,465,447...44,503,157
Ensembl chr15:44,465,448...44,503,160 		JBrowse link
G Epor erythropoietin receptor decreases expression ISO Arsenic Trioxide results in decreased expression of EPOR protein CTD PMID:16360329 NCBI chr 8:28,765,738...28,770,371
Ensembl chr 8:28,765,746...28,770,322 		JBrowse link
G Epsti1 epithelial stromal interaction 1 increases expression ISO Arsenic Trioxide results in increased expression of EPSTI1 mRNA CTD PMID:20458559 NCBI chr15:59,692,712...59,791,376
Ensembl chr15:59,693,142...59,791,380 		JBrowse link
G Epx eosinophil peroxidase increases expression ISO Arsenic Trioxide results in increased expression of EPX mRNA CTD PMID:15070760 PMID:15761015 NCBI chr10:73,164,096...73,175,180
Ensembl chr10:73,164,096...73,175,180 		JBrowse link
G Epyc epiphycan decreases expression ISO Arsenic Trioxide results in decreased expression of EPYC mRNA CTD PMID:26705709 NCBI chr 7:34,323,332...34,360,845
Ensembl chr 7:34,323,273...34,361,032 		JBrowse link
G Eqtn equatorin multiple interactions
decreases expression 		ISO Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of EQTN mRNA] CTD PMID:29095437 NCBI chr 5:114,851,981...114,880,683
Ensembl chr 5:114,862,608...114,878,954 		JBrowse link
G Erbb2 erb-b2 receptor tyrosine kinase 2 increases expression ISO Arsenic Trioxide results in increased expression of ERBB2 gene mutant form CTD PMID:38746032 NCBI chr10:83,907,491...83,931,365
Ensembl chr10:83,907,460...83,931,481 		JBrowse link
G Erbb4 erb-b2 receptor tyrosine kinase 4 increases expression ISO Arsenic Trioxide results in increased expression of ERBB4 gene mutant form; Arsenic Trioxide results in increased expression of ERBB4 mRNA CTD PMID:19769630 PMID:20458559 PMID:38746032 NCBI chr 9:76,973,386...78,045,633
Ensembl chr 9:76,973,227...78,045,772 		JBrowse link
G Erc1 ELKS/RAB6-interacting/CAST family member 1 decreases expression ISO Arsenic Trioxide results in decreased expression of ERC1 mRNA CTD PMID:20458559 NCBI chr 4:154,435,936...154,727,987
Ensembl chr 4:154,435,944...154,727,987 		JBrowse link
G Erc2 ELKS/RAB6-interacting/CAST family member 2 increases expression ISO Arsenic Trioxide results in increased expression of ERC2 mRNA CTD PMID:15761015 NCBI chr16:2,819,399...3,680,258
Ensembl chr16:2,819,512...3,680,258 		JBrowse link
G Ercc2 ERCC excision repair 2, TFIIH core complex helicase subunit decreases expression ISO Arsenic Trioxide results in decreased expression of ERCC2 mRNA CTD PMID:22521957 NCBI chr 1:88,161,342...88,175,102
Ensembl chr 1:88,160,988...88,175,102 		JBrowse link
G Ercc4 ERCC excision repair 4, endonuclease catalytic subunit increases expression ISO Arsenic Trioxide results in increased expression of ERCC4 mRNA CTD PMID:17530438 NCBI chr10:2,926,085...2,958,176
Ensembl chr10:2,920,455...2,955,539 		JBrowse link
G Ercc5 ERCC excision repair 5, endonuclease increases expression ISO Arsenic Trioxide results in increased expression of ERCC5 mRNA CTD PMID:39716349 NCBI chr 9:53,801,471...53,846,611
Ensembl chr 9:53,801,714...53,875,084 		JBrowse link
G Ercc6 ERCC excision repair 6, chromatin remodeling factor affects response to substance ISO ERCC6 protein affects the susceptibility to Arsenic Trioxide CTD PMID:22280988 NCBI chr16:7,771,311...7,841,895
Ensembl chr16:7,771,581...7,841,895 		JBrowse link
G Ercc8 ERCC excision repair 8, CSA ubiquitin ligase complex subunit increases expression ISO Arsenic Trioxide results in increased expression of ERCC8 mRNA CTD PMID:22521957 NCBI chr 2:41,380,901...41,418,294
Ensembl chr 2:41,380,901...41,418,294 		JBrowse link
G Erh ERH, mRNA splicing and mitosis factor decreases expression ISO Arsenic Trioxide results in decreased expression of ERH protein CTD PMID:25419056 NCBI chr 6:106,012,255...106,022,521
Ensembl chr 6:106,012,255...106,022,623 		JBrowse link
G Ern1 endoplasmic reticulum to nucleus signaling 1 multiple interactions
increases expression
increases phosphorylation 		EXP
ISO 		Taurine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of ERN1 protein]
Arsenic Trioxide results in increased expression of ERN1 mRNA; Arsenic Trioxide results in increased expression of ERN1 protein 		CTD PMID:17963750 PMID:19176121 PMID:22521957 PMID:25449439 PMID:30660605 More... NCBI chr10:91,826,663...91,920,976
Ensembl chr10:91,830,428...91,920,791 		JBrowse link
G Ern2 endoplasmic reticulum to nucleus signaling 2 multiple interactions
increases expression 		ISO [Arsenic Trioxide co-treated with antimony trichloride] results in increased expression of ERN2 mRNA
Arsenic Trioxide results in increased expression of ERN2 mRNA 		CTD PMID:34091186 NCBI chr 1:186,153,115...186,174,521
Ensembl chr 1:186,157,691...186,174,521 		JBrowse link
G Errfi1 ERBB receptor feedback inhibitor 1 decreases expression ISO Arsenic Trioxide results in decreased expression of ERRFI1 mRNA CTD PMID:20458559 NCBI chr 5:166,606,841...166,620,124
Ensembl chr 5:166,606,834...166,620,432 		JBrowse link
G Esd esterase D increases expression ISO Arsenic Trioxide results in increased expression of ESD mRNA CTD PMID:20458559 NCBI chr15:56,453,082...56,472,582
Ensembl chr15:56,453,044...56,473,508 		JBrowse link
G Esr1 estrogen receptor 1 decreases methylation
increases expression
multiple interactions
decreases expression 		ISO Arsenic Trioxide results in decreased methylation of ESR1 promoter
[Arsenic Trioxide results in increased expression of ESR1 protein] which results in increased expression of GREB1 mRNA; [Arsenic Trioxide results in increased expression of ESR1 protein] which results in increased expression of TFF1 mRNA; Arsenic Trioxide results in increased expression of ESR1 mRNA; Arsenic Trioxide results in increased expression of ESR1 protein
[Arsenic Trioxide results in decreased methylation of ESR1 promoter] which results in increased expression of ESR1 mRNA; [Arsenic Trioxide results in increased expression of ESR1 protein] which results in increased susceptibility to Estradiol; afimoxifene inhibits the reaction [[Arsenic Trioxide results in increased expression of ESR1 protein] which results in increased expression of GREB1 mRNA]; afimoxifene inhibits the reaction [[Arsenic Trioxide results in increased expression of ESR1 protein] which results in increased expression of TFF1 mRNA]; Arsenic Trioxide inhibits the reaction [DNMT1 protein binds to ESR1 promoter]; Arsenic Trioxide promotes the reaction [Estradiol results in decreased expression of ESR1 mRNA]; Arsenic Trioxide promotes the reaction [Estradiol results in decreased expression of ESR1 protein]; Estradiol promotes the reaction [Arsenic Trioxide results in decreased expression of ESR1 mRNA]; Estradiol promotes the reaction [Arsenic Trioxide results in decreased expression of ESR1 protein]; Fulvestrant inhibits the reaction [[Arsenic Trioxide results in increased expression of ESR1 protein] which results in increased expression of GREB1 mRNA]; Fulvestrant inhibits the reaction [[Arsenic Trioxide results in increased expression of ESR1 protein] which results in increased expression of TFF1 mRNA]; S-Adenosylmethionine inhibits the reaction [[Arsenic Trioxide results in increased expression of ESR1 protein] which results in increased expression of GREB1 mRNA]; S-Adenosylmethionine inhibits the reaction [[Arsenic Trioxide results in increased expression of ESR1 protein] which results in increased expression of TFF1 mRNA]; S-Adenosylmethionine inhibits the reaction [Arsenic Trioxide inhibits the reaction [DNMT1 protein binds to ESR1 promoter]]; S-Adenosylmethionine inhibits the reaction [Arsenic Trioxide results in decreased methylation of ESR1 promoter]; S-Adenosylmethionine inhibits the reaction [Arsenic Trioxide results in increased expression of ESR1 mRNA]; S-Adenosylmethionine inhibits the reaction [Arsenic Trioxide results in increased expression of ESR1 protein]
Arsenic Trioxide results in decreased expression of ESR1 mRNA; Arsenic Trioxide results in decreased expression of ESR1 protein
[Arsenic Trioxide co-treated with Tamoxifen] results in decreased methylation of ESR1 gene; [Arsenic Trioxide co-treated with Tamoxifen] results in increased expression of ESR1 mRNA; [Arsenic Trioxide co-treated with Tamoxifen] results in increased expression of ESR1 protein
Arsenic Trioxide results in decreased methylation of ESR1 gene; Arsenic Trioxide results in decreased methylation of ESR1 promoter 		CTD PMID:12014631 PMID:15073043 PMID:15283693 PMID:19088370 PMID:20458559 More... NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354 		JBrowse link
G Esr2 estrogen receptor 2 multiple interactions ISO [Arsenic Trioxide co-treated with Bortezomib] results in decreased expression of ESR2 mRNA CTD PMID:25913414 NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709 		JBrowse link
G Esrp1 epithelial splicing regulatory protein 1 increases expression ISO Arsenic Trioxide results in increased expression of ESRP1 mRNA CTD PMID:27829220 NCBI chr 5:29,224,831...29,279,381
Ensembl chr 5:29,225,360...29,279,278 		JBrowse link
G Esrra estrogen related receptor, alpha decreases expression
multiple interactions 		EXP Arsenic Trioxide results in decreased expression of ESRRA mRNA
Nicorandil inhibits the reaction [Arsenic Trioxide results in decreased expression of ESRRA mRNA] 		CTD PMID:38741475 NCBI chr 1:213,533,309...213,543,432
Ensembl chr 1:213,533,310...213,543,811 		JBrowse link
G Esrrg estrogen-related receptor gamma increases expression ISO Arsenic Trioxide results in increased expression of ESRRG mRNA CTD PMID:20458559 NCBI chr13:101,699,043...102,316,877
Ensembl chr13:101,889,706...102,316,877 		JBrowse link
G Esx1 ESX homeobox 1 increases expression ISO Arsenic Trioxide results in increased expression of ESX1 mRNA CTD PMID:20458559 NCBI chr  X:105,241,568...105,246,733 JBrowse link
G Esyt1 extended synaptotagmin 1 increases expression ISO Arsenic Trioxide results in increased expression of ESYT1 protein CTD PMID:25419056 NCBI chr 7:1,513,381...1,530,836
Ensembl chr 7:1,513,381...1,530,732 		JBrowse link
G Etfa electron transfer flavoprotein subunit alpha increases expression ISO Arsenic Trioxide results in increased expression of ETFA mRNA; Arsenic Trioxide results in increased expression of ETFA protein CTD PMID:22521957 PMID:25419056 PMID:35676786 NCBI chr 8:64,731,192...64,787,965
Ensembl chr 8:64,731,193...64,788,080 		JBrowse link
G Etfb electron transfer flavoprotein subunit beta increases expression ISO Arsenic Trioxide results in increased expression of ETFB protein CTD PMID:25419056 NCBI chr 1:102,988,499...103,002,663
Ensembl chr 1:102,988,499...103,002,659 		JBrowse link
G Ethe1 ETHE1, persulfide dioxygenase decreases expression
decreases response to substance 		ISO Arsenic Trioxide results in decreased expression of ETHE1 mRNA
ETHE1 protein results in decreased susceptibility to Arsenic Trioxide 		CTD PMID:20707922 PMID:27829220 NCBI chr 1:89,311,948...89,327,000
Ensembl chr 1:89,311,934...89,326,998 		JBrowse link
G Ets1 ETS proto-oncogene 1, transcription factor decreases expression ISO Arsenic Trioxide results in decreased expression of ETS1 mRNA CTD PMID:20458559 NCBI chr 8:39,303,936...39,426,022
Ensembl chr 8:39,303,925...39,426,021 		JBrowse link
G Ets2 ETS proto-oncogene 2, transcription factor increases expression ISO Arsenic Trioxide results in increased expression of ETS2 mRNA CTD PMID:20458559 NCBI chr11:48,491,057...48,507,843
Ensembl chr11:48,491,394...48,507,842 		JBrowse link
G Etv3 ETS variant transcription factor 3 increases expression ISO Arsenic Trioxide results in increased expression of ETV3 mRNA CTD PMID:25258189 NCBI chr 2:175,263,389...175,278,217
Ensembl chr 2:175,263,459...175,278,208 		JBrowse link
G Etv4 ETS variant transcription factor 4 decreases expression ISO Arsenic Trioxide results in decreased expression of ETV4 mRNA CTD PMID:20458559 NCBI chr10:87,206,977...87,222,202
Ensembl chr10:87,206,977...87,222,318 		JBrowse link
G Evi2a ecotropic viral integration site 2A increases expression ISO Arsenic Trioxide results in increased expression of EVI2A mRNA CTD PMID:24356939 NCBI chr10:64,983,727...64,987,627
Ensembl chr10:64,983,705...64,999,516 		JBrowse link
G Evl Enah/Vasp-like decreases expression ISO Arsenic Trioxide results in decreased expression of EVL mRNA CTD PMID:15725085 NCBI chr 6:133,238,547...133,358,730
Ensembl chr 6:133,238,547...133,358,729 		JBrowse link
G Evpl envoplakin decreases response to substance ISO EVPL protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr10:101,957,107...101,973,656
Ensembl chr10:101,941,064...101,973,656 		JBrowse link
G Ewsr1 EWS RNA-binding protein 1 increases expression ISO Arsenic Trioxide results in increased expression of EWSR1 protein CTD PMID:25419056 NCBI chr14:84,179,413...84,208,149
Ensembl chr14:84,179,618...84,208,095 		JBrowse link
G Exoc5 exocyst complex component 5 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to EXOC5 protein] CTD PMID:26598702 NCBI chr15:24,788,738...24,834,941
Ensembl chr15:24,790,337...24,834,970 		JBrowse link
G Exog exo/endonuclease G increases expression ISO Arsenic Trioxide results in increased expression of EXOG mRNA CTD PMID:15761015 NCBI chr 8:128,062,688...128,082,529
Ensembl chr 8:128,059,126...128,083,460 		JBrowse link
G Exosc2 exosome component 2 decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of EXOSC2 mRNA
Arsenic Trioxide results in increased expression of EXOSC2 mRNA 		CTD PMID:18231732 PMID:39716349 NCBI chr 3:35,360,652...35,370,948
Ensembl chr 3:35,360,666...35,371,373 		JBrowse link
G Exosc5 exosome component 5 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to EXOSC5 protein] CTD PMID:26598702 NCBI chr 1:90,295,495...90,305,047
Ensembl chr 1:90,293,797...90,305,046 		JBrowse link
G Ext2 exostosin glycosyltransferase 2 decreases expression ISO Arsenic Trioxide results in decreased expression of EXT2 mRNA CTD PMID:39716349 NCBI chr 3:100,120,776...100,253,424
Ensembl chr 3:100,120,776...100,253,596 		JBrowse link
G Eya3 EYA transcriptional coactivator and phosphatase 3 increases expression ISO Arsenic Trioxide results in increased expression of EYA3 mRNA CTD PMID:39716349 NCBI chr 5:150,090,535...150,218,855
Ensembl chr 5:150,137,256...150,218,852 		JBrowse link
G Eya4 EYA transcriptional coactivator and phosphatase 4 decreases expression ISO Arsenic Trioxide results in decreased expression of EYA4 mRNA CTD PMID:26705709 NCBI chr 1:23,991,431...24,235,132
Ensembl chr 1:23,991,431...24,235,131 		JBrowse link
G Ezh2 enhancer of zeste 2 polycomb repressive complex 2 subunit decreases expression
increases expression
multiple interactions
decreases response to substance 		ISO Arsenic Trioxide results in decreased expression of EZH2 mRNA; Arsenic Trioxide results in decreased expression of EZH2 protein
Arsenic Trioxide results in increased expression of EZH2 protein
Arsenic Trioxide inhibits the reaction [EZH2 protein binds to RELA protein]
EZH2 protein results in decreased susceptibility to Arsenic Trioxide 		CTD PMID:26592252 PMID:30612216 PMID:35467087 NCBI chr 4:77,624,223...77,698,598
Ensembl chr 4:77,624,223...77,687,183 		JBrowse link
G Ezr ezrin increases expression ISO Arsenic Trioxide results in increased expression of EZR mRNA; Arsenic Trioxide results in increased expression of EZR protein CTD PMID:22521957 PMID:25419056 NCBI chr 1:49,373,033...49,416,573
Ensembl chr 1:49,373,035...49,416,573 		JBrowse link
G F12 coagulation factor XII decreases response to substance ISO F12 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr17:9,212,819...9,220,664
Ensembl chr17:9,212,819...9,220,664 		JBrowse link
G F13a1 coagulation factor XIII A1 chain increases expression ISO Arsenic Trioxide results in increased expression of F13A1 mRNA CTD PMID:20458559 NCBI chr17:28,021,197...28,197,960
Ensembl chr17:28,020,845...28,197,948 		JBrowse link
G F2r coagulation factor II (thrombin) receptor increases expression ISO Arsenic Trioxide results in increased expression of F2R mRNA CTD PMID:22535156 NCBI chr 2:28,604,066...28,620,579
Ensembl chr 2:28,604,066...28,620,579 		JBrowse link
G F2rl1 F2R like trypsin receptor 1 decreases response to substance
increases expression 		ISO F2RL1 protein results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in increased expression of F2RL1 mRNA 		CTD PMID:20707922 PMID:25258189 NCBI chr 2:28,507,003...28,519,954
Ensembl chr 2:28,507,003...28,519,954 		JBrowse link
G F3 coagulation factor III, tissue factor decreases expression
affects expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of F3 mRNA; Arsenic Trioxide results in decreased expression of F3 protein
Arsenic Trioxide affects the expression of F3 protein
Arsenic Trioxide inhibits the reaction [Tretinoin results in decreased expression of F3 mRNA]; Arsenic Trioxide inhibits the reaction [Tretinoin results in decreased expression of F3 protein]; Arsenic Trioxide results in decreased expression of and results in decreased activity of F3 protein 		CTD PMID:10400422 PMID:10803529 PMID:11721405 PMID:11775254 PMID:11779431 More... NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:212,511,680...212,523,369 		JBrowse link
G F5 coagulation factor V increases expression ISO Arsenic Trioxide results in increased expression of F5 mRNA CTD PMID:20458559 NCBI chr13:79,046,657...79,116,247
Ensembl chr13:79,046,448...79,116,247 		JBrowse link
G F8 coagulation factor VIII multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of F8 protein CTD PMID:15894607 NCBI chr18:155,237...187,186
Ensembl chr18:155,309...186,683 		JBrowse link
G Fa2h fatty acid 2-hydroxylase decreases expression
decreases response to substance 		ISO Arsenic Trioxide results in decreased expression of FA2H mRNA
FA2H protein results in decreased susceptibility to Arsenic Trioxide 		CTD PMID:19128835 PMID:20707922 NCBI chr19:56,222,240...56,273,480
Ensembl chr19:56,222,242...56,273,623 		JBrowse link
G Faap20 FA core complex associated protein 20 multiple interactions
increases expression 		ISO Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of FAAP20 mRNA] CTD PMID:29095437 NCBI chr 5:171,083,328...171,097,599
Ensembl chr 5:171,087,847...171,097,599 		JBrowse link
G Fabp1 fatty acid binding protein 1 decreases expression ISO Arsenic Trioxide results in decreased expression of FABP1 mRNA CTD PMID:39716349 NCBI chr 4:104,744,302...104,753,119
Ensembl chr 4:104,744,309...104,753,113 		JBrowse link
G Fabp2 fatty acid binding protein 2 decreases expression ISO Arsenic Trioxide results in decreased expression of FABP2 mRNA CTD PMID:39716349 NCBI chr 2:213,724,629...213,728,686
Ensembl chr 2:213,724,629...213,728,686 		JBrowse link
G Fabp3 fatty acid binding protein 3 increases expression ISO Arsenic Trioxide results in increased expression of FABP3 mRNA CTD PMID:36801614 NCBI chr 5:147,936,027...147,942,870
Ensembl chr 5:147,936,119...147,942,881 		JBrowse link
G Fabp5 fatty acid binding protein 5 increases expression ISO Arsenic Trioxide results in increased expression of FABP5 mRNA CTD PMID:22521957 NCBI chr 2:93,672,451...93,676,186
Ensembl chr 2:93,672,458...93,676,127 		JBrowse link
G Fabp7 fatty acid binding protein 7 decreases expression ISO Arsenic Trioxide results in decreased expression of FABP7 mRNA CTD PMID:26705709 PMID:35676786 NCBI chr20:37,667,125...37,673,299
Ensembl chr20:37,669,601...37,675,907 		JBrowse link
G Fadd Fas associated via death domain increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of FADD mRNA; Arsenic Trioxide results in increased expression of FADD protein
FAS protein affects the reaction [Arsenic Trioxide results in increased expression of FADD protein] 		CTD PMID:34953944 NCBI chr 1:209,169,245...209,175,423
Ensembl chr 1:209,169,318...209,174,976 		JBrowse link
G Fads3 fatty acid desaturase 3 increases expression ISO Arsenic Trioxide results in increased expression of FADS3 mRNA CTD PMID:39716349 NCBI chr 1:216,110,547...216,127,431
Ensembl chr 1:216,110,201...216,141,758 		JBrowse link
G Fahd2a fumarylacetoacetate hydrolase domain containing 2A increases expression ISO Arsenic Trioxide results in increased expression of FAHD2A mRNA CTD PMID:25258189 NCBI chr 3:135,110,480...135,118,653
Ensembl chr 3:135,109,482...135,118,853 		JBrowse link
G Fam107a family with sequence similarity 107, member A increases expression ISO Arsenic Trioxide results in increased expression of FAM107A mRNA CTD PMID:35676786 NCBI chr15:19,038,726...19,060,644
Ensembl chr15:19,038,616...19,065,219 		JBrowse link
G Fam107b family with sequence similarity 107, member B increases expression ISO Arsenic Trioxide results in increased expression of FAM107B mRNA CTD PMID:24356939 NCBI chr17:79,387,795...79,594,165
Ensembl chr17:79,387,795...79,594,288 		JBrowse link
G Fam110b family with sequence similarity 110, member B increases expression ISO Arsenic Trioxide results in increased expression of FAM110B mRNA CTD PMID:15761015 NCBI chr 5:23,587,093...23,727,188
Ensembl chr 5:23,586,867...23,799,583 		JBrowse link
G Fam117b family with sequence similarity 117, member B increases expression ISO Arsenic Trioxide results in increased expression of FAM117B mRNA CTD PMID:20458559 NCBI chr 9:68,834,334...68,902,543
Ensembl chr 9:68,834,354...68,902,543 		JBrowse link
G Fam120a family with sequence similarity 120 member A increases expression ISO Arsenic Trioxide results in increased expression of FAM120A mRNA CTD PMID:39716349 NCBI chr17:15,890,151...15,981,337
Ensembl chr17:15,890,605...15,981,332 		JBrowse link
G Fam199x family with sequence similarity 199, X-linked decreases expression ISO Arsenic Trioxide results in decreased expression of FAM199X mRNA CTD PMID:39716349 NCBI chr  X:105,176,504...105,212,207
Ensembl chr  X:105,176,504...105,212,207 		JBrowse link
G Fam20c FAM20C, golgi associated secretory pathway kinase decreases expression ISO Arsenic Trioxide results in decreased expression of FAM20C mRNA CTD PMID:22521957 NCBI chr12:20,940,654...20,999,072
Ensembl chr12:20,940,654...20,998,318 		JBrowse link
G Fam217b family with sequence similarity 217, member B decreases expression ISO Arsenic Trioxide results in decreased expression of FAM217B mRNA CTD PMID:39716349 NCBI chr 3:185,883,277...185,892,976
Ensembl chr 3:185,883,367...185,892,974 		JBrowse link
G Fam220a family with sequence similarity 220, member A increases expression ISO Arsenic Trioxide results in increased expression of FAM220A mRNA CTD PMID:39716349 NCBI chr12:16,111,593...16,127,584
Ensembl chr12:16,109,425...16,133,421 		JBrowse link
G Fanca FA complementation group A increases expression ISO Arsenic Trioxide results in increased expression of FANCA mRNA CTD PMID:20458559 NCBI chr19:68,210,562...68,271,080
Ensembl chr19:68,212,643...68,271,019 		JBrowse link
G Fancc FA complementation group C increases expression ISO Arsenic Trioxide results in increased expression of FANCC mRNA CTD PMID:15070760 NCBI chr17:1,686,374...1,818,672
Ensembl chr17:1,687,017...1,835,096 		JBrowse link
G Fancd2 FA complementation group D2 multiple interactions ISO [Arsenic Trioxide results in decreased activity of FANCD2 protein] which results in increased susceptibility to diepoxybutane; [Arsenic Trioxide results in decreased activity of FANCD2 protein] which results in increased susceptibility to Hydroxyurea; [Arsenic Trioxide results in decreased activity of FANCD2 protein] which results in increased susceptibility to Mitomycin CTD PMID:25092648 NCBI chr 4:148,234,633...148,299,035
Ensembl chr 4:148,234,708...148,299,035 		JBrowse link
G Fap fibroblast activation protein, alpha increases expression ISO Arsenic Trioxide results in increased expression of FAP mRNA CTD PMID:25258189 NCBI chr 3:67,547,398...67,616,271
Ensembl chr 3:67,546,921...67,617,601 		JBrowse link
G Fas Fas cell surface death receptor multiple interactions
increases expression
increases response to substance 		ISO [Arsenic Trioxide co-treated with Curcumin] results in increased expression of FAS protein; [sanguinarine co-treated with Arsenic Trioxide] results in increased expression of FAS mRNA; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of FAS protein]; FAS protein affects the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; FAS protein affects the reaction [Arsenic Trioxide results in increased cleavage of CASP8 protein]; FAS protein affects the reaction [Arsenic Trioxide results in increased expression of FADD protein]; FAS protein affects the reaction [Arsenic Trioxide results in increased expression of FAS protein]; FAS protein affects the reaction [Arsenic Trioxide results in increased expression of FASLG protein]; NFKBIA protein inhibits the reaction [Arsenic Trioxide results in increased expression of FAS protein]
Arsenic Trioxide results in increased expression of FAS; Arsenic Trioxide results in increased expression of FAS mRNA; Arsenic Trioxide results in increased expression of FAS protein
FAS results in increased susceptibility to Arsenic Trioxide 		CTD PMID:11135700 PMID:12126518 PMID:12452020 PMID:12478894 PMID:12684647 More... NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104 		JBrowse link
G Faslg Fas ligand multiple interactions
increases expression
decreases expression
affects expression 		ISO [Arsenic Trioxide co-treated with Curcumin] results in increased expression of FASLG protein; [Arsenic Trioxide co-treated with VS-5584] results in increased expression of FASLG mRNA; [sanguinarine co-treated with Arsenic Trioxide] results in increased expression of FASLG mRNA; Arsenic Trioxide promotes the reaction [puerarin results in increased expression of FASLG protein]; Bortezomib promotes the reaction [Arsenic Trioxide results in increased activity of FASLG]; FAS protein affects the reaction [Arsenic Trioxide results in increased expression of FASLG protein]; FOXO3 protein affects the reaction [Arsenic Trioxide results in increased expression of FASLG protein]
Arsenic Trioxide results in increased expression of FASL protein; Arsenic Trioxide results in increased expression of FASLG; Arsenic Trioxide results in increased expression of FASLG mRNA; Arsenic Trioxide results in increased expression of FASLG protein
Arsenic Trioxide results in decreased expression of FASLG mRNA
Arsenic Trioxide affects the expression of FASL protein 		CTD PMID:12684647 PMID:12975549 PMID:17530438 PMID:20416161 PMID:20471514 More... NCBI chr13:76,680,885...76,706,042
Ensembl chr13:76,688,243...76,695,503 		JBrowse link
G Fasn fatty acid synthase decreases expression
increases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of FASN mRNA
Arsenic Trioxide results in increased expression of FASN protein
Taurine inhibits the reaction [Arsenic Trioxide results in decreased expression of FASN mRNA]
[Arsenic Trioxide co-treated with Tretinoin] results in decreased expression of FASN mRNA 		CTD PMID:25419056 PMID:30237538 PMID:38179723 NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583 		JBrowse link
G Fastk Fas-activated serine/threonine kinase decreases expression ISO Arsenic Trioxide results in decreased expression of FASTK mRNA CTD PMID:39716349 NCBI chr 4:11,624,697...11,628,769
Ensembl chr 4:11,624,689...11,629,867 		JBrowse link
G Fat1 FAT atypical cadherin 1 multiple interactions
increases expression 		ISO [Arsenic Trioxide co-treated with Ascorbic Acid] results in increased expression of FAT1 mRNA
Arsenic Trioxide results in increased expression of FAT1 mRNA 		CTD PMID:25555879 NCBI chr16:53,909,759...54,029,175
Ensembl chr16:53,909,556...54,028,609 		JBrowse link
G Fbf1 Fas binding factor 1 increases expression ISO Arsenic Trioxide results in increased expression of FBF1 mRNA CTD PMID:20458559 NCBI chr10:101,874,661...101,900,497
Ensembl chr10:101,874,664...101,900,738 		JBrowse link
G Fbh1 F-box DNA helicase 1 increases expression ISO Arsenic Trioxide results in increased expression of FBH1 mRNA CTD PMID:39716349 NCBI chr17:71,659,351...71,697,431
Ensembl chr17:71,659,249...71,697,432 		JBrowse link
G Fbln1 fibulin 1 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of FBLN1 mRNA
[Arsenic Trioxide co-treated with Ascorbic Acid] results in increased expression of FBLN1 mRNA 		CTD PMID:25555879 NCBI chr 7:118,190,347...118,269,965
Ensembl chr 7:118,190,478...118,269,965 		JBrowse link
G Fbln5 fibulin 5 increases expression ISO Arsenic Trioxide results in increased expression of FBLN5 mRNA CTD PMID:15761015 NCBI chr 6:126,664,100...126,742,847
Ensembl chr 6:126,664,100...126,746,296 		JBrowse link
G Fbn2 fibrillin 2 decreases expression ISO Arsenic Trioxide results in decreased expression of FBN2 protein CTD PMID:15894607 NCBI chr18:53,696,197...53,901,992
Ensembl chr18:53,697,708...53,902,191 		JBrowse link
G Fbp1 fructose-bisphosphatase 1 increases expression
multiple interactions
decreases expression 		ISO Arsenic Trioxide results in increased expression of FBP1 mRNA
Taurine inhibits the reaction [Arsenic Trioxide results in increased expression of FBP1 mRNA]
Arsenic Trioxide results in increased expression of FBP1 protein
Arsenic Trioxide results in decreased expression of FBP1 mRNA 		CTD PMID:19128835 PMID:25419056 PMID:30362509 NCBI chr17:2,212,941...2,235,749
Ensembl chr17:2,213,492...2,235,746 		JBrowse link
G Fbxl4 F-box and leucine-rich repeat protein 4 increases expression ISO Arsenic Trioxide results in increased expression of FBXL4 mRNA CTD PMID:20458559 NCBI chr 5:40,752,513...40,826,154
Ensembl chr 5:40,752,521...40,850,826 		JBrowse link
G Fbxl7 F-box and leucine-rich repeat protein 7 decreases expression ISO Arsenic Trioxide results in decreased expression of FBXL7 mRNA CTD PMID:15725085 NCBI chr 2:78,870,236...79,239,697
Ensembl chr 2:78,871,287...79,239,697 		JBrowse link
G Fbxl8 F-box and leucine-rich repeat protein 8 increases expression ISO Arsenic Trioxide results in increased expression of FBXL8 mRNA CTD PMID:39716349 NCBI chr19:50,048,221...50,057,191
Ensembl chr19:50,052,393...50,057,453 		JBrowse link
G Fbxo25 F-box protein 25 multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of FBXO25 mRNA CTD PMID:15894607 NCBI chr16:82,370,123...82,404,002
Ensembl chr16:82,370,059...82,403,919 		JBrowse link
G Fbxo30 F-box protein 30 increases expression ISO Arsenic Trioxide results in increased expression of FBXO30 mRNA CTD PMID:27829220 NCBI chr 1:7,475,636...7,491,719
Ensembl chr 1:7,475,575...7,493,199 		JBrowse link
G Fbxo32 F-box protein 32 increases expression ISO Arsenic Trioxide results in increased expression of FBXO32 mRNA
Arsenic Trioxide results in increased expression of FBXO32 protein 		CTD PMID:24356939 PMID:32184170 PMID:32635466 NCBI chr 7:91,620,925...91,654,491
Ensembl chr 7:91,620,925...91,654,491 		JBrowse link
G Fbxo38 F-box protein 38 increases expression ISO Arsenic Trioxide results in increased expression of FBXO38 mRNA CTD PMID:39716349 NCBI chr18:58,227,253...58,274,320
Ensembl chr18:58,227,262...58,274,262 		JBrowse link
G Fbxw4 F-box and WD repeat domain containing 4 decreases expression ISO Arsenic Trioxide results in decreased expression of FBXW4 mRNA CTD PMID:39716349 NCBI chr 1:254,375,921...254,465,173
Ensembl chr 1:254,375,923...254,463,277 		JBrowse link
G Fbxw5 F-box and WD repeat domain containing 5 decreases expression ISO Arsenic Trioxide results in decreased expression of FBXW5 mRNA CTD PMID:35676786 NCBI chr 3:28,720,670...28,725,237
Ensembl chr 3:28,720,778...28,725,235 		JBrowse link
G Fbxw7 F-box and WD repeat domain containing 7 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of FBXW7 protein
[Arsenic Trioxide binds to PIN1 protein] affects the reaction [Arsenic Trioxide results in decreased expression of FBXW7 protein]; Arsenic Trioxide promotes the reaction [Tretinoin results in decreased expression of FBXW7 protein]; PIN1 protein affects the reaction [Arsenic Trioxide results in increased expression of FBXW7 protein]; Tretinoin promotes the reaction [Arsenic Trioxide results in decreased expression of FBXW7 protein] 		CTD PMID:24801890 PMID:30093655 PMID:31597699 NCBI chr 2:172,447,738...172,609,591
Ensembl chr 2:172,447,738...172,609,591 		JBrowse link
G Fcer1g Fc epsilon receptor Ig multiple interactions ISO [Arsenic Trioxide co-treated with nilotinib] affects the expression of FCER1G mRNA CTD PMID:28786057 NCBI chr13:86,181,908...86,186,766
Ensembl chr13:86,181,908...86,186,859 		JBrowse link
G Fcgr1a Fc gamma receptor 1A increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of FCGR1A protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide inhibits the reaction [Sirolimus results in decreased expression of FCGR1A protein]]; Arsenic Trioxide inhibits the reaction [Sirolimus results in decreased expression of FCGR1A protein] 		CTD PMID:25758096 NCBI chr 2:186,539,941...186,548,941
Ensembl chr 2:186,539,942...186,548,858 		JBrowse link
G Fcgr3a Fc gamma receptor 3A increases expression ISO Arsenic Trioxide results in increased expression of FCGR3A mRNA CTD PMID:20458559 NCBI chr13:85,782,636...85,792,656
Ensembl chr13:85,782,490...85,792,651 		JBrowse link
G Fcrl5 Fc receptor-like 5 increases expression ISO Arsenic Trioxide results in increased expression of FCRL5 mRNA CTD PMID:20458559 NCBI chr 2:175,179,630...175,211,180
Ensembl chr 2:175,179,690...175,211,039 		JBrowse link
G Fdps farnesyl diphosphate synthase decreases expression ISO Arsenic Trioxide results in decreased expression of FDPS mRNA CTD PMID:27829220 NCBI chr 2:176,795,192...176,804,816
Ensembl chr 2:176,795,192...176,807,136 		JBrowse link
G Fen1 flap structure-specific endonuclease 1 decreases expression ISO Arsenic Trioxide results in decreased expression of FEN1 mRNA CTD PMID:34413873 NCBI chr 1:216,270,016...216,274,873
Ensembl chr 1:216,269,163...216,275,016 		JBrowse link
G Fer FER tyrosine kinase increases expression ISO Arsenic Trioxide results in increased expression of FER mRNA CTD PMID:29633893 NCBI chr 9:110,967,317...111,274,315
Ensembl chr 9:110,967,390...111,274,315 		JBrowse link
G Ferd3l Fer3-like bHLH transcription factor multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to FERD3L protein] CTD PMID:26598702 NCBI chr 6:56,372,778...56,373,667
Ensembl chr 6:56,372,479...56,373,501 		JBrowse link
G Fermt1 FERM domain containing kindlin 1 decreases response to substance ISO FERMT1 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 3:140,624,434...140,666,419
Ensembl chr 3:140,624,434...140,666,419 		JBrowse link
G Fermt2 FERM domain containing kindlin 2 increases expression ISO Arsenic Trioxide results in increased expression of FERMT2 mRNA CTD PMID:27829220 NCBI chr15:21,162,603...21,257,995
Ensembl chr15:21,162,605...21,258,115 		JBrowse link
G Fermt3 FERM domain containing kindlin 3 multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of FERMT3 mRNA CTD PMID:15894607 NCBI chr 1:213,618,691...213,636,889
Ensembl chr 1:213,618,208...213,636,273 		JBrowse link
G Ffar2 free fatty acid receptor 2 decreases expression ISO Arsenic Trioxide results in decreased expression of FFAR2 mRNA CTD PMID:39716349 NCBI chr 1:95,199,277...95,202,599
Ensembl chr 1:95,199,271...95,202,623 		JBrowse link
G Fgf1 fibroblast growth factor 1 decreases expression ISO Arsenic Trioxide results in decreased expression of FGF1 mRNA CTD PMID:21461292 NCBI chr18:30,937,670...31,023,786
Ensembl chr18:30,939,870...30,961,393 		JBrowse link
G Fgf10 fibroblast growth factor 10 decreases expression ISO Arsenic Trioxide results in decreased expression of FGF10 mRNA CTD PMID:26705709 NCBI chr 2:52,533,939...52,610,980
Ensembl chr 2:52,533,939...52,610,980 		JBrowse link
G Fgf12 fibroblast growth factor 12 increases expression ISO Arsenic Trioxide results in increased expression of FGF12 mRNA CTD PMID:22521957 NCBI chr11:85,501,947...86,069,543
Ensembl chr11:85,501,936...86,069,543 		JBrowse link
G Fgf14 fibroblast growth factor 14 decreases expression ISO Arsenic Trioxide results in decreased expression of FGF14 mRNA CTD PMID:26705709 NCBI chr15:107,442,800...108,086,486
Ensembl chr15:107,451,634...108,085,808 		JBrowse link
G Fgf2 fibroblast growth factor 2 multiple interactions
decreases expression 		ISO Arsenic Trioxide inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK1 protein]; Arsenic Trioxide inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK3 protein]
Arsenic Trioxide results in decreased expression of FGF2 mRNA 		CTD PMID:15723287 PMID:22521957 NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:122,164,454...122,224,493 		JBrowse link
G Fgf6 fibroblast growth factor 6 increases expression ISO Arsenic Trioxide results in increased expression of FGF6 mRNA CTD PMID:35676786 NCBI chr 4:161,541,089...161,549,624
Ensembl chr 4:161,541,089...161,553,521 		JBrowse link
G Fgf7 fibroblast growth factor 7 decreases expression ISO Arsenic Trioxide results in decreased expression of FGF7 mRNA CTD PMID:20458559 NCBI chr 3:133,734,557...133,786,678
Ensembl chr 3:133,734,673...133,786,328 		JBrowse link
G Fgfr1 Fibroblast growth factor receptor 1 increases expression
decreases response to substance
multiple interactions
decreases phosphorylation
decreases expression 		ISO Arsenic Trioxide results in increased expression of FGFR1 mRNA
FGFR1 protein results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide promotes the reaction [PD 173074 results in decreased expression of FGFR1 protein]; PD 173074 promotes the reaction [Arsenic Trioxide results in decreased expression of FGFR1 protein]
Arsenic Trioxide results in decreased phosphorylation of FGFR1 protein mutant form
Arsenic Trioxide results in decreased expression of FGFR1 mRNA; Arsenic Trioxide results in decreased expression of FGFR1 protein 		CTD PMID:15761015 PMID:17027752 PMID:17258074 PMID:19128835 PMID:20458559 More... NCBI chr16:73,194,631...73,249,855
Ensembl chr16:73,194,631...73,249,855 		JBrowse link
G Fgfr1op2 FGFR1 oncogene partner 2 increases expression ISO Arsenic Trioxide results in increased expression of FGFR1OP2 mRNA CTD PMID:20458559 NCBI chr 4:181,222,298...181,243,318
Ensembl chr 4:181,222,323...181,243,322 		JBrowse link
G Fgfr2 fibroblast growth factor receptor 2 decreases expression ISO Arsenic Trioxide results in decreased expression of FGFR2 mRNA CTD PMID:15761015 NCBI chr 1:194,175,703...194,280,914
Ensembl chr 1:194,175,705...194,280,914 		JBrowse link
G Fgl1 fibrinogen-like 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to FGL1 protein] CTD PMID:26598702 NCBI chr16:57,824,127...57,854,413
Ensembl chr16:57,824,200...57,854,429 		JBrowse link
G Fgl2 fibrinogen-like 2 decreases expression ISO Arsenic Trioxide results in decreased expression of FGL2 mRNA CTD PMID:19128835 NCBI chr 4:14,602,762...14,608,405
Ensembl chr 4:14,602,771...14,608,405 		JBrowse link
G Fgr FGR proto-oncogene, Src family tyrosine kinase increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of FGR mRNA
[Arsenic Trioxide co-treated with Tretinoin] results in increased expression of FGR mRNA 		CTD PMID:15761015 PMID:38179723 NCBI chr 5:150,473,767...150,503,524
Ensembl chr 5:150,473,792...150,503,169 		JBrowse link
G Fh fumarate hydratase increases expression ISO Arsenic Trioxide results in increased expression of FH mRNA CTD PMID:22521957 NCBI chr13:90,056,565...90,082,450
Ensembl chr13:90,056,570...90,089,627 		JBrowse link
G Fhl1 four and a half LIM domains 1 increases expression ISO Arsenic Trioxide results in increased expression of FHL1 mRNA CTD PMID:17258074 NCBI chr  X:139,592,794...139,652,290
Ensembl chr  X:139,592,604...139,652,282 		JBrowse link
G Fhl2 four and a half LIM domains 2 increases expression ISO Arsenic Trioxide results in increased expression of FHL2 mRNA CTD PMID:26705709 PMID:36801614 NCBI chr 9:52,881,091...52,954,540
Ensembl chr 9:52,880,998...52,923,326 		JBrowse link
G Fhod1 formin homology 2 domain containing 1 decreases expression ISO Arsenic Trioxide results in decreased expression of FHOD1 mRNA CTD PMID:20458559 NCBI chr19:50,116,415...50,135,868
Ensembl chr19:50,116,415...50,135,330 		JBrowse link
G Filip1 filamin A interacting protein 1 increases expression ISO Arsenic Trioxide results in increased expression of FILIP1 mRNA CTD PMID:20458559 NCBI chr 8:89,641,509...89,836,772
Ensembl chr 8:89,644,579...89,802,771 		JBrowse link
G Fkbp11 FKBP prolyl isomerase 11 increases expression ISO Arsenic Trioxide results in increased expression of FKBP11 mRNA CTD PMID:20458559 NCBI chr 7:131,750,828...131,757,784
Ensembl chr 7:131,750,672...131,770,123 		JBrowse link
G Fkbp5 FKBP prolyl isomerase 5 affects expression
multiple interactions 		ISO Arsenic Trioxide affects the expression of FKBP5 mRNA
Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to FKBP5 protein] 		CTD PMID:25873331 PMID:26598702 NCBI chr20:6,458,931...6,577,227
Ensembl chr20:6,458,940...6,543,118 		JBrowse link
G Fkbp7 FKBP prolyl isomerase 7 increases expression ISO Arsenic Trioxide results in increased expression of FKBP7 mRNA CTD PMID:39716349 NCBI chr 3:82,016,647...82,030,913
Ensembl chr 3:82,016,513...82,028,573 		JBrowse link
G Flcn folliculin decreases expression ISO Arsenic Trioxide results in decreased expression of FLCN mRNA CTD PMID:34108876 NCBI chr10:45,088,164...45,107,581
Ensembl chr10:45,088,167...45,107,309 		JBrowse link
G Flna filamin A increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of FLNA mRNA
Arsenic Trioxide results in decreased expression of FLNA mRNA 		CTD PMID:35676786 PMID:39716349 NCBI chr  X:157,159,051...157,185,559
Ensembl chr  X:157,159,051...157,182,343 		JBrowse link
G Flnb filamin B increases expression
decreases expression
decreases response to substance 		ISO Arsenic Trioxide results in increased expression of FLNB protein
Arsenic Trioxide results in decreased expression of FLNB protein
FLNB protein results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in decreased expression of FLNB mRNA 		CTD PMID:20707922 PMID:25419056 PMID:30093655 PMID:39716349 NCBI chr15:19,392,212...19,525,278
Ensembl chr15:19,392,216...19,525,209 		JBrowse link
G Flnc filamin C increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of FLNC mRNA; Arsenic Trioxide results in increased expression of FLNC protein
FLNC protein affects the reaction [Arsenic Trioxide results in increased cleavage of GSDME protein] 		CTD PMID:36801614 NCBI chr 4:58,999,445...59,027,240
Ensembl chr 4:58,999,547...59,027,240 		JBrowse link
G Flrt3 fibronectin leucine rich transmembrane protein 3 decreases expression ISO Arsenic Trioxide results in decreased expression of FLRT3 mRNA CTD PMID:27829220 NCBI chr 3:148,448,115...148,461,458
Ensembl chr 3:148,439,354...148,461,650 		JBrowse link
G Flt1 Fms related receptor tyrosine kinase 1 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of FLT1 mRNA
Arsenic Trioxide results in decreased expression of FLT1 		CTD PMID:15073043 PMID:18161919 NCBI chr12:12,333,050...12,504,750
Ensembl chr12:12,333,430...12,504,750 		JBrowse link
G Flt3 Fms related receptor tyrosine kinase 3 decreases phosphorylation
increases degradation
multiple interactions
increases expression 		ISO Arsenic Trioxide results in decreased phosphorylation of FLT3 protein
Arsenic Trioxide results in increased degradation of FLT3 protein mutant form
Arsenic Trioxide inhibits the reaction [bafilomycin A results in increased expression of FLT3 protein modified form]; Arsenic Trioxide promotes the reaction [SQSTM1 protein binds to FLT3 protein mutant form]; ATG5 protein promotes the reaction [Arsenic Trioxide results in increased degradation of FLT3 protein mutant form]; ATG7 protein promotes the reaction [Arsenic Trioxide results in increased degradation of FLT3 protein mutant form]; bafilomycin A inhibits the reaction [Arsenic Trioxide results in increased degradation of FLT3 protein mutant form]
Arsenic Trioxide results in increased expression of FLT3 gene mutant form 		CTD PMID:17121903 PMID:32284743 PMID:38746032 NCBI chr12:12,660,035...12,735,584
Ensembl chr12:12,659,946...12,735,581 		JBrowse link
G Flt4 Fms related receptor tyrosine kinase 4 decreases expression ISO Arsenic Trioxide results in decreased expression of FLT4 mRNA; Arsenic Trioxide results in decreased expression of FLT4 protein CTD PMID:19099632 PMID:38275666 NCBI chr10:34,414,834...34,455,878
Ensembl chr10:34,414,733...34,456,645 		JBrowse link
G Fmn2 formin 2 increases expression ISO Arsenic Trioxide results in increased expression of FMN2 mRNA CTD PMID:20458559 NCBI chr13:88,986,863...89,303,789
Ensembl chr13:88,986,842...89,303,789 		JBrowse link
G Fmod fibromodulin decreases expression ISO Arsenic Trioxide results in decreased expression of FMOD mRNA CTD PMID:26705709 PMID:35676786 NCBI chr13:48,045,567...48,056,184
Ensembl chr13:47,990,774...48,056,183 		JBrowse link
G Fn1 fibronectin 1 decreases expression
multiple interactions
increases expression 		ISO Arsenic Trioxide results in decreased expression of FN1 protein
[Arsenic Trioxide co-treated with FN1 protein] results in decreased expression of POU5F1 mRNA
Arsenic Trioxide results in increased expression of FN1 mRNA
[Arsenic Trioxide co-treated with apatinib] results in decreased expression of FN1 mRNA 		CTD PMID:17258074 PMID:20458559 PMID:22641096 PMID:30093655 PMID:39223679 NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:80,645,507...80,714,137 		JBrowse link
G Fn3krp fructosamine-3-kinase-related protein increases expression ISO Arsenic Trioxide results in increased expression of FN3KRP mRNA CTD PMID:25555879 NCBI chr10:107,186,695...107,195,419 JBrowse link
G Fnbp1l formin binding protein 1-like decreases expression ISO Arsenic Trioxide results in decreased expression of FNBP1L mRNA CTD PMID:15761015 NCBI chr 2:213,331,871...213,432,821
Ensembl chr 2:213,318,662...213,423,051 		JBrowse link
G Fnbp4 formin binding protein 4 increases expression ISO Arsenic Trioxide results in increased expression of FNBP4 mRNA CTD PMID:20458559 NCBI chr 3:97,188,852...97,218,916
Ensembl chr 3:97,188,884...97,219,435 		JBrowse link
G Fndc1 fibronectin type III domain containing 1 decreases expression ISO Arsenic Trioxide results in decreased expression of FNDC1 mRNA CTD PMID:26705709 NCBI chr 1:49,686,856...49,769,263
Ensembl chr 1:49,686,856...49,769,263 		JBrowse link
G Fndc11 fibronectin type III domain containing 11 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to FNDC11 protein] CTD PMID:26598702 NCBI chr 3:188,708,045...188,710,670
Ensembl chr 3:188,707,334...188,714,164 		JBrowse link
G Fnip1 folliculin interacting protein 1 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of FNIP1 mRNA
[Arsenic Trioxide co-treated with apatinib] results in increased expression of FNIP1 mRNA 		CTD PMID:26705709 PMID:39223679 NCBI chr10:39,068,432...39,151,552
Ensembl chr10:39,068,445...39,151,552 		JBrowse link
G Fnip2 folliculin interacting protein 2 increases expression ISO Arsenic Trioxide results in increased expression of FNIP2 mRNA CTD PMID:27829220 NCBI chr 2:166,894,726...167,006,490
Ensembl chr 2:166,897,075...167,006,055 		JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit decreases expression
increases expression
affects expression
decreases activity
multiple interactions 		ISO
EXP 		Arsenic Trioxide results in decreased expression of FOS mRNA
Arsenic Trioxide results in increased expression of FOS mRNA; Arsenic Trioxide results in increased expression of FOS protein
Arsenic Trioxide affects the expression of FOS mRNA; Arsenic Trioxide affects the expression of FOS protein
Arsenic Trioxide results in decreased activity of FOS protein
[Arsenic Trioxide results in increased phosphorylation of and results in increased activity of FOS protein] promotes the reaction [FOS protein binds to CDKN1A promoter]; [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of FOS protein] promotes the reaction [FOS protein results in increased expression of CDKN1A mRNA]; Arsenic Trioxide promotes the reaction [[FOS protein binds to JUN promoter] which binds to CDKN1A promoter]; Arsenic Trioxide promotes the reaction [[FOS protein binds to JUN protein] which results in increased expression of CDKN1A mRNA]; Arsenic Trioxide promotes the reaction [FOS protein binds to CDKN1A promoter]; Arsenic Trioxide promotes the reaction [MAPK1 protein promotes the reaction [FOS protein binds to CDKN1A promoter]]; Arsenic Trioxide promotes the reaction [MAPK3 protein promotes the reaction [FOS protein binds to CDKN1A promoter]]; Arsenic Trioxide promotes the reaction [nilotinib results in increased expression of FOS mRNA]; Arsenic Trioxide promotes the reaction [nilotinib results in increased expression of FOS protein]; Arsenic Trioxide results in increased expression of and results in increased phosphorylation of FOS protein; Atrazine promotes the reaction [Arsenic Trioxide results in increased expression of FOS mRNA]; U 0126 inhibits the reaction [Arsenic Trioxide results in increased expression of and results in increased phosphorylation of FOS protein]; U 0126 inhibits the reaction [Arsenic Trioxide results in increased expression of FOS mRNA]; U 0126 inhibits the reaction [Arsenic Trioxide results in increased expression of FOS protein] 		CTD PMID:11678611 PMID:12749819 PMID:14682389 PMID:18822310 PMID:19410645 More... NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598 		JBrowse link
G Fosb FosB proto-oncogene, AP-1 transcription factor subunit decreases expression ISO Arsenic Trioxide results in decreased expression of FOSB mRNA CTD PMID:19410645 NCBI chr 1:88,082,324...88,089,506
Ensembl chr 1:88,082,127...88,089,477 		JBrowse link
G Fosl1 FOS like 1, AP-1 transcription factor subunit increases expression ISO Arsenic Trioxide results in increased expression of FOSL1 mRNA CTD PMID:29633893 PMID:36801614 NCBI chr 1:212,183,885...212,192,391
Ensembl chr 1:212,183,833...212,192,391 		JBrowse link
G Foxa1 forkhead box A1 affects methylation
multiple interactions 		ISO Arsenic Trioxide affects the methylation of FOXA1 promoter
[Arsenic Trioxide co-treated with Bortezomib] results in increased expression of FOXA1 mRNA 		CTD PMID:25913414 PMID:26046465 NCBI chr 6:80,838,380...80,871,195
Ensembl chr 6:80,800,960...80,871,191 		JBrowse link
G Foxm1 forkhead box M1 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of FOXM1 mRNA; Arsenic Trioxide results in increased expression of FOXM1 protein
Arsenic Trioxide results in decreased expression of FOXM1 mRNA 		CTD PMID:23255470 PMID:26705709 NCBI chr 4:163,325,628...163,338,100
Ensembl chr 4:163,325,614...163,337,172 		JBrowse link
G Foxo1 forkhead box O1 multiple interactions
increases expression 		ISO Taurine inhibits the reaction [Arsenic Trioxide results in increased expression of FOXO1 mRNA]
[Cisplatin co-treated with Arsenic Trioxide] results in decreased phosphorylation of FOXO1 protein 		CTD PMID:23911876 PMID:29442453 PMID:29944906 PMID:30362509 PMID:34108876 NCBI chr 2:138,462,974...138,541,420
Ensembl chr 2:138,462,697...138,541,419 		JBrowse link
G Foxo3 forkhead box O3 decreases expression
multiple interactions
affects localization
affects response to substance
increases expression 		ISO Arsenic Trioxide results in decreased expression of FOXO3 mRNA
[Arsenic Trioxide co-treated with NVP-BKM120] results in increased expression of FOXO3 mRNA; [Cisplatin co-treated with Arsenic Trioxide] results in decreased phosphorylation of FOXO3 protein; Arsenic Trioxide results in increased expression of and results in decreased phosphorylation of and results in increased localization of FOXO3 protein; Arsenic Trioxide results in increased expression of and results in decreased phosphorylation of FOXO3 protein; Arsenic Trioxide results in increased expression of and results in increased localization of FOXO3 mRNA; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Arsenic Trioxide results in increased expression of FOXO3 protein]; FOXO3 protein affects the reaction [Arsenic Trioxide results in decreased expression of VEGFA protein]; FOXO3 protein affects the reaction [Arsenic Trioxide results in increased expression of FASLG protein]; TNF protein inhibits the reaction [Arsenic Trioxide results in increased expression of FOXO3 mRNA]; TNF protein inhibits the reaction [Arsenic Trioxide results in increased expression of FOXO3 protein]
Arsenic Trioxide affects the localization of FOXO3 protein
FOXO3 protein affects the susceptibility to Arsenic Trioxide
FOXO3 protein affects the reaction [Arsenic Trioxide results in decreased expression of MKI67 protein] 		CTD PMID:22521957 PMID:22988968 PMID:29944906 PMID:31421153 PMID:31539632 NCBI chr20:47,251,968...47,348,254
Ensembl chr20:47,255,878...47,346,845 		JBrowse link
G Foxo4 forkhead box O4 multiple interactions ISO [Arsenic Trioxide co-treated with NVP-BKM120] results in increased expression of FOXO4 mRNA CTD PMID:31539632 NCBI chr  X:70,425,218...70,432,120
Ensembl chr  X:70,425,563...70,432,120 		JBrowse link
G Foxp3 forkhead box P3 increases expression
decreases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of FOXP3 mRNA
Arsenic Trioxide results in decreased expression of FOXP3 mRNA
Arsenic Trioxide results in increased expression of and affects the localization of FOXP3 protein 		CTD PMID:23802174 PMID:29950232 PMID:34108876 NCBI chr  X:17,580,380...17,601,181
Ensembl chr  X:17,580,380...17,595,894 		JBrowse link
G Foxred2 FAD-dependent oxidoreductase domain containing 2 increases expression ISO Arsenic Trioxide results in increased expression of FOXRED2 mRNA CTD PMID:15761015 NCBI chr 7:111,402,322...111,419,056
Ensembl chr 7:111,402,322...111,417,988 		JBrowse link
G Fpgs folylpolyglutamate synthase increases expression ISO Arsenic Trioxide results in increased expression of FPGS mRNA CTD PMID:39716349 NCBI chr 3:36,370,505...36,391,314
Ensembl chr 3:36,370,300...36,391,068 		JBrowse link
G Fpr1 formyl peptide receptor 1 decreases expression ISO Arsenic Trioxide results in decreased expression of FPR1 mRNA CTD PMID:29633893 NCBI chr 1:67,417,991...67,429,813
Ensembl chr 1:67,421,313...67,422,520 		JBrowse link
G Frat1 FRAT regulator of WNT signaling pathway 1 decreases expression ISO Arsenic Trioxide results in decreased expression of FRAT1 mRNA CTD PMID:29633893 NCBI chr 1:250,587,641...250,590,189
Ensembl chr 1:250,587,506...250,603,039 		JBrowse link
G Frk fyn-related Src family tyrosine kinase decreases expression ISO Arsenic Trioxide results in decreased expression of FRK mRNA CTD PMID:15761015 NCBI chr20:39,820,441...39,926,065
Ensembl chr20:39,820,295...39,926,362 		JBrowse link
G Frmd4b FERM domain containing 4B increases expression ISO Arsenic Trioxide results in increased expression of FRMD4B mRNA CTD PMID:35676786 NCBI chr 4:131,452,361...131,778,734
Ensembl chr 4:131,452,365...131,640,287 		JBrowse link
G Fryl FRY like transcription coactivator decreases expression ISO Arsenic Trioxide results in decreased expression of FRYL mRNA CTD PMID:39716349 NCBI chr14:35,307,225...35,545,199
Ensembl chr14:35,310,656...35,545,147 		JBrowse link
G Fscn1 fascin actin-bundling protein 1 decreases expression
multiple interactions
increases expression 		ISO Arsenic Trioxide results in decreased expression of FSCN1 mRNA
[Arsenic Trioxide results in decreased expression of MEG3 protein] promotes the reaction [NQO1 protein binds to FSCN1 protein]; Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to FSCN1 protein]; Arsenic Trioxide promotes the reaction [FSCN1 protein binds to NQO1 protein]; MEG3 inhibits the reaction [Arsenic Trioxide results in increased expression of FSCN1 protein]; NQO1 promotes the reaction [Arsenic Trioxide results in increased expression of FSCN1 protein] 		CTD PMID:15070760 PMID:15761015 PMID:20458559 PMID:26598702 PMID:37424815 NCBI chr12:16,710,601...16,723,734
Ensembl chr12:16,710,601...16,723,734 		JBrowse link
G Fscn2 fascin actin-bundling protein 2, retinal increases expression ISO Arsenic Trioxide results in increased expression of FSCN2 mRNA CTD PMID:39716349 NCBI chr10:106,121,038...106,139,683
Ensembl chr10:106,133,144...106,139,683 		JBrowse link
G Fst follistatin multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to FST protein] CTD PMID:26598702 NCBI chr 2:47,856,345...47,863,670
Ensembl chr 2:47,856,345...47,863,491 		JBrowse link
G Fstl4 follistatin-like 4 multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of FSTL4 mRNA CTD PMID:15894607 NCBI chr10:37,412,288...37,845,405
Ensembl chr10:37,412,288...37,845,393 		JBrowse link
G Fstl5 follistatin-like 5 decreases expression ISO Arsenic Trioxide results in decreased expression of FSTL5 mRNA CTD PMID:26705709 NCBI chr 2:163,156,576...163,825,140
Ensembl chr 2:163,156,576...163,825,140 		JBrowse link
G Fth1 ferritin heavy chain 1 multiple interactions
increases expression
decreases response to substance
decreases expression 		ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to FTH1 protein]
Arsenic Trioxide results in increased expression of FTH1 mRNA
FTH1 protein results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in decreased expression of FTH1 protein 		CTD PMID:14703492 PMID:15725085 PMID:19417148 PMID:20458559 PMID:20707922 More... NCBI chr 1:216,052,037...216,054,325
Ensembl chr 1:216,051,998...216,055,214 		JBrowse link
G Ftl1 ferritin light chain 1 multiple interactions
increases expression 		ISO [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of FTL mRNA
Arsenic Trioxide results in increased expression of FTL mRNA 		CTD PMID:15894607 PMID:20458559 PMID:26705709 NCBI chr 1:105,072,858...105,074,705
Ensembl chr  X:45,399,355...45,399,915
Ensembl chr 2:45,399,355...45,399,915
Ensembl chr 1:45,399,355...45,399,915 		JBrowse link
G Ftmt ferritin mitochondrial increases expression ISO Arsenic Trioxide results in increased expression of FTMT mRNA CTD PMID:20458559 NCBI chr18:47,957,235...47,958,484
Ensembl chr18:47,957,228...47,958,768 		JBrowse link
G Ftsj1 FtsJ RNA 2'-O-methyltransferase 1 decreases expression ISO Arsenic Trioxide results in decreased expression of FTSJ1 mRNA CTD PMID:39716349 NCBI chr  X:16,915,087...16,929,426
Ensembl chr  X:16,916,033...16,923,999 		JBrowse link
G Ftx FTX transcript, XIST regulator affects expression ISO Arsenic Trioxide affects the expression of FTX mRNA CTD PMID:39716349 NCBI chr  X:72,654,112...72,696,097 JBrowse link
G Fubp1 far upstream element binding protein 1 increases response to substance
decreases expression 		ISO FUBP1 protein results in increased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in decreased expression of FUBP1 protein 		CTD PMID:19364129 PMID:20707922 PMID:25419056 NCBI chr 2:243,819,529...243,846,544
Ensembl chr 2:243,819,218...243,846,428 		JBrowse link
G Fuca1 alpha-L-fucosidase 1 increases expression ISO Arsenic Trioxide results in increased expression of FUCA1 mRNA CTD PMID:20458559 NCBI chr 5:153,436,262...153,453,512
Ensembl chr 5:153,436,248...153,453,511 		JBrowse link
G Fut11 fucosyltransferase 11 decreases expression ISO Arsenic Trioxide results in decreased expression of POFUT4 mRNA CTD PMID:27829220 NCBI chr15:3,648,022...3,651,582
Ensembl chr15:3,643,009...3,651,610 		JBrowse link
G Fut4 fucosyltransferase 4 decreases expression ISO Arsenic Trioxide results in decreased expression of FUT4 protein CTD PMID:29767511 NCBI chr 8:19,868,178...19,872,139
Ensembl chr 8:19,868,079...19,872,436 		JBrowse link
G Fut4-ps1 fucosyltransferase 4, pseudogene 1 increases expression ISO Arsenic Trioxide results in increased expression of FUT6 mRNA CTD PMID:20458559 NCBI chr 9:1,656,732...1,659,085 JBrowse link
G Fut7 fucosyltransferase 7 increases expression ISO Arsenic Trioxide results in increased expression of FUT7 mRNA CTD PMID:20458559 NCBI chr 3:28,635,913...28,640,407
Ensembl chr 3:28,637,107...28,641,388 		JBrowse link
G Fut8 fucosyltransferase 8 increases expression ISO Arsenic Trioxide results in increased expression of FUT8 mRNA CTD PMID:35676786 NCBI chr 6:101,682,354...101,909,784
Ensembl chr 6:101,683,007...101,909,775 		JBrowse link
G Fv1 Friend virus susceptibility 1 affects expression ISO Arsenic Trioxide affects the expression of C19ORF48P mRNA CTD PMID:39716349 NCBI chr 1:103,867,358...103,873,336
Ensembl chr 1:103,867,373...103,873,342 		JBrowse link
G Fyb1 FYN binding protein 1 increases expression ISO Arsenic Trioxide results in increased expression of FYB1 mRNA CTD PMID:15761015 NCBI chr 2:57,360,084...57,508,609
Ensembl chr 2:57,360,096...57,508,608 		JBrowse link
G Fyco1 FYVE and coiled-coil domain autophagy adaptor 1 increases expression ISO Arsenic Trioxide results in increased expression of FYCO1 protein CTD PMID:25419056 NCBI chr 8:132,289,538...132,356,810
Ensembl chr 8:132,289,539...132,356,451 		JBrowse link
G Fzd1 frizzled class receptor 1 decreases expression ISO Arsenic Trioxide results in decreased expression of FZD1 mRNA CTD PMID:20458559 NCBI chr 4:30,265,074...30,269,472
Ensembl chr 4:30,247,228...30,833,176 		JBrowse link
G Fzd3 frizzled class receptor 3 increases expression ISO Arsenic Trioxide results in increased expression of FZD3 mRNA CTD PMID:39716349 NCBI chr15:43,596,962...43,664,047
Ensembl chr15:43,596,965...43,663,960 		JBrowse link
G Fzd5 frizzled class receptor 5 increases expression ISO Arsenic Trioxide results in increased expression of FZD5 mRNA CTD PMID:22521957 NCBI chr 9:73,606,860...73,614,039
Ensembl chr 9:73,606,860...73,618,612 		JBrowse link
G G0s2 G0/G1switch 2 increases expression ISO Arsenic Trioxide results in increased expression of G0S2 mRNA CTD PMID:29633893 NCBI chr13:107,335,036...107,335,948
Ensembl chr13:107,335,036...107,336,293 		JBrowse link
G G3bp2 G3BP stress granule assembly factor 2 multiple interactions
decreases expression 		ISO [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of G3BP2 protein
Arsenic Trioxide results in decreased expression of G3BP2 protein 		CTD PMID:15894607 NCBI chr14:16,216,684...16,304,828
Ensembl chr14:16,248,744...16,304,823 		JBrowse link
G G6pc1 glucose-6-phosphatase catalytic subunit 1 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of G6PC1 mRNA
Plant Extracts inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic Trioxide] which results in decreased expression of G6PC1 protein]; Taurine inhibits the reaction [Arsenic Trioxide results in increased expression of G6PC1 mRNA] 		CTD PMID:30362509 PMID:32226249 PMID:35226250 NCBI chr10:86,807,659...86,819,023
Ensembl chr10:86,757,899...86,818,033 		JBrowse link
G G6pc3 glucose 6 phosphatase catalytic subunit 3 increases expression ISO Arsenic Trioxide results in increased expression of G6PC3 mRNA CTD PMID:25258189 NCBI chr10:87,647,149...87,651,385
Ensembl chr10:87,647,062...87,653,453 		JBrowse link
G G6pd glucose-6-phosphate dehydrogenase multiple interactions
decreases response to substance
decreases expression
increases expression 		ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to G6PD protein]
G6PD protein results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in decreased expression of G6PD protein
Plant Extracts inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic Trioxide] which results in decreased expression of G6PD protein]
Arsenic Trioxide results in increased expression of G6PD mRNA 		CTD PMID:20707922 PMID:25419056 PMID:26598702 PMID:32226249 PMID:39716349 NCBI chr  X:157,352,364...157,372,144
Ensembl chr  X:157,352,373...157,372,144 		JBrowse link
G Gabarapl2 GABA type A receptor associated protein like 2 increases expression ISO Arsenic Trioxide results in increased expression of GABARAPL2 mRNA CTD PMID:20458559 NCBI chr19:56,819,826...56,830,662
Ensembl chr19:56,819,791...56,830,660 		JBrowse link
G Gabbr1 gamma-aminobutyric acid type B receptor subunit 1 decreases expression ISO Arsenic Trioxide results in decreased expression of GABBR1 mRNA CTD PMID:18231732 NCBI chr20:1,469,779...1,499,352
Ensembl chr20:1,469,779...1,498,607 		JBrowse link
G Gabbr2 gamma-aminobutyric acid type B receptor subunit 2 decreases expression ISO Arsenic Trioxide results in decreased expression of GABBR2 mRNA
Arsenic Trioxide results in decreased expression of GABBR2 mRNA; Arsenic Trioxide results in decreased expression of GABBR2 protein 		CTD PMID:15761015 PMID:37402917 NCBI chr 5:65,743,073...66,083,695
Ensembl chr 5:65,743,073...66,083,695 		JBrowse link
G Gabpb2 GA binding protein transcription factor subunit beta 2 decreases expression ISO Arsenic Trioxide results in decreased expression of GABPB2 mRNA CTD PMID:12852829 NCBI chr 2:185,444,309...185,484,200
Ensembl chr 2:185,450,296...185,483,589 		JBrowse link
G Gabra1 gamma-aminobutyric acid type A receptor subunit alpha 1 increases expression ISO Arsenic Trioxide results in increased expression of GABRA1 mRNA CTD PMID:20458559 NCBI chr10:27,096,731...27,152,563
Ensembl chr10:27,096,740...27,152,442 		JBrowse link
G Gabrb3 gamma-aminobutyric acid type A receptor subunit beta 3 increases expression ISO Arsenic Trioxide results in increased expression of GABRB3 mRNA CTD PMID:26705709 NCBI chr 1:117,602,772...117,838,230
Ensembl chr 1:117,431,842...117,836,725 		JBrowse link
G Gabre gamma-aminobutyric acid type A receptor subunit epsilon decreases expression ISO Arsenic Trioxide results in decreased expression of GABRE mRNA CTD PMID:22521957 NCBI chr  X:155,102,078...155,120,821
Ensembl chr  X:155,102,083...155,120,735 		JBrowse link
G Gabrr1 gamma-aminobutyric acid type A receptor subunit rho 1 decreases expression ISO Arsenic Trioxide results in decreased expression of GABRR1 mRNA CTD PMID:26705709 NCBI chr 5:52,320,475...52,357,549
Ensembl chr 5:52,320,475...52,357,549 		JBrowse link
G Gad2 glutamate decarboxylase 2 decreases expression ISO Arsenic Trioxide results in decreased expression of GAD2 mRNA; Arsenic Trioxide results in decreased expression of GAD2 protein CTD PMID:37402917 NCBI chr17:89,671,718...89,734,246
Ensembl chr17:89,671,716...89,941,089 		JBrowse link
G Gadd45a growth arrest and DNA-damage-inducible, alpha decreases methylation
increases expression
decreases expression
affects expression
multiple interactions 		ISO
EXP 		Arsenic Trioxide results in decreased methylation of GADD45A promoter
Arsenic Trioxide results in increased expression of GADD45A mRNA; Arsenic Trioxide results in increased expression of GADD45A protein
Arsenic Trioxide results in decreased expression of GADD45A mRNA
Arsenic Trioxide affects the expression of GADD45A mRNA
Atrazine promotes the reaction [Arsenic Trioxide results in increased expression of GADD45A mRNA] 		CTD PMID:11678611 PMID:15493360 PMID:15761015 PMID:17374990 PMID:17530438 More... NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:97,484,502...97,486,807 		JBrowse link
G Gadd45b growth arrest and DNA-damage-inducible, beta increases expression ISO Arsenic Trioxide results in increased expression of GADD45B mRNA CTD PMID:25258189 NCBI chr 7:9,428,689...9,430,991
Ensembl chr 7:9,428,689...9,430,718 		JBrowse link
G Gak cyclin G associated kinase increases expression ISO Arsenic Trioxide results in increased expression of GAK mRNA CTD PMID:20458559 NCBI chr14:1,234,272...1,308,492
Ensembl chr14:1,234,266...1,323,974 		JBrowse link
G Gale UDP-galactose-4-epimerase multiple interactions
increases expression 		ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GALE protein]
Arsenic Trioxide results in increased expression of GALE protein 		CTD PMID:19364129 PMID:26598702 NCBI chr 5:153,477,420...153,481,926
Ensembl chr 5:153,478,325...153,481,922 		JBrowse link
G Galk1 galactokinase 1 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of GALK1 protein
Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GALK1 protein] 		CTD PMID:19364129 PMID:26598702 NCBI chr10:101,742,067...101,746,244
Ensembl chr10:101,735,061...101,746,258 		JBrowse link
G Galk2 galactokinase 2 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GALK2 protein] CTD PMID:26598702 NCBI chr 3:133,563,524...133,696,423
Ensembl chr 3:133,563,538...133,696,528 		JBrowse link
G Galm galactose mutarotase multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of GALM mRNA CTD PMID:15894607 NCBI chr 6:20,589,775...20,641,516
Ensembl chr 6:20,589,776...20,644,417 		JBrowse link
G Galnt12 polypeptide N-acetylgalactosaminyltransferase 12 decreases expression ISO Arsenic Trioxide results in decreased expression of GALNT12 mRNA CTD PMID:19128835 NCBI chr 5:66,180,171...66,208,931
Ensembl chr 5:66,180,164...66,208,938 		JBrowse link
G Galnt18 polypeptide N-acetylgalactosaminyltransferase 18 increases expression ISO Arsenic Trioxide results in increased expression of GALNT18 mRNA CTD PMID:20458559 NCBI chr 1:175,027,832...175,338,883
Ensembl chr 1:175,027,839...175,338,883 		JBrowse link
G Galnt3 polypeptide N-acetylgalactosaminyltransferase 3 increases expression ISO Arsenic Trioxide results in increased expression of GALNT3 mRNA CTD PMID:20458559 NCBI chr 3:71,150,559...71,187,321
Ensembl chr 3:71,150,571...71,174,323 		JBrowse link
G Ganab glucosidase II alpha subunit increases expression ISO Arsenic Trioxide results in increased expression of GANAB protein CTD PMID:19364129 NCBI chr 1:215,222,918...215,242,808
Ensembl chr 1:215,222,995...215,243,036 		JBrowse link
G Gap43 growth associated protein 43 decreases expression ISO Arsenic Trioxide results in decreased expression of GAP43 mRNA CTD PMID:26705709 NCBI chr11:71,882,131...71,975,799
Ensembl chr11:71,882,131...71,975,797 		JBrowse link
G Gapdh glyceraldehyde-3-phosphate dehydrogenase decreases activity
multiple interactions
increases expression
decreases expression 		ISO Arsenic Trioxide results in decreased activity of GAPDH protein
[Ascorbic Acid co-treated with Arsenic Trioxide] results in decreased expression of GAPDH protein; Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GAPDH protein]; Arsenic Trioxide promotes the reaction [Ascorbic Acid results in decreased expression of GAPDH mRNA]; Ascorbic Acid promotes the reaction [Arsenic Trioxide results in decreased expression of GAPDH mRNA]; Ascorbic Acid promotes the reaction [Arsenic Trioxide results in decreased expression of GAPDH protein]
Arsenic Trioxide results in increased expression of GAPDH mRNA
Arsenic Trioxide results in decreased expression of GAPDH mRNA; Arsenic Trioxide results in decreased expression of GAPDH protein 		CTD PMID:15916724 PMID:26598702 PMID:35676786 PMID:38160894 NCBI chr 4:159,648,592...159,653,436
Ensembl chr 4:159,648,592...159,653,377 		JBrowse link
G Garem1 GRB2 associated regulator of MAPK1 subtype 1 decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of GAREM mRNA
Arsenic Trioxide results in increased expression of GAREM1 mRNA 		CTD PMID:26705709 PMID:39716349 NCBI chr18:12,695,082...12,860,219
Ensembl chr18:12,695,082...12,860,219 		JBrowse link
G Garnl3 GTPase activating Rap/RanGAP domain-like 3 increases expression ISO Arsenic Trioxide results in increased expression of GARNL3 mRNA CTD PMID:20458559 NCBI chr 3:36,686,388...36,830,011
Ensembl chr 3:36,686,389...36,830,020 		JBrowse link
G Gars1 glycyl-tRNA synthetase 1 increases expression ISO Arsenic Trioxide results in increased expression of GARS1 mRNA CTD PMID:20458559 NCBI chr 4:85,484,939...85,542,876
Ensembl chr 4:85,493,753...85,542,876 		JBrowse link
G Gart phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase decreases expression
increases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of GART protein
Arsenic Trioxide results in increased expression of GART mRNA; Arsenic Trioxide results in increased expression of GART protein
Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GART protein] 		CTD PMID:19364129 PMID:22521957 PMID:25419056 PMID:26598702 NCBI chr11:44,351,841...44,377,086
Ensembl chr11:44,351,851...44,377,086 		JBrowse link
G Gas1 growth arrest-specific 1 decreases expression ISO Arsenic Trioxide results in decreased expression of GAS1 mRNA CTD PMID:26705709 NCBI chr17:4,487,716...4,490,701
Ensembl chr17:4,484,283...4,497,657 		JBrowse link
G Gas2 growth arrest-specific 2 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GAS2 protein] CTD PMID:26598702 NCBI chr 1:110,587,952...110,721,572
Ensembl chr 1:110,717,312...110,718,541 		JBrowse link
G Gas7 growth arrest specific 7 multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of GAS7 mRNA CTD PMID:15894607 NCBI chr10:52,651,690...52,882,244
Ensembl chr10:52,651,690...52,882,244 		JBrowse link
G Gata1 GATA binding protein 1 decreases expression ISO Arsenic Trioxide results in decreased expression of GATA1 protein CTD PMID:16360329 NCBI chr  X:17,193,291...17,209,462
Ensembl chr  X:17,201,633...17,209,459 		JBrowse link
G Gata2 GATA binding protein 2 affects methylation
increases expression 		ISO Arsenic Trioxide affects the methylation of GATA2 promoter
Arsenic Trioxide results in increased expression of GATA2 protein 		CTD PMID:16360329 PMID:26046465 NCBI chr 4:122,211,501...122,225,058
Ensembl chr 4:122,211,829...122,225,055 		JBrowse link
G Gata3 GATA binding protein 3 multiple interactions ISO Arsenic Trioxide inhibits the reaction [GATA3 protein binds to IL13 promoter]; Arsenic Trioxide inhibits the reaction [GATA3 protein binds to KPNA2 protein] CTD PMID:19080345 NCBI chr17:73,544,234...73,575,670
Ensembl chr17:73,553,548...73,575,670 		JBrowse link
G Gata4 GATA binding protein 4 increases expression ISO
EXP 		Arsenic Trioxide results in increased expression of GATA4 mRNA
Arsenic Trioxide results in increased expression of GATA4 protein 		CTD PMID:29767511 PMID:31734849 NCBI chr15:41,635,572...41,707,252
Ensembl chr15:41,635,572...41,681,609 		JBrowse link
G Gata6 GATA binding protein 6 increases expression ISO Arsenic Trioxide results in increased expression of GATA6 mRNA CTD PMID:29767511 NCBI chr18:2,460,909...2,492,322
Ensembl chr18:2,458,253...2,492,322 		JBrowse link
G Gba1 glucosylceramidase beta 1 increases expression ISO Arsenic Trioxide results in increased expression of GBA1 mRNA CTD PMID:15761015 NCBI chr 2:176,902,141...176,916,015
Ensembl chr 2:176,907,154...176,916,985 		JBrowse link
G Gbe1 1,4-alpha-glucan branching enzyme 1 decreases expression ISO Arsenic Trioxide results in decreased expression of GBE1 mRNA CTD PMID:35676786 NCBI chr11:22,181,194...22,446,640
Ensembl chr11:22,181,103...22,446,638 		JBrowse link
G Gbp5 guanylate binding protein 5 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GBP5 protein] CTD PMID:26598702 NCBI chr 2:233,910,999...233,930,320
Ensembl chr 2:233,902,113...233,930,826 		JBrowse link
G Gca grancalcin decreases expression ISO Arsenic Trioxide results in decreased expression of GCA mRNA CTD PMID:39716349 NCBI chr 3:67,705,874...67,738,475
Ensembl chr 3:67,705,890...67,737,387 		JBrowse link
G Gcc2 GRIP and coiled-coil domain containing 2 increases expression ISO Arsenic Trioxide results in increased expression of GCC2 mRNA CTD PMID:22521957 NCBI chr20:26,788,472...26,836,728
Ensembl chr20:26,790,516...26,836,726 		JBrowse link
G Gck glucokinase multiple interactions
decreases expression 		ISO Plant Extracts inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic Trioxide] which results in decreased activity of GCK protein]; Taurine inhibits the reaction [Arsenic Trioxide results in decreased expression of GCK mRNA]
Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GCK protein] 		CTD PMID:26598702 PMID:30362509 PMID:32226249 NCBI chr14:84,999,019...85,041,098
Ensembl chr14:84,999,020...85,040,949 		JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit decreases response to substance
increases expression
decreases expression
multiple interactions 		ISO GCLC protein results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in increased expression of GCLC mRNA
Arsenic Trioxide results in decreased expression of GCLC protein
Arsenic Trioxide results in increased expression of GCLC mRNA; Arsenic Trioxide results in increased expression of GCLC protein
NFE2L2 protein affects the reaction [Arsenic Trioxide results in increased expression of GCLC mRNA]
[Arsenic Trioxide results in increased abundance of Arsenic] which results in increased expression of GCLC mRNA; [Arsenic Trioxide results in increased abundance of Arsenic] which results in increased expression of GCLC protein 		CTD PMID:19417148 PMID:20707922 PMID:22521957 PMID:23426167 PMID:25341331 More... NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893 		JBrowse link
G Gclm glutamate cysteine ligase, modifier subunit multiple interactions
increases expression
decreases expression 		ISO [Arsenic Trioxide results in increased abundance of Arsenic] which results in increased expression of GCLM mRNA; [Arsenic Trioxide results in increased abundance of Arsenic] which results in increased expression of GCLM protein; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of GCLM mRNA]; Arsenic Trioxide promotes the reaction [nilotinib results in increased expression of GCLM mRNA]; Ethionamide inhibits the reaction [Arsenic Trioxide results in increased expression of GCLM mRNA]
Arsenic Trioxide results in decreased expression of GCLM protein 		CTD PMID:15725085 PMID:19128835 PMID:19350554 PMID:19417148 PMID:23883479 More... NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:213,031,838...213,055,003 		JBrowse link
G Gcnt3 glucosaminyl (N-acetyl) transferase 3, mucin type decreases response to substance
multiple interactions
decreases expression
increases expression 		ISO GCNT3 protein results in decreased susceptibility to Arsenic Trioxide
Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of GCNT3 mRNA]
Arsenic Trioxide results in decreased expression of GCNT3 mRNA 		CTD PMID:20707922 PMID:21461292 PMID:29095437 NCBI chr 8:79,570,081...79,577,389
Ensembl chr 8:79,566,753...79,581,595 		JBrowse link
G Gda guanine deaminase decreases expression ISO Arsenic Trioxide results in decreased expression of GDA mRNA CTD PMID:21461292 PMID:27829220 NCBI chr 1:228,333,401...228,408,901
Ensembl chr 1:228,333,364...228,409,348 		JBrowse link
G Gde1 glycerophosphodiester phosphodiesterase 1 decreases response to substance ISO GDE1 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 1:182,451,182...182,466,569
Ensembl chr 1:182,451,184...182,466,772 		JBrowse link
G Gdf15 growth differentiation factor 15 increases expression ISO Arsenic Trioxide results in increased expression of GDF15 mRNA CTD PMID:19036111 PMID:25258189 PMID:26705709 PMID:27829220 NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,838,436...18,842,022 		JBrowse link
G Gdi1 GDP dissociation inhibitor 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GDI1 protein] CTD PMID:26598702 NCBI chr  X:157,238,900...157,245,562
Ensembl chr  X:157,238,892...157,245,560 		JBrowse link
G Gdi2 GDP dissociation inhibitor 2 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GDI2 protein] CTD PMID:26598702 NCBI chr17:71,559,460...71,586,147
Ensembl chr17:71,559,461...71,586,147 		JBrowse link
G Gdnf glial cell derived neurotrophic factor increases expression ISO Arsenic Trioxide results in increased expression of GDNF mRNA CTD PMID:20458559 NCBI chr 2:58,621,327...58,647,242
Ensembl chr 2:58,621,327...58,647,240 		JBrowse link
G Get3 guided entry of tail-anchored proteins factor 3, ATPase increases expression ISO Arsenic Trioxide results in increased expression of GET3 mRNA; Arsenic Trioxide results in increased expression of GET3 protein CTD PMID:27736728 NCBI chr19:40,034,675...40,043,064
Ensembl chr19:40,034,967...40,043,061 		JBrowse link
G Gfod1 Gfo/Idh/MocA-like oxidoreductase domain containing 1 increases expression ISO Arsenic Trioxide results in increased expression of GFOD1 mRNA CTD PMID:39716349 NCBI chr17:21,606,090...21,710,922
Ensembl chr17:21,605,415...21,710,920 		JBrowse link
G Gfus GDP-L-fucose synthase multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GFUS protein] CTD PMID:26598702 NCBI chr 7:109,492,808...109,497,719
Ensembl chr 7:109,492,809...109,497,662 		JBrowse link
G Gga1 golgi associated, gamma adaptin ear containing, ARF binding protein 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GGA1 protein] CTD PMID:26598702 NCBI chr 7:112,316,530...112,332,249
Ensembl chr 7:112,315,449...112,332,249 		JBrowse link
G Gga3 golgi associated, gamma adaptin ear containing, ARF binding protein 3 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GGA3 protein] CTD PMID:26598702 NCBI chr10:101,324,378...101,342,373
Ensembl chr10:101,324,378...101,342,373 		JBrowse link
G Ggh gamma-glutamyl hydrolase increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of GGH mRNA
Arsenic Trioxide results in decreased expression of GGH mRNA 		CTD PMID:25258189 PMID:39716349 NCBI chr 5:38,326,747...38,349,655
Ensembl chr 5:38,326,594...38,349,647 		JBrowse link
G Ggt1 gamma-glutamyltransferase 1 multiple interactions
increases secretion 		EXP Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased secretion of GGT1 protein] CTD PMID:24634002 NCBI chr20:13,074,141...13,103,551
Ensembl chr20:13,074,141...13,088,050 		JBrowse link
G Gh1 growth hormone 1 multiple interactions
increases response to substance
decreases expression 		ISO
EXP 		GH1 protein promotes the reaction [Arsenic Trioxide results in decreased activity of MMP9 protein]; GH1 protein promotes the reaction [Arsenic Trioxide results in decreased expression of BCL2 mRNA]; GH1 protein promotes the reaction [Arsenic Trioxide results in decreased expression of BIRC5 mRNA]; GH1 protein promotes the reaction [Arsenic Trioxide results in decreased expression of CDH1 mRNA]; GH1 protein promotes the reaction [Arsenic Trioxide results in decreased expression of MMP2 mRNA]; GH1 protein promotes the reaction [Arsenic Trioxide results in decreased expression of MMP9 mRNA]; GH1 protein promotes the reaction [Arsenic Trioxide results in decreased expression of PLAU mRNA]; GH1 protein promotes the reaction [Arsenic Trioxide results in decreased expression of PLAUR mRNA]; GH1 protein promotes the reaction [Arsenic Trioxide results in decreased expression of TERT mRNA]; GH1 protein promotes the reaction [Arsenic Trioxide results in increased expression of BAX mRNA]; GH1 protein promotes the reaction [Arsenic Trioxide results in increased expression of CDKN2A mRNA]; GH1 protein promotes the reaction [Arsenic Trioxide results in increased expression of MYC mRNA]; GH1 protein promotes the reaction [Arsenic Trioxide results in increased expression of PMAIP1 mRNA]; GH1 protein promotes the reaction [Arsenic Trioxide results in increased expression of TP53 mRNA]
GH1 protein results in increased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in decreased expression of GH1 protein 		CTD PMID:23851143 PMID:31258454 NCBI chr10:91,727,883...91,729,860
Ensembl chr10:91,727,884...91,729,859 		JBrowse link
G Gigyf2 GRB10 interacting GYF protein 2 increases expression ISO Arsenic Trioxide results in increased expression of GIGYF2 mRNA CTD PMID:20458559 NCBI chr 9:95,449,143...95,574,927
Ensembl chr 9:95,449,167...95,574,927 		JBrowse link
G Gimap6 GTPase, IMAP family member 6 increases expression ISO Arsenic Trioxide results in increased expression of GIMAP6 mRNA CTD PMID:15761015 NCBI chr 4:78,984,597...78,990,006
Ensembl chr 4:78,983,504...78,990,010 		JBrowse link
G Gimd1 GIMAP family P-loop NTPase domain containing 1 decreases expression ISO Arsenic Trioxide results in decreased expression of GIMD1 mRNA CTD PMID:39716349 NCBI chr 2:223,777,876...223,812,582
Ensembl chr 2:223,777,889...223,812,576 		JBrowse link
G Gipc1 GIPC PDZ domain containing family, member 1 decreases response to substance ISO GIPC1 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr19:41,380,125...41,392,078
Ensembl chr19:41,380,125...41,391,725 		JBrowse link
G Git2 GIT ArfGAP 2 increases expression ISO Arsenic Trioxide results in increased expression of GIT2 mRNA CTD PMID:15761015 NCBI chr12:47,490,350...47,531,232
Ensembl chr12:47,490,369...47,533,250 		JBrowse link
G Gja1 gap junction protein, alpha 1 decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of GJA1 mRNA
acetylleucyl-leucyl-norleucinal inhibits the reaction [Arsenic Trioxide results in decreased expression of GJA1 mRNA]; leupeptin inhibits the reaction [Arsenic Trioxide results in decreased expression of GJA1 mRNA] 		CTD PMID:15070760 PMID:15761015 PMID:17559834 NCBI chr20:36,302,490...36,315,010
Ensembl chr20:36,302,352...36,319,689 		JBrowse link
G Gja4 gap junction protein, alpha 4 decreases expression EXP Arsenic Trioxide results in decreased expression of GJA4 protein CTD PMID:17559834 NCBI chr 5:144,917,791...144,920,324
Ensembl chr 5:144,914,147...144,921,216 		JBrowse link
G Gja5 gap junction protein, alpha 5 decreases expression EXP Arsenic Trioxide results in decreased expression of GJA5 protein CTD PMID:17559834 NCBI chr 2:187,291,227...187,310,770
Ensembl chr 2:187,234,674...187,318,512 		JBrowse link
G Gja8 gap junction protein, alpha 8 increases expression ISO Arsenic Trioxide results in increased expression of GJA8 mRNA CTD PMID:20458559 NCBI chr 2:187,179,668...187,181,284
Ensembl chr 2:187,175,507...187,186,167 		JBrowse link
G Gjb3 gap junction protein, beta 3 decreases response to substance ISO GJB3 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 5:144,933,692...144,939,435
Ensembl chr 5:144,933,696...144,940,280 		JBrowse link
G Gkn1 gastrokine 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GKN1 protein] CTD PMID:26598702 NCBI chr 4:121,347,417...121,352,705
Ensembl chr 4:121,347,417...121,352,830 		JBrowse link
G Gla galactosidase, alpha increases expression ISO Arsenic Trioxide results in increased expression of GLA mRNA CTD PMID:17547211 NCBI chr  X:102,062,497...102,073,915
Ensembl chr  X:102,056,718...102,073,915 		JBrowse link
G Glb1 galactosidase, beta 1 increases activity
increases expression
multiple interactions 		ISO
EXP 		Arsenic Trioxide results in increased activity of GLB1 protein
Arsenic Trioxide results in increased expression of GLB1 protein
pyrazolanthrone inhibits the reaction [Arsenic Trioxide results in increased activity of GLB1 protein]; pyrazolanthrone promotes the reaction [SB 203580 inhibits the reaction [Arsenic Trioxide results in increased activity of GLB1 protein]]; SB 203580 inhibits the reaction [Arsenic Trioxide results in increased activity of GLB1 protein]; SB 203580 promotes the reaction [pyrazolanthrone inhibits the reaction [Arsenic Trioxide results in increased activity of GLB1 protein]] 		CTD PMID:31734849 PMID:36801614 NCBI chr 8:122,963,718...123,036,326
Ensembl chr 8:122,963,718...123,036,326 		JBrowse link
G Gli1 GLI family zinc finger 1 decreases expression
increases response to substance
multiple interactions 		ISO
EXP 		Arsenic Trioxide results in decreased expression of GLI1 mRNA; Arsenic Trioxide results in decreased expression of GLI1 protein
GLI1 protein results in increased susceptibility to Arsenic Trioxide
[Arsenic Trioxide co-treated with Curcumin] inhibits the reaction [Cisplatin results in increased expression of GLI1 protein]; Arsenic Trioxide inhibits the reaction [Cisplatin results in increased expression of GLI1 protein]
Arsenic Trioxide inhibits the reaction [pralsetinib results in increased expression of GLI1 protein] 		CTD PMID:21183792 PMID:23861973 PMID:25945059 PMID:30983542 PMID:31612257 More... NCBI chr 7:65,042,237...65,054,888
Ensembl chr 7:65,042,237...65,054,540 		JBrowse link
G Gli2 GLI family zinc finger 2 increases response to substance
decreases expression
decreases response to substance
multiple interactions
increases expression 		ISO
EXP 		GLI2 protein results in increased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in decreased expression of GLI2 mRNA
GLI2 protein results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide inhibits the reaction [Cisplatin results in increased expression of GLI2 protein]; Curcumin promotes the reaction [Arsenic Trioxide inhibits the reaction [Cisplatin results in increased expression of GLI2 protein]]
Arsenic Trioxide results in increased expression of GLI2 mRNA 		CTD PMID:20707922 PMID:21183792 PMID:23861973 PMID:24685274 PMID:25945059 More... NCBI chr13:32,499,678...32,716,418
Ensembl chr13:32,499,678...32,716,418 		JBrowse link
G Gli3 GLI family zinc finger 3 multiple interactions ISO Arsenic Trioxide promotes the reaction [[GLI3 protein binds to KIT promoter] which results in decreased expression of KIT mRNA]; Arsenic Trioxide promotes the reaction [GLI3 protein binds to KIT promoter] CTD PMID:27793025 NCBI chr17:54,134,064...54,405,198
Ensembl chr17:54,134,064...54,405,198 		JBrowse link
G Glipr1 GLI pathogenesis-related 1 decreases expression ISO Arsenic Trioxide results in decreased expression of GLIPR1 mRNA CTD PMID:19128835 NCBI chr 7:49,373,579...49,399,190
Ensembl chr 7:49,373,581...49,384,640 		JBrowse link
G Glo1 glyoxalase 1 increases expression ISO Arsenic Trioxide results in increased expression of GLO1 mRNA CTD PMID:20458559 NCBI chr20:8,665,061...8,683,095
Ensembl chr20:8,665,061...8,683,191 		JBrowse link
G Glrx3 glutaredoxin 3 increases expression ISO Arsenic Trioxide results in increased expression of GLRX3 mRNA CTD PMID:20458559 NCBI chr 1:201,671,410...201,701,722
Ensembl chr 1:201,671,481...201,701,717 		JBrowse link
G Gls glutaminase increases expression
decreases response to substance 		ISO Arsenic Trioxide results in increased expression of GLS mRNA
GLS protein results in decreased susceptibility to Arsenic Trioxide 		CTD PMID:20458559 PMID:24276018 NCBI chr 9:56,836,584...56,908,861
Ensembl chr 9:56,836,584...56,908,861 		JBrowse link
G Gls2 glutaminase 2 affects response to substance ISO GLS2 protein affects the susceptibility to Arsenic Trioxide CTD PMID:24276018 NCBI chr 7:1,201,757...1,218,014
Ensembl chr 7:1,201,838...1,218,013 		JBrowse link
G Glt6d1 glycosyltransferase 6 domain containing 1 increases expression ISO Arsenic Trioxide results in increased expression of GLT6D1 mRNA CTD PMID:21461292 NCBI chr 3:29,026,023...29,037,010
Ensembl chr 3:29,026,025...29,036,699 		JBrowse link
G Gltp glycolipid transfer protein decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of GLTP mRNA
Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GLTP protein] 		CTD PMID:20458559 PMID:26598702 NCBI chr12:47,567,797...47,587,949
Ensembl chr12:47,567,770...47,587,946 		JBrowse link
G Glud1 glutamate dehydrogenase 1 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of GLUD1 protein
Arsenic Trioxide results in decreased expression of GLUD1 protein 		CTD PMID:19364129 PMID:25419056 NCBI chr16:9,646,569...9,680,215
Ensembl chr16:9,646,509...9,680,210 		JBrowse link
G Glul glutamate-ammonia ligase multiple interactions
increases expression 		ISO [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of GLUL mRNA; Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GLUL protein]
Arsenic Trioxide results in increased expression of GLUL mRNA 		CTD PMID:15894607 PMID:26598702 NCBI chr13:68,519,500...68,585,554
Ensembl chr13:68,576,067...68,585,520 		JBrowse link
G Gmps guanine monophosphate synthase increases expression
decreases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of GMPS protein
Arsenic Trioxide results in decreased expression of GMPS protein
Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GMPS protein] 		CTD PMID:19364129 PMID:25419056 PMID:26598702 NCBI chr 2:150,587,824...150,641,564
Ensembl chr 2:150,587,854...150,648,986 		JBrowse link
G Gna11 G protein subunit alpha 11 decreases expression ISO Arsenic Trioxide results in decreased expression of GNA11 mRNA CTD PMID:22521957 NCBI chr 7:8,814,285...8,828,628
Ensembl chr 7:8,814,327...8,830,558 		JBrowse link
G Gnai3 G protein subunit alpha i3 increases expression ISO Arsenic Trioxide results in increased expression of GNAI3 protein CTD PMID:25419056 NCBI chr 2:198,430,920...198,468,874 JBrowse link
G Gnal G protein subunit alpha L increases expression ISO Arsenic Trioxide results in increased expression of GNAL mRNA CTD PMID:15761015 NCBI chr18:62,892,257...63,032,510
Ensembl chr18:62,892,226...63,043,129 		JBrowse link
G Gne glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase decreases expression ISO Arsenic Trioxide results in decreased expression of GNE mRNA CTD PMID:27829220 NCBI chr 5:63,062,953...63,103,320
Ensembl chr 5:63,062,850...63,103,251 		JBrowse link
G Golga2 golgin A2 increases expression ISO Arsenic Trioxide results in increased expression of GOLGA2 mRNA CTD PMID:20458559 NCBI chr 3:35,981,783...36,002,023
Ensembl chr 3:35,981,499...36,002,022 		JBrowse link
G Golph3 golgi phosphoprotein 3 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GOLPH3 protein] CTD PMID:26598702 NCBI chr 2:63,072,610...63,103,091
Ensembl chr 2:63,074,256...63,113,577 		JBrowse link
G Gopc golgi associated PDZ and coiled-coil motif containing multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GOPC protein] CTD PMID:26598702 NCBI chr20:32,270,314...32,319,635
Ensembl chr20:32,270,314...32,319,611 		JBrowse link
G Got1 glutamic-oxaloacetic transaminase 1 decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of GOT1 protein
Arsenic Trioxide results in increased expression of GOT1 mRNA 		CTD PMID:19364129 PMID:20458559 NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:252,284,434...252,329,871 		JBrowse link
G Got2 glutamic-oxaloacetic transaminase 2 increases expression ISO Arsenic Trioxide results in increased expression of GOT2 mRNA CTD PMID:20458559 NCBI chr19:9,180,428...9,206,113
Ensembl chr19:9,180,431...9,206,111 		JBrowse link
G Gpc1 glypican 1 increases expression ISO Arsenic Trioxide results in increased expression of GPC1 mRNA CTD PMID:25555879 NCBI chr 9:100,843,645...100,871,458
Ensembl chr 9:100,843,645...100,879,933 		JBrowse link
G Gpc3 glypican 3 decreases expression ISO Arsenic Trioxide results in decreased expression of GPC3 protein CTD PMID:33634982 NCBI chr  X:136,789,770...137,157,598
Ensembl chr  X:136,789,770...137,157,639 		JBrowse link
G Gpc4 glypican 4 decreases expression ISO Arsenic Trioxide results in decreased expression of GPC4 mRNA CTD PMID:19128835 NCBI chr  X:136,565,536...136,676,142
Ensembl chr  X:136,565,591...136,676,057 		JBrowse link
G Gpc6 glypican 6 increases expression ISO Arsenic Trioxide results in increased expression of GPC6 mRNA CTD PMID:25258189 NCBI chr15:100,437,415...101,435,038
Ensembl chr15:100,437,943...101,435,027 		JBrowse link
G Gpd1 glycerol-3-phosphate dehydrogenase 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GPD1 protein] CTD PMID:26598702 NCBI chr 7:132,722,982...132,730,373
Ensembl chr 7:132,721,915...132,730,368 		JBrowse link
G Gpd2 glycerol-3-phosphate dehydrogenase 2 increases expression ISO Arsenic Trioxide results in increased expression of GPD2 mRNA CTD PMID:22521957 NCBI chr 3:62,209,432...62,346,590
Ensembl chr 3:62,210,814...62,346,593 		JBrowse link
G Gper1 G protein-coupled estrogen receptor 1 decreases expression ISO Arsenic Trioxide results in decreased expression of GPER1 mRNA CTD PMID:17547211 PMID:19128835 NCBI chr12:20,331,073...20,336,527
Ensembl chr12:20,327,679...20,337,144 		JBrowse link
G Gpi glucose-6-phosphate isomerase increases expression ISO Arsenic Trioxide results in increased expression of GPI mRNA CTD PMID:22521957 NCBI chr 1:95,965,389...95,996,932
Ensembl chr 1:95,965,396...95,993,261 		JBrowse link
G Gpkow G patch domain and KOW motifs multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GPKOW protein] CTD PMID:26598702 NCBI chr  X:17,463,521...17,478,298
Ensembl chr  X:17,463,525...17,478,298 		JBrowse link
G Gpm6a glycoprotein m6a increases expression ISO Arsenic Trioxide results in increased expression of GPM6A mRNA CTD PMID:15761015 NCBI chr16:43,374,385...43,706,461
Ensembl chr16:43,374,385...43,706,705 		JBrowse link
G Gpm6b glycoprotein m6b decreases expression ISO Arsenic Trioxide results in decreased expression of GPM6B mRNA CTD PMID:26705709 NCBI chr  X:31,689,485...31,836,199
Ensembl chr  X:31,690,359...31,733,272 		JBrowse link
G Gpn1 GPN-loop GTPase 1 decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of GPN1 mRNA
[Arsenic Trioxide co-treated with Ascorbic Acid] results in decreased expression of GPN1 mRNA 		CTD PMID:25555879 NCBI chr 6:30,667,337...30,685,011
Ensembl chr 6:30,666,868...30,685,011 		JBrowse link
G Gpn3 GPN-loop GTPase 3 decreases expression ISO Arsenic Trioxide results in decreased expression of GPN3 mRNA CTD PMID:20458559 NCBI chr12:39,850,070...39,859,032
Ensembl chr12:39,850,070...39,859,032 		JBrowse link
G Gpnmb glycoprotein nmb increases expression ISO Arsenic Trioxide results in increased expression of GPNMB mRNA CTD PMID:26705709 PMID:27829220 NCBI chr 4:79,341,128...79,362,366
Ensembl chr 4:79,341,021...79,380,240 		JBrowse link
G Gpr119 G protein-coupled receptor 119 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GPR119 protein] CTD PMID:26598702 NCBI chr  X:132,730,027...132,736,080
Ensembl chr  X:132,730,027...132,736,080 		JBrowse link
G Gpr15 G protein-coupled receptor 15 increases expression ISO Arsenic Trioxide results in increased expression of GPR15 mRNA CTD PMID:20458559 NCBI chr11:55,367,496...55,368,842
Ensembl chr11:55,358,614...55,374,150 		JBrowse link
G Gpr17 G protein-coupled receptor 17 decreases expression ISO Arsenic Trioxide results in decreased expression of GPR17 mRNA CTD PMID:24356939 NCBI chr18:23,850,460...23,857,381
Ensembl chr18:23,850,107...23,857,702 		JBrowse link
G Gpr174 G protein-coupled receptor 174 decreases expression ISO Arsenic Trioxide results in decreased expression of GPR174 mRNA CTD PMID:27829220 NCBI chr  X:76,428,274...76,469,020
Ensembl chr  X:76,377,973...76,468,985 		JBrowse link
G Gpr18 G protein-coupled receptor 18 increases expression ISO Arsenic Trioxide results in increased expression of GPR18 mRNA CTD PMID:23824090 PMID:24356939 PMID:25424538 NCBI chr15:105,404,062...105,407,812
Ensembl chr15:105,404,077...105,408,836 		JBrowse link
G Gpr183 G protein-coupled receptor 183 increases expression ISO Arsenic Trioxide results in increased expression of GPR183 mRNA CTD PMID:15761015 NCBI chr15:105,445,129...105,457,192
Ensembl chr15:105,437,561...105,466,977 		JBrowse link
G Gpr37 G protein-coupled receptor 37 decreases expression ISO Arsenic Trioxide results in decreased expression of GPR37 mRNA CTD PMID:26705709 NCBI chr 4:55,104,355...55,126,420
Ensembl chr 4:55,104,365...55,126,494 		JBrowse link
G Gpr75 G protein-coupled receptor 75 increases expression ISO Arsenic Trioxide results in increased expression of GPR75 mRNA CTD PMID:39716349 NCBI chr14:108,810,462...108,821,926
Ensembl chr14:108,817,086...108,821,926 		JBrowse link
G Gpr87 G protein-coupled receptor 87 increases expression ISO Arsenic Trioxide results in increased expression of GPR87 mRNA CTD PMID:26705709 NCBI chr 2:145,589,630...145,608,094
Ensembl chr 2:145,589,569...145,604,442 		JBrowse link
G Gprasp1 G protein-coupled receptor associated sorting protein 1 decreases expression ISO Arsenic Trioxide results in decreased expression of GPRASP1 mRNA CTD PMID:35676786 NCBI chr  X:103,556,493...103,564,275
Ensembl chr  X:103,501,377...103,565,649 		JBrowse link
G Gprc5a G protein-coupled receptor, class C, group 5, member A decreases response to substance ISO GPRC5A protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 4:169,634,896...169,653,627
Ensembl chr 4:169,634,748...169,653,625 		JBrowse link
G Gprc5d G protein-coupled receptor, class C, group 5, member D decreases expression ISO Arsenic Trioxide results in decreased expression of GPRC5D mRNA CTD PMID:15725085 NCBI chr 4:169,674,874...169,686,965
Ensembl chr 4:169,674,846...169,686,965 		JBrowse link
G Gpsm3 G-protein signaling modulator 3 decreases expression ISO Arsenic Trioxide results in decreased expression of GPSM3 mRNA CTD PMID:20458559 NCBI chr20:4,161,730...4,163,591
Ensembl chr20:4,161,730...4,189,072 		JBrowse link
G Gpt glutamic--pyruvic transaminase multiple interactions
increases activity
increases expression 		EXP
ISO 		dapagliflozin inhibits the reaction [Arsenic Trioxide results in increased expression of GPT protein]; eriodictyol inhibits the reaction [Arsenic Trioxide results in increased expression of GPT protein]; naringenin inhibits the reaction [Arsenic Trioxide results in increased activity of GPT protein]
Docosahexaenoic Acids inhibits the reaction [Arsenic Trioxide results in increased activity of GPT protein]
18alpha,20beta-hydroxy-11-oxo-norolean-12-en-3beta-yl-2-O-beta-D-glucopyranurosyl-alpha-D-glucopyranosiduronate magnesium tetrahydrate inhibits the reaction [Arsenic Trioxide results in increased activity of GPT protein]; baicalin inhibits the reaction [Arsenic Trioxide results in increased activity of GPT protein] 		CTD PMID:23283742 PMID:28978146 PMID:29751151 PMID:33846815 PMID:35088608 More... NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:110,296,206...110,300,160 		JBrowse link
G Gpt2 glutamic--pyruvic transaminase 2 increases expression ISO Arsenic Trioxide results in increased expression of GPT2 mRNA CTD PMID:24356939 NCBI chr19:37,700,023...37,734,551
Ensembl chr19:37,691,901...37,733,917 		JBrowse link
G Gpx1 glutathione peroxidase 1 decreases activity
increases expression
decreases expression 		EXP
ISO 		Arsenic Trioxide results in decreased activity of GPX1 protein
Arsenic Trioxide results in increased expression of GPX1 mRNA
Arsenic Trioxide results in decreased expression of GPX1 protein 		CTD PMID:16867262 PMID:29986281 NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581 		JBrowse link
G Gpx3 glutathione peroxidase 3 increases expression ISO Arsenic Trioxide results in increased expression of GPX3 mRNA CTD PMID:15073043 NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,529,448...39,537,405 		JBrowse link
G Gpx4 glutathione peroxidase 4 increases expression
multiple interactions
decreases expression 		ISO
EXP 		Arsenic Trioxide results in increased expression of GPX4 mRNA
ferrostatin-1 inhibits the reaction [Arsenic Trioxide results in decreased expression of GPX4 mRNA]; ferrostatin-1 inhibits the reaction [Arsenic Trioxide results in decreased expression of GPX4 protein]
Arsenic Trioxide results in decreased expression of GPX4 mRNA; Arsenic Trioxide results in decreased expression of GPX4 protein 		CTD PMID:20458559 PMID:35195477 PMID:36509116 PMID:38266058 NCBI chr 7:10,300,833...10,303,629
Ensembl chr 7:10,300,832...10,303,629 		JBrowse link
G Gpx7 glutathione peroxidase 7 increases expression ISO Arsenic Trioxide results in increased expression of GPX7 mRNA CTD PMID:25258189 NCBI chr 5:128,373,881...128,381,866
Ensembl chr 5:128,372,875...128,381,725 		JBrowse link
G Gramd2b GRAM domain containing 2B increases expression ISO Arsenic Trioxide results in increased expression of GRAMD2B mRNA CTD PMID:15070760 NCBI chr18:52,082,128...52,180,056
Ensembl chr18:52,082,029...52,180,054 		JBrowse link
G Grb10 growth factor receptor bound protein 10 increases expression
affects response to substance
multiple interactions 		ISO Arsenic Trioxide results in increased expression of GRB10 mRNA
GRB10 mRNA affects the susceptibility to Arsenic Trioxide
[Arsenic Trioxide co-treated with apatinib] results in increased expression of GRB10 mRNA; [Arsenic Trioxide co-treated with apatinib] results in increased expression of GRB10 protein; GRB10 protein promotes the reaction [[Arsenic Trioxide co-treated with apatinib] results in decreased expression of BCL2 protein]; GRB10 protein promotes the reaction [[Arsenic Trioxide co-treated with apatinib] results in decreased expression of CTNNB1 protein]; GRB10 protein promotes the reaction [[Arsenic Trioxide co-treated with apatinib] results in decreased expression of MYC protein]; GRB10 protein promotes the reaction [[Arsenic Trioxide co-treated with apatinib] results in decreased phosphorylation of GSK3B protein]; GRB10 protein promotes the reaction [[Arsenic Trioxide co-treated with apatinib] results in decreased phosphorylation of MTOR protein]; GRB10 protein promotes the reaction [[Arsenic Trioxide co-treated with apatinib] results in increased cleavage of CASP3 protein]; GRB10 protein promotes the reaction [[Arsenic Trioxide co-treated with apatinib] results in increased cleavage of CASP9 protein]; GRB10 protein promotes the reaction [[Arsenic Trioxide co-treated with apatinib] results in increased cleavage of PARP1 protein]; GRB10 protein promotes the reaction [[Arsenic Trioxide co-treated with apatinib] results in increased expression of BAX protein] 		CTD PMID:20458559 PMID:23911876 PMID:27829220 PMID:39223679 NCBI chr14:90,708,653...90,816,399
Ensembl chr14:90,708,653...90,816,387 		JBrowse link
G Grb2 growth factor receptor bound protein 2 decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of GRB2 protein
Arsenic Trioxide results in increased expression of GRB2 mRNA 		CTD PMID:20458559 PMID:25419056 NCBI chr10:101,380,354...101,448,138
Ensembl chr10:101,380,356...101,448,138 		JBrowse link
G Grb7 growth factor receptor bound protein 7 decreases response to substance ISO GRB7 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr10:83,936,538...83,949,344
Ensembl chr10:83,939,299...83,949,382 		JBrowse link
G Greb1 growth regulating estrogen receptor binding 1 multiple interactions
increases expression 		ISO afimoxifene inhibits the reaction [[Arsenic Trioxide results in increased expression of ESR1 protein] which results in increased expression of GREB1 mRNA]; afimoxifene inhibits the reaction [Arsenic Trioxide results in increased expression of GREB1 mRNA]; Fulvestrant inhibits the reaction [[Arsenic Trioxide results in increased expression of ESR1 protein] which results in increased expression of GREB1 mRNA]; Fulvestrant inhibits the reaction [Arsenic Trioxide results in increased expression of GREB1 mRNA]; S-Adenosylmethionine inhibits the reaction [[Arsenic Trioxide results in increased expression of ESR1 protein] which results in increased expression of GREB1 mRNA]; S-Adenosylmethionine inhibits the reaction [Arsenic Trioxide results in increased expression of GREB1 mRNA]
[Arsenic Trioxide results in increased expression of ESR1 protein] which results in increased expression of GREB1 mRNA; Arsenic Trioxide results in increased expression of GREB1 mRNA 		CTD PMID:22558281 NCBI chr 6:45,169,289...45,321,973
Ensembl chr 6:45,169,289...45,291,126 		JBrowse link
G Grem1 gremlin 1, DAN family BMP antagonist decreases expression ISO Arsenic Trioxide results in decreased expression of GREM1 mRNA CTD PMID:19128835 NCBI chr 3:120,966,639...120,978,319
Ensembl chr 3:120,966,623...120,979,089 		JBrowse link
G Grhpr glyoxylate and hydroxypyruvate reductase decreases expression ISO Arsenic Trioxide results in decreased expression of GRHPR mRNA CTD PMID:39716349 NCBI chr 5:64,029,856...64,039,287
Ensembl chr 5:64,022,368...64,039,276 		JBrowse link
G Gria1 glutamate ionotropic receptor AMPA type subunit 1 decreases expression ISO Arsenic Trioxide results in decreased expression of GRIA1 mRNA CTD PMID:24831965 NCBI chr10:41,710,540...42,030,105
Ensembl chr10:41,711,080...42,030,309 		JBrowse link
G Gria2 glutamate ionotropic receptor AMPA type subunit 2 decreases expression ISO Arsenic Trioxide results in decreased expression of GRIA2 mRNA CTD PMID:24831965 NCBI chr 2:168,247,490...168,367,616
Ensembl chr 2:168,247,496...168,367,616 		JBrowse link
G Grid2 glutamate ionotropic receptor delta type subunit 2 decreases expression ISO Arsenic Trioxide results in decreased expression of GRID2 mRNA CTD PMID:24831965 NCBI chr 4:93,745,165...95,222,354
Ensembl chr 4:93,745,277...95,219,868 		JBrowse link
G Grik3 glutamate ionotropic receptor kainate type subunit 3 decreases expression ISO Arsenic Trioxide results in decreased expression of GRIK3 mRNA CTD PMID:26705709 NCBI chr 5:143,052,442...143,268,873
Ensembl chr 5:143,052,442...143,268,873 		JBrowse link
G Grik4 glutamate ionotropic receptor kainate type subunit 4 increases expression ISO Arsenic Trioxide results in increased expression of GRIK4 mRNA CTD PMID:20458559 NCBI chr 8:51,802,045...52,228,751
Ensembl chr 8:51,802,058...52,102,063 		JBrowse link
G Grin1 glutamate ionotropic receptor NMDA type subunit 1 decreases expression ISO Arsenic Trioxide results in decreased expression of GRIN1 mRNA CTD PMID:24831965 NCBI chr 3:28,501,836...28,528,754
Ensembl chr 3:28,501,836...28,528,754 		JBrowse link
G Grin2b glutamate ionotropic receptor NMDA type subunit 2B decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of GRIN2B protein
Resveratrol inhibits the reaction [Arsenic Trioxide results in decreased expression of GRIN2B protein] 		CTD PMID:34050381 NCBI chr 4:170,297,811...170,775,420
Ensembl chr 4:170,322,617...170,773,570 		JBrowse link
G Grk4 G protein-coupled receptor kinase 4 increases expression ISO Arsenic Trioxide results in increased expression of GRK4 mRNA CTD PMID:15761015 PMID:22535156 NCBI chr14:80,230,699...80,305,292
Ensembl chr14:80,230,816...80,305,292 		JBrowse link
G Grm1 glutamate metabotropic receptor 1 decreases expression ISO Arsenic Trioxide results in decreased expression of GRM1 mRNA CTD PMID:24831965 NCBI chr 1:6,878,542...7,273,447
Ensembl chr 1:6,878,545...7,273,443 		JBrowse link
G Grn granulin precursor increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of GRN mRNA
[Arsenic Trioxide co-treated with Ascorbic Acid] results in increased expression of GRN mRNA 		CTD PMID:25555879 NCBI chr10:87,887,834...87,893,938
Ensembl chr10:87,886,122...87,893,936 		JBrowse link
G Grp gastrin releasing peptide decreases expression ISO Arsenic Trioxide results in decreased expression of GRP mRNA CTD PMID:20458559 NCBI chr18:61,658,655...61,672,037
Ensembl chr18:61,658,250...61,672,037 		JBrowse link
G Gsc goosecoid homeobox multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GSC protein] CTD PMID:26598702 NCBI chr 6:129,152,836...129,154,875
Ensembl chr 6:129,152,836...129,154,875 		JBrowse link
G Gsdma gasdermin A increases expression ISO Arsenic Trioxide results in increased expression of GSDMA mRNA CTD PMID:20458559 NCBI chr10:84,110,590...84,135,804
Ensembl chr10:84,123,314...84,135,804 		JBrowse link
G Gsdmc gasdermin C multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GSDMC protein] CTD PMID:26598702 NCBI chr 7:97,482,713...97,509,985
Ensembl chr 7:97,483,257...97,499,587 		JBrowse link
G Gsdme gasdermin E multiple interactions
increases cleavage 		ISO Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased cleavage of GSDME protein]; FLNC protein affects the reaction [Arsenic Trioxide results in increased cleavage of GSDME protein] CTD PMID:36801614 NCBI chr 4:80,590,344...80,651,943
Ensembl chr 4:80,588,614...80,641,525 		JBrowse link
G Gsk3b glycogen synthase kinase 3 beta multiple interactions
increases phosphorylation
decreases phosphorylation
increases expression
affects response to substance 		ISO 3-methyladenine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of GSK3B protein]; [Arsenic Trioxide co-treated with apatinib] results in decreased phosphorylation of GSK3B protein; [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of GSK3B protein] which results in increased phosphorylation of and results in increased ubiquitination of and results in increased degradation of CCND1 protein; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of GSK3B protein]; AKT1 protein inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of GSK3B protein]; Arsenic Trioxide inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]; Arsenic Trioxide inhibits the reaction [Sorafenib results in increased phosphorylation of GSK3B protein]; Arsenic Trioxide results in increased phosphorylation of and results in increased activity of GSK3B protein; AS3MT mRNA promotes the reaction [Arsenic Trioxide inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]]; Deoxyglucose inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of GSK3B protein]; GRB10 protein promotes the reaction [[Arsenic Trioxide co-treated with apatinib] results in decreased phosphorylation of GSK3B protein]; GSK3B protein modified form affects the reaction [Arsenic Trioxide results in increased expression of CDKN1A protein]; IGF2BP2 protein promotes the reaction [Arsenic Trioxide inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]]; METTL14 protein promotes the reaction [Arsenic Trioxide inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Arsenic Trioxide inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]]; N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of GSK3B protein]; Palmitic Acid inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of GSK3B protein]; Rosiglitazone inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of GSK3B protein]; Sorafenib inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of GSK3B protein]; Taurine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of GSK3B protein]; U 0126 inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of GSK3B protein]
Arsenic Trioxide inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]; Taurine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of GSK3B protein]
Arsenic Trioxide results in increased expression of GSK3B mRNA
GSK3B protein affects the susceptibility to Arsenic Trioxide 		CTD PMID:21278055 PMID:22521957 PMID:23949314 PMID:25246272 PMID:25416439 More... NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249 		JBrowse link
G Gsn gelsolin multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GSN protein] CTD PMID:26598702 NCBI chr 3:38,982,605...39,035,849
Ensembl chr 3:38,982,671...39,035,850 		JBrowse link
G Gspt1 G1 to S phase transition 1 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of GSPT1 mRNA
Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of GSPT1 mRNA] 		CTD PMID:22521957 PMID:29095437 NCBI chr10:4,867,687...4,904,186
Ensembl chr10:4,869,465...4,908,040 		JBrowse link
G Gspt2 G1 to S phase transition 2 increases expression ISO Arsenic Trioxide results in increased expression of GSPT2 mRNA CTD PMID:25258189 NCBI chr  X:63,582,649...63,597,467
Ensembl chr  X:63,582,690...63,700,401 		JBrowse link
G Gsr glutathione-disulfide reductase multiple interactions
decreases response to substance
increases expression
decreases activity 		ISO
EXP 		Ascorbic Acid inhibits the reaction [Arsenic Trioxide results in decreased activity of GSR protein]; beta Carotene inhibits the reaction [Arsenic Trioxide results in decreased activity of GSR protein]
Acetylcysteine inhibits the reaction [Arsenic Trioxide inhibits the reaction [GSR protein results in increased oxidation of NADP]]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased activity of GSR protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of GSR mRNA]; Arsenic Trioxide inhibits the reaction [GSR protein results in increased oxidation of NADP]; Arsenic Trioxide inhibits the reaction [GSR protein results in increased reduction of Glutathione Disulfide]; Arsenic Trioxide promotes the reaction [GSR protein binds to Glutathione Disulfide]; Arsenic Trioxide results in increased expression of and results in decreased activity of GSR protein; Buthionine Sulfoximine promotes the reaction [Arsenic Trioxide results in increased expression of GSR mRNA]; GSR protein inhibits the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]
GSR protein results in decreased susceptibility to Arsenic Trioxide
[Arsenic Trioxide results in increased abundance of Arsenic] which results in increased expression of GSR mRNA; [Arsenic Trioxide results in increased abundance of Arsenic] which results in increased expression of GSR protein; [ruxolitinib co-treated with Arsenic Trioxide] results in decreased expression of GSR mRNA 		CTD PMID:17258074 PMID:18715643 PMID:19417148 PMID:20707922 PMID:24634002 More... NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394 		JBrowse link
G Gsta1 glutathione S-transferase alpha 1 multiple interactions
increases expression 		ISO Atrazine promotes the reaction [Arsenic Trioxide results in increased expression of GSTA1 mRNA] CTD PMID:11678611 PMID:20458559 NCBI chr 9:31,199,887...31,216,606
Ensembl chr 9:31,199,888...31,211,528 		JBrowse link
G Gstm1 glutathione S-transferase mu 1 decreases response to substance
increases expression 		ISO GSTM1 protein results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in increased expression of GSTM1 mRNA 		CTD PMID:20067466 PMID:20458559 PMID:22521957 NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:198,338,008...198,343,569 		JBrowse link
G Gstm4 glutathione S-transferase mu 4 increases expression ISO Arsenic Trioxide results in increased expression of GSTM4 mRNA CTD PMID:22521957 NCBI chr 2:198,356,114...198,373,487
Ensembl chr 2:198,358,744...198,373,638 		JBrowse link
G Gstm5 glutathione S-transferase, mu 5 increases expression ISO Arsenic Trioxide results in increased expression of GSTM3 mRNA CTD PMID:22521957 NCBI chr 2:198,219,769...198,222,732
Ensembl chr 2:198,219,647...198,222,731 		JBrowse link
G Gstm5l glutathione S-transferase, mu 5-like multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GSTM5 protein] CTD PMID:26598702 NCBI chr 2:198,231,285...198,238,122
Ensembl chr 2:198,232,596...198,238,252 		JBrowse link
G Gsto1 glutathione S-transferase omega 1 multiple interactions
increases expression 		ISO [Arsenic Trioxide results in increased abundance of Arsenic] which results in increased expression of GSTO1 mRNA
Arsenic Trioxide results in increased expression of GSTO1 mRNA 		CTD PMID:33434570 PMID:35676786 NCBI chr 1:256,662,377...256,672,515
Ensembl chr 1:256,662,531...256,676,167 		JBrowse link
G Gsto2 glutathione S-transferase omega 2 multiple interactions ISO [Arsenic Trioxide results in increased abundance of Arsenic] which results in increased expression of GSTO2 mRNA CTD PMID:33434570 NCBI chr 1:256,673,376...256,695,154
Ensembl chr 1:256,673,274...256,695,146 		JBrowse link
G Gstp1 glutathione S-transferase pi 1 decreases response to substance
multiple interactions
decreases methylation
increases expression 		ISO GSTP1 protein results in decreased susceptibility to Arsenic Trioxide
[Arsenic Trioxide results in decreased methylation of GSTP1 promoter] which results in increased expression of GSTP1 mRNA; Arsenic Trioxide promotes the reaction [Decitabine results in increased expression of GSTP1 mRNA]; Arsenic Trioxide results in increased expression of and affects the localization of GSTP1 protein; Decitabine promotes the reaction [Arsenic Trioxide results in increased expression of GSTP1 mRNA]; GSTP1 mutant form promotes the reaction [[Arsenic Trioxide co-treated with Ethacrynic Acid] results in increased cleavage of CASP3 protein]; GSTP1 mutant form promotes the reaction [[Arsenic Trioxide co-treated with Ethacrynic Acid] results in increased cleavage of CASP9 protein]; GSTP1 mutant form promotes the reaction [[Arsenic Trioxide co-treated with Ethacrynic Acid] results in increased cleavage of PARP1 protein]; GSTP1 protein results in decreased susceptibility to [Arsenic Trioxide co-treated with Ethacrynic Acid] 		CTD PMID:15231573 PMID:16613325 PMID:23082001 NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705 		JBrowse link
G Gstt1 glutathione S-transferase theta 1 decreases expression ISO Arsenic Trioxide results in decreased expression of GSTT1 mRNA CTD PMID:20458559 NCBI chr20:12,856,068...12,873,020
Ensembl chr20:12,856,083...12,873,019 		JBrowse link
G Gstz1 glutathione S-transferase zeta 1 multiple interactions
increases expression 		ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GSTZ1 protein]
Arsenic Trioxide results in increased expression of GSTZ1 mRNA 		CTD PMID:15761015 PMID:26598702 NCBI chr 6:112,525,576...112,536,228
Ensembl chr 6:112,525,377...112,536,233 		JBrowse link
G Gtf2a1 general transcription factor 2A subunit 1 increases sumoylation ISO Arsenic Trioxide results in increased sumoylation of GTF2A1 protein CTD PMID:28318385 NCBI chr 6:116,219,614...116,252,220
Ensembl chr 6:116,219,614...116,252,220 		JBrowse link
G Gtf2h2 general transcription factor IIH subunit 2 decreases expression ISO Arsenic Trioxide results in decreased expression of GTF2H2 mRNA CTD PMID:35676786 NCBI chr 2:33,358,863...33,386,726
Ensembl chr 2:33,358,869...33,386,688 		JBrowse link
G Gtf2i general transcription factor II I increases expression ISO Arsenic Trioxide results in increased expression of GTF2I mRNA CTD PMID:39716349 NCBI chr12:28,037,344...28,112,677
Ensembl chr12:28,037,853...28,112,677 		JBrowse link
G Gucy1a2 guanylate cyclase 1 soluble subunit alpha 2 increases expression ISO Arsenic Trioxide results in increased expression of GUCY1A2 mRNA alternative form CTD PMID:35676786 NCBI chr 8:8,785,212...9,174,322
Ensembl chr 8:8,785,121...9,174,272 		JBrowse link
G Guk1 guanylate kinase 1 decreases expression ISO Arsenic Trioxide results in decreased expression of GUK1 mRNA CTD PMID:39716349 NCBI chr10:44,471,075...44,488,332
Ensembl chr10:44,471,085...44,479,355 		JBrowse link
G Gulp1 GULP PTB domain containing engulfment adaptor 1 decreases response to substance ISO GULP1 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 9:54,114,823...54,391,058
Ensembl chr 9:54,114,731...54,397,452 		JBrowse link
G Gypa glycophorin A decreases expression ISO Arsenic Trioxide results in decreased expression of GYPA protein CTD PMID:16360329 NCBI chr19:44,354,669...44,370,304
Ensembl chr19:44,354,706...44,370,291 		JBrowse link
G Gys1 glycogen synthase 1 decreases phosphorylation
multiple interactions 		ISO Arsenic Trioxide results in decreased phosphorylation of GYS1 protein
Taurine inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of GYS1 protein]
3-methyladenine inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of GYS1 protein]; Palmitic Acid inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of GYS1 protein]; Rosiglitazone inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of GYS1 protein]; Taurine inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of GYS1 protein] 		CTD PMID:30362509 NCBI chr 1:105,051,916...105,071,763
Ensembl chr 1:105,051,961...105,072,419 		JBrowse link
G H1f0 H1.0 linker histone decreases expression ISO Arsenic Trioxide results in decreased expression of H1-0 mRNA CTD PMID:22521957 NCBI chr 7:112,473,280...112,475,140
Ensembl chr 7:112,473,222...112,475,006 		JBrowse link
G H1f2 H1.2 linker histone, cluster member multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of H1-2 mRNA CTD PMID:15894607 NCBI chr17:41,818,962...41,820,453
Ensembl chr17:41,779,051...41,822,317 		JBrowse link
G H2ac20 H2A clustered histone 20 increases expression ISO Arsenic Trioxide results in increased expression of H2AC20 mRNA CTD PMID:25258189 NCBI chr 2:186,468,748...186,469,226 JBrowse link
G H2ac4 H2A clustered histone 4 decreases expression ISO Arsenic Trioxide results in decreased expression of HIST1H2AC mRNA CTD PMID:26705709 NCBI chr17:47,495,624...47,496,127
Ensembl chr17:47,495,546...47,496,173 		JBrowse link
G H2ax H2A.X variant histone multiple interactions
increases expression
increases phosphorylation 		ISO
EXP 		[Arsenic Trioxide co-treated with ruxolitinib] results in increased phosphorylation of H2AX protein; [Arsenic Trioxide co-treated with Sulindac] results in increased phosphorylation of H2AX protein; Arsenic Trioxide inhibits the reaction [SHH protein inhibits the reaction [Cisplatin results in increased phosphorylation of H2AX protein]]; MUS81 protein mutant form inhibits the reaction [Arsenic Trioxide results in increased expression of H2AX protein modified form]
2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [Arsenic Trioxide results in increased expression of H2AX protein]
Arsenic Trioxide results in increased expression of H2AX protein; Arsenic Trioxide results in increased expression of H2AX protein modified form
Arsenic Trioxide results in increased phosphorylation of H2AX protein 		CTD PMID:16891316 PMID:18636201 PMID:23337567 PMID:23861973 PMID:28265077 More... NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079 		JBrowse link
G H2bc14 H2B clustered histone 14 multiple interactions
decreases expression 		ISO [Arsenic Trioxide co-treated with Ascorbic Acid] results in decreased expression of H2BC5 mRNA
Arsenic Trioxide results in decreased expression of H2BC5 mRNA 		CTD PMID:25555879 NCBI chr17:47,488,627...47,489,008 JBrowse link
G H2bc9 H2B clustered histone 9 decreases expression ISO Arsenic Trioxide results in decreased expression of H2BC9 mRNA CTD PMID:26705709 NCBI chr17:47,166,372...47,174,369 JBrowse link
G H3f3b H3.3 histone B decreases expression ISO Arsenic Trioxide results in decreased expression of H3-3B mRNA CTD PMID:39716349 NCBI chr10:101,755,404...101,764,616
Ensembl chr10:101,755,404...101,757,636 		JBrowse link
G H3f4 H3.4 histone, cluster member multiple interactions
increases acetylation 		ISO Arsenic Trioxide results in increased phosphorylation of and results in increased acetylation of H3-4 protein
Arsenic Trioxide results in increased acetylation of H3F4 protein 		CTD PMID:12388546 PMID:19679824 NCBI chr10:44,240,282...44,240,842 JBrowse link
G H4c3 H4 clustered histone 3 decreases expression ISO Arsenic Trioxide results in decreased expression of H4C6 mRNA CTD PMID:22521957 NCBI chr17:41,796,600...41,860,389 JBrowse link
G H6pd hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) decreases expression ISO Arsenic Trioxide results in decreased expression of H6PD mRNA CTD PMID:27829220 NCBI chr 5:165,717,456...165,753,158
Ensembl chr 5:165,721,654...165,753,125 		JBrowse link
G Hacd4 3-hydroxyacyl-CoA dehydratase 4 increases expression ISO Arsenic Trioxide results in increased expression of HACD4 mRNA CTD PMID:26705709 NCBI chr 5:107,935,514...107,961,271
Ensembl chr 5:107,934,937...107,962,836 		JBrowse link
G Hacl1 2-hydroxyacyl-CoA lyase 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to HACL1 protein] CTD PMID:26598702 NCBI chr16:6,831,293...6,869,410
Ensembl chr16:6,833,268...6,869,410 		JBrowse link
G Hadh hydroxyacyl-CoA dehydrogenase increases expression ISO Arsenic Trioxide results in increased expression of HADH mRNA CTD PMID:30237538 NCBI chr 2:222,462,049...222,504,446
Ensembl chr 2:222,462,049...222,504,446 		JBrowse link
G Hagh hydroxyacyl glutathione hydrolase multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to HAGH protein] CTD PMID:26598702 NCBI chr10:14,379,400...14,394,046
Ensembl chr10:14,382,410...14,394,043 		JBrowse link
G Hal histidine ammonia lyase increases expression ISO Arsenic Trioxide results in increased expression of HAL mRNA CTD PMID:34108876 NCBI chr 7:29,894,495...29,924,744
Ensembl chr 7:29,893,855...29,924,744 		JBrowse link
G Hapln1 hyaluronan and proteoglycan link protein 1 decreases expression ISO Arsenic Trioxide results in decreased expression of HAPLN1 mRNA CTD PMID:35676786 NCBI chr 2:22,366,967...22,431,709
Ensembl chr 2:22,366,967...22,429,098 		JBrowse link
G Hars1 histidyl-tRNA synthetase 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to HARS1 protein] CTD PMID:26598702 NCBI chr18:28,655,669...28,672,712
Ensembl chr18:28,655,671...28,672,712 		JBrowse link
G Hars2 histidyl-tRNA synthetase 2, mitochondrial multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to HARS2 protein] CTD PMID:26598702 NCBI chr18:28,672,810...28,682,367
Ensembl chr18:28,672,824...28,682,359 		JBrowse link
G Has2 hyaluronan synthase 2 decreases expression ISO Arsenic Trioxide results in decreased expression of HAS2 mRNA CTD PMID:25258189 PMID:26705709 NCBI chr 7:90,002,929...90,028,933
Ensembl chr 7:90,002,929...90,018,535 		JBrowse link
G Has3 hyaluronan synthase 3 increases expression ISO Arsenic Trioxide results in increased expression of HAS3 mRNA CTD PMID:26705709 NCBI chr19:51,668,276...51,691,042 JBrowse link
G Hat1 histone acetyltransferase 1 increases expression ISO Arsenic Trioxide results in increased expression of HAT1 protein CTD PMID:25419056 NCBI chr 3:76,624,442...76,672,701
Ensembl chr 3:76,624,869...76,672,696 		JBrowse link
G Haus6 HAUS augmin like complex subunit 6 decreases expression ISO Arsenic Trioxide results in decreased expression of HAUS6 mRNA CTD PMID:25258189 NCBI chr 5:106,162,526...106,201,503
Ensembl chr 5:106,162,526...106,199,072 		JBrowse link
G Havcr1 hepatitis A virus cellular receptor 1 multiple interactions
increases expression 		EXP Febuxostat inhibits the reaction [Arsenic Trioxide results in increased expression of HAVCR1 protein] CTD PMID:37689273 NCBI chr10:31,619,914...31,652,955
Ensembl chr10:31,619,897...31,653,268 		JBrowse link
G Havcr2 hepatitis A virus cellular receptor 2 increases expression ISO Arsenic Trioxide results in increased expression of HAVCR2 mRNA CTD PMID:20458559 NCBI chr10:31,383,801...31,415,334
Ensembl chr10:31,383,925...31,413,872 		JBrowse link
G Hbb hemoglobin subunit beta affects expression ISO Arsenic Trioxide affects the expression of HBB mRNA CTD PMID:20458559 NCBI chr 1:167,662,310...167,663,721
Ensembl chr 1:167,630,245...167,663,873 		JBrowse link
G Hbegf heparin-binding EGF-like growth factor increases expression ISO Arsenic Trioxide results in increased expression of HBEGF mRNA CTD PMID:25258189 PMID:26705709 NCBI chr18:28,380,337...28,390,220
Ensembl chr18:28,380,337...28,390,220 		JBrowse link
G Hbp1 HMG-box transcription factor 1 increases expression ISO Arsenic Trioxide results in increased expression of HBP1 mRNA CTD PMID:20458559 NCBI chr 6:54,257,118...54,283,373
Ensembl chr 6:54,256,864...54,283,366 		JBrowse link
G Hcfc1 host cell factor C1 multiple interactions
increases expression 		ISO [Arsenic Trioxide co-treated with Ascorbic Acid] results in increased expression of HCFC1 mRNA
Arsenic Trioxide results in increased expression of HCFC1 mRNA 		CTD PMID:25555879 NCBI chr  X:156,839,100...156,864,132
Ensembl chr  X:156,839,100...156,863,813 		JBrowse link
G Hcls1 hematopoietic cell specific Lyn substrate 1 increases expression ISO Arsenic Trioxide results in increased expression of HCLS1 mRNA CTD PMID:26705709 NCBI chr11:77,322,873...77,346,333
Ensembl chr11:77,322,873...77,346,387 		JBrowse link
G Hcrtr1 hypocretin receptor 1 decreases expression ISO Arsenic Trioxide results in decreased expression of HCRTR1 mRNA CTD PMID:15761015 NCBI chr 5:147,761,392...147,771,846
Ensembl chr 5:147,760,145...147,770,850 		JBrowse link
G Hcst hematopoietic cell signal transducer decreases expression ISO Arsenic Trioxide results in decreased expression of HCST mRNA CTD PMID:19128835 NCBI chr 1:94,804,429...94,806,661
Ensembl chr 1:94,804,430...94,806,641 		JBrowse link
G Hdac1 histone deacetylase 1 multiple interactions ISO [[Arsenic Trioxide results in increased phosphorylation of JUN protein] which binds to HDAC1 protein] which binds to CDKN1A promoter; [Arsenic Trioxide results in increased phosphorylation of JUN protein] which binds to HDAC1 protein; [Valproic Acid co-treated with Arsenic Trioxide] results in decreased expression of HDAC1 mRNA; Arsenic Trioxide promotes the reaction [[TGIF1 protein co-treated with HDAC1 protein] binds to CDKN1A promoter]; Arsenic Trioxide promotes the reaction [[TGIF1 protein co-treated with HDAC1 protein] results in decreased expression of CDKN1A mRNA] CTD PMID:18210215 PMID:20074581 PMID:25815518 NCBI chr 5:147,138,328...147,165,387
Ensembl chr 5:147,138,156...147,165,387 		JBrowse link
G Hdac10 histone deacetylase 10 increases expression ISO Arsenic Trioxide results in increased expression of HDAC10 mRNA CTD PMID:35676786 NCBI chr 7:122,078,768...122,084,457
Ensembl chr 7:122,078,768...122,083,870 		JBrowse link
G Hdac2 histone deacetylase 2 affects expression
increases methylation 		ISO Arsenic Trioxide affects the expression of HDAC2 mRNA
Arsenic Trioxide results in increased methylation of HDAC2 promoter 		CTD PMID:25574600 PMID:26046465 NCBI chr20:42,101,815...42,126,486
Ensembl chr20:42,102,861...42,126,311 		JBrowse link
G Hdac4 histone deacetylase 4 increases expression ISO Arsenic Trioxide results in increased expression of HDAC4 mRNA CTD PMID:22521957 NCBI chr 9:99,950,972...100,200,994
Ensembl chr 9:99,955,116...100,197,637 		JBrowse link
G Hdac8 histone deacetylase 8 increases expression ISO Arsenic Trioxide results in increased expression of HDAC8 mRNA CTD PMID:22521957 NCBI chr  X:71,425,240...71,632,865
Ensembl chr  X:71,394,928...71,632,865 		JBrowse link
G Hdgf heparin binding growth factor affects expression ISO Arsenic Trioxide affects the expression of HDGF mRNA CTD PMID:39716349 NCBI chr 2:175,668,290...175,677,614
Ensembl chr 2:175,668,324...175,677,225 		JBrowse link
G Hdhd3 haloacid dehalogenase-like hydrolase domain containing 3 decreases response to substance ISO HDHD3 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 5:80,966,878...80,970,345
Ensembl chr 5:80,954,610...80,970,854 		JBrowse link
G Heatr5b HEAT repeat containing 5B decreases expression ISO Arsenic Trioxide results in decreased expression of HEATR5B mRNA CTD PMID:27829220 NCBI chr 6:21,995,558...22,075,582
Ensembl chr 6:21,995,602...22,075,582 		JBrowse link
G Heatr6 HEAT repeat containing 6 decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of HEATR6 mRNA
Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of HEATR6 mRNA] 		CTD PMID:29095437 NCBI chr10:69,132,532...69,161,334
Ensembl chr10:69,132,181...69,162,945 		JBrowse link
G Heca hdc homolog, cell cycle regulator increases expression ISO Arsenic Trioxide results in increased expression of HECA mRNA CTD PMID:20458559 NCBI chr 1:14,345,306...14,395,226
Ensembl chr 1:14,345,306...14,395,191 		JBrowse link
G Henmt1 HEN methyltransferase 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to HENMT1 protein] CTD PMID:26598702 NCBI chr 2:199,258,107...199,291,739
Ensembl chr 2:199,274,480...199,287,822 		JBrowse link
G Herc1 HECT and RLD domain containing E3 ubiquitin protein ligase family member 1 increases expression ISO Arsenic Trioxide results in increased expression of HERC1 mRNA CTD PMID:20458559 NCBI chr 8:75,796,347...75,965,347
Ensembl chr 8:75,796,357...75,965,347 		JBrowse link
G Hes1 hes family bHLH transcription factor 1 multiple interactions
decreases expression 		ISO Arsenic Trioxide inhibits the reaction [PROM1 protein results in increased expression of HES1 mRNA]
Arsenic Trioxide results in decreased expression of HES1 mRNA 		CTD PMID:20458559 PMID:23497375 PMID:23832679 PMID:24685274 NCBI chr11:84,210,632...84,213,045
Ensembl chr11:84,210,633...84,213,061 		JBrowse link
G Hes5 hes family bHLH transcription factor 5 decreases expression ISO Arsenic Trioxide results in decreased expression of HES5 mRNA CTD PMID:24685274 NCBI chr 5:170,804,511...170,807,988
Ensembl chr 5:170,803,940...170,806,021 		JBrowse link
G Hes7 hes family bHLH transcription factor 7 increases expression ISO Arsenic Trioxide results in increased expression of HES7 mRNA CTD PMID:39716349 NCBI chr10:54,322,971...54,327,776
Ensembl chr10:54,322,971...54,327,776 		JBrowse link
G Hey1 hes-related family bHLH transcription factor with YRPW motif 1 affects methylation
decreases expression 		ISO Arsenic Trioxide affects the methylation of HEY1 promoter
Arsenic Trioxide results in decreased expression of HEY1 mRNA 		CTD PMID:24685274 PMID:26046465 NCBI chr 2:95,003,935...95,006,457
Ensembl chr 2:95,002,943...95,007,624 		JBrowse link
G Hey2 hes-related family bHLH transcription factor with YRPW motif 2 decreases expression ISO Arsenic Trioxide results in decreased expression of HEY2 mRNA CTD PMID:26705709 NCBI chr 1:28,641,100...28,651,187
Ensembl chr 1:28,641,057...28,651,187 		JBrowse link
G Hfe homeostatic iron regulator decreases response to substance ISO HFE protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr17:41,841,302...41,849,359
Ensembl chr17:41,841,252...41,851,208 		JBrowse link
G Hgf hepatocyte growth factor increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of HGF mRNA
Arsenic Trioxide results in decreased expression of HGF mRNA 		CTD PMID:15761015 PMID:18414637 NCBI chr 4:19,628,902...19,700,467
Ensembl chr 4:19,632,267...19,700,851 		JBrowse link
G Hhipl2 HHIP like 2 increases expression ISO Arsenic Trioxide results in increased expression of HHIPL2 mRNA CTD PMID:29633893 NCBI chr13:97,586,296...97,606,223
Ensembl chr13:97,586,341...97,606,223 		JBrowse link
G Hibadh 3-hydroxyisobutyrate dehydrogenase increases expression ISO Arsenic Trioxide results in increased expression of HIBADH mRNA CTD PMID:22521957 NCBI chr 4:82,979,759...83,077,819
Ensembl chr 4:82,979,765...83,111,242 		JBrowse link
G Hif1a hypoxia inducible factor 1 subunit alpha decreases expression
affects expression
increases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of HIF1A; Arsenic Trioxide results in decreased expression of HIF1A mRNA; Arsenic Trioxide results in decreased expression of HIF1A protein
Arsenic Trioxide affects the expression of HIF1A mRNA
Arsenic Trioxide results in increased expression of HIF1A protein
[Oxygen deficiency co-treated with Arsenic Trioxide] results in increased expression of HIF1A protein; Arsenic Trioxide promotes the reaction [cobaltous chloride results in increased expression of HIF1A protein]; Arsenic Trioxide promotes the reaction [Deferoxamine results in increased expression of HIF1A protein] 		CTD PMID:12482858 PMID:15888669 PMID:16330433 PMID:19769630 PMID:19825857 More... NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323 		JBrowse link
G Higd1a HIG1 hypoxia inducible domain family, member 1A increases expression ISO Arsenic Trioxide results in increased expression of HIGD1A mRNA CTD PMID:20458559 NCBI chr 8:130,391,658...130,400,888
Ensembl chr 8:130,391,661...130,400,888 		JBrowse link
G Hilpda hypoxia inducible lipid droplet-associated decreases expression ISO Arsenic Trioxide results in decreased expression of HILPDA mRNA CTD PMID:15725085 NCBI chr 4:58,836,463...58,839,423
Ensembl chr 4:58,836,463...58,839,423 		JBrowse link
G Hinfp histone H4 transcription factor decreases expression ISO Arsenic Trioxide results in decreased expression of HINFP mRNA CTD PMID:22521957 NCBI chr 8:53,525,576...53,541,101
Ensembl chr 8:53,527,236...53,540,555 		JBrowse link
G Hip1r huntingtin interacting protein 1 related decreases response to substance ISO HIP1R protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr12:38,251,085...38,279,756
Ensembl chr12:38,251,086...38,279,654 		JBrowse link
G Hipk1 homeodomain interacting protein kinase 1 increases expression ISO Arsenic Trioxide results in increased expression of HIPK1 mRNA CTD PMID:20458559 NCBI chr 2:193,937,261...193,988,247
Ensembl chr 2:193,937,261...193,975,164 		JBrowse link
G Hira histone cell cycle regulator increases expression ISO Arsenic Trioxide results in increased expression of HIRA mRNA CTD PMID:35676786 NCBI chr11:95,528,831...95,637,565
Ensembl chr11:95,528,831...95,638,549 		JBrowse link
G Hk1 hexokinase 1 multiple interactions
increases expression
decreases expression 		ISO [Ascorbic Acid co-treated with Arsenic Trioxide] results in decreased expression of HK1 protein; Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to HK1 protein]; Arsenic Trioxide promotes the reaction [Ascorbic Acid results in decreased expression of HK1 mRNA]; Arsenic Trioxide promotes the reaction [Ascorbic Acid results in decreased expression of HK1 protein]; Ascorbic Acid promotes the reaction [Arsenic Trioxide results in decreased expression of HK1 mRNA]; Ascorbic Acid promotes the reaction [Arsenic Trioxide results in decreased expression of HK1 protein]
Arsenic Trioxide results in increased expression of HK1 mRNA
Arsenic Trioxide results in decreased expression of HK1 mRNA; Arsenic Trioxide results in decreased expression of HK1 protein 		CTD PMID:15761015 PMID:26598702 PMID:38160894 NCBI chr20:30,773,222...30,874,814
Ensembl chr20:30,773,220...30,874,814 		JBrowse link
G Hk2 hexokinase 2 decreases activity
multiple interactions 		ISO Arsenic Trioxide results in decreased activity of HK2 protein
Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to HK2 protein] 		CTD PMID:26598702 NCBI chr 4:116,792,258...116,841,275
Ensembl chr 4:116,792,258...116,841,275 		JBrowse link
G Hk3 hexokinase 3 decreases expression ISO Arsenic Trioxide results in decreased expression of HK3 mRNA CTD PMID:19128835 NCBI chr17:9,602,119...9,620,038
Ensembl chr17:9,605,016...9,620,037 		JBrowse link
G Hm13 histocompatibility minor 13 decreases expression ISO Arsenic Trioxide results in decreased expression of HM13 protein
Arsenic Trioxide results in decreased expression of HM13 mRNA 		CTD PMID:25419056 PMID:39716349 NCBI chr 3:161,606,059...161,641,382
Ensembl chr 3:161,606,052...161,644,805 		JBrowse link
G Hmbs hydroxymethylbilane synthase increases expression ISO Arsenic Trioxide results in increased expression of HMBS mRNA CTD PMID:25258189 NCBI chr 8:53,570,364...53,577,758
Ensembl chr 8:53,570,364...53,577,802 		JBrowse link
G Hmcn2 hemicentin 2 decreases expression ISO Arsenic Trioxide results in decreased expression of HMCN2 mRNA CTD PMID:35676786 NCBI chr 3:34,986,246...35,136,047
Ensembl chr 3:34,986,263...35,136,106 		JBrowse link
G Hmga1 high mobility group AT-hook 1 increases expression ISO Arsenic Trioxide results in increased expression of HMGA1 mRNA CTD PMID:17547211 NCBI chr20:5,612,902...5,620,596
Ensembl chr20:5,613,471...5,620,593 		JBrowse link
G Hmgb1 high mobility group box 1 increases expression
increases secretion
decreases response to substance 		ISO Arsenic Trioxide results in increased expression of HMGB1 protein
Arsenic Trioxide results in increased secretion of HMGB1 protein
HMGB1 protein results in decreased susceptibility to Arsenic Trioxide 		CTD PMID:25258189 PMID:27807322 PMID:37166470 PMID:38684648 NCBI chr12:11,009,236...11,015,941
Ensembl chr16:39,039,050...39,041,327
Ensembl chr12:39,039,050...39,041,327 		JBrowse link
G Hmgb2 high mobility group box 2 increases expression ISO Arsenic Trioxide results in increased expression of HMGB2 mRNA CTD PMID:14703492 NCBI chr16:37,721,374...37,723,950
Ensembl chr16:37,721,379...37,723,860 		JBrowse link
G Hmgcs1 3-hydroxy-3-methylglutaryl-CoA synthase 1 decreases expression ISO Arsenic Trioxide results in decreased expression of HMGCS1 mRNA CTD PMID:27829220 NCBI chr 2:53,379,457...53,399,807
Ensembl chr 2:53,382,643...53,399,802 		JBrowse link
G Hmgn2 high mobility group nucleosomal binding domain 2 increases expression
increases response to substance 		ISO Arsenic Trioxide results in increased expression of HMGN2 mRNA
HMGN2 protein results in increased susceptibility to Arsenic Trioxide 		CTD PMID:17547211 PMID:20458559 PMID:20707922 NCBI chr 5:151,475,907...151,479,361
Ensembl chr 5:151,475,909...151,479,397 		JBrowse link
G Hmgxb3 HMG-box containing 3 decreases expression ISO Arsenic Trioxide results in decreased expression of HMGXB3 mRNA CTD PMID:35676786 NCBI chr18:56,860,947...56,908,419
Ensembl chr18:56,860,947...56,908,419 		JBrowse link
G Hmox1 heme oxygenase 1 decreases response to substance
multiple interactions
increases expression
decreases expression
decreases activity 		ISO
EXP 		HMOX1 protein results in decreased susceptibility to Arsenic Trioxide
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased expression of HMOX1 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Sulindac promotes the reaction [Arsenic Trioxide results in increased expression of HMOX1 protein]]; 6-Aminonicotinamide inhibits the reaction [Arsenic Trioxide results in increased expression of HMOX1 protein]; [Arsenic Trioxide co-treated with Bortezomib] results in decreased expression of HMOX1 mRNA; [Arsenic Trioxide results in increased abundance of Arsenic] which results in increased expression of HMOX1 mRNA; [Arsenic Trioxide results in increased abundance of Arsenic] which results in increased expression of HMOX1 protein; [zinc protoporphyrin results in decreased activity of HMOX1 protein] which results in increased susceptibility to Arsenic Trioxide; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of HMOX1 protein]; Acetylcysteine promotes the reaction [Arsenic Trioxide results in increased expression of HMOX1 protein]; allicin inhibits the reaction [Arsenic Trioxide results in decreased expression of HMOX1 protein]; cobaltiprotoporphyrin promotes the reaction [Arsenic Trioxide results in increased expression of HMOX1 protein]; Dactinomycin inhibits the reaction [Arsenic Trioxide results in increased expression of HMOX1 mRNA]; Deoxyglucose inhibits the reaction [Arsenic Trioxide results in increased expression of HMOX1 protein]; Ethionamide inhibits the reaction [Arsenic Trioxide results in increased expression of HMOX1 mRNA]; HMOX1 protein inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; HMOX1 protein inhibits the reaction [Arsenic Trioxide results in increased expression of JUN protein modified form]; HMOX1 protein inhibits the reaction [Arsenic Trioxide results in increased expression of JUN protein]; HMOX1 protein inhibits the reaction [Arsenic Trioxide results in increased expression of MMP9 mRNA]; HMOX1 protein inhibits the reaction [Arsenic Trioxide results in increased expression of MMP9 protein]; JUN protein promotes the reaction [Arsenic Trioxide results in increased expression of HMOX1 protein]; MIR155 mRNA inhibits the reaction [Arsenic Trioxide results in decreased expression of HMOX1 protein]; N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Arsenic Trioxide results in increased expression of HMOX1]; NFE2L2 protein affects the reaction [Arsenic Trioxide results in increased expression of HMOX1 mRNA]; NFE2L2 protein promotes the reaction [Arsenic Trioxide results in increased expression of HMOX1 protein]; PRKACA protein affects the reaction [Arsenic Trioxide results in increased expression of HMOX1 mRNA]; PRKACA protein affects the reaction [TRIM44 protein promotes the reaction [Arsenic Trioxide results in increased expression of HMOX1 mRNA]]; pyrazolanthrone inhibits the reaction [Sulindac promotes the reaction [Arsenic Trioxide results in increased expression of HMOX1 protein]]; RARA gene mutant form inhibits the reaction [Tretinoin inhibits the reaction [Arsenic Trioxide results in increased expression of HMOX1 protein]]; SB 203580 inhibits the reaction [Sulindac promotes the reaction [Arsenic Trioxide results in increased expression of HMOX1 protein]]; Sulindac promotes the reaction [Arsenic Trioxide results in increased expression of HMOX1 protein]; Tetrachlorodibenzodioxin promotes the reaction [Arsenic Trioxide results in increased expression of HMOX1 mRNA]; Tetrachlorodibenzodioxin promotes the reaction [Arsenic Trioxide results in increased expression of HMOX1 protein]; Thioctic Acid inhibits the reaction [Arsenic Trioxide results in increased expression of HMOX1 mRNA]; Thioctic Acid inhibits the reaction [Arsenic Trioxide results in increased expression of HMOX1 protein]; Tretinoin inhibits the reaction [Arsenic Trioxide results in increased expression of HMOX1 protein]; TRIM44 protein promotes the reaction [Arsenic Trioxide results in increased expression of HMOX1 mRNA]; zinc protoporphyrin promotes the reaction [Arsenic Trioxide results in increased expression of HMOX1 protein]
Arsenic Trioxide results in increased expression of HMOX1; Arsenic Trioxide results in increased expression of HMOX1 mRNA; Arsenic Trioxide results in increased expression of HMOX1 protein
3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Arsenic Trioxide results in increased expression of HMOX1 mRNA]; [Arsenic Trioxide co-treated with Grape Seed Proanthocyanidins] results in increased expression of HMOX1 mRNA; [Arsenic Trioxide co-treated with Tetrachlorodibenzodioxin] results in increased expression of HMOX1 protein; [Arsenic Trioxide results in increased abundance of Reactive Oxygen Species] which results in increased expression of HMOX1 protein; [Tetrachlorodibenzodioxin co-treated with Arsenic Trioxide] affects the expression of HMOX1 mRNA; Acetylcysteine inhibits the reaction [[Arsenic Trioxide results in increased abundance of Peroxides] which results in increased expression of HMOX1 protein]; Arsenic Trioxide promotes the reaction [Lutein results in increased expression of HMOX1 mRNA]; Arsenic Trioxide promotes the reaction [Lutein results in increased expression of HMOX1 protein]; CAT protein inhibits the reaction [Arsenic Trioxide results in increased expression of HMOX1 protein]; diphenyleneiodonium inhibits the reaction [Arsenic Trioxide results in increased expression of HMOX1 protein]; HMOX1 mRNA affects the reaction [Arsenic Trioxide results in increased expression of VEGFA mRNA]; Lutein promotes the reaction [Arsenic Trioxide results in increased expression of HMOX1 mRNA]; Lutein promotes the reaction [Arsenic Trioxide results in increased expression of HMOX1 protein]; NFE2L2 protein affects the reaction [Arsenic Trioxide results in increased expression of HMOX1 mRNA]; SB 203580 inhibits the reaction [Arsenic Trioxide results in increased expression of HMOX1 mRNA]; Thioctic Acid inhibits the reaction [Arsenic Trioxide results in increased expression of HMOX1 mRNA]; Thioctic Acid inhibits the reaction [Arsenic Trioxide results in increased expression of HMOX1 protein]
Arsenic Trioxide results in decreased expression of HMOX1 mRNA; Arsenic Trioxide results in decreased expression of HMOX1 protein
crocin inhibits the reaction [Arsenic Trioxide results in decreased expression of HMOX1 protein]; dapagliflozin inhibits the reaction [Arsenic Trioxide results in decreased activity of HMOX1 protein]; eriodictyol promotes the reaction [Arsenic Trioxide results in increased expression of HMOX1 mRNA]; eriodictyol promotes the reaction [Arsenic Trioxide results in increased expression of HMOX1 protein]; Nicorandil inhibits the reaction [Arsenic Trioxide results in decreased expression of HMOX1 protein]; oxymatrine promotes the reaction [Arsenic Trioxide results in increased expression of HMOX1 protein]; Resveratrol inhibits the reaction [Arsenic Trioxide results in decreased expression of HMOX1 mRNA] 		CTD PMID:15725085 PMID:15894607 PMID:16487037 PMID:17258074 PMID:17547211 More... NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818 		JBrowse link
G Hmox2 heme oxygenase 2 increases expression ISO Arsenic Trioxide results in increased expression of HMOX2 mRNA CTD PMID:20458559 NCBI chr10:11,303,512...11,337,640
Ensembl chr10:11,303,512...11,318,800 		JBrowse link
G Hnmt histamine N-methyltransferase multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to HNMT protein] CTD PMID:26598702 NCBI chr 3:26,978,274...27,010,291
Ensembl chr 3:26,977,933...27,010,482 		JBrowse link
G Hnrnpa1 heterogeneous nuclear ribonucleoprotein A1 increases expression ISO Arsenic Trioxide results in increased expression of HNRNPA1 mRNA CTD PMID:20458559 PMID:25258189 NCBI chr 7:136,253,633...136,260,085
Ensembl chr 7:136,253,278...136,260,085 		JBrowse link
G Hnrnpa2b1 heterogeneous nuclear ribonucleoprotein A2/B1 decreases expression ISO Arsenic Trioxide results in decreased expression of HNRNPA2B1 protein CTD PMID:25419056 NCBI chr 4:81,867,354...81,875,886
Ensembl chr 4:81,869,661...81,877,572 		JBrowse link
G Hnrnph1 heterogeneous nuclear ribonucleoprotein H1 increases expression ISO Arsenic Trioxide results in increased expression of HNRNPH1 mRNA; Arsenic Trioxide results in increased expression of HNRNPH1 protein CTD PMID:20458559 PMID:25258189 NCBI chr10:35,187,412...35,203,909
Ensembl chr10:35,193,890...35,203,906 		JBrowse link
G Hnrnph2 heterogeneous nuclear ribonucleoprotein H2 increases expression ISO Arsenic Trioxide results in increased expression of HNRNPH2 mRNA CTD PMID:20458559 NCBI chr  X:102,074,175...102,080,115
Ensembl chr  X:102,074,179...102,081,025 		JBrowse link
G Hnrnpk heterogeneous nuclear ribonucleoprotein K increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of HNRNPK protein
Arsenic Trioxide results in decreased expression of HNRNPK protein 		CTD PMID:19364129 PMID:19747914 PMID:25419056 NCBI chr17:6,269,302...6,280,429
Ensembl chr17:6,268,385...6,280,565 		JBrowse link
G Hnrnpl heterogeneous nuclear ribonucleoprotein L decreases expression ISO Arsenic Trioxide results in decreased expression of HNRNPL protein CTD PMID:25419056 NCBI chr 1:93,226,373...93,239,084
Ensembl chr 1:93,235,729...93,239,061 		JBrowse link
G Hnrnpr heterogeneous nuclear ribonucleoprotein R increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of HNRNPR mRNA
Arsenic Trioxide results in decreased expression of HNRNPR mRNA 		CTD PMID:20458559 PMID:39716349 NCBI chr 5:153,826,482...153,872,272
Ensembl chr 5:153,826,692...153,858,344 		JBrowse link
G Homer2 homer scaffold protein 2 decreases expression ISO Arsenic Trioxide results in decreased expression of HOMER2 mRNA CTD PMID:29633893 NCBI chr 1:144,968,207...145,069,022
Ensembl chr 1:144,976,436...145,068,997 		JBrowse link
G Homer3 homer scaffold protein 3 multiple interactions ISO HOMER3 protein affects the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein] CTD PMID:23725168 NCBI chr16:19,166,141...19,176,701
Ensembl chr16:19,165,482...19,176,640 		JBrowse link
G Hook2 hook microtubule-tethering protein 2 decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of HOOK2 mRNA
Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of HOOK2 mRNA] 		CTD PMID:29095437 NCBI chr19:40,056,732...40,075,027
Ensembl chr19:40,056,732...40,081,270 		JBrowse link
G Hopx HOP homeobox decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of HOPX mRNA
Arsenic Trioxide results in increased expression of HOPX mRNA 		CTD PMID:22521957 PMID:26705709 PMID:39716349 NCBI chr14:31,410,235...31,437,189
Ensembl chr14:31,410,221...31,437,188 		JBrowse link
G Hoxa2 homeobox A2 decreases expression ISO Arsenic Trioxide results in decreased expression of HOXA2 mRNA CTD PMID:26705709 NCBI chr 4:82,593,389...82,597,589
Ensembl chr 4:82,593,389...82,595,692 		JBrowse link
G Hoxa3 homeobox A3 decreases expression ISO Arsenic Trioxide results in decreased expression of HOXA3 mRNA CTD PMID:26705709 NCBI chr 4:82,599,860...82,643,831
Ensembl chr 4:82,599,860...82,643,831 		JBrowse link
G Hoxa5 homeo box A5 decreases expression ISO Arsenic Trioxide results in decreased expression of HOXA5 mRNA CTD PMID:21461292 NCBI chr 4:82,632,958...82,636,851
Ensembl chr 4:82,632,306...82,639,038 		JBrowse link
G Hoxa9 homeobox A9 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of HOXA9 mRNA; Arsenic Trioxide results in increased expression of HOXA9 protein
Arsenic Trioxide results in decreased expression of HOXA9 mRNA; Arsenic Trioxide results in decreased expression of HOXA9 protein 		CTD PMID:22541086 PMID:28961318 NCBI chr 4:82,653,847...82,659,958
Ensembl chr 4:82,653,825...82,662,093 		JBrowse link
G Hoxb9 homeo box B9 increases expression ISO Arsenic Trioxide results in increased expression of HOXB9 mRNA CTD PMID:27829220 NCBI chr10:81,733,857...81,737,363
Ensembl chr10:81,733,658...81,738,872 		JBrowse link
G Hoxc9 homeobox C9 increases expression ISO Arsenic Trioxide results in increased expression of HOXC9 protein CTD PMID:35467087 NCBI chr 7:135,997,292...135,999,969
Ensembl chr 7:135,992,023...135,999,964 		JBrowse link
G Hoxd4 homeo box D4 increases expression ISO Arsenic Trioxide results in increased expression of HOXD4 mRNA CTD PMID:15073043 NCBI chr 3:80,021,886...80,041,462
Ensembl chr 3:80,036,900...80,038,948 		JBrowse link
G Hoxd8 homeobox D8 increases expression ISO Arsenic Trioxide results in increased expression of HOXD8 protein CTD PMID:35467087 NCBI chr 3:80,015,223...80,017,789
Ensembl chr 3:80,014,735...80,018,765 		JBrowse link
G Hpca hippocalcin decreases expression ISO Arsenic Trioxide results in decreased expression of HPCA mRNA CTD PMID:20458559 NCBI chr 5:146,739,978...146,750,961
Ensembl chr 5:146,739,978...146,749,983 		JBrowse link
G Hpcal1 hippocalcin-like 1 multiple interactions
increases expression 		ISO [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of HPCAL1 mRNA
Arsenic Trioxide results in increased expression of HPCAL1 mRNA 		CTD PMID:15894607 PMID:20458559 NCBI chr 6:46,206,809...46,313,364
Ensembl chr 6:46,260,494...46,313,353 		JBrowse link
G Hpgd 15-hydroxyprostaglandin dehydrogenase decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of HPGD mRNA
Arsenic Trioxide results in increased expression of HPGD mRNA 		CTD PMID:19128835 PMID:20458559 NCBI chr16:38,996,876...39,034,831
Ensembl chr16:38,996,876...39,034,831 		JBrowse link
G Hpgds hematopoietic prostaglandin D synthase decreases expression ISO Arsenic Trioxide results in decreased expression of HPGDS mRNA CTD PMID:19128835 NCBI chr 4:95,698,265...95,727,733
Ensembl chr 4:95,702,392...95,938,501 		JBrowse link
G Hps3 HPS3, biogenesis of lysosomal organelles complex 2 subunit 1 increases expression ISO Arsenic Trioxide results in increased expression of HPS3 mRNA CTD PMID:20458559 NCBI chr 2:104,413,618...104,455,091
Ensembl chr 2:104,413,417...104,455,091 		JBrowse link
G Hps4 HPS4, biogenesis of lysosomal organelles complex 3 subunit 2 increases expression ISO Arsenic Trioxide results in increased expression of HPS4 mRNA CTD PMID:35676786 NCBI chr12:49,924,444...49,955,201
Ensembl chr12:49,924,444...49,953,613 		JBrowse link
G Hras HRas proto-oncogene, GTPase increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of HRAS mRNA
[Tetradecanoylphorbol Acetate co-treated with Arsenic Trioxide] results in increased expression of HRAS mRNA 		CTD PMID:18922899 PMID:29633893 NCBI chr 1:205,712,625...205,729,406
Ensembl chr 1:205,725,975...205,729,590 		JBrowse link
G Hrg histidine-rich glycoprotein increases expression ISO Arsenic Trioxide results in increased expression of HRG mRNA CTD PMID:27829220 NCBI chr11:91,559,087...91,573,982
Ensembl chr11:91,559,091...91,573,982 		JBrowse link
G Hrk harakiri, BCL2 interacting protein increases expression EXP
ISO 		Arsenic Trioxide results in increased expression of HRK mRNA CTD PMID:19730151 PMID:20471514 PMID:24345465 NCBI chr12:44,048,402...44,070,561
Ensembl chr12:44,048,402...44,070,561 		JBrowse link
G Hs3st6 heparan sulfate-glucosamine 3-sulfotransferase 6 decreases expression ISO Arsenic Trioxide results in decreased expression of HS3ST6 mRNA CTD PMID:25258189 NCBI chr10:14,286,555...14,292,660
Ensembl chr10:14,286,507...14,292,660 		JBrowse link
G Hsd17b12 hydroxysteroid (17-beta) dehydrogenase 12 increases expression ISO Arsenic Trioxide results in increased expression of HSD17B12 mRNA CTD PMID:39716349 NCBI chr 3:100,445,393...100,568,898
Ensembl chr 3:100,445,400...100,568,938 		JBrowse link
G Hsd17b2 hydroxysteroid (17-beta) dehydrogenase 2 decreases expression ISO Arsenic Trioxide results in decreased expression of HSD17B2 mRNA CTD PMID:17547211 NCBI chr19:62,662,320...62,733,944
Ensembl chr19:62,662,098...62,733,943 		JBrowse link
G Hsd17b4 hydroxysteroid (17-beta) dehydrogenase 4 increases expression ISO Arsenic Trioxide results in increased expression of HSD17B4 protein CTD PMID:25419056 NCBI chr18:45,515,427...45,604,467
Ensembl chr18:45,515,373...45,604,467 		JBrowse link
G Hsd17b6 hydroxysteroid (17-beta) dehydrogenase 6 increases expression ISO Arsenic Trioxide results in increased expression of HSD17B6 mRNA CTD PMID:22521957 NCBI chr 7:831,407...850,950
Ensembl chr 7:831,421...850,873 		JBrowse link
G Hsd17b8 hydroxysteroid (17-beta) dehydrogenase 8 decreases expression ISO Arsenic Trioxide results in decreased expression of HSD17B8 mRNA CTD PMID:27829220 NCBI chr20:4,828,571...4,830,635
Ensembl chr20:4,828,608...4,830,634 		JBrowse link
G Hsd3b2 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to HSD3B2 protein] CTD PMID:26598702 NCBI chr 2:188,784,614...188,812,535
Ensembl chr 2:188,784,614...188,790,569 		JBrowse link
G Hsdl1 hydroxysteroid dehydrogenase like 1 multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of HSDL1 mRNA CTD PMID:15894607 NCBI chr19:64,524,435...64,540,527
Ensembl chr19:64,525,891...64,540,762 		JBrowse link
G Hsf1 heat shock transcription factor 1 affects response to substance
increases phosphorylation
multiple interactions
increases activity 		ISO HSF1 protein affects the susceptibility to Arsenic Trioxide
Arsenic Trioxide results in increased phosphorylation of HSF1 protein
2-(morpholin-4-yl)benzo(h)chromen-4-one inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of HSF1 protein]; Arsenic Trioxide results in increased phosphorylation of and affects the localization of HSF1 protein; HSF1 protein affects the reaction [Arsenic Trioxide results in increased activity of CASP9 protein]; HSF1 protein affects the reaction [Arsenic Trioxide results in increased cleavage of PARP1 protein]; HSF1 protein affects the reaction [Arsenic Trioxide results in increased expression of HSPA1A protein]; HSPA1A protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of HSF1 protein]; MAP2K4 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of HSF1 protein]; PI103 inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of HSF1 protein]; pyrazolanthrone inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of HSF1 protein]
Arsenic Trioxide results in increased activity of HSF1 protein 		CTD PMID:15978632 PMID:20724260 PMID:22496356 PMID:34170685 NCBI chr 7:110,076,710...110,103,665
Ensembl chr 7:110,076,710...110,103,665 		JBrowse link
G Hsf2 heat shock transcription factor 2 increases expression ISO Arsenic Trioxide results in increased expression of HSF2 mRNA CTD PMID:25258189 NCBI chr20:37,366,301...37,393,922
Ensembl chr20:37,366,279...37,401,022 		JBrowse link
G Hsp90aa1 heat shock protein 90 alpha family class A member 1 increases expression
multiple interactions
affects response to substance 		ISO
EXP 		Arsenic Trioxide results in increased expression of HSP90AA1 mRNA; Arsenic Trioxide results in increased expression of HSP90AA1 protein
sulforaphane promotes the reaction [Arsenic Trioxide results in increased expression of HSP90AA1 protein]
HSP90AA1 protein affects the susceptibility to Arsenic Trioxide 		CTD PMID:11940349 PMID:18081892 PMID:19364129 PMID:19371599 PMID:19417148 More... NCBI chr 6:135,523,604...135,529,687
Ensembl chr 6:135,523,616...135,528,499 		JBrowse link
G Hsp90ab1 heat shock protein 90 alpha family class B member 1 increases expression
affects response to substance
decreases expression 		ISO Arsenic Trioxide results in increased expression of HSP90AB1 mRNA; Arsenic Trioxide results in increased expression of HSP90AB1 protein
HSP90AB1 protein affects the susceptibility to Arsenic Trioxide
Arsenic Trioxide results in decreased expression of HSP90AB1 protein 		CTD PMID:19364129 PMID:19371599 PMID:20458559 PMID:22521957 PMID:25419056 NCBI chr 9:22,930,249...22,935,929
Ensembl chr 9:22,931,070...22,935,926 		JBrowse link
G Hsp90b1 heat shock protein 90 beta family member 1 increases expression
multiple interactions
decreases expression 		EXP
ISO 		Arsenic Trioxide results in increased expression of HSP90B1 protein
Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of HSP90B1 mRNA]; ATF4 protein promotes the reaction [Arsenic Trioxide results in increased expression of HSP90B1 protein]; Thapsigargin promotes the reaction [Arsenic Trioxide results in increased expression of HSP90B1 protein]
Arsenic Trioxide results in increased expression of HSP90B1 mRNA; Arsenic Trioxide results in increased expression of HSP90B1 protein
Arsenic Trioxide results in decreased expression of HSP90B1 mRNA
Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of HSP90B1 protein] 		CTD PMID:19364129 PMID:20458559 PMID:21145380 PMID:21533816 PMID:27638049 NCBI chr 7:22,997,962...23,012,293
Ensembl chr 7:22,997,962...23,012,293 		JBrowse link
G Hspa1a heat shock protein family A (Hsp70) member 1A multiple interactions
increases expression
affects response to substance
affects expression 		ISO 2-(morpholin-4-yl)benzo(h)chromen-4-one inhibits the reaction [Arsenic Trioxide results in increased expression of HSPA1A protein]; HSF1 protein affects the reaction [Arsenic Trioxide results in increased expression of HSPA1A protein]; HSPA1A protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of HSF1 protein]; KNK 437 inhibits the reaction [Arsenic Trioxide results in increased expression of HSPA1A protein]; PI103 inhibits the reaction [Arsenic Trioxide results in increased expression of HSPA1A mRNA]
Arsenic Trioxide results in increased expression of HSPA1A mRNA; Arsenic Trioxide results in increased expression of HSPA1A protein
HSPA1A protein affects the susceptibility to Arsenic Trioxide
Arsenic Trioxide affects the expression of HSPA1A mRNA 		CTD PMID:12749819 PMID:14610070 PMID:18081892 PMID:19364129 PMID:19371599 More... NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,855,780...3,877,979 		JBrowse link
G Hspa1b heat shock protein family A (Hsp70) member 1B increases expression
affects response to substance
affects expression 		ISO Arsenic Trioxide results in increased expression of HSPA1B mRNA
HSPA1B protein affects the susceptibility to Arsenic Trioxide
Arsenic Trioxide affects the expression of HSPA1B mRNA 		CTD PMID:17530438 PMID:19371599 PMID:19417148 PMID:23824090 PMID:24356939 More... NCBI chr20:3,859,756...3,863,800
Ensembl chr20:3,855,780...3,877,979 		JBrowse link
G Hspa1l heat shock protein family A (Hsp70) member 1 like increases expression ISO Arsenic Trioxide results in increased expression of HSPA1L mRNA CTD PMID:27829220 NCBI chr20:3,853,496...3,860,223
Ensembl chr20:3,853,331...3,876,877 		JBrowse link
G Hspa2 heat shock protein family A (Hsp70) member 2 increases expression ISO Arsenic Trioxide results in increased expression of HSPA2 protein CTD PMID:25419056 NCBI chr 6:100,864,172...100,866,946
Ensembl chr 6:100,864,553...100,867,133 		JBrowse link
G Hspa4 heat shock protein family A (Hsp70) member 4 multiple interactions
increases expression 		ISO Atrazine inhibits the reaction [Arsenic Trioxide results in increased expression of HSPA4 mRNA]
Arsenic Trioxide results in increased expression of HSPA4 mRNA; Arsenic Trioxide results in increased expression of HSPA4 protein 		CTD PMID:11678611 PMID:14682389 PMID:15665116 PMID:19417148 PMID:20458559 NCBI chr10:37,908,866...37,951,994
Ensembl chr10:37,908,866...37,949,835 		JBrowse link
G Hspa4l heat shock protein family A (Hsp70) member 4 like increases expression ISO Arsenic Trioxide results in increased expression of HSPA4L mRNA CTD PMID:26705709 NCBI chr 2:125,668,346...125,726,404
Ensembl chr 2:125,668,236...125,720,986 		JBrowse link
G Hspa5 heat shock protein family A (Hsp70) member 5 increases expression
multiple interactions
affects response to substance
decreases expression 		ISO
EXP 		Arsenic Trioxide results in increased expression of HSPA5 mRNA; Arsenic Trioxide results in increased expression of HSPA5 protein
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Arsenic Trioxide results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [Arsenic Trioxide results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of HSPA5 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of HSPA5 protein]; antimony trichloride promotes the reaction [Arsenic Trioxide results in increased expression of HSPA5 mRNA]; Arsenic Trioxide promotes the reaction [antimony trichloride results in increased expression of HSPA5 mRNA]; ATF4 protein promotes the reaction [Arsenic Trioxide results in increased expression of HSPA5 protein]; HSPA5 mutant form inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; HSPA5 mutant form inhibits the reaction [Arsenic Trioxide results in increased activity of CASP7 protein]; HSPA5 mutant form inhibits the reaction [Arsenic Trioxide results in increased degradation of CASP12 protein]; Thapsigargin promotes the reaction [Arsenic Trioxide results in increased expression of HSPA5 protein]; Thioctic Acid inhibits the reaction [Arsenic Trioxide results in increased expression of HSPA5 protein]
HSPA5 protein affects the susceptibility to Arsenic Trioxide
[Arsenic Trioxide co-treated with Dactinomycin] results in decreased expression of HSPA5 mRNA; [Arsenic Trioxide co-treated with Dactinomycin] results in increased expression of HSPA5 protein; Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [Resveratrol results in increased expression of HSPA5 protein]]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [Resveratrol promotes the reaction [Arsenic Trioxide results in increased expression of HSPA5 protein]]; Arsenic Trioxide promotes the reaction [nilotinib results in increased expression of HSPA5 mRNA]; Arsenic Trioxide promotes the reaction [Resveratrol results in increased expression of HSPA5 protein]; Atrazine promotes the reaction [Arsenic Trioxide results in increased expression of HSPA5 mRNA]; Cycloheximide inhibits the reaction [Arsenic Trioxide results in increased expression of HSPA5 protein]; KIRA6 inhibits the reaction [Arsenic Trioxide results in increased expression of HSPA5 protein]; Resveratrol promotes the reaction [Arsenic Trioxide results in increased expression of HSPA5 protein]; SB 203580 inhibits the reaction [Arsenic Trioxide results in increased expression of HSPA5 protein]; selonsertib inhibits the reaction [Arsenic Trioxide results in increased expression of HSPA5 protein]
Arsenic Trioxide results in decreased expression of HSPA5 mRNA 		CTD PMID:11678611 PMID:19695276 PMID:21145380 PMID:21533816 PMID:22959511 More... NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790 		JBrowse link
G Hspa6l-ps1 heat shock protein family A (Hsp70) member 6 like, pseudogene 1 multiple interactions
increases expression 		ISO MAP2K4 protein promotes the reaction [Arsenic Trioxide results in increased expression of HSPA6 mRNA]; MAP2K4 protein promotes the reaction [Arsenic Trioxide results in increased expression of HSPA6 protein]; pyrazolanthrone inhibits the reaction [Arsenic Trioxide results in increased expression of HSPA6 mRNA]; pyrazolanthrone inhibits the reaction [Arsenic Trioxide results in increased expression of HSPA6 protein]
Arsenic Trioxide results in increased expression of HSPA6 mRNA; Arsenic Trioxide results in increased expression of HSPA6 protein 		CTD PMID:15978632 PMID:19364129 PMID:19417148 PMID:24356939 NCBI chr13:85,805,911...85,807,052 JBrowse link
G Hspa8 heat shock protein family A (Hsp70) member 8 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of HSPA8 protein
Arsenic Trioxide results in increased expression of HSPA6 mRNA
Arsenic Trioxide results in decreased expression of HSPA8 mRNA 		CTD PMID:19364129 PMID:39716349 NCBI chr 8:50,080,514...50,084,376
Ensembl chr 8:50,080,199...50,084,372 		JBrowse link
G Hspa9 heat shock protein family A (Hsp70) member 9 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of HSPA9 protein
ATF4 protein promotes the reaction [Arsenic Trioxide results in increased expression of HSPA9 protein] 		CTD PMID:27638049 NCBI chr18:26,810,004...26,832,958
Ensembl chr18:26,804,774...26,828,398 		JBrowse link
G Hspb1 heat shock protein family B (small) member 1 decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of HSPB1 mRNA
Arsenic Trioxide results in increased expression of HSPB1 mRNA; Arsenic Trioxide results in increased expression of HSPB1 protein 		CTD PMID:15070760 PMID:15761015 PMID:18081892 PMID:19364129 PMID:19417148 More... NCBI chr12:26,430,640...26,432,301
Ensembl chr12:26,430,640...26,432,301 		JBrowse link
G Hspb8 heat shock protein family B (small) member 8 increases expression ISO Arsenic Trioxide results in increased expression of HSPB8 mRNA CTD PMID:26705709 NCBI chr12:45,835,899...45,866,449
Ensembl chr12:45,837,066...45,851,937 		JBrowse link
G Hspd1 heat shock protein family D (Hsp60) member 1 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of HSPD1 mRNA; Arsenic Trioxide results in increased expression of HSPD1 protein
[Arsenic Trioxide co-treated with Curcumin] results in increased expression of HSPD1 protein 		CTD PMID:19417148 PMID:20458559 PMID:22521957 PMID:27430728 NCBI chr 9:64,073,610...64,084,332
Ensembl chr 9:64,073,611...64,084,037 		JBrowse link
G Hsph1 heat shock protein family H (Hsp110) member 1 increases expression ISO Arsenic Trioxide results in increased expression of HSPH1 mRNA CTD PMID:17530438 PMID:19417148 PMID:24356939 NCBI chr12:10,427,368...10,446,602
Ensembl chr12:10,427,297...10,446,891 		JBrowse link
G Htatip2 HIV-1 Tat interactive protein 2 increases expression
decreases response to substance 		ISO Arsenic Trioxide results in increased expression of HTATIP2 mRNA
HTATIP2 protein results in decreased susceptibility to Arsenic Trioxide 		CTD PMID:15761015 PMID:20707922 PMID:22521957 PMID:26705709 NCBI chr 1:108,609,424...108,624,810
Ensembl chr 1:108,605,811...108,624,815 		JBrowse link
G Htatsf1 HIV-1 Tat specific factor 1 increases response to substance ISO HTATSF1 protein results in increased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr  X:139,972,742...139,986,923
Ensembl chr  X:139,972,742...139,986,923 		JBrowse link
G Htr1d 5-hydroxytryptamine receptor 1D decreases response to substance ISO HTR1D protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 5:153,939,735...153,960,012
Ensembl chr 5:153,939,516...153,960,012 		JBrowse link
G Htra2 HtrA serine peptidase 2 multiple interactions
increases expression
decreases localization 		ISO [Arsenic Trioxide co-treated with Quercetin] affects the localization of HTRA2 protein; [Arsenic Trioxide co-treated with TNF protein] affects the localization of HTRA2 protein; [lonidamine co-treated with Arsenic Trioxide] affects the localization of HTRA2 protein; Deoxyglucose promotes the reaction [Arsenic Trioxide results in decreased localization of HTRA2 protein]
Arsenic Trioxide results in increased expression of HTRA2 mRNA 		CTD PMID:17673311 PMID:18359480 PMID:21889928 PMID:22521957 PMID:23041229 NCBI chr 4:117,114,631...117,117,793
Ensembl chr 4:117,114,633...117,117,793 		JBrowse link
G Htra3 HtrA serine peptidase 3 increases expression ISO Arsenic Trioxide results in increased expression of HTRA3 mRNA CTD PMID:19128835 NCBI chr14:79,293,535...79,321,936
Ensembl chr14:79,293,541...79,321,936 		JBrowse link
G Hus1 HUS1 checkpoint clamp component increases expression ISO Arsenic Trioxide results in increased expression of HUS1 mRNA CTD PMID:22521957 NCBI chr14:87,902,458...87,917,221
Ensembl chr14:87,902,458...87,917,134 		JBrowse link
G Huwe1 HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1 increases expression ISO Arsenic Trioxide results in increased expression of HUWE1 mRNA CTD PMID:20458559 NCBI chr  X:24,350,708...24,480,798
Ensembl chr  X:24,353,217...24,480,798 		JBrowse link
G Hyal1 hyaluronidase 1 increases expression ISO Arsenic Trioxide results in increased expression of HYAL1 mRNA CTD PMID:20458559 PMID:22521957 NCBI chr 8:117,129,311...117,133,162
Ensembl chr 8:117,129,277...117,133,146 		JBrowse link
G Hykk hydroxylysine kinase multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to HYKK protein] CTD PMID:26598702 NCBI chr 8:64,212,043...64,235,809
Ensembl chr 8:64,212,071...64,235,818 		JBrowse link
G Iars1 isoleucyl-tRNA synthetase 1 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of IARS1 mRNA
Arsenic Trioxide results in decreased expression of IARS1 mRNA 		CTD PMID:19128835 PMID:20458559 NCBI chr17:15,147,357...15,193,716
Ensembl chr17:15,147,357...15,193,652 		JBrowse link
G Icam1 intercellular adhesion molecule 1 multiple interactions
increases expression
decreases expression 		ISO [Arsenic Trioxide co-treated with Bortezomib] results in decreased expression of ICAM1 mRNA; [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of ICAM1 mRNA; AG 1879 promotes the reaction [Arsenic Trioxide promotes the reaction [Tretinoin results in increased expression of ICAM1 protein]]; Arsenic Trioxide promotes the reaction [AG 1879 results in increased expression of ICAM1 protein]; Arsenic Trioxide promotes the reaction [Tretinoin results in increased expression of ICAM1 protein]
Arsenic Trioxide results in increased expression of ICAM1; Arsenic Trioxide results in increased expression of ICAM1 mRNA; Arsenic Trioxide results in increased expression of ICAM1 protein
Arsenic Trioxide results in decreased expression of ICAM1 mRNA 		CTD PMID:12083632 PMID:15073043 PMID:15894607 PMID:18055984 PMID:20471514 More... NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617 		JBrowse link
G Icoslg inducible T-cell co-stimulator ligand decreases expression ISO Arsenic Trioxide results in decreased expression of ICOSLG mRNA CTD PMID:22521957 NCBI chr20:10,600,078...10,610,385
Ensembl chr20:10,600,078...10,610,365 		JBrowse link
G Id1 inhibitor of DNA binding 1 increases expression
decreases response to substance
decreases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of ID1 mRNA
ID1 protein results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in decreased expression of ID1 mRNA
ID1 protein inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]; ID1 protein inhibits the reaction [Arsenic Trioxide results in increased expression of BAX protein]; ID1 protein inhibits the reaction [Arsenic Trioxide results in increased expression of CASP3 protein] 		CTD PMID:15761015 PMID:20707922 PMID:31079498 NCBI chr 3:161,671,525...161,672,691
Ensembl chr 3:161,671,538...161,672,685 		JBrowse link
G Id2 inhibitor of DNA binding 2 increases expression
multiple interactions
affects expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of ID2 mRNA
[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of ID2 mRNA
Arsenic Trioxide affects the expression of ID2 mRNA; Arsenic Trioxide affects the expression of ID2 protein
Arsenic Trioxide results in decreased expression of ID2 mRNA 		CTD PMID:15761015 PMID:15894607 PMID:21921037 PMID:24356939 PMID:25076250 NCBI chr 6:47,469,162...47,470,995
Ensembl chr 6:47,457,554...47,472,961 		JBrowse link
G Id3 inhibitor of DNA binding 3 multiple interactions ISO [Arsenic Trioxide co-treated with apatinib] results in decreased expression of ID3 mRNA CTD PMID:39223679 NCBI chr 5:153,656,253...153,657,860
Ensembl chr 5:153,630,498...153,657,856 		JBrowse link
G Id4 inhibitor of DNA binding 4 multiple interactions ISO [Arsenic Trioxide results in decreased methylation of ID4 promoter] which results in increased expression of ID4 mRNA CTD PMID:21223739 NCBI chr17:16,595,724...16,598,293
Ensembl chr17:16,595,724...16,598,492 		JBrowse link
G Idh1 isocitrate dehydrogenase (NADP(+)) 1 decreases expression EXP Arsenic Trioxide results in decreased expression of IDH1 mRNA CTD PMID:29223816 NCBI chr 9:74,027,887...74,057,442
Ensembl chr 9:74,027,892...74,049,555 		JBrowse link
G Idh2 isocitrate dehydrogenase (NADP(+)) 2 decreases expression
increases expression 		EXP
ISO 		Arsenic Trioxide results in decreased expression of IDH2 mRNA
Arsenic Trioxide results in increased expression of IDH2 protein 		CTD PMID:25419056 PMID:29223816 NCBI chr 1:143,447,925...143,467,248
Ensembl chr 1:143,439,323...143,467,248 		JBrowse link
G Idnk Idnk, gluconokinase multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to IDNK protein] CTD PMID:26598702 NCBI chr17:6,489,397...6,496,520
Ensembl chr17:6,488,982...6,499,822 		JBrowse link
G Ids iduronate 2-sulfatase increases expression ISO Arsenic Trioxide results in increased expression of IDS mRNA CTD PMID:15761015 NCBI chr  X:154,070,781...154,093,681
Ensembl chr  X:154,070,781...154,091,444 		JBrowse link
G Ier2 immediate early response 2 affects expression ISO Arsenic Trioxide affects the expression of IER2 mRNA CTD PMID:12749819 NCBI chr19:40,399,373...40,400,897
Ensembl chr19:40,398,160...40,402,708 		JBrowse link
G Ier5l immediate early response 5-like decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of IER5L mRNA
Arsenic Trioxide results in increased expression of IER5L mRNA 		CTD PMID:20458559 PMID:39716349 NCBI chr 3:34,141,866...34,143,457
Ensembl chr 3:34,139,672...34,144,452 		JBrowse link
G Ifi44 interferon-induced protein 44 decreases expression ISO Arsenic Trioxide results in decreased expression of IFI44 mRNA CTD PMID:39716349 NCBI chr 2:243,286,050...243,303,869
Ensembl chr 2:243,286,052...243,306,877 		JBrowse link
G Ifih1 interferon induced with helicase C domain 1 decreases expression ISO Arsenic Trioxide results in decreased expression of IFIH1 mRNA CTD PMID:15761015 NCBI chr 3:67,635,924...67,683,968
Ensembl chr 3:67,637,545...67,683,968 		JBrowse link
G Ifit2 interferon-induced protein with tetratricopeptide repeats 2 increases expression ISO Arsenic Trioxide results in increased expression of IFIT2 mRNA CTD PMID:26705709 NCBI chr 1:241,515,735...241,521,799
Ensembl chr 1:241,515,709...241,521,798 		JBrowse link
G Ifit3 interferon-induced protein with tetratricopeptide repeats 3 multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of IFIT3 mRNA CTD PMID:15894607 NCBI chr 1:241,527,326...241,532,469
Ensembl chr 1:241,526,880...241,532,521 		JBrowse link
G Ifitm3 interferon induced transmembrane protein 3 increases expression ISO Arsenic Trioxide results in increased expression of IFITM3 mRNA CTD PMID:20458559 NCBI chr 1:205,540,649...205,541,758
Ensembl chr 1:205,481,168...205,547,920 		JBrowse link
G Ifnb1 interferon beta 1 multiple interactions
decreases expression
increases secretion 		ISO Arsenic Trioxide inhibits the reaction [Lipopolysaccharides results in increased expression of IFNB1 mRNA]; Arsenic Trioxide inhibits the reaction [Lipopolysaccharides results in increased expression of IFNB1 protein]
Arsenic Trioxide results in decreased expression of IFNB1 mRNA
Arsenic Trioxide results in increased secretion of IFNB1 protein 		CTD PMID:23106696 PMID:38684648 NCBI chr 5:108,066,650...108,067,487
Ensembl chr 5:108,066,650...108,067,487 		JBrowse link
G Ifng interferon gamma decreases expression
multiple interactions
increases expression
increases activity
affects expression 		ISO
EXP 		Arsenic Trioxide results in decreased expression of IFNG mRNA; Arsenic Trioxide results in decreased expression of IFNG protein
[Arsenic Trioxide co-treated with Cyclosporine] affects the expression of IFNG mRNA
Arsenic Trioxide results in increased expression of IFNG mRNA; Arsenic Trioxide results in increased expression of IFNG protein
Arsenic Trioxide results in increased activity of IFNG protein
boric acid inhibits the reaction [Arsenic Trioxide results in increased expression of IFNG mRNA]; boric acid inhibits the reaction [Arsenic Trioxide results in increased expression of IFNG protein]; Phloretin inhibits the reaction [Arsenic Trioxide results in increased expression of IFNG protein]
Arsenic Trioxide promotes the reaction [[IFNG protein results in increased activity of STAT1 protein] which results in increased expression of IRF1 mRNA]; Arsenic Trioxide promotes the reaction [IFNG protein results in increased activity of STAT1 protein]; Arsenic Trioxide promotes the reaction [IFNG protein results in increased expression of IRF1 mRNA]; Arsenic Trioxide promotes the reaction [IFNG protein results in increased expression of IRF1 protein]; Arsenic Trioxide promotes the reaction [IFNG protein results in increased phosphorylation of STAT1 protein]; CASP3 protein promotes the reaction [Arsenic Trioxide results in increased activity of IFNG protein]
Arsenic Trioxide affects the expression of IFNG mRNA 		CTD PMID:14668793 PMID:16914093 PMID:19545743 PMID:23802174 PMID:29049341 More... NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216 		JBrowse link
G Ifngr2 interferon gamma receptor 2 increases expression ISO Arsenic Trioxide results in increased expression of IFNGR2 mRNA CTD PMID:29633893 NCBI chr11:44,265,703...44,283,975
Ensembl chr11:44,265,703...44,283,975 		JBrowse link
G Ifrd1 interferon-related developmental regulator 1 decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of IFRD1 mRNA
Arsenic Trioxide results in increased expression of IFRD1 mRNA 		CTD PMID:17547211 PMID:20458559 PMID:24356939 NCBI chr 6:62,996,560...63,044,996
Ensembl chr 6:62,996,562...63,016,131 		JBrowse link
G Ift122 intraflagellar transport 122 decreases expression ISO Arsenic Trioxide results in decreased expression of IFT122 mRNA CTD PMID:39716349 NCBI chr 4:150,577,525...150,648,052
Ensembl chr 4:150,539,786...150,648,052 		JBrowse link
G Ift140 intraflagellar transport 140 increases expression ISO Arsenic Trioxide results in increased expression of IFT140 mRNA CTD PMID:35676786 NCBI chr10:14,537,134...14,624,926
Ensembl chr10:14,537,466...14,624,926 		JBrowse link
G Ift172 intraflagellar transport 172 multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of IFT172 mRNA CTD PMID:15894607 NCBI chr 6:30,801,841...30,841,239
Ensembl chr 6:30,801,918...30,840,830 		JBrowse link
G Igf1 insulin-like growth factor 1 affects response to substance
decreases expression
multiple interactions
increases expression 		ISO
EXP 		IGF1 mRNA affects the susceptibility to Arsenic Trioxide
Arsenic Trioxide results in decreased expression of IGF1 mRNA
Arsenic Trioxide inhibits the reaction [IGF1 protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Arsenic Trioxide inhibits the reaction [IGF1 protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]
Arsenic Trioxide results in increased expression of IGF1 mRNA
Arsenic Trioxide results in decreased expression of IGF1 mRNA; Arsenic Trioxide results in decreased expression of IGF1 protein
Phloretin inhibits the reaction [Arsenic Trioxide results in decreased expression of IGF1 mRNA] 		CTD PMID:18414637 PMID:20458559 PMID:23041229 PMID:23911876 PMID:31258454 More... NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764 		JBrowse link
G Igf1r insulin-like growth factor 1 receptor decreases expression
increases expression
affects response to substance 		ISO Arsenic Trioxide results in decreased expression of IGF1R mRNA
Arsenic Trioxide results in increased expression of IGF1R mRNA
IGF1R mRNA affects the susceptibility to Arsenic Trioxide 		CTD PMID:19769630 PMID:23911876 PMID:24831965 NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:130,959,997...131,248,664 		JBrowse link
G Igf2 insulin-like growth factor 2 multiple interactions
increases expression
decreases expression 		ISO
EXP 		[Arsenic Trioxide co-treated with Curcumin] results in increased expression of IGF2 protein
Arsenic Trioxide results in increased expression of IGF2 mRNA; Arsenic Trioxide results in increased expression of IGF2 protein
Arsenic Trioxide results in decreased expression of IGF2 protein 		CTD PMID:25258189 PMID:27430728 PMID:31258454 NCBI chr 1:207,243,873...207,261,263
Ensembl chr 1:207,243,873...207,260,667 		JBrowse link
G Igf2bp2 insulin-like growth factor 2 mRNA binding protein 2 decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of IGF2BP2 mRNA
IGF2BP2 protein promotes the reaction [Arsenic Trioxide inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]]; IGF2BP2 protein promotes the reaction [Arsenic Trioxide results in increased expression of CASP1 protein modified form]; IGF2BP2 protein promotes the reaction [Arsenic Trioxide results in increased expression of NLRP3 protein]; IGF2BP2 protein promotes the reaction [Arsenic Trioxide results in increased secretion of IL18 protein]; IGF2BP2 protein promotes the reaction [Arsenic Trioxide results in increased secretion of IL1B protein]; IGF2BP2 protein promotes the reaction [Arsenic Trioxide results in increased stability of NLRP3 mRNA] 		CTD PMID:22521957 PMID:35226250 NCBI chr11:92,378,908...92,478,893
Ensembl chr11:92,378,908...92,478,867 		JBrowse link
G Igf2r insulin-like growth factor 2 receptor decreases expression ISO Arsenic Trioxide results in decreased expression of IGF2R protein CTD PMID:25419056 NCBI chr 1:50,526,878...50,615,265
Ensembl chr 1:50,526,878...50,615,265 		JBrowse link
G Igfals insulin-like growth factor binding protein, acid labile subunit decreases expression ISO Arsenic Trioxide results in decreased expression of IGFALS mRNA CTD PMID:35676786 NCBI chr10:14,397,076...14,408,439
Ensembl chr10:14,403,399...14,407,138 		JBrowse link
G Igfbp1 insulin-like growth factor binding protein 1 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of IGFBP1 mRNA
[Arsenic Trioxide co-treated with Curcumin] results in decreased expression of IGFBP1 protein 		CTD PMID:15073043 PMID:27430728 NCBI chr14:86,261,277...86,266,344
Ensembl chr14:86,261,277...86,266,344 		JBrowse link
G Igfbp2 insulin-like growth factor binding protein 2 decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of IGFBP2 mRNA
[Arsenic Trioxide co-treated with Curcumin] results in decreased expression of IGFBP2 protein; Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to IGFBP2 protein] 		CTD PMID:15070760 PMID:15761015 PMID:26598702 PMID:27430728 NCBI chr 9:81,864,811...81,892,179
Ensembl chr 9:81,864,783...81,892,171 		JBrowse link
G Igfbp3 insulin-like growth factor binding protein 3 multiple interactions
increases expression 		ISO [Arsenic Trioxide co-treated with Curcumin] results in increased expression of IGFBP3 protein
Arsenic Trioxide results in increased expression of IGFBP3 protein 		CTD PMID:27430728 NCBI chr14:86,270,208...86,277,944
Ensembl chr14:86,270,208...86,277,944 		JBrowse link
G Igfbp4 insulin-like growth factor binding protein 4 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of IGFBP4 protein
[Arsenic Trioxide co-treated with Curcumin] results in increased expression of IGFBP4 protein; [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of IGFBP4 mRNA 		CTD PMID:15894607 PMID:27430728 NCBI chr10:84,491,471...84,503,487
Ensembl chr10:84,485,775...84,503,473 		JBrowse link
G Igfbp5 insulin-like growth factor binding protein 5 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of IGFBP5 protein
[Arsenic Trioxide co-treated with Curcumin] results in increased expression of IGFBP5 protein 		CTD PMID:27430728 NCBI chr 9:81,901,605...81,914,187
Ensembl chr 9:81,897,616...81,914,390 		JBrowse link
G Igfbp7 insulin-like growth factor binding protein 7 decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of IGFBP7 mRNA
Arsenic Trioxide inhibits the reaction [Dasatinib results in increased expression of IGFBP7 mRNA] 		CTD PMID:15725085 PMID:29266867 NCBI chr14:31,091,681...31,151,623
Ensembl chr14:31,091,347...31,151,620 		JBrowse link
G Ighg1 immunoglobulin heavy constant gamma 1 decreases expression ISO Arsenic Trioxide results in decreased expression of IGHG1 mRNA CTD PMID:20458559
G Igkc immunoglobulin kappa constant multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to IGKC protein] CTD PMID:26598702
G Igsf6 immunoglobulin superfamily, member 6 decreases expression ISO Arsenic Trioxide results in decreased expression of IGSF6 mRNA CTD PMID:19128835 NCBI chr 1:185,041,462...185,051,956
Ensembl chr 1:185,041,462...185,052,245 		JBrowse link
G Ihh Indian hedgehog signaling molecule increases expression ISO Arsenic Trioxide results in increased expression of IHH mRNA CTD PMID:29767511 NCBI chr 9:83,952,986...83,959,203
Ensembl chr 9:83,952,986...83,959,203 		JBrowse link
G Ik IK cytokine increases expression ISO Arsenic Trioxide results in increased expression of IK mRNA CTD PMID:20458559 NCBI chr18:28,632,025...28,646,829
Ensembl chr18:28,631,616...28,653,463 		JBrowse link
G Ikbkb inhibitor of nuclear factor kappa B kinase subunit beta increases expression
decreases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of IKBKB mRNA
Arsenic Trioxide results in decreased expression of IKBKB mRNA; Arsenic Trioxide results in decreased expression of IKBKB protein
[Arsenic Trioxide results in increased phosphorylation of and results in increased activity of IKBKB protein] which results in increased phosphorylation of and results in increased ubiquitination of and results in increased degradation of CCND1 protein; Arsenic Trioxide results in increased phosphorylation of and results in increased activity of IKBKB protein; TNF protein inhibits the reaction [Arsenic Trioxide results in decreased expression of IKBKB mRNA]; TNF protein inhibits the reaction [Arsenic Trioxide results in decreased expression of IKBKB protein] 		CTD PMID:19763917 PMID:22988968 PMID:23949314 PMID:29633893 NCBI chr16:76,021,968...76,075,717
Ensembl chr16:76,022,008...76,081,911 		JBrowse link
G Ikbkg inhibitor of nuclear factor kappa B kinase regulatory subunit gamma decreases expression ISO Arsenic Trioxide results in decreased expression of IKBKG mRNA CTD PMID:19763917 NCBI chr  X:157,358,279...157,397,563
Ensembl chr  X:157,367,639...157,392,757 		JBrowse link
G Il10 interleukin 10 multiple interactions
decreases expression
increases expression
increases secretion 		ISO
EXP 		Arsenic Trioxide affects the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of IL10 mRNA]; Arsenic Trioxide affects the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of IL10 protein]; ATF4 protein affects the reaction [Arsenic Trioxide results in increased expression of IL10 mRNA]; Taurine inhibits the reaction [Arsenic Trioxide results in increased expression of IL10 protein]
Arsenic Trioxide results in decreased expression of IL10 mRNA; Arsenic Trioxide results in decreased expression of IL10 protein
Arsenic Trioxide results in increased expression of IL10 mRNA; Arsenic Trioxide results in increased expression of IL10 protein
Arsenic Trioxide results in increased secretion of IL10 protein
dapagliflozin inhibits the reaction [Arsenic Trioxide results in decreased expression of IL10 protein]; Febuxostat inhibits the reaction [Arsenic Trioxide results in decreased expression of IL10 protein]; Nicorandil inhibits the reaction [Arsenic Trioxide results in decreased expression of IL10 protein]; Phloretin inhibits the reaction [Arsenic Trioxide results in decreased expression of IL10 protein] 		CTD PMID:23802174 PMID:27461142 PMID:28454374 PMID:30237538 PMID:34037972 More... NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580 		JBrowse link
G Il11 interleukin 11 increases expression ISO Arsenic Trioxide results in increased expression of IL11 mRNA CTD PMID:22535156 NCBI chr 1:78,098,622...78,104,915
Ensembl chr 1:78,096,930...78,104,915 		JBrowse link
G Il12rb2 interleukin 12 receptor subunit beta 2 increases expression ISO Arsenic Trioxide results in increased expression of IL12RB2 mRNA CTD PMID:15761015 NCBI chr 4:97,756,089...97,844,937
Ensembl chr 4:97,756,089...97,844,937 		JBrowse link
G Il13 interleukin 13 decreases secretion
decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased secretion of IL13 protein
Arsenic Trioxide results in decreased expression of IL13 mRNA
Arsenic Trioxide inhibits the reaction [GATA3 protein binds to IL13 promoter] 		CTD PMID:19080345 NCBI chr10:38,290,926...38,293,483
Ensembl chr10:38,290,926...38,293,483 		JBrowse link
G Il15 interleukin 15 decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of IL15 mRNA
Arsenic Trioxide results in increased expression of IL15 mRNA 		CTD PMID:20458559 PMID:22521957 PMID:34108876 NCBI chr19:42,536,160...42,611,349
Ensembl chr19:42,545,346...42,611,348 		JBrowse link
G Il17a interleukin 17A decreases expression
decreases secretion 		ISO Arsenic Trioxide results in decreased expression of IL17A mRNA; Arsenic Trioxide results in decreased expression of IL17A protein
Arsenic Trioxide results in decreased secretion of IL17A protein 		CTD PMID:29950232 PMID:34108876 NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:30,640,844...30,644,331 		JBrowse link
G Il17rd interleukin 17 receptor D decreases expression ISO Arsenic Trioxide results in decreased expression of IL17RD mRNA CTD PMID:39716349 NCBI chr16:2,235,172...2,489,827
Ensembl chr16:2,235,169...2,301,850 		JBrowse link
G Il18 interleukin 18 decreases expression
increases secretion
multiple interactions
increases expression 		ISO Arsenic Trioxide results in decreased expression of IL18
Arsenic Trioxide results in increased secretion of IL18 protein
IGF2BP2 protein promotes the reaction [Arsenic Trioxide results in increased secretion of IL18 protein]; METTL14 protein promotes the reaction [Arsenic Trioxide results in increased secretion of IL18 protein]
Arsenic Trioxide results in increased expression of IL18 mRNA 		CTD PMID:20693187 PMID:35226250 PMID:36801614 NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:59,809,592...59,831,286 		JBrowse link
G Il18r1 interleukin 18 receptor 1 decreases expression ISO Arsenic Trioxide results in decreased expression of IL18R1 mRNA CTD PMID:35676786 NCBI chr 9:50,223,274...50,257,370
Ensembl chr 9:50,223,200...50,257,367 		JBrowse link
G Il19 interleukin 19 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of IL19 mRNA
Arsenic Trioxide results in decreased expression of IL19 protein 		CTD PMID:20458559 PMID:37166470 NCBI chr13:44,949,989...44,958,714
Ensembl chr13:44,949,989...44,958,714 		JBrowse link
G Il1a interleukin 1 alpha increases expression
decreases expression
affects expression
multiple interactions 		ISO
EXP 		Arsenic Trioxide results in increased expression of IL1A mRNA
Arsenic Trioxide results in decreased expression of IL1A mRNA
Arsenic Trioxide affects the expression of IL1A mRNA
Arsenic Trioxide results in increased expression of IL1A protein
trans-sodium crocetinate inhibits the reaction [Arsenic Trioxide results in increased expression of IL1A protein] 		CTD PMID:17530438 PMID:22521957 PMID:31734849 PMID:33173984 NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:136,979,805...136,998,013 		JBrowse link
G Il1b interleukin 1 beta increases expression
multiple interactions
decreases expression
affects expression
increases secretion 		ISO
EXP 		Arsenic Trioxide results in increased expression of IL1B mRNA; Arsenic Trioxide results in increased expression of IL1B protein
3-methyladenine inhibits the reaction [[Arsenic Trioxide co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of IL1B protein]; [acetyl-11-ketoboswellic acid co-treated with Arsenic Trioxide] results in decreased secretion of IL1B protein; [Arsenic Trioxide co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of IL1B protein; Arsenic Trioxide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of IL1B protein]; Arsenic Trioxide promotes the reaction [Tretinoin results in increased expression of IL1B mRNA]; Arsenic Trioxide promotes the reaction [Tretinoin results in increased secretion of IL1B protein]; AS3MT mRNA promotes the reaction [Arsenic Trioxide results in increased expression of IL1B protein]; CA 074 methyl ester inhibits the reaction [[Arsenic Trioxide co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of IL1B protein]; IGF2BP2 protein promotes the reaction [Arsenic Trioxide results in increased secretion of IL1B protein]; METTL14 protein promotes the reaction [Arsenic Trioxide results in increased secretion of IL1B protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[Arsenic Trioxide co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of IL1B protein]; Taurine inhibits the reaction [[Arsenic Trioxide co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of IL1B protein]
Arsenic Trioxide results in decreased expression of IL1B; Arsenic Trioxide results in decreased expression of IL1B mRNA
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Arsenic Trioxide results in increased expression of and results in increased secretion of IL1B protein]; [Arsenic Trioxide co-treated with Lipopolysaccharides] results in increased expression of IL1B protein; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Arsenic Trioxide results in increased expression of and results in increased secretion of IL1B protein]; Arsenic Trioxide results in increased expression of and results in increased secretion of IL1B protein; boric acid inhibits the reaction [Arsenic Trioxide results in increased expression of IL1B mRNA]; boric acid inhibits the reaction [Arsenic Trioxide results in increased expression of IL1B protein]; dapagliflozin inhibits the reaction [Arsenic Trioxide results in increased expression of IL1B protein]; Febuxostat inhibits the reaction [Arsenic Trioxide results in increased expression of IL1B protein]; Lenalidomide inhibits the reaction [[Arsenic Trioxide co-treated with Lipopolysaccharides] results in increased expression of IL1B protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[Arsenic Trioxide co-treated with Lipopolysaccharides] results in increased expression of IL1B protein]; NEAT1 mRNA affects the reaction [Arsenic Trioxide affects the expression of IL1B mRNA]; NEAT1 mRNA affects the reaction [Arsenic Trioxide affects the expression of IL1B protein]; Nicorandil inhibits the reaction [Arsenic Trioxide results in increased expression of IL1B protein]; polydatin inhibits the reaction [Arsenic Trioxide results in increased expression of IL1B mRNA]; pyrazolanthrone inhibits the reaction [Arsenic Trioxide results in increased expression of and results in increased secretion of IL1B protein]; Taurine inhibits the reaction [[Arsenic Trioxide co-treated with Lipopolysaccharides] results in increased expression of IL1B protein]; Taurine inhibits the reaction [Arsenic Trioxide results in increased expression of IL1B protein]; trans-sodium crocetinate inhibits the reaction [Arsenic Trioxide results in increased expression of IL1B protein]
18alpha,20beta-hydroxy-11-oxo-norolean-12-en-3beta-yl-2-O-beta-D-glucopyranurosyl-alpha-D-glucopyranosiduronate magnesium tetrahydrate inhibits the reaction [Arsenic Trioxide results in increased expression of IL1B mRNA]; 18alpha,20beta-hydroxy-11-oxo-norolean-12-en-3beta-yl-2-O-beta-D-glucopyranurosyl-alpha-D-glucopyranosiduronate magnesium tetrahydrate inhibits the reaction [Arsenic Trioxide results in increased expression of IL1B protein]; 2-aminoethoxydiphenyl borate inhibits the reaction [Arsenic Trioxide results in decreased expression of IL1B mRNA]; 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid inhibits the reaction [Arsenic Trioxide results in decreased expression of IL1B mRNA]; [Arsenic Trioxide results in increased abundance of arsenite] which results in increased expression of IL1B protein; Arsenic Trioxide affects the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the cleavage of IL1B protein]; Arsenic Trioxide affects the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of IL1B mRNA]; Arsenic Trioxide inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of IL1B protein]; Arsenic Trioxide inhibits the reaction [anthrax toxin results in increased secretion of and results in increased cleavage of IL1B protein]; Arsenic Trioxide inhibits the reaction [Nigericin results in increased cleavage of IL1B protein]; Arsenic Trioxide promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; ATF4 protein affects the reaction [Arsenic Trioxide results in decreased expression of IL1B mRNA]; baicalin inhibits the reaction [Arsenic Trioxide results in increased expression of IL1B protein]; Plant Extracts inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic Trioxide] which results in increased expression of IL1B protein]; Quin2 inhibits the reaction [Arsenic Trioxide results in decreased expression of IL1B mRNA]; Taurine inhibits the reaction [Arsenic Trioxide results in increased expression of IL1B protein]
Arsenic Trioxide affects the expression of IL1B mRNA; Arsenic Trioxide affects the expression of IL1B protein 		CTD PMID:20339114 PMID:20458559 PMID:20693187 PMID:21078271 PMID:22535156 More... NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601 		JBrowse link
G Il1f10 interleukin 1 family member 10 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to IL1F10 protein] CTD PMID:26598702 NCBI chr 3:27,470,798...27,473,726
Ensembl chr 3:27,470,798...27,473,726 		JBrowse link
G Il1r2 interleukin 1 receptor type 2 increases expression ISO Arsenic Trioxide results in increased expression of IL1R2 mRNA CTD PMID:21461292 PMID:37969188 NCBI chr 9:49,879,928...49,920,374
Ensembl chr 9:49,877,266...49,920,374 		JBrowse link
G Il1rn interleukin 1 receptor antagonist multiple interactions
decreases response to substance
decreases expression 		ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to IL1RN protein]
IL1RN protein results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in decreased expression of IL1RN mRNA 		CTD PMID:19128835 PMID:26598702 PMID:27174766 NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:27,509,798...27,525,732 		JBrowse link
G Il2 interleukin 2 decreases expression
multiple interactions
increases expression 		ISO
EXP 		Arsenic Trioxide results in decreased expression of IL2 mRNA; Arsenic Trioxide results in decreased expression of IL2 protein
[Arsenic Trioxide results in increased abundance of arsenite] which results in increased expression of IL2 protein
Phloretin inhibits the reaction [Arsenic Trioxide results in increased expression of IL2 protein] 		CTD PMID:23802174 PMID:29049341 PMID:34037972 PMID:34108876 PMID:36791901 More... NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672 		JBrowse link
G Il20rb interleukin 20 receptor subunit beta increases expression ISO Arsenic Trioxide results in increased expression of IL20RB mRNA CTD PMID:26705709 NCBI chr 8:109,858,108...109,896,066
Ensembl chr 8:109,854,012...109,889,363 		JBrowse link
G Il22ra1 interleukin 22 receptor subunit alpha 1 increases expression ISO Arsenic Trioxide results in increased expression of IL22RA1 mRNA CTD PMID:22521957 NCBI chr 5:153,245,067...153,269,865
Ensembl chr 5:153,245,002...153,271,683 		JBrowse link
G Il23a interleukin 23 subunit alpha decreases expression ISO Arsenic Trioxide results in decreased expression of IL23A CTD PMID:20693187 NCBI chr 7:1,306,320...1,308,434
Ensembl chr 7:1,306,320...1,308,434 		JBrowse link
G Il24 interleukin 24 increases activity
multiple interactions 		ISO Arsenic Trioxide results in increased activity of IL24 protein
[Arsenic Trioxide co-treated with IL24 protein] results in decreased expression of BCL2L1; [Arsenic Trioxide co-treated with IL24 protein] results in decreased expression of CASP3; [Arsenic Trioxide co-treated with IL24 protein] results in decreased expression of PARP1; [IL24 protein co-treated with Arsenic Trioxide] results in increased phosphorylation of MAPK1 protein; [IL24 protein co-treated with Arsenic Trioxide] results in increased phosphorylation of MAPK3 protein; [IL24 protein co-treated with Arsenic Trioxide] results in increased phosphorylation of MAPK7 protein; [IL24 protein co-treated with Arsenic Trioxide] results in increased phosphorylation of MAPK8 protein; [IL24 protein co-treated with Arsenic Trioxide] results in increased phosphorylation of MAPK9 protein 		CTD PMID:12883035 PMID:14678967 PMID:15580305 NCBI chr13:44,905,362...44,910,760
Ensembl chr13:44,905,363...44,910,760 		JBrowse link
G Il27ra interleukin 27 receptor subunit alpha decreases expression ISO Arsenic Trioxide results in decreased expression of IL27RA mRNA CTD PMID:19128835 NCBI chr19:41,014,730...41,026,740
Ensembl chr19:41,014,730...41,026,760 		JBrowse link
G Il2ra interleukin 2 receptor subunit alpha increases expression ISO Arsenic Trioxide results in increased expression of IL2RA mRNA CTD PMID:34108876 NCBI chr17:71,759,802...71,808,475
Ensembl chr17:71,759,802...71,808,507 		JBrowse link
G Il36a interleukin 36, alpha multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to IL36A protein] CTD PMID:26598702 NCBI chr 3:27,395,146...27,399,695
Ensembl chr 3:27,395,146...27,399,695 		JBrowse link
G Il3ra interleukin 3 receptor subunit alpha multiple interactions
decreases expression 		ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to IL3RA protein]
Arsenic Trioxide results in decreased expression of IL3RA mRNA; Arsenic Trioxide results in decreased expression of IL3RA protein 		CTD PMID:24791595 PMID:26598702 NCBI chr12:21,431,848...21,437,336
Ensembl chr12:21,431,848...21,437,250 		JBrowse link
G Il4 interleukin 4 decreases expression
affects expression 		ISO Arsenic Trioxide results in decreased expression of IL4 protein
Arsenic Trioxide results in decreased expression of IL4 mRNA
Arsenic Trioxide affects the expression of IL4 protein 		CTD PMID:12243866 PMID:15073043 PMID:18357729 PMID:29950232 NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549 		JBrowse link
G Il4r interleukin 4 receptor decreases expression ISO Arsenic Trioxide results in decreased expression of IL4R mRNA CTD PMID:12243866 PMID:22521957 NCBI chr 1:189,545,739...189,570,639
Ensembl chr 1:189,544,988...189,570,636 		JBrowse link
G Il6 interleukin 6 decreases expression
increases expression
multiple interactions
increases secretion
decreases secretion
affects expression 		EXP
ISO 		Arsenic Trioxide results in decreased expression of IL6 mRNA
Arsenic Trioxide results in increased expression of IL6 protein
Arsenic Trioxide results in increased expression of IL6 mRNA; Arsenic Trioxide results in increased expression of IL6 protein
18alpha,20beta-hydroxy-11-oxo-norolean-12-en-3beta-yl-2-O-beta-D-glucopyranurosyl-alpha-D-glucopyranosiduronate magnesium tetrahydrate inhibits the reaction [Arsenic Trioxide results in increased expression of IL6 mRNA]; 18alpha,20beta-hydroxy-11-oxo-norolean-12-en-3beta-yl-2-O-beta-D-glucopyranurosyl-alpha-D-glucopyranosiduronate magnesium tetrahydrate inhibits the reaction [Arsenic Trioxide results in increased expression of IL6 protein]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Arsenic Trioxide results in increased expression of IL6 mRNA]; [Arsenic Trioxide results in increased abundance of arsenite] which results in increased expression of IL6 protein; Arsenic Trioxide affects the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of IL6 mRNA]; Arsenic Trioxide affects the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of IL6 protein]; baicalin inhibits the reaction [Arsenic Trioxide results in increased expression of IL6 protein]; pyrazolanthrone promotes the reaction [Arsenic Trioxide results in increased expression of IL6 mRNA]; Taurine inhibits the reaction [Arsenic Trioxide results in increased expression of IL6 protein]; Thioctic Acid inhibits the reaction [Arsenic Trioxide results in increased expression of IL6 mRNA]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased expression of and results in increased secretion of IL6 protein]; [Folic Acid co-treated with Vitamin B 12] inhibits the reaction [Arsenic Trioxide results in increased expression of IL6 protein]; Arsenic Trioxide results in increased expression of and results in increased secretion of IL6 protein; crocin inhibits the reaction [Arsenic Trioxide results in increased expression of IL6 mRNA]; crocin inhibits the reaction [Arsenic Trioxide results in increased expression of IL6 protein]; dapagliflozin inhibits the reaction [Arsenic Trioxide results in increased expression of IL6 protein]; Diosgenin inhibits the reaction [Arsenic Trioxide results in increased expression of and results in increased secretion of IL6 protein]; Febuxostat inhibits the reaction [Arsenic Trioxide results in increased expression of IL6 protein]; NEAT1 mRNA affects the reaction [Arsenic Trioxide affects the expression of IL6 mRNA]; NEAT1 mRNA affects the reaction [Arsenic Trioxide affects the expression of IL6 protein]; Nicorandil inhibits the reaction [Arsenic Trioxide results in increased expression of IL6 protein]; NR3C1 promotes the reaction [Diosgenin inhibits the reaction [Arsenic Trioxide results in increased expression of and results in increased secretion of IL6 protein]]; Phloretin inhibits the reaction [Arsenic Trioxide results in increased expression of IL6 protein]; trans-sodium crocetinate inhibits the reaction [Arsenic Trioxide results in increased expression of IL6 protein]
[Arsenic Trioxide co-treated with IFNA2 protein] results in decreased expression of IL6 mRNA; Arsenic Trioxide inhibits the reaction [IL6 protein results in increased phosphorylation of and results in increased activity of STAT3 protein]; Arsenic Trioxide inhibits the reaction [IL6 protein results in increased phosphorylation of JAK1 protein]; Arsenic Trioxide inhibits the reaction [IL6 protein results in increased phosphorylation of JAK2 protein]; Arsenic Trioxide results in decreased susceptibility to and results in decreased expression of IL6 protein; MIR491 mRNA promotes the reaction [Arsenic Trioxide results in decreased expression of IL6 mRNA]
Arsenic Trioxide results in increased secretion of IL6 protein
Arsenic Trioxide results in decreased secretion of IL6 protein
Arsenic Trioxide affects the expression of IL6 mRNA; Arsenic Trioxide affects the expression of IL6 protein 		CTD PMID:12492118 PMID:12560223 PMID:16214333 PMID:22465848 PMID:22488045 More... NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610 		JBrowse link
G Il6st interleukin 6 cytokine family signal transducer increases expression ISO Arsenic Trioxide results in increased expression of IL6ST mRNA CTD PMID:15073043 NCBI chr 2:45,798,872...45,839,501
Ensembl chr 2:45,799,380...45,843,182 		JBrowse link
G Il7r interleukin 7 receptor increases expression ISO Arsenic Trioxide results in increased expression of IL7R protein CTD PMID:34108876 NCBI chr 2:60,179,561...60,204,937
Ensembl chr 2:60,181,382...60,211,027 		JBrowse link
G Ilkap ILK associated serine/threonine phosphatase multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ILKAP protein] CTD PMID:26598702 NCBI chr 9:99,413,981...99,436,262
Ensembl chr 9:99,413,978...99,436,418 		JBrowse link
G Impa2 inositol monophosphatase 2 decreases expression ISO Arsenic Trioxide results in decreased expression of IMPA2 mRNA CTD PMID:29633893 NCBI chr18:63,104,113...63,135,232
Ensembl chr18:63,104,083...63,137,543 		JBrowse link
G Impdh2 inosine monophosphate dehydrogenase 2 increases expression ISO Arsenic Trioxide results in increased expression of IMPDH2 mRNA CTD PMID:22521957 NCBI chr 8:118,135,204...118,139,892
Ensembl chr 8:118,135,262...118,139,873 		JBrowse link
G Ing2 inhibitor of growth family, member 2 decreases expression ISO Arsenic Trioxide results in decreased expression of ING2 mRNA CTD PMID:35676786 NCBI chr16:51,305,311...51,316,177
Ensembl chr16:51,307,466...51,316,177 		JBrowse link
G Ing5 inhibitor of growth family, member 5 increases expression ISO Arsenic Trioxide results in increased expression of ING5 mRNA CTD PMID:20458559 NCBI chr 9:101,772,845...101,793,734
Ensembl chr 9:101,773,724...101,793,728 		JBrowse link
G Inhba inhibin subunit beta A decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of INHBA mRNA
[Arsenic Trioxide co-treated with Tretinoin] results in decreased expression of INHBA mRNA 		CTD PMID:20458559 PMID:38179723 NCBI chr17:53,787,159...53,810,942
Ensembl chr17:53,791,444...53,804,508 		JBrowse link
G Inhbb inhibin subunit beta B increases expression ISO Arsenic Trioxide results in increased expression of INHBB mRNA CTD PMID:29633893 NCBI chr13:33,083,671...33,089,373
Ensembl chr13:33,083,671...33,089,609 		JBrowse link
G Inhbc inhibin subunit beta C multiple interactions ISO [Arsenic Trioxide co-treated with apatinib] results in increased expression of INHBC mRNA CTD PMID:39223679 NCBI chr 7:65,069,450...65,082,919
Ensembl chr 7:65,069,451...65,082,919 		JBrowse link
G Inhbe inhibin subunit beta E increases expression ISO Arsenic Trioxide results in increased expression of INHBE mRNA CTD PMID:27829220 NCBI chr 7:65,061,531...65,064,519
Ensembl chr 7:65,061,531...65,064,519 		JBrowse link
G Inip INTS3 and NABP interacting protein increases expression ISO Arsenic Trioxide results in increased expression of INIP mRNA CTD PMID:39716349 NCBI chr 5:79,443,317...79,457,552
Ensembl chr 5:79,443,317...79,457,552 		JBrowse link
G Inka1 inka box actin regulator 1 decreases expression ISO Arsenic Trioxide results in decreased expression of INKA1 mRNA CTD PMID:20458559 NCBI chr 8:117,552,875...117,554,565
Ensembl chr 8:117,552,875...117,554,565 		JBrowse link
G Ino80 INO80 complex ATPase subunit increases expression ISO Arsenic Trioxide results in increased expression of INO80 mRNA CTD PMID:29633893 NCBI chr 3:126,822,280...126,919,532
Ensembl chr 3:126,822,280...126,919,532 		JBrowse link
G Inpp1 inositol polyphosphate-1-phosphatase decreases response to substance ISO INPP1 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 9:56,161,816...56,209,774
Ensembl chr 9:56,161,852...56,234,569 		JBrowse link
G Inpp5b inositol polyphosphate-5-phosphatase B increases expression ISO Arsenic Trioxide results in increased expression of INPP5B mRNA CTD PMID:15761015 NCBI chr 5:142,281,454...142,345,993
Ensembl chr 5:142,281,418...142,345,991 		JBrowse link
G Inppl1 inositol polyphosphate phosphatase-like 1 increases expression ISO Arsenic Trioxide results in increased expression of INPPL1 mRNA CTD PMID:20458559 NCBI chr 1:165,595,047...165,609,503
Ensembl chr 1:165,595,063...165,609,503 		JBrowse link
G Ins1 insulin 1 decreases secretion
increases expression
decreases expression
multiple interactions 		ISO
EXP 		Arsenic Trioxide results in decreased secretion of INS1 protein
Arsenic Trioxide results in increased expression of INS1 protein
Arsenic Trioxide results in decreased expression of INS1 protein
7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine inhibits the reaction [Arsenic Trioxide inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; [Estrogens deficiency co-treated with Arsenic Trioxide] inhibits the reaction [INS1 protein results in decreased abundance of Blood Glucose]; [Estrogens deficiency co-treated with Arsenic Trioxide] results in increased expression of INS1 protein; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased secretion of INS1 protein]; Arsenic Trioxide inhibits the reaction [Estradiol promotes the reaction [Glucose results in increased secretion of INS1 protein]]; Arsenic Trioxide inhibits the reaction [Glucose results in increased secretion of INS1 protein]; Arsenic Trioxide promotes the reaction [Estrogens deficiency inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; Estradiol inhibits the reaction [[Arsenic Trioxide co-treated with Estrogens deficiency] inhibits the reaction [INS1 protein results in decreased abundance of Blood Glucose]]; Estradiol inhibits the reaction [[Estrogens deficiency co-treated with Arsenic Trioxide] results in increased expression of INS1 protein]; Estradiol inhibits the reaction [Arsenic Trioxide promotes the reaction [Estrogens deficiency inhibits the reaction [Glucose results in increased secretion of INS1 protein]]]
Arsenic Trioxide inhibits the reaction [[Glucose co-treated with Lipopolysaccharides] results in increased secretion of INS1 protein]; Lenalidomide inhibits the reaction [Arsenic Trioxide inhibits the reaction [[Glucose co-treated with Lipopolysaccharides] results in increased secretion of INS1 protein]]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Arsenic Trioxide inhibits the reaction [[Glucose co-treated with Lipopolysaccharides] results in increased secretion of INS1 protein]]; Taurine inhibits the reaction [Arsenic Trioxide inhibits the reaction [[Glucose co-treated with Lipopolysaccharides] results in increased secretion of INS1 protein]] 		CTD PMID:21145380 PMID:25859628 PMID:29111283 PMID:30385301 PMID:30660605 More... NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:261,186,119...261,186,682 		JBrowse link
G Ins2 insulin 2 multiple interactions ISO Arsenic Trioxide inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]; Plant Extracts inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic Trioxide] which results in decreased expression of INS2 protein]
Arsenic Trioxide inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]; AS3MT mRNA promotes the reaction [Arsenic Trioxide inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]]; IGF2BP2 protein promotes the reaction [Arsenic Trioxide inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]]; INS protein inhibits the reaction [[Arsenic Trioxide co-treated with Glucose] results in increased expression of AQP7 mRNA]; INS protein inhibits the reaction [[Arsenic Trioxide co-treated with Glucose] results in increased expression of AQP7 protein]; METTL14 protein promotes the reaction [Arsenic Trioxide inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Arsenic Trioxide inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]] 		CTD PMID:32226249 PMID:35226250 PMID:37146668 NCBI chr 1:207,272,738...207,421,998
Ensembl chr 1:207,272,742...207,273,805 		JBrowse link
G Insig1 insulin induced gene 1 multiple interactions
decreases expression 		ISO [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of INSIG1 mRNA
Arsenic Trioxide results in decreased expression of INSIG1 mRNA 		CTD PMID:15894607 NCBI chr 4:8,049,339...8,057,812
Ensembl chr 4:8,049,556...8,057,778 		JBrowse link
G Insm1 INSM transcriptional repressor 1 increases expression ISO Arsenic Trioxide results in increased expression of INSM1 mRNA CTD PMID:15761015 NCBI chr 3:154,093,310...154,096,243
Ensembl chr 3:154,092,734...154,096,047 		JBrowse link
G Insrr insulin receptor-related receptor decreases expression ISO Arsenic Trioxide results in decreased expression of INSRR mRNA CTD PMID:35676786 NCBI chr 2:175,553,244...175,572,676
Ensembl chr 2:175,553,293...175,572,676 		JBrowse link
G Ints6 integrator complex subunit 6 increases expression ISO Arsenic Trioxide results in increased expression of INTS6 mRNA CTD PMID:20458559 PMID:35676786 NCBI chr15:41,080,584...41,224,350
Ensembl chr15:41,109,125...41,197,519 		JBrowse link
G Iqch IQ motif containing H increases expression ISO Arsenic Trioxide results in increased expression of IQCH mRNA CTD PMID:15761015 NCBI chr 8:72,784,932...72,978,632
Ensembl chr 8:72,787,756...72,978,598 		JBrowse link
G Irak1 interleukin-1 receptor-associated kinase 1 decreases expression ISO Arsenic Trioxide results in decreased expression of IRAK1 mRNA CTD PMID:23911876 NCBI chr  X:156,919,927...156,929,825
Ensembl chr  X:156,920,081...156,929,825 		JBrowse link
G Irf1 interferon regulatory factor 1 decreases expression
multiple interactions
increases expression 		ISO Arsenic Trioxide results in decreased expression of IRF1 mRNA
Arsenic Trioxide promotes the reaction [[IFNG protein results in increased activity of STAT1 protein] which results in increased expression of IRF1 mRNA]; Arsenic Trioxide promotes the reaction [IFNG protein results in increased expression of IRF1 mRNA]; Arsenic Trioxide promotes the reaction [IFNG protein results in increased expression of IRF1 protein]
Arsenic Trioxide results in increased expression of IRF1 mRNA 		CTD PMID:14668793 PMID:16914093 PMID:20458559 PMID:20953137 PMID:22521957 NCBI chr10:38,417,935...38,424,946
Ensembl chr10:38,417,148...38,424,947 		JBrowse link
G Irf3 interferon regulatory factor 3 multiple interactions
increases phosphorylation 		ISO Arsenic Trioxide inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of IRF3 protein]; STING1 promotes the reaction [Arsenic Trioxide results in increased phosphorylation of IRF3 protein] CTD PMID:23106696 PMID:38684648 NCBI chr 1:104,616,608...104,621,402
Ensembl chr 1:104,616,469...104,621,401 		JBrowse link
G Irf4 interferon regulatory factor 4 affects methylation
increases expression 		ISO Arsenic Trioxide affects the methylation of IRF4 promoter
Arsenic Trioxide results in increased expression of IRF4 mRNA 		CTD PMID:26046465 PMID:35676786 NCBI chr17:33,930,460...33,948,842
Ensembl chr17:33,930,471...33,948,730 		JBrowse link
G Irf6 interferon regulatory factor 6 decreases response to substance ISO IRF6 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr13:107,200,876...107,220,083
Ensembl chr13:107,200,731...107,220,049 		JBrowse link
G Irf7 interferon regulatory factor 7 decreases expression ISO Arsenic Trioxide results in decreased expression of IRF7 mRNA; Arsenic Trioxide results in decreased expression of IRF7 protein CTD PMID:32642412 NCBI chr 1:205,796,956...205,800,543
Ensembl chr 1:205,796,959...205,800,023 		JBrowse link
G Irf8 interferon regulatory factor 8 increases expression ISO Arsenic Trioxide results in increased expression of IRF8 mRNA CTD PMID:39716349 NCBI chr19:65,699,284...65,721,066
Ensembl chr19:65,699,284...65,721,062 		JBrowse link
G Irs1 insulin receptor substrate 1 increases phosphorylation
decreases expression
affects response to substance
multiple interactions 		ISO Arsenic Trioxide results in increased phosphorylation of IRS1 protein
Arsenic Trioxide results in decreased expression of IRS1 mRNA
IRS1 mRNA affects the susceptibility to Arsenic Trioxide
3-methyladenine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of IRS1 protein]; Palmitic Acid inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of IRS1 protein]; Rosiglitazone inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of IRS1 protein]; Taurine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of IRS1 protein] 		CTD PMID:20458559 PMID:23911876 PMID:30362509 NCBI chr 9:91,001,137...91,053,959
Ensembl chr 9:90,993,519...91,054,538 		JBrowse link
G Isg15 ISG15 ubiquitin-like modifier decreases expression ISO Arsenic Trioxide results in decreased expression of ISG15 protein CTD PMID:19364129 NCBI chr 5:172,066,369...172,067,656
Ensembl chr 5:172,066,369...172,067,656 		JBrowse link
G Isl2 ISL LIM homeobox 2 increases expression ISO Arsenic Trioxide results in increased expression of ISL2 mRNA CTD PMID:24356939 NCBI chr 8:64,819,879...64,824,864
Ensembl chr 8:64,819,879...64,824,864 		JBrowse link
G Islr2 immunoglobulin superfamily containing leucine-rich repeat 2 increases expression ISO Arsenic Trioxide results in increased expression of ISLR2 mRNA CTD PMID:35676786 NCBI chr 8:67,504,042...67,512,125
Ensembl chr 8:67,504,037...67,513,708 		JBrowse link
G Itga2 integrin subunit alpha 2 decreases response to substance
decreases expression 		ISO ITGA2 protein results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in decreased expression of ITGA2 mRNA 		CTD PMID:20707922 PMID:25258189 NCBI chr 2:48,253,412...48,354,509
Ensembl chr 2:48,253,412...48,354,509 		JBrowse link
G Itga2b integrin subunit alpha 2b increases expression ISO Arsenic Trioxide results in increased expression of ITGA2B mRNA CTD PMID:15761015 NCBI chr10:87,908,697...87,926,225
Ensembl chr10:87,908,697...87,925,833 		JBrowse link
G Itga4 integrin subunit alpha 4 decreases expression ISO Arsenic Trioxide results in decreased expression of ITGA4 mRNA CTD PMID:26238599 NCBI chr 3:84,569,487...84,646,276
Ensembl chr 3:84,560,369...84,641,039 		JBrowse link
G Itga6 integrin subunit alpha 6 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of ITGA6 mRNA
[Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of ITGA6 mRNA 		CTD PMID:15894607 PMID:29633893 NCBI chr 3:77,012,168...77,097,076
Ensembl chr 3:77,017,766...77,097,076 		JBrowse link
G Itga9 integrin subunit alpha 9 decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of ITGA9 mRNA
Arsenic Trioxide results in increased expression of ITGA9 mRNA 		CTD PMID:26705709 PMID:35676786 NCBI chr 8:127,185,244...127,493,296
Ensembl chr 8:127,169,226...127,493,296 		JBrowse link
G Itgam integrin subunit alpha M decreases expression
increases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of ITGAM protein
Arsenic Trioxide results in increased expression of ITGAM mRNA; Arsenic Trioxide results in increased expression of ITGAM protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Sirolimus co-treated with Arsenic Trioxide] results in increased expression of ITGAM protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased expression of ITGAM protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Gefitinib promotes the reaction [Arsenic Trioxide results in increased expression of ITGAM protein]]; [Arsenic Trioxide co-treated with Tretinoin] results in increased expression of ITGAM protein; [Sirolimus co-treated with Arsenic Trioxide] results in increased expression of ITGAM protein; [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of ITGAM mRNA; AG 1879 promotes the reaction [[Arsenic Trioxide co-treated with Tretinoin] results in increased expression of ITGAM protein]; Arsenic Trioxide promotes the reaction [Tretinoin results in increased expression of ITGAM protein]; Gefitinib promotes the reaction [Arsenic Trioxide results in increased expression of ITGAM mRNA]; Gefitinib promotes the reaction [Arsenic Trioxide results in increased expression of ITGAM protein]
ATF4 protein affects the reaction [Arsenic Trioxide results in decreased expression of ITGAM protein] 		CTD PMID:10648417 PMID:16174796 PMID:16430862 PMID:16468075 PMID:20226526 More... NCBI chr 1:192,089,496...192,139,947
Ensembl chr 1:192,089,542...192,139,943 		JBrowse link
G Itgav integrin subunit alpha V multiple interactions ISO [Arsenic Trioxide co-treated with Bortezomib] results in decreased expression of ITGAV mRNA CTD PMID:25913414 NCBI chr 3:89,245,382...89,333,512
Ensembl chr 3:89,245,095...89,333,511 		JBrowse link
G Itgax integrin subunit alpha X decreases expression
multiple interactions
increases expression 		ISO Arsenic Trioxide results in decreased expression of ITGAX protein
RELA protein inhibits the reaction [Arsenic Trioxide results in decreased expression of ITGAX protein]
Arsenic Trioxide results in increased expression of ITGAX protein 		CTD PMID:16174796 PMID:32587277 NCBI chr 1:192,140,089...192,171,151
Ensembl chr 1:192,149,905...192,171,151 		JBrowse link
G Itgb1 integrin subunit beta 1 decreases expression ISO Arsenic Trioxide results in decreased expression of ITGB1 mRNA CTD PMID:12852829 PMID:26238599 NCBI chr19:73,602,277...73,650,271
Ensembl chr19:73,602,126...73,650,269 		JBrowse link
G Itgb1bp1 integrin subunit beta 1 binding protein 1 decreases expression ISO Arsenic Trioxide results in decreased expression of ITGB1BP1 mRNA CTD PMID:39716349 NCBI chr 6:46,549,994...46,564,735
Ensembl chr 6:46,549,999...46,564,398 		JBrowse link
G Itgb2 integrin subunit beta 2 increases expression ISO Arsenic Trioxide results in increased expression of ITGB2 mRNA CTD PMID:20458559 NCBI chr20:11,061,009...11,097,242
Ensembl chr20:11,058,492...11,097,182 		JBrowse link
G Itgb3 integrin subunit beta 3 increases expression ISO Arsenic Trioxide results in increased expression of ITGB3 protein CTD PMID:16360329 NCBI chr10:90,009,927...90,067,787
Ensembl chr10:90,009,900...90,067,800 		JBrowse link
G Itgb3bp integrin subunit beta 3 binding protein increases expression ISO Arsenic Trioxide results in increased expression of ITGB3BP mRNA CTD PMID:17547211 NCBI chr 5:119,575,657...119,640,974
Ensembl chr 5:119,575,248...119,640,997 		JBrowse link
G Itgb4 integrin subunit beta 4 decreases response to substance
increases expression 		ISO ITGB4 protein results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in increased expression of ITGB4 mRNA 		CTD PMID:20707922 PMID:39716349 NCBI chr10:101,705,592...101,741,933
Ensembl chr10:101,705,587...101,741,932 		JBrowse link
G Itgb7 integrin subunit beta 7 increases expression ISO Arsenic Trioxide results in increased expression of ITGB7 mRNA CTD PMID:15761015 NCBI chr 7:135,225,962...135,243,522
Ensembl chr 7:135,226,555...135,243,597 		JBrowse link
G Itgbl1 integrin subunit beta like 1 decreases expression ISO Arsenic Trioxide results in decreased expression of ITGBL1 mRNA CTD PMID:26705709 NCBI chr15:107,186,792...107,448,335
Ensembl chr15:107,186,689...107,451,098 		JBrowse link
G Itih1 inter-alpha trypsin inhibitor, heavy chain 1 increases expression ISO Arsenic Trioxide results in increased expression of ITIH1 mRNA CTD PMID:20458559 NCBI chr16:6,128,696...6,142,813
Ensembl chr16:6,128,698...6,142,853 		JBrowse link
G Itm2a integral membrane protein 2A decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of ITM2A mRNA
[Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of ITM2A mRNA 		CTD PMID:15725085 PMID:15894607 PMID:26705709 NCBI chr  X:76,559,183...76,565,144
Ensembl chr  X:76,559,181...76,565,437 		JBrowse link
G Itm2b integral membrane protein 2B increases expression ISO Arsenic Trioxide results in increased expression of ITM2B mRNA CTD PMID:20458559 NCBI chr15:54,955,549...54,978,455
Ensembl chr15:54,955,552...54,978,455 		JBrowse link
G Itpr1 inositol 1,4,5-trisphosphate receptor, type 1 multiple interactions
increases phosphorylation
decreases expression
increases expression 		ISO 2-aminoethyl diphenylborinate inhibits the reaction [Arsenic Trioxide results in increased expression of ITPR1 protein modified form]; 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid inhibits the reaction [Arsenic Trioxide results in increased expression of ITPR1 protein modified form]; ATF4 protein promotes the reaction [Arsenic Trioxide results in increased expression of ITPR1 protein modified form]
Arsenic Trioxide results in increased phosphorylation of ITPR1 protein
Arsenic Trioxide results in decreased expression of ITPR1 mRNA
Arsenic Trioxide results in increased expression of ITPR1 mRNA 		CTD PMID:24831965 PMID:27461142 PMID:27638049 PMID:27829220 NCBI chr 4:142,743,401...143,066,505
Ensembl chr 4:142,743,334...143,066,504 		JBrowse link
G Itpr2 inositol 1,4,5-trisphosphate receptor, type 2 multiple interactions
decreases expression
increases expression 		ISO antimony trichloride promotes the reaction [Arsenic Trioxide results in increased expression of ITPR2 mRNA]; Arsenic Trioxide promotes the reaction [antimony trichloride results in increased expression of ITPR2 mRNA]; Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of ITPR2 mRNA]
Arsenic Trioxide results in increased expression of ITPR2 protein 		CTD PMID:29095437 PMID:30093655 PMID:34091186 NCBI chr 4:180,759,325...181,165,361
Ensembl chr 4:180,760,442...181,164,763 		JBrowse link
G Itprid2 ITPR interacting domain containing 2 increases expression ISO Arsenic Trioxide results in increased expression of ITPRID2 mRNA CTD PMID:20458559 NCBI chr 3:84,943,572...84,980,993
Ensembl chr 3:84,939,808...84,980,899 		JBrowse link
G Ivl involucrin increases expression ISO Arsenic Trioxide results in increased expression of IVL protein CTD PMID:25419056 NCBI chr 2:180,842,307...180,854,646
Ensembl chr 2:180,842,307...180,846,578 		JBrowse link
G Jag2 jagged canonical Notch ligand 2 decreases expression ISO Arsenic Trioxide results in decreased expression of JAG2 mRNA CTD PMID:23497375 NCBI chr 6:137,804,133...137,826,738
Ensembl chr 6:137,804,133...137,826,738 		JBrowse link
G Jak1 Janus kinase 1 multiple interactions
increases phosphorylation
decreases expression 		ISO
EXP 		Arsenic Trioxide inhibits the reaction [IL6 protein results in increased phosphorylation of JAK1 protein]; Arsenic Trioxide results in decreased expression of and results in decreased phosphorylation of JAK1 protein; JAK1 protein inhibits the reaction [Arsenic Trioxide results in decreased expression of NFKB1 protein]; JAK1 protein inhibits the reaction [Arsenic Trioxide results in decreased expression of RELA protein]
Arsenic Trioxide results in increased phosphorylation of JAK1 protein
Arsenic Trioxide results in decreased expression of JAK1 mRNA
Arsenic Trioxide affects the expression of and affects the phosphorylation of JAK1 protein; Nicorandil affects the reaction [Arsenic Trioxide affects the expression of and affects the phosphorylation of JAK1 protein] 		CTD PMID:12492118 PMID:19951532 PMID:33634982 PMID:38741475 PMID:39716349 NCBI chr 5:120,895,606...121,004,207
Ensembl chr 5:120,896,046...120,996,758 		JBrowse link
G Jak2 Janus kinase 2 increases expression
multiple interactions
decreases expression
decreases phosphorylation
increases phosphorylation 		ISO Arsenic Trioxide results in increased expression of JAK2 mRNA
[ruxolitinib co-treated with Arsenic Trioxide] results in decreased phosphorylation of JAK2 protein; Arsenic Trioxide inhibits the reaction [IL6 protein results in increased phosphorylation of JAK2 protein]; Arsenic Trioxide promotes the reaction [Curcumin results in decreased expression of JAK2 protein]; pervanadate inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of JAK2 protein]; PTPN6 protein affects the reaction [Arsenic Trioxide results in decreased phosphorylation of JAK2 protein]
Arsenic Trioxide results in decreased expression of JAK2 protein
Arsenic Trioxide results in increased phosphorylation of JAK2 protein
baicalin promotes the reaction [Arsenic Trioxide results in increased phosphorylation of JAK2 protein] 		CTD PMID:11721366 PMID:12492118 PMID:29409467 PMID:29633893 PMID:30012499 More... NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:236,408,662...236,468,762 		JBrowse link
G Jak3 Janus kinase 3 multiple interactions
decreases expression 		ISO [Arsenic Trioxide co-treated with Decitabine] results in decreased expression of JAK3 mRNA
Arsenic Trioxide results in decreased expression of JAK3 mRNA 		CTD PMID:24762999 NCBI chr16:18,418,807...18,432,515
Ensembl chr16:18,420,415...18,433,222 		JBrowse link
G Jam2 junctional adhesion molecule 2 increases expression ISO Arsenic Trioxide results in increased expression of JAM2 mRNA CTD PMID:27829220 NCBI chr11:37,316,287...37,366,517
Ensembl chr11:37,317,511...37,367,510 		JBrowse link
G Jarid2 jumonji and AT-rich interaction domain containing 2 increases response to substance ISO JARID2 protein results in increased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr17:19,983,217...20,163,598
Ensembl chr17:19,983,217...20,161,970 		JBrowse link
G Jkamp JNK1/MAPK8-associated membrane protein increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of JKAMP mRNA
Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of JKAMP mRNA] 		CTD PMID:29095437 NCBI chr 6:96,383,976...96,397,917
Ensembl chr 6:96,366,624...96,398,432 		JBrowse link
G Josd2 Josephin domain containing 2 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to JOSD2 protein] CTD PMID:26598702 NCBI chr 1:104,097,382...104,101,271
Ensembl chr 1:104,097,376...104,101,277 		JBrowse link
G Jph2 junctophilin 2 increases expression ISO Arsenic Trioxide results in increased expression of JPH2 mRNA CTD PMID:20458559 NCBI chr 3:172,414,246...172,478,678
Ensembl chr 3:172,414,256...172,478,348 		JBrowse link
G Jpt1 Jupiter microtubule associated homolog 1 increases expression ISO Arsenic Trioxide results in increased expression of JPT1 mRNA CTD PMID:22521957 NCBI chr10:101,243,428...101,261,464
Ensembl chr10:101,243,424...101,261,469 		JBrowse link
G Jpx JPX transcript, XIST activator affects expression ISO Arsenic Trioxide affects the expression of JPX mRNA CTD PMID:39716349 NCBI chr  X:72,577,163...72,730,887 JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit decreases expression
multiple interactions
affects response to substance
increases activity
affects expression
increases expression
increases phosphorylation
decreases phosphorylation
affects phosphorylation 		ISO
EXP 		Arsenic Trioxide results in decreased expression of JUN mRNA; Arsenic Trioxide results in decreased expression of JUN protein
Arsenic Trioxide promotes the reaction [Berberine affects the localization of JUN protein]
JUN mRNA affects the susceptibility to Arsenic Trioxide
Arsenic Trioxide results in increased activity of JUN protein
Arsenic Trioxide affects the expression of JUN mRNA
Arsenic Trioxide results in increased expression of JUN mRNA; Arsenic Trioxide results in increased expression of JUN protein; Arsenic Trioxide results in increased expression of JUN protein modified form
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of JUN protein]; [[Arsenic Trioxide results in increased phosphorylation of JUN protein] which binds to HDAC1 protein] which binds to CDKN1A promoter; [Arsenic Trioxide co-treated with Bortezomib] results in decreased expression of JUN mRNA; [Arsenic Trioxide co-treated with Bortezomib] results in increased activity of JUN protein modified form; [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of JUN protein] which results in decreased expression of CDKN1A mRNA; [Arsenic Trioxide results in increased phosphorylation of JUN protein] which binds to HDAC1 protein; [Arsenic Trioxide results in increased phosphorylation of JUN protein] which results in decreased expression of CDKN1A; [Arsenic Trioxide results in increased phosphorylation of JUN protein] which results in decreased expression of CDKN1A mRNA; [Ethacrynic Acid co-treated with Arsenic Trioxide] results in increased phosphorylation of JUN protein; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of JUN protein]; Arsenic Trioxide promotes the reaction [[FOS protein binds to JUN promoter] which binds to CDKN1A promoter]; Arsenic Trioxide promotes the reaction [[FOS protein binds to JUN protein] which results in increased expression of CDKN1A mRNA]; Arsenic Trioxide promotes the reaction [[JUN protein binds to CDKN1A promoter] which results in increased expression of CDKN1A protein]; Arsenic Trioxide promotes the reaction [JUN protein binds to TGIF1 protein]; Arsenic Trioxide promotes the reaction [nilotinib results in increased expression of JUN mRNA]; Arsenic Trioxide promotes the reaction [nilotinib results in increased expression of JUN protein]; Arsenic Trioxide promotes the reaction [Tretinoin results in decreased expression of JUN protein]; Arsenic Trioxide results in increased expression of and results in increased phosphorylation of JUN protein; Arsenic Trioxide results in increased phosphorylation of and results in increased activity of JUN protein; benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [PRAM1 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of JUN protein]]; Dasatinib promotes the reaction [Arsenic Trioxide results in increased phosphorylation of JUN protein]; HMOX1 protein inhibits the reaction [Arsenic Trioxide results in increased expression of JUN protein modified form]; HMOX1 protein inhibits the reaction [Arsenic Trioxide results in increased expression of JUN protein]; JUN protein promotes the reaction [Arsenic Trioxide results in increased expression of HMOX1 protein]; JUN protein promotes the reaction [Arsenic Trioxide results in increased expression of MMP9 mRNA]; JUN protein promotes the reaction [Arsenic Trioxide results in increased expression of MMP9 protein]; PRAM1 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of JUN protein]; pyrazolanthrone inhibits the reaction [[Ethacrynic Acid co-treated with Arsenic Trioxide] results in increased phosphorylation of JUN protein]; pyrazolanthrone inhibits the reaction [Arsenic Trioxide results in increased expression of JUN protein]; Tretinoin promotes the reaction [Arsenic Trioxide results in decreased expression of JUN protein]; zinc protoporphyrin promotes the reaction [Arsenic Trioxide results in increased expression of JUN protein]
Arsenic Trioxide results in decreased phosphorylation of JUN protein
Arsenic Trioxide affects the phosphorylation of JUN protein
Arsenic Trioxide promotes the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of JUN protein] 		CTD PMID:12749819 PMID:15637062 PMID:16646077 PMID:17495969 PMID:18210215 More... NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285 		JBrowse link
G Junb JunB proto-oncogene, AP-1 transcription factor subunit multiple interactions
decreases expression
increases expression 		ISO Arsenic Trioxide promotes the reaction [nilotinib results in increased expression of JUNB mRNA]; Arsenic Trioxide promotes the reaction [nilotinib results in increased expression of JUNB protein]
Arsenic Trioxide results in decreased expression of JUNB mRNA
Arsenic Trioxide results in increased expression of JUNB mRNA; Arsenic Trioxide results in increased expression of JUNB protein 		CTD PMID:19410645 PMID:20458559 PMID:23883479 PMID:25258189 NCBI chr19:40,081,126...40,082,910
Ensembl chr19:40,073,541...40,085,218 		JBrowse link
G Jund JunD proto-oncogene, AP-1 transcription factor subunit multiple interactions
increases expression 		ISO [Arsenic Trioxide co-treated with IFNA2 protein co-treated with Docosahexaenoic Acids co-treated with Emodin] results in decreased expression of JUND protein
Arsenic Trioxide results in increased expression of JUND mRNA 		CTD PMID:15761015 PMID:17077332 NCBI chr16:18,768,093...18,769,771
Ensembl chr16:18,764,985...18,782,148 		JBrowse link
G Kalrn kalirin, RhoGEF kinase increases expression ISO Arsenic Trioxide results in increased expression of KALRN mRNA CTD PMID:20458559 PMID:26705709 NCBI chr11:79,703,345...80,309,210
Ensembl chr11:79,703,366...80,133,329 		JBrowse link
G Kank2 KN motif and ankyrin repeat domains 2 increases expression ISO Arsenic Trioxide results in increased expression of KANK2 mRNA CTD PMID:39716349 NCBI chr 8:28,587,770...28,617,212
Ensembl chr 8:28,587,770...28,616,993 		JBrowse link
G Kank4 KN motif and ankyrin repeat domains 4 decreases expression ISO Arsenic Trioxide results in decreased expression of KANK4 mRNA CTD PMID:26705709 NCBI chr 5:118,516,994...118,581,024
Ensembl chr 5:118,517,971...118,581,002 		JBrowse link
G Kansl1 KAT8 regulatory NSL complex subunit 1 increases expression ISO Arsenic Trioxide results in increased expression of KANSL1 mRNA CTD PMID:39716349 NCBI chr10:89,737,637...89,868,620
Ensembl chr10:89,737,637...89,868,620 		JBrowse link
G Kat2a lysine acetyltransferase 2A affects expression ISO Arsenic Trioxide affects the expression of KAT2A mRNA CTD PMID:25574600 NCBI chr10:86,132,535...86,140,877
Ensembl chr10:86,132,535...86,140,485 		JBrowse link
G Kat2b lysine acetyltransferase 2B increases expression ISO Arsenic Trioxide results in increased expression of KAT2B mRNA CTD PMID:20458559 NCBI chr 9:6,799,101...6,903,616
Ensembl chr 9:6,799,145...6,903,616 		JBrowse link
G Kat5 lysine acetyltransferase 5 decreases expression ISO Arsenic Trioxide results in decreased expression of KAT5 mRNA CTD PMID:19763917 NCBI chr 1:212,325,089...212,332,640
Ensembl chr 1:212,325,090...212,332,587 		JBrowse link
G Kat6b lysine acetyltransferase 6B decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of KAT6B mRNA
Arsenic Trioxide results in increased expression of KAT6B mRNA 		CTD PMID:15761015 PMID:20458559 NCBI chr15:2,688,535...2,861,443
Ensembl chr15:2,688,811...2,844,343 		JBrowse link
G Kat8 lysine acetyltransferase 8 increases expression ISO Arsenic Trioxide results in increased expression of KAT8 mRNA CTD PMID:22521957 NCBI chr 1:191,954,827...191,967,107
Ensembl chr 1:191,954,438...191,967,105 		JBrowse link
G Kbtbd11 kelch repeat and BTB domain containing 11 multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of KBTBD11 mRNA CTD PMID:15894607 NCBI chr16:81,318,596...81,340,334
Ensembl chr16:81,313,093...81,340,390 		JBrowse link
G Kcnb1 potassium voltage-gated channel subfamily B member 1 decreases expression ISO Arsenic Trioxide results in decreased expression of KCNB1 mRNA CTD PMID:35676786 NCBI chr 3:176,239,285...176,332,408
Ensembl chr 3:176,242,589...176,332,408 		JBrowse link
G Kcng1 potassium voltage-gated channel modifier subfamily G member 1 increases expression ISO Arsenic Trioxide results in increased expression of KCNG1 mRNA CTD PMID:20458559 NCBI chr 3:177,379,593...177,412,986
Ensembl chr 3:177,392,031...177,411,507 		JBrowse link
G Kcnh2 potassium voltage-gated channel subfamily H member 2 decreases localization
increases expression
increases degradation
decreases expression
decreases activity
multiple interactions 		ISO
EXP 		Arsenic Trioxide results in decreased localization of KCNH2 protein
Arsenic Trioxide results in increased expression of KCNH2 mRNA
Arsenic Trioxide results in increased degradation of KCNH2 protein
Arsenic Trioxide results in decreased expression of KCNH2 protein
Arsenic Trioxide results in decreased activity of KCNH2 protein
Arsenic Trioxide affects the expression of and results in increased activity of KCNH2 protein; Arsenic Trioxide results in decreased expression of and affects the localization of and results in decreased activity of KCNH2 protein; Astemizole inhibits the reaction [Arsenic Trioxide results in increased degradation of KCNH2 protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Arsenic Trioxide results in increased degradation of KCNH2 protein]; fexofenadine inhibits the reaction [Arsenic Trioxide results in decreased expression of KCNH2 protein]; fexofenadine inhibits the reaction [Arsenic Trioxide results in increased degradation of KCNH2 protein]; MALAT1 protein affects the reaction [Arsenic Trioxide results in decreased activity of KCNH2 protein]; Matrines inhibits the reaction [Arsenic Trioxide results in decreased localization of KCNH2 protein]; MIR21 mRNA promotes the reaction [Arsenic Trioxide results in decreased expression of KCNH2 protein]; MIR23A mRNA promotes the reaction [Arsenic Trioxide results in decreased expression of and affects the localization of and results in decreased activity of KCNH2 protein]; oxymatrine inhibits the reaction [Arsenic Trioxide results in decreased localization of KCNH2 protein]; Ranolazine inhibits the reaction [Arsenic Trioxide results in increased degradation of KCNH2 protein]; Resveratrol inhibits the reaction [Arsenic Trioxide results in decreased activity of KCNH2 protein] 		CTD PMID:15070760 PMID:15213294 PMID:22977528 PMID:23103450 PMID:25107562 More... NCBI chr 4:11,719,357...11,751,424
Ensembl chr 4:11,692,980...11,751,421 		JBrowse link
G Kcnip4 potassium voltage-gated channel interacting protein 4 decreases expression ISO Arsenic Trioxide results in decreased expression of KCNIP4 mRNA CTD PMID:26705709 NCBI chr14:65,593,297...66,743,994
Ensembl chr14:65,593,366...66,743,993 		JBrowse link
G Kcnj3 potassium inwardly-rectifying channel, subfamily J, member 3 decreases expression ISO Arsenic Trioxide results in decreased expression of KCNJ3 mRNA CTD PMID:26705709 NCBI chr 3:60,353,990...60,518,110
Ensembl chr 3:60,354,146...60,518,104 		JBrowse link
G Kcnk12 potassium two pore domain channel subfamily K member 12 increases expression ISO Arsenic Trioxide results in increased expression of KCNK12 mRNA CTD PMID:20458559 NCBI chr 6:12,492,609...12,544,250
Ensembl chr 6:12,494,850...12,544,221 		JBrowse link
G Kcnk2 potassium two pore domain channel subfamily K member 2 decreases expression ISO Arsenic Trioxide results in decreased expression of KCNK2 mRNA CTD PMID:26705709 NCBI chr13:103,297,387...103,494,686
Ensembl chr13:103,297,393...103,494,686 		JBrowse link
G Kcnk6 potassium two pore domain channel subfamily K member 6 decreases expression ISO Arsenic Trioxide results in decreased expression of KCNK6 mRNA CTD PMID:22521957 NCBI chr 1:93,652,888...93,661,419 JBrowse link
G Kcnma1 potassium calcium-activated channel subfamily M alpha 1 increases expression ISO Arsenic Trioxide results in increased expression of KCNMA1 mRNA CTD PMID:20458559 NCBI chr15:351,065...1,057,117
Ensembl chr15:351,659...1,057,117 		JBrowse link
G Kcnn2 potassium calcium-activated channel subfamily N member 2 decreases expression ISO Arsenic Trioxide results in decreased expression of KCNN2 mRNA CTD PMID:26705709 NCBI chr18:40,004,693...40,445,043
Ensembl chr18:40,155,939...40,445,045 		JBrowse link
G Kcns3 potassium voltage-gated channel, modifier subfamily S, member 3 decreases expression ISO Arsenic Trioxide results in decreased expression of KCNS3 mRNA CTD PMID:26705709 NCBI chr 6:39,527,410...39,584,105
Ensembl chr 6:39,523,777...39,618,848 		JBrowse link
G Kcnu1 potassium calcium-activated channel subfamily U member 1 increases expression ISO Arsenic Trioxide results in increased expression of KCNU1 mRNA CTD PMID:26705709 NCBI chr16:72,844,692...72,932,216
Ensembl chr16:72,844,712...72,932,334 		JBrowse link
G Kcnv2 potassium voltage-gated channel modifier subfamily V member 2 decreases expression ISO Arsenic Trioxide results in decreased expression of KCNV2 mRNA CTD PMID:35676786 NCBI chr 1:234,409,067...234,485,894
Ensembl chr 1:234,413,096...234,495,298 		JBrowse link
G Kcp kielin cysteine rich BMP regulator increases expression ISO Arsenic Trioxide results in increased expression of KCP mRNA CTD PMID:39716349 NCBI chr 4:59,048,209...59,083,522
Ensembl chr 4:59,047,968...59,083,531 		JBrowse link
G Kctd12 potassium channel tetramerization domain containing 12 decreases expression ISO Arsenic Trioxide results in decreased expression of KCTD12 mRNA CTD PMID:15761015 PMID:25258189 PMID:39716349 NCBI chr15:86,214,786...86,220,725
Ensembl chr15:86,214,840...86,224,539 		JBrowse link
G Kctd20 potassium channel tetramerization domain containing 20 increases expression ISO Arsenic Trioxide results in increased expression of KCTD20 mRNA CTD PMID:39716349 NCBI chr20:7,017,480...7,034,440
Ensembl chr20:7,017,502...7,034,441 		JBrowse link
G Kctd5 potassium channel tetramerization domain containing 5 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to KCTD5 protein] CTD PMID:26598702 NCBI chr10:13,583,781...13,609,762
Ensembl chr10:13,583,781...13,610,062 		JBrowse link
G Kctd6 potassium channel tetramerization domain containing 6 increases expression ISO Arsenic Trioxide results in increased expression of KCTD6 mRNA CTD PMID:20458559 NCBI chr15:19,125,529...19,142,038
Ensembl chr15:19,124,932...19,134,583 		JBrowse link
G Kctd9 potassium channel tetramerization domain containing 9 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of KCTD9 mRNA
Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to KCTD9 protein] 		CTD PMID:20458559 PMID:26598702 NCBI chr15:46,117,211...46,145,258
Ensembl chr15:46,117,874...46,145,266 		JBrowse link
G Kdelr3 KDEL endoplasmic reticulum protein retention receptor 3 decreases expression ISO Arsenic Trioxide results in decreased expression of KDELR3 mRNA CTD PMID:39716349 NCBI chr 7:112,959,632...112,969,858
Ensembl chr 7:112,959,718...112,969,858 		JBrowse link
G Kdm1a lysine demethylase 1A multiple interactions ISO [Valproic Acid co-treated with Arsenic Trioxide] results in increased expression of KDM1A mRNA; [Valproic Acid co-treated with Arsenic Trioxide] results in increased expression of KDM1A protein CTD PMID:25815518 NCBI chr 5:154,066,436...154,121,913
Ensembl chr 5:154,065,543...154,121,775 		JBrowse link
G Kdm2a lysine demethylase 2A increases expression ISO Arsenic Trioxide results in increased expression of KDM2A mRNA CTD PMID:20458559 NCBI chr 1:211,041,859...211,125,749
Ensembl chr 1:211,041,885...211,084,479 		JBrowse link
G Kdm3a lysine demethylase 3A increases expression ISO Arsenic Trioxide results in increased expression of KDM3A mRNA CTD PMID:20458559 NCBI chr 4:105,189,208...105,233,526
Ensembl chr 4:105,189,208...105,233,370 		JBrowse link
G Kdm7a lysine demethylase 7A increases expression ISO Arsenic Trioxide results in increased expression of KDM7A mRNA CTD PMID:26705709 PMID:35676786 NCBI chr 4:68,866,263...68,992,979
Ensembl chr 4:68,871,677...68,931,506 		JBrowse link
G Kdr kinase insert domain receptor decreases expression
increases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of KDR; Arsenic Trioxide results in decreased expression of KDR mRNA; Arsenic Trioxide results in decreased expression of KDR protein
Arsenic Trioxide results in increased expression of KDR gene mutant form
[Arsenic Trioxide co-treated with apatinib] results in decreased expression of KDR mRNA; [Arsenic Trioxide co-treated with apatinib] results in decreased expression of KDR protein 		CTD PMID:18161919 PMID:25088040 PMID:30014256 PMID:38275666 PMID:38746032 More... NCBI chr14:32,572,031...32,615,204
Ensembl chr14:32,572,049...32,615,192 		JBrowse link
G Kdsr 3-ketodihydrosphingosine reductase increases expression ISO Arsenic Trioxide results in increased expression of KDSR mRNA CTD PMID:39716349 NCBI chr13:23,374,101...23,408,779
Ensembl chr13:23,376,779...23,408,897 		JBrowse link
G Keap1 Kelch-like ECH-associated protein 1 increases response to substance
multiple interactions
increases expression
decreases response to substance
decreases expression
affects response to substance 		ISO
EXP 		KEAP1 mRNA results in increased susceptibility to Arsenic Trioxide
[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of KEAP1 mRNA; Arsenic Trioxide affects the reaction [KEAP1 protein results in increased expression of CCND1 protein]; KEAP1 mRNA inhibits the reaction [Ethionamide results in increased susceptibility to Arsenic Trioxide]; KEAP1 protein inhibits the reaction [Arsenic Trioxide results in decreased expression of CCND1 mRNA]; KEAP1 protein inhibits the reaction [Arsenic Trioxide results in increased expression of PPARG mRNA]; KEAP1 protein inhibits the reaction [Arsenic Trioxide results in increased expression of PPARG protein]; KEAP1 protein promotes the reaction [Rosiglitazone results in increased susceptibility to Arsenic Trioxide]; KEAP1 protein promotes the reaction [Troglitazone results in increased susceptibility to Arsenic Trioxide]; NFE2L2 protein promotes the reaction [Arsenic Trioxide results in increased expression of KEAP1 protein]
Arsenic Trioxide results in increased expression of KEAP1 mRNA
KEAP1 protein results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in decreased expression of KEAP1 protein
KEAP1 gene mutant form affects the susceptibility to Arsenic Trioxide
Arsenic Trioxide results in increased expression of KEAP1 mRNA; Arsenic Trioxide results in increased expression of KEAP1 protein
crocin inhibits the reaction [Arsenic Trioxide results in decreased expression of KEAP1 protein]
18alpha,20beta-hydroxy-11-oxo-norolean-12-en-3beta-yl-2-O-beta-D-glucopyranurosyl-alpha-D-glucopyranosiduronate magnesium tetrahydrate inhibits the reaction [Arsenic Trioxide results in increased expression of KEAP1 protein] 		CTD PMID:15894607 PMID:19417148 PMID:22684020 PMID:24634002 PMID:26708503 More... NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:28,044,555...28,054,042 		JBrowse link
G Khdc4 KH domain containing 4, pre-mRNA splicing factor increases expression ISO Arsenic Trioxide results in increased expression of KHDC4 mRNA CTD PMID:39716349 NCBI chr 2:176,446,895...176,475,405
Ensembl chr 2:176,446,910...176,475,392 		JBrowse link
G Khk ketohexokinase multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to KHK protein] CTD PMID:26598702 NCBI chr 6:31,165,246...31,175,779
Ensembl chr 6:31,165,248...31,175,481 		JBrowse link
G Kiaa0232 KIAA0232 homolog decreases expression ISO Arsenic Trioxide results in decreased expression of D5ERTD579E mRNA CTD PMID:35676786 NCBI chr14:78,318,660...78,384,012
Ensembl chr14:78,319,105...78,384,014 		JBrowse link
G Kiaa0319l KIAA0319 like decreases expression ISO Arsenic Trioxide results in decreased expression of KIAA0319L mRNA CTD PMID:27829220 NCBI chr 5:144,332,242...144,425,182
Ensembl chr 5:144,332,207...144,425,190 		JBrowse link
G Kif13b kinesin family member 13B increases expression ISO Arsenic Trioxide results in increased expression of KIF13B mRNA CTD PMID:20458559 NCBI chr15:43,084,059...43,241,719
Ensembl chr15:43,080,910...43,241,719 		JBrowse link
G Kif21b kinesin family member 21B increases expression ISO Arsenic Trioxide results in increased expression of KIF21B mRNA CTD PMID:15761015 PMID:24356939 NCBI chr13:50,127,842...50,177,822
Ensembl chr13:50,127,842...50,177,822 		JBrowse link
G Kif27 kinesin family member 27 increases expression ISO Arsenic Trioxide results in increased expression of KIF27 mRNA CTD PMID:25258189 NCBI chr17:6,304,960...6,383,745
Ensembl chr17:6,304,989...6,375,182 		JBrowse link
G Kif3a kinesin family member 3a increases expression ISO Arsenic Trioxide results in increased expression of KIF3A mRNA CTD PMID:20458559 NCBI chr10:38,226,388...38,263,062
Ensembl chr10:38,226,741...38,260,516 		JBrowse link
G Kifc2 kinesin family member C2 decreases expression ISO Arsenic Trioxide results in decreased expression of KIFC2 mRNA CTD PMID:22521957 NCBI chr 7:110,261,257...110,269,007
Ensembl chr 7:110,261,009...110,269,005 		JBrowse link
G Kit KIT proto-oncogene receptor tyrosine kinase decreases phosphorylation
increases expression
decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased phosphorylation of KIT protein
Arsenic Trioxide results in increased expression of KIT gene mutant form; Arsenic Trioxide results in increased expression of KIT mRNA
Arsenic Trioxide results in decreased expression of KIT protein
Arsenic Trioxide promotes the reaction [[GLI3 protein binds to KIT promoter] which results in decreased expression of KIT mRNA]; Arsenic Trioxide promotes the reaction [GLI3 protein binds to KIT promoter]
Arsenic Trioxide results in decreased expression of KIT mRNA; Arsenic Trioxide results in decreased expression of KIT protein modified form 		CTD PMID:19619438 PMID:19950550 PMID:20609355 PMID:23815908 PMID:26705709 More... NCBI chr14:32,901,615...32,978,895
Ensembl chr14:32,903,033...32,978,812 		JBrowse link
G Kitlg KIT ligand decreases response to substance
decreases expression
increases expression 		ISO KITLG protein results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in decreased expression of KITLG mRNA
Arsenic Trioxide results in increased expression of KITLG mRNA 		CTD PMID:15761015 PMID:16360329 PMID:20458559 PMID:26705709 NCBI chr 7:36,782,621...36,863,796
Ensembl chr 7:36,782,638...36,863,793 		JBrowse link
G Kl Klotho increases expression ISO Arsenic Trioxide results in increased expression of KL mRNA CTD PMID:27829220 NCBI chr12:5,326,003...5,367,016
Ensembl chr12:5,325,959...5,367,015 		JBrowse link
G Klc3 kinesin light chain 3 increases expression ISO Arsenic Trioxide results in increased expression of KLC3 mRNA CTD PMID:20458559 NCBI chr 1:88,173,842...88,183,806
Ensembl chr 1:88,173,404...88,184,253 		JBrowse link
G Klf11 KLF transcription factor 11 decreases expression ISO Arsenic Trioxide results in decreased expression of KLF11 mRNA CTD PMID:15761015 NCBI chr 6:47,014,312...47,026,152
Ensembl chr 6:47,014,326...47,037,044 		JBrowse link
G Klf13 KLF transcription factor 13 decreases expression ISO Arsenic Trioxide results in decreased expression of KLF13 mRNA CTD PMID:20458559 NCBI chr 1:126,917,671...126,948,436
Ensembl chr 1:126,916,781...126,961,056 		JBrowse link
G Klf2 KLF transcription factor 2 decreases expression ISO Arsenic Trioxide results in decreased expression of KLF2 mRNA CTD PMID:26705709 NCBI chr16:17,555,136...17,557,768
Ensembl chr16:17,555,136...17,557,768 		JBrowse link
G Klf3 KLF transcription factor 3 increases expression ISO Arsenic Trioxide results in increased expression of KLF3 mRNA CTD PMID:20458559 NCBI chr14:43,828,387...43,859,418
Ensembl chr14:43,828,387...43,850,826 		JBrowse link
G Klf4 KLF transcription factor 4 multiple interactions
decreases response to substance
increases expression 		ISO [Arsenic Trioxide co-treated with Tretinoin] results in decreased expression of KLF4 protein; Arsenic Trioxide promotes the reaction [MSI1 protein results in increased expression of KLF4 protein]; EIF2AK2 protein affects the reaction [Arsenic Trioxide promotes the reaction [MSI1 protein results in increased expression of KLF4 protein]]; EIF2AK2 protein affects the reaction [Arsenic Trioxide results in increased expression of KLF4 protein]; EIF2S1 protein affects the reaction [Arsenic Trioxide promotes the reaction [MSI1 protein results in increased expression of KLF4 protein]]; MSI1 protein affects the reaction [Arsenic Trioxide results in increased expression of KLF4 protein]
KLF4 protein results in decreased susceptibility to Arsenic Trioxide 		CTD PMID:20707922 PMID:29486283 PMID:30093655 NCBI chr 5:75,074,107...75,079,182
Ensembl chr 5:75,074,236...75,078,592 		JBrowse link
G Klf5 KLF transcription factor 5 increases expression
decreases response to substance 		ISO Arsenic Trioxide results in increased expression of KLF5 mRNA
KLF5 protein results in decreased susceptibility to Arsenic Trioxide 		CTD PMID:15761015 PMID:20458559 PMID:20707922 NCBI chr15:82,472,081...82,487,267
Ensembl chr15:82,472,065...82,487,262 		JBrowse link
G Klf9 KLF transcription factor 9 multiple interactions
decreases expression 		ISO [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of KLF9 mRNA; allicin inhibits the reaction [Arsenic Trioxide results in decreased expression of KLF9 protein]
Arsenic Trioxide results in decreased expression of KLF9 mRNA; Arsenic Trioxide results in decreased expression of KLF9 protein 		CTD PMID:15894607 PMID:19128835 PMID:27561292 NCBI chr 1:230,126,646...230,151,641
Ensembl chr 1:230,126,646...230,151,641 		JBrowse link
G Klhdc1 kelch domain containing 1 increases expression ISO Arsenic Trioxide results in increased expression of KLHDC1 mRNA CTD PMID:20458559 NCBI chr 6:93,406,226...93,501,475
Ensembl chr 6:93,448,758...93,501,702 		JBrowse link
G Klhdc8a kelch domain containing 8A increases expression ISO Arsenic Trioxide results in increased expression of KLHDC8A mRNA CTD PMID:21461292 NCBI chr13:46,287,011...46,296,429
Ensembl chr13:46,288,344...46,296,429 		JBrowse link
G Klhdc9 kelch domain containing 9 increases expression ISO Arsenic Trioxide results in increased expression of KLHDC9 mRNA CTD PMID:20458559 NCBI chr13:86,323,004...86,326,237
Ensembl chr13:86,323,004...86,325,653 		JBrowse link
G Klhl14 kelch-like family member 14 decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of KLHL14 mRNA
Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to KLHL14 protein] 		CTD PMID:26598702 PMID:26705709 NCBI chr18:13,079,159...13,192,728
Ensembl chr18:13,079,159...13,193,557 		JBrowse link
G Klhl21 kelch-like family member 21 increases expression ISO Arsenic Trioxide results in increased expression of KLHL21 mRNA CTD PMID:27829220 NCBI chr 5:167,797,621...167,806,276
Ensembl chr 5:167,797,591...167,806,276 		JBrowse link
G Klhl24 kelch-like family member 24 increases expression ISO Arsenic Trioxide results in increased expression of KLHL24 mRNA CTD PMID:20458559 PMID:24356939 PMID:26705709 NCBI chr11:94,348,024...94,382,085
Ensembl chr11:94,351,157...94,382,050 		JBrowse link
G Klhl3 kelch-like family member 3 increases expression ISO Arsenic Trioxide results in increased expression of KLHL3 mRNA CTD PMID:35676786 NCBI chr17:6,528,114...6,651,338
Ensembl chr17:6,528,487...6,651,338 		JBrowse link
G Klhl32 kelch-like family member 32 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to KLHL32 protein] CTD PMID:26598702 NCBI chr 5:43,117,861...43,365,080
Ensembl chr 5:43,122,167...43,365,042 		JBrowse link
G Klhl42 kelch-like family, member 42 increases expression ISO Arsenic Trioxide results in increased expression of KLHL42 mRNA CTD PMID:39716349 NCBI chr 4:181,730,343...181,760,899
Ensembl chr 4:181,735,244...181,757,013 		JBrowse link
G Klhl6 kelch-like family member 6 increases expression ISO Arsenic Trioxide results in increased expression of KLHL6 mRNA CTD PMID:27829220 NCBI chr11:94,475,262...94,514,653
Ensembl chr11:94,475,262...94,514,623 		JBrowse link
G Klk1c10 kallikrein 1-related peptidase C10 multiple interactions ISO Arsenic Trioxide inhibits the reaction [Metribolone promotes the reaction [AR protein binds to KLK3 promoter]]; Arsenic Trioxide inhibits the reaction [Metribolone promotes the reaction [NCOA2 protein binds to KLK3 promoter]] CTD PMID:19131511 NCBI chr 1:103,539,527...103,543,586
Ensembl chr 1:103,539,527...103,543,586 		JBrowse link
G Klkb1 kallikrein B1 decreases expression ISO Arsenic Trioxide results in decreased expression of KLKB1 mRNA CTD PMID:29633893 NCBI chr16:53,690,180...53,714,570
Ensembl chr16:53,691,220...53,716,339 		JBrowse link
G Klrk1 killer cell lectin like receptor K1 increases response to substance ISO KLRK1 protein results in increased susceptibility to Arsenic Trioxide CTD PMID:18463537 NCBI chr 4:164,767,377...164,778,453
Ensembl chr 4:164,767,946...164,778,382 		JBrowse link
G Kmt2a lysine methyltransferase 2A multiple interactions
decreases expression 		ISO [Arsenic Trioxide co-treated with Bortezomib] results in decreased expression of KMT2A mRNA
Arsenic Trioxide results in decreased expression of KMT2A mRNA 		CTD PMID:25913414 PMID:39716349 NCBI chr 8:54,013,547...54,089,219
Ensembl chr 8:54,013,547...54,089,317 		JBrowse link
G Kmt2c lysine methyltransferase 2C increases expression ISO Arsenic Trioxide results in increased expression of KMT2C mRNA CTD PMID:22521957 NCBI chr 4:10,353,698...10,755,965
Ensembl chr 4:10,353,735...10,568,620 		JBrowse link
G Kpna2 karyopherin subunit alpha 2 multiple interactions ISO Arsenic Trioxide inhibits the reaction [GATA3 protein binds to KPNA2 protein] CTD PMID:19080345 NCBI chr10:92,433,678...92,445,841
Ensembl chr10:92,433,679...92,445,937 		JBrowse link
G Krt13 keratin 13 increases expression ISO Arsenic Trioxide results in increased expression of KRT13 protein CTD PMID:25419056 NCBI chr10:85,552,287...85,556,499
Ensembl chr10:85,552,287...85,556,499 		JBrowse link
G Krt14 keratin 14 decreases expression ISO Arsenic Trioxide results in decreased expression of KRT14 protein CTD PMID:25419056 NCBI chr10:85,638,182...85,642,450 JBrowse link
G Krt18 keratin 18 decreases response to substance
increases expression 		ISO KRT18 protein results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in increased expression of KRT18 mRNA 		CTD PMID:15073043 PMID:20707922 NCBI chr 7:135,036,168...135,039,844
Ensembl chr 7:135,035,982...135,039,848
Ensembl chr10:135,035,982...135,039,848 		JBrowse link
G Krt19 keratin 19 decreases expression
decreases response to substance 		ISO Arsenic Trioxide results in decreased expression of KRT19 mRNA; Arsenic Trioxide results in decreased expression of KRT19 protein
KRT19 protein results in decreased susceptibility to Arsenic Trioxide 		CTD PMID:20707922 PMID:25419056 PMID:26705709 PMID:33634982 NCBI chr10:85,576,235...85,580,952
Ensembl chr10:85,576,235...85,580,952 		JBrowse link
G Krt27 keratin 27 decreases expression ISO Arsenic Trioxide results in decreased expression of KRT27 protein CTD PMID:25419056 NCBI chr10:84,794,848...84,800,131
Ensembl chr10:84,794,684...84,800,131 		JBrowse link
G Krt7 keratin 7 decreases expression ISO Arsenic Trioxide results in decreased expression of KRT7 protein CTD PMID:25419056 NCBI chr 7:134,407,626...134,423,787
Ensembl chr 7:134,407,584...134,423,786 		JBrowse link
G Krt71 keratin 71 decreases expression ISO Arsenic Trioxide results in decreased expression of KRT71 protein CTD PMID:25419056 NCBI chr 7:134,752,240...134,778,765
Ensembl chr 7:134,752,248...134,761,033 		JBrowse link
G Krt8 keratin 8 decreases response to substance
decreases expression
increases expression 		ISO KRT8 protein results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in decreased expression of KRT8 protein
Arsenic Trioxide results in increased expression of KRT8 protein 		CTD PMID:20707922 PMID:25419056 PMID:33634982 NCBI chr 7:135,002,886...135,010,339
Ensembl chr 7:135,002,894...135,010,403 		JBrowse link
G Krt85 keratin 85 decreases expression ISO Arsenic Trioxide results in decreased expression of KRT85 protein CTD PMID:25419056 NCBI chr 7:134,508,913...134,515,786
Ensembl chr 7:134,508,913...134,515,786 		JBrowse link
G Ktn1 kinectin 1 increases expression ISO Arsenic Trioxide results in increased expression of KTN1 protein CTD PMID:25419056 NCBI chr15:23,392,570...23,485,061
Ensembl chr15:23,394,315...23,482,263 		JBrowse link
G Kynu kynureninase increases expression ISO Arsenic Trioxide results in increased expression of KYNU mRNA CTD PMID:15761015 PMID:36801614 NCBI chr 3:48,188,286...48,338,996
Ensembl chr 3:48,188,182...48,339,014 		JBrowse link
G Lama3 laminin subunit alpha 3 increases expression ISO Arsenic Trioxide results in increased expression of LAMA3 mRNA CTD PMID:20458559 NCBI chr18:3,797,898...4,033,021
Ensembl chr18:3,797,939...4,026,449 		JBrowse link
G Lamb3 laminin subunit beta 3 increases expression ISO Arsenic Trioxide results in increased expression of LAMB3 mRNA CTD PMID:29633893 NCBI chr13:107,362,514...107,404,081
Ensembl chr13:107,322,526...107,404,081 		JBrowse link
G Lamc1 laminin subunit gamma 1 decreases expression ISO Arsenic Trioxide results in decreased expression of LAMC1 mRNA CTD PMID:12852829 NCBI chr13:67,924,872...68,051,986
Ensembl chr13:67,924,872...68,051,986 		JBrowse link
G Lamc2 laminin subunit gamma 2 decreases response to substance ISO LAMC2 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr13:67,835,199...67,894,694
Ensembl chr13:67,835,199...67,895,102 		JBrowse link
G Lamp1 lysosomal-associated membrane protein 1 multiple interactions
increases expression
affects expression 		ISO 3-methyladenine inhibits the reaction [Arsenic Trioxide results in increased expression of LAMP1 mRNA]; 3-methyladenine inhibits the reaction [Arsenic Trioxide results in increased expression of LAMP1 protein]; Acetylcysteine affects the reaction [Arsenic Trioxide results in increased expression of LAMP1 mRNA]; Acetylcysteine affects the reaction [Arsenic Trioxide results in increased expression of LAMP1 protein]; Taurine inhibits the reaction [Arsenic Trioxide results in increased expression of LAMP1 protein]; TFEB protein affects the reaction [Arsenic Trioxide results in increased expression of LAMP1 protein]
Arsenic Trioxide results in increased expression of LAMP1 mRNA; Arsenic Trioxide results in increased expression of LAMP1 protein
Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of LAMP1 mRNA]; TFEB protein affects the reaction [Arsenic Trioxide results in increased expression of LAMP1 mRNA]; TFEB protein affects the reaction [Arsenic Trioxide results in increased expression of LAMP1 protein]
Arsenic Trioxide affects the expression of LAMP1 protein 		CTD PMID:29307831 PMID:30237538 PMID:33462182 NCBI chr16:83,058,131...83,082,843
Ensembl chr16:83,058,385...83,075,159 		JBrowse link
G Lamp5 lysosomal-associated membrane protein family, member 5 decreases expression ISO Arsenic Trioxide results in decreased expression of LAMP5 mRNA CTD PMID:26705709 NCBI chr 3:143,825,197...143,837,699
Ensembl chr 3:143,819,281...143,837,678 		JBrowse link
G Lamtor5 late endosomal/lysosomal adaptor, MAPK and MTOR activator 5 increases expression ISO Arsenic Trioxide results in increased expression of LAMTOR5 mRNA CTD PMID:20458559 NCBI chr 2:197,588,242...197,593,598
Ensembl chr 2:197,588,242...197,593,598 		JBrowse link
G Lap3 leucine aminopeptidase 3 decreases expression ISO Arsenic Trioxide results in decreased expression of LAP3 protein CTD PMID:19364129 NCBI chr14:69,820,907...69,839,891
Ensembl chr14:69,820,908...69,839,891 		JBrowse link
G Laptm5 lysosomal protein transmembrane 5 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of LAPTM5 mRNA
[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of LAPTM5 mRNA 		CTD PMID:15894607 PMID:20458559 NCBI chr 5:148,371,880...148,393,927
Ensembl chr 5:148,339,435...148,393,927 		JBrowse link
G Lasp1 LIM and SH3 protein 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to LASP1 protein] CTD PMID:26598702 NCBI chr10:83,290,820...83,331,989
Ensembl chr10:83,290,865...83,331,988 		JBrowse link
G Lat linker for activation of T cells increases expression ISO Arsenic Trioxide results in increased expression of LAT mRNA CTD PMID:15761015 NCBI chr 1:190,367,111...190,372,515
Ensembl chr 1:190,367,109...190,372,153 		JBrowse link
G Lat2 linker for activation of T cells family, member 2 decreases response to substance
decreases expression 		ISO LAT2 protein results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in decreased expression of LAT2 mRNA; Arsenic Trioxide results in decreased expression of LAT2 protein 		CTD PMID:19128835 PMID:23001822 PMID:32587277 NCBI chr12:27,740,647...27,754,760
Ensembl chr12:27,740,654...27,755,843 		JBrowse link
G Lats2 large tumor suppressor kinase 2 increases expression ISO Arsenic Trioxide results in increased expression of LATS2 mRNA CTD PMID:20458559 NCBI chr15:35,940,632...35,992,225
Ensembl chr15:35,940,632...35,980,842 		JBrowse link
G Lbp lipopolysaccharide binding protein multiple interactions ISO [Arsenic Trioxide results in increased abundance of arsenite] which results in increased expression of LBP protein CTD PMID:36791901 NCBI chr 3:167,373,786...167,400,941
Ensembl chr 3:167,373,924...167,401,518 		JBrowse link
G Lcat lecithin cholesterol acyltransferase increases expression ISO Arsenic Trioxide results in increased expression of LCAT mRNA CTD PMID:39716349 NCBI chr19:50,744,598...50,748,064
Ensembl chr19:50,744,601...50,748,081 		JBrowse link
G Lcn1 lipocalin 1 decreases expression ISO Arsenic Trioxide results in decreased expression of LCN1 mRNA CTD PMID:25258189 NCBI chr 3:29,930,943...29,935,418 JBrowse link
G Lcn2 lipocalin 2 increases expression ISO Arsenic Trioxide results in increased expression of LCN2 mRNA CTD PMID:19763917 NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:36,078,436...36,081,842 		JBrowse link
G Lcorl ligand dependent nuclear receptor corepressor-like multiple interactions
decreases expression 		ISO Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of LCORL mRNA] CTD PMID:29095437 NCBI chr14:69,482,919...69,620,269
Ensembl chr14:69,518,837...69,587,177 		JBrowse link
G Lcp1 lymphocyte cytosolic protein 1 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of LCP1 mRNA
Arsenic Trioxide results in decreased expression of LCP1 protein 		CTD PMID:22521957 PMID:25419056 NCBI chr15:56,846,375...56,954,090
Ensembl chr15:56,847,433...56,954,092 		JBrowse link
G Ldb2 LIM domain binding 2 decreases expression ISO Arsenic Trioxide results in decreased expression of LDB2 mRNA CTD PMID:26705709 NCBI chr14:70,489,243...70,810,573
Ensembl chr14:70,489,620...70,810,574 		JBrowse link
G Ldb3 LIM domain binding 3 increases expression ISO Arsenic Trioxide results in increased expression of LDB3 mRNA CTD PMID:39716349 NCBI chr16:9,862,161...9,926,338
Ensembl chr16:9,862,161...9,926,985 		JBrowse link
G Ldha lactate dehydrogenase A increases expression
decreases expression
multiple interactions 		ISO
EXP 		Arsenic Trioxide results in increased expression of LDHA mRNA
Arsenic Trioxide results in decreased expression of LDHA mRNA; Arsenic Trioxide results in decreased expression of LDHA protein
[Ascorbic Acid co-treated with Arsenic Trioxide] results in decreased expression of LDHA protein; Arsenic Trioxide promotes the reaction [Ascorbic Acid results in decreased expression of LDHA mRNA]; Arsenic Trioxide promotes the reaction [Ascorbic Acid results in decreased expression of LDHA protein]; Ascorbic Acid promotes the reaction [Arsenic Trioxide results in decreased expression of LDHA mRNA]; Ascorbic Acid promotes the reaction [Arsenic Trioxide results in decreased expression of LDHA protein]
Diosgenin inhibits the reaction [Arsenic Trioxide results in increased expression of LDHA protein] 		CTD PMID:20458559 PMID:38160894 PMID:39059093 NCBI chr 1:106,508,092...106,517,512
Ensembl chr 1:106,502,182...106,517,521 		JBrowse link
G Ldhb lactate dehydrogenase B decreases expression ISO Arsenic Trioxide results in decreased expression of LDHB protein CTD PMID:19364129 NCBI chr 4:177,159,389...177,177,408
Ensembl chr 4:177,159,392...177,177,408 		JBrowse link
G Ldlrad1 low density lipoprotein receptor class A domain containing 1 increases expression ISO Arsenic Trioxide results in increased expression of LDLRAD1 mRNA CTD PMID:25258189 NCBI chr 5:127,212,581...127,229,753
Ensembl chr 5:127,220,764...127,229,725 		JBrowse link
G Ldlrad4 low density lipoprotein receptor class A domain containing 4 decreases expression ISO Arsenic Trioxide results in decreased expression of LDLRAD4 mRNA CTD PMID:39716349 NCBI chr18:63,789,089...64,118,166
Ensembl chr18:63,790,440...64,113,064 		JBrowse link
G Ldoc1 LDOC1, regulator of NFKB signaling increases expression ISO Arsenic Trioxide results in increased expression of LDOC1 mRNA CTD PMID:25258189 NCBI chr  X:144,837,879...145,110,607
Ensembl chr  X:144,837,865...145,111,017 		JBrowse link
G Lemd3 LEM domain containing 3 increases expression ISO Arsenic Trioxide results in increased expression of LEMD3 mRNA CTD PMID:39716349 NCBI chr 7:58,300,556...58,389,485
Ensembl chr 7:58,316,851...58,384,707 		JBrowse link
G Lep leptin multiple interactions ISO Arsenic Trioxide results in decreased expression of and results in decreased secretion of LEP protein; Fenofibrate inhibits the reaction [Arsenic Trioxide results in decreased expression of and results in decreased secretion of LEP protein] CTD PMID:32929351 NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:58,626,523...58,640,661 		JBrowse link
G Lfng LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of LFNG mRNA
Arsenic Trioxide results in increased expression of LFNG mRNA 		CTD PMID:20458559 PMID:35676786 NCBI chr12:19,144,474...19,152,951
Ensembl chr12:19,124,662...19,152,918 		JBrowse link
G Lgals1 galectin 1 decreases expression
decreases secretion
increases response to substance 		ISO Arsenic Trioxide results in decreased expression of LGALS1 protein
LGALS1 protein results in decreased secretion of Arsenic Trioxide
Arsenic Trioxide results in decreased expression of LGALS1 mRNA; Arsenic Trioxide results in decreased expression of LGALS1 protein
LGALS1 protein results in increased susceptibility to Arsenic Trioxide 		CTD PMID:20458559 PMID:21596116 NCBI chr 7:112,365,695...112,368,801
Ensembl chr 7:112,361,850...112,368,800 		JBrowse link
G Lgals2 galectin 2 decreases expression ISO Arsenic Trioxide results in decreased expression of LGALS2 mRNA CTD PMID:19128835 NCBI chr 7:112,283,630...112,290,228
Ensembl chr 7:112,282,822...112,285,392 		JBrowse link
G Lgals3 galectin 3 increases expression ISO Arsenic Trioxide results in increased expression of LGALS3 mRNA CTD PMID:20458559 NCBI chr15:23,099,795...23,111,731
Ensembl chr15:23,086,841...23,111,737 		JBrowse link
G Lgals3bp galectin 3 binding protein multiple interactions
increases expression 		ISO [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of LGALS3BP mRNA
Arsenic Trioxide results in increased expression of LGALS3BP protein 		CTD PMID:15894607 PMID:25419056 NCBI chr10:104,118,510...104,127,848
Ensembl chr10:104,118,510...104,127,848 		JBrowse link
G Lgals8 galectin 8 affects expression
increases expression 		ISO Arsenic Trioxide affects the expression of LGALS8 mRNA
Arsenic Trioxide results in increased expression of LGALS8 mRNA 		CTD PMID:20458559 PMID:25873331 NCBI chr17:62,716,368...62,744,272
Ensembl chr17:62,719,828...62,744,482 		JBrowse link
G Lgals9 galectin 9 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of LGALS9 mRNA
[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of LGALS9 mRNA 		CTD PMID:15761015 PMID:15894607 NCBI chr10:64,405,044...64,428,249
Ensembl chr10:64,405,044...64,428,070 		JBrowse link
G Lgalsl galectin-like multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to LGALSL protein] CTD PMID:26598702 NCBI chr14:99,198,340...99,205,846
Ensembl chr14:99,198,339...99,206,487 		JBrowse link
G Lgi1 leucine-rich, glioma inactivated 1 decreases expression ISO Arsenic Trioxide results in decreased expression of LGI1 mRNA CTD PMID:26705709 NCBI chr 1:245,455,691...245,497,036
Ensembl chr 1:245,455,599...245,499,095 		JBrowse link
G Lgi3 leucine-rich repeat LGI family, member 3 decreases expression ISO Arsenic Trioxide results in decreased expression of LGI3 mRNA CTD PMID:20458559 NCBI chr15:52,015,317...52,022,445
Ensembl chr15:52,015,230...52,022,443 		JBrowse link
G Lgmn legumain decreases expression ISO Arsenic Trioxide results in decreased expression of LGMN mRNA CTD PMID:15725085 NCBI chr 6:127,308,913...127,347,355
Ensembl chr 6:127,308,913...127,347,328 		JBrowse link
G Lgr4 leucine-rich repeat-containing G protein-coupled receptor 4 decreases expression ISO Arsenic Trioxide results in decreased expression of LGR4 mRNA CTD PMID:27829220 NCBI chr 3:116,901,968...117,004,584
Ensembl chr 3:116,901,968...117,004,153 		JBrowse link
G Lgr5 leucine rich repeat containing G protein coupled receptor 5 decreases expression ISO Arsenic Trioxide results in decreased expression of LGR5 mRNA CTD PMID:26705709 NCBI chr 7:52,973,151...53,107,964
Ensembl chr 7:52,974,332...53,108,163 		JBrowse link
G Lhb luteinizing hormone subunit beta decreases expression ISO Arsenic Trioxide results in decreased expression of LHB protein CTD PMID:18630931 NCBI chr 1:105,037,457...105,038,446
Ensembl chr 1:105,037,457...105,038,445 		JBrowse link
G Lhfpl2 LHFPL tetraspan subfamily member 2 decreases expression ISO Arsenic Trioxide results in decreased expression of LHFPL2 mRNA CTD PMID:39716349 NCBI chr 2:27,016,404...27,169,830
Ensembl chr 2:27,016,700...27,162,859 		JBrowse link
G Lhfpl5 LHFPL tetraspan subfamily member 5 increases expression ISO Arsenic Trioxide results in increased expression of LHFPL5 mRNA CTD PMID:39716349 NCBI chr20:6,634,058...6,644,264
Ensembl chr20:6,633,979...6,644,657 		JBrowse link
G Lhfpl6 LHFPL tetraspan subfamily member 6 decreases expression ISO Arsenic Trioxide results in decreased expression of LHFPL6 mRNA CTD PMID:15070760 PMID:15761015 NCBI chr 2:139,276,810...139,474,740
Ensembl chr 2:139,276,789...139,474,737 		JBrowse link
G Lhx6 LIM homeobox 6 decreases expression ISO Arsenic Trioxide results in decreased expression of LHX6 mRNA CTD PMID:15761015 NCBI chr 3:39,829,846...39,853,681
Ensembl chr 3:39,830,990...39,853,559 		JBrowse link
G Lif LIF, interleukin 6 family cytokine increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of LIF mRNA
Arsenic Trioxide results in decreased expression of LIF mRNA; Arsenic Trioxide results in decreased expression of LIF protein 		CTD PMID:20458559 PMID:26705709 PMID:33634982 NCBI chr14:83,354,602...83,364,053
Ensembl chr14:83,358,164...83,364,053 		JBrowse link
G Limd1 LIM domain containing 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to LIMD1 protein] CTD PMID:26598702 NCBI chr 8:131,998,262...132,045,924
Ensembl chr 8:131,999,770...132,045,922 		JBrowse link
G Limd2 LIM domain containing 2 increases response to substance ISO LIMD2 protein results in increased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr10:91,590,079...91,592,747
Ensembl chr10:91,590,082...91,592,439 		JBrowse link
G Lin7c lin-7 homolog C, crumbs cell polarity complex component decreases expression ISO Arsenic Trioxide results in decreased expression of LIN7C mRNA CTD PMID:20458559 NCBI chr 3:116,859,425...116,872,363
Ensembl chr 3:116,860,282...116,872,363 		JBrowse link
G Litaf lipopolysaccharide-induced TNF factor multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to LITAF protein] CTD PMID:26598702 NCBI chr10:5,163,258...5,199,930
Ensembl chr10:5,163,242...5,199,930 		JBrowse link
G Lix1l limb and CNS expressed 1 like increases expression ISO Arsenic Trioxide results in increased expression of LIX1L mRNA CTD PMID:22521957 NCBI chr 2:186,824,864...186,850,761
Ensembl chr 2:186,824,884...186,850,759 		JBrowse link
G Llgl2 LLGL scribble cell polarity complex component 2 decreases response to substance
multiple interactions 		ISO LLGL2 protein results in decreased susceptibility to Arsenic Trioxide
[Arsenic Trioxide co-treated with apatinib] results in decreased expression of LLGL2 mRNA 		CTD PMID:20707922 PMID:39223679 NCBI chr10:101,549,911...101,585,466
Ensembl chr10:101,549,862...101,585,464 		JBrowse link
G Lmf1 lipase maturation factor 1 decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of LMF1 mRNA
Arsenic Trioxide results in increased expression of LMF1 mRNA 		CTD PMID:26705709 PMID:35676786 NCBI chr10:15,094,432...15,188,665
Ensembl chr10:15,098,138...15,188,664 		JBrowse link
G Lmna lamin A/C multiple interactions
increases expression 		ISO Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of LMNA mRNA] CTD PMID:29095437 NCBI chr 2:176,237,564...176,265,301
Ensembl chr 2:176,237,564...176,288,072 		JBrowse link
G Lmo2 LIM domain only 2 decreases expression ISO Arsenic Trioxide results in decreased expression of LMO2 mRNA CTD PMID:19128835 NCBI chr 3:110,810,162...110,832,895
Ensembl chr 3:110,809,912...110,833,075 		JBrowse link
G Lmod1 leiomodin 1 increases expression ISO Arsenic Trioxide results in increased expression of LMOD1 mRNA CTD PMID:20458559 NCBI chr13:49,305,693...49,347,970
Ensembl chr13:49,305,830...49,348,116 		JBrowse link
G Lmx1a LIM homeobox transcription factor 1 alpha increases expression ISO Arsenic Trioxide results in increased expression of LMX1A mRNA CTD PMID:20458559 NCBI chr13:82,367,493...82,511,157
Ensembl chr13:82,367,933...82,511,154 		JBrowse link
G Lnpep leucyl and cystinyl aminopeptidase decreases expression ISO Arsenic Trioxide results in decreased expression of LNPEP mRNA CTD PMID:35676786 NCBI chr 1:66,931,712...67,027,610
Ensembl chr 1:66,931,712...67,027,610 		JBrowse link
G Lnpk lunapark, ER junction formation factor decreases expression ISO Arsenic Trioxide results in decreased expression of LNPK mRNA CTD PMID:35676786 NCBI chr 3:79,826,318...79,894,514
Ensembl chr 3:79,832,753...79,894,403 		JBrowse link
G Loxl4 lysyl oxidase-like 4 decreases expression ISO Arsenic Trioxide results in decreased expression of LOXL4 mRNA CTD PMID:39716349 NCBI chr 1:251,345,445...251,365,640
Ensembl chr 1:251,347,238...251,365,577 		JBrowse link
G Lpar2 lysophosphatidic acid receptor 2 decreases response to substance ISO LPAR2 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr16:19,625,974...19,633,905
Ensembl chr16:19,625,983...19,633,905 		JBrowse link
G Lpar4 lysophosphatidic acid receptor 4 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to LPAR4 protein] CTD PMID:26598702 NCBI chr  X:76,106,319...76,119,807
Ensembl chr  X:76,106,071...76,119,808 		JBrowse link
G Lpcat1 lysophosphatidylcholine acyltransferase 1 multiple interactions
decreases expression 		ISO [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of LPCAT1 mRNA
Arsenic Trioxide results in decreased expression of LPCAT1 mRNA 		CTD PMID:15894607 PMID:39716349 NCBI chr 1:31,594,621...31,644,946
Ensembl chr 1:31,594,622...31,644,946 		JBrowse link
G Lpcat4 lysophosphatidylcholine acyltransferase 4 decreases expression ISO Arsenic Trioxide results in decreased expression of LPCAT4 mRNA CTD PMID:39716349 NCBI chr 3:119,499,128...119,507,275
Ensembl chr 3:119,499,128...119,507,362 		JBrowse link
G Lpin3 lipin 3 increases expression ISO Arsenic Trioxide results in increased expression of LPIN3 mRNA CTD PMID:35676786 PMID:39716349 NCBI chr 3:169,953,479...169,978,034
Ensembl chr 3:169,960,522...169,978,031 		JBrowse link
G Lpl lipoprotein lipase decreases expression ISO Arsenic Trioxide results in decreased expression of LPL mRNA CTD PMID:19128835 PMID:26705709 NCBI chr16:25,596,205...25,621,928
Ensembl chr16:25,596,211...25,622,107 		JBrowse link
G Lrp1 LDL receptor related protein 1 decreases expression ISO Arsenic Trioxide results in decreased expression of LRP1 mRNA CTD PMID:22521957 NCBI chr 7:65,265,639...65,346,196
Ensembl chr 7:65,265,639...65,346,196 		JBrowse link
G Lrp4 LDL receptor related protein 4 increases expression ISO Arsenic Trioxide results in increased expression of LRP4 mRNA CTD PMID:20458559 NCBI chr 3:97,885,373...97,939,366
Ensembl chr 3:97,885,400...97,939,370 		JBrowse link
G Lrpap1 LDL receptor related protein associated protein 1 multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of LRPAP1 mRNA CTD PMID:15894607 NCBI chr14:79,876,002...79,888,011
Ensembl chr14:79,875,708...79,890,034 		JBrowse link
G Lrrc31 leucine rich repeat containing 31 decreases expression ISO Arsenic Trioxide results in decreased expression of LRRC31 mRNA CTD PMID:39716349 NCBI chr 2:114,624,177...114,654,909
Ensembl chr 2:114,631,136...114,652,269 		JBrowse link
G Lrrc3b leucine rich repeat containing 3B decreases expression ISO Arsenic Trioxide results in decreased expression of LRRC3B mRNA CTD PMID:26705709 NCBI chr15:12,404,309...12,481,618
Ensembl chr15:12,336,369...12,481,866 		JBrowse link
G Lrrc59 leucine rich repeat containing 59 decreases expression ISO Arsenic Trioxide results in decreased expression of LRRC59 protein CTD PMID:25419056 NCBI chr10:80,069,162...80,083,820
Ensembl chr10:80,069,120...80,084,079 		JBrowse link
G Lrrc7 leucine rich repeat containing 7 decreases expression ISO Arsenic Trioxide results in decreased expression of LRRC7 mRNA CTD PMID:26705709 NCBI chr 2:249,792,441...250,294,267
Ensembl chr 2:249,805,448...250,293,718 		JBrowse link
G Lrrc8b leucine rich repeat containing 8 VRAC subunit B decreases expression ISO Arsenic Trioxide results in decreased expression of LRRC8B mRNA CTD PMID:20458559 NCBI chr14:4,655,273...4,721,648
Ensembl chr14:4,655,273...4,721,076 		JBrowse link
G Lrrfip1 LRR binding FLII interacting protein 1 affects expression ISO Arsenic Trioxide affects the expression of LRRFIP1 mRNA CTD PMID:25258189 NCBI chr 9:99,039,590...99,167,805
Ensembl chr 9:99,039,614...99,167,779 		JBrowse link
G Lrrk1 leucine-rich repeat kinase 1 multiple interactions
increases expression 		ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to LRRK1 protein]
Arsenic Trioxide results in increased expression of LRRK1 mRNA 		CTD PMID:20458559 PMID:26598702 NCBI chr 1:129,254,815...129,390,217
Ensembl chr 1:129,254,515...129,389,941 		JBrowse link
G Lrrn4 leucine rich repeat neuronal 4 decreases expression ISO Arsenic Trioxide results in decreased expression of LRRN4 mRNA CTD PMID:35676786 NCBI chr 3:140,592,303...140,603,986
Ensembl chr 3:140,592,076...140,605,574 		JBrowse link
G Lsamp limbic system-associated membrane protein decreases expression ISO Arsenic Trioxide results in decreased expression of LSAMP mRNA CTD PMID:26705709 NCBI chr11:72,053,285...74,223,019
Ensembl chr11:72,053,285...72,702,134 		JBrowse link
G Lsm11 LSM11, U7 small nuclear RNA associated increases expression ISO Arsenic Trioxide results in increased expression of LSM11 mRNA CTD PMID:20458559 NCBI chr10:30,869,168...30,887,275
Ensembl chr10:30,872,054...30,887,269 		JBrowse link
G Lsm12 LSM12 homolog multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to LSM12 protein] CTD PMID:26598702 NCBI chr10:87,618,518...87,640,556
Ensembl chr10:87,618,518...87,640,556 		JBrowse link
G Lsm2 LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated decreases expression ISO Arsenic Trioxide results in decreased expression of LSM2 mRNA CTD PMID:35676786 NCBI chr20:3,848,120...3,853,298
Ensembl chr20:3,848,119...3,851,891 		JBrowse link
G Lsp1 lymphocyte-specific protein 1 multiple interactions
increases expression 		ISO [Arsenic Trioxide co-treated with Tretinoin] results in increased expression of LSP1 mRNA; [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of LSP1 mRNA
Arsenic Trioxide results in increased expression of LSP1 mRNA 		CTD PMID:15761015 PMID:15894607 PMID:38179723 NCBI chr 1:207,044,157...207,077,891
Ensembl chr 1:207,044,159...207,077,893 		JBrowse link
G Lsr lipolysis stimulated lipoprotein receptor decreases expression
decreases response to substance 		ISO Arsenic Trioxide results in decreased expression of LSR mRNA
LSR protein results in decreased susceptibility to Arsenic Trioxide 		CTD PMID:20707922 PMID:22521957 NCBI chr 1:95,313,830...95,329,471
Ensembl chr 1:95,313,033...95,329,354 		JBrowse link
G Lta lymphotoxin alpha multiple interactions
increases expression 		ISO
EXP 		[Arsenic Trioxide co-treated with Curcumin] results in increased expression of LTA protein
Arsenic Trioxide results in increased expression of LTA mRNA 		CTD PMID:19730151 PMID:20458559 PMID:27430728 NCBI chr20:3,622,291...3,625,852
Ensembl chr20:3,623,527...3,625,533 		JBrowse link
G Lta4h leukotriene A4 hydrolase decreases response to substance ISO LTA4H protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 7:29,856,846...29,888,642
Ensembl chr 7:29,856,802...29,888,641 		JBrowse link
G Ltb lymphotoxin beta multiple interactions
increases expression 		ISO [sanguinarine co-treated with Arsenic Trioxide] results in increased expression of LTB mRNA
Arsenic Trioxide results in increased expression of LTB mRNA 		CTD PMID:24345465 NCBI chr20:3,632,209...3,634,054
Ensembl chr20:3,632,210...3,634,054 		JBrowse link
G Ltbr lymphotoxin beta receptor increases expression EXP Arsenic Trioxide results in increased expression of LTBR mRNA CTD PMID:19730151 NCBI chr 4:159,795,115...159,801,571
Ensembl chr 4:159,795,115...159,807,296 		JBrowse link
G Ltc4s leukotriene C4 synthase increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of LTC4S mRNA
Arsenic Trioxide results in decreased expression of LTC4S mRNA 		CTD PMID:15761015 PMID:20458559 NCBI chr10:35,060,002...35,066,466
Ensembl chr10:35,061,437...35,063,768 		JBrowse link
G Ly6e lymphocyte antigen 6 family member E multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of LY6E mRNA; Arsenic Trioxide inhibits the reaction [Tretinoin results in increased expression of LY6E protein] CTD PMID:11133770 PMID:15894607 NCBI chr 7:108,815,970...108,820,444
Ensembl chr 7:108,816,887...108,820,443 		JBrowse link
G Ly96 lymphocyte antigen 96 multiple interactions
increases expression 		ISO [Arsenic Trioxide co-treated with Bortezomib] results in increased expression of LY96 mRNA
Arsenic Trioxide results in increased expression of LY96 mRNA 		CTD PMID:25913414 PMID:26705709 PMID:27829220 NCBI chr 5:7,365,536...7,397,864
Ensembl chr 5:7,365,557...7,395,816 		JBrowse link
G Lypd6 Ly6/Plaur domain containing 6 decreases expression ISO Arsenic Trioxide results in decreased expression of LYPD6 mRNA CTD PMID:39716349 NCBI chr 3:54,896,618...55,041,928
Ensembl chr 3:54,896,575...55,041,929 		JBrowse link
G Lypd6b Ly6/Plaur domain containing 6B decreases expression ISO Arsenic Trioxide results in decreased expression of LYPD6B mRNA CTD PMID:39716349 NCBI chr 3:54,608,320...54,769,974
Ensembl chr 3:54,757,444...54,769,974 		JBrowse link
G Lypd8 Ly6/Plaur domain containing 8 decreases expression ISO Arsenic Trioxide results in decreased expression of LYPD8 mRNA CTD PMID:39716349 NCBI chr10:43,062,261...43,073,108
Ensembl chr10:43,065,186...43,073,105 		JBrowse link
G Lypla1 lysophospholipase 1 decreases expression ISO Arsenic Trioxide results in decreased expression of LYPLA1 protein CTD PMID:19364129 NCBI chr 5:19,477,408...19,506,568
Ensembl chr 5:19,477,409...19,506,522 		JBrowse link
G Lypla2 lysophospholipase 2 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to LYPLA2 protein] CTD PMID:26598702 NCBI chr 5:153,481,973...153,486,692
Ensembl chr 5:153,481,974...153,486,601 		JBrowse link
G Lyve1 lymphatic vessel endothelial hyaluronan receptor 1 decreases expression ISO Arsenic Trioxide results in decreased expression of LYVE1 mRNA; Arsenic Trioxide results in decreased expression of LYVE1 protein CTD PMID:38275666 NCBI chr 1:174,393,387...174,410,977 JBrowse link
G Lztfl1 leucine zipper transcription factor-like 1 increases response to substance ISO LZTFL1 protein results in increased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 8:132,222,339...132,237,757
Ensembl chr 8:132,222,342...132,237,684 		JBrowse link
G Macf1 microtubule-actin crosslinking factor 1 decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of MACF1 protein
Arsenic Trioxide results in increased expression of MACF1 mRNA 		CTD PMID:15894607 PMID:39716349 NCBI chr 5:140,908,829...141,234,127
Ensembl chr 5:140,908,837...141,233,890 		JBrowse link
G Macrod2 mono-ADP ribosylhydrolase 2 decreases expression ISO Arsenic Trioxide results in decreased expression of MACROD2 mRNA CTD PMID:35676786 NCBI chr 3:148,173,821...150,191,077
Ensembl chr 3:148,173,829...150,188,058 		JBrowse link
G Macroh2a2 macroH2A.2 histone decreases expression ISO Arsenic Trioxide results in decreased expression of MACROH2A2 mRNA CTD PMID:22521957 NCBI chr20:30,220,975...30,270,652
Ensembl chr20:30,221,011...30,270,652 		JBrowse link
G Mad1l1 mitotic arrest deficient 1 like 1 increases expression ISO Arsenic Trioxide results in increased expression of MAD1L1 mRNA CTD PMID:39716349 NCBI chr12:19,434,782...19,744,574
Ensembl chr12:19,434,746...19,744,567 		JBrowse link
G Mad2l1 mitotic arrest deficient 2 like 1 decreases expression ISO Arsenic Trioxide results in decreased expression of MAD2L1 mRNA CTD PMID:27829220 NCBI chr 4:97,236,419...97,247,603
Ensembl chr 4:97,236,503...97,243,222 		JBrowse link
G Maff MAF bZIP transcription factor F increases expression ISO Arsenic Trioxide results in increased expression of MAFF mRNA; Arsenic Trioxide results in increased expression of MAFF protein CTD PMID:16487037 PMID:26705709 NCBI chr 7:112,792,787...112,804,139
Ensembl chr 7:112,791,416...112,804,147 		JBrowse link
G Mafk MAF bZIP transcription factor K affects methylation ISO Arsenic Trioxide affects the methylation of MAFK promoter CTD PMID:26046465 NCBI chr12:19,948,473...19,970,351
Ensembl chr12:19,948,476...19,959,192 		JBrowse link
G Magea13 MAGE family member A13 increases expression ISO Arsenic Trioxide results in increased expression of MAGEA12 mRNA CTD PMID:39716349 NCBI chr  X:142,106,603...142,112,462
Ensembl chr  X:142,106,603...142,112,457 		JBrowse link
G Maged2 MAGE family member D2 increases expression ISO Arsenic Trioxide results in increased expression of MAGED2 mRNA CTD PMID:39716349 NCBI chr  X:23,160,928...23,364,994
Ensembl chr  X:23,160,931...23,169,104 		JBrowse link
G Mak male germ cell-associated kinase decreases expression ISO Arsenic Trioxide results in decreased expression of MAK mRNA CTD PMID:21461292 NCBI chr17:23,889,417...23,936,857
Ensembl chr17:23,889,516...23,936,855 		JBrowse link
G Mall mal, T-cell differentiation protein-like decreases response to substance ISO MALL protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 3:135,381,180...135,404,136
Ensembl chr 3:135,377,410...135,404,066 		JBrowse link
G Mamdc2 MAM domain containing 2 decreases expression ISO Arsenic Trioxide results in decreased expression of MAMDC2 mRNA CTD PMID:26705709 NCBI chr 1:230,290,482...230,443,014
Ensembl chr 1:230,290,499...230,442,711 		JBrowse link
G Maml1 mastermind-like transcriptional coactivator 1 increases expression ISO Arsenic Trioxide results in increased expression of MAML1 mRNA CTD PMID:20458559 NCBI chr10:35,089,715...35,124,100
Ensembl chr10:35,089,715...35,124,100 		JBrowse link
G Man1a1 mannosidase, alpha, class 1A, member 1 increases expression ISO Arsenic Trioxide results in increased expression of MAN1A1 mRNA CTD PMID:15761015 NCBI chr20:33,745,158...33,928,584
Ensembl chr20:33,745,165...33,928,584 		JBrowse link
G Man1a2 mannosidase, alpha, class 1A, member 2 increases expression ISO Arsenic Trioxide results in increased expression of MAN1A2 mRNA CTD PMID:20458559 NCBI chr 2:190,636,134...190,784,975
Ensembl chr 2:190,615,094...190,784,975 		JBrowse link
G Man1c1 mannosidase, alpha, class 1C, member 1 decreases expression ISO Arsenic Trioxide results in decreased expression of MAN1C1 mRNA CTD PMID:26705709 NCBI chr 5:152,057,839...152,197,737
Ensembl chr 5:152,057,967...152,197,138 		JBrowse link
G Manf mesencephalic astrocyte-derived neurotrophic factor decreases expression ISO Arsenic Trioxide results in decreased expression of MANF mRNA CTD PMID:20458559 NCBI chr 8:116,427,053...116,430,259
Ensembl chr 8:116,427,048...116,429,910 		JBrowse link
G Maoa monoamine oxidase A increases expression ISO Arsenic Trioxide results in increased expression of MAOA mRNA CTD PMID:15761015 PMID:22521957 NCBI chr  X:8,615,239...8,681,372
Ensembl chr  X:8,615,239...8,682,631 		JBrowse link
G Map1b microtubule-associated protein 1B increases expression ISO Arsenic Trioxide results in increased expression of MAP1B mRNA CTD PMID:20458559 NCBI chr 2:32,551,423...32,644,471
Ensembl chr 2:32,551,423...32,657,094 		JBrowse link
G Map1lc3a microtubule-associated protein 1 light chain 3 alpha increases expression
multiple interactions 		ISO
EXP 		Arsenic Trioxide results in increased expression of MAP1LC3A protein
Arsenic Trioxide results in increased expression of MAP1LC3A mRNA
Riboflavin inhibits the reaction [Arsenic Trioxide results in increased expression of MAP1LC3A mRNA] 		CTD PMID:20200477 PMID:30032600 PMID:30225639 PMID:31846860 PMID:34062077 NCBI chr 3:164,243,204...164,244,850
Ensembl chr 3:164,243,093...164,244,850 		JBrowse link
G Map1lc3b microtubule-associated protein 1 light chain 3 beta multiple interactions
increases expression
increases lipidation
increases cleavage 		ISO
EXP 		3-methyladenine inhibits the reaction [Arsenic Trioxide results in increased cleavage of MAP1LC3B protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of MAP1LC3B mRNA]; Arsenic Trioxide inhibits the reaction [TRIM44 protein results in increased lipidation of MAP1LC3B protein]; Arsenic Trioxide promotes the reaction [bafilomycin A results in increased expression of MAP1LC3B protein modified form]; Arsenic Trioxide results in increased metabolism of and affects the localization of MAP1LC3B protein; Chloroquine promotes the reaction [Arsenic Trioxide results in increased expression of MAP1LC3B protein]; MK-886 inhibits the reaction [Arsenic Trioxide results in increased cleavage of MAP1LC3B protein]; Taurine inhibits the reaction [Arsenic Trioxide results in increased cleavage of MAP1LC3B protein]; Taurine inhibits the reaction [Arsenic Trioxide results in increased expression of MAP1LC3B protein]; TFEB protein affects the reaction [Arsenic Trioxide results in increased expression of MAP1LC3B mRNA]; TP73 protein affects the reaction [Arsenic Trioxide promotes the reaction [bafilomycin A results in increased expression of MAP1LC3B protein modified form]]
Arsenic Trioxide results in increased expression of MAP1LC3B mRNA; Arsenic Trioxide results in increased expression of MAP1LC3B protein
Arsenic Trioxide results in increased expression of MAP1LC3B mRNA; Arsenic Trioxide results in increased expression of MAP1LC3B protein; Arsenic Trioxide results in increased expression of MAP1LC3B protein modified form
Arsenic Trioxide results in increased lipidation of MAP1LC3B protein
[ferrostatin-1 co-treated with Arsenic Trioxide] results in increased lipidation of MAP1LC3B protein; dapagliflozin inhibits the reaction [Arsenic Trioxide results in increased expression of MAP1LC3B protein]; MAP1LC3B protein affects the reaction [Arsenic Trioxide results in decreased expression of SQSTM1 protein]; MAP1LC3B protein affects the reaction [Arsenic Trioxide results in increased lipidation of MAP1LC3B protein] 		CTD PMID:28978663 PMID:29111283 PMID:29307831 PMID:29743969 PMID:30032600 More... NCBI chr19:66,571,631...66,582,270
Ensembl chr19:66,574,407...66,584,358
Ensembl chr16:66,574,407...66,584,358 		JBrowse link
G Map2 microtubule-associated protein 2 decreases expression ISO Arsenic Trioxide results in decreased expression of MAP2 protein CTD PMID:15894607 NCBI chr 9:75,173,038...75,431,606
Ensembl chr 9:75,288,262...75,428,459 		JBrowse link
G Map2k1 mitogen activated protein kinase kinase 1 decreases phosphorylation
multiple interactions
increases expression
decreases activity 		ISO Arsenic Trioxide results in decreased phosphorylation of MAP2K1 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide promotes the reaction [Tretinoin results in increased phosphorylation of and results in increased activity of MAP2K1 protein]]; Arsenic Trioxide promotes the reaction [Tretinoin results in increased phosphorylation of and results in increased activity of MAP2K1 protein]; Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAP2K1 protein
Arsenic Trioxide results in increased expression of MAP2K1 mRNA
Arsenic Trioxide results in decreased activity of MAP2K1 protein 		CTD PMID:11304686 PMID:20592496 PMID:20615082 PMID:22521957 PMID:28454374 NCBI chr 8:73,578,747...73,650,184
Ensembl chr 8:73,578,752...73,650,184 		JBrowse link
G Map2k2 mitogen activated protein kinase kinase 2 decreases activity
multiple interactions
increases expression 		ISO Arsenic Trioxide results in decreased activity of MAP2K2 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide promotes the reaction [Tretinoin results in increased phosphorylation of and results in increased activity of MAP2K2 protein]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAP2K2 protein]; Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to MAP2K2 protein]; Arsenic Trioxide promotes the reaction [Tretinoin results in increased phosphorylation of and results in increased activity of MAP2K2 protein]; Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAP2K2 protein
Arsenic Trioxide results in increased expression of MAP2K2 protein 		CTD PMID:11304686 PMID:20615082 PMID:25419056 PMID:26598702 NCBI chr 7:9,241,449...9,264,216
Ensembl chr 7:9,241,310...9,260,940 		JBrowse link
G Map2k3 mitogen activated protein kinase kinase 3 multiple interactions
affects response to substance
increases expression 		ISO MAP2K3 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK14 protein]
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAP2K3 protein]; Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAP2K3 protein
MAP2K3 protein affects the susceptibility to Arsenic Trioxide
Arsenic Trioxide results in increased expression of MAP2K3 mRNA 		CTD PMID:16818652 PMID:20615082 PMID:29633893 NCBI chr10:46,107,639...46,128,986
Ensembl chr10:46,106,548...46,129,004 		JBrowse link
G Map2k4 mitogen activated protein kinase kinase 4 multiple interactions
increases response to substance 		ISO MAP2K4 gene mutant form inhibits the reaction [Arsenic Trioxide results in increased activity of MAPK8 protein]; MAP2K4 protein promotes the reaction [Arsenic Trioxide results in increased expression of HSPA6 mRNA]; MAP2K4 protein promotes the reaction [Arsenic Trioxide results in increased expression of HSPA6 protein]; MAP2K4 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of HSF1 protein]
MAP2K4 protein results in increased susceptibility to Arsenic Trioxide; MAP2K4 results in increased susceptibility to Arsenic Trioxide 		CTD PMID:14701702 PMID:15978632 PMID:16184197 PMID:18633430 NCBI chr10:50,842,348...50,947,063
Ensembl chr10:50,844,034...50,947,185 		JBrowse link
G Map2k6 mitogen-activated protein kinase kinase 6 decreases expression
affects response to substance
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of MAP2K6 mRNA
MAP2K6 protein affects the susceptibility to Arsenic Trioxide
Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAP2K6 protein
MAP2K6 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK14 protein] 		CTD PMID:16818652 PMID:26705709 PMID:39716349 NCBI chr10:95,872,747...95,987,747
Ensembl chr10:95,872,546...95,987,721 		JBrowse link
G Map3k12 mitogen activated protein kinase kinase kinase 12 increases expression ISO Arsenic Trioxide results in increased expression of MAP3K12 mRNA CTD PMID:35676786 NCBI chr 7:135,507,082...135,527,396
Ensembl chr 7:135,508,790...135,515,137 		JBrowse link
G Map3k6 mitogen-activated protein kinase kinase kinase 6 increases expression ISO Arsenic Trioxide results in increased expression of MAP3K6 mRNA CTD PMID:35676786 NCBI chr 5:150,724,029...150,736,113
Ensembl chr 5:150,724,216...150,736,111 		JBrowse link
G Map3k7cl MAP3K7 C-terminal like increases expression ISO Arsenic Trioxide results in increased expression of MAP3K7CL mRNA CTD PMID:26705709 NCBI chr11:40,276,839...40,321,848
Ensembl chr11:40,277,688...40,321,847 		JBrowse link
G Map4k2 mitogen activated protein kinase kinase kinase kinase 2 decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of MAP4K2 mRNA
Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of MAP4K2 mRNA] 		CTD PMID:29095437 NCBI chr 1:213,074,360...213,090,042
Ensembl chr 1:213,074,377...213,096,987 		JBrowse link
G Map4k3 mitogen-activated protein kinase kinase kinase kinase 3 increases expression ISO Arsenic Trioxide results in increased expression of MAP4K3 mRNA CTD PMID:20458559 NCBI chr 6:20,029,246...20,198,583
Ensembl chr 6:20,029,397...20,198,583 		JBrowse link
G Map7 microtubule-associated protein 7 increases expression ISO Arsenic Trioxide results in increased expression of MAP7 mRNA CTD PMID:15761015 NCBI chr 1:16,730,000...16,857,173
Ensembl chr 1:16,730,075...16,857,170 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions
affects activity
increases phosphorylation
decreases expression
affects expression
decreases phosphorylation
increases activity
decreases activity
increases expression 		EXP
ISO 		2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK1 protein]; Arsenic Trioxide results in decreased phosphorylation of and results in decreased activity of MAPK1 protein; Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK1 protein; HTS 466284 inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Phloretin inhibits the reaction [Arsenic Trioxide results in decreased expression of MAPK1 mRNA]
Arsenic Trioxide affects the activity of MAPK1 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK1 protein]; [Arsenic Trioxide co-treated with 6,7-dimethoxy-3-phenylquinoxaline] results in decreased activity of MAPK1 protein; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of MAPK1 protein]
Arsenic Trioxide results in decreased expression of MAPK1 protein
Arsenic Trioxide affects the expression of MAPK1 mRNA
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Arsenic Trioxide co-treated with Tetradecanoylphorbol Acetate] results in increased phosphorylation of and results in increased activity of MAPK1 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK1 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK1 protein]; 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK1 protein]; 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK1 protein]; 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK1 protein]; [acetyl-11-ketoboswellic acid co-treated with Arsenic Trioxide] results in decreased phosphorylation of MAPK1 protein; [Arsenic Trioxide co-treated with 6,7-dimethoxy-3-phenylquinoxaline] results in decreased activity of MAPK1 protein; [Arsenic Trioxide co-treated with phytosphingosine] results in decreased phosphorylation of MAPK1 protein; [Arsenic Trioxide co-treated with Tetradecanoylphorbol Acetate] results in increased phosphorylation of and results in increased activity of MAPK1 protein; [IL24 protein co-treated with Arsenic Trioxide] results in increased phosphorylation of MAPK1 protein; [Quercetin co-treated with Arsenic Trioxide] results in increased phosphorylation of and results in increased activity of MAPK1 protein; [Sulindac co-treated with Arsenic Trioxide] results in increased phosphorylation of MAPK1 protein; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK1 protein]; AKT1 protein inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK1 protein]; ARL6IP5 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Arsenic Trioxide inhibits the reaction [Deoxyglucose results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Arsenic Trioxide inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK1 protein]; Arsenic Trioxide inhibits the reaction [IGF1 protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Arsenic Trioxide inhibits the reaction [Indomethacin results in decreased phosphorylation of MAPK1 protein]; Arsenic Trioxide inhibits the reaction [lonidamine results in increased phosphorylation of MAPK1 protein]; Arsenic Trioxide inhibits the reaction [Sirolimus results in increased phosphorylation of MAPK1 protein]; Arsenic Trioxide inhibits the reaction [temsirolimus results in increased phosphorylation of MAPK1 protein]; Arsenic Trioxide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein]; Arsenic Trioxide inhibits the reaction [TNF protein results in increased phosphorylation of MAPK1 protein]; Arsenic Trioxide inhibits the reaction [Tunicamycin results in decreased phosphorylation of MAPK1 protein]; Arsenic Trioxide inhibits the reaction [VEGFA protein results in increased phosphorylation of MAPK1 protein]; Arsenic Trioxide promotes the reaction [Curcumin results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Arsenic Trioxide promotes the reaction [MAPK1 protein promotes the reaction [FOS protein binds to CDKN1A promoter]]; Arsenic Trioxide promotes the reaction [Sulindac results in increased phosphorylation of MAPK1 protein]; Arsenic Trioxide promotes the reaction [Tretinoin results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK1 protein; bisindolylmaleimide I inhibits the reaction [[Arsenic Trioxide co-treated with Tetradecanoylphorbol Acetate] results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Indomethacin inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of MAPK1 protein]; KIRA6 inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK1 protein]; MAPK1 protein affects the reaction [Arsenic Trioxide results in increased expression of CCND1 protein]; MAPK1 protein affects the reaction [Arsenic Trioxide results in increased expression of CDC6 protein]; MAPK8 mutant form inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK1 protein]; MT2A protein inhibits the reaction [Arsenic Trioxide results in increased expression of MAPK1 protein modified form]; setanaxib inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK1 protein]; Sorafenib inhibits the reaction [Arsenic Trioxide results in increased activity of MAPK1 protein]; Sulindac promotes the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK1 protein]; temsirolimus inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK1 protein]; U 0126 inhibits the reaction [[Arsenic Trioxide co-treated with Tetradecanoylphorbol Acetate] results in increased phosphorylation of and results in increased activity of MAPK1 protein]; U 0126 inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK1 protein]; U 0126 inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK1 protein]; U 0126 promotes the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK1 protein]
Arsenic Trioxide results in decreased activity of MAPK1 protein
Arsenic Trioxide results in increased expression of MAPK1 mRNA 		CTD PMID:11304686 PMID:12296996 PMID:12754411 PMID:14610070 PMID:15580305 More... NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825 		JBrowse link
G Mapk11 mitogen-activated protein kinase 11 increases activity
multiple interactions 		ISO Arsenic Trioxide results in increased activity of MAPK11 protein
Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to MAPK11 protein]; MAPK11 protein modified form inhibits the reaction [Arsenic Trioxide results in increased activity of MAPK11 protein]; MAPK11 protein modified form inhibits the reaction [Arsenic Trioxide results in increased activity of MAPKAPK2 protein] 		CTD PMID:12239215 PMID:26598702 NCBI chr 7:122,098,120...122,105,023
Ensembl chr 7:122,098,121...122,105,038 		JBrowse link
G Mapk13 mitogen activated protein kinase 13 increases expression ISO Arsenic Trioxide results in increased expression of MAPK13 mRNA CTD PMID:29633893 NCBI chr20:6,836,979...6,847,197
Ensembl chr20:6,837,013...6,847,191 		JBrowse link
G Mapk14 mitogen activated protein kinase 14 multiple interactions
decreases response to substance
increases phosphorylation 		ISO Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK14 protein; MAP2K3 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK14 protein]; MAP2K6 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK14 protein]
3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone inhibits the reaction [[Arsenic Trioxide co-treated with phytosphingosine] results in increased phosphorylation of MAPK14 protein]; [Arsenic Trioxide co-treated with phytosphingosine] results in increased phosphorylation of MAPK14 protein; Acetylcysteine inhibits the reaction [[Arsenic Trioxide co-treated with phytosphingosine] results in increased phosphorylation of MAPK14 protein]; Acetylcysteine inhibits the reaction [Emodin promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK14 protein]]; Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK14 protein; Emodin promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK14 protein]; MAPK14 mutant form inhibits the reaction [Arsenic Trioxide affects the localization of BAX protein]; MAPK14 mutant form inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of BCL2 protein]; MAPK14 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of EIF4E protein]; MAPK14 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MKNK1 protein]; MAPK14 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MKNK2 protein]; PPM1D mutant form promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK14 protein]; SB 203580 inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK14 protein]]; Tetradecanoylphorbol Acetate promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK14 protein]
MAPK14 results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in increased phosphorylation of MAPK14 protein 		CTD PMID:12239215 PMID:14610070 PMID:14729614 PMID:16818652 PMID:16972261 More... NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,751,357...6,812,294 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 increases expression
decreases phosphorylation
multiple interactions
increases phosphorylation
decreases expression
decreases activity
increases activity 		EXP
ISO 		Arsenic Trioxide results in increased expression of MAPK3 protein modified form
Arsenic Trioxide results in decreased phosphorylation of MAPK3 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK3 protein]; [Arsenic Trioxide co-treated with 6,7-dimethoxy-3-phenylquinoxaline] results in decreased activity of MAPK3 protein; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of MAPK3 protein]
Arsenic Trioxide results in decreased expression of MAPK3 mRNA; Arsenic Trioxide results in decreased expression of MAPK3 protein
Arsenic Trioxide results in decreased activity of MAPK3 protein
Arsenic Trioxide results in increased activity of MAPK3 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK3 protein]; Arsenic Trioxide results in decreased phosphorylation of and results in decreased activity of MAPK3 protein; Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK3 protein; HTS 466284 inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Phloretin inhibits the reaction [Arsenic Trioxide results in decreased expression of MAPK3 mRNA]
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Arsenic Trioxide co-treated with Tetradecanoylphorbol Acetate] results in increased phosphorylation of and results in increased activity of MAPK3 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK3 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK3 protein]; 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK3 protein]; 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK3 protein]; 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK3 protein]; [acetyl-11-ketoboswellic acid co-treated with Arsenic Trioxide] results in decreased phosphorylation of MAPK3 protein; [Arsenic Trioxide co-treated with 6,7-dimethoxy-3-phenylquinoxaline] results in decreased activity of MAPK3 protein; [Arsenic Trioxide co-treated with phytosphingosine] results in decreased phosphorylation of MAPK3 protein; [Arsenic Trioxide co-treated with Tetradecanoylphorbol Acetate] results in increased phosphorylation of and results in increased activity of MAPK3 protein; [IL24 protein co-treated with Arsenic Trioxide] results in increased phosphorylation of MAPK3 protein; [Quercetin co-treated with Arsenic Trioxide] results in increased phosphorylation of and results in increased activity of MAPK3 protein; [Sulindac co-treated with Arsenic Trioxide] results in increased phosphorylation of MAPK3 protein; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK3 protein]; AKT1 protein inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK3 protein]; ARL6IP5 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Arsenic Trioxide inhibits the reaction [Deoxyglucose results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Arsenic Trioxide inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK3 protein]; Arsenic Trioxide inhibits the reaction [IGF1 protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Arsenic Trioxide inhibits the reaction [Indomethacin results in decreased phosphorylation of MAPK3 protein]; Arsenic Trioxide inhibits the reaction [lonidamine results in increased phosphorylation of MAPK3 protein]; Arsenic Trioxide inhibits the reaction [Sirolimus results in increased phosphorylation of MAPK3 protein]; Arsenic Trioxide inhibits the reaction [temsirolimus results in increased phosphorylation of MAPK3 protein]; Arsenic Trioxide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein]; Arsenic Trioxide inhibits the reaction [TNF protein results in increased phosphorylation of MAPK3 protein]; Arsenic Trioxide inhibits the reaction [Tunicamycin results in decreased phosphorylation of MAPK3 protein]; Arsenic Trioxide inhibits the reaction [VEGFA protein results in increased phosphorylation of MAPK3 protein]; Arsenic Trioxide promotes the reaction [Curcumin results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Arsenic Trioxide promotes the reaction [MAPK3 protein promotes the reaction [FOS protein binds to CDKN1A promoter]]; Arsenic Trioxide promotes the reaction [Sulindac results in increased phosphorylation of MAPK3 protein]; Arsenic Trioxide promotes the reaction [Tretinoin results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK3 protein; bisindolylmaleimide I inhibits the reaction [[Arsenic Trioxide co-treated with Tetradecanoylphorbol Acetate] results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Indomethacin inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of MAPK3 protein]; KIRA6 inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK3 protein]; MAPK3 protein affects the reaction [Arsenic Trioxide results in increased expression of CCND1 protein]; MAPK3 protein affects the reaction [Arsenic Trioxide results in increased expression of CDC6 protein]; MAPK8 mutant form inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK3 protein]; MT2A protein inhibits the reaction [Arsenic Trioxide results in increased expression of MAPK3 protein modified form]; setanaxib inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK3 protein]; Sorafenib inhibits the reaction [Arsenic Trioxide results in increased activity of MAPK3 protein]; Sulindac promotes the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK3 protein]; temsirolimus inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK3 protein]; U 0126 inhibits the reaction [[Arsenic Trioxide co-treated with Tetradecanoylphorbol Acetate] results in increased phosphorylation of and results in increased activity of MAPK3 protein]; U 0126 inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK3 protein]; U 0126 inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK3 protein]; U 0126 promotes the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK3 protein] 		CTD PMID:11304686 PMID:12296996 PMID:12754411 PMID:14610070 PMID:15580305 More... NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411 		JBrowse link
G Mapk7 mitogen-activated protein kinase 7 multiple interactions
decreases activity 		ISO [IL24 protein co-treated with Arsenic Trioxide] results in increased phosphorylation of MAPK7 protein
Arsenic Trioxide results in decreased activity of MAPK7 protein 		CTD PMID:15580305 PMID:15761769 NCBI chr10:46,669,721...46,675,768
Ensembl chr10:46,669,721...46,675,806 		JBrowse link
G Mapk8 mitogen-activated protein kinase 8 increases response to substance
multiple interactions
increases phosphorylation
increases activity
affects response to substance
increases expression 		ISO
EXP 		MAPK8 results in increased susceptibility to Arsenic Trioxide
Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK8 protein]; Phloretin inhibits the reaction [Arsenic Trioxide results in increased expression of MAPK8 mRNA]; pyrazolanthrone inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK8 protein]
MAPK8 protein results in increased susceptibility to Arsenic Trioxide; MAPK8 results in increased susceptibility to Arsenic Trioxide
[IL24 protein co-treated with Arsenic Trioxide] results in increased phosphorylation of MAPK8 protein; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK8 protein]; Arsenic Trioxide promotes the reaction [puerarin results in increased expression of MAPK8 protein]; Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK8 protein; Buthionine Sulfoximine promotes the reaction [Arsenic Trioxide results in increased activity of MAPK8 protein]; Dicumarol inhibits the reaction [Arsenic Trioxide results in increased activity of MAPK8 protein]; indole-5-carboxamide promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK8 protein]; KIRA6 inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK8 protein]; MAP2K4 gene mutant form inhibits the reaction [Arsenic Trioxide results in increased activity of MAPK8 protein]; MAPK8 affects the reaction [[Sulindac co-treated with Arsenic Trioxide] results in increased phosphorylation of BCL2L1 protein]; MAPK8 mutant form inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; MAPK8 mutant form inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of BCL2 protein]; MAPK8 mutant form inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK1 protein]; MAPK8 mutant form inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK3 protein]; MAPK8 mutant form inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK9 protein]; MAPK8 protein affects the reaction [Arsenic Trioxide results in decreased phosphorylation of and results in decreased activity of AKT1 protein]; MAPK8 protein affects the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; MAPK8 protein affects the reaction [Arsenic Trioxide results in increased activity of CASP8 protein]; MAPK8 protein affects the reaction [Arsenic Trioxide results in increased activity of CASP9 protein]; MAPK8 protein affects the reaction [Arsenic Trioxide results in increased expression of PTEN protein]; MAPK9 mutant form inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK8 protein]; pyrazolanthrone inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK8 protein]; pyrazolanthrone inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK8 protein]]; SB 203580 promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK8 protein]; SCIO-469 promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK8 protein]; selonsertib inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK8 protein]; Tetradecanoylphorbol Acetate promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK8 protein]
MAPK8 protein affects the susceptibility to Arsenic Trioxide
Arsenic Trioxide results in increased expression of MAPK8 protein
Arsenic Trioxide results in increased expression of MAPK8 mRNA; Arsenic Trioxide results in increased expression of MAPK8 protein 		CTD PMID:11304686 PMID:12296996 PMID:12931215 PMID:14610070 PMID:14701702 More... NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427 		JBrowse link
G Mapk8ip1 mitogen-activated protein kinase 8 interacting protein 1 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of MAPK8IP1 protein
Arsenic Trioxide inhibits the reaction [AKT1 protein binds to MAPK8IP1 protein] 		CTD PMID:18566239 NCBI chr 3:98,810,540...98,829,302
Ensembl chr 3:98,810,541...98,828,368 		JBrowse link
G Mapk9 mitogen-activated protein kinase 9 increases expression
increases phosphorylation
multiple interactions
increases response to substance
increases activity 		ISO
EXP 		Arsenic Trioxide results in increased expression of MAPK9 protein
Arsenic Trioxide results in increased phosphorylation of MAPK9 protein
[Bortezomib co-treated with Arsenic Trioxide] affects the expression of MAPK9 protein; [IL24 protein co-treated with Arsenic Trioxide] results in increased phosphorylation of MAPK9 protein; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK9 protein]; Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK9 protein; indole-5-carboxamide promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK9 protein]; MAPK8 mutant form inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK9 protein]; MAPK9 mutant form inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; MAPK9 mutant form inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of BCL2 protein]; MAPK9 mutant form inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK8 protein]; pyrazolanthrone inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK9 protein]; SB 203580 promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK9 protein]; SCIO-469 promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK9 protein]
MAPK9 results in increased susceptibility to Arsenic Trioxide
Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK9 protein]; pyrazolanthrone inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK9 protein]
Arsenic Trioxide results in increased activity of MAPK9 protein
MAPK9 protein results in increased susceptibility to Arsenic Trioxide; MAPK9 results in increased susceptibility to Arsenic Trioxide
[Arsenic Trioxide results in increased abundance of arsenite] which results in increased phosphorylation of MAPK9 protein 		CTD PMID:12296996 PMID:15580305 PMID:15688020 PMID:16818652 PMID:17374990 More... NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,670,756...34,712,228 		JBrowse link
G Mapkap1 MAPK associated protein 1 increases expression ISO Arsenic Trioxide results in increased expression of MAPKAP1 mRNA CTD PMID:39716349 NCBI chr 3:38,113,268...38,315,913
Ensembl chr 3:38,113,323...38,315,913 		JBrowse link
G Mapkapk2 MAPK activated protein kinase 2 decreases expression
increases activity
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of MAPKAPK2 mRNA
Arsenic Trioxide results in increased activity of MAPKAPK2 protein
MAPK11 protein modified form inhibits the reaction [Arsenic Trioxide results in increased activity of MAPKAPK2 protein]; SB 203580 inhibits the reaction [Arsenic Trioxide results in increased activity of MAPKAPK2 protein] 		CTD PMID:12239215 PMID:20458559 NCBI chr13:45,066,027...45,112,326
Ensembl chr13:45,066,031...45,112,326 		JBrowse link
G Mapre1 microtubule-associated protein, RP/EB family, member 1 increases expression ISO Arsenic Trioxide results in increased expression of MAPRE1 mRNA CTD PMID:20458559 NCBI chr 3:162,679,020...162,707,167
Ensembl chr 3:162,673,195...162,711,210 		JBrowse link
G Mapt microtubule-associated protein tau increases expression ISO Arsenic Trioxide results in increased expression of MAPT protein CTD PMID:35467087 NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,638,599...89,736,108 		JBrowse link
G Marchf2 membrane associated ring-CH-type finger 2 increases expression ISO Arsenic Trioxide results in increased expression of MARCHF2 mRNA CTD PMID:15761015 NCBI chr 7:15,183,931...15,209,988
Ensembl chr 7:15,183,925...15,202,002 		JBrowse link
G Marchf3 membrane associated ring-CH-type finger 3 decreases expression ISO Arsenic Trioxide results in decreased expression of MARCHF3 mRNA CTD PMID:20458559 NCBI chr18:52,435,292...52,587,321
Ensembl chr18:52,435,296...52,587,297 		JBrowse link
G Marchf4 membrane associated ring-CH-type finger 4 increases expression ISO Arsenic Trioxide results in increased expression of MARCHF4 mRNA CTD PMID:20458559 NCBI chr 9:81,527,703...81,647,448
Ensembl chr 9:81,527,703...81,647,448 		JBrowse link
G Marcks myristoylated alanine rich protein kinase C substrate increases expression ISO Arsenic Trioxide results in increased expression of MARCKS protein CTD PMID:25419056 NCBI chr20:42,240,185...42,245,882
Ensembl chr20:42,240,185...42,245,882 		JBrowse link
G Mark3 microtubule affinity regulating kinase 3 increases expression ISO Arsenic Trioxide results in increased expression of MARK3 mRNA CTD PMID:39716349 NCBI chr 6:136,447,327...136,537,409
Ensembl chr 6:136,448,531...136,537,404 		JBrowse link
G Marveld1 MARVEL domain containing 1 decreases response to substance
multiple interactions
increases expression 		ISO MARVELD1 protein results in decreased susceptibility to Arsenic Trioxide
[MARVELD1 protein results in decreased susceptibility to Arsenic Trioxide] which results in decreased cleavage of CASP3 protein; [MARVELD1 protein results in decreased susceptibility to Arsenic Trioxide] which results in decreased cleavage of PARP1 protein; [MARVELD1 protein results in decreased susceptibility to Arsenic Trioxide] which results in decreased expression of BAX protein; [MARVELD1 protein results in decreased susceptibility to Arsenic Trioxide] which results in increased expression of BCL2 protein; [MARVELD1 protein results in decreased susceptibility to Arsenic Trioxide] which results in increased expression of TXNRD1 mRNA; [MARVELD1 protein results in decreased susceptibility to Arsenic Trioxide] which results in increased expression of TXNRD1 protein; MARVELD1 protein inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]; MARVELD1 protein inhibits the reaction [Arsenic Trioxide results in decreased expression of TXNRD1 mRNA]; MARVELD1 protein inhibits the reaction [Arsenic Trioxide results in decreased expression of TXNRD1 protein]; MARVELD1 protein inhibits the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; MARVELD1 protein inhibits the reaction [Arsenic Trioxide results in increased cleavage of PARP1 protein]; MARVELD1 protein inhibits the reaction [Arsenic Trioxide results in increased expression of BAX protein]
Arsenic Trioxide results in increased expression of MARVELD1 mRNA 		CTD PMID:31205918 PMID:39716349 NCBI chr 1:250,903,342...250,907,393
Ensembl chr 1:250,903,342...250,907,393 		JBrowse link
G Mat2b methionine adenosyltransferase 2 non-catalytic beta subunit multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to MAT2B protein] CTD PMID:26598702 NCBI chr10:25,609,202...25,626,694
Ensembl chr10:25,609,204...25,625,176 		JBrowse link
G Matk megakaryocyte-associated tyrosine kinase decreases expression ISO Arsenic Trioxide results in decreased expression of MATK mRNA CTD PMID:19128835 NCBI chr 7:9,107,711...9,116,864
Ensembl chr 7:9,107,722...9,112,746 		JBrowse link
G Matn1 matrilin 1 increases expression ISO Arsenic Trioxide results in increased expression of MATN1 mRNA CTD PMID:20458559 NCBI chr 5:148,401,364...148,411,256
Ensembl chr 5:148,401,620...148,411,256 		JBrowse link
G Matn2 matrilin 2 decreases expression ISO Arsenic Trioxide results in decreased expression of MATN2 mRNA CTD PMID:26705709 NCBI chr 7:67,380,140...67,529,767
Ensembl chr 7:67,380,168...67,530,153 		JBrowse link
G Mau2 MAU2 sister chromatid cohesion factor decreases expression ISO Arsenic Trioxide results in decreased expression of MAU2 mRNA CTD PMID:22521957 NCBI chr16:19,417,812...19,448,922
Ensembl chr16:19,417,613...19,445,841 		JBrowse link
G Max MYC associated factor X affects methylation
decreases expression 		ISO Arsenic Trioxide affects the methylation of MAX promoter
Arsenic Trioxide results in decreased expression of MAX mRNA 		CTD PMID:26046465 NCBI chr 6:101,369,989...101,395,333
Ensembl chr 6:101,369,988...101,395,549 		JBrowse link
G Mbd2 methyl-CpG binding domain protein 2 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of MBD2 protein
S-Adenosylmethionine inhibits the reaction [Arsenic Trioxide results in increased expression of MBD2 protein] 		CTD PMID:22558281 NCBI chr18:66,449,196...66,516,112
Ensembl chr18:66,449,358...66,516,111 		JBrowse link
G Mbd3 methyl-CpG binding domain protein 3 decreases expression ISO Arsenic Trioxide results in decreased expression of MBD3 mRNA CTD PMID:22521957 NCBI chr 7:9,961,053...9,970,845
Ensembl chr 7:9,963,797...9,970,265 		JBrowse link
G Mbd4 methyl-CpG binding domain 4 DNA glycosylase increases expression ISO Arsenic Trioxide results in increased expression of MBD4 mRNA CTD PMID:20458559 NCBI chr 4:150,565,646...150,577,433
Ensembl chr 4:150,565,655...150,577,578 		JBrowse link
G Mbnl2 muscleblind-like splicing regulator 2 increases expression ISO Arsenic Trioxide results in increased expression of MBNL2 mRNA CTD PMID:22521957 NCBI chr15:103,792,134...103,949,827
Ensembl chr15:103,792,152...103,949,827 		JBrowse link
G Mbp myelin basic protein affects expression EXP Arsenic Trioxide affects the expression of MBP mRNA CTD PMID:22954530 NCBI chr18:78,130,652...78,241,174
Ensembl chr18:78,130,325...78,241,174 		JBrowse link
G Mbtd1 mbt domain containing 1 decreases expression ISO Arsenic Trioxide results in decreased expression of MBTD1 mRNA CTD PMID:35676786 NCBI chr10:79,336,041...79,392,315
Ensembl chr10:79,335,235...79,392,315 		JBrowse link
G Mc1r melanocortin 1 receptor increases expression ISO Arsenic Trioxide results in increased expression of MC1R mRNA CTD PMID:20458559 NCBI chr19:68,360,950...68,363,877
Ensembl chr19:68,360,950...68,363,877 		JBrowse link
G Mc2r melanocortin 2 receptor increases expression ISO Arsenic Trioxide results in increased expression of MC2R mRNA CTD PMID:20458559 NCBI chr18:64,279,878...64,291,775
Ensembl chr18:64,277,360...64,291,881 		JBrowse link
G Mccc2 methylcrotonyl-CoA carboxylase subunit 2 decreases expression ISO Arsenic Trioxide results in decreased expression of MCCC2 mRNA CTD PMID:39716349 NCBI chr 2:33,039,044...33,110,092
Ensembl chr 2:33,039,045...33,110,299 		JBrowse link
G Mcf2l MCF.2 cell line derived transforming sequence-like decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of MCF2L mRNA
Arsenic Trioxide results in increased expression of MCF2L mRNA 		CTD PMID:12852829 PMID:35676786 NCBI chr16:83,209,277...83,355,683
Ensembl chr16:83,209,280...83,354,956 		JBrowse link
G Mcl1 MCL1 apoptosis regulator, BCL2 family member decreases expression
increases expression
multiple interactions 		ISO
EXP 		Arsenic Trioxide results in decreased expression of MCL1 mRNA
Arsenic Trioxide results in decreased expression of MCL1; Arsenic Trioxide results in decreased expression of MCL1 mRNA; Arsenic Trioxide results in decreased expression of MCL1 protein
Arsenic Trioxide results in increased expression of MCL1 mRNA
3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Arsenic Trioxide results in decreased expression of MCL1 mRNA]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Arsenic Trioxide results in decreased expression of MCL1 protein]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Arsenic Trioxide results in decreased expression of MCL1 mRNA]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Arsenic Trioxide results in decreased expression of MCL1 protein]; [AKT1 protein co-treated with 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole] inhibits the reaction [Arsenic Trioxide results in decreased expression of MCL1 protein]; [Arsenic Trioxide co-treated with Aprepitant] results in decreased expression of MCL1 mRNA; [Arsenic Trioxide co-treated with sepantronium] results in decreased expression of MCL1 protein; [Curcumin co-treated with Arsenic Trioxide] results in decreased expression of MCL1 protein; [MCL1 mutant form results in increased susceptibility to [Ethacrynic Acid co-treated with Arsenic Trioxide]] which results in increased cleavage of CASP3 protein; [NVP-BKM120 co-treated with Arsenic Trioxide] results in decreased expression of MCL1 mRNA; [Sirolimus co-treated with Arsenic Trioxide] results in decreased expression of MCL1 protein; Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [Ethacrynic Acid results in decreased expression of MCL1 protein]]; Arsenic Trioxide inhibits the reaction [BCL2L11 protein binds to MCL1 protein]; Arsenic Trioxide promotes the reaction [Ethacrynic Acid results in decreased expression of MCL1 protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Arsenic Trioxide promotes the reaction [Ethacrynic Acid results in decreased expression of MCL1 protein]]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Arsenic Trioxide results in decreased expression of MCL1 protein]; CAT mutant form promotes the reaction [Arsenic Trioxide promotes the reaction [Ethacrynic Acid results in decreased expression of MCL1 protein]]; MCL1 mutant form promotes the reaction [[Arsenic Trioxide co-treated with Ethacrynic Acid] results in increased cleavage of CASP9 protein]; MCL1 mutant form promotes the reaction [[Arsenic Trioxide co-treated with Ethacrynic Acid] results in increased cleavage of PARP1 protein]; MCL1 mutant form results in increased susceptibility to [Ethacrynic Acid co-treated with Arsenic Trioxide]; MMP9 protein inhibits the reaction [Arsenic Trioxide inhibits the reaction [BCL2L11 protein binds to MCL1 protein]]; MMP9 protein inhibits the reaction [Arsenic Trioxide results in decreased expression of MCL1 protein]; N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea inhibits the reaction [Arsenic Trioxide results in decreased expression of MCL1 protein]; NSC 680410 promotes the reaction [Arsenic Trioxide results in decreased expression of MCL1 protein]; pyrazolanthrone inhibits the reaction [Arsenic Trioxide promotes the reaction [Ethacrynic Acid results in decreased expression of MCL1 protein]]; trichostatin A inhibits the reaction [Arsenic Trioxide results in decreased expression of MCL1 protein]
Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of MCL1 mRNA] 		CTD PMID:12883267 PMID:18349030 PMID:19364129 PMID:19549371 PMID:19730151 More... NCBI chr 2:185,884,840...185,912,532
Ensembl chr 2:185,908,168...185,938,782 		JBrowse link
G Mcm2 minichromosome maintenance complex component 2 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of MCM2 mRNA; Arsenic Trioxide results in increased expression of MCM2 protein
Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to MCM2 protein] 		CTD PMID:17530438 PMID:17547211 PMID:25419056 PMID:26598702 NCBI chr 4:122,903,679...122,918,205
Ensembl chr 4:122,903,682...122,918,094 		JBrowse link
G Mcm3 minichromosome maintenance complex component 3 decreases expression ISO Arsenic Trioxide results in decreased expression of MCM3 mRNA CTD PMID:34413873 NCBI chr 9:30,715,602...30,733,746
Ensembl chr 9:30,715,602...30,733,746 		JBrowse link
G Mcm4 minichromosome maintenance complex component 4 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of MCM4 mRNA; Arsenic Trioxide results in increased expression of MCM4 protein
Arsenic Trioxide results in decreased expression of MCM4 mRNA 		CTD PMID:19364129 PMID:20458559 PMID:25419056 PMID:34413873 NCBI chr11:98,762,599...98,776,300
Ensembl chr11:98,762,634...98,776,536 		JBrowse link
G Mcm5 minichromosome maintenance complex component 5 decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of MCM5 mRNA
Arsenic Trioxide results in increased expression of MCM5 mRNA 		CTD PMID:20458559 PMID:26705709 NCBI chr19:13,488,813...13,510,131
Ensembl chr19:13,488,813...13,517,758 		JBrowse link
G Mcm6 minichromosome maintenance complex component 6 increases expression ISO Arsenic Trioxide results in increased expression of MCM6 protein CTD PMID:19364129 NCBI chr13:42,379,161...42,404,352
Ensembl chr13:42,379,162...42,465,467 		JBrowse link
G Mcm7 minichromosome maintenance complex component 7 decreases expression
multiple interactions
increases expression 		ISO Arsenic Trioxide results in decreased expression of MCM7 mRNA; Arsenic Trioxide results in decreased expression of MCM7 protein
Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to MCM7 protein]
Arsenic Trioxide results in increased expression of MCM7 protein 		CTD PMID:19364129 PMID:26598702 PMID:26705709 PMID:34413873 NCBI chr12:22,155,921...22,163,320
Ensembl chr12:22,155,921...22,163,771 		JBrowse link
G Mcoln3 mucolipin TRP cation channel 3 increases expression ISO Arsenic Trioxide results in increased expression of MCOLN3 mRNA CTD PMID:20458559 PMID:27829220 NCBI chr 2:237,596,544...237,705,770
Ensembl chr 2:237,626,302...237,705,769 		JBrowse link
G Mctp1 multiple C2 and transmembrane domain containing 1 multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of MCTP1 mRNA CTD PMID:15894607 NCBI chr 2:7,798,968...8,493,596
Ensembl chr 2:7,803,382...8,493,596 		JBrowse link
G Mctp2 multiple C2 and transmembrane domain containing 2 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of MCTP2 mRNA
Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of MCTP2 mRNA] 		CTD PMID:29095437 NCBI chr 1:135,179,845...135,412,798
Ensembl chr 1:135,179,845...135,412,694 		JBrowse link
G Mcts1 MCTS1, re-initiation and release factor increases expression ISO Arsenic Trioxide results in increased expression of MCTS1 mRNA CTD PMID:20458559 NCBI chr  X:122,215,602...122,228,101
Ensembl chr  X:122,216,439...122,229,631 		JBrowse link
G Mdfi MyoD family inhibitor multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to MDFI protein] CTD PMID:26598702 NCBI chr 9:20,654,359...20,672,768
Ensembl chr 9:20,654,417...20,672,767 		JBrowse link
G Mdh1 malate dehydrogenase 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to MDH1 protein] CTD PMID:26598702 NCBI chr14:99,831,934...99,847,227
Ensembl chr14:99,831,615...99,847,232 		JBrowse link
G Mdm2 MDM2 proto-oncogene decreases expression
multiple interactions
increases expression 		EXP
ISO 		Arsenic Trioxide results in decreased expression of MDM2 mRNA; Arsenic Trioxide results in decreased expression of MDM2 protein
dapagliflozin inhibits the reaction [Arsenic Trioxide results in decreased expression of MDM2 mRNA]; pifithrin inhibits the reaction [Arsenic Trioxide results in increased expression of MDM2 mRNA] 		CTD PMID:17487067 PMID:20458559 PMID:20862710 PMID:21145380 PMID:25574600 More... NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:55,176,560...55,200,791 		JBrowse link
G Mdm4 MDM4 regulator of p53 decreases expression ISO Arsenic Trioxide results in decreased expression of MDM4 mRNA CTD PMID:20458559 NCBI chr13:46,922,236...47,068,241
Ensembl chr13:46,958,298...47,026,372 		JBrowse link
G Mdn1 midasin AAA ATPase 1 decreases expression ISO Arsenic Trioxide results in decreased expression of MDN1 mRNA CTD PMID:39716349 NCBI chr 5:51,851,785...51,982,688
Ensembl chr 5:51,851,809...51,982,688 		JBrowse link
G Me1 malic enzyme 1 decreases response to substance
increases expression
multiple interactions 		ISO ME1 protein results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in increased expression of ME1 mRNA
[Arsenic Trioxide co-treated with Tretinoin] results in increased expression of ME1 mRNA 		CTD PMID:15725085 PMID:19417148 PMID:20458559 PMID:20707922 PMID:25258189 More... NCBI chr 8:96,429,057...96,540,244
Ensembl chr 8:96,429,057...96,540,275 		JBrowse link
G Meaf6 MYST/Esa1-associated factor 6 decreases expression ISO Arsenic Trioxide results in decreased expression of MEAF6 mRNA CTD PMID:39716349 NCBI chr 5:142,628,281...142,653,076
Ensembl chr 5:142,628,968...142,656,293 		JBrowse link
G Meak7 MTOR associated protein, eak-7 homolog increases expression ISO Arsenic Trioxide results in increased expression of MEAK7 mRNA CTD PMID:15761015 NCBI chr19:64,722,528...64,745,443
Ensembl chr19:64,722,528...64,751,330 		JBrowse link
G Mecom MDS1 and EVI1 complex locus increases sumoylation
increases response to substance
multiple interactions
decreases expression 		ISO Arsenic Trioxide results in increased sumoylation of MECOM protein
MECOM protein results in increased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in increased localization of [MECOM protein co-treated with SUMO1 protein]
Arsenic Trioxide results in decreased expression of MECOM mRNA; Arsenic Trioxide results in decreased expression of MECOM protein 		CTD PMID:15203277 PMID:20458559 PMID:23770046 PMID:24944602 PMID:30472098 NCBI chr 2:114,837,815...115,393,052
Ensembl chr 2:114,837,840...115,393,038 		JBrowse link
G Mecp2 methyl CpG binding protein 2 decreases expression EXP Arsenic Trioxide results in decreased expression of MECP2 mRNA CTD PMID:29223816 NCBI chr  X:156,932,481...156,995,981
Ensembl chr  X:156,941,234...156,943,560 		JBrowse link
G Med1 mediator complex subunit 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to MED1 protein] CTD PMID:26598702 NCBI chr10:83,641,851...83,685,560
Ensembl chr10:83,641,862...83,685,545 		JBrowse link
G Med13 mediator complex subunit 13 increases expression ISO Arsenic Trioxide results in increased expression of MED13 mRNA CTD PMID:35676786 NCBI chr10:71,584,354...71,674,614
Ensembl chr10:71,584,354...71,673,901 		JBrowse link
G Med23 mediator complex subunit 23 decreases expression ISO Arsenic Trioxide results in decreased expression of MED23 mRNA CTD PMID:35676786 NCBI chr 1:22,309,613...22,377,745
Ensembl chr 1:22,309,613...22,356,754 		JBrowse link
G Med29 mediator complex subunit 29 multiple interactions
increases expression 		ISO Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of MED29 mRNA] CTD PMID:29095437 NCBI chr 1:92,805,505...92,810,908 JBrowse link
G Mef2b myocyte enhancer factor 2B decreases expression ISO Arsenic Trioxide results in decreased expression of MEF2B mRNA CTD PMID:19128835 NCBI chr16:19,286,951...19,305,547
Ensembl chr16:19,286,953...19,302,910 		JBrowse link
G Meg3 maternally expressed 3 multiple interactions
increases expression
decreases expression
decreases methylation 		ISO [[Arsenic Trioxide results in increased expression of DNMT3A protein] which results in increased methylation of MEG3 promoter] which results in decreased expression of MEG3 protein; [Arsenic Trioxide results in decreased expression of MEG3 protein] promotes the reaction [NQO1 protein binds to FSCN1 protein]; [Arsenic Trioxide results in decreased expression of MEG3 protein] which results in increased expression of NQO1 protein; MEG3 inhibits the reaction [Arsenic Trioxide results in increased expression of FSCN1 protein]; MEG3 inhibits the reaction [Arsenic Trioxide results in increased expression of NQO1 protein]; MEG3 protein affects the reaction [Arsenic Trioxide results in decreased expression of CDH2 protein]; MEG3 protein affects the reaction [Arsenic Trioxide results in decreased expression of PKM mRNA]; MEG3 protein affects the reaction [Arsenic Trioxide results in decreased expression of PKM protein]; MEG3 protein affects the reaction [Arsenic Trioxide results in decreased expression of VIM protein]; MEG3 protein affects the reaction [Arsenic Trioxide results in increased expression of CDH1 protein]; PKM protein inhibits the reaction [Arsenic Trioxide results in increased expression of MEG3 mRNA]
Arsenic Trioxide results in decreased methylation of MEG3 promoter 		CTD PMID:31003765 PMID:37424815 NCBI chr 6:134,274,056...134,306,249 JBrowse link
G Megf6 multiple EGF-like-domains 6 decreases expression ISO Arsenic Trioxide results in decreased expression of MEGF6 mRNA CTD PMID:26705709 PMID:35676786 NCBI chr 5:170,020,699...170,121,557
Ensembl chr 5:170,020,778...170,121,554 		JBrowse link
G Meioc meiosis specific with coiled-coil domain decreases expression ISO Arsenic Trioxide results in decreased expression of MEIOC mRNA CTD PMID:26705709 NCBI chr10:88,128,939...88,147,833
Ensembl chr10:88,128,990...88,147,829 		JBrowse link
G Meox1 mesenchyme homeobox 1 decreases expression ISO Arsenic Trioxide results in decreased expression of MEOX1 mRNA CTD PMID:26705709 NCBI chr10:87,318,668...87,338,169
Ensembl chr10:87,318,695...87,337,976 		JBrowse link
G Mep1a meprin A subunit alpha increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of MEP1A mRNA
Arsenic Trioxide results in decreased expression of MEP1A mRNA 		CTD PMID:20458559 PMID:39716349 NCBI chr 9:24,971,901...25,001,414
Ensembl chr 9:24,971,886...25,001,414 		JBrowse link
G Mertk MER proto-oncogene, tyrosine kinase increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of MERTK mRNA
Arsenic Trioxide results in decreased expression of MERTK mRNA 		CTD PMID:20458559 PMID:29633893 NCBI chr 3:136,391,936...136,498,366
Ensembl chr 3:136,383,560...136,500,192 		JBrowse link
G Mesd mesoderm development LRP chaperone multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to MESD protein] CTD PMID:26598702 NCBI chr 1:147,275,904...147,289,134
Ensembl chr 1:147,275,396...147,289,134 		JBrowse link
G Met MET proto-oncogene, receptor tyrosine kinase decreases expression ISO Arsenic Trioxide results in decreased expression of MET mRNA CTD PMID:19769630 PMID:20458559 NCBI chr 4:46,756,823...46,864,041
Ensembl chr 4:46,756,506...46,870,821 		JBrowse link
G Metap1 methionyl aminopeptidase 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to METAP1 protein] CTD PMID:26598702 NCBI chr 2:229,664,677...229,697,730
Ensembl chr 2:229,664,677...229,719,084 		JBrowse link
G Mettl1 methyltransferase 1, tRNA methylguanosine multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to METTL1 protein] CTD PMID:26598702 NCBI chr 7:64,750,189...64,754,531
Ensembl chr 7:64,750,198...64,754,639 		JBrowse link
G Mettl14 methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit multiple interactions
increases expression 		ISO Arsenic Trioxide promotes the reaction [METTL14 protein binds to NLRP3 mRNA]; AS3MT mRNA promotes the reaction [Arsenic Trioxide promotes the reaction [METTL14 protein binds to NLRP3 mRNA]]; METTL14 protein promotes the reaction [Arsenic Trioxide inhibits the reaction [INS protein results in increased phosphorylation of GSK3B protein]]; METTL14 protein promotes the reaction [Arsenic Trioxide results in increased expression of CASP1 protein modified form]; METTL14 protein promotes the reaction [Arsenic Trioxide results in increased expression of NLRP3 protein]; METTL14 protein promotes the reaction [Arsenic Trioxide results in increased secretion of IL18 protein]; METTL14 protein promotes the reaction [Arsenic Trioxide results in increased secretion of IL1B protein]; METTL14 protein promotes the reaction [Arsenic Trioxide results in increased stability of NLRP3 mRNA]
Arsenic Trioxide results in increased expression of METTL14 protein 		CTD PMID:35226250 NCBI chr 2:214,215,165...214,231,412
Ensembl chr 2:214,215,165...214,231,412 		JBrowse link
G Mettl2 methyltransferase like 2 decreases expression ISO Arsenic Trioxide results in decreased expression of METTL2 mRNA CTD PMID:35676786 NCBI chr10:90,595,411...90,609,234
Ensembl chr10:90,595,411...90,610,228 		JBrowse link
G Mettl22 methyltransferase 22, Kin17 lysine multiple interactions
decreases expression 		ISO Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of METTL22 mRNA] CTD PMID:29095437 NCBI chr10:7,620,279...7,637,334
Ensembl chr10:7,620,279...7,638,222 		JBrowse link
G Mettl27 methyltransferase like 27 increases expression ISO Arsenic Trioxide results in increased expression of METTL27 mRNA CTD PMID:20458559 NCBI chr12:27,394,067...27,403,220
Ensembl chr12:27,393,678...27,403,202 		JBrowse link
G Mettl3 methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit decreases expression ISO Arsenic Trioxide results in decreased expression of METTL3 mRNA CTD PMID:15894607 PMID:34108876 NCBI chr15:27,476,659...27,491,134
Ensembl chr15:27,476,660...27,487,487 		JBrowse link
G Mex3d mex-3 RNA binding family member D decreases expression ISO Arsenic Trioxide results in decreased expression of MEX3D mRNA CTD PMID:22521957 NCBI chr 7:9,976,253...9,983,383
Ensembl chr 7:9,976,253...9,983,383 		JBrowse link
G Mfn1 mitofusin 1 increases expression
multiple interactions 		EXP
ISO 		Arsenic Trioxide results in increased expression of MFN1 protein
salvianolic acid A inhibits the reaction [Arsenic Trioxide results in increased expression of MFN1 protein] 		CTD PMID:29867492 NCBI chr 2:117,240,525...117,288,017
Ensembl chr 2:117,241,759...117,290,190 		JBrowse link
G Mfn2 mitofusin 2 increases expression
multiple interactions 		ISO
EXP 		Arsenic Trioxide results in increased expression of MFN2 protein
salvianolic acid A inhibits the reaction [Arsenic Trioxide results in increased expression of MFN2 protein] 		CTD PMID:29867492 NCBI chr 5:163,587,463...163,617,363
Ensembl chr 5:163,587,463...163,618,495 		JBrowse link
G Mfsd4b2 major facilitator superfamily domain containing 4B2 increases expression ISO Arsenic Trioxide results in increased expression of SLC60A2 mRNA CTD PMID:20458559 NCBI chr20:44,899,164...44,907,624
Ensembl chr20:44,899,164...44,907,624 		JBrowse link
G Mgat4b alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B decreases response to substance ISO MGAT4B protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr10:35,049,421...35,060,307
Ensembl chr10:35,050,512...35,060,309 		JBrowse link
G Mgp matrix Gla protein increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of MGP mRNA
Arsenic Trioxide results in decreased expression of MGP mRNA 		CTD PMID:20458559 PMID:26705709 NCBI chr 4:171,497,472...171,500,888
Ensembl chr 4:171,497,471...171,500,859 		JBrowse link
G Mgst1 microsomal glutathione S-transferase 1 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of MGST1 mRNA
Arsenic Trioxide promotes the reaction [Lutein results in increased expression of MGST1 mRNA]; Lutein promotes the reaction [Arsenic Trioxide results in increased expression of MGST1 mRNA] 		CTD PMID:25815309 PMID:26187899 NCBI chr 4:172,760,930...172,776,157
Ensembl chr 4:172,760,886...172,776,875 		JBrowse link
G Mib2 MIB E3 ubiquitin protein ligase 2 increases expression ISO Arsenic Trioxide results in increased expression of MIB2 mRNA CTD PMID:39716349 NCBI chr 5:171,526,037...171,542,479
Ensembl chr 5:171,526,037...171,541,910 		JBrowse link
G Micb MHC class I polypeptide-related sequence B increases expression ISO Arsenic Trioxide results in increased expression of MICB mRNA; Arsenic Trioxide results in increased expression of MICB protein CTD PMID:18463537 PMID:26705709 NCBI chr 1:87,623,826...87,641,075
Ensembl chr 1:87,623,826...87,640,872 		JBrowse link
G Micu3 mitochondrial calcium uptake family, member 3 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to MICU3 protein] CTD PMID:26598702 NCBI chr16:58,624,702...58,714,302
Ensembl chr16:58,629,208...58,714,045 		JBrowse link
G Mif macrophage migration inhibitory factor decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of MIF protein
Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to MIF protein] 		CTD PMID:19364129 PMID:25419056 PMID:26598702 NCBI chr20:12,767,138...12,791,222
Ensembl chr 4:134,041,774...134,042,121
Ensembl chr20:134,041,774...134,042,121 		JBrowse link
G Mill1 MHC I like leukocyte 1 increases expression ISO Arsenic Trioxide results in increased expression of MICA mRNA; Arsenic Trioxide results in increased expression of MICA protein CTD PMID:18463537 PMID:22521957 NCBI chr 1:87,500,591...87,526,983
Ensembl chr 1:87,500,676...87,526,981 		JBrowse link
G Mir100 microRNA 100 increases expression ISO Arsenic Trioxide results in increased expression of MIR100 mRNA CTD PMID:22072212 NCBI chr 8:50,798,295...50,798,374
Ensembl chr 8:50,798,295...50,798,374 		JBrowse link
G Mir107 microRNA 107 increases expression ISO Arsenic Trioxide results in increased expression of MIR107 mRNA CTD PMID:22967415 NCBI chr 1:241,750,418...241,750,504 JBrowse link
G Mir10a microRNA 10a increases expression ISO Arsenic Trioxide results in increased expression of MIR10A mRNA CTD PMID:22072212 NCBI chr10:81,779,709...81,779,818
Ensembl chr10:81,779,709...81,779,818 		JBrowse link
G Mir10b microRNA 10b increases expression ISO Arsenic Trioxide results in increased expression of MIR10B mRNA CTD PMID:22072212 NCBI chr 3:80,035,859...80,035,967
Ensembl chr 3:80,035,859...80,035,967 		JBrowse link
G Mir122 microRNA 122 increases expression
multiple interactions 		ISO
EXP 		Arsenic Trioxide results in increased expression of MIR122 mRNA
Butyrates inhibits the reaction [Arsenic Trioxide results in increased expression of MIR122 mRNA]; MIR122 mRNA affects the reaction [Butyrates inhibits the reaction [Arsenic Trioxide results in decreased expression of OCLN protein]]
dapagliflozin inhibits the reaction [Arsenic Trioxide results in increased expression of MIR122 mRNA] 		CTD PMID:22072212 PMID:35676786 PMID:36473683 PMID:38070468 NCBI chr18:61,028,817...61,028,901 JBrowse link
G Mir125a microRNA 125a increases expression ISO Arsenic Trioxide results in increased expression of MIR125A mRNA CTD PMID:22072212 NCBI chr 1:67,350,675...67,350,759
Ensembl chr 1:67,350,675...67,350,759 		JBrowse link
G Mir126a microRNA 126a increases expression ISO Arsenic Trioxide results in increased expression of MIR126 mRNA CTD PMID:22072212 NCBI chr 3:29,813,150...29,813,267 JBrowse link
G Mir128-1 microRNA 128-1 increases expression ISO Arsenic Trioxide results in increased expression of MIR128-1 mRNA CTD PMID:22072212 NCBI chr13:42,251,884...42,251,965
Ensembl chr13:42,251,884...42,251,965 		JBrowse link
G Mir132 microRNA 132 increases expression
multiple interactions 		ISO
EXP 		Arsenic Trioxide results in increased expression of MIR132 mRNA
Nicorandil inhibits the reaction [Arsenic Trioxide results in increased expression of MIR132 mRNA] 		CTD PMID:22072212 PMID:38741475 NCBI chr10:60,522,033...60,522,133
Ensembl chr10:60,522,033...60,522,133 		JBrowse link
G Mir133b microRNA 133b increases expression ISO Arsenic Trioxide results in increased expression of MIR133B mRNA CTD PMID:22072212 NCBI chr 9:30,594,582...30,594,665
Ensembl chr 9:30,594,582...30,594,665 		JBrowse link
G Mir135a2 microRNA 135a-2 decreases expression ISO Arsenic Trioxide results in decreased expression of MIR135A-2 mRNA CTD PMID:35676786 NCBI chr 7:28,499,166...28,499,265 JBrowse link
G Mir140 microRNA 140 increases expression ISO Arsenic Trioxide results in increased expression of MIR140 mRNA CTD PMID:22072212 NCBI chr19:52,375,293...52,375,391
Ensembl chr19:52,375,293...52,375,391 		JBrowse link
G Mir143 microRNA 143 increases expression ISO Arsenic Trioxide results in increased expression of MIR143 mRNA CTD PMID:22072212 NCBI chr18:57,371,349...57,371,453 JBrowse link
G Mir144 microRNA 144 increases expression ISO Arsenic Trioxide results in increased expression of MIR144 mRNA CTD PMID:22072212 NCBI chr10:63,459,397...63,459,479
Ensembl chr10:63,459,397...63,459,479 		JBrowse link
G Mir146a microRNA 146a increases expression ISO Arsenic Trioxide results in increased expression of MIR146A mRNA CTD PMID:22072212 NCBI chr10:28,349,996...28,350,090 JBrowse link
G Mir146b microRNA 146b increases expression ISO Arsenic Trioxide results in increased expression of MIR146B mRNA CTD PMID:22072212 NCBI chr 1:255,144,860...255,144,947
Ensembl chr 1:255,144,860...255,144,947 		JBrowse link
G Mir148a microRNA 148a increases expression ISO Arsenic Trioxide results in increased expression of MIR148A mRNA CTD PMID:22072212 NCBI chr 4:81,664,431...81,664,527 JBrowse link
G Mir148b microRNA 148b increases expression ISO Arsenic Trioxide results in increased expression of MIR148B mRNA CTD PMID:22072212 NCBI chr 7:136,299,870...136,299,966
Ensembl chr 7:136,299,870...136,299,966 		JBrowse link
G Mir150 microRNA 150 increases expression ISO Arsenic Trioxide results in increased expression of MIR150 mRNA CTD PMID:22072212 NCBI chr 1:104,741,487...104,741,571
Ensembl chr 1:104,741,487...104,741,571 		JBrowse link
G Mir155 microRNA 155 increases expression
decreases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of MIR155 mRNA
Arsenic Trioxide results in decreased expression of MIR155 mRNA
MIR155 mRNA inhibits the reaction [Arsenic Trioxide results in decreased expression of HMOX1 protein]; MIR155 mRNA inhibits the reaction [Arsenic Trioxide results in decreased expression of NQO1 protein]; MIR155 mRNA inhibits the reaction [Arsenic Trioxide results in increased expression of BACH1 protein] 		CTD PMID:22072212 PMID:29260515 PMID:35676786 NCBI chr11:37,261,114...37,261,178
Ensembl chr11:37,261,114...37,261,178 		JBrowse link
G Mir15b microRNA 15b increases expression ISO Arsenic Trioxide results in increased expression of MIR15B mRNA CTD PMID:22967415 NCBI chr 2:155,555,178...155,555,275
Ensembl chr 2:155,555,178...155,555,275 		JBrowse link
G Mir17 microRNA 17 increases expression ISO Arsenic Trioxide results in increased expression of MIR17 mRNA CTD PMID:22072212 NCBI chr15:98,587,848...98,587,931
Ensembl chr15:98,587,848...98,587,931 		JBrowse link
G Mir181a-1 microRNA 181a-1 multiple interactions
increases expression 		EXP Febuxostat inhibits the reaction [Arsenic Trioxide results in increased expression of MIR181A-1 mRNA] CTD PMID:37689273 NCBI chr13:52,037,067...52,037,166 JBrowse link
G Mir181c microRNA 181c increases expression ISO Arsenic Trioxide results in increased expression of MIR181C mRNA CTD PMID:22072212 NCBI chr19:40,888,291...40,888,396
Ensembl chr19:40,888,291...40,888,396 		JBrowse link
G Mir181d microRNA 181d increases expression ISO Arsenic Trioxide results in increased expression of MIR181D mRNA CTD PMID:22072212 NCBI chr19:40,888,474...40,888,556
Ensembl chr19:40,888,474...40,888,556 		JBrowse link
G Mir182 microRNA 182 decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of MIR182 mRNA
Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of MIR182 mRNA]; TGFB1 protein inhibits the reaction [Arsenic Trioxide results in decreased expression of MIR182 mRNA] 		CTD PMID:29662624 NCBI chr 4:59,752,246...59,752,307 JBrowse link
G Mir183 microRNA 183 decreases expression
multiple interactions
increases expression 		ISO Arsenic Trioxide results in decreased expression of MIR183 mRNA
TGFB1 protein inhibits the reaction [Arsenic Trioxide results in decreased expression of MIR183 mRNA]
Arsenic Trioxide results in increased expression of MIR183 mRNA 		CTD PMID:22072212 PMID:29662624 NCBI chr 4:59,756,044...59,756,153 JBrowse link
G Mir184 microRNA 184 increases expression ISO Arsenic Trioxide results in increased expression of MIR184 mRNA CTD PMID:22072212 NCBI chr 8:99,222,982...99,223,058 JBrowse link
G Mir18a microRNA 18a increases expression ISO Arsenic Trioxide results in increased expression of MIR18A mRNA CTD PMID:22072212 NCBI chr15:98,587,984...98,588,079
Ensembl chr15:98,587,984...98,588,079 		JBrowse link
G Mir191 microRNA 191 increases expression ISO Arsenic Trioxide results in increased expression of MIR191 mRNA CTD PMID:22072212 NCBI chr 8:118,142,627...118,142,717 JBrowse link
G Mir193a microRNA 193a increases expression ISO Arsenic Trioxide results in increased expression of MIR193A mRNA CTD PMID:22072212 NCBI chr10:65,170,306...65,170,417 JBrowse link
G Mir193b microRNA 193b increases expression ISO Arsenic Trioxide results in increased expression of MIR193B mRNA CTD PMID:22072212 NCBI chr10:1,824,944...1,825,026
Ensembl chr10:1,824,944...1,825,026 		JBrowse link
G Mir19a microRNA 19a decreases expression
increases expression
multiple interactions
affects response to substance 		ISO Arsenic Trioxide results in decreased expression of MIR19A mRNA
Arsenic Trioxide results in increased expression of MIR19A mRNA
MIR19A inhibits the reaction [Arsenic Trioxide results in increased expression of PTEN protein]
MIR19A affects the susceptibility to Arsenic Trioxide 		CTD PMID:20857258 PMID:22072212 NCBI chr15:98,588,131...98,588,212
Ensembl chr15:98,588,131...98,588,212 		JBrowse link
G Mir1a-1 microRNA 1a-1 increases expression ISO Arsenic Trioxide results in increased expression of MIR1-1 mRNA CTD PMID:22072212 NCBI chr 3:187,864,685...187,864,769
Ensembl chr 3:187,864,685...187,864,769 		JBrowse link
G Mir200c microRNA 200c increases expression ISO Arsenic Trioxide results in increased expression of MIR200C mRNA CTD PMID:22072212 NCBI chr 4:159,209,965...159,210,033 JBrowse link
G Mir20b microRNA 20b increases expression ISO Arsenic Trioxide results in increased expression of MIR20B mRNA CTD PMID:22072212 NCBI chr  X:137,343,197...137,343,268 JBrowse link
G Mir21 microRNA 21 decreases response to substance
multiple interactions
increases expression 		ISO
EXP 		MIR21 results in decreased susceptibility to Arsenic Trioxide
ATF3 promotes the reaction [Arsenic Trioxide results in increased expression of MIR21 protein]; MIR21 mRNA promotes the reaction [Arsenic Trioxide results in decreased expression of KCNH2 protein]; MIR21 mRNA promotes the reaction [Arsenic Trioxide results in decreased expression of SP1 protein]; NFE2L2 promotes the reaction [Arsenic Trioxide results in increased expression of MIR21 protein]
Arsenic Trioxide results in increased expression of MIR21; Arsenic Trioxide results in increased expression of MIR21 mRNA
dapagliflozin inhibits the reaction [Arsenic Trioxide results in increased expression of MIR21 mRNA] 		CTD PMID:21187093 PMID:22072212 PMID:25395240 PMID:38070468 PMID:38295932 NCBI chr10:71,902,600...71,902,691 JBrowse link
G Mir210 microRNA 210 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of MIR210 mRNA
Arsenic Trioxide inhibits the reaction [PRAM1 protein results in decreased expression of MIR210 mRNA] 		CTD PMID:18941112 PMID:21175813 NCBI chr 1:205,755,923...205,756,032
Ensembl chr 1:205,755,917...205,756,034 		JBrowse link
G Mir212 microRNA 212 decreases expression ISO Arsenic Trioxide results in decreased expression of MIR212 mRNA CTD PMID:22072212 NCBI chr10:60,521,740...60,521,850
Ensembl chr10:60,521,740...60,521,850 		JBrowse link
G Mir214 microRNA 214 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of MIR214 mRNA
Arsenic Trioxide results in decreased expression of MIR214 mRNA 		CTD PMID:22072212 PMID:26705709 NCBI chr13:77,121,645...77,121,752
Ensembl chr13:77,121,643...77,121,752 		JBrowse link
G Mir216a microRNA 216a increases expression ISO Arsenic Trioxide results in increased expression of MIR216A mRNA CTD PMID:35676786 NCBI chr14:106,725,077...106,725,182
Ensembl chr14:106,725,077...106,725,182 		JBrowse link
G Mir222 microRNA 222 increases expression ISO Arsenic Trioxide results in increased expression of MIR222 mRNA CTD PMID:20857258 NCBI chr  X:6,022,621...6,022,723
Ensembl chr  X:6,022,621...6,022,723 		JBrowse link
G Mir223 microRNA 223 increases expression ISO Arsenic Trioxide results in increased expression of MIR223 mRNA CTD PMID:22967415 NCBI chr  X:65,151,383...65,151,492
Ensembl chr  X:65,151,383...65,151,492 		JBrowse link
G Mir23a microRNA 23a increases expression
multiple interactions 		EXP
ISO 		Arsenic Trioxide results in increased expression of MIR23A mRNA
Arsenic Trioxide inhibits the reaction [PRAM1 protein results in decreased expression of MIR23A mRNA]; MIR23A mRNA promotes the reaction [Arsenic Trioxide results in decreased expression of and affects the localization of and results in decreased activity of KCNH2 protein] 		CTD PMID:18941112 PMID:25395240 NCBI chr19:40,859,769...40,859,843 JBrowse link
G Mir23b microRNA 23b increases expression
multiple interactions
decreases expression 		ISO
EXP 		Arsenic Trioxide results in increased expression of MIR23B mRNA
Febuxostat inhibits the reaction [Arsenic Trioxide results in decreased expression of MIR23B mRNA] 		CTD PMID:22072212 PMID:37689273 NCBI chr17:1,819,386...1,819,482 JBrowse link
G Mir27a microRNA 27a increases expression ISO Arsenic Trioxide results in increased expression of MIR27A mRNA CTD PMID:22072212 NCBI chr19:40,859,603...40,859,689 JBrowse link
G Mir27b microRNA 27b increases expression ISO Arsenic Trioxide results in increased expression of MIR27B mRNA CTD PMID:22072212 NCBI chr17:1,819,147...1,819,243 JBrowse link
G Mir295-1 microRNA 295-1 decreases expression ISO Arsenic Trioxide results in decreased expression of MIR372 mRNA CTD PMID:22072212 NCBI chr 1:74,877,973...74,878,053 JBrowse link
G Mir29a microRNA 29a multiple interactions
increases expression 		ISO MIR29A protein affects the reaction [Arsenic Trioxide results in decreased expression of PPM1D protein]
Arsenic Trioxide results in increased expression of MIR29A mRNA 		CTD PMID:21175813 PMID:22072212 NCBI chr 4:60,617,955...60,618,042 JBrowse link
G Mir30a microRNA 30a increases expression ISO Arsenic Trioxide results in increased expression of MIR30A mRNA CTD PMID:21175813 NCBI chr 9:33,233,941...33,234,011
Ensembl chr 9:33,233,941...33,234,011 		JBrowse link
G Mir32 microRNA 32 increases expression ISO Arsenic Trioxide results in increased expression of MIR32 mRNA CTD PMID:22072212 NCBI chr 5:76,391,285...76,391,354 JBrowse link
G Mir342 microRNA 342 increases expression ISO Arsenic Trioxide results in increased expression of MIR342 mRNA CTD PMID:22967415 NCBI chr 6:133,329,655...133,329,753
Ensembl chr 6:133,329,655...133,329,753 		JBrowse link
G Mir34a microRNA 34a increases expression
multiple interactions
decreases expression 		ISO Arsenic Trioxide results in increased expression of MIR34A mRNA
MIR34A affects the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]; MIR34A affects the reaction [Arsenic Trioxide results in decreased expression of SIRT1 protein]; MIR34A affects the reaction [Arsenic Trioxide results in increased expression of BAX protein]; Propranolol inhibits the reaction [Arsenic Trioxide results in increased expression of MIR34A mRNA]
Arsenic Trioxide results in decreased expression of MIR34A mRNA 		CTD PMID:35676786 PMID:36707890 NCBI chr 5:165,815,952...165,816,053
Ensembl chr 5:165,815,952...165,816,053 		JBrowse link
G Mir34c microRNA 34c decreases expression ISO Arsenic Trioxide results in decreased expression of MIR34C mRNA CTD PMID:22072212 NCBI chr 8:60,306,091...60,306,167 JBrowse link
G Mir363 microRNA 363 increases expression ISO Arsenic Trioxide results in increased expression of MIR363 mRNA CTD PMID:22072212 NCBI chr  X:137,342,777...137,342,863 JBrowse link
G Mir582 microRNA 582 increases expression ISO Arsenic Trioxide results in increased expression of MIR582 mRNA CTD PMID:35676786 NCBI chr 2:42,661,954...42,662,034
Ensembl chr 2:42,661,954...42,662,034 		JBrowse link
G Mir96 microRNA 96 decreases expression
increases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of MIR96 mRNA
Arsenic Trioxide results in increased expression of MIR96 mRNA
TGFB1 protein inhibits the reaction [Arsenic Trioxide results in decreased expression of MIR96 mRNA] 		CTD PMID:22072212 PMID:29662624 NCBI chr 4:59,755,841...59,755,946 JBrowse link
G Mir98 microRNA 98 increases expression ISO Arsenic Trioxide results in increased expression of MIR98 mRNA CTD PMID:22072212 NCBI chr  X:24,460,648...24,460,755
Ensembl chr  X:24,460,648...24,460,755 		JBrowse link
G Mirlet7d microRNA let-7d increases expression ISO Arsenic Trioxide results in increased expression of MIRLET7D mRNA CTD PMID:22072212 NCBI chr17:16,322,260...16,322,357
Ensembl chr17:16,322,260...16,322,357 		JBrowse link
G Mirlet7g microRNA let-7g increases expression ISO Arsenic Trioxide results in increased expression of MIRLET7G mRNA CTD PMID:22072212 NCBI chr 8:115,701,020...115,701,107
Ensembl chr 8:115,701,007...115,701,115 		JBrowse link
G Misp mitotic spindle positioning decreases response to substance ISO MISP protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 7:10,526,980...10,537,159
Ensembl chr 7:10,503,209...10,537,159 		JBrowse link
G Mki67 marker of proliferation Ki-67 decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of MKI67 mRNA; Arsenic Trioxide results in decreased expression of MKI67 protein
3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [Arsenic Trioxide results in decreased expression of MKI67 mRNA]; Arsenic Trioxide promotes the reaction [Ascorbic Acid results in decreased expression of MKI67 protein]; Ascorbic Acid promotes the reaction [Arsenic Trioxide results in decreased expression of MKI67 protein]
FOXO3 protein affects the reaction [Arsenic Trioxide results in decreased expression of MKI67 protein] 		CTD PMID:27318970 PMID:30091188 PMID:31421153 PMID:38160894 NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593 		JBrowse link
G Mknk1 MAPK interacting serine/threonine kinase 1 affects binding
multiple interactions
decreases response to substance
decreases expression
increases activity
increases expression 		ISO Arsenic Trioxide binds to MKNK1 protein
[Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MKNK1 protein] which results in increased phosphorylation of EIF4E protein; Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MKNK1 protein; CGP 57380 inhibits the reaction [[Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MKNK1 protein] which results in increased phosphorylation of EIF4E protein]; MAPK14 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MKNK1 protein]; MKNK1 protein affects the reaction [Arsenic Trioxide results in increased phosphorylation of EIF4E protein]; MKNK1 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of EIF4E protein]
MKNK1 protein results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in decreased expression of MKNK1 mRNA
Arsenic Trioxide results in increased activity of MKNK1 protein
Arsenic Trioxide results in increased expression of MKNK1 mRNA 		CTD PMID:18299328 PMID:20458559 PMID:21461292 PMID:29042487 NCBI chr 5:134,554,881...134,594,392
Ensembl chr 5:134,554,943...134,594,393 		JBrowse link
G Mknk2 MAPK interacting serine/threonine kinase 2 multiple interactions
decreases response to substance 		ISO Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MKNK2 protein; MAPK14 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MKNK2 protein]; MKNK2 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of EIF4E protein]
MKNK2 protein results in decreased susceptibility to Arsenic Trioxide 		CTD PMID:18299328 NCBI chr 7:9,690,385...9,701,527
Ensembl chr 7:9,690,421...9,701,529 		JBrowse link
G Mkrn2 makorin, ring finger protein, 2 increases expression ISO Arsenic Trioxide results in increased expression of MKRN2 mRNA CTD PMID:20458559 NCBI chr 4:150,334,164...150,352,271
Ensembl chr 4:150,334,142...150,352,263 		JBrowse link
G Mkrn3 makorin, ring finger protein, 3 decreases expression ISO Arsenic Trioxide results in decreased expression of MKRN3 mRNA CTD PMID:39716349 NCBI chr 1:125,338,664...125,341,178
Ensembl chr 1:125,338,564...125,341,164 		JBrowse link
G Mlf1 myeloid leukemia factor 1 decreases expression ISO Arsenic Trioxide results in decreased expression of MLF1 mRNA CTD PMID:39716349 NCBI chr 2:153,958,060...153,991,705
Ensembl chr 2:153,958,546...153,994,220 		JBrowse link
G Mlip muscular LMNA-interacting protein decreases expression ISO Arsenic Trioxide results in decreased expression of MLIP mRNA CTD PMID:26705709 NCBI chr 8:86,815,491...87,085,117
Ensembl chr 8:86,814,798...87,082,408 		JBrowse link
G Mlkl mixed lineage kinase domain like pseudokinase increases phosphorylation
decreases expression 		ISO Arsenic Trioxide results in increased phosphorylation of MLKL protein
Arsenic Trioxide results in decreased expression of MLKL mRNA 		CTD PMID:36509116 PMID:37230480 NCBI chr19:56,186,860...56,213,886
Ensembl chr19:56,186,860...56,213,858 		JBrowse link
G Mllt10 MLLT10, histone lysine methyltransferase DOT1L cofactor increases expression ISO Arsenic Trioxide results in increased expression of MLLT10 mRNA CTD PMID:20458559 NCBI chr17:85,729,964...85,857,791
Ensembl chr17:85,730,751...85,857,789 		JBrowse link
G Mllt11 MLLT11, transcription factor 7 cofactor increases expression ISO Arsenic Trioxide results in increased expression of MLLT11 mRNA CTD PMID:25258189 NCBI chr 2:185,484,791...185,493,961
Ensembl chr 2:185,484,793...185,493,961 		JBrowse link
G Mlph melanophilin increases expression ISO Arsenic Trioxide results in increased expression of MLPH mRNA CTD PMID:39716349 NCBI chr 9:98,955,036...98,990,566
Ensembl chr 9:98,955,141...98,990,556 		JBrowse link
G Mmd monocyte to macrophage differentiation-associated increases expression ISO Arsenic Trioxide results in increased expression of MMD mRNA CTD PMID:20458559 NCBI chr10:75,570,366...75,598,610
Ensembl chr10:75,570,397...75,598,609 		JBrowse link
G Mmp1 matrix metallopeptidase 1 decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of MMP1 mRNA
[acetyl-11-ketoboswellic acid co-treated with Arsenic Trioxide] results in decreased activity of MMP1 protein; [acetyl-11-ketoboswellic acid co-treated with Arsenic Trioxide] results in decreased expression of MMP1 mRNA; [acetyl-11-ketoboswellic acid co-treated with Arsenic Trioxide] results in decreased secretion of MMP1 protein; Arsenic Trioxide inhibits the reaction [TNF protein results in increased expression of MMP1 mRNA]; Arsenic Trioxide inhibits the reaction [TNF protein results in increased secretion of and results in increased activity of MMP1 protein] 		CTD PMID:15761015 PMID:21078271 PMID:23253724 NCBI chr 8:12,943,453...12,963,966
Ensembl chr 8:12,943,453...12,963,964 		JBrowse link
G Mmp12 matrix metallopeptidase 12 decreases expression ISO Arsenic Trioxide results in decreased expression of MMP12 mRNA CTD PMID:19128835 NCBI chr 8:12,866,652...12,876,554
Ensembl chr 8:12,866,641...12,884,478 		JBrowse link
G Mmp13 matrix metallopeptidase 13 decreases expression
increases expression
decreases secretion 		ISO
EXP 		Arsenic Trioxide results in decreased expression of MMP13 mRNA
Arsenic Trioxide results in increased expression of MMP13 mRNA
Arsenic Trioxide results in decreased secretion of MMP13 protein 		CTD PMID:26705709 PMID:31734849 PMID:34108876 NCBI chr 8:12,782,829...12,793,108
Ensembl chr 8:12,782,813...12,793,105 		JBrowse link
G Mmp14 matrix metallopeptidase 14 decreases expression
multiple interactions
affects expression 		ISO
EXP 		Arsenic Trioxide results in decreased expression of MMP14 mRNA; Arsenic Trioxide results in decreased expression of MMP14 protein
Arsenic Trioxide promotes the reaction [Berberine results in decreased expression of MMP14 protein]
[Arsenic Trioxide co-treated with Silybin] results in decreased expression of MMP14 mRNA; Arsenic Trioxide inhibits the reaction [Silybin results in increased expression of MMP14 mRNA]
Arsenic Trioxide affects the expression of MMP14 mRNA 		CTD PMID:15962302 PMID:18294404 PMID:21969006 PMID:27039805 NCBI chr15:31,857,824...31,867,049
Ensembl chr15:31,857,546...31,869,893 		JBrowse link
G Mmp16 matrix metallopeptidase 16 decreases expression ISO Arsenic Trioxide results in decreased expression of MMP16 mRNA CTD PMID:25258189 NCBI chr 5:36,109,265...36,353,252
Ensembl chr 5:36,109,265...36,353,252 		JBrowse link
G Mmp2 matrix metallopeptidase 2 increases activity
increases expression
decreases activity
multiple interactions
decreases expression 		ISO
EXP 		Arsenic Trioxide results in increased activity of MMP2 protein
Arsenic Trioxide results in increased expression of MMP2 protein
Arsenic Trioxide results in decreased activity of MMP2 protein
Arsenic Trioxide promotes the reaction [Berberine results in decreased activity of MMP2 protein]; Arsenic Trioxide promotes the reaction [Berberine results in decreased expression of MMP2 protein]; Berberine promotes the reaction [Arsenic Trioxide results in decreased activity of MMP2 protein]
[acetyl-11-ketoboswellic acid co-treated with Arsenic Trioxide] results in decreased activity of MMP2 protein; [acetyl-11-ketoboswellic acid co-treated with Arsenic Trioxide] results in decreased expression of MMP2 mRNA; [acetyl-11-ketoboswellic acid co-treated with Arsenic Trioxide] results in decreased secretion of MMP2 protein; [Arsenic Trioxide co-treated with Silybin] results in decreased activity of MMP2 protein; [Arsenic Trioxide co-treated with Silybin] results in decreased expression of MMP2 mRNA; [Erlotinib Hydrochloride co-treated with Arsenic Trioxide] results in decreased expression of MMP2 mRNA; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of MMP2 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased secretion of MMP2 protein]; Arsenic Trioxide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP2 protein]; Arsenic Trioxide inhibits the reaction [TNF protein results in increased expression of MMP2 mRNA]; Arsenic Trioxide inhibits the reaction [TNF protein results in increased secretion of and results in increased activity of MMP2 protein]; Arsenic Trioxide promotes the reaction [Berberine results in decreased activity of MMP2 protein]; Arsenic Trioxide results in decreased expression of and results in decreased secretion of MMP2 protein; Berberine promotes the reaction [Arsenic Trioxide results in decreased activity of MMP2 protein]; Celecoxib promotes the reaction [Arsenic Trioxide results in decreased expression of MMP2 mRNA]; Celecoxib promotes the reaction [Arsenic Trioxide results in decreased expression of MMP2 protein]; GH1 protein promotes the reaction [Arsenic Trioxide results in decreased expression of MMP2 mRNA]; MIR491 mRNA affects the reaction [Arsenic Trioxide results in decreased expression of MMP2 mRNA]; Silybin promotes the reaction [Arsenic Trioxide results in decreased expression of MMP2 mRNA]
Arsenic Trioxide results in decreased expression of MMP2 mRNA; Arsenic Trioxide results in decreased expression of MMP2 protein 		CTD PMID:15553829 PMID:15962302 PMID:16624393 PMID:17512576 PMID:18294404 More... NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856 		JBrowse link
G Mmp28 matrix metallopeptidase 28 decreases expression ISO Arsenic Trioxide results in decreased expression of MMP28 mRNA CTD PMID:15761015 PMID:26705709 NCBI chr10:68,738,651...68,762,377
Ensembl chr10:68,738,651...68,824,884 		JBrowse link
G Mmp3 matrix metallopeptidase 3 decreases expression ISO Arsenic Trioxide results in decreased expression of MMP3 mRNA CTD PMID:34108876 NCBI chr 8:12,925,267...12,938,828
Ensembl chr 8:12,925,280...12,938,826 		JBrowse link
G Mmp7 matrix metallopeptidase 7 decreases expression ISO Arsenic Trioxide results in decreased expression of MMP7 mRNA CTD PMID:19128835 PMID:26966376 PMID:28901456 NCBI chr 8:13,133,043...13,140,761
Ensembl chr 8:13,133,043...13,140,755 		JBrowse link
G Mmp9 matrix metallopeptidase 9 multiple interactions
decreases expression
increases expression
decreases activity
decreases response to substance 		ISO [acetyl-11-ketoboswellic acid co-treated with Arsenic Trioxide] results in decreased activity of MMP9 protein; [acetyl-11-ketoboswellic acid co-treated with Arsenic Trioxide] results in decreased expression of MMP9 mRNA; [acetyl-11-ketoboswellic acid co-treated with Arsenic Trioxide] results in decreased secretion of MMP9 protein; [Arsenic Trioxide co-treated with apatinib] results in decreased expression of MMP9 protein; [Arsenic Trioxide co-treated with Silybin] results in decreased expression of MMP9 mRNA; [Erlotinib Hydrochloride co-treated with Arsenic Trioxide] results in decreased expression of MMP9 mRNA; [Silybin co-treated with Arsenic Trioxide] results in decreased activity of MMP9 protein; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of MMP9 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased secretion of MMP9 protein]; Arsenic Trioxide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]; Arsenic Trioxide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of and results in increased activity of MMP9 protein]; Arsenic Trioxide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]; Arsenic Trioxide results in decreased expression of and results in decreased secretion of MMP9 protein; Arsenic Trioxide results in increased expression of and affects the localization of and results in decreased secretion of MMP9 protein; benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane inhibits the reaction [Arsenic Trioxide results in increased expression of and affects the localization of MMP9 protein]; benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane inhibits the reaction [Arsenic Trioxide results in increased expression of MMP9 mRNA]; Dactinomycin inhibits the reaction [Arsenic Trioxide results in increased expression of MMP9 mRNA]; GH1 protein promotes the reaction [Arsenic Trioxide results in decreased activity of MMP9 protein]; GH1 protein promotes the reaction [Arsenic Trioxide results in decreased expression of MMP9 mRNA]; HMOX1 protein inhibits the reaction [Arsenic Trioxide results in increased expression of MMP9 mRNA]; HMOX1 protein inhibits the reaction [Arsenic Trioxide results in increased expression of MMP9 protein]; JUN protein promotes the reaction [Arsenic Trioxide results in increased expression of MMP9 mRNA]; JUN protein promotes the reaction [Arsenic Trioxide results in increased expression of MMP9 protein]; MIR491 mRNA affects the reaction [Arsenic Trioxide results in decreased expression of MMP9 mRNA]; MMP9 protein inhibits the reaction [Arsenic Trioxide inhibits the reaction [BCL2L11 protein binds to MCL1 protein]]; MMP9 protein inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2L1 protein]; MMP9 protein inhibits the reaction [Arsenic Trioxide results in decreased expression of MCL1 protein]; MMP9 protein inhibits the reaction [Arsenic Trioxide results in increased expression of BAX protein]; MMP9 protein inhibits the reaction [Arsenic Trioxide results in increased expression of BCL2L11 protein]; SB 203580 inhibits the reaction [Arsenic Trioxide results in increased expression of MMP9 mRNA]; SB 203580 inhibits the reaction [Arsenic Trioxide results in increased expression of MMP9 protein]; SR 11302 inhibits the reaction [Arsenic Trioxide results in increased expression of MMP9 mRNA]; SR 11302 inhibits the reaction [Arsenic Trioxide results in increased expression of MMP9 protein]; zinc protoporphyrin promotes the reaction [Arsenic Trioxide results in increased expression of MMP9 protein]
Arsenic Trioxide results in decreased expression of MMP9 mRNA; Arsenic Trioxide results in decreased expression of MMP9 protein
Arsenic Trioxide results in increased expression of MMP9; Arsenic Trioxide results in increased expression of MMP9 mRNA; Arsenic Trioxide results in increased expression of MMP9 protein
MMP9 protein results in decreased susceptibility to Arsenic Trioxide 		CTD PMID:15949266 PMID:15962302 PMID:16624393 PMID:19128835 PMID:19236750 More... NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442 		JBrowse link
G Mnd1 meiotic nuclear divisions 1 decreases expression ISO Arsenic Trioxide results in decreased expression of MND1 mRNA CTD PMID:26705709 NCBI chr 2:171,731,523...171,794,124
Ensembl chr 2:171,731,523...171,794,095 		JBrowse link
G Mnt MAX network transcriptional repressor decreases expression ISO Arsenic Trioxide results in decreased expression of MNT mRNA CTD PMID:20458559 NCBI chr10:60,197,654...60,213,221
Ensembl chr10:60,197,948...60,213,209 		JBrowse link
G Mocos molybdenum cofactor sulfurase increases expression ISO Arsenic Trioxide results in increased expression of MOCOS mRNA CTD PMID:20458559 NCBI chr18:16,206,402...16,251,928
Ensembl chr18:16,206,402...16,251,928 		JBrowse link
G Mpdu1 mannose-P-dolichol utilization defect 1 multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of MPDU1 mRNA CTD PMID:15894607 NCBI chr10:54,873,467...54,880,536
Ensembl chr10:54,873,473...54,879,195 		JBrowse link
G Mpl MPL proto-oncogene, thrombopoietin receptor decreases expression ISO Arsenic Trioxide results in decreased expression of MPL mRNA CTD PMID:15761015 NCBI chr 5:137,259,288...137,281,540
Ensembl chr 5:137,259,288...137,272,177 		JBrowse link
G Mpo myeloperoxidase multiple interactions
decreases expression
increases expression
increases activity 		ISO
EXP 		Arsenic Trioxide promotes the reaction [1,2-Dimethylhydrazine results in increased activity of MPO protein]; Taurine inhibits the reaction [Arsenic Trioxide results in increased expression of MPO protein]
[Tretinoin co-treated with Arsenic Trioxide co-treated with Butyrates] results in decreased expression of MPO mRNA; [Tretinoin co-treated with Arsenic Trioxide co-treated with hexamethylene bisacetamide] results in decreased expression of MPO mRNA; [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of MPO mRNA; Arsenic Trioxide inhibits the reaction [Tretinoin results in decreased expression of MPO protein]
Arsenic Trioxide results in decreased expression of MPO protein
dapagliflozin inhibits the reaction [Arsenic Trioxide results in increased activity of MPO protein]; Febuxostat inhibits the reaction [Arsenic Trioxide results in increased expression of MPO protein]; Taurine inhibits the reaction [Arsenic Trioxide results in increased expression of MPO protein] 		CTD PMID:11133770 PMID:12130515 PMID:20693187 PMID:30090573 PMID:30237538 More... NCBI chr10:73,092,124...73,102,057
Ensembl chr10:73,092,400...73,102,056 		JBrowse link
G Mpp4 MAGUK p55 scaffold protein 4 increases expression ISO Arsenic Trioxide results in increased expression of MPP4 mRNA CTD PMID:26705709 NCBI chr 9:68,063,867...68,103,050
Ensembl chr 9:68,063,867...68,106,128 		JBrowse link
G Mpped2 metallophosphoesterase domain containing 2 decreases expression ISO Arsenic Trioxide results in decreased expression of MPPED2 mRNA CTD PMID:26705709 NCBI chr 3:113,635,614...113,810,307
Ensembl chr 3:113,635,407...113,811,783 		JBrowse link
G Mpz myelin protein zero increases expression ISO Arsenic Trioxide results in increased expression of MPZ mRNA CTD PMID:27829220 NCBI chr13:86,103,290...86,109,156
Ensembl chr13:86,103,290...86,109,155 		JBrowse link
G Mr1 major histocompatibility complex, class I-related increases expression ISO Arsenic Trioxide results in increased expression of MR1 mRNA CTD PMID:22521957 NCBI chr13:69,850,420...69,868,302
Ensembl chr13:69,850,420...69,868,502 		JBrowse link
G Mrap2 melanocortin 2 receptor accessory protein 2 decreases expression ISO Arsenic Trioxide results in decreased expression of MRAP2 mRNA CTD PMID:26705709 NCBI chr 8:96,968,239...97,024,581
Ensembl chr 8:96,988,079...97,024,579 		JBrowse link
G Mrc2 mannose receptor, C type 2 decreases expression ISO Arsenic Trioxide results in decreased expression of MRC2 mRNA CTD PMID:21461292 NCBI chr10:90,761,751...90,823,055
Ensembl chr10:90,761,878...90,823,055 		JBrowse link
G Mrpl17 mitochondrial ribosomal protein L17 increases expression ISO Arsenic Trioxide results in increased expression of MRPL17 protein CTD PMID:25419056 NCBI chr 1:169,574,010...169,575,699
Ensembl chr 1:169,574,010...169,575,818 		JBrowse link
G Mrpl24 mitochondrial ribosomal protein L24 increases expression ISO Arsenic Trioxide results in increased expression of MRPL24 mRNA CTD PMID:20458559 NCBI chr 2:175,680,872...175,687,107
Ensembl chr 2:175,681,070...175,688,660 		JBrowse link
G Mrpl30 mitochondrial ribosomal protein L30 increases expression ISO Arsenic Trioxide results in increased expression of MRPL30 mRNA CTD PMID:20458559 NCBI chr 9:47,621,226...47,631,986
Ensembl chr 9:47,621,227...47,633,484 		JBrowse link
G Mrpl37 mitochondrial ribosomal protein L37 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to MRPL37 protein] CTD PMID:26598702 NCBI chr 5:127,056,679...127,075,000
Ensembl chr 5:127,058,716...127,074,980 		JBrowse link
G Mrpl42 mitochondrial ribosomal protein L42 decreases expression ISO Arsenic Trioxide results in decreased expression of MRPL42 mRNA CTD PMID:20458559 NCBI chr 7:32,004,863...32,028,640
Ensembl chr 7:32,004,777...32,035,104 		JBrowse link
G Mrpl49 mitochondrial ribosomal protein L49 decreases response to substance ISO MRPL49 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 1:212,775,357...212,779,364
Ensembl chr 1:212,775,357...212,779,888 		JBrowse link
G Mrpl57 mitochondrial ribosomal protein L57 increases expression ISO Arsenic Trioxide results in increased expression of MRPL57 mRNA CTD PMID:20458559 NCBI chr15:36,086,457...36,087,319
Ensembl chr15:36,086,457...36,087,298 		JBrowse link
G Mrps12 mitochondrial ribosomal protein S12 decreases expression ISO Arsenic Trioxide results in decreased expression of MRPS12 protein CTD PMID:19364129 NCBI chr 1:93,153,424...93,156,422
Ensembl chr 1:93,153,425...93,159,629 		JBrowse link
G Mrps16 mitochondrial ribosomal protein S16 increases expression ISO Arsenic Trioxide results in increased expression of MRPS16 mRNA CTD PMID:14703492 NCBI chr15:3,967,809...3,970,211
Ensembl chr15:3,968,054...3,970,185 		JBrowse link
G Mrps2 mitochondrial ribosomal protein S2 increases expression ISO Arsenic Trioxide results in increased expression of MRPS2 mRNA CTD PMID:39716349 NCBI chr 3:32,201,037...32,204,317
Ensembl chr 3:32,198,641...32,204,892 		JBrowse link
G Mrps30 mitochondrial ribosomal protein S30 increases expression ISO Arsenic Trioxide results in increased expression of MRPS30 mRNA CTD PMID:20458559 PMID:22521957 NCBI chr 2:52,189,049...52,196,136
Ensembl chr 2:52,189,058...52,195,904 		JBrowse link
G Ms4a4a membrane spanning 4-domains A4A increases expression ISO Arsenic Trioxide results in increased expression of MS4A4A mRNA CTD PMID:35676786 NCBI chr 1:217,495,704...217,510,019
Ensembl chr 1:217,487,996...217,510,503 		JBrowse link
G Ms4a6a membrane spanning 4-domains A6A increases expression ISO Arsenic Trioxide results in increased expression of MS4A6A mRNA CTD PMID:20458559 NCBI chr 1:217,826,261...217,839,606
Ensembl chr 1:217,826,261...217,850,013 		JBrowse link
G Ms4a8 membrane spanning 4-domains A8 decreases expression ISO Arsenic Trioxide results in decreased expression of MS4A8 mRNA CTD PMID:39716349 NCBI chr 1:217,155,557...217,169,151
Ensembl chr 1:217,155,557...217,169,215 		JBrowse link
G Msc musculin decreases expression ISO Arsenic Trioxide results in decreased expression of MSC mRNA CTD PMID:15761015 NCBI chr 5:9,330,522...9,336,391
Ensembl chr 5:9,330,544...9,336,857 		JBrowse link
G Msh2 mutS homolog 2 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to MSH2 protein] CTD PMID:26598702 NCBI chr 6:12,567,368...12,626,534
Ensembl chr 6:12,567,368...12,626,503 		JBrowse link
G Msi1 musashi RNA-binding protein 1 multiple interactions ISO Arsenic Trioxide promotes the reaction [MSI1 protein binds to EIF2AK2 protein modified form]; Arsenic Trioxide promotes the reaction [MSI1 protein binds to EIF2S1 protein modified form]; Arsenic Trioxide promotes the reaction [MSI1 protein results in increased expression of KLF4 protein]; Arsenic Trioxide promotes the reaction [MSI1 protein results in increased expression of MYC protein]; Arsenic Trioxide promotes the reaction [MSI1 protein results in increased expression of POU5F1 protein]; Arsenic Trioxide promotes the reaction [MSI1 protein results in increased expression of SOX2 protein]; EIF2AK2 protein affects the reaction [Arsenic Trioxide promotes the reaction [MSI1 protein results in increased expression of KLF4 protein]]; EIF2AK2 protein affects the reaction [Arsenic Trioxide promotes the reaction [MSI1 protein results in increased expression of MYC protein]]; EIF2AK2 protein affects the reaction [Arsenic Trioxide promotes the reaction [MSI1 protein results in increased expression of POU5F1 protein]]; EIF2AK2 protein affects the reaction [Arsenic Trioxide promotes the reaction [MSI1 protein results in increased expression of SOX2 protein]]; EIF2AK2 protein affects the reaction [MSI1 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of EIF2S1 protein]]; EIF2S1 protein affects the reaction [Arsenic Trioxide promotes the reaction [MSI1 protein results in increased expression of KLF4 protein]]; EIF2S1 protein affects the reaction [Arsenic Trioxide promotes the reaction [MSI1 protein results in increased expression of MYC protein]]; EIF2S1 protein affects the reaction [Arsenic Trioxide promotes the reaction [MSI1 protein results in increased expression of POU5F1 protein]]; EIF2S1 protein affects the reaction [Arsenic Trioxide promotes the reaction [MSI1 protein results in increased expression of SOX2 protein]]; EIF2S1 protein affects the reaction [MSI1 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of EIF2AK2 protein]]; MSI1 protein affects the reaction [Arsenic Trioxide results in increased expression of KLF4 protein]; MSI1 protein affects the reaction [Arsenic Trioxide results in increased expression of MYC protein]; MSI1 protein affects the reaction [Arsenic Trioxide results in increased expression of POU5F1 protein]; MSI1 protein affects the reaction [Arsenic Trioxide results in increased expression of SOX2 protein]; MSI1 protein inhibits the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]; MSI1 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of EIF2AK2 protein]; MSI1 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of EIF2S1 protein] CTD PMID:29486283 NCBI chr12:46,815,225...46,911,852
Ensembl chr12:46,819,039...46,845,425 		JBrowse link
G Msl1 MSL complex subunit 1 increases expression ISO Arsenic Trioxide results in increased expression of MSL1 mRNA CTD PMID:35676786 NCBI chr10:84,251,362...84,263,384
Ensembl chr10:84,251,642...84,261,971 		JBrowse link
G Msl2 MSL complex subunit 2 increases response to substance ISO MSL2 protein results in increased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 8:110,555,579...110,642,096
Ensembl chr 8:110,555,271...110,647,889 		JBrowse link
G Msmo1 methylsterol monooxygenase 1 multiple interactions
decreases expression 		ISO [Dasatinib co-treated with Arsenic Trioxide] results in decreased expression of MSMO1 mRNA; [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of MSMO1 mRNA
Arsenic Trioxide results in decreased expression of MSMO1 mRNA 		CTD PMID:15894607 PMID:29266867 NCBI chr16:29,747,113...29,764,360
Ensembl chr16:29,747,137...29,764,445 		JBrowse link
G Msn moesin decreases expression ISO Arsenic Trioxide results in decreased expression of MSN protein CTD PMID:25419056 NCBI chr  X:65,005,546...65,073,512
Ensembl chr  X:65,005,458...65,075,129 		JBrowse link
G Msr1 macrophage scavenger receptor 1 decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of MSR1 mRNA
Arsenic Trioxide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA]; Thioctic Acid inhibits the reaction [Arsenic Trioxide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA]] 		CTD PMID:20458559 PMID:21315065 NCBI chr16:59,421,250...59,507,070
Ensembl chr16:59,421,057...59,507,070 		JBrowse link
G Msra methionine sulfoxide reductase A increases expression
affects expression 		ISO Arsenic Trioxide results in increased expression of MSRA mRNA; Arsenic Trioxide results in increased expression of MSRA protein
Arsenic Trioxide affects the expression of MSRA protein 		CTD PMID:31473893 NCBI chr15:42,514,818...42,853,278
Ensembl chr15:42,527,045...42,853,279 		JBrowse link
G Msrb1 methionine sulfoxide reductase B1 affects expression ISO Arsenic Trioxide affects the expression of MSRB1 mRNA; Arsenic Trioxide affects the expression of MSRB1 protein CTD PMID:31473893 NCBI chr10:14,269,414...14,275,140
Ensembl chr10:14,269,414...14,274,184 		JBrowse link
G Msrb2 methionine sulfoxide reductase B2 decreases expression
affects expression 		ISO Arsenic Trioxide results in decreased expression of MSRB2 mRNA
Arsenic Trioxide affects the expression of MSRB2 mRNA 		CTD PMID:15725085 PMID:31473893 NCBI chr17:86,882,750...86,908,392
Ensembl chr17:86,882,394...86,908,391 		JBrowse link
G Mst1r macrophage stimulating 1 receptor decreases response to substance ISO MST1R protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 8:117,471,928...117,491,059
Ensembl chr 8:117,475,968...117,490,515 		JBrowse link
G Msx2 msh homeobox 2 decreases response to substance ISO MSX2 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr17:11,102,284...11,107,949
Ensembl chr17:11,102,247...11,107,945 		JBrowse link
G Mt-atp6 mitochondrially encoded ATP synthase membrane subunit 6 decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of ATP6 mRNA
Arsenic Trioxide results in increased expression of ATP6 mRNA 		CTD PMID:14703492 PMID:15949261 NCBI chr MT:7,919...8,599
Ensembl chr MT:7,904...8,584 		JBrowse link
G Mt-nd4 mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 increases expression ISO Arsenic Trioxide results in increased expression of ND4 mRNA CTD PMID:14703492 NCBI chr MT:10,160...11,537
Ensembl chr MT:10,145...11,522 		JBrowse link
G Mt1-ps3 metallothionein 1, pseudogene 3 increases expression
decreases expression
affects expression 		ISO Arsenic Trioxide results in increased expression of MT1E mRNA
Arsenic Trioxide results in decreased expression of MT1E mRNA
Arsenic Trioxide affects the expression of MT1E mRNA 		CTD PMID:15725085 PMID:19128835 PMID:19417148 PMID:22555517 PMID:25873331 More... NCBI chr17:79,695,812...79,696,200
Ensembl chr17:79,695,809...79,696,200 		JBrowse link
G Mt1a metallothionein 1A affects response to substance
decreases expression
increases expression 		ISO MT1A SNP affects the susceptibility to Arsenic Trioxide
Arsenic Trioxide results in decreased expression of MT1A mRNA
Arsenic Trioxide results in increased expression of MT1A mRNA
Arsenic Trioxide results in increased expression of MT1X mRNA 		CTD PMID:19128835 PMID:22555517 PMID:24924344 PMID:27829220 PMID:39716349 NCBI chr19:10,831,959...10,832,975
Ensembl chr17:79,695,809...79,696,200
Ensembl chr  X:79,695,809...79,696,200
Ensembl chr19:79,695,809...79,696,200 		JBrowse link
G Mt2 metallothionein 2 decreases expression
decreases response to substance
multiple interactions
increases expression 		ISO Arsenic Trioxide results in decreased expression of MT2A mRNA
MT2A protein results in decreased susceptibility to Arsenic Trioxide
[Arsenic Trioxide co-treated with Tretinoin] results in increased expression of MT2A mRNA; Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to MT2A protein]; Atrazine promotes the reaction [Arsenic Trioxide results in increased expression of MT2A mRNA]; MT2A protein inhibits the reaction [Arsenic Trioxide results in increased expression of BAX protein]; MT2A protein inhibits the reaction [Arsenic Trioxide results in increased expression of CASP12 protein modified form]; MT2A protein inhibits the reaction [Arsenic Trioxide results in increased expression of CASP3 protein modified form]; MT2A protein inhibits the reaction [Arsenic Trioxide results in increased expression of MAPK1 protein modified form]; MT2A protein inhibits the reaction [Arsenic Trioxide results in increased expression of MAPK3 protein modified form]; MT2A protein promotes the reaction [Arsenic Trioxide results in increased expression of DDIT3 protein]
Arsenic Trioxide results in increased expression of MT2A mRNA; Arsenic Trioxide results in increased expression of MT2A protein
Arsenic Trioxide results in increased expression of MT1E mRNA; Arsenic Trioxide results in increased expression of MT1F mRNA; Arsenic Trioxide results in increased expression of MT1G mRNA; Arsenic Trioxide results in increased expression of MT2A mRNA 		CTD PMID:11678611 PMID:14682389 PMID:15725085 PMID:19128835 PMID:19417148 More... NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,837,927...10,838,709 		JBrowse link
G Mt2-ps1 metallothionein 2, pseudogene 1 increases expression ISO Arsenic Trioxide results in increased expression of MT1HL1 mRNA CTD PMID:15725085 PMID:26705709 NCBI chr20:3,163,749...3,164,121 JBrowse link
G Mt3 metallothionein 3 multiple interactions
decreases expression 		ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to MT3 protein]
Arsenic Trioxide results in decreased expression of MT3 mRNA 		CTD PMID:22555517 PMID:26598702 NCBI chr19:10,854,676...10,856,080
Ensembl chr19:10,854,677...10,856,080 		JBrowse link
G Mta1 metastasis associated 1 decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of MTA1 mRNA
Arsenic Trioxide results in increased expression of MTA1 mRNA 		CTD PMID:12478894 PMID:20458559 PMID:35676786 PMID:39716349 NCBI chr 6:137,999,845...138,038,696
Ensembl chr 6:137,999,915...138,038,696 		JBrowse link
G Mtap methylthioadenosine phosphorylase multiple interactions
decreases expression
increases expression 		ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to MTAP protein]
Arsenic Trioxide results in decreased expression of MTAP protein
Arsenic Trioxide results in increased expression of MTAP mRNA 		CTD PMID:19364129 PMID:22521957 PMID:26598702 NCBI chr 5:108,990,270...109,036,494
Ensembl chr 5:108,988,830...109,055,214 		JBrowse link
G Mtarc2 mitochondrial amidoxime reducing component 2 increases expression ISO Arsenic Trioxide results in increased expression of MTARC2 mRNA CTD PMID:35676786 NCBI chr13:98,894,347...98,928,754
Ensembl chr13:98,897,108...98,928,781 		JBrowse link
G Mtch2 mitochondrial carrier 2 decreases expression ISO Arsenic Trioxide results in decreased expression of MTCH2 mRNA CTD PMID:39716349 NCBI chr 3:97,286,388...97,306,028
Ensembl chr 3:97,285,894...97,307,327 		JBrowse link
G Mtcl3 MTCL family member 3 increases expression ISO Arsenic Trioxide results in increased expression of MTCL3 mRNA CTD PMID:26705709 NCBI chr 1:30,469,698...30,530,205
Ensembl chr 1:30,453,046...30,529,122 		JBrowse link
G Mterf3 mitochondrial transcription termination factor 3 increases expression ISO Arsenic Trioxide results in increased expression of MTERF3 mRNA CTD PMID:20458559 NCBI chr 7:65,711,654...65,729,926
Ensembl chr 7:65,711,662...65,729,895 		JBrowse link
G Mtf1 metal-regulatory transcription factor 1 affects response to substance ISO MTF1 gene mutant form affects the susceptibility to Arsenic Trioxide CTD PMID:30815697 NCBI chr 5:142,347,024...142,391,810
Ensembl chr 5:142,347,054...142,391,810 		JBrowse link
G Mtf2 metal response element binding transcription factor 2 increases response to substance
multiple interactions
decreases expression 		ISO MTF2 protein results in increased susceptibility to Arsenic Trioxide
Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to MTF2 protein]
Arsenic Trioxide results in decreased expression of MTF2 mRNA 		CTD PMID:20707922 PMID:26598702 PMID:35676786 NCBI chr14:1,784,218...1,828,463
Ensembl chr14:1,783,627...1,828,414 		JBrowse link
G Mtfr1l mitochondrial fission regulator 1-like multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to MTFR1L protein] CTD PMID:26598702 NCBI chr 5:152,020,617...152,030,417
Ensembl chr 5:152,020,622...152,030,417 		JBrowse link
G Mthfd1 methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1 decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of MTHFD1 mRNA
Arsenic Trioxide results in increased sumoylation of and results in increased degradation of MTHFD1 protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Arsenic Trioxide results in increased degradation of MTHFD1 protein] 		CTD PMID:20458559 PMID:28265077 NCBI chr 6:100,713,510...100,781,013
Ensembl chr 6:100,713,681...100,781,957 		JBrowse link
G Mthfd1l methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like increases expression ISO Arsenic Trioxide results in increased expression of MTHFD1L mRNA CTD PMID:22521957 NCBI chr 1:42,849,424...43,038,313
Ensembl chr 1:42,849,374...43,038,309 		JBrowse link
G Mthfd2 methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase increases expression ISO Arsenic Trioxide results in increased expression of MTHFD2 mRNA CTD PMID:24356939 NCBI chr 4:117,368,833...117,380,350
Ensembl chr 4:117,368,835...117,380,350 		JBrowse link
G Mtif3 mitochondrial translational initiation factor 3 decreases expression ISO Arsenic Trioxide results in decreased expression of MTIF3 mRNA CTD PMID:39716349 NCBI chr12:13,240,091...13,251,350
Ensembl chr12:13,240,173...13,254,373 		JBrowse link
G Mtmr11 myotubularin related protein 11 decreases expression ISO Arsenic Trioxide results in decreased expression of MTMR11 mRNA CTD PMID:29633893 NCBI chr 2:186,410,851...186,421,024
Ensembl chr 2:186,412,291...186,421,026 		JBrowse link
G Mtmr2 myotubularin related protein 2 decreases expression ISO Arsenic Trioxide results in decreased expression of MTMR2 mRNA CTD PMID:20458559 NCBI chr 8:18,899,303...18,949,767
Ensembl chr 8:18,928,126...18,949,766 		JBrowse link
G Mtor mechanistic target of rapamycin kinase decreases expression
decreases phosphorylation
multiple interactions
increases expression
affects expression
increases phosphorylation 		ISO
EXP 		Arsenic Trioxide results in decreased expression of MTOR mRNA; Arsenic Trioxide results in decreased expression of MTOR protein
Arsenic Trioxide results in decreased phosphorylation of MTOR protein
[Arsenic Trioxide co-treated with apatinib] results in decreased phosphorylation of MTOR protein; Arsenic Trioxide inhibits the reaction [Sorafenib results in increased expression of MTOR protein]; Gemcitabine promotes the reaction [Arsenic Trioxide results in decreased phosphorylation of MTOR protein]; GRB10 protein promotes the reaction [[Arsenic Trioxide co-treated with apatinib] results in decreased phosphorylation of MTOR protein]
Arsenic Trioxide results in increased expression of MTOR mRNA
Arsenic Trioxide affects the expression of MTOR mRNA
3-methyladenine inhibits the reaction [Arsenic Trioxide results in decreased phosphorylation of MTOR protein]; Sirolimus promotes the reaction [Arsenic Trioxide results in decreased phosphorylation of MTOR protein]
Arsenic Trioxide results in increased phosphorylation of MTOR protein
dapagliflozin inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MTOR protein] 		CTD PMID:21594580 PMID:25416439 PMID:25449439 PMID:29633893 PMID:30032600 More... NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:164,167,928...164,277,435 		JBrowse link
G Mtr 5-methyltetrahydrofolate-homocysteine methyltransferase decreases expression ISO Arsenic Trioxide results in decreased expression of MTR protein CTD PMID:15894607 NCBI chr17:62,911,705...62,996,544
Ensembl chr17:62,911,771...62,996,541 		JBrowse link
G Mtrex Mtr4 exosome RNA helicase increases expression ISO Arsenic Trioxide results in increased expression of MTREX mRNA CTD PMID:20458559 NCBI chr 2:46,233,528...46,293,827
Ensembl chr 2:46,194,647...46,293,827 		JBrowse link
G Mtrf1l mitochondrial translation release factor 1 like decreases expression ISO Arsenic Trioxide results in decreased expression of MTRF1L mRNA CTD PMID:39716349 NCBI chr 1:44,614,162...44,626,367
Ensembl chr 1:44,615,921...44,626,178 		JBrowse link
G Mtus1 microtubule associated scaffold protein 1 decreases response to substance ISO MTUS1 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr16:57,905,991...58,051,466
Ensembl chr16:57,906,128...58,051,474 		JBrowse link
G Mtx1 Metaxin 1 decreases expression ISO Arsenic Trioxide results in decreased expression of MTX1 mRNA CTD PMID:20458559 NCBI chr 2:176,913,225...176,919,148
Ensembl chr 2:176,913,225...176,918,824 		JBrowse link
G Muc2 mucin 2, oligomeric mucus/gel-forming multiple interactions ISO [Arsenic Trioxide results in increased abundance of arsenite] which results in increased expression of MUC2 mRNA; [Arsenic Trioxide results in increased abundance of arsenite] which results in increased expression of MUC2 protein CTD PMID:36791901 NCBI chr 1:206,225,775...206,261,280
Ensembl chr 1:206,229,035...206,261,280 		JBrowse link
G Muc3a mucin 3A, cell surface associated decreases response to substance ISO MUC3A protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr12:25,082,728...25,091,494
Ensembl chr12:25,082,837...25,097,265 		JBrowse link
G Mug2 murinoglobulin 2 decreases expression ISO Arsenic Trioxide results in decreased expression of PZP mRNA CTD PMID:20458559 NCBI chr 4:156,836,140...156,908,972 JBrowse link
G Mus81 MUS81 structure-specific endonuclease subunit multiple interactions
increases sumoylation
affects response to substance 		ISO MUS81 protein mutant form inhibits the reaction [Arsenic Trioxide results in increased expression of H2AX protein modified form]
Arsenic Trioxide results in increased sumoylation of MUS81 protein
[MUS81 protein affects the susceptibility to Arsenic Trioxide] which affects the susceptibility to Camptothecin; [MUS81 protein affects the susceptibility to Arsenic Trioxide] which affects the susceptibility to olaparib; MUS81 protein affects the susceptibility to Arsenic Trioxide 		CTD PMID:28318385 PMID:37530740 NCBI chr 1:212,219,793...212,225,214
Ensembl chr 1:212,219,795...212,225,068 		JBrowse link
G Mutyh mutY DNA glycosylase affects activity ISO MUTYH protein affects the activity of Arsenic Trioxide CTD PMID:17101720 NCBI chr 5:135,510,666...135,522,777
Ensembl chr 5:135,517,695...135,522,776 		JBrowse link
G Mvp major vault protein increases expression ISO Arsenic Trioxide results in increased expression of MVP protein
Arsenic Trioxide results in increased expression of MVP mRNA 		CTD PMID:25419056 PMID:39716349 NCBI chr 1:191,025,259...191,052,866
Ensembl chr 1:191,025,268...191,052,873 		JBrowse link
G Mx1 MX dynamin like GTPase 1 increases expression ISO Arsenic Trioxide results in increased expression of MX1 protein
Arsenic Trioxide results in increased expression of MX1 mRNA 		CTD PMID:19364129 PMID:35676786 NCBI chr11:50,269,056...50,294,699
Ensembl chr11:50,269,057...50,292,904 		JBrowse link
G Mxd1 max dimerization protein 1 increases expression ISO Arsenic Trioxide results in increased expression of MXD1 mRNA CTD PMID:25258189 PMID:26705709 NCBI chr 4:120,654,731...120,678,972
Ensembl chr 4:120,654,731...120,675,129 		JBrowse link
G Mxra7 matrix remodeling associated 7 increases expression ISO Arsenic Trioxide results in increased expression of MXRA7 mRNA CTD PMID:17547211 NCBI chr10:102,501,848...102,530,231
Ensembl chr10:102,489,604...102,530,231 		JBrowse link
G Mybbp1a MYB binding protein 1a decreases expression ISO Arsenic Trioxide results in decreased expression of MYBBP1A protein CTD PMID:25419056 NCBI chr10:57,555,458...57,565,819
Ensembl chr10:57,555,452...57,566,041 		JBrowse link
G Mybl1 MYB proto-oncogene like 1 decreases expression ISO Arsenic Trioxide results in decreased expression of MYBL1 mRNA CTD PMID:15725085 PMID:25258189 PMID:26705709 NCBI chr 5:14,365,768...14,401,012
Ensembl chr 5:14,365,768...14,399,588 		JBrowse link
G Mybph myosin binding protein H multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to MYBPH protein] CTD PMID:26598702 NCBI chr13:48,205,162...48,212,928
Ensembl chr13:48,205,269...48,212,928 		JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor affects methylation
multiple interactions
decreases expression
increases expression
affects expression 		ISO
EXP 		Arsenic Trioxide affects the methylation of MYC promoter
[Genistein co-treated with Arsenic Trioxide] results in decreased expression of MYC protein
Arsenic Trioxide results in decreased expression of MYC mRNA; Arsenic Trioxide results in decreased expression of MYC protein
[Arsenic Trioxide co-treated with apatinib] results in decreased expression of MYC protein; [Arsenic Trioxide co-treated with Aprepitant] results in decreased expression of MYC mRNA; [Arsenic Trioxide co-treated with Cisplatin] results in decreased expression of MYC mRNA; [Arsenic Trioxide co-treated with Cisplatin] results in decreased expression of MYC protein; [Arsenic Trioxide co-treated with Tretinoin] results in decreased expression of MYC mRNA; [Arsenic Trioxide co-treated with Tretinoin] results in decreased expression of MYC protein; [Genistein co-treated with Arsenic Trioxide] results in decreased expression of MYC protein; [NVP-BKM120 co-treated with Arsenic Trioxide] results in decreased expression of MYC mRNA; [ruxolitinib co-treated with Arsenic Trioxide] results in decreased expression of MYC mRNA; Acetylcysteine inhibits the reaction [[Arsenic Trioxide co-treated with Cisplatin] results in decreased expression of MYC protein]; Arsenic Trioxide inhibits the reaction [Lithium Chloride results in increased expression of MYC protein]; Arsenic Trioxide inhibits the reaction [MYC protein binds to PRDX3 protein]; Arsenic Trioxide inhibits the reaction [MYC protein results in increased activity of PRDX3 protein]; Arsenic Trioxide inhibits the reaction [SP1 protein binds to MYC promoter]; Arsenic Trioxide promotes the reaction [MSI1 protein results in increased expression of MYC protein]; Arsenic Trioxide promotes the reaction [Tretinoin results in decreased expression of MYC protein]; BCL2 protein inhibits the reaction [Arsenic Trioxide results in decreased expression of MYC mRNA]; CAB39L protein alternative form inhibits the reaction [Arsenic Trioxide results in decreased expression of MYC protein]; EIF2AK2 protein affects the reaction [Arsenic Trioxide promotes the reaction [MSI1 protein results in increased expression of MYC protein]]; EIF2AK2 protein affects the reaction [Arsenic Trioxide results in increased expression of MYC protein]; EIF2S1 protein affects the reaction [Arsenic Trioxide promotes the reaction [MSI1 protein results in increased expression of MYC protein]]; GH1 protein promotes the reaction [Arsenic Trioxide results in increased expression of MYC mRNA]; GRB10 protein promotes the reaction [[Arsenic Trioxide co-treated with apatinib] results in decreased expression of MYC protein]; MSI1 protein affects the reaction [Arsenic Trioxide results in increased expression of MYC protein]; RORB protein affects the reaction [Arsenic Trioxide affects the expression of MYC protein]; Tretinoin promotes the reaction [Arsenic Trioxide results in decreased expression of MYC protein]; VS-5584 promotes the reaction [Arsenic Trioxide results in decreased expression of MYC mRNA]
Arsenic Trioxide results in increased expression of MYC mRNA; Arsenic Trioxide results in increased expression of MYC protein
Arsenic Trioxide promotes the reaction [Berberine affects the localization of MYC protein] 		CTD PMID:11714746 PMID:11775218 PMID:12903497 PMID:12903512 PMID:15283693 More... NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028 		JBrowse link
G Mycbp2 MYC binding protein 2 increases expression ISO Arsenic Trioxide results in increased expression of MYCBP2 mRNA CTD PMID:20458559 NCBI chr15:86,352,061...86,590,126
Ensembl chr15:86,352,061...86,590,325 		JBrowse link
G Mycn MYCN proto-oncogene, bHLH transcription factor decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of MYCN mRNA; Arsenic Trioxide results in decreased expression of MYCN protein
Arsenic Trioxide results in increased expression of MYCN mRNA 		CTD PMID:12478894 PMID:20458559 PMID:24685274 PMID:38130211 NCBI chr 6:41,446,683...41,452,584
Ensembl chr 6:41,446,684...41,452,508 		JBrowse link
G Myd88 MYD88, innate immune signal transduction adaptor increases expression ISO Arsenic Trioxide results in increased expression of MYD88 mRNA CTD PMID:17530438 NCBI chr 8:127,952,161...127,956,230
Ensembl chr 8:127,952,161...127,956,230 		JBrowse link
G Myh10 myosin heavy chain 10 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of MYH10 mRNA
Arsenic Trioxide results in decreased expression of MYH10 mRNA 		CTD PMID:20458559 PMID:26238599 NCBI chr10:53,891,955...54,024,032
Ensembl chr10:53,893,166...54,024,036 		JBrowse link
G Myh6 myosin heavy chain 6 increases expression ISO Arsenic Trioxide results in increased expression of MYH6 mRNA CTD PMID:20458559 NCBI chr15:32,388,102...32,413,663
Ensembl chr15:32,387,487...32,411,333 		JBrowse link
G Myh7 myosin heavy chain 7 decreases expression ISO Arsenic Trioxide results in decreased expression of MYH7 mRNA CTD PMID:35676786 NCBI chr15:32,416,525...32,439,851
Ensembl chr15:32,416,527...32,438,194 		JBrowse link
G Myh9 myosin, heavy chain 9 decreases expression ISO Arsenic Trioxide results in decreased expression of MYH9 protein CTD PMID:25258189 NCBI chr 7:111,224,291...111,304,963
Ensembl chr 7:111,224,291...111,304,963 		JBrowse link
G Myl4 myosin, light chain 4 increases expression ISO Arsenic Trioxide results in increased expression of MYL4 mRNA CTD PMID:20458559 NCBI chr10:89,949,733...89,985,308
Ensembl chr10:89,949,404...89,985,308 		JBrowse link
G Mylk myosin light chain kinase decreases expression
increases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of MYLK mRNA
Arsenic Trioxide results in increased expression of MYLK mRNA; Arsenic Trioxide results in increased expression of MYLK protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased expression of MYLK mRNA] 		CTD PMID:26238599 PMID:32683294 NCBI chr11:79,288,243...79,535,450
Ensembl chr11:79,288,243...79,535,659 		JBrowse link
G Myo18a myosin XVIIIa decreases expression ISO Arsenic Trioxide results in decreased expression of MYO18A mRNA CTD PMID:39716349 NCBI chr10:63,152,303...63,253,543
Ensembl chr10:63,152,103...63,253,543 		JBrowse link
G Myo1b myosin Ib decreases expression ISO Arsenic Trioxide results in decreased expression of MYO1B mRNA CTD PMID:15070760 PMID:15761015 NCBI chr 9:57,182,059...57,344,335
Ensembl chr 9:57,181,987...57,344,328 		JBrowse link
G Myo1e myosin IE decreases expression ISO Arsenic Trioxide results in decreased expression of MYO1E mRNA CTD PMID:39716349 NCBI chr 8:79,768,828...79,961,048
Ensembl chr 8:79,753,596...79,961,045 		JBrowse link
G Myo5b myosin Vb increases expression ISO Arsenic Trioxide results in increased expression of MYO5B mRNA CTD PMID:22521957 NCBI chr18:70,313,717...70,613,918
Ensembl chr18:70,311,990...70,613,918 		JBrowse link
G Myo5c myosin VC decreases response to substance ISO MYO5C protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 8:84,870,031...84,946,996
Ensembl chr 8:84,870,043...84,946,996 		JBrowse link
G Myo6 myosin VI increases expression ISO Arsenic Trioxide results in increased expression of MYO6 mRNA CTD PMID:17258074 NCBI chr 8:89,967,351...90,122,219
Ensembl chr 8:89,967,377...90,122,215 		JBrowse link
G Myo9b myosin IXb multiple interactions
decreases expression 		ISO [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of MYO9B protein
Arsenic Trioxide results in decreased expression of MYO9B protein 		CTD PMID:15894607 NCBI chr16:17,979,374...18,064,100
Ensembl chr16:17,979,439...18,064,332 		JBrowse link
G Myocd myocardin increases expression ISO Arsenic Trioxide results in increased expression of MYOCD mRNA CTD PMID:26705709 NCBI chr10:50,332,356...50,426,819
Ensembl chr10:50,332,356...50,426,819 		JBrowse link
G Myof myoferlin decreases expression ISO Arsenic Trioxide results in decreased expression of MYOF mRNA CTD PMID:19128835 NCBI chr 1:245,086,109...245,234,768
Ensembl chr 1:245,086,109...245,234,768 		JBrowse link
G Myom1 myomesin 1 decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of MYOM1 protein
[Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of MYOM1 protein 		CTD PMID:15894607 NCBI chr 9:118,362,547...118,485,954
Ensembl chr 9:118,362,621...118,485,952 		JBrowse link
G Myt1l myelin transcription factor 1-like decreases expression ISO Arsenic Trioxide results in decreased expression of MYT1L mRNA CTD PMID:20458559 NCBI chr 6:51,892,858...52,291,830
Ensembl chr 6:52,155,754...52,291,828 		JBrowse link
G Myzap myocardial zonula adherens protein multiple interactions
increases expression 		ISO Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of MYZAP mRNA] CTD PMID:29095437 NCBI chr 8:81,036,599...81,123,933
Ensembl chr 8:81,036,601...81,123,810 		JBrowse link
G N4bp1 Nedd4 binding protein 1 increases expression ISO Arsenic Trioxide results in increased expression of N4BP1 mRNA CTD PMID:15761015 NCBI chr19:36,396,082...36,446,835
Ensembl chr19:36,396,324...36,446,835 		JBrowse link
G N4bp2l1 NEDD4 binding protein 2-like 1 decreases expression ISO Arsenic Trioxide results in decreased expression of N4BP2L1 mRNA CTD PMID:15761015 NCBI chr12:4,938,199...4,965,003
Ensembl chr12:4,927,142...4,963,045 		JBrowse link
G Naa20 N(alpha)-acetyltransferase 20, NatB catalytic subunit increases expression ISO Arsenic Trioxide results in increased expression of NAA20 mRNA CTD PMID:39716349 NCBI chr 3:153,775,351...153,790,129
Ensembl chr 3:153,775,338...153,790,916 		JBrowse link
G Naaa N-acylethanolamine acid amidase increases expression ISO Arsenic Trioxide results in increased expression of NAAA mRNA CTD PMID:22521957 NCBI chr14:16,061,599...16,080,703
Ensembl chr14:16,061,583...16,080,702 		JBrowse link
G Nab2 Ngfi-A binding protein 2 decreases expression ISO Arsenic Trioxide results in decreased expression of NAB2 mRNA CTD PMID:15761015 PMID:20458559 NCBI chr 7:65,382,863...65,389,527
Ensembl chr 7:65,382,863...65,389,255 		JBrowse link
G Nabp1 nucleic acid binding protein 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to NABP1 protein] CTD PMID:26598702 NCBI chr 9:57,570,326...57,625,926
Ensembl chr 9:57,618,505...57,626,052 		JBrowse link
G Naca nascent polypeptide associated complex subunit alpha increases expression ISO Arsenic Trioxide results in increased expression of NACA mRNA CTD PMID:20458559 NCBI chr 7:1,053,474...1,066,606
Ensembl chr 7:1,054,338...1,066,605 		JBrowse link
G Nadk2 NAD kinase 2, mitochondrial affects expression ISO Arsenic Trioxide affects the expression of NADK2 mRNA CTD PMID:35676786 NCBI chr 2:59,844,854...59,886,989
Ensembl chr 2:59,844,854...59,886,988 		JBrowse link
G Naglu N-acetyl-alpha-glucosaminidase multiple interactions
decreases expression 		ISO Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of NAGLU mRNA] CTD PMID:29095437 NCBI chr10:86,501,864...86,509,333
Ensembl chr10:86,501,836...86,509,315 		JBrowse link
G Naip5 NLR family, apoptosis inhibitory protein 5 decreases expression EXP Arsenic Trioxide results in decreased expression of NAIP5 mRNA CTD PMID:19730151 NCBI chr 2:33,289,785...33,342,807
Ensembl chr 2:33,282,466...33,323,401 		JBrowse link
G Naip6 NLR family, apoptosis inhibitory protein 6 decreases expression EXP Arsenic Trioxide results in decreased expression of NAIP2 mRNA CTD PMID:19730151 NCBI chr 2:33,241,520...33,293,184
Ensembl chr 2:33,241,521...33,276,859 		JBrowse link
G Nampt nicotinamide phosphoribosyltransferase multiple interactions
decreases expression 		ISO Arsenic Trioxide promotes the reaction [N-(4-(1-benzoylpiperidin-4-yl)butyl)-3-(pyridin-3-yl)acrylamide results in decreased expression of NAMPT mRNA]; N-(4-(1-benzoylpiperidin-4-yl)butyl)-3-(pyridin-3-yl)acrylamide promotes the reaction [Arsenic Trioxide results in decreased expression of NAMPT mRNA]
Arsenic Trioxide results in decreased expression of NAMPT mRNA; Arsenic Trioxide results in decreased expression of NAMPT protein 		CTD PMID:28501332 PMID:39716349 NCBI chr 6:55,152,756...55,189,547
Ensembl chr 6:55,151,926...55,189,544 		JBrowse link
G Nanog Nanog homeobox increases cleavage
decreases expression
multiple interactions
increases expression 		ISO Arsenic Trioxide results in increased cleavage of NANOG protein
Arsenic Trioxide results in decreased expression of NANOG mRNA
[Arsenic Trioxide co-treated with Tretinoin] results in decreased expression of NANOG protein; ICG 001 affects the reaction [RORB protein affects the reaction [Arsenic Trioxide results in decreased expression of NANOG protein]]; PTGS2 protein affects the reaction [Arsenic Trioxide results in increased expression of NANOG protein]; RORB protein affects the reaction [Arsenic Trioxide results in decreased expression of NANOG protein]; SOX2 protein affects the reaction [Arsenic Trioxide results in increased expression of NANOG protein]; SOX2 protein affects the reaction [PTGS2 protein affects the reaction [Arsenic Trioxide results in increased expression of NANOG protein]]
Arsenic Trioxide results in increased expression of NANOG mRNA; Arsenic Trioxide results in increased expression of NANOG protein
Arsenic Trioxide results in decreased expression of NANOG mRNA; Arsenic Trioxide results in decreased expression of NANOG protein 		CTD PMID:29396848 PMID:29767511 PMID:30093655 PMID:33634982 PMID:38797699 NCBI chr 4:157,615,687...157,623,061
Ensembl chr 4:157,615,687...157,623,061 		JBrowse link
G Nanp N-acetylneuraminic acid phosphatase multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to NANP protein] CTD PMID:26598702 NCBI chr 3:160,289,269...160,302,001
Ensembl chr 3:160,288,830...160,302,002 		JBrowse link
G Nans N-acetylneuraminate synthase decreases expression
multiple interactions
increases expression 		ISO Arsenic Trioxide results in decreased expression of NANS protein
Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to NANS protein]
Arsenic Trioxide results in increased expression of NANS mRNA 		CTD PMID:19364129 PMID:25419056 PMID:26598702 PMID:39716349 NCBI chr 5:65,575,970...65,593,164
Ensembl chr 5:65,576,015...65,610,547 		JBrowse link
G Nap1l1 nucleosome assembly protein 1-like 1 increases expression ISO Arsenic Trioxide results in increased expression of NAP1L1 mRNA CTD PMID:20458559 NCBI chr 7:48,819,464...48,844,108
Ensembl chr 7:48,819,477...48,844,104 		JBrowse link
G Napb NSF attachment protein beta multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to NAPB protein] CTD PMID:26598702 NCBI chr 3:156,585,394...156,632,418
Ensembl chr 3:156,585,394...156,632,418 		JBrowse link
G Napg NSF attachment protein gamma multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to NAPG protein] CTD PMID:26598702 NCBI chr18:58,710,702...58,729,450
Ensembl chr18:58,708,655...58,729,450 		JBrowse link
G Nasp nuclear autoantigenic sperm protein increases response to substance ISO NASP protein results in increased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 5:135,294,599...135,319,992
Ensembl chr 5:135,294,032...135,319,591 		JBrowse link
G Nav1 neuron navigator 1 decreases expression ISO Arsenic Trioxide results in decreased expression of NAV1 mRNA CTD PMID:39716349 NCBI chr13:49,418,755...49,671,117
Ensembl chr13:49,418,755...49,671,004 		JBrowse link
G Nav3 neuron navigator 3 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of NAV3 mRNA
Arsenic Trioxide results in decreased expression of NAV3 mRNA 		CTD PMID:15761015 PMID:22521957 NCBI chr 7:46,938,577...47,726,839
Ensembl chr 7:46,940,670...47,504,893 		JBrowse link
G Nbl1 NBL1, DAN family BMP antagonist multiple interactions ISO [Arsenic Trioxide co-treated with apatinib] results in decreased expression of NBL1 mRNA CTD PMID:39223679 NCBI chr 5:156,601,986...156,613,182
Ensembl chr 5:156,601,986...156,613,186 		JBrowse link
G Nbn nibrin increases expression ISO
EXP 		Arsenic Trioxide results in increased expression of NBN mRNA
Arsenic Trioxide results in increased expression of NBN protein 		CTD PMID:17530438 PMID:23337567 NCBI chr 5:34,256,678...34,291,163
Ensembl chr 5:34,256,627...34,291,162 		JBrowse link
G Ncam2 neural cell adhesion molecule 2 decreases expression ISO Arsenic Trioxide results in decreased expression of NCAM2 mRNA CTD PMID:26705709 NCBI chr11:33,591,748...34,078,788
Ensembl chr11:33,591,713...34,078,788 		JBrowse link
G Ncaph non-SMC condensin I complex, subunit H decreases expression ISO Arsenic Trioxide results in decreased expression of NCAPH mRNA CTD PMID:19128835 NCBI chr 3:134,825,271...134,852,502
Ensembl chr 3:134,825,271...134,852,502 		JBrowse link
G Nceh1 neutral cholesterol ester hydrolase 1 increases expression ISO Arsenic Trioxide results in increased expression of NCEH1 mRNA CTD PMID:20458559 NCBI chr 2:112,003,677...112,064,274
Ensembl chr 2:112,003,502...112,064,272 		JBrowse link
G Ncf1 neutrophil cytosolic factor 1 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of NCF1 protein
ATF4 protein promotes the reaction [Arsenic Trioxide results in increased expression of NCF1 protein]
Arsenic Trioxide results in increased expression of NCF1 mRNA; Arsenic Trioxide results in increased expression of NCF1 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide promotes the reaction [Tretinoin results in increased expression of NCF1 protein]]; acetovanillone inhibits the reaction [Arsenic Trioxide affects the localization of NCF1 protein]; Arsenic Trioxide promotes the reaction [Tretinoin results in increased expression of NCF1 protein]; Arsenic Trioxide results in increased phosphorylation of and affects the localization of NCF1 protein; SB 203580 inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of and affects the localization of NCF1 protein]; Y 27632 inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of and affects the localization of NCF1 protein] 		CTD PMID:15070760 PMID:15761015 PMID:18424721 PMID:20615082 PMID:27638049 NCBI chr12:28,121,816...28,131,080
Ensembl chr12:28,121,366...28,131,079 		JBrowse link
G Ncf2 neutrophil cytosolic factor 2 affects localization
multiple interactions
increases expression 		ISO Arsenic Trioxide affects the localization of NCF2 protein
NCF2 mutant form inhibits the reaction [Arsenic Trioxide results in increased abundance of Reactive Oxygen Species]; NCF2 mutant form inhibits the reaction [Arsenic Trioxide results in increased cleavage of PARP1 protein]; NCF2 mutant form inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of EGFR protein]
Arsenic Trioxide results in increased expression of NCF2 protein
ATF4 protein promotes the reaction [Arsenic Trioxide results in increased expression of NCF2 protein]
Arsenic Trioxide results in increased expression of NCF2 mRNA; Arsenic Trioxide results in increased expression of NCF2 protein 		CTD PMID:15070760 PMID:18424721 PMID:22532027 PMID:27638049 NCBI chr13:67,505,492...67,536,015
Ensembl chr13:67,505,375...67,536,149 		JBrowse link
G Nckap1 NCK-associated protein 1 increases expression ISO Arsenic Trioxide results in increased expression of NCKAP1 mRNA CTD PMID:20458559 NCBI chr 3:85,824,333...85,898,748
Ensembl chr 3:85,824,336...85,898,797 		JBrowse link
G Nckipsd NCK interacting protein with SH3 domain decreases expression ISO Arsenic Trioxide results in decreased expression of NCKIPSD mRNA CTD PMID:27829220 NCBI chr 8:118,390,121...118,401,121
Ensembl chr 8:118,390,159...118,401,118 		JBrowse link
G Ncl nucleolin multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of NCL mRNA CTD PMID:15894607 NCBI chr 9:94,447,559...94,456,083
Ensembl chr 9:94,446,682...94,456,083 		JBrowse link
G Ncmap noncompact myelin associated protein decreases expression ISO Arsenic Trioxide results in decreased expression of NCMAP mRNA CTD PMID:39716349 NCBI chr 5:152,893,173...152,921,175
Ensembl chr 5:152,894,316...152,902,414 		JBrowse link
G Ncoa2 nuclear receptor coactivator 2 multiple interactions ISO Arsenic Trioxide inhibits the reaction [Metribolone promotes the reaction [NCOA2 protein binds to KLK3 promoter]] CTD PMID:19131511 NCBI chr 5:10,618,712...10,852,776
Ensembl chr 5:10,618,722...10,852,776 		JBrowse link
G Ncoa4 nuclear receptor coactivator 4 increases expression ISO Arsenic Trioxide results in increased expression of NCOA4 mRNA CTD PMID:20458559 NCBI chr16:7,395,502...7,415,846
Ensembl chr16:7,401,802...7,415,840 		JBrowse link
G Ncoa7 nuclear receptor coactivator 7 increases expression ISO Arsenic Trioxide results in increased expression of NCOA7 mRNA CTD PMID:22521957 PMID:24356939 NCBI chr 1:28,674,614...28,835,891
Ensembl chr 1:28,675,426...28,835,886 		JBrowse link
G Ndc80 NDC80 kinetochore complex component increases expression ISO Arsenic Trioxide results in increased expression of NDC80 mRNA CTD PMID:20458559 NCBI chr 9:118,853,806...118,887,582
Ensembl chr 9:118,853,806...118,887,568 		JBrowse link
G Ndel1 nudE neurodevelopment protein 1-like 1 increases expression ISO Arsenic Trioxide results in increased expression of NDEL1 mRNA CTD PMID:35676786 NCBI chr10:54,001,435...54,080,909
Ensembl chr10:54,016,149...54,062,375 		JBrowse link
G Ndor1 NADPH dependent diflavin oxidoreductase 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to NDOR1 protein] CTD PMID:26598702 NCBI chr 3:28,460,787...28,469,018
Ensembl chr 3:28,460,797...28,469,018 		JBrowse link
G Ndp norrin cystine knot growth factor NDP decreases expression ISO Arsenic Trioxide results in decreased expression of NDP mRNA CTD PMID:26705709 NCBI chr  X:8,379,569...8,404,019
Ensembl chr  X:8,379,569...8,406,802 		JBrowse link
G Ndrg1 N-myc downstream regulated 1 multiple interactions
increases expression 		ISO [Arsenic Trioxide co-treated with Tretinoin] results in decreased expression of NDRG1 mRNA; [Arsenic Trioxide co-treated with Tretinoin] results in decreased expression of NDRG1 protein; [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of NDRG1 mRNA
Arsenic Trioxide results in increased expression of NDRG1 mRNA 		CTD PMID:15894607 PMID:21575456 PMID:39716349 NCBI chr 7:100,573,526...100,614,902
Ensembl chr 7:100,573,523...100,614,913 		JBrowse link
G Ndrg3 NDRG family member 3 increases expression ISO Arsenic Trioxide results in increased expression of NDRG3 mRNA CTD PMID:35676786 NCBI chr 3:166,007,556...166,070,981
Ensembl chr 3:165,890,091...166,049,887 		JBrowse link
G Ndrg4 NDRG family member 4 increases expression ISO Arsenic Trioxide results in increased expression of NDRG4 mRNA CTD PMID:22521957 NCBI chr19:9,357,470...9,393,465
Ensembl chr19:9,357,470...9,392,972 		JBrowse link
G Ndst1 N-deacetylase and N-sulfotransferase 1 increases expression ISO Arsenic Trioxide results in increased expression of NDST1 mRNA CTD PMID:20458559 NCBI chr18:56,407,308...56,470,007
Ensembl chr18:56,411,200...56,448,612 		JBrowse link
G Ndst3 N-deacetylase and N-sulfotransferase 3 decreases expression ISO Arsenic Trioxide results in decreased expression of NDST3 mRNA CTD PMID:26705709 NCBI chr 2:214,386,804...214,552,739
Ensembl chr 2:214,389,447...214,539,164 		JBrowse link
G Ndufa10 NADH:ubiquinone oxidoreductase subunit A10 increases expression ISO Arsenic Trioxide results in increased expression of NDUFA10 mRNA CTD PMID:22521957 NCBI chr 9:100,454,498...100,490,023
Ensembl chr 9:100,437,379...100,489,264 		JBrowse link
G Ndufa12 NADH:ubiquinone oxidoreductase subunit A12 decreases expression ISO Arsenic Trioxide results in decreased expression of NDUFA12 protein
Arsenic Trioxide results in decreased expression of NDUFA12 mRNA 		CTD PMID:19422848 PMID:25419056 NCBI chr 7:30,658,316...30,685,302
Ensembl chr 7:30,658,322...30,686,300 		JBrowse link
G Ndufa4 Ndufa4, mitochondrial complex associated increases expression ISO Arsenic Trioxide results in increased expression of COXFA4 mRNA CTD PMID:20458559 NCBI chr 4:40,968,391...40,975,559
Ensembl chr 4:40,968,391...40,975,559 		JBrowse link
G Ndufa9 NADH:ubiquinone oxidoreductase subunit A9 increases expression ISO Arsenic Trioxide results in increased expression of NDUFA9 mRNA CTD PMID:22521957 NCBI chr 4:161,345,398...161,374,188
Ensembl chr 4:161,345,400...161,375,025 		JBrowse link
G Ndufab1 NADH:ubiquinone oxidoreductase subunit AB1 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of NDUFAB1 mRNA
Arsenic Trioxide results in decreased expression of NDUFAB1 mRNA 		CTD PMID:19422848 PMID:22521957 PMID:29633893 NCBI chr 1:186,075,933...186,091,843
Ensembl chr 1:186,057,113...186,089,373 		JBrowse link
G Ndufaf1 NADH:ubiquinone oxidoreductase complex assembly factor 1 increases expression ISO Arsenic Trioxide results in increased expression of NDUFAF1 mRNA CTD PMID:22521957 NCBI chr 3:127,089,893...127,104,357
Ensembl chr 3:127,093,659...127,104,020 		JBrowse link
G Ndufb2 NADH:ubiquinone oxidoreductase subunit B2 decreases expression ISO Arsenic Trioxide results in decreased expression of NDUFB2 mRNA CTD PMID:19422848 NCBI chr 4:69,334,307...69,341,394
Ensembl chr 4:69,334,307...69,340,136
Ensembl chr15:69,334,307...69,340,136 		JBrowse link
G Ndufc1 NADH:ubiquinone oxidoreductase subunit C1 decreases expression ISO Arsenic Trioxide results in decreased expression of NDUFC1 mRNA CTD PMID:39716349 NCBI chr 2:137,597,944...137,601,819
Ensembl chr 2:137,600,156...137,601,735 		JBrowse link
G Ndufs1 NADH:ubiquinone oxidoreductase core subunit S1 increases expression ISO Arsenic Trioxide results in increased expression of NDUFS1 mRNA CTD PMID:22521957 NCBI chr 9:72,040,286...72,073,605
Ensembl chr 9:72,040,090...72,073,605 		JBrowse link
G Ndufs2 NADH:ubiquinone oxidoreductase core subunit S2 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of NDUFS2 mRNA
Arsenic Trioxide results in decreased expression of NDUFS2 mRNA 		CTD PMID:22521957 PMID:35676786 PMID:39716349 NCBI chr13:86,186,867...86,203,914
Ensembl chr13:86,186,870...86,203,608 		JBrowse link
G Ndufs8 NADH:ubiquinone oxidoreductase core subunit S8 increases expression ISO Arsenic Trioxide results in increased expression of NDUFS8 mRNA CTD PMID:24831965 NCBI chr 1:210,569,823...210,573,707
Ensembl chr 1:210,569,824...210,572,971 		JBrowse link
G Neat1 nuclear paraspeckle assembly transcript 1 decreases expression
multiple interactions
increases expression 		EXP
ISO 		Arsenic Trioxide results in decreased expression of NEAT1 mRNA
NEAT1 mRNA affects the reaction [Arsenic Trioxide affects the expression of IL1B mRNA]; NEAT1 mRNA affects the reaction [Arsenic Trioxide affects the expression of IL1B protein]; NEAT1 mRNA affects the reaction [Arsenic Trioxide affects the expression of IL6 mRNA]; NEAT1 mRNA affects the reaction [Arsenic Trioxide affects the expression of IL6 protein]; NEAT1 mRNA affects the reaction [Arsenic Trioxide affects the expression of TNF mRNA]; NEAT1 mRNA affects the reaction [Arsenic Trioxide affects the expression of TNF protein]
Arsenic Trioxide results in increased expression of NEAT1 mRNA 		CTD PMID:32096187 PMID:39716349 NCBI chr 1:212,507,512...212,568,055 JBrowse link
G Necab2 N-terminal EF-hand calcium binding protein 2 decreases expression ISO Arsenic Trioxide results in decreased expression of NECAB2 mRNA CTD PMID:20458559 NCBI chr19:64,409,627...64,436,371
Ensembl chr19:64,409,751...64,436,369 		JBrowse link
G Nectin1 nectin cell adhesion molecule 1 increases expression ISO Arsenic Trioxide results in increased expression of PVRL1 mRNA
Arsenic Trioxide results in increased expression of NECTIN1 mRNA 		CTD PMID:29633893 PMID:39716349 NCBI chr 8:52,998,662...53,061,745
Ensembl chr 8:52,998,662...53,086,664 		JBrowse link
G Nectin3 nectin cell adhesion molecule 3 decreases expression ISO Arsenic Trioxide results in decreased expression of NECTIN3 mRNA CTD PMID:22521957 NCBI chr11:67,825,296...67,931,999
Ensembl chr11:67,827,137...67,871,383 		JBrowse link
G Nedd1 NEDD1 gamma-tubulin ring complex targeting factor increases expression ISO Arsenic Trioxide results in increased expression of NEDD1 mRNA CTD PMID:20458559 NCBI chr 7:29,120,200...29,161,634
Ensembl chr 7:29,120,200...29,161,634 		JBrowse link
G Nedd8 NEDD8 ubiquitin like modifier decreases expression ISO Arsenic Trioxide results in decreased expression of NEDD8 protein CTD PMID:19364129 NCBI chr15:33,123,505...33,135,522
Ensembl chr15:33,123,505...33,135,522 		JBrowse link
G Nefm neurofilament medium chain increases expression ISO Arsenic Trioxide results in increased expression of NEFM protein CTD PMID:35467087 NCBI chr15:46,535,857...46,541,161
Ensembl chr15:46,535,517...46,541,163 		JBrowse link
G Nek1 NIMA-related kinase 1 increases expression ISO Arsenic Trioxide results in increased expression of NEK1 mRNA CTD PMID:22521957 NCBI chr16:34,009,092...34,137,418
Ensembl chr16:34,009,094...34,128,576 		JBrowse link
G Nek7 NIMA-related kinase 7 increases expression ISO Arsenic Trioxide results in increased expression of NEK7 mRNA CTD PMID:22521957 NCBI chr13:52,573,730...52,700,869
Ensembl chr13:52,573,730...52,700,823 		JBrowse link
G Nenf neudesin neurotrophic factor decreases expression ISO Arsenic Trioxide results in decreased expression of NENF mRNA CTD PMID:39716349 NCBI chr13:105,419,113...105,425,911
Ensembl chr13:105,419,113...105,426,091 		JBrowse link
G Neo1 neogenin 1 increases expression ISO Arsenic Trioxide results in increased expression of NEO1 mRNA CTD PMID:27829220 NCBI chr 8:68,169,711...68,322,158
Ensembl chr 8:68,169,716...68,322,152 		JBrowse link
G Nes nestin increases expression ISO Arsenic Trioxide results in increased expression of NES mRNA CTD PMID:22521957 NCBI chr 2:175,735,715...175,745,631
Ensembl chr 2:175,736,551...175,746,228 		JBrowse link
G Neto2 neuropilin and tolloid like 2 decreases expression ISO Arsenic Trioxide results in decreased expression of NETO2 mRNA CTD PMID:25258189 NCBI chr19:37,517,518...37,588,961
Ensembl chr19:37,517,587...37,591,413 		JBrowse link
G Neu2 neuraminidase 2 increases expression ISO Arsenic Trioxide results in increased expression of NEU2 mRNA CTD PMID:35676786 NCBI chr 9:95,666,338...95,715,209
Ensembl chr 9:95,696,507...95,715,208 		JBrowse link
G Neu3 neuraminidase 3 increases expression ISO Arsenic Trioxide results in increased expression of NEU3 mRNA CTD PMID:15070760 NCBI chr 1:163,549,834...163,560,997
Ensembl chr 1:163,549,738...163,561,049 		JBrowse link
G Nf2 NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor decreases expression ISO Arsenic Trioxide results in decreased expression of NF2 mRNA CTD PMID:11940349 PMID:25258189 NCBI chr14:83,850,894...83,934,263
Ensembl chr14:83,850,894...83,934,151 		JBrowse link
G Nfatc1 nuclear factor of activated T-cells 1 increases expression
multiple interactions 		EXP Arsenic Trioxide results in increased expression of NFATC1 mRNA; Arsenic Trioxide results in increased expression of NFATC1 protein
Phloretin inhibits the reaction [Arsenic Trioxide results in increased expression of NFATC1 mRNA]; Phloretin inhibits the reaction [Arsenic Trioxide results in increased expression of NFATC1 protein] 		CTD PMID:34037972 NCBI chr18:76,321,386...76,430,997
Ensembl chr18:76,321,386...76,430,990 		JBrowse link
G Nfatc3 nuclear factor of activated T-cells 3 decreases expression
affects expression 		ISO Arsenic Trioxide results in decreased expression of NFATC3 mRNA
Arsenic Trioxide affects the expression of NFATC3 mRNA 		CTD PMID:29633893 PMID:39716349 NCBI chr19:50,870,464...50,944,992
Ensembl chr19:50,870,489...50,944,992 		JBrowse link
G Nfe2l1 NFE2 like bZIP transcription factor 1 multiple interactions ISO Arsenic Trioxide results in increased expression of and results in increased activity of NFE2L1 protein CTD PMID:16487037 NCBI chr10:82,296,824...82,309,472
Ensembl chr10:82,292,508...82,309,375 		JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 multiple interactions
affects response to substance
increases expression
decreases expression
decreases response to substance
affects localization 		EXP
ISO 		Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of and affects the localization of NFE2L2 protein]; alpha-Tocopherol inhibits the reaction [Arsenic Trioxide results in decreased expression of NFE2L2 mRNA]; Arsenic Trioxide affects the expression of and affects the phosphorylation of NFE2L2 protein; Arsenic Trioxide results in increased expression of and affects the localization of NFE2L2 protein; Arsenic Trioxide results in increased phosphorylation of and affects the localization of NFE2L2 protein; Ascorbic Acid inhibits the reaction [Arsenic Trioxide results in decreased expression of NFE2L2 mRNA]; Buthionine Sulfoximine promotes the reaction [Arsenic Trioxide results in increased expression of and affects the localization of NFE2L2 protein]; crocin inhibits the reaction [Arsenic Trioxide results in decreased expression of NFE2L2 protein]; eriodictyol promotes the reaction [Arsenic Trioxide results in increased expression of NFE2L2 mRNA]; eriodictyol promotes the reaction [Arsenic Trioxide results in increased expression of NFE2L2 protein]; Nicorandil affects the reaction [Arsenic Trioxide affects the expression of and affects the phosphorylation of NFE2L2 protein]; oxymatrine promotes the reaction [Arsenic Trioxide results in increased expression of NFE2L2 protein]; Resveratrol inhibits the reaction [Arsenic Trioxide results in decreased expression of NFE2L2 mRNA]
NFE2L2 protein affects the susceptibility to Arsenic Trioxide
Arsenic Trioxide results in increased expression of NFE2L2 mRNA; Arsenic Trioxide results in increased expression of NFE2L2 protein
Arsenic Trioxide results in decreased expression of NFE2L2 mRNA; Arsenic Trioxide results in decreased expression of NFE2L2 protein
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Arsenic Trioxide results in increased expression of NFE2L2 mRNA]; 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Arsenic Trioxide results in increased expression of NFE2L2 protein]; 18alpha,20beta-hydroxy-11-oxo-norolean-12-en-3beta-yl-2-O-beta-D-glucopyranurosyl-alpha-D-glucopyranosiduronate magnesium tetrahydrate inhibits the reaction [Arsenic Trioxide results in decreased expression of NFE2L2 protein]; [Arsenic Trioxide co-treated with Grape Seed Proanthocyanidins] results in increased expression of NFE2L2 mRNA; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of NFE2L2 protein]; Arsenic Trioxide promotes the reaction [Lutein results in increased expression of NFE2L2 mRNA]; Arsenic Trioxide promotes the reaction [Lutein results in increased expression of NFE2L2 protein]; Lutein promotes the reaction [Arsenic Trioxide results in increased expression of NFE2L2 mRNA]; Lutein promotes the reaction [Arsenic Trioxide results in increased expression of NFE2L2 protein]; NFE2L2 protein affects the reaction [Arsenic Trioxide results in decreased expression of TNF protein]; NFE2L2 protein affects the reaction [Arsenic Trioxide results in increased expression of GCLC mRNA]; NFE2L2 protein affects the reaction [Arsenic Trioxide results in increased expression of HMOX1 mRNA]; NFE2L2 protein affects the reaction [Arsenic Trioxide results in increased expression of NQO1 mRNA]; NFE2L2 protein promotes the reaction [Arsenic Trioxide results in increased expression of NQO1 protein]; SB 203580 inhibits the reaction [Arsenic Trioxide results in increased expression of NFE2L2 mRNA]; Thioctic Acid inhibits the reaction [Arsenic Trioxide results in increased expression of NFE2L2 mRNA]; Thioctic Acid inhibits the reaction [Arsenic Trioxide results in increased expression of NFE2L2 protein]
NFE2L2 mRNA results in decreased susceptibility to Arsenic Trioxide; NFE2L2 protein results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide affects the localization of NFE2L2 protein
[Arsenic Trioxide results in increased abundance of Arsenic] which results in increased expression of and affects the localization of NFE2L2 protein; [Arsenic Trioxide results in increased abundance of Arsenic] which results in increased expression of NFE2L2 mRNA; [Arsenic Trioxide results in increased abundance of Arsenic] which results in increased expression of NFE2L2 protein; [Resveratrol co-treated with Arsenic Trioxide] results in increased expression of NFE2L2 protein; [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of NFE2L2 mRNA; Acetylcysteine inhibits the reaction [Arsenic Trioxide affects the localization of NFE2L2 protein]; allicin inhibits the reaction [Arsenic Trioxide results in decreased expression of NFE2L2 protein]; Arsenic Trioxide promotes the reaction [NFE2L2 protein binds to VMP1 gene]; Arsenic Trioxide promotes the reaction [Resveratrol results in increased expression of NFE2L2 protein]; Arsenic Trioxide results in increased expression of and affects the localization of NFE2L2 protein; NFE2L2 mRNA promotes the reaction [Ethionamide results in increased susceptibility to Arsenic Trioxide]; NFE2L2 promotes the reaction [Arsenic Trioxide results in increased expression of MIR21 protein]; NFE2L2 protein affects the reaction [Arsenic Trioxide results in decreased expression of ACTA2 protein]; NFE2L2 protein affects the reaction [Arsenic Trioxide results in increased expression of HMOX1 mRNA]; NFE2L2 protein inhibits the reaction [Arsenic Trioxide results in increased abundance of Reactive Oxygen Species]; NFE2L2 protein promotes the reaction [Arsenic Trioxide results in increased expression of HMOX1 protein]; NFE2L2 protein promotes the reaction [Arsenic Trioxide results in increased expression of KEAP1 protein]; NFE2L2 protein promotes the reaction [Arsenic Trioxide results in increased expression of NQO1 protein]; NFE2L2 protein promotes the reaction [Arsenic Trioxide results in increased expression of PPARG mRNA]; NFE2L2 protein promotes the reaction [Rosiglitazone results in increased susceptibility to Arsenic Trioxide]; NFE2L2 protein promotes the reaction [Troglitazone results in increased susceptibility to Arsenic Trioxide]; Resveratrol promotes the reaction [Arsenic Trioxide results in increased expression of NFE2L2 protein]; TGM2 protein affects the reaction [[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of NFE2L2 mRNA]; Tretinoin inhibits the reaction [Arsenic Trioxide affects the localization of NFE2L2 protein] 		CTD PMID:19350554 PMID:20707922 PMID:21327864 PMID:22155346 PMID:22488045 More... NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090 		JBrowse link
G Nfia nuclear factor I/A decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of NFIA mRNA
Arsenic Trioxide results in increased expression of NFIA mRNA 		CTD PMID:19128835 PMID:26705709 NCBI chr 5:117,359,006...117,897,391
Ensembl chr 5:117,359,077...117,891,395 		JBrowse link
G Nfkb1 nuclear factor kappa B subunit 1 affects localization
increases expression
multiple interactions
decreases expression
decreases activity 		ISO Arsenic Trioxide affects the localization of NFKB1 protein
Arsenic Trioxide results in increased expression of NFKB1 mRNA
[BIBR 1532 co-treated with Arsenic Trioxide] affects the expression of NFKB1 mRNA; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased activity of NFKB1 protein]; Arsenic Trioxide inhibits the reaction [RELA protein binds to NFKB1 protein]; JAK1 protein inhibits the reaction [Arsenic Trioxide results in decreased expression of NFKB1 protein]; STAT3 protein inhibits the reaction [Arsenic Trioxide results in decreased expression of NFKB1 protein]
Arsenic Trioxide results in decreased expression of NFKB1 mRNA; Arsenic Trioxide results in decreased expression of NFKB1 protein 		CTD PMID:15073043 PMID:15314284 PMID:18349030 PMID:18922898 PMID:20458559 More... NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088 		JBrowse link
G Nfkb2 nuclear factor kappa B subunit 2 increases expression
decreases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of NFKB2 mRNA
Arsenic Trioxide results in decreased expression of NFKB2 protein
Arsenic Trioxide inhibits the reaction [Homoharringtonine results in increased expression of NFKB2 protein] 		CTD PMID:18349030 PMID:29633893 PMID:31307525 PMID:33634982 NCBI chr 1:255,106,010...255,114,649
Ensembl chr 1:255,107,374...255,114,637 		JBrowse link
G Nfkbia NFKB inhibitor alpha multiple interactions
decreases expression
increases expression
decreases phosphorylation
decreases degradation 		ISO
EXP 		[[Sulindac co-treated with Arsenic Trioxide] results in decreased phosphorylation of and results in decreased degradation of NFKBIA protein] which affects the localization of RELA protein; [Arsenic Trioxide co-treated with Tetradecanoylphorbol Acetate] results in decreased degradation of NFKBIA protein; [BIBR 1532 co-treated with Arsenic Trioxide] affects the expression of NFKBIA mRNA; [Bortezomib co-treated with Arsenic Trioxide] affects the expression of NFKBIA protein; [Sulindac co-treated with Arsenic Trioxide] results in decreased phosphorylation of and results in decreased degradation of NFKBIA protein; Arsenic Trioxide inhibits the reaction [CXCL12 protein results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; Arsenic Trioxide promotes the reaction [Aprepitant results in decreased phosphorylation of NFKBIA protein]; Arsenic Trioxide promotes the reaction [VS-5584 results in decreased phosphorylation of NFKBIA protein]; Arsenic Trioxide results in decreased degradation of and results in increased stability of NFKBIA protein; NFKBIA protein inhibits the reaction [Arsenic Trioxide results in increased expression of FAS protein]
Arsenic Trioxide results in increased phosphorylation of and results in increased degradation of NFKBIA protein; Febuxostat inhibits the reaction [Arsenic Trioxide results in decreased expression of NFKBIA protein]
Arsenic Trioxide results in decreased expression of NFKBIA; Arsenic Trioxide results in decreased expression of NFKBIA mRNA
Arsenic Trioxide results in increased expression of NFKBIA mRNA; Arsenic Trioxide results in increased expression of NFKBIA protein
Arsenic Trioxide results in decreased phosphorylation of NFKBIA protein
Arsenic Trioxide results in decreased degradation of NFKBIA protein
Arsenic Trioxide inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in decreased expression of NFKBIA protein] 		CTD PMID:11739184 PMID:12560223 PMID:15382040 PMID:15476326 PMID:15547942 More... NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072 		JBrowse link
G Nfkbib NFKB inhibitor beta decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of NFKBIB mRNA
Arsenic Trioxide results in increased expression of NFKBIB mRNA 		CTD PMID:19769630 PMID:20471514 NCBI chr 1:93,173,817...93,181,387
Ensembl chr 1:93,173,820...93,326,366 		JBrowse link
G Nfkbie NFKB inhibitor epsilon multiple interactions
decreases expression 		ISO Arsenic Trioxide results in decreased degradation of and results in increased stability of NFKBIE protein; Bortezomib inhibits the reaction [Arsenic Trioxide results in decreased expression of NFKBIE mRNA] CTD PMID:12560223 PMID:20471514 NCBI chr 9:22,941,037...22,947,872
Ensembl chr 9:22,941,040...22,947,872 		JBrowse link
G Ngfr nerve growth factor receptor multiple interactions
increases expression 		ISO Arsenic Trioxide promotes the reaction [Drugs, Chinese Herbal results in increased expression of TNFRSF10B protein]; Drugs, Chinese Herbal promotes the reaction [Arsenic Trioxide results in increased expression of TNFRSF10B protein] CTD PMID:28587418 NCBI chr10:81,012,077...81,030,305
Ensembl chr10:81,012,089...81,030,305 		JBrowse link
G Ngrn neugrin, neurite outgrowth associated increases expression ISO Arsenic Trioxide results in increased expression of NGRN mRNA CTD PMID:20458559 NCBI chr 1:143,622,494...143,628,609
Ensembl chr 1:143,622,731...143,628,609 		JBrowse link
G Nherf1 NHERF family PDZ scaffold protein 1 increases expression ISO Arsenic Trioxide results in increased expression of NHERF1 protein CTD PMID:25419056 NCBI chr10:100,902,165...100,919,265
Ensembl chr10:100,901,227...100,919,579 		JBrowse link
G Nhsl3 NHS like 3 increases expression ISO Arsenic Trioxide results in increased expression of NHSL3 mRNA CTD PMID:20458559 NCBI chr 5:146,848,747...146,877,504
Ensembl chr 5:146,848,747...146,877,504 		JBrowse link
G Niban1 niban apoptosis regulator 1 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of NIBAN1 protein
Arsenic Trioxide results in decreased expression of NIBAN1 mRNA 		CTD PMID:30093655 PMID:35676786 NCBI chr13:66,224,219...66,377,728
Ensembl chr13:66,224,021...66,377,724 		JBrowse link
G Niban2 niban apoptosis regulator 2 decreases expression ISO Arsenic Trioxide results in decreased expression of NIBAN2 mRNA CTD PMID:35676786 NCBI chr 3:36,572,356...36,621,968
Ensembl chr 3:36,572,377...36,621,967 		JBrowse link
G Nifk nucleolar protein interacting with the FHA domain of MKI67 increases expression ISO Arsenic Trioxide results in increased expression of NIFK mRNA CTD PMID:14703492 NCBI chr13:31,946,119...31,955,950
Ensembl chr13:31,946,108...31,959,561 		JBrowse link
G Ninj2 ninjurin 2 decreases expression ISO Arsenic Trioxide results in decreased expression of NINJ2 mRNA CTD PMID:26705709 NCBI chr 4:154,978,660...155,080,860
Ensembl chr 4:155,073,295...155,080,860 		JBrowse link
G Nipal3 NIPA-like domain containing 3 increases expression ISO Arsenic Trioxide results in increased expression of NIPAL3 mRNA CTD PMID:26705709 NCBI chr 5:152,970,934...153,010,006
Ensembl chr 5:152,968,910...153,008,845 		JBrowse link
G Nit1 nitrilase 1 increases expression ISO Arsenic Trioxide results in increased expression of NIT1 mRNA CTD PMID:39716349 NCBI chr13:86,302,334...86,305,770
Ensembl chr13:86,298,387...86,305,770 		JBrowse link
G Nkd1 NKD inhibitor of WNT signaling pathway 1 multiple interactions ISO [Arsenic Trioxide co-treated with apatinib] results in decreased expression of NKD1 mRNA CTD PMID:39223679 NCBI chr19:34,649,803...34,722,846 JBrowse link
G Nkd2 NKD inhibitor of WNT signaling pathway 2 increases expression ISO Arsenic Trioxide results in increased expression of NKD2 mRNA CTD PMID:19128835 NCBI chr 1:31,268,856...31,299,390
Ensembl chr 1:31,272,519...31,299,387 		JBrowse link
G Nktr natural killer cell triggering receptor decreases expression ISO Arsenic Trioxide results in decreased expression of NKTR mRNA CTD PMID:22521957 NCBI chr 8:130,255,541...130,298,001
Ensembl chr 8:130,259,461...130,298,008 		JBrowse link
G Nkx3-2 NK3 homeobox 2 decreases expression ISO Arsenic Trioxide results in decreased expression of NKX3-2 mRNA CTD PMID:20458559 NCBI chr14:73,396,198...73,398,585
Ensembl chr14:73,395,619...73,399,558 		JBrowse link
G Nlgn1 neuroligin 1 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of NLGN1 mRNA
Arsenic Trioxide results in decreased expression of NLGN1 mRNA 		CTD PMID:20458559 PMID:26705709 NCBI chr 2:110,184,987...111,110,316
Ensembl chr 2:110,186,573...110,909,984 		JBrowse link
G Nlrc4 NLR family, CARD domain containing 4 decreases expression ISO Arsenic Trioxide results in decreased expression of NLRC4 protein CTD PMID:35226250 NCBI chr 6:26,743,658...26,771,783
Ensembl chr 6:26,743,698...26,770,563 		JBrowse link
G Nlrp12 NLR family, pyrin domain containing 12 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of NLRP12 mRNA
Bortezomib promotes the reaction [Arsenic Trioxide results in increased expression of NLRP12 mRNA] 		CTD PMID:20471514 NCBI chr 1:74,848,020...74,885,945
Ensembl chr 1:74,848,063...74,876,341 		JBrowse link
G Nlrp1a NLR family, pyrin domain containing 1A increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of NLRP1 mRNA
[sanguinarine co-treated with Arsenic Trioxide] results in increased expression of NLRP1 mRNA 		CTD PMID:24345465 NCBI chr10:56,277,134...56,332,229
Ensembl chr10:56,277,134...56,323,880 		JBrowse link
G Nlrp3 NLR family, pyrin domain containing 3 multiple interactions
increases expression 		ISO
EXP 		[Arsenic Trioxide results in increased abundance of arsenite] which results in increased expression of NLRP3 mRNA; Arsenic Trioxide affects the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of NLRP3 mRNA]; Arsenic Trioxide affects the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of NLRP3 protein]; Arsenic Trioxide promotes the reaction [AS3MT protein binds to NLRP3 protein]; Arsenic Trioxide promotes the reaction [METTL14 protein binds to NLRP3 mRNA]; Taurine inhibits the reaction [Arsenic Trioxide results in increased expression of NLRP3 protein]
[Arsenic Trioxide co-treated with Lipopolysaccharides] results in increased expression of NLRP3 protein; Febuxostat inhibits the reaction [Arsenic Trioxide results in increased expression of NLRP3 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[Arsenic Trioxide co-treated with Lipopolysaccharides] results in increased expression of NLRP3 protein]; Taurine inhibits the reaction [[Arsenic Trioxide co-treated with Lipopolysaccharides] results in increased expression of NLRP3 protein]; Taurine inhibits the reaction [Arsenic Trioxide results in increased expression of NLRP3 protein]
[Arsenic Trioxide co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of NLRP3 protein; Arsenic Trioxide promotes the reaction [AS3MT protein binds to NLRP3 protein]; Arsenic Trioxide promotes the reaction [METTL14 protein binds to NLRP3 mRNA]; AS3MT mRNA promotes the reaction [Arsenic Trioxide promotes the reaction [METTL14 protein binds to NLRP3 mRNA]]; AS3MT mRNA promotes the reaction [Arsenic Trioxide results in increased expression of NLRP3 protein]; AS3MT mRNA promotes the reaction [Arsenic Trioxide results in increased stability of NLRP3 mRNA]; IGF2BP2 protein promotes the reaction [Arsenic Trioxide results in increased expression of NLRP3 protein]; IGF2BP2 protein promotes the reaction [Arsenic Trioxide results in increased stability of NLRP3 mRNA]; METTL14 protein promotes the reaction [Arsenic Trioxide results in increased expression of NLRP3 protein]; METTL14 protein promotes the reaction [Arsenic Trioxide results in increased stability of NLRP3 mRNA]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[Arsenic Trioxide co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of NLRP3 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Arsenic Trioxide results in increased expression of NLRP3 protein]; Taurine inhibits the reaction [[Arsenic Trioxide co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of NLRP3 protein]
Arsenic Trioxide results in increased expression of NLRP3 mRNA; Arsenic Trioxide results in increased expression of NLRP3 protein 		CTD PMID:30237538 PMID:30660605 PMID:35226250 PMID:36791901 PMID:37689273 More... NCBI chr10:44,826,299...44,853,373
Ensembl chr10:44,828,014...44,853,394 		JBrowse link
G Nme1 NME/NM23 nucleoside diphosphate kinase 1 increases expression ISO Arsenic Trioxide results in increased expression of NME1 protein
Arsenic Trioxide results in increased expression of NME1 mRNA; Arsenic Trioxide results in increased expression of NME1 protein 		CTD PMID:12452020 PMID:12478894 PMID:19822495 NCBI chr10:79,403,939...79,426,620
Ensembl chr10:79,403,940...79,413,310 		JBrowse link
G Nmt1 N-myristoyltransferase 1 increases expression ISO Arsenic Trioxide results in increased expression of NMT1 mRNA CTD PMID:20458559 NCBI chr10:88,488,918...88,525,496
Ensembl chr10:88,488,990...88,522,729 		JBrowse link
G Nmt2 N-myristoyltransferase 2 increases expression ISO Arsenic Trioxide results in increased expression of NMT2 mRNA CTD PMID:20458559 NCBI chr17:79,826,999...79,874,088
Ensembl chr17:79,826,999...79,870,259 		JBrowse link
G Nnt nicotinamide nucleotide transhydrogenase increases expression ISO Arsenic Trioxide results in increased expression of NNT mRNA CTD PMID:39716349 NCBI chr 2:53,144,157...53,237,857
Ensembl chr 2:53,144,160...53,237,310 		JBrowse link
G Nol3 nucleolar protein 3 decreases response to substance ISO NOL3 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr19:50,066,493...50,068,175
Ensembl chr19:50,063,986...50,068,722 		JBrowse link
G Nol6 nucleolar protein 6 increases expression ISO Arsenic Trioxide results in increased expression of NOL6 mRNA CTD PMID:20458559 NCBI chr 5:61,055,863...61,083,249
Ensembl chr 5:61,055,863...61,083,264 		JBrowse link
G Nolc1 nucleolar and coiled-body phosphoprotein 1 decreases expression ISO Arsenic Trioxide results in decreased expression of NOLC1 mRNA CTD PMID:20458559 NCBI chr 1:254,870,195...254,881,070
Ensembl chr 1:254,870,319...254,881,069 		JBrowse link
G Nop53 NOP53 ribosome biogenesis factor increases expression ISO Arsenic Trioxide results in increased expression of NOP53 mRNA CTD PMID:39716349 NCBI chr 1:85,757,271...85,765,089
Ensembl chr 1:85,756,586...85,765,089 		JBrowse link
G Nop56 NOP56 ribonucleoprotein increases expression ISO Arsenic Trioxide results in increased expression of NOP56 mRNA CTD PMID:39716349 NCBI chr 3:137,926,187...137,934,971
Ensembl chr 3:137,929,646...137,934,959 		JBrowse link
G Nos2 nitric oxide synthase 2 decreases expression
increases expression
multiple interactions 		ISO
EXP 		Arsenic Trioxide results in decreased expression of NOS2 mRNA
Arsenic Trioxide results in increased expression of NOS2 protein; Arsenic Trioxide results in increased expression of NOS2A mRNA
Arsenic Trioxide inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]
4-amino-1,8-naphthalimide inhibits the reaction [Arsenic Trioxide results in increased expression of NOS2 protein]
Arsenic Trioxide results in increased expression of NOS2 mRNA 		CTD PMID:20458559 PMID:20693187 PMID:23106696 PMID:25972196 PMID:28454374 More... NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880 		JBrowse link
G Nos3 nitric oxide synthase 3 increases expression
multiple interactions
decreases expression 		ISO
EXP 		Arsenic Trioxide results in increased expression of NOS3 mRNA
Arsenic Trioxide results in increased phosphorylation of and results in increased activity of NOS3 protein
Arsenic Trioxide results in decreased expression of NOS3 protein
Nicorandil inhibits the reaction [Arsenic Trioxide results in decreased expression of NOS3 protein] 		CTD PMID:17559834 PMID:18414637 PMID:20458559 PMID:38741475 NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664 		JBrowse link
G Notch1 notch receptor 1 decreases response to substance
decreases activity
multiple interactions
decreases expression
increases expression 		ISO NOTCH1 protein results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in decreased activity of NOTCH1 protein
4-(4-(N-benzoylamino)anilino)-6-methoxy-7-(3-(1-morpholino)propoxy)quinazoline inhibits the reaction [Arsenic Trioxide results in decreased expression of NOTCH1 protein]; [Arsenic Trioxide results in decreased activity of NOTCH1 protein] which results in decreased phosphorylation of and results in decreased activity of STAT3 protein; Arsenic Trioxide inhibits the reaction [Homoharringtonine results in increased expression of NOTCH1 protein]; Arsenic Trioxide inhibits the reaction [PROM1 protein results in increased activity of NOTCH1 protein]; Arsenic Trioxide results in decreased expression of and results in increased phosphorylation of NOTCH1 protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Arsenic Trioxide results in decreased expression of NOTCH1 protein]; BI 2536 inhibits the reaction [Arsenic Trioxide results in decreased expression of NOTCH1 protein]; RO3280 inhibits the reaction [Arsenic Trioxide results in decreased expression of NOTCH1 protein]
Arsenic Trioxide results in decreased expression of NOTCH1; Arsenic Trioxide results in decreased expression of NOTCH1 mRNA; Arsenic Trioxide results in decreased expression of NOTCH1 protein
Arsenic Trioxide results in increased expression of NOTCH1 mRNA; Arsenic Trioxide results in increased expression of NOTCH1 protein 		CTD PMID:22949821 PMID:22978106 PMID:23497375 PMID:23542114 PMID:23832679 More... NCBI chr 3:29,676,040...29,721,613
Ensembl chr 3:29,676,171...29,721,613 		JBrowse link
G Notch2 notch receptor 2 multiple interactions ISO [Arsenic Trioxide co-treated with Homoharringtonine] results in decreased expression of NOTCH2 protein CTD PMID:31307525 NCBI chr 2:188,299,336...188,432,823
Ensembl chr 2:188,299,336...188,432,823 		JBrowse link
G Nova1 NOVA alternative splicing regulator 1 decreases expression ISO Arsenic Trioxide results in decreased expression of NOVA1 mRNA CTD PMID:20458559 NCBI chr 6:69,506,983...69,632,437
Ensembl chr 6:69,506,983...69,632,437 		JBrowse link
G Nox1 NADPH oxidase 1 multiple interactions
increases expression
increases activity 		ISO
EXP 		[ruxolitinib co-treated with Arsenic Trioxide] results in increased expression of NOX1 mRNA
Arsenic Trioxide results in increased expression of NOX1 protein
Arsenic Trioxide results in increased activity of NOX1 protein
dapagliflozin inhibits the reaction [Arsenic Trioxide results in increased activity of NOX1 protein]; Febuxostat inhibits the reaction [Arsenic Trioxide results in increased expression of NOX1 protein]; Nicorandil inhibits the reaction [Arsenic Trioxide results in increased expression of NOX1 protein] 		CTD PMID:30012499 PMID:37689273 PMID:38070468 PMID:38741475 NCBI chr  X:101,572,338...101,625,571
Ensembl chr  X:101,572,340...101,595,520 		JBrowse link
G Nox4 NADPH oxidase 4 multiple interactions ISO Arsenic Trioxide inhibits the reaction [TGFB1 protein results in increased expression of NOX4 mRNA] CTD PMID:24762191 NCBI chr 1:150,313,736...150,491,480
Ensembl chr 1:150,313,728...150,491,483 		JBrowse link
G Np4 defensin NP-4 precursor multiple interactions
increases expression 		ISO [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of DEFA4 mRNA
Arsenic Trioxide results in increased expression of DEFA4 mRNA 		CTD PMID:15070760 PMID:15761015 PMID:15894607 NCBI chr16:77,197,061...77,199,713
Ensembl chr16:77,121,639...77,122,502
Ensembl chr16:77,121,639...77,122,502 		JBrowse link
G Npas1 neuronal PAS domain protein 1 increases expression ISO Arsenic Trioxide results in increased expression of NPAS1 mRNA CTD PMID:15761015 NCBI chr 1:86,295,509...86,316,018
Ensembl chr 1:86,295,515...86,314,893 		JBrowse link
G Npc1 NPC intracellular cholesterol transporter 1 decreases expression ISO Arsenic Trioxide results in decreased expression of NPC1 protein CTD PMID:25419056 NCBI chr18:3,654,237...3,699,853
Ensembl chr18:3,654,237...3,699,800 		JBrowse link
G Nphp4 nephrocystin 4 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to NPHP4 protein] CTD PMID:26598702 NCBI chr 5:168,270,522...168,356,393
Ensembl chr 5:168,271,073...168,358,242 		JBrowse link
G Nphs2 NPHS2 stomatin family member, podocin increases expression ISO Arsenic Trioxide results in increased expression of NPHS2 mRNA CTD PMID:20458559 NCBI chr13:70,993,622...71,011,585
Ensembl chr13:70,999,186...71,011,572 		JBrowse link
G Nploc4 NPL4 homolog, ubiquitin recognition factor multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to NPLOC4 protein] CTD PMID:26598702 NCBI chr10:106,152,756...106,208,306
Ensembl chr10:106,153,173...106,208,264 		JBrowse link
G Npm1 nucleophosmin 1 increases expression
increases response to substance
multiple interactions
affects response to substance 		ISO Arsenic Trioxide results in increased expression of NPM1 mRNA
NPM1 protein mutant form results in increased susceptibility to Arsenic Trioxide
Acetylcysteine inhibits the reaction [NPM1 protein mutant form results in increased susceptibility to Arsenic Trioxide]
NPM1 protein affects the susceptibility to Arsenic Trioxide 		CTD PMID:20458559 PMID:22521957 PMID:23877794 NCBI chr10:18,245,739...18,255,913
Ensembl chr10:18,245,740...18,256,024
Ensembl chr  X:18,245,740...18,256,024 		JBrowse link
G Npr3 natriuretic peptide receptor 3 decreases expression ISO Arsenic Trioxide results in decreased expression of NPR3 mRNA CTD PMID:35676786 NCBI chr 2:62,592,557...62,660,497
Ensembl chr 2:62,597,668...62,660,066 		JBrowse link
G Nptn neuroplastin increases expression ISO Arsenic Trioxide results in increased expression of NPTN protein CTD PMID:25419056 NCBI chr 8:67,892,678...67,959,231
Ensembl chr 8:67,892,702...67,959,236 		JBrowse link
G Nptx2 neuronal pentraxin 2 decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of NPTX2 mRNA
Arsenic Trioxide results in increased expression of NPTX2 mRNA 		CTD PMID:15761015 PMID:26705709 NCBI chr12:15,151,136...15,162,045
Ensembl chr12:15,151,136...15,162,045 		JBrowse link
G Npy neuropeptide Y increases expression ISO Arsenic Trioxide results in increased expression of NPY mRNA CTD PMID:11027660 NCBI chr 4:80,212,111...80,219,310
Ensembl chr 4:80,212,111...80,219,310 		JBrowse link
G Npy1r neuropeptide Y receptor Y1 decreases expression ISO Arsenic Trioxide results in decreased expression of NPY1R mRNA CTD PMID:39716349 NCBI chr16:27,804,416...27,814,070
Ensembl chr16:27,804,416...27,813,387 		JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 increases expression
multiple interactions
decreases expression
decreases response to substance 		ISO
EXP 		Arsenic Trioxide results in increased expression of NQO1 mRNA; Arsenic Trioxide results in increased expression of NQO1 protein
[Arsenic Trioxide results in decreased expression of MEG3 protein] promotes the reaction [NQO1 protein binds to FSCN1 protein]; [Arsenic Trioxide results in decreased expression of MEG3 protein] which results in increased expression of NQO1 protein; [Arsenic Trioxide results in increased abundance of Arsenic] which results in increased expression of NQO1 mRNA; [Arsenic Trioxide results in increased abundance of Arsenic] which results in increased expression of NQO1 protein; [Resveratrol co-treated with Arsenic Trioxide] results in increased expression of NQO1 protein; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of NQO1 protein]; allicin inhibits the reaction [Arsenic Trioxide results in decreased expression of NQO1 protein]; Arsenic Trioxide promotes the reaction [FSCN1 protein binds to NQO1 protein]; MEG3 inhibits the reaction [Arsenic Trioxide results in increased expression of NQO1 protein]; MIR155 mRNA inhibits the reaction [Arsenic Trioxide results in decreased expression of NQO1 protein]; NFE2L2 protein promotes the reaction [Arsenic Trioxide results in increased expression of NQO1 protein]; NQO1 promotes the reaction [Arsenic Trioxide results in increased expression of FSCN1 protein]; Tretinoin inhibits the reaction [Arsenic Trioxide results in increased expression of NQO1 protein]
Arsenic Trioxide results in decreased expression of NQO1 mRNA
[Arsenic Trioxide co-treated with Grape Seed Proanthocyanidins] results in increased expression of NQO1 mRNA; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of NQO1 mRNA]; AHR protein promotes the reaction [Arsenic Trioxide results in increased expression of NQO1 protein]; Arsenic Trioxide promotes the reaction [Lutein results in increased expression of NQO1 mRNA]; Arsenic Trioxide promotes the reaction [Lutein results in increased expression of NQO1 protein]; Arsenic Trioxide promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of NQO1 protein]; Arsenic Trioxide promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA]; Arsenic Trioxide results in increased expression of and results in increased activity of NQO1 protein; Buthionine Sulfoximine promotes the reaction [Arsenic Trioxide promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA]]; Lutein promotes the reaction [Arsenic Trioxide results in increased expression of NQO1 mRNA]; Lutein promotes the reaction [Arsenic Trioxide results in increased expression of NQO1 protein]; NFE2L2 protein affects the reaction [Arsenic Trioxide results in increased expression of NQO1 mRNA]; NFE2L2 protein promotes the reaction [Arsenic Trioxide results in increased expression of NQO1 protein]; Tetrachlorodibenzodioxin promotes the reaction [Arsenic Trioxide results in increased expression of and results in increased activity of NQO1 protein]; Tetrachlorodibenzodioxin promotes the reaction [Arsenic Trioxide results in increased expression of NQO1 mRNA]
NQO1 protein results in decreased susceptibility to Arsenic Trioxide
crocin inhibits the reaction [Arsenic Trioxide results in decreased expression of NQO1 protein] 		CTD PMID:16274885 PMID:19417148 PMID:20707922 PMID:21533816 PMID:22155346 More... NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260 		JBrowse link
G Nqo2 N-ribosyldihydronicotinamide:quinone dehydrogenase 2 increases expression ISO Arsenic Trioxide results in increased expression of NQO2 mRNA CTD PMID:21461292 NCBI chr17:31,114,825...31,144,062
Ensembl chr17:31,114,529...31,143,662 		JBrowse link
G Nr1h2 nuclear receptor subfamily 1, group H, member 2 decreases expression
increases expression
multiple interactions 		ISO
EXP 		Arsenic Trioxide results in decreased expression of NR1H2 mRNA; Arsenic Trioxide results in decreased expression of NR1H2 protein
Arsenic Trioxide results in increased expression of NR1H2 mRNA
Cholesterol, Dietary promotes the reaction [Arsenic Trioxide results in decreased expression of NR1H2 protein] 		CTD PMID:15073043 PMID:21851829 PMID:27622732 NCBI chr 1:104,178,483...104,183,863
Ensembl chr 1:104,178,234...104,183,863 		JBrowse link
G Nr2f2 nuclear receptor subfamily 2, group F, member 2 decreases expression ISO Arsenic Trioxide results in decreased expression of NR2F2 mRNA CTD PMID:20458559 NCBI chr 1:133,419,161...133,434,290
Ensembl chr 1:133,420,227...133,431,975 		JBrowse link
G Nr2f6 nuclear receptor subfamily 2, group F, member 6 decreases expression ISO Arsenic Trioxide results in decreased expression of NR2F6 mRNA CTD PMID:20458559 NCBI chr16:18,080,003...18,087,449
Ensembl chr16:18,080,003...18,087,449 		JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 multiple interactions
decreases expression 		ISO
EXP 		Arsenic Trioxide affects the reaction [NR3C1 protein modified form binds to DAXX protein]; Arsenic Trioxide inhibits the reaction [[DAXX protein binds to NR3C1 protein] which binds to TSC22D3 promoter]; Arsenic Trioxide results in decreased expression of and results in increased degradation of NR3C1 protein; Diosgenin inhibits the reaction [Arsenic Trioxide results in decreased expression of NR3C1 protein]; NR3C1 promotes the reaction [Diosgenin inhibits the reaction [Arsenic Trioxide results in decreased expression of CDH5 protein]]; NR3C1 promotes the reaction [Diosgenin inhibits the reaction [Arsenic Trioxide results in decreased expression of PECAM1 protein]]; NR3C1 promotes the reaction [Diosgenin inhibits the reaction [Arsenic Trioxide results in increased expression of ACTA2 protein]]; NR3C1 promotes the reaction [Diosgenin inhibits the reaction [Arsenic Trioxide results in increased expression of TAGLN protein]]
Diosgenin inhibits the reaction [Arsenic Trioxide results in decreased expression of and results in increased degradation of NR3C1 protein]; NR3C1 promotes the reaction [Diosgenin inhibits the reaction [Arsenic Trioxide results in increased expression of and results in increased secretion of IL6 protein]] 		CTD PMID:17081986 PMID:39059093 NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,522,783...31,643,843 		JBrowse link
G Nr4a1 nuclear receptor subfamily 4, group A, member 1 decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of NR4A1 mRNA
Arsenic Trioxide results in increased expression of NR4A1 mRNA 		CTD PMID:20458559 PMID:37969188 NCBI chr 7:134,247,153...134,268,044
Ensembl chr 7:134,247,192...134,268,041 		JBrowse link
G Nr4a2 nuclear receptor subfamily 4, group A, member 2 decreases expression ISO Arsenic Trioxide results in decreased expression of NR4A2 mRNA CTD PMID:26705709 NCBI chr 3:62,098,739...62,115,926
Ensembl chr 3:62,098,743...62,106,769 		JBrowse link
G Nr4a3 nuclear receptor subfamily 4, group A, member 3 increases expression ISO Arsenic Trioxide results in increased expression of NR4A3 mRNA CTD PMID:35676786 NCBI chr 5:67,157,141...67,198,287
Ensembl chr 5:67,157,375...67,198,285 		JBrowse link
G Nrep neuronal regeneration related protein decreases expression ISO Arsenic Trioxide results in decreased expression of NREP mRNA CTD PMID:15725085 NCBI chr18:25,291,219...25,320,742
Ensembl chr18:25,291,219...25,320,742 		JBrowse link
G Nrf1 nuclear respiratory factor 1 affects methylation ISO Arsenic Trioxide affects the methylation of NRF1 promoter CTD PMID:26046465 NCBI chr 4:59,632,366...59,738,166
Ensembl chr 4:59,632,372...59,738,353 		JBrowse link
G Nrg1 neuregulin 1 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of NRG1 mRNA
Arsenic Trioxide results in decreased expression of NRG1 mRNA 		CTD PMID:22521957 PMID:35676786 NCBI chr16:65,954,084...67,007,484
Ensembl chr16:65,953,865...66,999,849 		JBrowse link
G Nrg3 neuregulin 3 increases expression ISO Arsenic Trioxide results in increased expression of NRG3 mRNA CTD PMID:20458559 NCBI chr16:14,256,540...15,374,107
Ensembl chr16:14,257,148...15,374,147 		JBrowse link
G Nrip3 nuclear receptor interacting protein 3 increases expression ISO Arsenic Trioxide results in increased expression of NRIP3 mRNA CTD PMID:20458559 NCBI chr 1:173,224,532...173,249,829
Ensembl chr 1:173,224,532...173,251,769 		JBrowse link
G Nrtn neurturin decreases expression ISO Arsenic Trioxide results in decreased expression of NRTN mRNA CTD PMID:26705709 NCBI chr 9:1,669,099...1,674,957
Ensembl chr 9:1,641,618...1,675,133 		JBrowse link
G Nrxn3 neurexin 3 decreases expression ISO Arsenic Trioxide results in decreased expression of NRXN3 mRNA CTD PMID:26705709 NCBI chr 6:113,372,667...115,004,073
Ensembl chr 6:113,443,524...115,002,540 		JBrowse link
G Nsa2 NSA2 ribosome biogenesis factor increases expression ISO Arsenic Trioxide results in increased expression of NSA2 mRNA CTD PMID:20458559 NCBI chr 2:30,177,753...30,184,004
Ensembl chr 2:30,177,702...30,184,031 		JBrowse link
G Nsd2 nuclear receptor binding SET domain protein 2 increases expression ISO Arsenic Trioxide results in increased expression of NSD2 mRNA CTD PMID:20458559 NCBI chr14:81,057,727...81,135,866
Ensembl chr14:81,057,727...81,123,027 		JBrowse link
G Nsd3 nuclear receptor binding SET domain protein 3 decreases expression ISO Arsenic Trioxide results in decreased expression of NSD3 mRNA CTD PMID:22521957 NCBI chr16:73,056,748...73,170,082
Ensembl chr16:73,061,694...73,168,130 		JBrowse link
G Nsdhl NAD(P) dependent 3-beta-hydroxysteroid dehydrogenase NSDHL multiple interactions
decreases expression 		ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to NSDHL protein]
Arsenic Trioxide results in decreased expression of NSDHL protein 		CTD PMID:25419056 PMID:26598702 NCBI chr  X:155,817,301...155,848,224
Ensembl chr  X:155,817,340...155,848,220 		JBrowse link
G Nsl1 NSL1 component of MIS12 kinetochore complex increases expression ISO Arsenic Trioxide results in increased expression of NSL1 mRNA CTD PMID:22521957 NCBI chr13:105,176,163...105,205,179
Ensembl chr13:105,180,183...105,196,117 		JBrowse link
G Nt5c 5', 3'-nucleotidase, cytosolic decreases expression ISO Arsenic Trioxide results in decreased expression of NT5C mRNA CTD PMID:21461292 NCBI chr10:101,238,552...101,240,666
Ensembl chr10:101,238,576...101,240,865 		JBrowse link
G Nt5e 5' nucleotidase, ecto decreases expression ISO Arsenic Trioxide results in decreased expression of NT5E mRNA CTD PMID:22521957 NCBI chr 8:98,150,925...98,195,646
Ensembl chr 8:98,150,900...98,195,645 		JBrowse link
G Ntaq1 N-terminal glutamine amidase 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to NTAQ1 protein] CTD PMID:26598702 NCBI chr 7:91,573,816...91,593,980
Ensembl chr 7:91,553,676...91,626,071 		JBrowse link
G Nthl1 nth-like DNA glycosylase 1 increases expression ISO Arsenic Trioxide results in increased expression of NTHL1 mRNA CTD PMID:35676786 NCBI chr10:14,160,334...14,166,502
Ensembl chr10:14,160,330...14,166,966 		JBrowse link
G Ntrk1 neurotrophic receptor tyrosine kinase 1 decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of NTRK1
Arsenic Trioxide results in increased expression of NTRK1 mRNA; Arsenic Trioxide results in increased expression of NTRK1 protein 		CTD PMID:16569477 PMID:29898774 NCBI chr 2:175,534,844...175,551,664
Ensembl chr 2:175,534,844...175,551,787 		JBrowse link
G Ntrk2 neurotrophic receptor tyrosine kinase 2 increases sumoylation
decreases expression
multiple interactions
increases expression 		ISO Arsenic Trioxide results in increased sumoylation of NTRK2 protein
Arsenic Trioxide results in decreased expression of NTRK2 mRNA; Arsenic Trioxide results in decreased expression of NTRK2 protein
Arsenic Trioxide promotes the reaction [Reserpine results in decreased expression of NTRK2 protein]
Arsenic Trioxide results in increased expression of NTRK2 mRNA; Arsenic Trioxide results in increased expression of NTRK2 protein 		CTD PMID:16569477 PMID:16711005 PMID:26114099 PMID:26705709 PMID:28318385 More... NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,564,570...5,874,628 		JBrowse link
G Ntrk3 neurotrophic receptor tyrosine kinase 3 increases expression ISO Arsenic Trioxide results in increased expression of NTRK3 mRNA; Arsenic Trioxide results in increased expression of NTRK3 protein CTD PMID:29898774 NCBI chr 1:141,526,192...141,913,575
Ensembl chr 1:141,542,569...141,913,004 		JBrowse link
G Nts neurotensin decreases expression ISO Arsenic Trioxide results in decreased expression of NTS mRNA CTD PMID:26705709 NCBI chr 7:39,451,484...39,460,888
Ensembl chr 7:39,451,073...39,460,961 		JBrowse link
G Ntsr1 neurotensin receptor 1 decreases expression ISO Arsenic Trioxide results in decreased expression of NTSR1 mRNA CTD PMID:25258189 NCBI chr 3:187,983,778...188,033,934
Ensembl chr 3:187,983,778...188,033,934 		JBrowse link
G Nuak1 NUAK family kinase 1 decreases expression ISO Arsenic Trioxide results in decreased expression of NUAK1 mRNA CTD PMID:20458559 NCBI chr 7:21,217,729...21,289,608
Ensembl chr 7:21,217,681...21,289,354 		JBrowse link
G Nuak2 NUAK family kinase 2 increases expression ISO Arsenic Trioxide results in increased expression of NUAK2 mRNA CTD PMID:20458559 NCBI chr13:46,305,744...46,322,755
Ensembl chr13:46,305,975...46,322,748 		JBrowse link
G Nubp1 NUBP iron-sulfur cluster assembly factor 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to NUBP1 protein] CTD PMID:26598702 NCBI chr10:5,766,157...5,777,648
Ensembl chr10:5,766,157...5,786,422 		JBrowse link
G Nubpl NUBP iron-sulfur cluster assembly factor, mitochondrial decreases expression ISO Arsenic Trioxide results in decreased expression of NUBPL mRNA CTD PMID:39716349 NCBI chr 6:75,294,609...75,516,603
Ensembl chr 6:75,294,632...75,516,601 		JBrowse link
G Nucb2 nucleobindin 2 decreases expression ISO Arsenic Trioxide results in decreased expression of NUCB2 mRNA CTD PMID:17547211 NCBI chr 1:180,185,121...180,221,644
Ensembl chr 1:180,199,551...180,230,116 		JBrowse link
G Nudt12 nudix hydrolase 12 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to NUDT12 protein] CTD PMID:26598702 NCBI chr 9:106,188,930...106,202,340
Ensembl chr 9:106,189,661...106,202,340 		JBrowse link
G Nudt16l2 nudix hydrolase 16 like 2 decreases expression ISO Arsenic Trioxide results in decreased expression of NUDT16L2P mRNA CTD PMID:39716349 NCBI chr 8:114,633,615...114,635,346
Ensembl chr 8:114,632,701...114,635,296 		JBrowse link
G Nudt18 nudix hydrolase 18 increases expression ISO Arsenic Trioxide results in increased expression of NUDT18 mRNA CTD PMID:15761015 NCBI chr15:52,060,297...52,062,822
Ensembl chr15:52,060,293...52,063,661 		JBrowse link
G Nudt4 nudix hydrolase 4 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to NUDT4 protein] CTD PMID:26598702 NCBI chr 7:32,074,978...32,091,491
Ensembl chr 7:32,075,002...32,091,491 		JBrowse link
G Nudt7 nudix hydrolase 7 decreases expression ISO Arsenic Trioxide results in decreased expression of NUDT7 mRNA CTD PMID:27829220 NCBI chr19:59,034,808...59,049,148
Ensembl chr19:59,034,839...59,063,994 		JBrowse link
G Numa1 nuclear mitotic apparatus protein 1 increases expression ISO Arsenic Trioxide results in increased expression of NUMA1 protein CTD PMID:25419056 NCBI chr 1:165,709,893...165,784,848
Ensembl chr 1:165,709,905...165,784,848 		JBrowse link
G Numb NUMB, endocytic adaptor protein decreases expression ISO Arsenic Trioxide results in decreased expression of NUMB mRNA CTD PMID:19128835 NCBI chr 6:109,162,499...109,284,527
Ensembl chr 6:109,162,499...109,284,463 		JBrowse link
G Nup107 nucleoporin 107 increases expression ISO Arsenic Trioxide results in increased expression of NUP107 mRNA CTD PMID:17547211 NCBI chr 7:55,239,610...55,285,050
Ensembl chr 7:55,239,613...55,285,234 		JBrowse link
G Nup153 nucleoporin 153 decreases expression ISO Arsenic Trioxide results in decreased expression of NUP153 mRNA CTD PMID:21461292 NCBI chr17:18,178,434...18,231,109
Ensembl chr17:18,178,456...18,231,109 		JBrowse link
G Nup37 nucleoporin 37 decreases response to substance ISO NUP37 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 7:24,443,998...24,497,088
Ensembl chr 7:24,463,301...24,508,741 		JBrowse link
G Nupr1 nuclear protein 1, transcriptional regulator increases expression ISO Arsenic Trioxide results in increased expression of NUPR1 mRNA CTD PMID:19128835 NCBI chr 1:190,643,866...190,645,901
Ensembl chr 1:190,643,867...190,645,901 		JBrowse link
G Nusap1 nucleolar and spindle associated protein 1 increases expression ISO Arsenic Trioxide results in increased expression of NUSAP1 mRNA CTD PMID:20458559 NCBI chr 3:127,057,220...127,092,779
Ensembl chr 3:127,057,265...127,087,237 		JBrowse link
G Nvl nuclear VCP-like increases expression ISO Arsenic Trioxide results in increased expression of NVL mRNA CTD PMID:39716349 NCBI chr13:95,385,389...95,438,490
Ensembl chr13:95,372,641...95,442,291 		JBrowse link
G Nxph2 neurexophilin 2 decreases expression ISO Arsenic Trioxide results in decreased expression of NXPH2 mRNA CTD PMID:26705709 NCBI chr 3:26,373,858...26,392,392
Ensembl chr 3:26,153,756...26,391,876 		JBrowse link
G Obp2b odorant binding protein 2B decreases expression ISO Arsenic Trioxide results in decreased expression of OBP2B mRNA CTD PMID:25258189 NCBI chr 3:28,960,375...28,983,394
Ensembl chr 3:28,980,186...28,983,370 		JBrowse link
G Obsl1 obscurin like cytoskeletal adaptor 1 increases expression ISO Arsenic Trioxide results in increased expression of OBSL1 mRNA CTD PMID:15761015 NCBI chr 9:84,416,447...84,442,415
Ensembl chr 9:84,416,240...84,442,415 		JBrowse link
G Oc90 otoconin 90 decreases expression ISO Arsenic Trioxide results in decreased expression of OC90 mRNA CTD PMID:39716349 NCBI chr 7:99,524,975...99,558,386
Ensembl chr 7:99,524,975...99,558,386 		JBrowse link
G Ocln occludin decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of OCLN mRNA; Arsenic Trioxide results in decreased expression of OCLN protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in decreased expression of OCLN protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of OCLN mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of OCLN protein]; Resveratrol inhibits the reaction [Arsenic Trioxide results in decreased expression of OCLN protein]; SB 203580 inhibits the reaction [Arsenic Trioxide results in decreased expression of OCLN protein]
[Arsenic Trioxide results in increased abundance of arsenite] which results in decreased expression of OCLN mRNA; Butyrates inhibits the reaction [Arsenic Trioxide results in decreased expression of OCLN protein]; MIR122 mRNA affects the reaction [Butyrates inhibits the reaction [Arsenic Trioxide results in decreased expression of OCLN protein]] 		CTD PMID:30032600 PMID:30225639 PMID:32683294 PMID:36473683 PMID:36791901 NCBI chr 2:33,391,303...33,442,207
Ensembl chr 2:33,391,303...33,430,411 		JBrowse link
G Odc1 ornithine decarboxylase 1 multiple interactions ISO
EXP 		Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ODC1 protein]
Arsenic Trioxide promotes the reaction [Berberine results in decreased expression of ODC1 protein] 		CTD PMID:18294404 PMID:26598702 NCBI chr 6:46,058,439...46,065,148
Ensembl chr 6:46,058,463...46,065,146 		JBrowse link
G Ogfod1 2-oxoglutarate and iron-dependent oxygenase domain containing 1 decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of OGFOD1 mRNA
[Arsenic Trioxide co-treated with Ascorbic Acid] results in decreased expression of OGFOD1 mRNA 		CTD PMID:25555879 NCBI chr19:10,950,950...10,980,519
Ensembl chr19:10,950,060...10,980,519 		JBrowse link
G Ogg1 8-oxoguanine DNA glycosylase affects activity
decreases expression 		ISO OGG1 protein affects the activity of Arsenic Trioxide
Arsenic Trioxide results in decreased expression of OGG1 mRNA 		CTD PMID:17101720 PMID:20458559 NCBI chr 4:148,030,237...148,037,599
Ensembl chr 4:148,030,349...148,037,604 		JBrowse link
G Ogn osteoglycin decreases expression ISO Arsenic Trioxide results in decreased expression of OGN mRNA CTD PMID:26705709 NCBI chr17:15,238,500...15,259,167
Ensembl chr17:15,238,500...15,259,252 		JBrowse link
G Ogt O-linked N-acetylglucosamine (GlcNAc) transferase increases response to substance ISO OGT protein results in increased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr  X:70,811,317...70,856,123
Ensembl chr  X:70,811,319...70,856,123 		JBrowse link
G Olfm1 olfactomedin 1 decreases expression ISO Arsenic Trioxide results in decreased expression of OLFM1 mRNA CTD PMID:35676786 NCBI chr 3:31,918,512...31,956,261
Ensembl chr 3:31,918,573...31,956,260 		JBrowse link
G Olfml2a olfactomedin-like 2A increases expression ISO Arsenic Trioxide results in increased expression of OLFML2A mRNA CTD PMID:20458559 NCBI chr 3:43,098,299...43,127,621
Ensembl chr 3:43,098,299...43,127,621 		JBrowse link
G Olfml3 olfactomedin-like 3 decreases expression ISO Arsenic Trioxide results in decreased expression of OLFML3 mRNA CTD PMID:20458559 PMID:22521957 NCBI chr 2:193,932,665...193,935,494
Ensembl chr 2:193,932,665...193,935,494 		JBrowse link
G Olig2 oligodendrocyte transcription factor 2 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to OLIG2 protein] CTD PMID:26598702 NCBI chr11:43,961,585...43,964,961
Ensembl chr11:43,958,940...43,968,634 		JBrowse link
G Olr1 oxidized low density lipoprotein receptor 1 decreases expression ISO Arsenic Trioxide results in decreased expression of OLR1 mRNA CTD PMID:19128835 NCBI chr 4:164,612,460...164,635,082
Ensembl chr 4:164,612,463...164,634,598 		JBrowse link
G Onecut2 one cut homeobox 2 multiple interactions ISO [Arsenic Trioxide co-treated with Tretinoin] results in decreased expression of ONECUT2 mRNA CTD PMID:38179723 NCBI chr18:60,101,967...60,161,095
Ensembl chr18:60,102,126...60,107,668 		JBrowse link
G Opa1 OPA1, mitochondrial dynamin like GTPase multiple interactions
increases expression 		ISO
EXP 		salvianolic acid A inhibits the reaction [Arsenic Trioxide results in increased expression of OPA1 protein] CTD PMID:29867492 NCBI chr11:84,612,943...84,690,025
Ensembl chr11:84,615,340...84,689,955 		JBrowse link
G Opalin oligodendrocytic myelin paranodal and inner loop protein increases expression ISO Arsenic Trioxide results in increased expression of OPALIN mRNA CTD PMID:20458559 NCBI chr 1:249,840,539...249,858,423
Ensembl chr 1:249,840,539...249,858,190 		JBrowse link
G Opcml opioid binding protein/cell adhesion molecule-like increases expression ISO Arsenic Trioxide results in increased expression of OPCML mRNA CTD PMID:20458559 NCBI chr 8:34,451,629...35,562,897
Ensembl chr 8:34,451,500...35,558,966 		JBrowse link
G Opn3 opsin 3 increases expression ISO Arsenic Trioxide results in increased expression of OPN3 mRNA CTD PMID:22521957 NCBI chr13:90,121,560...90,152,076
Ensembl chr13:90,121,560...90,152,076 		JBrowse link
G Optn optineurin multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to OPTN protein] CTD PMID:26598702 NCBI chr17:78,118,847...78,169,543
Ensembl chr17:78,118,866...78,169,543 		JBrowse link
G Or10a5 olfactory receptor family 10 subfamily A member 5 increases expression ISO Arsenic Trioxide results in increased expression of OR10A5 mRNA CTD PMID:20458559 NCBI chr 1:170,275,374...170,276,327
Ensembl chr 1:170,275,353...170,276,327 		JBrowse link
G Or51e1 olfactory receptor family 51 subfamily E member 1 decreases expression ISO Arsenic Trioxide results in decreased expression of OR51E1 mRNA CTD PMID:39716349 NCBI chr 1:166,554,112...166,564,147
Ensembl chr 1:166,554,061...166,564,105 		JBrowse link
G Orc4 origin recognition complex, subunit 4 decreases expression ISO Arsenic Trioxide results in decreased expression of ORC4 mRNA CTD PMID:15761015 NCBI chr 3:53,700,046...53,743,293
Ensembl chr 3:53,703,615...53,742,264 		JBrowse link
G Os9 OS9, endoplasmic reticulum lectin decreases expression ISO Arsenic Trioxide results in decreased expression of OS9 mRNA CTD PMID:17547211 NCBI chr 7:64,802,517...64,829,185
Ensembl chr 7:64,802,103...64,829,070 		JBrowse link
G Osbpl6 oxysterol binding protein-like 6 increases expression ISO Arsenic Trioxide results in increased expression of OSBPL6 mRNA CTD PMID:20458559 NCBI chr 3:81,751,020...81,948,186
Ensembl chr 3:81,750,982...81,946,615 		JBrowse link
G Osbpl8 oxysterol binding protein-like 8 increases expression ISO Arsenic Trioxide results in increased expression of OSBPL8 mRNA CTD PMID:20458559 NCBI chr 7:48,483,259...48,636,151
Ensembl chr 7:48,483,022...48,636,151 		JBrowse link
G Osbpl9 oxysterol binding protein-like 9 decreases expression ISO Arsenic Trioxide results in decreased expression of OSBPL9 mRNA CTD PMID:39716349 NCBI chr 5:129,047,776...129,190,838
Ensembl chr 5:129,047,781...129,190,836 		JBrowse link
G Oscar osteoclast associated Ig-like receptor decreases expression ISO Arsenic Trioxide results in decreased expression of OSCAR mRNA CTD PMID:19128835 NCBI chr 1:74,521,626...74,529,119
Ensembl chr 1:74,515,001...74,529,119 		JBrowse link
G Osgepl1 O-sialoglycoprotein endopeptidase-like 1 increases expression ISO Arsenic Trioxide results in increased expression of OSGEPL1 mRNA CTD PMID:20458559 NCBI chr 9:55,707,389...55,725,325
Ensembl chr 9:55,707,392...55,721,346 		JBrowse link
G Ostc oligosaccharyltransferase complex non-catalytic subunit decreases expression ISO Arsenic Trioxide results in decreased expression of OSTC mRNA CTD PMID:20458559 NCBI chr 2:221,924,727...221,940,253
Ensembl chr 2:221,874,948...221,940,267 		JBrowse link
G Ovol2 ovo-like zinc finger 2 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to OVOL2 protein] CTD PMID:26598702 NCBI chr 3:152,130,767...152,160,487
Ensembl chr 3:152,130,767...152,160,487 		JBrowse link
G P2ry1 purinergic receptor P2Y1 decreases expression ISO Arsenic Trioxide results in decreased expression of P2RY1 mRNA CTD PMID:39716349 NCBI chr 2:147,391,661...147,397,870
Ensembl chr 2:147,390,681...147,398,027 		JBrowse link
G P2ry13 purinergic receptor P2Y13 increases expression ISO Arsenic Trioxide results in increased expression of P2RY13 protein CTD PMID:25258189 NCBI chr 2:145,620,321...145,624,730
Ensembl chr 2:145,619,655...145,622,787 		JBrowse link
G P3h2 prolyl 3-hydroxylase 2 decreases expression ISO Arsenic Trioxide results in decreased expression of P3H2 mRNA CTD PMID:39716349 NCBI chr11:88,139,086...88,280,221
Ensembl chr11:88,139,078...88,281,203 		JBrowse link
G P4ha1 prolyl 4-hydroxylase subunit alpha 1 decreases expression ISO Arsenic Trioxide results in decreased expression of P4HA1 mRNA CTD PMID:15725085 NCBI chr20:27,784,696...27,895,785
Ensembl chr20:27,845,141...27,895,404 		JBrowse link
G P4hb prolyl 4-hydroxylase subunit beta increases expression ISO Arsenic Trioxide results in increased expression of P4HB mRNA CTD PMID:20458559 NCBI chr10:106,335,300...106,346,911
Ensembl chr10:106,335,300...106,346,911 		JBrowse link
G P4htm prolyl 4-hydroxylase, transmembrane decreases response to substance ISO P4HTM protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 8:118,153,158...118,172,199
Ensembl chr 8:118,153,158...118,171,002 		JBrowse link
G Pabpc4 poly(A) binding protein, cytoplasmic 4 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PABPC4 protein] CTD PMID:26598702 NCBI chr 5:140,847,835...140,864,089
Ensembl chr 5:140,848,225...140,864,087 		JBrowse link
G Pabpc6 poly(A) binding protein, cytoplasmic 6 increases expression ISO Arsenic Trioxide results in increased expression of PABPC3 mRNA CTD PMID:20458559 NCBI chr 1:53,592,902...53,595,978
Ensembl chr 1:53,592,884...53,595,973 		JBrowse link
G Pacsin2 protein kinase C and casein kinase substrate in neurons 2 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PACSIN2 protein] CTD PMID:26598702 NCBI chr 7:116,385,571...116,478,609
Ensembl chr 7:116,384,190...116,478,537 		JBrowse link
G Padi1 peptidyl arginine deiminase 1 increases expression ISO Arsenic Trioxide results in increased expression of PADI1 mRNA CTD PMID:39716349 NCBI chr 5:158,402,614...158,435,077
Ensembl chr 5:158,402,614...158,435,077 		JBrowse link
G Pafah1b1 platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 increases expression ISO Arsenic Trioxide results in increased expression of PAFAH1B1 protein CTD PMID:25419056 NCBI chr10:60,031,441...60,090,259
Ensembl chr10:60,032,514...60,090,196 		JBrowse link
G Pafah1b3 platelet-activating factor acetylhydrolase 1b, catalytic subunit 3 increases expression ISO Arsenic Trioxide results in increased expression of PAFAH1B3 mRNA CTD PMID:20458559 NCBI chr 1:90,009,085...90,011,611
Ensembl chr 1:90,009,085...90,011,611 		JBrowse link
G Pafah2 platelet-activating factor acetylhydrolase 2 increases expression ISO Arsenic Trioxide results in increased expression of PAFAH2 mRNA CTD PMID:15761015 NCBI chr 5:151,890,751...151,919,896
Ensembl chr 5:151,896,832...151,919,894 		JBrowse link
G Paics phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase increases expression ISO Arsenic Trioxide results in increased expression of PAICS mRNA CTD PMID:20458559 NCBI chr14:31,553,355...31,586,843
Ensembl chr14:31,553,357...31,587,027 		JBrowse link
G Pak2 p21 (RAC1) activated kinase 2 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PAK2 protein] CTD PMID:26598702 NCBI chr11:82,212,896...82,273,803
Ensembl chr11:82,212,951...82,273,803 		JBrowse link
G Pak3 p21 (RAC1) activated kinase 3 multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of PAK3 mRNA CTD PMID:15894607 NCBI chr  X:111,912,967...112,171,037
Ensembl chr  X:111,913,059...112,165,035 		JBrowse link
G Pakap paralemmin A kinase anchor protein decreases expression ISO Arsenic Trioxide results in decreased expression of PALM2AKAP2 mRNA CTD PMID:20458559 NCBI chr 5:76,976,906...77,443,656
Ensembl chr 5:76,977,112...77,443,656 		JBrowse link
G Palld palladin, cytoskeletal associated protein decreases expression ISO Arsenic Trioxide results in decreased expression of PALLD mRNA CTD PMID:39716349 NCBI chr16:33,238,943...33,632,236
Ensembl chr16:33,238,956...33,632,232 		JBrowse link
G Pals1 protein associated with LIN7 1, MAGUK p55 family member increases expression ISO Arsenic Trioxide results in increased expression of PALS1 mRNA CTD PMID:20458559 NCBI chr 6:103,327,965...103,384,543
Ensembl chr 6:103,281,154...103,387,209 		JBrowse link
G Pan2 poly(A) specific ribonuclease subunit PAN2 decreases expression ISO Arsenic Trioxide results in decreased expression of PAN2 mRNA CTD PMID:27829220 NCBI chr 7:1,313,654...1,332,252
Ensembl chr 7:1,313,655...1,332,252 		JBrowse link
G Pank2 pantothenate kinase 2 increases expression ISO Arsenic Trioxide results in increased expression of PANK2 mRNA CTD PMID:39716349 NCBI chr 3:138,936,448...138,974,196
Ensembl chr 3:138,936,452...138,974,194 		JBrowse link
G Panx2 pannexin 2 decreases expression ISO Arsenic Trioxide results in decreased expression of PANX2 mRNA CTD PMID:20458559 NCBI chr 7:122,018,937...122,032,009
Ensembl chr 7:122,018,937...122,032,004 		JBrowse link
G Paox polyamine oxidase increases expression ISO Arsenic Trioxide results in increased expression of PAOX mRNA CTD PMID:15761015 NCBI chr 1:204,349,326...204,358,140
Ensembl chr 1:204,348,987...204,358,481 		JBrowse link
G Pappa pappalysin 1 decreases expression ISO Arsenic Trioxide results in decreased expression of PAPPA mRNA CTD PMID:22521957 NCBI chr 5:83,513,358...83,751,364
Ensembl chr 5:83,513,358...83,751,361 		JBrowse link
G Pappa2 pappalysin 2 decreases expression ISO Arsenic Trioxide results in decreased expression of PAPPA2 mRNA CTD PMID:35676786 NCBI chr13:73,407,385...73,683,699
Ensembl chr13:73,407,385...73,681,568 		JBrowse link
G Papss1 3'-phosphoadenosine 5'-phosphosulfate synthase 1 multiple interactions
decreases expression 		ISO [Arsenic Trioxide co-treated with Ascorbic Acid] results in decreased expression of PAPSS1 mRNA
Arsenic Trioxide results in decreased expression of PAPSS1 mRNA 		CTD PMID:25555879 NCBI chr 2:222,646,103...222,788,475
Ensembl chr 2:222,714,487...222,788,670 		JBrowse link
G Papss2 3'-phosphoadenosine 5'-phosphosulfate synthase 2 increases expression ISO Arsenic Trioxide results in increased expression of PAPSS2 mRNA CTD PMID:22521957 NCBI chr 1:239,867,597...239,952,614
Ensembl chr 1:239,867,574...239,952,616 		JBrowse link
G Paqr6 progestin and adipoQ receptor family member 6 decreases expression ISO Arsenic Trioxide results in decreased expression of PAQR6 mRNA CTD PMID:15725085 NCBI chr 2:176,131,345...176,136,266
Ensembl chr 2:176,131,859...176,136,265 		JBrowse link
G Pard3 par-3 family cell polarity regulator decreases expression ISO Arsenic Trioxide results in decreased expression of PARD3 mRNA alternative form CTD PMID:35676786 NCBI chr19:71,977,420...72,527,273
Ensembl chr19:71,977,470...72,526,941 		JBrowse link
G Parn poly(A)-specific ribonuclease increases expression ISO Arsenic Trioxide results in increased expression of PARN mRNA CTD PMID:25258189 NCBI chr10:1,917,830...2,055,749
Ensembl chr10:1,917,830...2,055,722 		JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 increases expression
multiple interactions
increases degradation
decreases expression
increases activity
increases cleavage
affects localization 		ISO
EXP 		Arsenic Trioxide results in increased expression of PARP1 protein; Arsenic Trioxide results in increased expression of PARP1 protein modified form
17-(dimethylaminoethylamino)-17-demethoxygeldanamycin promotes the reaction [Arsenic Trioxide results in increased cleavage of PARP1 protein]; 3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone inhibits the reaction [[Arsenic Trioxide co-treated with phytosphingosine] results in increased activity of PARP1 protein]; 6-Aminonicotinamide inhibits the reaction [Arsenic Trioxide results in increased cleavage of PARP1 protein]; [Arsenic Trioxide co-treated with apatinib] results in increased cleavage of PARP1 protein; [Arsenic Trioxide co-treated with Bortezomib] results in increased degradation of PARP1 protein; [Arsenic Trioxide co-treated with Ethacrynic Acid] results in increased cleavage of PARP1 protein; [Arsenic Trioxide co-treated with IL24 protein] results in decreased expression of PARP1; [Arsenic Trioxide co-treated with MIR15A co-treated with MIR16-1] results in increased cleavage of PARP1 protein; [Arsenic Trioxide co-treated with PD 173074] results in increased expression of PARP1 protein modified form; [Arsenic Trioxide co-treated with phytosphingosine] results in increased activity of PARP1 protein; [Arsenic Trioxide co-treated with phytosphingosine] results in increased cleavage of PARP1 protein; [Arsenic Trioxide co-treated with Plant Extracts] results in increased cleavage of PARP1 protein; [Arsenic Trioxide results in increased susceptibility to PD 173074] which results in increased expression of PARP1 protein modified form; [Dasatinib co-treated with Arsenic Trioxide] results in increased cleavage of PARP1 protein; [Genistein co-treated with Arsenic Trioxide] results in increased cleavage of PARP1 protein; [MARVELD1 protein results in decreased susceptibility to Arsenic Trioxide] which results in decreased cleavage of PARP1 protein; [monomethylarsonous acid co-treated with dimethylarsinous acid co-treated with Arsenic Trioxide] results in increased cleavage of PARP1 protein; [PD 173074 results in increased susceptibility to Arsenic Trioxide] which results in increased expression of PARP1 protein modified form; [pifithrin co-treated with Arsenic Trioxide] results in decreased expression of PARP1 protein; [pifithrin co-treated with Arsenic Trioxide] results in increased cleavage of PARP1 protein; [sulforaphane co-treated with Arsenic Trioxide] results in increased cleavage of PARP1 protein; [Sulindac co-treated with Arsenic Trioxide] results in increased cleavage of PARP1 protein; Acetylcysteine inhibits the reaction [[Arsenic Trioxide co-treated with Ethacrynic Acid] results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [[Arsenic Trioxide co-treated with phytosphingosine] results in increased activity of PARP1 protein]; Acetylcysteine inhibits the reaction [[monomethylarsonous acid co-treated with dimethylarsinous acid co-treated with Arsenic Trioxide] results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [[sulforaphane co-treated with Arsenic Trioxide] results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [[Sulindac co-treated with Arsenic Trioxide] results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [Cisplatin results in increased cleavage of PARP1 protein]]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of PARP1 protein]; Acetylcysteine inhibits the reaction [Cisplatin promotes the reaction [Arsenic Trioxide results in increased cleavage of PARP1 protein]]; Arsenic Trioxide promotes the reaction [Chloroquine results in increased cleavage of PARP1 protein]; Arsenic Trioxide promotes the reaction [Cisplatin results in increased cleavage of PARP1 protein]; Arsenic Trioxide promotes the reaction [Curcumin results in increased expression of PARP1 protein modified form]; Arsenic Trioxide promotes the reaction [Dasatinib results in increased cleavage of PARP1 protein]; Arsenic Trioxide promotes the reaction [Matrines results in increased cleavage of PARP1 protein]; Arsenic Trioxide promotes the reaction [pralsetinib results in increased cleavage of PARP1 protein]; Arsenic Trioxide promotes the reaction [Zoledronic Acid results in increased cleavage of PARP1 protein]; Arsenic Trioxide results in increased cleavage of and results in increased activity of PARP1 protein; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[Arsenic Trioxide co-treated with Ethacrynic Acid] results in increased cleavage of PARP1 protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[monomethylarsonous acid co-treated with dimethylarsinous acid co-treated with Arsenic Trioxide] results in increased cleavage of PARP1 protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [Arsenic Trioxide results in increased cleavage of PARP1 protein]; Cisplatin promotes the reaction [Arsenic Trioxide results in increased cleavage of PARP1 protein]; Curcumin promotes the reaction [Arsenic Trioxide results in increased expression of PARP1 protein modified form]; Dasatinib promotes the reaction [Arsenic Trioxide results in increased cleavage of PARP1 protein]; Deoxyglucose inhibits the reaction [Arsenic Trioxide results in increased cleavage of PARP1 protein]; Dithiothreitol inhibits the reaction [Arsenic Trioxide results in increased cleavage of PARP1 protein]; GRB10 protein promotes the reaction [[Arsenic Trioxide co-treated with apatinib] results in increased cleavage of PARP1 protein]; GSTP1 mutant form promotes the reaction [[Arsenic Trioxide co-treated with Ethacrynic Acid] results in increased cleavage of PARP1 protein]; HSF1 protein affects the reaction [Arsenic Trioxide results in increased cleavage of PARP1 protein]; KNK 437 promotes the reaction [Arsenic Trioxide results in increased cleavage of PARP1 protein]; MARVELD1 protein inhibits the reaction [Arsenic Trioxide results in increased cleavage of PARP1 protein]; Matrines promotes the reaction [Arsenic Trioxide results in increased cleavage of PARP1 protein]; MCL1 mutant form promotes the reaction [[Arsenic Trioxide co-treated with Ethacrynic Acid] results in increased cleavage of PARP1 protein]; NCF2 mutant form inhibits the reaction [Arsenic Trioxide results in increased cleavage of PARP1 protein]; PRDX3 protein affects the reaction [Arsenic Trioxide results in increased cleavage of and results in increased activity of PARP1 protein]; pyrazolanthrone inhibits the reaction [[Arsenic Trioxide co-treated with Ethacrynic Acid] results in increased cleavage of PARP1 protein]; pyrazolanthrone inhibits the reaction [[Sulindac co-treated with Arsenic Trioxide] results in increased cleavage of PARP1 protein]; pyrazolanthrone inhibits the reaction [Arsenic Trioxide results in increased cleavage of PARP1 protein]; SB 203580 inhibits the reaction [Arsenic Trioxide results in increased cleavage of PARP1 protein]; TGIF1 mutant form promotes the reaction [Arsenic Trioxide results in increased cleavage of PARP1 protein]; TGIF1 protein inhibits the reaction [Arsenic Trioxide results in increased cleavage of PARP1 protein]
Arsenic Trioxide results in increased degradation of PARP1 protein
Arsenic Trioxide results in decreased expression of PARP1 protein
Arsenic Trioxide results in increased activity of PARP1 protein
Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased cleavage of PARP1 protein]; salvianolic acid A inhibits the reaction [Arsenic Trioxide results in increased expression of PARP1 protein]
Arsenic Trioxide affects the localization of PARP1 protein modified form
[Genistein co-treated with Arsenic Trioxide] results in increased cleavage of PARP1 protein; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased activity of PARP1 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased cleavage of PARP1 protein]; Arsenic Trioxide promotes the reaction [Drugs, Chinese Herbal results in increased cleavage of PARP1 protein]; Deoxyglucose promotes the reaction [Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of PARP1 protein modified form]]; Glucose deficiency inhibits the reaction [Arsenic Trioxide results in increased expression of PARP1 protein modified form]; Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of PARP1 protein modified form]; Rotenone inhibits the reaction [Arsenic Trioxide results in increased expression of PARP1 protein modified form] 		CTD PMID:10382944 PMID:10477740 PMID:10648417 PMID:10850458 PMID:11146441 More... NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567 		JBrowse link
G Parp2 poly (ADP-ribose) polymerase 2 increases expression ISO Arsenic Trioxide results in increased expression of PARP2 mRNA CTD PMID:20458559 NCBI chr15:26,494,722...26,517,893
Ensembl chr15:26,494,731...26,517,891 		JBrowse link
G Parp8 poly (ADP-ribose) polymerase family, member 8 increases expression ISO Arsenic Trioxide results in increased expression of PARP8 mRNA CTD PMID:39716349 NCBI chr 2:50,408,404...50,581,513
Ensembl chr 2:50,408,404...50,581,233 		JBrowse link
G Patz1 POZ (BTB) and AT hook containing zinc finger 1 decreases expression ISO Arsenic Trioxide results in decreased expression of PATZ1 mRNA CTD PMID:35676786 NCBI chr14:82,378,226...82,396,679
Ensembl chr14:82,377,697...82,396,686 		JBrowse link
G Pawr pro-apoptotic WT1 regulator increases expression ISO Arsenic Trioxide results in increased expression of PAWR mRNA; Arsenic Trioxide results in increased expression of PAWR protein CTD PMID:16966277 NCBI chr 7:45,531,480...45,611,492
Ensembl chr 7:45,531,637...45,611,492 		JBrowse link
G Pax3 paired box 3 decreases expression ISO Arsenic Trioxide results in decreased expression of PAX3 mRNA CTD PMID:35676786 NCBI chr 9:87,015,960...87,112,531
Ensembl chr 9:87,016,999...87,124,141 		JBrowse link
G Pax5 paired box 5 increases expression ISO Arsenic Trioxide results in increased expression of PAX5 mRNA CTD PMID:20458559 NCBI chr 5:63,554,784...63,741,380
Ensembl chr 5:63,560,722...63,739,987 		JBrowse link
G Pax6 paired box 6 decreases expression ISO Arsenic Trioxide results in decreased expression of PAX6 mRNA CTD PMID:37969188 NCBI chr 3:112,590,034...112,611,771
Ensembl chr 3:112,590,391...112,611,763 		JBrowse link
G Pax9 paired box 9 decreases expression ISO Arsenic Trioxide results in decreased expression of PAX9 mRNA CTD PMID:26705709 NCBI chr 6:79,917,466...79,938,551
Ensembl chr 6:79,921,801...79,938,549 		JBrowse link
G Pbrm1 polybromo 1 decreases expression ISO Arsenic Trioxide results in decreased expression of PBRM1 mRNA CTD PMID:34108876 NCBI chr16:6,219,933...6,319,336
Ensembl chr16:6,219,917...6,319,336 		JBrowse link
G Pbx3 PBX homeobox 3 increases expression ISO Arsenic Trioxide results in increased expression of PBX3 mRNA CTD PMID:39716349 NCBI chr 3:37,886,241...38,079,956
Ensembl chr 3:37,886,687...38,079,895 		JBrowse link
G Pcbd1 pterin-4 alpha-carbinolamine dehydratase 1 decreases response to substance ISO PCBD1 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr20:29,573,362...29,587,181
Ensembl chr20:29,573,423...29,587,180 		JBrowse link
G Pcbp1 poly(rC) binding protein 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PCBP1 protein] CTD PMID:26598702 NCBI chr 4:120,530,100...120,532,107
Ensembl chr 4:120,529,172...120,539,111 		JBrowse link
G Pcbp2 poly(rC) binding protein 2 decreases expression
increases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of PCBP2 protein
Arsenic Trioxide results in increased expression of PCBP2 mRNA
Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PCBP2 protein] 		CTD PMID:20458559 PMID:25419056 PMID:26598702 NCBI chr 7:135,483,702...135,508,254
Ensembl chr 7:135,483,856...135,509,412 		JBrowse link
G Pcca propionyl-CoA carboxylase subunit alpha increases expression ISO Arsenic Trioxide results in increased expression of PCCA mRNA CTD PMID:22521957 NCBI chr15:106,034,586...106,374,908
Ensembl chr15:106,034,610...106,374,908 		JBrowse link
G Pcdh17 protocadherin 17 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PCDH17 protein] CTD PMID:26598702 NCBI chr15:66,631,549...66,725,007
Ensembl chr15:66,633,142...66,722,105 		JBrowse link
G Pcdh19 protocadherin 19 decreases expression ISO Arsenic Trioxide results in decreased expression of PCDH19 mRNA CTD PMID:20458559 NCBI chr  X:101,061,002...101,166,777
Ensembl chr  X:101,065,263...101,165,269 		JBrowse link
G Pcdh20 protocadherin 20 decreases expression ISO Arsenic Trioxide results in decreased expression of PCDH20 mRNA CTD PMID:26705709 NCBI chr15:70,834,042...70,840,298
Ensembl chr15:70,834,042...70,840,298 		JBrowse link
G Pcdhac1 protocadherin alpha subfamily C, 1 increases expression ISO Arsenic Trioxide results in increased expression of PCDHAC1 mRNA CTD PMID:39716349
G Pcf11 PCF11 cleavage and polyadenylation factor subunit increases expression ISO Arsenic Trioxide results in increased expression of PCF11 mRNA CTD PMID:20458559 NCBI chr 1:156,109,724...156,136,950
Ensembl chr 1:156,109,724...156,136,435 		JBrowse link
G Pcgf6 polycomb group ring finger 6 decreases expression ISO Arsenic Trioxide results in decreased expression of PCGF6 mRNA CTD PMID:39716349 NCBI chr 1:255,866,709...255,886,306
Ensembl chr 1:255,866,711...255,886,266 		JBrowse link
G Pck1 phosphoenolpyruvate carboxykinase 1 increases expression
multiple interactions
decreases expression 		ISO Arsenic Trioxide results in increased expression of PCK1 mRNA
Taurine inhibits the reaction [Arsenic Trioxide results in increased expression of PCK1 mRNA]
Arsenic Trioxide results in increased expression of PCK1 protein
Arsenic Trioxide results in decreased expression of PCK1 mRNA 		CTD PMID:30362509 PMID:33634982 PMID:35226250 PMID:39716349 NCBI chr 3:182,348,572...182,354,521
Ensembl chr 3:182,348,572...182,354,561 		JBrowse link
G Pck2 phosphoenolpyruvate carboxykinase 2 (mitochondrial) decreases expression ISO Arsenic Trioxide results in decreased expression of PCK2 protein CTD PMID:19364129 NCBI chr15:32,997,853...33,006,691
Ensembl chr15:32,997,834...33,016,864 		JBrowse link
G Pcm1 pericentriolar material 1 increases response to substance
decreases expression 		ISO PCM1 protein results in increased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in decreased expression of PCM1 mRNA 		CTD PMID:20707922 PMID:22521957 NCBI chr16:57,711,833...57,808,842
Ensembl chr16:57,711,833...57,808,599 		JBrowse link
G Pcna proliferating cell nuclear antigen decreases expression
increases expression
multiple interactions 		ISO
EXP 		Arsenic Trioxide results in decreased expression of PCNA protein
Arsenic Trioxide results in increased expression of PCNA mRNA
Arsenic Trioxide results in decreased expression of PCNA mRNA; Arsenic Trioxide results in decreased expression of PCNA protein
Arsenic Trioxide promotes the reaction [CDKN1A protein binds to PCNA protein]
pifithrin inhibits the reaction [Arsenic Trioxide results in increased expression of PCNA mRNA] 		CTD PMID:12783709 PMID:16029599 PMID:17390014 PMID:17487067 PMID:21565247 More... NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901 		JBrowse link
G Pcolce procollagen C-endopeptidase enhancer decreases expression ISO Arsenic Trioxide results in decreased expression of PCOLCE mRNA CTD PMID:20458559 NCBI chr12:24,720,972...24,727,287
Ensembl chr12:24,720,936...24,727,287 		JBrowse link
G Pcolce2 procollagen C-endopeptidase enhancer 2 decreases expression ISO Arsenic Trioxide results in decreased expression of PCOLCE2 mRNA CTD PMID:26705709 NCBI chr 8:105,073,086...105,130,725
Ensembl chr 8:105,073,086...105,145,160 		JBrowse link
G Pcsk1 proprotein convertase subtilisin/kexin type 1 increases expression ISO Arsenic Trioxide results in increased expression of PCSK1 mRNA CTD PMID:21461292 NCBI chr 2:6,130,045...6,176,974
Ensembl chr 2:6,129,592...6,176,974 		JBrowse link
G Pcsk5 proprotein convertase subtilisin/kexin type 5 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of PCSK5 mRNA
Arsenic Trioxide results in decreased expression of PCSK5 mRNA 		CTD PMID:15761015 PMID:37969188 NCBI chr 1:224,263,823...224,694,350
Ensembl chr 1:224,264,678...224,694,347 		JBrowse link
G Pcsk7 proprotein convertase subtilisin/kexin type 7 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PCSK7 protein] CTD PMID:26598702 NCBI chr 8:55,098,821...55,121,416
Ensembl chr 8:55,098,806...55,121,382 		JBrowse link
G Pcsk9 proprotein convertase subtilisin/kexin type 9 decreases expression ISO Arsenic Trioxide results in decreased expression of PCSK9 mRNA CTD PMID:26705709 NCBI chr 5:126,440,102...126,462,507
Ensembl chr 5:126,440,102...126,462,507 		JBrowse link
G Pcyt2 phosphate cytidylyltransferase 2, ethanolamine decreases expression ISO Arsenic Trioxide results in decreased expression of PCYT2 mRNA CTD PMID:27829220 NCBI chr10:106,387,150...106,394,500
Ensembl chr10:106,387,148...106,394,468 		JBrowse link
G Pdcd2 programmed cell death 2 multiple interactions
increases expression 		ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PDCD2 protein]
Arsenic Trioxide results in increased expression of PDCD2 mRNA 		CTD PMID:20458559 PMID:26598702 NCBI chr 1:65,158,034...65,163,524
Ensembl chr 1:65,158,034...65,163,524 		JBrowse link
G Pdcd4 programmed cell death 4 increases expression ISO Arsenic Trioxide results in increased expression of PDCD4 mRNA; Arsenic Trioxide results in increased expression of PDCD4 protein CTD PMID:17259349 PMID:20458559 PMID:24356939 PMID:25419056 PMID:30093655 NCBI chr 1:262,912,659...262,949,581
Ensembl chr 1:262,926,656...262,950,189 		JBrowse link
G Pdcd5 programmed cell death 5 increases expression ISO Arsenic Trioxide results in increased expression of PDCD5 mRNA CTD PMID:20458559 NCBI chr 1:97,442,755...97,448,084
Ensembl chr 1:97,442,755...97,449,844 		JBrowse link
G Pdcd6ip programmed cell death 6 interacting protein decreases expression ISO Arsenic Trioxide results in decreased expression of PDCD6IP mRNA CTD PMID:39716349 NCBI chr 8:122,469,223...122,524,993
Ensembl chr 8:122,469,223...122,524,993 		JBrowse link
G Pdcl3 phosducin-like 3 decreases expression ISO Arsenic Trioxide results in decreased expression of PDCL3 protein CTD PMID:30093655 NCBI chr 9:48,730,083...48,738,554
Ensembl chr 9:48,723,767...48,739,529 		JBrowse link
G Pde1a phosphodiesterase 1A decreases expression ISO Arsenic Trioxide results in decreased expression of PDE1A mRNA CTD PMID:26705709 NCBI chr 3:85,152,053...85,432,289
Ensembl chr 3:85,154,184...85,519,212 		JBrowse link
G Pde2a phosphodiesterase 2A decreases expression ISO Arsenic Trioxide results in decreased expression of PDE2A mRNA CTD PMID:20458559 NCBI chr 1:165,235,623...165,327,466
Ensembl chr 1:165,235,623...165,327,466 		JBrowse link
G Pde4a phosphodiesterase 4A decreases expression ISO Arsenic Trioxide results in decreased expression of PDE4A mRNA CTD PMID:15070760 NCBI chr 8:27,966,978...28,029,721
Ensembl chr 8:27,966,996...28,046,924 		JBrowse link
G Pde4b phosphodiesterase 4B decreases expression ISO Arsenic Trioxide results in decreased expression of PDE4B mRNA CTD PMID:15761015 NCBI chr 5:122,028,956...122,598,267
Ensembl chr 5:122,135,174...122,598,267 		JBrowse link
G Pde4d phosphodiesterase 4D increases expression ISO Arsenic Trioxide results in increased expression of PDE4D mRNA CTD PMID:22521957 NCBI chr 2:41,748,337...43,262,567
Ensembl chr 2:42,110,838...43,262,569 		JBrowse link
G Pde4dip phosphodiesterase 4D interacting protein increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of PDE4DIP mRNA
[Tretinoin co-treated with Arsenic Trioxide] affects the expression of PDE4DIP mRNA 		CTD PMID:15761015 PMID:15894607 NCBI chr 2:187,982,002...188,178,937
Ensembl chr 2:187,981,878...188,178,869 		JBrowse link
G Pde7b phosphodiesterase 7B decreases expression ISO Arsenic Trioxide results in decreased expression of PDE7B mRNA CTD PMID:26705709 NCBI chr 1:16,994,072...17,312,828
Ensembl chr 1:17,002,286...17,312,456 		JBrowse link
G Pde8a phosphodiesterase 8A increases expression ISO Arsenic Trioxide results in increased expression of PDE8A mRNA CTD PMID:22521957 NCBI chr 1:144,575,203...144,698,216
Ensembl chr 1:144,575,428...144,698,215 		JBrowse link
G Pdgfa platelet derived growth factor subunit A decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of PDGFA mRNA
Arsenic Trioxide results in increased expression of PDGFA mRNA 		CTD PMID:20458559 PMID:27829220 NCBI chr12:20,759,366...20,780,337
Ensembl chr12:20,754,208...20,780,322 		JBrowse link
G Pdgfb platelet derived growth factor subunit B multiple interactions ISO Arsenic Trioxide inhibits the reaction [PDGFB protein results in increased expression of CCNA1 protein]; Arsenic Trioxide inhibits the reaction [PDGFB protein results in increased expression of CDK2 protein]; Arsenic Trioxide inhibits the reaction [PDGFB protein results in increased expression of CDK4 protein] CTD PMID:35276128 NCBI chr 7:113,419,882...113,438,343
Ensembl chr 7:113,420,710...113,438,343 		JBrowse link
G Pdgfrb platelet derived growth factor receptor beta increases expression ISO Arsenic Trioxide results in increased expression of PDGFRB mRNA CTD PMID:29633893 NCBI chr18:56,770,348...56,809,228
Ensembl chr18:56,770,348...56,809,233 		JBrowse link
G Pdha1 pyruvate dehydrogenase E1 subunit alpha 1 increases expression ISO Arsenic Trioxide results in increased expression of PDHA1 mRNA CTD PMID:22521957 NCBI chr  X:38,509,158...38,522,986
Ensembl chr  X:38,509,084...38,522,536 		JBrowse link
G Pdia3 protein disulfide isomerase family A, member 3 decreases expression ISO Arsenic Trioxide results in decreased expression of PDIA3 protein CTD PMID:19364129 NCBI chr 3:128,841,781...128,865,733
Ensembl chr 3:128,841,917...128,867,327 		JBrowse link
G Pdk1 pyruvate dehydrogenase kinase 1 increases expression ISO Arsenic Trioxide results in increased expression of PDK1 mRNA CTD PMID:32112876 NCBI chr 3:77,113,464...77,144,145
Ensembl chr 3:77,113,473...77,144,145 		JBrowse link
G Pdk3 pyruvate dehydrogenase kinase 3 increases expression ISO Arsenic Trioxide results in increased expression of PDK3 mRNA CTD PMID:34108876 NCBI chr  X:62,480,535...62,547,371
Ensembl chr  X:62,480,535...62,547,371 		JBrowse link
G Pdlim5 PDZ and LIM domain 5 decreases expression
affects expression 		ISO Arsenic Trioxide results in decreased expression of PDLIM5 mRNA
Arsenic Trioxide affects the expression of PDLIM5 mRNA 		CTD PMID:20458559 PMID:39716349 NCBI chr 2:233,625,478...233,793,582
Ensembl chr 2:233,628,503...233,793,528 		JBrowse link
G Pdlim7 PDZ and LIM domain 7 increases expression ISO Arsenic Trioxide results in increased expression of PDLIM7 mRNA CTD PMID:15761015 NCBI chr17:9,129,603...9,144,956
Ensembl chr17:9,129,525...9,144,956 		JBrowse link
G Pdpk1 3-phosphoinositide dependent protein kinase-1 decreases expression
decreases activity
increases expression 		ISO Arsenic Trioxide results in decreased expression of PDPK1 mRNA
Arsenic Trioxide results in decreased activity of PDPK1 protein
Arsenic Trioxide results in increased expression of PDPK1 mRNA 		CTD PMID:14633726 PMID:30032600 PMID:32781346 NCBI chr10:13,610,000...13,687,226
Ensembl chr10:13,610,063...13,679,181 		JBrowse link
G Pdrg1 p53 and DNA damage regulated 1 multiple interactions
increases expression 		ISO Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of PDRG1 mRNA] CTD PMID:29095437 NCBI chr 3:161,937,812...161,943,981
Ensembl chr 3:161,937,815...161,948,995 		JBrowse link
G Pdxdc1 pyridoxal-dependent decarboxylase domain containing 1 increases expression ISO Arsenic Trioxide results in increased expression of PDXDC1 mRNA CTD PMID:22521957 NCBI chr10:2,528,989...2,620,669
Ensembl chr10:2,532,485...2,620,669 		JBrowse link
G Pdzd2 PDZ domain containing 2 decreases expression ISO Arsenic Trioxide results in decreased expression of PDZD2 mRNA CTD PMID:15761015 NCBI chr 2:63,111,650...63,497,520
Ensembl chr 2:63,111,650...63,497,478 		JBrowse link
G Pdzd7 PDZ domain containing 7 increases expression ISO Arsenic Trioxide results in increased expression of PDZD7 mRNA CTD PMID:20458559 NCBI chr 1:253,837,454...253,856,919
Ensembl chr 1:253,837,459...253,855,999 		JBrowse link
G Pdzd8 PDZ domain containing 8 decreases expression ISO Arsenic Trioxide results in decreased expression of PDZD8 mRNA CTD PMID:39716349 NCBI chr 1:268,435,304...268,492,923
Ensembl chr 1:268,435,304...268,492,913 		JBrowse link
G Pdzrn4 PDZ domain containing RING finger 4 decreases expression ISO Arsenic Trioxide results in decreased expression of PDZRN4 mRNA CTD PMID:26705709 NCBI chr 7:125,696,448...125,844,965
Ensembl chr 7:125,696,448...125,844,965 		JBrowse link
G Pecam1 platelet and endothelial cell adhesion molecule 1 increases expression
multiple interactions
decreases expression 		ISO
EXP 		Arsenic Trioxide results in increased expression of PECAM1 mRNA
[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of PECAM1 mRNA; Diosgenin inhibits the reaction [Arsenic Trioxide results in decreased expression of PECAM1 protein]; NR3C1 promotes the reaction [Diosgenin inhibits the reaction [Arsenic Trioxide results in decreased expression of PECAM1 protein]]
Arsenic Trioxide results in decreased expression of PECAM1 mRNA; Arsenic Trioxide results in decreased expression of PECAM1 protein 		CTD PMID:15761015 PMID:15894607 PMID:30014256 PMID:39059093 NCBI chr10:92,090,263...92,152,002
Ensembl chr10:92,090,235...92,151,839 		JBrowse link
G Peli1 pellino E3 ubiquitin protein ligase 1 increases expression ISO Arsenic Trioxide results in increased expression of PELI1 mRNA CTD PMID:24356939 NCBI chr14:99,455,970...99,510,474
Ensembl chr14:99,455,811...99,510,466 		JBrowse link
G Per2 period circadian regulator 2 decreases expression ISO Arsenic Trioxide results in decreased expression of PER2 mRNA CTD PMID:20458559 PMID:26705709 PMID:27829220 NCBI chr 9:99,454,828...99,497,069
Ensembl chr 9:99,454,830...99,496,993 		JBrowse link
G Pex3 peroxisomal biogenesis factor 3 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of PEX3 mRNA
[Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of PEX3 mRNA 		CTD PMID:15761015 PMID:15894607 NCBI chr 1:9,732,641...9,774,479
Ensembl chr 1:9,732,492...9,774,576 		JBrowse link
G Pfas phosphoribosylformylglycinamidine synthase increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of PFAS mRNA
[Arsenic Trioxide co-treated with Ascorbic Acid] results in increased expression of PFAS mRNA 		CTD PMID:25555879 NCBI chr10:54,189,157...54,210,685
Ensembl chr10:54,189,157...54,207,272 		JBrowse link
G Pfkfb4 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 decreases expression ISO Arsenic Trioxide results in decreased expression of PFKFB4 mRNA CTD PMID:27829220 NCBI chr 8:118,522,371...118,565,478
Ensembl chr 8:118,522,365...118,565,468 		JBrowse link
G Pfkm phosphofructokinase, muscle decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of PFKM mRNA; Arsenic Trioxide results in decreased expression of PFKM protein
[Ascorbic Acid co-treated with Arsenic Trioxide] results in decreased expression of PFKM protein; Arsenic Trioxide promotes the reaction [Ascorbic Acid results in decreased expression of PFKM mRNA]; Arsenic Trioxide promotes the reaction [Ascorbic Acid results in decreased expression of PFKM protein]; Ascorbic Acid promotes the reaction [Arsenic Trioxide results in decreased expression of PFKM mRNA]; Ascorbic Acid promotes the reaction [Arsenic Trioxide results in decreased expression of PFKM protein] 		CTD PMID:38160894 NCBI chr 7:131,100,684...131,138,250
Ensembl chr 7:131,100,753...131,138,248 		JBrowse link
G Pfkp phosphofructokinase, platelet decreases expression ISO Arsenic Trioxide results in decreased expression of PFKP protein CTD PMID:25419056 NCBI chr17:68,639,749...68,704,055
Ensembl chr17:68,639,481...68,705,752 		JBrowse link
G Pfn2 profilin 2 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PFN2 protein] CTD PMID:26598702 NCBI chr 2:144,217,100...144,222,936
Ensembl chr 2:144,205,636...144,222,936 		JBrowse link
G Pfn4 profilin family, member 4 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PFN4 protein] CTD PMID:26598702 NCBI chr 6:33,506,077...33,516,163
Ensembl chr 6:33,506,077...33,516,163 		JBrowse link
G Pgam5 PGAM family member 5, mitochondrial serine/threonine protein phosphatase decreases expression ISO Arsenic Trioxide results in decreased expression of PGAM5 protein CTD PMID:25419056 NCBI chr12:52,069,023...52,076,131
Ensembl chr12:52,069,103...52,076,131 		JBrowse link
G Pgc progastricsin decreases expression ISO Arsenic Trioxide results in decreased expression of PGC mRNA CTD PMID:17547211 NCBI chr 9:20,755,002...20,763,220
Ensembl chr 9:20,755,002...20,763,220 		JBrowse link
G Pgd phosphogluconate dehydrogenase decreases response to substance
multiple interactions
increases expression 		ISO PGD protein results in decreased susceptibility to Arsenic Trioxide
[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of PGD mRNA; Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PGD protein]
Arsenic Trioxide results in increased expression of PGD mRNA 		CTD PMID:15894607 PMID:20458559 PMID:20707922 PMID:25258189 PMID:26598702 NCBI chr 5:164,865,830...164,882,029
Ensembl chr 5:164,865,830...164,882,029 		JBrowse link
G Pgf placental growth factor decreases expression ISO Arsenic Trioxide results in decreased expression of PGF mRNA CTD PMID:17547211 NCBI chr 6:110,547,165...110,557,747
Ensembl chr 6:110,547,153...110,557,747 		JBrowse link
G Pgghg protein-glucosylgalactosylhydroxylysine glucosidase decreases expression ISO Arsenic Trioxide results in decreased expression of PGGHG mRNA CTD PMID:25258189 NCBI chr 1:205,467,179...205,474,185
Ensembl chr 1:205,467,993...205,474,183 		JBrowse link
G Pggt1b protein geranylgeranyltransferase type I subunit beta decreases expression ISO Arsenic Trioxide results in decreased expression of PGGT1B mRNA CTD PMID:20458559 NCBI chr18:41,138,536...41,182,145
Ensembl chr18:41,139,965...41,182,139 		JBrowse link
G Pgk1 phosphoglycerate kinase 1 increases expression
multiple interactions
decreases expression 		ISO Arsenic Trioxide results in increased expression of PGK1 mRNA
[Ascorbic Acid co-treated with Arsenic Trioxide] results in decreased expression of PGK1 protein; Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PGK1 protein]; Arsenic Trioxide promotes the reaction [Ascorbic Acid results in decreased expression of PGK1 mRNA]; Arsenic Trioxide promotes the reaction [Ascorbic Acid results in decreased expression of PGK1 protein]; Ascorbic Acid promotes the reaction [Arsenic Trioxide results in decreased expression of PGK1 mRNA]; Ascorbic Acid promotes the reaction [Arsenic Trioxide results in decreased expression of PGK1 protein]
Arsenic Trioxide results in decreased expression of PGK1 mRNA; Arsenic Trioxide results in decreased expression of PGK1 protein 		CTD PMID:22521957 PMID:26598702 PMID:38160894 NCBI chr  X:75,336,988...75,352,962
Ensembl chr  X:75,336,687...75,352,959 		JBrowse link
G Pgm1 phosphoglucomutase 1 increases expression
multiple interactions
decreases expression 		ISO Arsenic Trioxide results in increased expression of PGM1 mRNA; Arsenic Trioxide results in increased expression of PGM1 protein
[Ascorbic Acid co-treated with Arsenic Trioxide] results in decreased expression of PGM1 protein; Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PGM1 protein]; Arsenic Trioxide promotes the reaction [Ascorbic Acid results in decreased expression of PGM1 mRNA]; Arsenic Trioxide promotes the reaction [Ascorbic Acid results in decreased expression of PGM1 protein]; Ascorbic Acid promotes the reaction [Arsenic Trioxide results in decreased expression of PGM1 mRNA]; Ascorbic Acid promotes the reaction [Arsenic Trioxide results in decreased expression of PGM1 protein]
Arsenic Trioxide results in decreased expression of PGM1 mRNA; Arsenic Trioxide results in decreased expression of PGM1 protein 		CTD PMID:20458559 PMID:25419056 PMID:26598702 PMID:38160894 NCBI chr 5:119,710,734...119,770,159
Ensembl chr 5:119,710,737...119,770,159 		JBrowse link
G Pgm2 phosphoglucomutase 2 decreases expression
increases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of PGM2 mRNA
Arsenic Trioxide results in increased expression of PGM2 protein
Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of PGM2 mRNA] 		CTD PMID:25419056 PMID:29095437 NCBI chr14:44,519,906...44,553,420
Ensembl chr14:44,519,906...44,553,770 		JBrowse link
G Pgm3 phosphoglucomutase 3 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PGM3 protein] CTD PMID:26598702 NCBI chr 8:96,398,331...96,416,045
Ensembl chr 8:96,398,269...96,416,021 		JBrowse link
G Phb1 prohibitin 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PHB1 protein] CTD PMID:26598702 NCBI chr10:81,102,043...81,114,815
Ensembl chr10:81,102,028...81,116,233 		JBrowse link
G Phf1 PHD finger protein 1 increases expression ISO Arsenic Trioxide results in increased expression of PHF1 mRNA CTD PMID:25258189 NCBI chr20:5,019,650...5,024,732
Ensembl chr20:5,019,673...5,024,731 		JBrowse link
G Phf12 PHD finger protein 12 decreases expression ISO Arsenic Trioxide results in decreased expression of PHF12 mRNA CTD PMID:21461292 NCBI chr10:63,368,547...63,417,079
Ensembl chr10:63,370,210...63,417,073 		JBrowse link
G Phf21a PHD finger protein 21A increases expression ISO Arsenic Trioxide results in increased expression of PHF21A mRNA CTD PMID:20458559 PMID:22521957 NCBI chr 3:98,600,933...98,791,132
Ensembl chr 3:98,613,844...98,787,350 		JBrowse link
G Phf5a PHD finger protein 5A decreases expression ISO Arsenic Trioxide results in decreased expression of PHF5A protein CTD PMID:25419056 NCBI chr 7:115,258,609...115,265,174
Ensembl chr 7:115,258,609...115,265,174 		JBrowse link
G Phgdh phosphoglycerate dehydrogenase multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PHGDH protein] CTD PMID:26598702 NCBI chr 2:188,595,700...188,624,789
Ensembl chr 2:188,595,700...188,624,789 		JBrowse link
G Phkg2 phosphorylase kinase catalytic subunit gamma 2 increases expression ISO Arsenic Trioxide results in increased expression of PHKG2 mRNA CTD PMID:20458559 NCBI chr 1:191,614,738...191,627,615
Ensembl chr 1:191,614,865...191,627,616 		JBrowse link
G Phlda1 pleckstrin homology-like domain, family A, member 1 decreases expression ISO Arsenic Trioxide results in decreased expression of PHLDA1 mRNA CTD PMID:20458559 NCBI chr 7:48,853,690...48,855,894
Ensembl chr 7:48,853,260...48,857,542 		JBrowse link
G Phlda2 pleckstrin homology-like domain, family A, member 2 decreases expression ISO Arsenic Trioxide results in decreased expression of PHLDA2 mRNA CTD PMID:15761015 NCBI chr 1:208,126,302...208,127,241
Ensembl chr 1:208,126,302...208,127,920 		JBrowse link
G Phlda3 pleckstrin homology-like domain, family A, member 3 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of PHLDA3 mRNA
Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of PHLDA3 mRNA] 		CTD PMID:29095437 NCBI chr13:49,745,003...49,748,088
Ensembl chr13:49,742,591...49,749,621 		JBrowse link
G Phldb1 pleckstrin homology-like domain, family B, member 1 decreases expression ISO Arsenic Trioxide results in decreased expression of PHLDB1 mRNA CTD PMID:39716349 NCBI chr 8:53,900,338...53,948,325
Ensembl chr 8:53,900,338...53,949,518 		JBrowse link
G Phldb2 pleckstrin homology-like domain, family B, member 2 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of PHLDB2 mRNA
Arsenic Trioxide results in decreased expression of PHLDB2 mRNA 		CTD PMID:20458559 PMID:39716349 NCBI chr11:68,321,738...68,540,724
Ensembl chr11:68,355,959...68,540,734 		JBrowse link
G Phlpp1 PH domain and leucine rich repeat protein phosphatase 1 increases expression ISO Arsenic Trioxide results in increased expression of PHLPP1 mRNA CTD PMID:29633893 NCBI chr13:22,823,132...23,045,619
Ensembl chr13:22,823,132...23,045,619 		JBrowse link
G Phospho2 phosphatase, orphan 2 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PHOSPHO2 protein] CTD PMID:26598702 NCBI chr 3:74,962,649...74,969,810
Ensembl chr 3:74,962,361...74,970,892 		JBrowse link
G Phox2b paired-like homeobox 2b decreases expression ISO Arsenic Trioxide results in decreased expression of PHOX2B protein CTD PMID:35467087 NCBI chr14:41,420,011...41,424,527
Ensembl chr14:41,420,011...41,424,494 		JBrowse link
G Phyhipl phytanoyl-CoA 2-hydroxylase interacting protein-like multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PHYHIPL protein] CTD PMID:26598702 NCBI chr20:18,023,831...18,064,903
Ensembl chr20:17,934,683...18,065,756 		JBrowse link
G Pi4k2a phosphatidylinositol 4-kinase type 2 alpha increases expression ISO Arsenic Trioxide results in increased expression of PI4K2A protein CTD PMID:30093655 NCBI chr 1:250,850,440...250,878,399
Ensembl chr 1:250,852,154...250,881,811 		JBrowse link
G Pi4ka phosphatidylinositol 4-kinase alpha decreases expression ISO Arsenic Trioxide results in decreased expression of PI4KA mRNA CTD PMID:12852829 NCBI chr11:97,113,390...97,234,374
Ensembl chr11:97,113,245...97,228,315 		JBrowse link
G Pias1 protein inhibitor of activated STAT, 1 multiple interactions ISO PIAS1 protein promotes the reaction [Arsenic Trioxide results in increased degradation of PML protein] CTD PMID:22406621 NCBI chr 8:72,233,566...72,347,085
Ensembl chr 8:72,233,566...72,334,315 		JBrowse link
G Pias2 protein inhibitor of activated STAT, 2 multiple interactions
decreases expression 		ISO Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of PIAS2 mRNA] CTD PMID:29095437 NCBI chr18:72,883,008...72,989,486
Ensembl chr18:72,882,890...73,006,662 		JBrowse link
G Pigh phosphatidylinositol glycan anchor biosynthesis, class H multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PIGH protein] CTD PMID:26598702 NCBI chr 6:103,601,369...103,630,214
Ensembl chr 6:103,601,520...103,630,159 		JBrowse link
G Pigo phosphatidylinositol glycan anchor biosynthesis, class O increases expression ISO Arsenic Trioxide results in increased expression of PIGO mRNA CTD PMID:15761015 NCBI chr 5:62,040,979...62,052,067
Ensembl chr 5:62,037,308...62,052,075 		JBrowse link
G Pigr polymeric immunoglobulin receptor decreases expression ISO Arsenic Trioxide results in decreased expression of PIGR mRNA CTD PMID:39716349 NCBI chr13:44,851,001...44,879,143
Ensembl chr13:44,851,182...44,879,141 		JBrowse link
G Pik3c3 phosphatidylinositol 3-kinase, catalytic subunit type 3 decreases expression ISO Arsenic Trioxide results in decreased expression of PIK3C3 protein CTD PMID:34042274 NCBI chr18:22,119,677...22,203,546
Ensembl chr18:22,119,792...22,203,539 		JBrowse link
G Pik3ca phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha decreases expression ISO Arsenic Trioxide results in decreased expression of PIK3CA mRNA; Arsenic Trioxide results in decreased expression of PIK3CA protein CTD PMID:20458559 PMID:34042274 NCBI chr 2:117,103,643...117,177,411
Ensembl chr 2:117,143,468...117,177,411 		JBrowse link
G Pik3cb phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta decreases expression ISO Arsenic Trioxide results in decreased expression of PIK3CB protein CTD PMID:34042274 NCBI chr 8:108,474,017...108,579,140
Ensembl chr 8:108,474,019...108,579,331 		JBrowse link
G Pik3cg phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma decreases expression ISO Arsenic Trioxide results in decreased expression of PIK3CG protein CTD PMID:34042274 NCBI chr 6:54,494,247...54,529,563
Ensembl chr 6:54,478,603...54,529,509 		JBrowse link
G Pik3r1 phosphoinositide-3-kinase regulatory subunit 1 decreases expression
increases expression
increases phosphorylation
multiple interactions 		ISO
EXP 		Arsenic Trioxide results in decreased expression of PIK3R1 mRNA
Arsenic Trioxide results in increased expression of PIK3R1 mRNA
Arsenic Trioxide results in decreased expression of PIK3R1 protein modified form
Arsenic Trioxide results in increased phosphorylation of PIK3R1 protein
dapagliflozin inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of PIK3R1 protein] 		CTD PMID:30032600 PMID:30225639 PMID:32112876 PMID:34042274 PMID:38070468 NCBI chr 2:34,612,946...34,697,660
Ensembl chr 2:34,612,946...34,626,347 		JBrowse link
G Pik3r2 phosphoinositide-3-kinase regulatory subunit 2 decreases expression ISO Arsenic Trioxide results in decreased expression of PIK3R2 mRNA CTD PMID:20458559 NCBI chr16:18,699,389...18,708,045
Ensembl chr16:18,699,448...18,709,665 		JBrowse link
G Pilra paired immunoglobin-like type 2 receptor alpha multiple interactions
increases expression 		ISO Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of PILRA mRNA] CTD PMID:29095437 NCBI chr12:23,452,626...23,464,772 JBrowse link
G Pilral1 paired immunoglobin-like type 2 receptor alpha like 1 increases expression ISO Arsenic Trioxide results in increased expression of ZNF37A mRNA CTD PMID:15761015 NCBI chr12:23,409,774...23,421,574 JBrowse link
G Pim1 Pim-1 proto-oncogene, serine/threonine kinase increases expression ISO Arsenic Trioxide results in increased expression of PIM1 mRNA CTD PMID:20458559 NCBI chr20:7,556,496...7,560,747
Ensembl chr20:7,556,113...7,561,764 		JBrowse link
G Pin1 peptidylprolyl cis/trans isomerase, NIMA-interacting 1 multiple interactions
affects binding
affects response to substance
decreases expression 		ISO [Arsenic Trioxide binds to PIN1 protein] affects the reaction [Arsenic Trioxide results in decreased expression of CTNNB1 protein]; [Arsenic Trioxide binds to PIN1 protein] affects the reaction [Arsenic Trioxide results in decreased expression of FBXW7 protein]; [Arsenic Trioxide binds to PIN1 protein] affects the reaction [Arsenic Trioxide results in decreased expression of RAB2A protein]; [Arsenic Trioxide binds to PIN1 protein] affects the reaction [Arsenic Trioxide results in decreased expression of RELA protein]; [Arsenic Trioxide co-treated with NVP-BKM120] results in decreased expression of PIN1 mRNA; [Arsenic Trioxide co-treated with Tretinoin] results in decreased expression of PIN1 protein; AQP9 protein affects the reaction [Arsenic Trioxide promotes the reaction [Tretinoin results in decreased expression of and results in increased degradation of PIN1 protein]]; AQP9 protein affects the reaction [PIN1 protein affects the susceptibility to Arsenic Trioxide]; AQP9 protein affects the reaction [Tretinoin promotes the reaction [Arsenic Trioxide results in decreased expression of and results in increased degradation of PIN1 protein]]; Arsenic Trioxide promotes the reaction [Tretinoin results in decreased expression of and results in increased degradation of PIN1 protein]; Arsenic Trioxide results in decreased expression of and results in increased degradation of PIN1 protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Arsenic Trioxide results in decreased expression of PIN1 protein]; PIN1 protein affects the reaction [Arsenic Trioxide results in decreased expression of CTNNB1 protein]; PIN1 protein affects the reaction [Arsenic Trioxide results in decreased expression of RAB2A protein]; PIN1 protein affects the reaction [Arsenic Trioxide results in decreased expression of RELA protein]; PIN1 protein affects the reaction [Arsenic Trioxide results in increased expression of FBXW7 protein]; Tretinoin promotes the reaction [Arsenic Trioxide results in decreased expression of and results in increased degradation of PIN1 protein]; Tretinoin promotes the reaction [Arsenic Trioxide results in increased degradation of PIN1 protein]
Arsenic Trioxide analog binds to PIN1 protein 		CTD PMID:30093655 PMID:31539632 NCBI chr 8:27,465,538...27,477,016 JBrowse link
G Pink1 PTEN induced kinase 1 multiple interactions
increases expression
decreases expression 		EXP
ISO 		Taurine inhibits the reaction [Arsenic Trioxide results in decreased expression of PINK1 protein]
Arsenic Trioxide results in increased expression of PINK1 protein
3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [Arsenic Trioxide results in increased expression of PINK1 protein]; Cyclosporine inhibits the reaction [Arsenic Trioxide results in increased expression of PINK1 protein] 		CTD PMID:27318970 PMID:30551535 NCBI chr 5:155,813,838...155,825,950
Ensembl chr 5:155,813,838...155,825,950 		JBrowse link
G Pinx1 PIN2/TERF1 interacting, telomerase inhibitor 1 decreases expression ISO Arsenic Trioxide results in decreased expression of PINX1 mRNA CTD PMID:22944098 NCBI chr15:42,273,805...42,333,047
Ensembl chr15:42,273,799...42,333,047 		JBrowse link
G Pip4k2c phosphatidylinositol-5-phosphate 4-kinase type 2 gamma increases response to substance ISO PIP4K2C protein results in increased susceptibility to Arsenic Trioxide CTD PMID:22496355 NCBI chr 7:64,905,322...64,920,380
Ensembl chr 7:64,905,328...64,920,373 		JBrowse link
G Pip4p1 phosphatidylinositol-4,5-bisphosphate 4-phosphatase 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PIP4P1 protein] CTD PMID:26598702 NCBI chr15:26,620,399...26,624,369
Ensembl chr15:26,620,401...26,624,246 		JBrowse link
G Pir pirin increases expression ISO Arsenic Trioxide results in increased expression of PIR mRNA CTD PMID:15761015 PMID:19417148 NCBI chr  X:33,740,428...33,851,049
Ensembl chr  X:33,740,429...33,851,049 		JBrowse link
G Pirt phosphoinositide-interacting regulator of transient receptor potential channels decreases expression ISO Arsenic Trioxide results in decreased expression of PIRT mRNA CTD PMID:35676786 NCBI chr10:52,112,235...52,127,140
Ensembl chr10:52,111,959...52,131,422 		JBrowse link
G Pitpnc1 phosphatidylinositol transfer protein, cytoplasmic 1 increases expression ISO Arsenic Trioxide results in increased expression of PITPNC1 mRNA CTD PMID:26705709 NCBI chr10:92,663,260...92,928,616
Ensembl chr10:92,663,260...92,928,344 		JBrowse link
G Pitpnm2 phosphatidylinositol transfer protein, membrane-associated 2 increases expression ISO Arsenic Trioxide results in increased expression of PITPNM2 mRNA CTD PMID:39716349 NCBI chr12:38,008,399...38,140,046
Ensembl chr12:38,066,006...38,140,046 		JBrowse link
G Pkd2l1 polycystin 2 like 1, transient receptor potential cation channel decreases expression ISO Arsenic Trioxide results in decreased expression of PKD2L1 mRNA CTD PMID:19128835 NCBI chr 1:252,982,096...253,019,235
Ensembl chr 1:252,982,096...253,023,359 		JBrowse link
G Pkib cAMP-dependent protein kinase inhibitor beta decreases expression ISO Arsenic Trioxide results in decreased expression of PKIB mRNA CTD PMID:20458559 NCBI chr20:37,511,564...37,608,607
Ensembl chr20:37,512,822...37,608,401 		JBrowse link
G Pklr pyruvate kinase L/R multiple interactions
decreases expression 		ISO Taurine inhibits the reaction [Arsenic Trioxide results in decreased expression of PKLR mRNA] CTD PMID:30362509 NCBI chr 2:176,840,779...176,849,637
Ensembl chr 2:176,840,764...176,849,644 		JBrowse link
G Pkm pyruvate kinase M1/2 multiple interactions
increases expression
decreases expression 		ISO [Ascorbic Acid co-treated with Arsenic Trioxide] results in decreased expression of PKM protein; [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of PKM mRNA; Arsenic Trioxide promotes the reaction [Ascorbic Acid results in decreased expression of PKM mRNA]; Arsenic Trioxide promotes the reaction [Ascorbic Acid results in decreased expression of PKM protein]; Ascorbic Acid promotes the reaction [Arsenic Trioxide results in decreased expression of PKM mRNA]; Ascorbic Acid promotes the reaction [Arsenic Trioxide results in decreased expression of PKM protein]; MEG3 protein affects the reaction [Arsenic Trioxide results in decreased expression of PKM mRNA]; MEG3 protein affects the reaction [Arsenic Trioxide results in decreased expression of PKM protein]; PKM protein inhibits the reaction [Arsenic Trioxide results in decreased expression of CDH2 mRNA]; PKM protein inhibits the reaction [Arsenic Trioxide results in decreased expression of CDH2 protein]; PKM protein inhibits the reaction [Arsenic Trioxide results in decreased expression of VIM mRNA]; PKM protein inhibits the reaction [Arsenic Trioxide results in decreased expression of VIM protein]; PKM protein inhibits the reaction [Arsenic Trioxide results in increased expression of CDH1 mRNA]; PKM protein inhibits the reaction [Arsenic Trioxide results in increased expression of CDH1 protein]; PKM protein inhibits the reaction [Arsenic Trioxide results in increased expression of MEG3 mRNA]
Arsenic Trioxide results in increased expression of PKM protein
Arsenic Trioxide results in decreased expression of PKM mRNA; Arsenic Trioxide results in decreased expression of PKM protein 		CTD PMID:15894607 PMID:25419056 PMID:31003765 PMID:38160894 NCBI chr 8:68,949,731...68,975,394
Ensembl chr 8:68,948,815...68,975,396 		JBrowse link
G Pkmyt1 protein kinase, membrane associated tyrosine/threonine 1 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of PKMYT1 mRNA
Arsenic Trioxide results in decreased expression of PKMYT1 mRNA 		CTD PMID:20458559 PMID:20862710 NCBI chr10:13,252,805...13,263,584
Ensembl chr10:13,252,816...13,264,263 		JBrowse link
G Pknox1 PBX/knotted 1 homeobox 1 decreases expression ISO Arsenic Trioxide results in decreased expression of PKNOX1 mRNA CTD PMID:15761015 NCBI chr20:9,664,120...9,706,328
Ensembl chr20:9,664,312...9,706,349 		JBrowse link
G Pknox2 PBX/knotted 1 homeobox 2 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PKNOX2 protein] CTD PMID:26598702 NCBI chr 8:44,789,464...45,051,933
Ensembl chr 8:44,789,467...44,979,754 		JBrowse link
G Pkp1 plakophilin 1 increases expression ISO Arsenic Trioxide results in increased expression of PKP1 protein CTD PMID:25419056 NCBI chr13:49,861,340...49,909,162
Ensembl chr13:49,861,340...49,909,162 		JBrowse link
G Pkp3 plakophilin 3 decreases response to substance ISO PKP3 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 1:205,617,511...205,628,441
Ensembl chr 1:205,617,511...205,628,440 		JBrowse link
G Pla2g1b phospholipase A2 group IB increases expression ISO Arsenic Trioxide results in increased expression of PLA2G1B mRNA CTD PMID:20458559 NCBI chr12:46,802,932...46,814,511
Ensembl chr12:46,802,939...46,813,693 		JBrowse link
G Pla2g4a phospholipase A2 group 4A increases expression ISO Arsenic Trioxide results in increased expression of PLA2G4A mRNA CTD PMID:24831965 PMID:38758479 NCBI chr13:64,427,921...64,572,352
Ensembl chr13:64,427,916...64,589,641 		JBrowse link
G Pla2g6 phospholipase A2 group VI multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PLA2G6 protein] CTD PMID:26598702 NCBI chr 7:112,731,803...112,771,978
Ensembl chr 7:112,731,803...112,771,609 		JBrowse link
G Pla2r1 phospholipase A2 receptor 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PLA2R1 protein] CTD PMID:26598702 NCBI chr 3:65,292,629...65,422,462
Ensembl chr 3:65,292,629...65,422,335 		JBrowse link
G Plac1 placenta enriched 1 increases expression ISO Arsenic Trioxide results in increased expression of PLAC1 mRNA CTD PMID:22521957 NCBI chr  X:137,740,896...137,874,688
Ensembl chr  X:137,740,890...137,905,210 		JBrowse link
G Plagl2 PLAG1 like zinc finger 2 increases expression ISO Arsenic Trioxide results in increased expression of PLAGL2 mRNA CTD PMID:20458559 NCBI chr 3:162,155,554...162,168,748
Ensembl chr 3:162,155,554...162,168,748 		JBrowse link
G Plat plasminogen activator, tissue type decreases expression ISO Arsenic Trioxide results in decreased expression of PLAT mRNA CTD PMID:20458559 PMID:22521957 NCBI chr16:75,943,061...76,022,037
Ensembl chr16:75,943,064...75,967,696 		JBrowse link
G Plau plasminogen activator, urokinase increases expression
multiple interactions
decreases expression 		ISO Arsenic Trioxide results in increased expression of PLAU mRNA
[Silybin co-treated with Arsenic Trioxide] results in decreased expression of PLAU mRNA; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased secretion of PLAU protein]; Arsenic Trioxide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of PLAU protein]; Arsenic Trioxide promotes the reaction [Silybin results in decreased expression of PLAU mRNA]; Arsenic Trioxide results in decreased expression of and results in decreased secretion of PLAU protein; GH1 protein promotes the reaction [Arsenic Trioxide results in decreased expression of PLAU mRNA]; Silybin promotes the reaction [Arsenic Trioxide results in decreased expression of PLAU mRNA] 		CTD PMID:15962302 PMID:20458559 PMID:21969006 PMID:23851143 PMID:27039805 More... NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,505,487...3,512,030 		JBrowse link
G Plaur plasminogen activator, urokinase receptor decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of PLAUR mRNA; Arsenic Trioxide results in decreased expression of PLAUR protein
GH1 protein promotes the reaction [Arsenic Trioxide results in decreased expression of PLAUR mRNA] 		CTD PMID:15761015 PMID:15962302 PMID:19128835 PMID:19642359 PMID:23851143 NCBI chr 1:89,181,363...89,196,308
Ensembl chr 1:89,178,453...89,198,130 		JBrowse link
G Plcb1 phospholipase C beta 1 decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of PLCB1 mRNA
Arsenic Trioxide results in increased expression of PLCB1 mRNA 		CTD PMID:24831965 PMID:39716349 NCBI chr 3:142,512,765...143,224,042
Ensembl chr 3:142,513,033...143,225,646 		JBrowse link
G Plcb4 phospholipase C, beta 4 decreases expression ISO Arsenic Trioxide results in decreased expression of PLCB4 mRNA; Arsenic Trioxide results in decreased expression of PLCB4 protein CTD PMID:24831965 NCBI chr 3:143,405,721...143,775,129
Ensembl chr 3:143,405,950...143,775,113 		JBrowse link
G Plcd1 phospholipase C, delta 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PLCD1 protein] CTD PMID:26598702 NCBI chr 8:127,672,955...127,695,939
Ensembl chr 8:127,672,980...127,695,939 		JBrowse link
G Plcg2 phospholipase C, gamma 2 decreases phosphorylation ISO Arsenic Trioxide results in decreased phosphorylation of PLCG2 protein CTD PMID:20129490 NCBI chr19:62,456,196...62,592,684
Ensembl chr19:62,453,259...62,592,684 		JBrowse link
G Plcl1 phospholipase C-like 1 increases expression ISO Arsenic Trioxide results in increased expression of PLCL1 mRNA CTD PMID:24356939 NCBI chr 9:64,395,976...64,733,171
Ensembl chr 9:64,361,520...64,733,171 		JBrowse link
G Plcxd1 phosphatidylinositol-specific phospholipase C, X domain containing 1 decreases expression ISO Arsenic Trioxide results in decreased expression of PLCXD1 mRNA CTD PMID:20458559 NCBI chr12:52,238,450...52,241,884
Ensembl chr12:52,238,623...52,241,865 		JBrowse link
G Pld1 phospholipase D1 decreases expression ISO Arsenic Trioxide results in decreased expression of PLD1 mRNA CTD PMID:39716349 NCBI chr 2:112,777,820...112,975,857
Ensembl chr 2:112,777,951...112,976,245 		JBrowse link
G Pld3 phospholipase D family, member 3 decreases expression ISO Arsenic Trioxide results in decreased expression of PLD3 mRNA CTD PMID:22521957 NCBI chr 1:91,949,465...91,971,834
Ensembl chr 1:91,949,467...91,961,207 		JBrowse link
G Pld5 phospholipase D family, member 5 decreases expression ISO Arsenic Trioxide results in decreased expression of PLD5 mRNA CTD PMID:26705709 NCBI chr13:90,426,689...90,765,072
Ensembl chr13:90,428,490...90,783,066 		JBrowse link
G Plek2 pleckstrin 2 decreases response to substance ISO PLEK2 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 6:103,434,156...103,452,457
Ensembl chr 6:103,434,156...103,452,371 		JBrowse link
G Plekha6 pleckstrin homology domain containing A6 decreases response to substance ISO PLEKHA6 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr13:47,166,899...47,307,003
Ensembl chr13:47,167,160...47,307,003 		JBrowse link
G Plekhg1 pleckstrin homology and RhoGEF domain containing G1 decreases expression ISO Arsenic Trioxide results in decreased expression of PLEKHG1 mRNA CTD PMID:20458559 NCBI chr 1:42,612,023...42,841,727
Ensembl chr 1:42,612,122...42,841,719 		JBrowse link
G Plekhg3 pleckstrin homology and RhoGEF domain containing G3 decreases response to substance ISO PLEKHG3 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 6:100,998,965...101,042,120
Ensembl chr 6:100,994,417...101,042,118 		JBrowse link
G Plekhg6 pleckstrin homology and RhoGEF domain containing G6 decreases response to substance ISO PLEKHG6 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 4:159,849,987...159,885,730
Ensembl chr 4:159,849,364...159,868,122 		JBrowse link
G Plekhm2 pleckstrin homology and RUN domain containing M2 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PLEKHM2 protein] CTD PMID:26598702 NCBI chr 5:159,222,620...159,261,666
Ensembl chr 5:159,223,300...159,261,642 		JBrowse link
G Plekhm3 pleckstrin homology domain containing M3 decreases expression ISO Arsenic Trioxide results in decreased expression of PLEKHM3 mRNA CTD PMID:35676786 NCBI chr 9:73,659,998...73,819,079
Ensembl chr 9:73,664,817...73,799,503 		JBrowse link
G Plekho1 pleckstrin homology domain containing O1 decreases expression
increases response to substance 		ISO Arsenic Trioxide results in decreased expression of PLEKHO1 mRNA
PLEKHO1 protein results in increased susceptibility to Arsenic Trioxide 		CTD PMID:15761015 PMID:20707922 NCBI chr 2:186,233,435...186,242,114
Ensembl chr 2:186,233,452...186,241,354 		JBrowse link
G Plg plasminogen decreases activity ISO Arsenic Trioxide results in decreased activity of PLG protein CTD PMID:19781379 NCBI chr 1:50,872,927...50,915,406
Ensembl chr 1:50,872,926...50,917,320 		JBrowse link
G Plin2 perilipin 2 increases expression ISO Arsenic Trioxide results in increased expression of PLIN2 mRNA CTD PMID:20458559 NCBI chr 5:106,202,634...106,258,748
Ensembl chr 5:106,202,634...106,258,878 		JBrowse link
G Plk1 polo-like kinase 1 multiple interactions
increases phosphorylation 		ISO 4-(4-(N-benzoylamino)anilino)-6-methoxy-7-(3-(1-morpholino)propoxy)quinazoline inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of PLK1 protein]; BI 2536 inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of PLK1 protein]; RO3280 inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of PLK1 protein] CTD PMID:31597699 NCBI chr 1:186,147,658...186,157,637
Ensembl chr 1:186,147,658...186,157,637 		JBrowse link
G Plk3 polo-like kinase 3 decreases expression ISO Arsenic Trioxide results in decreased expression of PLK3 mRNA CTD PMID:39716349 NCBI chr 5:135,843,725...135,848,900
Ensembl chr 5:135,843,725...135,848,900 		JBrowse link
G Plk4 polo-like kinase 4 decreases expression ISO Arsenic Trioxide results in decreased expression of PLK4 mRNA CTD PMID:26705709 NCBI chr 2:125,730,480...125,748,894
Ensembl chr 2:125,730,460...125,748,892 		JBrowse link
G Pllp plasmolipin decreases response to substance ISO PLLP protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr19:10,321,080...10,341,869
Ensembl chr19:10,321,080...10,342,226 		JBrowse link
G Plp1 proteolipid protein 1 decreases expression ISO Arsenic Trioxide results in decreased expression of PLP1 mRNA CTD PMID:26705709 NCBI chr  X:104,933,921...104,993,317
Ensembl chr  X:104,975,780...104,993,314 		JBrowse link
G Plpp1 phospholipid phosphatase 1 increases expression ISO Arsenic Trioxide results in increased expression of PLPP1 mRNA CTD PMID:22521957 NCBI chr 2:46,172,202...46,233,632
Ensembl chr 2:46,172,197...46,234,676 		JBrowse link
G Plpp2 phospholipid phosphatase 2 decreases response to substance ISO PLPP2 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 7:10,826,534...10,834,628
Ensembl chr 7:10,826,549...10,834,627 		JBrowse link
G Plpp3 phospholipid phosphatase 3 increases expression ISO Arsenic Trioxide results in increased expression of PLPP3 mRNA CTD PMID:19128835 NCBI chr 5:125,156,000...125,231,119
Ensembl chr 5:125,155,945...125,235,667 		JBrowse link
G Plppr5 phospholipid phosphatase related 5 decreases expression ISO Arsenic Trioxide results in decreased expression of PLPPR5 mRNA CTD PMID:26705709 NCBI chr 2:208,143,058...208,422,836
Ensembl chr 2:208,142,871...208,439,051 		JBrowse link
G Plscr1 phospholipid scramblase 1 increases expression ISO Arsenic Trioxide results in increased expression of PLSCR1 mRNA CTD PMID:20458559 NCBI chr 8:101,662,512...101,684,474
Ensembl chr 8:101,664,056...101,684,614 		JBrowse link
G Pltp phospholipid transfer protein decreases expression ISO Arsenic Trioxide results in decreased expression of PLTP mRNA CTD PMID:19128835 NCBI chr 3:173,994,162...174,011,982
Ensembl chr 3:173,994,162...174,012,505 		JBrowse link
G Plxna3 plexin A3 increases expression ISO Arsenic Trioxide results in increased expression of PLXNA3 mRNA CTD PMID:39716349 NCBI chr  X:157,266,986...157,282,896
Ensembl chr  X:157,267,107...157,282,891 		JBrowse link
G Plxnb1 plexin B1 increases expression ISO Arsenic Trioxide results in increased expression of PLXNB1 mRNA CTD PMID:35676786 NCBI chr 8:118,621,961...118,647,491
Ensembl chr 8:118,623,040...118,647,489 		JBrowse link
G Plxnb2 plexin B2 decreases response to substance ISO PLXNB2 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 7:122,111,917...122,138,201
Ensembl chr 7:122,111,917...122,127,746 		JBrowse link
G Plxnc1 plexin C1 increases expression ISO Arsenic Trioxide results in increased expression of PLXNC1 mRNA CTD PMID:15761015 NCBI chr 7:31,276,978...31,430,823
Ensembl chr 7:31,276,978...31,431,092 		JBrowse link
G Pmaip1 phorbol-12-myristate-13-acetate-induced protein 1 increases expression
decreases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of PMAIP1 mRNA
Arsenic Trioxide results in decreased expression of PMAIP1 mRNA
[Arsenic Trioxide co-treated with Bortezomib] results in decreased expression of PMAIP1 mRNA; [Bortezomib co-treated with Arsenic Trioxide] results in increased expression of PMAIP1 protein; [sanguinarine co-treated with Arsenic Trioxide] results in increased expression of PMAIP1 mRNA; GH1 protein promotes the reaction [Arsenic Trioxide results in increased expression of PMAIP1 mRNA]; PMAIP1 protein promotes the reaction [[Bortezomib co-treated with Arsenic Trioxide] results in increased activity of CASP3 protein]; PMAIP1 protein promotes the reaction [Arsenic Trioxide results in increased activity of CASP3 protein] 		CTD PMID:19417148 PMID:20458559 PMID:21518486 PMID:23851143 PMID:24345465 More... NCBI chr18:62,255,970...62,262,384
Ensembl chr18:62,255,598...62,262,382 		JBrowse link
G Pml PML nuclear body scaffold affects metabolic processing
increases expression
decreases response to substance
increases ubiquitination
increases response to substance
affects localization
multiple interactions
affects binding
increases sumoylation
decreases expression
affects response to substance
increases degradation 		ISO Arsenic Trioxide affects the metabolism of PML protein
Arsenic Trioxide results in increased expression of PML mRNA
PML gene mutant form results in decreased susceptibility to Arsenic Trioxide; PML protein mutant form results in decreased susceptibility to Arsenic Trioxide; PML protein results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in increased ubiquitination of PML protein; Arsenic Trioxide results in increased ubiquitination of PML protein alternative form
PML mutant form results in increased susceptibility to Arsenic Trioxide
Arsenic Trioxide affects the localization of PML protein
Arsenic Trioxide inhibits the reaction [Bleomycin results in increased expression of PML protein]; Arsenic Trioxide results in increased sumoylation of and results in increased localization of and results in increased degradation of [PML protein mutant form binds to PML protein mutant form]
Arsenic Trioxide binds to PML protein; Arsenic Trioxide binds to PML protein modified form
Arsenic Trioxide results in increased expression of PML protein modified form
Arsenic Trioxide results in increased sumoylation of PML protein; Arsenic Trioxide results in increased sumoylation of PML protein alternative form
Arsenic Trioxide results in decreased expression of PML mRNA mutant form; Arsenic Trioxide results in decreased expression of PML protein; Arsenic Trioxide results in decreased expression of PML protein mutant form
PML protein affects the susceptibility to Arsenic Trioxide
[[Arsenic Trioxide results in increased sumoylation of PML protein alternative form] promotes the reaction [PML protein alternative form binds to RNF4 protein]] which results in increased degradation of PML protein alternative form; [[Arsenic Trioxide results in increased sumoylation of PML protein] promotes the reaction [PML protein binds to RNF4 protein]] which results in increased degradation of PML protein; [Arsenic Trioxide affects the reaction [SUMO2 protein binds to PML protein]] promotes the reaction [SUMO1 protein binds to PML protein]; [Arsenic Trioxide affects the reaction [SUMO2 protein binds to PML protein]] which results in increased ubiquitination of PML protein; [Arsenic Trioxide co-treated with PML protein] results in decreased expression of BCL2; [Arsenic Trioxide co-treated with PML protein] results in increased expression of TP53; [Arsenic Trioxide promotes the reaction [SUMO1 protein binds to PML protein]] which results in increased ubiquitination of PML protein; [Arsenic Trioxide promotes the reaction [UBE2I protein binds to PML protein]] which results in increased sumoylation of PML protein; [Arsenic Trioxide results in increased sumoylation of PML protein alternative form] promotes the reaction [PML protein alternative form binds to RNF4 protein]; [Arsenic Trioxide results in increased sumoylation of PML protein] promotes the reaction [PML protein binds to RNF4 protein]; [monomethylarsonous acid co-treated with dimethylarsinous acid co-treated with Arsenic Trioxide] results in increased degradation of PML protein; [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of PML mRNA alternative form; [Tretinoin co-treated with Arsenic Trioxide] results in increased degradation of PML protein mutant form; [Vorinostat co-treated with Arsenic Trioxide] results in decreased expression of PML protein mutant form; ALDH3A1 protein inhibits the reaction [PML mutant form results in increased susceptibility to Arsenic Trioxide]; Arsenic Trioxide affects the localization of and results in decreased expression of PML protein; Arsenic Trioxide affects the reaction [PML protein modified form binds to DAXX protein]; Arsenic Trioxide affects the reaction [SUMO2 protein binds to PML protein]; Arsenic Trioxide affects the sumoylation of and results in increased ubiquitination of and results in increased cleavage of PML protein; Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PML protein]; Arsenic Trioxide inhibits the reaction [p-aminophenylarsine oxide binds to PML protein]; Arsenic Trioxide promotes the reaction [PML protein binds to PML protein]; Arsenic Trioxide promotes the reaction [puerarin results in decreased expression of PML mRNA alternative form]; Arsenic Trioxide promotes the reaction [RNF4 protein binds to and results in increased degradation of PML protein modified form]; Arsenic Trioxide promotes the reaction [RNF4 protein results in increased degradation of PML protein alternative form]; Arsenic Trioxide promotes the reaction [RNF4 protein results in increased degradation of PML protein]; Arsenic Trioxide promotes the reaction [SUMO1 protein binds to PML protein]; Arsenic Trioxide promotes the reaction [SUMO2 protein binds to PML protein]; Arsenic Trioxide promotes the reaction [tetraarsenic tetrasulfide results in increased degradation of [PML protein mutant form binds to RARA protein mutant form]]; Arsenic Trioxide promotes the reaction [UBE2I protein binds to PML protein]; Arsenic Trioxide results in increased degradation of [PML protein mutant form binds to RARA protein mutant form]; Arsenic Trioxide results in increased expression of and results in increased sumoylation of PML protein; Arsenic Trioxide results in increased localization of [CASP8AP2 protein co-treated with PML protein]; Arsenic Trioxide results in increased localization of and results in increased degradation of PML protein; Arsenic Trioxide results in increased phosphorylation of and results in increased sumoylation of PML protein; Arsenic Trioxide results in increased sumoylation of and results in increased localization of PML protein; Arsenic Trioxide results in increased ubiquitination of and results in increased degradation of PML protein; cobaltous chloride promotes the reaction [Arsenic Trioxide results in increased degradation of PML protein mutant form]; Cycloheximide inhibits the reaction [Arsenic Trioxide results in increased degradation of PML protein]; Fenofibrate promotes the reaction [Arsenic Trioxide results in decreased expression of PML protein mutant form]; PIAS1 protein promotes the reaction [Arsenic Trioxide results in increased degradation of PML protein]; PML gene mutant form results in decreased susceptibility to [Arsenic Trioxide co-treated with Tretinoin]; PML protein affects the reaction [Arsenic Trioxide results in increased expression of ACTA2 protein]; PML protein affects the reaction [Arsenic Trioxide results in increased expression of SUMO1 protein]; PML protein affects the reaction [Arsenic Trioxide results in increased expression of TGFB1 protein]; RNF4 protein promotes the reaction [Arsenic Trioxide results in increased degradation of PML protein]; RNF4 protein promotes the reaction [Arsenic Trioxide results in increased ubiquitination of PML protein]; SENP1 protein promotes the reaction [Arsenic Trioxide affects the reaction [SUMO2 protein binds to PML protein]]; SENP1 protein promotes the reaction [Arsenic Trioxide affects the sumoylation of and results in increased ubiquitination of PML protein]; SENP1 protein promotes the reaction [Arsenic Trioxide promotes the reaction [SUMO1 protein binds to PML protein]]; SUMO1 protein promotes the reaction [Arsenic Trioxide results in increased ubiquitination of PML protein]; SUMO2 protein mutant form inhibits the reaction [Arsenic Trioxide affects the reaction [SUMO2 protein binds to PML protein]]; SUMO2 protein mutant form inhibits the reaction [Arsenic Trioxide promotes the reaction [SUMO1 protein binds to PML protein]]; SUMO2 protein mutant form inhibits the reaction [Arsenic Trioxide results in increased ubiquitination of PML protein]; tetraarsenic tetrasulfide promotes the reaction [Arsenic Trioxide results in increased degradation of [PML protein mutant form binds to RARA protein mutant form]]; UBE2I protein affects the reaction [Arsenic Trioxide results in increased expression of and results in increased sumoylation of PML protein]
Arsenic Trioxide results in increased degradation of PML protein; Arsenic Trioxide results in increased degradation of PML protein mutant form 		CTD PMID:8704214 PMID:9450572 PMID:9716575 PMID:9834237 PMID:11721366 More... NCBI chr 8:67,523,164...67,557,801
Ensembl chr 8:67,523,164...67,576,083 		JBrowse link
G Pmm1 phosphomannomutase 1 decreases expression ISO Arsenic Trioxide results in decreased expression of PMM1 mRNA CTD PMID:35676786 NCBI chr 7:115,346,767...115,357,137
Ensembl chr 7:115,346,771...115,357,024 		JBrowse link
G Pmm2 phosphomannomutase 2 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of PMM2 mRNA
Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of PMM2 mRNA] 		CTD PMID:29095437 PMID:39716349 NCBI chr10:7,468,371...7,489,574
Ensembl chr10:7,468,372...7,489,554 		JBrowse link
G Pmpcb peptidase, mitochondrial processing subunit beta increases expression ISO Arsenic Trioxide results in increased expression of PMPCB protein CTD PMID:25419056 NCBI chr 4:14,189,807...14,202,584
Ensembl chr 4:14,165,844...14,202,615 		JBrowse link
G Pms2 PMS1 homolog 2, mismatch repair system component increases expression ISO Arsenic Trioxide results in increased expression of PMS2 mRNA CTD PMID:22521957 NCBI chr12:15,790,478...15,814,790
Ensembl chr12:15,790,478...15,815,248 		JBrowse link
G Pnma1 PNMA family member 1 increases expression ISO Arsenic Trioxide results in increased expression of PNMA1 mRNA CTD PMID:20458559 NCBI chr 6:109,513,382...109,515,167
Ensembl chr 6:109,507,773...109,515,451 		JBrowse link
G Pnp purine nucleoside phosphorylase decreases expression ISO Arsenic Trioxide results in decreased expression of PNP mRNA; Arsenic Trioxide results in decreased expression of PNP protein CTD PMID:19128835 PMID:25419056 NCBI chr15:26,644,147...26,651,808
Ensembl chr15:26,643,858...26,678,162 		JBrowse link
G Pnpla6 patatin-like phospholipase domain containing 6 increases expression ISO Arsenic Trioxide results in increased expression of PNPLA6 mRNA CTD PMID:20458559 NCBI chr12:6,372,284...6,401,632
Ensembl chr12:6,372,293...6,401,631 		JBrowse link
G Pnpo pyridoxamine 5'-phosphate oxidase decreases response to substance ISO PNPO protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr10:82,421,027...82,427,288
Ensembl chr10:82,421,027...82,427,288 		JBrowse link
G Pnrc1 proline-rich nuclear receptor coactivator 1 increases expression ISO Arsenic Trioxide results in increased expression of PNRC1 mRNA CTD PMID:20458559 PMID:24356939 NCBI chr 5:52,443,400...52,489,303
Ensembl chr 5:52,443,400...52,446,491 		JBrowse link
G Poc1b POC1 centriolar protein B increases expression ISO Arsenic Trioxide results in increased expression of POC1B mRNA CTD PMID:39716349 NCBI chr 7:35,810,761...35,912,571
Ensembl chr 7:35,810,820...35,912,571 		JBrowse link
G Podxl podocalyxin-like affects expression
decreases expression 		ISO Arsenic Trioxide affects the expression of PODXL mRNA
Arsenic Trioxide results in decreased expression of PODXL mRNA 		CTD PMID:19128835 PMID:26705709 PMID:28786057 NCBI chr 4:61,102,434...61,149,131
Ensembl chr 4:61,102,419...61,149,789 		JBrowse link
G Pofut2 protein O-fucosyltransferase 2 increases expression ISO Arsenic Trioxide results in increased expression of POFUT2 mRNA CTD PMID:39716349 NCBI chr20:11,366,636...11,378,252
Ensembl chr20:11,366,636...11,377,824 		JBrowse link
G Pold1 DNA polymerase delta 1, catalytic subunit increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of POLD1 mRNA
Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to POLD1 protein] 		CTD PMID:26598702 PMID:29633893 NCBI chr 1:104,161,984...104,178,074
Ensembl chr 1:104,162,016...104,172,982 		JBrowse link
G Pold3 DNA polymerase delta 3, accessory subunit increases expression ISO Arsenic Trioxide results in increased expression of POLD3 mRNA CTD PMID:20458559 NCBI chr 1:163,830,217...163,870,015
Ensembl chr 1:163,830,437...163,869,202 		JBrowse link
G Pold4 DNA polymerase delta 4, accessory subunit increases expression ISO Arsenic Trioxide results in increased expression of POLD4 mRNA CTD PMID:22521957 NCBI chr 1:210,956,110...210,957,863
Ensembl chr 1:210,956,099...210,957,860 		JBrowse link
G Poldip2 DNA polymerase delta interacting protein 2 increases expression
decreases response to substance 		ISO Arsenic Trioxide results in increased expression of POLDIP2 mRNA
POLDIP2 protein results in decreased susceptibility to Arsenic Trioxide 		CTD PMID:20458559 PMID:20707922 NCBI chr10:63,905,287...63,915,655
Ensembl chr10:63,904,691...63,915,655 		JBrowse link
G Pole DNA polymerase epsilon, catalytic subunit decreases expression ISO Arsenic Trioxide results in decreased expression of POLE mRNA CTD PMID:34413873 NCBI chr12:52,005,155...52,053,761
Ensembl chr12:52,005,155...52,053,662 		JBrowse link
G Pole2 DNA polymerase epsilon 2, accessory subunit decreases expression ISO Arsenic Trioxide results in decreased expression of POLE2 mRNA CTD PMID:34413873 NCBI chr 6:93,410,713...93,448,782
Ensembl chr 6:93,410,758...93,435,361 		JBrowse link
G Pole4 DNA polymerase epsilon 4, accessory subunit increases expression ISO Arsenic Trioxide results in increased expression of POLE4 mRNA CTD PMID:20458559 NCBI chr 4:116,723,040...116,728,873
Ensembl chr 4:116,716,719...116,728,851 		JBrowse link
G Polg2 DNA polymerase gamma 2, accessory subunit decreases expression ISO Arsenic Trioxide results in decreased expression of POLG2 mRNA CTD PMID:27829220 NCBI chr10:92,212,303...92,222,849
Ensembl chr10:92,212,304...92,222,726 		JBrowse link
G Polr2a RNA polymerase II subunit A increases expression ISO Arsenic Trioxide results in increased expression of POLR2A mRNA CTD PMID:20458559 NCBI chr10:54,951,162...54,977,179
Ensembl chr10:54,951,162...54,977,179 		JBrowse link
G Polr2c RNA polymerase II subunit C decreases expression ISO Arsenic Trioxide results in decreased expression of POLR2C mRNA CTD PMID:39716349 NCBI chr19:10,164,148...10,170,930
Ensembl chr19:10,164,145...10,170,971 		JBrowse link
G Polr2e RNA polymerase II, I and III subunit E increases expression ISO Arsenic Trioxide results in increased expression of POLR2E protein CTD PMID:25419056 NCBI chr 7:10,317,332...10,321,280
Ensembl chr 7:10,317,389...10,321,276 		JBrowse link
G Polr2f RNA polymerase II, I and III subunit F decreases expression ISO Arsenic Trioxide results in decreased expression of POLR2F protein CTD PMID:30093655 NCBI chr 7:112,592,977...112,604,681
Ensembl chr 7:112,593,027...112,604,666 		JBrowse link
G Pomt1 protein-O-mannosyltransferase 1 decreases expression ISO Arsenic Trioxide results in decreased expression of POMT1 mRNA CTD PMID:20458559 NCBI chr 3:35,918,370...35,936,330
Ensembl chr 3:35,918,188...35,936,364 		JBrowse link
G Popdc1 popeye domain cAMP effector 1 increases expression ISO Arsenic Trioxide results in increased expression of POPDC1 mRNA CTD PMID:27829220 NCBI chr20:50,401,611...50,442,653
Ensembl chr20:50,401,733...50,442,645 		JBrowse link
G Popdc2 popeye domain cAMP effector 2 increases expression ISO Arsenic Trioxide results in increased expression of POPDC2 mRNA CTD PMID:20458559 NCBI chr11:75,850,068...75,897,094
Ensembl chr11:75,880,274...75,896,269 		JBrowse link
G Postn periostin decreases expression ISO Arsenic Trioxide results in decreased expression of POSTN mRNA CTD PMID:26705709 NCBI chr 2:140,677,774...140,709,304
Ensembl chr 2:140,677,754...140,709,300 		JBrowse link
G Poteh POTE ankyrin domain family member H increases expression ISO Arsenic Trioxide results in increased expression of ANKRD18A mRNA CTD PMID:39716349 NCBI chr15:19,559,450...19,654,345 JBrowse link
G Pou2f1 POU class 2 homeobox 1 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of POU2F1 mRNA
Arsenic Trioxide results in decreased expression of POU2F1 mRNA 		CTD PMID:20458559 PMID:39716349 NCBI chr13:80,653,602...80,796,279
Ensembl chr13:80,663,714...80,796,356 		JBrowse link
G Pou4f1 POU class 4 homeobox 1 increases expression ISO Arsenic Trioxide results in increased expression of POU4F1 mRNA CTD PMID:20458559 NCBI chr15:87,668,328...87,674,643
Ensembl chr15:87,668,328...87,674,643 		JBrowse link
G Pou5f1 POU class 5 homeobox 1 decreases expression
increases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of POU5F1 mRNA; Arsenic Trioxide results in decreased expression of POU5F1 protein
Arsenic Trioxide results in increased expression of POU5F1 mRNA; Arsenic Trioxide results in increased expression of POU5F1 protein
[Arsenic Trioxide co-treated with FN1 protein] results in decreased expression of POU5F1 mRNA
Arsenic Trioxide promotes the reaction [MSI1 protein results in increased expression of POU5F1 protein]; EIF2AK2 protein affects the reaction [Arsenic Trioxide promotes the reaction [MSI1 protein results in increased expression of POU5F1 protein]]; EIF2AK2 protein affects the reaction [Arsenic Trioxide results in increased expression of POU5F1 protein]; EIF2S1 protein affects the reaction [Arsenic Trioxide promotes the reaction [MSI1 protein results in increased expression of POU5F1 protein]]; ICG 001 affects the reaction [RORB protein affects the reaction [Arsenic Trioxide results in decreased expression of POU5F1 protein]]; MSI1 protein affects the reaction [Arsenic Trioxide results in increased expression of POU5F1 protein]; PTGS2 protein affects the reaction [Arsenic Trioxide results in increased expression of POU5F1 protein]; RORB protein affects the reaction [Arsenic Trioxide results in decreased expression of POU5F1 protein]; SOX2 protein affects the reaction [Arsenic Trioxide results in increased expression of POU5F1 protein]; SOX2 protein affects the reaction [PTGS2 protein affects the reaction [Arsenic Trioxide results in increased expression of POU5F1 protein]] 		CTD PMID:22641096 PMID:29396848 PMID:29486283 PMID:29767511 PMID:33634982 More... NCBI chr20:3,227,836...3,232,598
Ensembl chr20:3,227,837...3,232,598 		JBrowse link
G Ppara peroxisome proliferator activated receptor alpha multiple interactions
increases expression
decreases expression 		ISO 3-methyladenine inhibits the reaction [Arsenic Trioxide results in increased expression of PPARA protein]; MK-886 inhibits the reaction [Arsenic Trioxide results in increased expression of PPARA protein]; Taurine inhibits the reaction [Arsenic Trioxide results in increased expression of PPARA protein]
Arsenic Trioxide results in decreased expression of PPARA mRNA; Arsenic Trioxide results in decreased expression of PPARA protein 		CTD PMID:21257625 PMID:22521957 PMID:30237538 PMID:30677399 NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:118,712,412...118,780,714 		JBrowse link
G Pparg peroxisome proliferator-activated receptor gamma decreases response to substance
decreases expression
increases expression
multiple interactions 		ISO
EXP 		PPARG protein results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in decreased expression of PPARG protein
Arsenic Trioxide results in increased expression of PPARG mRNA; Arsenic Trioxide results in increased expression of PPARG protein
[Rosiglitazone binds to and results in increased activity of PPARG protein] which results in increased susceptibility to Arsenic Trioxide; [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of PPARG protein; [Troglitazone binds to and results in increased activity of PPARG protein] which results in increased susceptibility to Arsenic Trioxide; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of and results in decreased phosphorylation of PPARG protein]; Arsenic Trioxide results in increased expression of and results in decreased activity of PPARG protein; Arsenic Trioxide results in increased expression of and results in decreased phosphorylation of PPARG protein; KEAP1 protein inhibits the reaction [Arsenic Trioxide results in increased expression of PPARG mRNA]; KEAP1 protein inhibits the reaction [Arsenic Trioxide results in increased expression of PPARG protein]; NFE2L2 protein promotes the reaction [Arsenic Trioxide results in increased expression of PPARG mRNA]; Pioglitazone inhibits the reaction [Arsenic Trioxide results in increased expression of and results in decreased phosphorylation of PPARG protein]; Rosiglitazone inhibits the reaction [Arsenic Trioxide results in decreased expression of PPARG protein]; Taurine inhibits the reaction [Arsenic Trioxide results in decreased expression of PPARG protein]
Arsenic Trioxide inhibits the reaction [AKT1 protein binds to PPARG protein]; Arsenic Trioxide inhibits the reaction [RXRA protein binds to PPARG protein]; Taurine inhibits the reaction [Arsenic Trioxide results in decreased expression of PPARG protein]
Arsenic Trioxide results in decreased expression of PPARG mRNA
Nicorandil inhibits the reaction [Arsenic Trioxide results in increased expression of PPARG protein] 		CTD PMID:15916724 PMID:20707922 PMID:22684020 PMID:30362509 PMID:31258454 More... NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104 		JBrowse link
G Ppargc1a PPARG coactivator 1 alpha increases expression
multiple interactions
decreases expression 		ISO
EXP 		Arsenic Trioxide results in increased expression of PPARGC1A mRNA
Nicorandil inhibits the reaction [Arsenic Trioxide results in increased expression of PPARGC1A mRNA]; salvianolic acid A inhibits the reaction [Arsenic Trioxide results in decreased expression of PPARGC1A protein]
salvianolic acid A inhibits the reaction [Arsenic Trioxide results in decreased expression of PPARGC1A protein]; Taurine inhibits the reaction [Arsenic Trioxide results in increased expression of PPARGC1A mRNA]
Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of PPARGC1A protein] 		CTD PMID:20458559 PMID:29867492 PMID:30362509 PMID:38741475 PMID:38781725 NCBI chr14:63,073,505...63,729,215
Ensembl chr14:63,273,189...63,729,213 		JBrowse link
G Ppat phosphoribosyl pyrophosphate amidotransferase increases expression ISO Arsenic Trioxide results in increased expression of PPAT mRNA CTD PMID:22521957 NCBI chr14:31,570,010...31,604,410
Ensembl chr14:31,551,388...31,604,405 		JBrowse link
G Ppbp pro-platelet basic protein increases expression ISO Arsenic Trioxide results in increased expression of PPBP mRNA CTD PMID:19128835 NCBI chr14:17,586,495...17,587,299
Ensembl chr14:17,586,495...17,587,299 		JBrowse link
G Ppfia4 PTPRF interacting protein alpha 4 increases expression ISO Arsenic Trioxide results in increased expression of PPFIA4 mRNA CTD PMID:39716349 NCBI chr13:48,305,844...48,354,329
Ensembl chr13:48,305,848...48,354,279 		JBrowse link
G Ppia peptidylprolyl isomerase A increases expression ISO Arsenic Trioxide results in increased expression of PPIA mRNA CTD PMID:20458559 PMID:22521957 NCBI chr14:85,491,223...85,496,884
Ensembl chr14:85,492,484...85,497,115 		JBrowse link
G Ppif peptidylprolyl isomerase F increases oxidation ISO Arsenic Trioxide results in increased oxidation of PPIF protein CTD PMID:26975474 NCBI chr16:1,264,001...1,270,722
Ensembl chr16:1,263,541...1,316,954 		JBrowse link
G Ppig peptidylprolyl isomerase G increases expression ISO Arsenic Trioxide results in increased expression of PPIG mRNA CTD PMID:20458559 NCBI chr 3:74,891,846...74,923,010
Ensembl chr 3:74,891,846...74,920,750 		JBrowse link
G Ppih peptidylprolyl isomerase H increases expression ISO Arsenic Trioxide results in increased expression of PPIH mRNA CTD PMID:17547211 NCBI chr 5:138,191,624...138,209,625
Ensembl chr 5:138,191,624...138,209,580 		JBrowse link
G Ppil1 peptidylprolyl isomerase like 1 decreases expression ISO Arsenic Trioxide results in decreased expression of PPIL1 mRNA CTD PMID:35676786 NCBI chr20:7,303,919...7,323,962
Ensembl chr20:7,303,922...7,318,781 		JBrowse link
G Ppil3 peptidylprolyl isomerase like 3 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PPIL3 protein] CTD PMID:26598702 NCBI chr 9:67,460,594...67,474,325
Ensembl chr 9:67,460,595...67,474,251 		JBrowse link
G Ppm1a protein phosphatase, Mg2+/Mn2+ dependent, 1A decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of PPM1A mRNA
Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PPM1A protein] 		CTD PMID:20458559 PMID:26598702 NCBI chr 6:97,174,955...97,216,585
Ensembl chr 6:97,174,916...97,216,574 		JBrowse link
G Ppm1d protein phosphatase, Mg2+/Mn2+ dependent, 1D multiple interactions
affects activity
decreases expression
increases expression 		ISO Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of PPM1D mRNA]
MIR29A protein affects the reaction [Arsenic Trioxide results in decreased expression of PPM1D protein]; PPM1D mutant form promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of CHEK2 protein]; PPM1D mutant form promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK14 protein]
Arsenic Trioxide affects the activity of PPM1D 		CTD PMID:18482988 PMID:21175813 PMID:29095437 NCBI chr10:70,670,026...70,706,030
Ensembl chr10:70,670,020...70,706,256 		JBrowse link
G Ppm1k protein phosphatase, Mg2+/Mn2+ dependent, 1K decreases expression ISO Arsenic Trioxide results in decreased expression of PPM1K mRNA CTD PMID:39716349 NCBI chr 4:88,942,226...88,969,139
Ensembl chr 4:88,942,386...88,969,136 		JBrowse link
G Ppme1 protein phosphatase methylesterase 1 increases expression ISO Arsenic Trioxide results in increased expression of PPME1 mRNA; Arsenic Trioxide results in increased expression of PPME1 protein CTD PMID:20458559 PMID:25419056 NCBI chr 1:164,080,242...164,127,261
Ensembl chr 1:164,080,242...164,127,220 		JBrowse link
G Ppp1ca protein phosphatase 1 catalytic subunit alpha decreases expression ISO Arsenic Trioxide results in decreased expression of PPP1CA protein CTD PMID:25419056 NCBI chr 1:210,914,576...210,918,193
Ensembl chr 1:210,914,567...210,918,193 		JBrowse link
G Ppp1cb protein phosphatase 1 catalytic subunit beta decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of PPP1CB mRNA; Arsenic Trioxide results in decreased expression of PPP1CB protein
Arsenic Trioxide results in increased expression of PPP1CB protein 		CTD PMID:12852829 PMID:19364129 PMID:25419056 NCBI chr 6:29,681,099...29,712,835
Ensembl chr 6:29,681,100...29,712,924 		JBrowse link
G Ppp1r13b protein phosphatase 1, regulatory subunit 13B decreases expression ISO Arsenic Trioxide results in decreased expression of PPP1R13B mRNA CTD PMID:21461292 NCBI chr 6:136,711,834...136,785,068
Ensembl chr 6:136,711,834...136,785,113 		JBrowse link
G Ppp1r15a protein phosphatase 1, regulatory subunit 15A increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of PPP1R15A mRNA
Arsenic Trioxide results in decreased expression of PPP1R15A mRNA 		CTD PMID:22521957 PMID:25258189 PMID:27829220 NCBI chr 1:105,136,521...105,139,596
Ensembl chr 1:105,136,525...105,139,774 		JBrowse link
G Ppp1r26 protein phosphatase 1, regulatory subunit 26 decreases response to substance ISO PPP1R26 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 3:32,179,686...32,188,069
Ensembl chr 3:32,177,235...32,188,264 		JBrowse link
G Ppp1r3d protein phosphatase 1, regulatory subunit 3D decreases expression ISO Arsenic Trioxide results in decreased expression of PPP1R3D mRNA CTD PMID:22521957 NCBI chr 3:185,880,087...185,883,158
Ensembl chr 3:185,876,709...185,883,703 		JBrowse link
G Ppp1r9a protein phosphatase 1, regulatory subunit 9A decreases expression ISO Arsenic Trioxide results in decreased expression of PPP1R9A mRNA CTD PMID:26705709 NCBI chr 4:33,936,949...34,258,927
Ensembl chr 4:33,988,827...34,258,927 		JBrowse link
G Ppp2ca protein phosphatase 2 catalytic subunit alpha decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of PPP2CA protein
Arsenic Trioxide promotes the reaction [AKT1 protein binds to PPP2CA protein]; aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Arsenic Trioxide promotes the reaction [AKT1 protein binds to PPP2CA protein]]; Okadaic Acid inhibits the reaction [Arsenic Trioxide promotes the reaction [AKT1 protein binds to PPP2CA protein]]; PPP2CA protein affects the reaction [Arsenic Trioxide results in decreased expression of CXCR4 protein] 		CTD PMID:21655183 PMID:25047463 NCBI chr10:36,856,534...36,878,789 JBrowse link
G Ppp2cb protein phosphatase 2 catalytic subunit beta increases expression ISO Arsenic Trioxide results in increased expression of PPP2CB mRNA CTD PMID:20458559 PMID:29633893 NCBI chr16:65,261,178...65,282,658
Ensembl chr16:65,261,181...65,282,634 		JBrowse link
G Ppp2r2c protein phosphatase 2, regulatory subunit B, gamma multiple interactions ISO [Arsenic Trioxide co-treated with apatinib] results in increased expression of PPP2R2C mRNA CTD PMID:39223679 NCBI chr14:78,071,274...78,156,212
Ensembl chr14:78,071,274...78,156,212 		JBrowse link
G Ppp2r5a protein phosphatase 2, regulatory subunit B', alpha decreases expression ISO Arsenic Trioxide results in decreased expression of PPP2R5A mRNA CTD PMID:20458559 NCBI chr13:105,462,371...105,506,767
Ensembl chr13:105,462,371...105,506,767 		JBrowse link
G Ppp2r5e protein phosphatase 2 regulatory subunit B', epsilon decreases expression ISO Arsenic Trioxide results in decreased expression of PPP2R5E mRNA CTD PMID:39716349 NCBI chr 6:99,904,569...100,053,672
Ensembl chr 6:99,904,569...100,053,573 		JBrowse link
G Ppp3ca protein phosphatase 3 catalytic subunit alpha decreases expression
increases expression
multiple interactions 		EXP
ISO 		Arsenic Trioxide results in decreased expression of PPP3CA mRNA
Arsenic Trioxide results in increased expression of PPP3CA mRNA
Arsenic Trioxide results in increased expression of PPP3CA protein
Phloretin inhibits the reaction [Arsenic Trioxide results in increased expression of PPP3CA protein] 		CTD PMID:17963750 PMID:29223816 PMID:34037972 NCBI chr 2:227,839,058...228,113,560
Ensembl chr 2:227,839,062...228,113,554 		JBrowse link
G Ppp3cb protein phosphatase 3 catalytic subunit beta increases expression ISO Arsenic Trioxide results in increased expression of PPP3CB mRNA CTD PMID:20138156 NCBI chr15:3,809,182...3,854,204
Ensembl chr15:3,809,262...3,854,203 		JBrowse link
G Ppp4c protein phosphatase 4, catalytic subunit multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of PPP4C protein CTD PMID:15894607 NCBI chr 1:190,823,447...190,830,247
Ensembl chr 1:190,823,486...190,830,168 		JBrowse link
G Ppp5c protein phosphatase 5, catalytic subunit increases expression ISO Arsenic Trioxide results in increased expression of PPP5C mRNA CTD PMID:35676786 NCBI chr 1:86,818,297...86,842,505
Ensembl chr 1:86,818,297...86,842,950 		JBrowse link
G Ppp6c protein phosphatase 6, catalytic subunit increases expression ISO Arsenic Trioxide results in increased expression of PPP6C mRNA CTD PMID:20458559 NCBI chr 3:43,339,521...43,371,807
Ensembl chr 3:43,341,108...43,371,807 		JBrowse link
G Pprc1 PPARG related coactivator 1 multiple interactions ISO [Arsenic Trioxide co-treated with Ascorbic Acid] results in increased expression of PPRC1 mRNA CTD PMID:25555879 NCBI chr 1:254,851,136...254,867,570
Ensembl chr 1:254,851,164...254,867,570 		JBrowse link
G Pram1 PML-RARA regulated adaptor molecule 1 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of PRAM1 mRNA; Arsenic Trioxide results in increased expression of PRAM1 protein
[Arsenic Trioxide co-treated with Tretinoin] results in increased expression of PRAM1 mRNA; [monomethylarsonous acid co-treated with dimethylarsinous acid co-treated with Arsenic Trioxide] results in increased expression of PRAM1 protein; Arsenic Trioxide inhibits the reaction [PRAM1 protein results in decreased expression of MIR210 mRNA]; Arsenic Trioxide inhibits the reaction [PRAM1 protein results in decreased expression of MIR23A mRNA]; Arsenic Trioxide inhibits the reaction [PRAM1 protein results in decreased expression of RARB mRNA]; benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [PRAM1 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of JUN protein]]; PRAM1 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of JUN protein] 		CTD PMID:15637062 PMID:18941112 PMID:29774349 PMID:38179723 NCBI chr 7:15,125,813...15,142,494 JBrowse link
G Prc1 protein regulator of cytokinesis 1 increases expression ISO Arsenic Trioxide results in increased expression of PRC1 mRNA CTD PMID:20458559 NCBI chr 1:143,659,312...143,681,019
Ensembl chr 1:143,659,481...143,681,012 		JBrowse link
G Prcc proline rich mitotic checkpoint control factor multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PRCC protein] CTD PMID:26598702 NCBI chr 2:175,624,134...175,649,664
Ensembl chr 2:175,624,134...175,649,664 		JBrowse link
G Prdm8 PR/SET domain 8 multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of PRDM8 mRNA CTD PMID:15894607 NCBI chr14:11,708,477...11,728,111
Ensembl chr14:11,708,269...11,715,125 		JBrowse link
G Prdx1 peroxiredoxin 1 increases expression ISO Arsenic Trioxide results in increased expression of PRDX1 mRNA CTD PMID:20458559 NCBI chr 5:135,383,906...135,399,504
Ensembl chr 5:135,383,906...135,399,504 		JBrowse link
G Prdx2 peroxiredoxin 2 decreases expression ISO Arsenic Trioxide results in decreased expression of PRDX2 mRNA CTD PMID:21173536 NCBI chr19:40,085,788...40,091,083
Ensembl chr19:40,084,430...40,091,006 		JBrowse link
G Prdx3 peroxiredoxin 3 decreases expression
increases expression
multiple interactions
increases oxidation
affects response to substance 		ISO Arsenic Trioxide results in decreased expression of PRDX3 mRNA; Arsenic Trioxide results in decreased expression of PRDX3 protein
Arsenic Trioxide results in increased expression of PRDX3 mRNA; Arsenic Trioxide results in increased expression of PRDX3 protein
Arsenic Trioxide inhibits the reaction [MYC protein binds to PRDX3 protein]; Arsenic Trioxide inhibits the reaction [MYC protein results in increased activity of PRDX3 protein]; PRDX3 protein affects the reaction [Arsenic Trioxide results in increased cleavage of and results in increased activity of PARP1 protein]
Arsenic Trioxide results in increased oxidation of PRDX3 protein
PRDX3 protein affects the susceptibility to Arsenic Trioxide 		CTD PMID:19364129 PMID:19408305 PMID:22521957 PMID:26975474 NCBI chr 1:269,987,691...270,000,111
Ensembl chr 1:269,987,685...270,000,300 		JBrowse link
G Prdx4 peroxiredoxin 4 increases expression ISO Arsenic Trioxide results in increased expression of PRDX4 protein CTD PMID:19364129 NCBI chr  X:43,876,374...43,893,815
Ensembl chr  X:43,876,417...43,893,812 		JBrowse link
G Prdx5 peroxiredoxin 5 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of PRDX5 mRNA
[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of PRDX5 mRNA; TGM2 protein affects the reaction [[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of PRDX5 mRNA] 		CTD PMID:25258189 PMID:37446117 NCBI chr 1:213,529,042...213,532,787
Ensembl chr 1:213,529,035...213,533,020 		JBrowse link
G Prelp proline and arginine rich end leucine rich repeat protein decreases expression ISO Arsenic Trioxide results in decreased expression of PRELP mRNA CTD PMID:20458559 PMID:26705709 NCBI chr13:47,920,480...47,943,547
Ensembl chr13:47,922,590...47,932,324 		JBrowse link
G Prg3 proteoglycan 3, pro eosinophil major basic protein 2 increases expression ISO Arsenic Trioxide results in increased expression of PRG3 mRNA CTD PMID:15761015 NCBI chr 3:90,478,627...90,484,760
Ensembl chr 3:90,479,154...90,484,759 		JBrowse link
G Prg4 proteoglycan 4 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of PRG4 mRNA
Arsenic Trioxide results in decreased expression of PRG4 mRNA 		CTD PMID:20458559 PMID:35676786 NCBI chr13:65,037,363...65,054,764
Ensembl chr13:65,037,363...65,054,508 		JBrowse link
G Prkaa1 protein kinase AMP-activated catalytic subunit alpha 1 increases expression
multiple interactions 		ISO
EXP 		Arsenic Trioxide results in increased expression of PRKAA1 mRNA
Arsenic Trioxide affects the expression of and affects the phosphorylation of PRKAA1 protein; Nicorandil affects the reaction [Arsenic Trioxide affects the expression of and affects the phosphorylation of PRKAA1 protein] 		CTD PMID:30032600 PMID:32112876 PMID:38741475 NCBI chr 2:55,967,766...56,003,450
Ensembl chr 2:55,967,351...56,003,450 		JBrowse link
G Prkaca protein kinase cAMP-activated catalytic subunit alpha multiple interactions ISO PRKACA protein affects the reaction [Arsenic Trioxide results in increased expression of HMOX1 mRNA]; PRKACA protein affects the reaction [Arsenic Trioxide results in increased expression of TXN mRNA]; PRKACA protein affects the reaction [TRIM44 protein promotes the reaction [Arsenic Trioxide results in increased expression of HMOX1 mRNA]]; PRKACA protein affects the reaction [TRIM44 protein promotes the reaction [Arsenic Trioxide results in increased expression of TXN mRNA]] CTD PMID:39152142 NCBI chr19:41,059,843...41,083,189
Ensembl chr19:41,059,843...41,086,494 		JBrowse link
G Prkar1a protein kinase cAMP-dependent type I regulatory subunit alpha increases expression ISO Arsenic Trioxide results in increased expression of PRKAR1A mRNA CTD PMID:22521957 NCBI chr10:95,120,537...95,139,028
Ensembl chr10:95,120,487...95,139,025 		JBrowse link
G Prkar1b protein kinase cAMP-dependent type I regulatory subunit beta decreases expression ISO Arsenic Trioxide results in decreased expression of PRKAR1B mRNA CTD PMID:21461292 NCBI chr12:20,606,066...20,738,766
Ensembl chr12:20,618,757...20,738,766 		JBrowse link
G Prkca protein kinase C, alpha decreases expression
affects response to substance
multiple interactions 		ISO
EXP 		Arsenic Trioxide results in decreased expression of PRKCA mRNA
PRKCA mRNA affects the susceptibility to Arsenic Trioxide
Arsenic Trioxide promotes the reaction [Berberine results in decreased activity of PRKCA protein] 		CTD PMID:18294404 PMID:23911876 PMID:24831965 NCBI chr10:93,388,991...93,787,617
Ensembl chr10:93,388,991...93,787,572 		JBrowse link
G Prkcb protein kinase C, beta multiple interactions
decreases expression
increases expression
affects response to substance 		ISO Tretinoin promotes the reaction [Arsenic Trioxide results in increased expression of PRKCB mRNA]
Arsenic Trioxide results in decreased expression of PRKCB mRNA
PRKCB mRNA affects the susceptibility to Arsenic Trioxide 		CTD PMID:10673743 PMID:15725085 PMID:23911876 PMID:29442453 NCBI chr 1:186,263,397...186,594,743
Ensembl chr 1:186,263,447...186,594,740 		JBrowse link
G Prkcd protein kinase C, delta multiple interactions
increases phosphorylation 		ISO
EXP 		[Arsenic Trioxide co-treated with Bortezomib] results in increased cleavage of and results in increased activity of PRKCD protein; Arsenic Trioxide results in increased cleavage of and results in increased activity of PRKCD protein
Arsenic Trioxide results in increased phosphorylation of PRKCD protein 		CTD PMID:17495969 PMID:19662097 PMID:29986281 NCBI chr16:5,775,681...5,806,122
Ensembl chr16:5,775,681...5,805,839 		JBrowse link
G Prkce protein kinase C, epsilon affects localization
multiple interactions 		EXP Arsenic Trioxide affects the localization of PRKCE protein
Arsenic Trioxide promotes the reaction [Berberine results in decreased activity of PRKCE protein] 		CTD PMID:18294404 NCBI chr 6:13,718,050...14,204,931
Ensembl chr 6:13,718,050...14,204,288 		JBrowse link
G Prkch protein kinase C, eta increases expression ISO Arsenic Trioxide results in increased expression of PRKCH mRNA CTD PMID:20458559 NCBI chr 6:98,027,830...98,226,486
Ensembl chr 6:98,027,646...98,226,477 		JBrowse link
G Prkcz protein kinase C, zeta affects response to substance ISO PRKCZ mRNA affects the susceptibility to Arsenic Trioxide CTD PMID:23911876 NCBI chr 5:171,101,774...171,212,694
Ensembl chr 5:171,101,774...171,212,674 		JBrowse link
G Prkd3 protein kinase D3 increases expression ISO Arsenic Trioxide results in increased expression of PRKD3 mRNA CTD PMID:20458559 NCBI chr 6:21,784,665...21,860,600
Ensembl chr 6:21,784,673...21,860,600 		JBrowse link
G Prkn parkin RBR E3 ubiquitin protein ligase multiple interactions
decreases expression
affects localization 		EXP
ISO 		Taurine inhibits the reaction [Arsenic Trioxide results in decreased expression of PRKN protein]
Arsenic Trioxide affects the localization of PRKN protein 		CTD PMID:24801902 PMID:30551535 NCBI chr 1:51,236,410...52,430,242
Ensembl chr 1:51,210,330...52,430,304 		JBrowse link
G Prlr prolactin receptor decreases expression ISO Arsenic Trioxide results in decreased expression of PRLR mRNA CTD PMID:39716349 NCBI chr 2:60,861,391...61,051,883
Ensembl chr 2:60,861,658...61,051,882 		JBrowse link
G Prmt1 protein arginine methyltransferase 1 decreases expression ISO Arsenic Trioxide results in decreased expression of PRMT1 mRNA CTD PMID:20458559 NCBI chr 1:104,595,339...104,605,552
Ensembl chr 1:104,595,335...104,604,827 		JBrowse link
G Prmt5 protein arginine methyltransferase 5 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PRMT5 protein] CTD PMID:26598702 NCBI chr15:31,938,927...31,948,318
Ensembl chr15:31,938,719...31,948,426 		JBrowse link
G Prnp prion protein multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PRNP protein] CTD PMID:26598702 NCBI chr 3:139,639,076...139,654,420
Ensembl chr 3:139,630,144...139,658,436 		JBrowse link
G Prom1 prominin 1 decreases response to substance
decreases expression
increases expression
multiple interactions 		ISO PROM1 protein results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in decreased expression of PROM1 mRNA; Arsenic Trioxide results in decreased expression of PROM1 protein
Arsenic Trioxide results in increased expression of PROM1 mRNA; Arsenic Trioxide results in increased expression of PROM1 protein
Arsenic Trioxide inhibits the reaction [PROM1 protein results in increased activity of NOTCH1 protein]; Arsenic Trioxide inhibits the reaction [PROM1 protein results in increased expression of HES1 mRNA]; ICG 001 affects the reaction [RORB protein affects the reaction [Arsenic Trioxide results in decreased expression of PROM1 protein]]; RORB protein affects the reaction [Arsenic Trioxide results in decreased expression of PROM1 protein]; SOX2 protein affects the reaction [Arsenic Trioxide results in increased expression of PROM1 protein] 		CTD PMID:21788103 PMID:23832679 PMID:24685274 PMID:29396848 PMID:30748021 More... NCBI chr14:71,202,303...71,307,008
Ensembl chr14:71,202,336...71,307,002 		JBrowse link
G Prom2 prominin 2 increases expression ISO Arsenic Trioxide results in increased expression of PROM2 mRNA CTD PMID:39716349 NCBI chr 3:135,200,944...135,215,130
Ensembl chr 3:135,200,944...135,215,077 		JBrowse link
G Prpf18 pre-mRNA processing factor 18 multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of PRPF18 mRNA CTD PMID:15894607 NCBI chr17:78,539,004...78,570,483
Ensembl chr17:78,539,839...78,600,250 		JBrowse link
G Prpf40a pre-mRNA processing factor 40 homolog A increases expression ISO Arsenic Trioxide results in increased expression of PRPF40A mRNA CTD PMID:35676786 NCBI chr 3:58,036,779...58,098,996
Ensembl chr 3:58,038,042...58,099,363 		JBrowse link
G Prpf8 pre-mRNA processing factor 8 multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of PRPF8 mRNA CTD PMID:15894607 NCBI chr10:60,829,778...60,852,887
Ensembl chr10:60,829,778...60,852,887 		JBrowse link
G Prps1 phosphoribosyl pyrophosphate synthetase 1 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of PRPS1 mRNA
Arsenic Trioxide results in decreased expression of PRPS1 protein 		CTD PMID:20458559 PMID:25419056 NCBI chr  X:108,920,663...108,942,713
Ensembl chr  X:108,920,651...108,942,711 		JBrowse link
G Prps2 phosphoribosyl pyrophosphate synthetase 2 multiple interactions
increases expression 		ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PRPS2 protein]
Arsenic Trioxide results in increased expression of PRPS2 protein 		CTD PMID:25419056 PMID:26598702 NCBI chr  X:30,592,845...30,630,127
Ensembl chr  X:30,593,019...30,630,126 		JBrowse link
G Prr16 proline rich 16 decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of PRR16 mRNA
Arsenic Trioxide results in increased expression of PRR16 mRNA 		CTD PMID:15761015 PMID:26705709 NCBI chr18:46,622,816...46,963,251
Ensembl chr18:46,623,058...46,830,385 		JBrowse link
G Prr3 proline rich 3 increases response to substance ISO PRR3 protein results in increased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr20:2,797,677...2,804,674
Ensembl chr20:2,797,105...2,798,617 		JBrowse link
G Prr5 proline rich 5 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of PRR5 mRNA
Arsenic Trioxide results in decreased expression of PRR5-ARHGAP8 mRNA 		CTD PMID:39716349 NCBI chr 7:117,675,308...117,717,833
Ensembl chr 7:117,675,383...117,717,831 		JBrowse link
G Prrc1 proline-rich coiled-coil 1 increases expression ISO Arsenic Trioxide results in increased expression of PRRC1 mRNA CTD PMID:22521957 NCBI chr18:53,010,606...53,047,601
Ensembl chr18:53,010,600...53,045,015 		JBrowse link
G Prrc2c proline-rich coiled-coil 2C increases response to substance
decreases expression 		ISO PRRC2C protein results in increased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in decreased expression of PRRC2C mRNA 		CTD PMID:20707922 PMID:39716349 NCBI chr13:77,537,226...77,606,926
Ensembl chr13:77,537,814...77,607,001 		JBrowse link
G Prrg1 proline rich and Gla domain 1 increases expression ISO Arsenic Trioxide results in increased expression of PRRG1 mRNA CTD PMID:20458559 NCBI chr  X:46,381,329...46,493,677
Ensembl chr  X:46,383,967...46,493,700 		JBrowse link
G Prss1 serine protease 1 increases expression ISO Arsenic Trioxide results in increased expression of PRSS1 mRNA CTD PMID:15761015 NCBI chr 4:71,331,249...71,334,452
Ensembl chr 4:71,331,246...71,334,452 		JBrowse link
G Prss16 serine protease 16 decreases expression ISO Arsenic Trioxide results in decreased expression of PRSS16 mRNA CTD PMID:39716349 NCBI chr17:47,210,071...47,225,377
Ensembl chr17:47,210,081...47,217,658 		JBrowse link
G Prss35 serine protease 35 decreases expression ISO Arsenic Trioxide results in decreased expression of PRSS35 mRNA CTD PMID:35676786 NCBI chr 8:96,594,460...96,610,992
Ensembl chr 8:96,590,571...96,613,024 		JBrowse link
G Prtn3 proteinase 3 multiple interactions ISO Arsenic Trioxide promotes the reaction [Tretinoin results in decreased expression of PRTN3 mRNA] CTD PMID:26892147 NCBI chr 7:10,472,750...10,482,037
Ensembl chr 7:10,472,755...10,482,474 		JBrowse link
G Prxl2b peroxiredoxin like 2B decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of PRXL2B mRNA
Arsenic Trioxide results in increased expression of PRXL2B mRNA 		CTD PMID:24356939 PMID:39716349 NCBI chr 5:170,744,953...170,747,556
Ensembl chr 5:170,744,953...170,747,556 		JBrowse link
G Psat1 phosphoserine aminotransferase 1 decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of PSAT1 mRNA
Arsenic Trioxide results in increased expression of PSAT1 mRNA 		CTD PMID:19128835 PMID:34108876 NCBI chr 1:222,623,553...222,646,187
Ensembl chr 1:222,623,556...222,655,693 		JBrowse link
G Psd3 pleckstrin and Sec7 domain containing 3 decreases expression ISO Arsenic Trioxide results in decreased expression of PSD3 mRNA CTD PMID:19128835 NCBI chr16:26,238,595...26,802,535
Ensembl chr16:26,340,028...26,802,535 		JBrowse link
G Psma1 proteasome 20S subunit alpha 1 increases expression ISO Arsenic Trioxide results in increased expression of PSMA1 mRNA CTD PMID:20458559 NCBI chr 1:177,876,838...177,887,857
Ensembl chr 1:177,875,353...177,887,949 		JBrowse link
G Psma5 proteasome 20S subunit alpha 5 decreases expression ISO Arsenic Trioxide results in decreased expression of PSMA5 protein CTD PMID:19364129 NCBI chr 2:198,584,502...198,607,867
Ensembl chr 2:198,584,505...198,607,867 		JBrowse link
G Psma6 proteasome 20S subunit alpha 6 increases expression ISO Arsenic Trioxide results in increased expression of PSMA6 mRNA CTD PMID:20458559 NCBI chr 6:78,500,676...78,531,693
Ensembl chr 6:78,500,736...78,531,717 		JBrowse link
G Psma7 proteasome 20S subunit alpha 7 increases expression ISO Arsenic Trioxide results in increased expression of PSMA7 mRNA CTD PMID:29633893 PMID:39716349 NCBI chr 3:187,514,901...187,521,289
Ensembl chr 3:187,513,441...187,521,253 		JBrowse link
G Psmb1 proteasome 20S subunit beta 1 increases expression ISO Arsenic Trioxide results in increased expression of PSMB1 mRNA; Arsenic Trioxide results in increased expression of PSMB1 protein CTD PMID:19549367 PMID:29633893 NCBI chr 1:65,115,770...65,136,516
Ensembl chr 1:65,114,724...65,136,640 		JBrowse link
G Psmb3 proteasome 20S subunit beta 3 increases expression ISO Arsenic Trioxide results in increased expression of PSMB3 mRNA CTD PMID:25258189 PMID:29633893 NCBI chr10:83,193,787...83,200,883
Ensembl chr10:83,193,787...83,200,883 		JBrowse link
G Psmb4 proteasome 20S subunit beta 4 increases expression ISO Arsenic Trioxide results in increased expression of PSMB4 mRNA CTD PMID:20458559 PMID:29633893 NCBI chr 2:185,131,787...185,134,561
Ensembl chr 2:185,131,786...185,135,287 		JBrowse link
G Psmb6 proteasome 20S subunit beta 6 multiple interactions
increases expression 		ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PSMB6 protein]
Arsenic Trioxide results in increased expression of PSMB6 mRNA 		CTD PMID:12852829 PMID:26598702 PMID:29633893 NCBI chr10:55,737,852...55,740,218
Ensembl chr10:55,737,888...55,740,218 		JBrowse link
G Psmb8 proteasome 20S subunit beta 8 decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of PSMB8 mRNA; Arsenic Trioxide results in decreased expression of PSMB8 protein
[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of PSMB8 mRNA 		CTD PMID:15725085 PMID:15894607 PMID:19364129 PMID:27829220 NCBI chr20:4,654,068...4,657,049
Ensembl chr20:4,654,068...4,657,031 		JBrowse link
G Psmb9 proteasome 20S subunit beta 9 decreases expression ISO Arsenic Trioxide results in decreased expression of PSMB9 mRNA CTD PMID:39716349 NCBI chr20:4,668,952...4,674,421
Ensembl chr20:4,668,739...4,674,421 		JBrowse link
G Psmc2 proteasome 26S subunit, ATPase 2 multiple interactions
decreases expression 		ISO [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of PSMC2 mRNA
Arsenic Trioxide results in decreased expression of PSMC2 protein 		CTD PMID:15894607 PMID:19364129 NCBI chr 4:14,148,080...14,162,390
Ensembl chr 4:14,148,090...14,162,390 		JBrowse link
G Psmc3 proteasome 26S subunit, ATPase 3 multiple interactions
increases expression 		ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PSMC3 protein]
Arsenic Trioxide results in increased expression of PSMC3 mRNA 		CTD PMID:26598702 PMID:29633893 NCBI chr 3:97,487,643...97,493,025
Ensembl chr 3:97,487,632...97,499,176 		JBrowse link
G Psmc4 proteasome 26S subunit, ATPase 4 increases expression ISO Arsenic Trioxide results in increased expression of PSMC4 mRNA CTD PMID:29633893 NCBI chr 1:92,476,690...92,485,268
Ensembl chr 1:92,476,690...92,485,060 		JBrowse link
G Psmd1 proteasome 26S subunit, non-ATPase 1 increases expression ISO Arsenic Trioxide results in increased expression of PSMD1 mRNA CTD PMID:20458559 PMID:29633893 NCBI chr 9:94,157,971...94,233,218
Ensembl chr 9:94,157,971...94,233,218 		JBrowse link
G Psmd11 proteasome 26S subunit, non-ATPase 11 increases expression ISO Arsenic Trioxide results in increased expression of PSMD11 mRNA CTD PMID:15894607 PMID:25258189 PMID:29633893 NCBI chr10:65,923,669...65,977,523
Ensembl chr10:65,931,279...65,976,234 		JBrowse link
G Psmd12 proteasome 26S subunit, non-ATPase 12 increases expression ISO Arsenic Trioxide results in increased expression of PSMD12 protein CTD PMID:25419056 NCBI chr10:92,937,957...92,956,601
Ensembl chr10:92,901,133...92,988,964 		JBrowse link
G Psmd13 proteasome 26S subunit, non-ATPase 13 multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of PSMD13 mRNA CTD PMID:15894607 NCBI chr 1:205,394,248...205,406,525
Ensembl chr 1:205,393,746...205,411,651 		JBrowse link
G Psmd3 proteasome 26S subunit, non-ATPase 3 multiple interactions
increases expression 		ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PSMD3 protein]
Arsenic Trioxide results in increased expression of PSMD3 mRNA 		CTD PMID:26598702 PMID:29633893 NCBI chr10:84,139,249...84,151,879
Ensembl chr10:84,139,677...84,151,878 		JBrowse link
G Psmd7 proteasome 26S subunit, non-ATPase 7 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of PSMD7 mRNA
Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PSMD7 protein] 		CTD PMID:26598702 PMID:29633893 NCBI chr19:52,404,032...52,411,316
Ensembl chr19:52,404,032...52,417,871 		JBrowse link
G Psmd8 proteasome 26S subunit, non-ATPase 8 increases expression ISO Arsenic Trioxide results in increased expression of PSMD8 mRNA CTD PMID:20458559 NCBI chr 1:93,601,857...93,608,689
Ensembl chr 1:93,601,853...93,608,689 		JBrowse link
G Psme2 proteasome activator subunit 2 increases expression ISO Arsenic Trioxide results in increased expression of PSME2 protein CTD PMID:25419056 NCBI chr15:33,048,452...33,053,055
Ensembl chr15:33,048,457...33,053,102 		JBrowse link
G Psme3 proteasome activator subunit 3 decreases expression ISO Arsenic Trioxide results in decreased expression of PSME3 protein CTD PMID:19364129 NCBI chr10:86,757,933...86,765,719
Ensembl chr10:86,757,899...86,818,033 		JBrowse link
G Psme4 proteasome activator subunit 4 increases expression ISO Arsenic Trioxide results in increased expression of PSME4 mRNA CTD PMID:22521957 PMID:26705709 NCBI chr14:108,706,643...108,810,330
Ensembl chr14:108,706,643...108,810,328 		JBrowse link
G Pspc1 paraspeckle component 1 decreases expression ISO Arsenic Trioxide results in decreased expression of PSPC1 protein CTD PMID:19364129 NCBI chr15:34,941,445...35,027,460
Ensembl chr15:34,967,477...35,026,828 		JBrowse link
G Psph phosphoserine phosphatase increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of PSPH mRNA
Arsenic Trioxide results in decreased expression of PSPH protein 		CTD PMID:25258189 PMID:25419056 NCBI chr12:32,527,091...32,541,182
Ensembl chr12:32,519,269...32,541,180 		JBrowse link
G Pstk phosphoseryl-tRNA kinase decreases response to substance ISO PSTK gene mutant form results in decreased susceptibility to Arsenic Trioxide CTD PMID:30815697 NCBI chr 1:195,587,911...195,598,326
Ensembl chr 1:195,587,890...195,604,035 		JBrowse link
G Ptbp3 polypyrimidine tract binding protein 3 increases expression ISO Arsenic Trioxide results in increased expression of PTBP3 mRNA CTD PMID:17258074 NCBI chr 5:79,108,376...79,194,533
Ensembl chr 5:79,108,376...79,194,508 		JBrowse link
G Ptch1 patched 1 decreases expression
multiple interactions 		ISO
EXP 		Arsenic Trioxide results in decreased expression of PTCH1 mRNA
[Arsenic Trioxide co-treated with Curcumin] inhibits the reaction [Cisplatin results in increased expression of PTCH1 mRNA]; Arsenic Trioxide inhibits the reaction [Cisplatin results in increased expression of PTCH1 mRNA] 		CTD PMID:23861973 PMID:24685274 PMID:31612257 NCBI chr17:1,548,449...1,613,461
Ensembl chr17:1,548,449...1,613,461 		JBrowse link
G Pten phosphatase and tensin homolog increases expression
multiple interactions
increases response to substance
decreases expression 		ISO
EXP 		Arsenic Trioxide results in increased expression of PTEN mRNA; Arsenic Trioxide results in increased expression of PTEN protein
MAPK8 protein affects the reaction [Arsenic Trioxide results in increased expression of PTEN protein]; MIR19A inhibits the reaction [Arsenic Trioxide results in increased expression of PTEN protein]; PTEN protein promotes the reaction [Arsenic Trioxide results in decreased phosphorylation of WEE1 protein]; PTEN protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of CDK1 protein]; pyrazolanthrone inhibits the reaction [Arsenic Trioxide results in increased expression of PTEN protein]; salvin promotes the reaction [Arsenic Trioxide results in increased expression of PTEN mRNA]
PTEN protein results in increased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in decreased expression of PTEN mRNA
dapagliflozin inhibits the reaction [Arsenic Trioxide results in decreased expression of PTEN mRNA]
Arsenic Trioxide results in decreased expression of PTEN protein 		CTD PMID:20534739 PMID:20857258 PMID:22185283 PMID:22521957 PMID:22730174 More... NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:240,043,707...240,110,330 		JBrowse link
G Ptgdr2 prostaglandin D2 receptor 2 increases expression ISO Arsenic Trioxide results in increased expression of PTGDR2 mRNA CTD PMID:15761015 NCBI chr 1:217,010,183...217,015,044
Ensembl chr 1:216,995,629...217,022,393 		JBrowse link
G Ptger2 prostaglandin E receptor 2 decreases expression ISO Arsenic Trioxide results in decreased expression of PTGER2 mRNA CTD PMID:20458559 NCBI chr15:20,694,765...20,708,475
Ensembl chr15:20,696,013...20,708,950 		JBrowse link
G Ptges prostaglandin E synthase multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Arsenic Trioxide] results in increased expression of PTGES mRNA CTD PMID:18922899 NCBI chr 3:34,575,643...34,586,987
Ensembl chr 3:34,575,639...34,586,995 		JBrowse link
G Ptges3 prostaglandin E synthase 3 increases expression ISO Arsenic Trioxide results in increased expression of PTGES3 mRNA CTD PMID:20458559 NCBI chr 7:1,075,230...1,092,363
Ensembl chr 7:1,075,227...1,092,695 		JBrowse link
G Ptgfr prostaglandin F receptor decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of PTGFR mRNA
Arsenic Trioxide results in increased expression of PTGFR mRNA 		CTD PMID:15761015 PMID:26705709 NCBI chr 2:243,390,820...243,426,647
Ensembl chr 2:243,393,350...243,425,623 		JBrowse link
G Ptgr1 prostaglandin reductase 1 increases expression ISO Arsenic Trioxide results in increased expression of PTGR1 mRNA CTD PMID:20458559 PMID:22521957 NCBI chr 5:78,579,060...78,597,671
Ensembl chr 5:78,579,057...78,597,811 		JBrowse link
G Ptgs1 prostaglandin-endoperoxide synthase 1 multiple interactions
decreases expression 		ISO Arsenic Trioxide inhibits the reaction [Tretinoin results in increased expression of PTGS1 protein]
Arsenic Trioxide results in decreased expression of PTGS1 mRNA 		CTD PMID:18354491 PMID:26705709 PMID:38758479 NCBI chr 3:39,981,419...40,002,993
Ensembl chr 3:39,981,415...40,002,990 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions
decreases expression
increases expression 		ISO
EXP 		[Genistein co-treated with Arsenic Trioxide] results in decreased expression of PTGS2 protein; Arsenic Trioxide promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]
3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [Arsenic Trioxide results in decreased expression of PTGS2 mRNA]; 3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [Arsenic Trioxide results in decreased expression of PTGS2 protein]; [Arsenic Trioxide co-treated with Dexamethasone] results in decreased expression of PTGS2 protein; [Genistein co-treated with Arsenic Trioxide] results in decreased expression of PTGS2 protein; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of PTGS2 mRNA]; Arsenic Trioxide results in decreased expression of and affects the localization of PTGS2 protein; CAT protein inhibits the reaction [Arsenic Trioxide results in increased expression of PTGS2 mRNA]; Celecoxib promotes the reaction [Arsenic Trioxide results in decreased expression of PTGS2 mRNA]; Celecoxib promotes the reaction [Arsenic Trioxide results in decreased expression of PTGS2 protein]; Cyclosporine inhibits the reaction [Arsenic Trioxide results in decreased expression of PTGS2 mRNA]; Cyclosporine inhibits the reaction [Arsenic Trioxide results in decreased expression of PTGS2 protein]; Melatonin inhibits the reaction [Arsenic Trioxide results in increased expression of PTGS2 mRNA]; Melatonin inhibits the reaction [Arsenic Trioxide results in increased expression of PTGS2 protein]; Potassium Iodide inhibits the reaction [Arsenic Trioxide results in increased expression of PTGS2 mRNA]; Potassium Iodide inhibits the reaction [Arsenic Trioxide results in increased expression of PTGS2 protein]; PTGS2 protein affects the reaction [Arsenic Trioxide results in increased expression of NANOG protein]; PTGS2 protein affects the reaction [Arsenic Trioxide results in increased expression of POU5F1 protein]; PTGS2 protein affects the reaction [Arsenic Trioxide results in increased expression of SOX2 protein]; SOX2 protein affects the reaction [PTGS2 protein affects the reaction [Arsenic Trioxide results in increased expression of NANOG protein]]; SOX2 protein affects the reaction [PTGS2 protein affects the reaction [Arsenic Trioxide results in increased expression of POU5F1 protein]]; SOX2 protein affects the reaction [PTGS2 protein affects the reaction [Arsenic Trioxide results in increased expression of SOX2 protein]]; zinc protoporphyrin promotes the reaction [Arsenic Trioxide results in increased expression of PTGS2]
Arsenic Trioxide results in decreased expression of PTGS2; Arsenic Trioxide results in decreased expression of PTGS2 mRNA; Arsenic Trioxide results in decreased expression of PTGS2 protein
Arsenic Trioxide results in increased expression of PTGS2; Arsenic Trioxide results in increased expression of PTGS2 mRNA; Arsenic Trioxide results in increased expression of PTGS2 protein
Febuxostat inhibits the reaction [Arsenic Trioxide results in increased expression of PTGS2 protein]; Nicorandil inhibits the reaction [Arsenic Trioxide results in increased expression of PTGS2 protein] 		CTD PMID:15547942 PMID:17530438 PMID:18588940 PMID:19236750 PMID:20339114 More... NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320 		JBrowse link
G Ptk2b protein tyrosine kinase 2 beta affects expression ISO Arsenic Trioxide affects the expression of PTK2B mRNA CTD PMID:28786057 NCBI chr15:44,536,275...44,656,754
Ensembl chr15:44,531,249...44,656,806 		JBrowse link
G Ptk6 protein tyrosine kinase 6 decreases response to substance ISO PTK6 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 3:188,684,633...188,693,224
Ensembl chr 3:188,684,633...188,693,224 		JBrowse link
G Ptma prothymosin alpha affects expression ISO Arsenic Trioxide affects the expression of PTMA mRNA CTD PMID:28786057 NCBI chr 9:94,624,194...94,628,276
Ensembl chr 9:94,624,196...94,628,276 		JBrowse link
G Ptpdc1 protein tyrosine phosphatase domain containing 1 decreases expression ISO Arsenic Trioxide results in decreased expression of PTPDC1 mRNA CTD PMID:20458559 NCBI chr17:16,235,311...16,284,160
Ensembl chr17:16,235,263...16,284,158 		JBrowse link
G Ptpn1 protein tyrosine phosphatase, non-receptor type 1 decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of PTPN1 mRNA
Acetylcysteine inhibits the reaction [Arsenic Trioxide promotes the reaction [Pamidronate results in decreased expression of and results in decreased activity of PTPN1 protein]]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in decreased expression of and results in decreased activity of PTPN1 protein]; Acetylcysteine inhibits the reaction [Pamidronate promotes the reaction [Arsenic Trioxide results in decreased expression of and results in decreased activity of PTPN1 protein]]; Arsenic Trioxide promotes the reaction [Pamidronate results in decreased expression of and results in decreased activity of PTPN1 protein]; Arsenic Trioxide results in decreased expression of and results in decreased activity of PTPN1 protein; Pamidronate promotes the reaction [Arsenic Trioxide results in decreased expression of and results in decreased activity of PTPN1 protein] 		CTD PMID:22521957 PMID:32337366 NCBI chr 3:177,056,588...177,106,424
Ensembl chr 3:177,057,659...177,106,416 		JBrowse link
G Ptpn11 protein tyrosine phosphatase, non-receptor type 11 decreases expression ISO Arsenic Trioxide results in decreased expression of PTPN11 mRNA CTD PMID:19763917 NCBI chr12:41,026,079...41,085,577
Ensembl chr12:41,043,785...41,085,577 		JBrowse link
G Ptpn13 protein tyrosine phosphatase, non-receptor type 13 decreases expression ISO Arsenic Trioxide results in decreased expression of PTPN13 mRNA CTD PMID:34108876 NCBI chr14:6,412,841...6,587,238
Ensembl chr14:6,412,841...6,587,171 		JBrowse link
G Ptpn21 protein tyrosine phosphatase, non-receptor type 21 decreases expression ISO Arsenic Trioxide results in decreased expression of PTPN21 mRNA CTD PMID:25258189 NCBI chr 6:123,662,783...123,727,809
Ensembl chr 6:123,662,783...123,727,809 		JBrowse link
G Ptpn6 protein tyrosine phosphatase, non-receptor type 6 increases expression
multiple interactions
decreases methylation 		ISO Arsenic Trioxide results in increased expression of PTPN6 mRNA; Arsenic Trioxide results in increased expression of PTPN6 protein
[Arsenic Trioxide co-treated with Decitabine] results in increased expression of PTPN6 mRNA; Arsenic Trioxide results in decreased methylation of and results in increased expression of PTPN6; pervanadate inhibits the reaction [Arsenic Trioxide results in increased expression of PTPN6 protein]; PTPN6 protein affects the reaction [Arsenic Trioxide results in decreased phosphorylation of JAK2 protein]; PTPN6 protein affects the reaction [Arsenic Trioxide results in decreased phosphorylation of STAT3 protein]
Arsenic Trioxide results in decreased methylation of PTPN6 promoter 		CTD PMID:19619438 PMID:19950550 PMID:23815908 PMID:24762999 PMID:29409467 More... NCBI chr 4:159,212,320...159,237,069
Ensembl chr 4:159,212,320...159,237,069 		JBrowse link
G Ptprc protein tyrosine phosphatase, receptor type, C increases response to substance
affects response to substance
increases expression 		ISO PTPRC protein results in increased susceptibility to Arsenic Trioxide
PTPRC protein alternative form affects the susceptibility to Arsenic Trioxide
Arsenic Trioxide results in increased expression of PTPRC mRNA; Arsenic Trioxide results in increased expression of PTPRC protein 		CTD PMID:20707922 PMID:25410152 NCBI chr13:52,147,717...52,259,810
Ensembl chr13:52,147,717...52,259,746 		JBrowse link
G Ptpre protein tyrosine phosphatase, receptor type, E increases expression ISO Arsenic Trioxide results in increased expression of PTPRE mRNA CTD PMID:22521957 NCBI chr 1:199,774,195...199,924,646
Ensembl chr 1:199,774,198...199,922,242 		JBrowse link
G Ptprk protein tyrosine phosphatase, receptor type, K decreases expression ISO Arsenic Trioxide results in decreased expression of PTPRK mRNA CTD PMID:39716349 NCBI chr 1:18,557,091...19,056,297
Ensembl chr 1:18,558,365...19,056,107 		JBrowse link
G Ptprn2 protein tyrosine phosphatase, receptor type N2 increases expression ISO Arsenic Trioxide results in increased expression of PTPRN2 mRNA CTD PMID:26705709 NCBI chr 6:143,582,568...144,334,573
Ensembl chr 6:143,582,547...144,336,744 		JBrowse link
G Ptpro protein tyrosine phosphatase, receptor type, O decreases expression ISO Arsenic Trioxide results in decreased expression of PTPRO mRNA CTD PMID:26705709 NCBI chr 4:171,895,104...172,105,911
Ensembl chr 4:171,895,232...172,105,903 		JBrowse link
G Ptpru protein tyrosine phosphatase, receptor type, U increases expression ISO Arsenic Trioxide results in increased expression of PTPRU mRNA CTD PMID:35676786 NCBI chr 5:149,234,624...149,308,857
Ensembl chr 5:149,234,624...149,308,833 		JBrowse link
G Ptrh2 peptidyl-tRNA hydrolase 2 increases expression ISO Arsenic Trioxide results in increased expression of PTRH2 mRNA CTD PMID:14703492 NCBI chr10:72,002,450...72,012,606
Ensembl chr10:71,985,245...72,045,352 		JBrowse link
G Pttg1 PTTG1 regulator of sister chromatid separation, securin multiple interactions
increases expression 		ISO 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin promotes the reaction [Arsenic Trioxide results in increased expression of PTTG1 protein]; KNK 437 promotes the reaction [Arsenic Trioxide results in increased expression of PTTG1 protein]
Arsenic Trioxide results in increased expression of PTTG1 mRNA; Arsenic Trioxide results in increased expression of PTTG1 protein 		CTD PMID:17547211 PMID:19371599 NCBI chr10:28,394,940...28,406,410
Ensembl chr10:28,394,814...28,406,309 		JBrowse link
G Ptx3 pentraxin 3 increases expression ISO Arsenic Trioxide results in increased expression of PTX3 mRNA; Arsenic Trioxide results in increased expression of PTX3 protein CTD PMID:27750169 NCBI chr 2:152,797,563...152,803,372
Ensembl chr 2:152,781,955...152,803,372 		JBrowse link
G Puf60 poly-U binding splicing factor 60 increases expression ISO Arsenic Trioxide results in increased expression of PUF60 mRNA CTD PMID:20458559 NCBI chr 7:109,663,490...109,674,443
Ensembl chr 7:109,663,490...109,674,724 		JBrowse link
G Purg purine-rich element binding protein G increases expression ISO Arsenic Trioxide results in increased expression of PURG mRNA CTD PMID:15761015 NCBI chr16:65,435,371...65,466,437
Ensembl chr16:65,412,238...65,466,185 		JBrowse link
G Pvt1 Pvt1 oncogene affects expression ISO Arsenic Trioxide affects the expression of PVT1 mRNA CTD PMID:39716349 NCBI chr 7:95,545,916...95,769,306 JBrowse link
G Pwwp3a PWWP domain containing 3A, DNA repair factor decreases expression ISO Arsenic Trioxide results in decreased expression of PWWP3A mRNA CTD PMID:22521957 NCBI chr 7:10,115,865...10,132,696
Ensembl chr 7:10,115,866...10,130,925 		JBrowse link
G Pxdn peroxidasin decreases expression ISO Arsenic Trioxide results in decreased expression of PXDN mRNA CTD PMID:15761015 NCBI chr 6:52,308,347...52,385,943
Ensembl chr 6:52,308,364...52,385,942 		JBrowse link
G Pxk PX domain containing serine/threonine kinase like increases expression ISO Arsenic Trioxide results in increased expression of PXK mRNA CTD PMID:20458559 NCBI chr15:19,190,085...19,258,711
Ensembl chr15:19,190,085...19,258,671 		JBrowse link
G Pxmp2 peroxisomal membrane protein 2 increases expression ISO Arsenic Trioxide results in increased expression of PXMP2 mRNA CTD PMID:20458559 NCBI chr12:52,053,951...52,064,283
Ensembl chr12:52,053,788...52,064,283 		JBrowse link
G Pycard PYD and CARD domain containing decreases methylation
decreases expression
increases expression
multiple interactions 		ISO
EXP 		Arsenic Trioxide results in decreased methylation of PYCARD promoter
Arsenic Trioxide results in decreased expression of PYCARD mRNA
Arsenic Trioxide results in increased expression of PYCARD mRNA; Arsenic Trioxide results in increased expression of PYCARD protein
[sanguinarine co-treated with Arsenic Trioxide] results in increased expression of PYCARD mRNA
Febuxostat inhibits the reaction [Arsenic Trioxide results in increased expression of PYCARD protein] 		CTD PMID:19730151 PMID:24345465 PMID:24993472 PMID:37689273 NCBI chr 1:192,032,124...192,033,419
Ensembl chr 1:192,032,124...192,033,419 		JBrowse link
G Pygb glycogen phosphorylase B increases expression ISO Arsenic Trioxide results in increased expression of PYGB mRNA CTD PMID:39716349 NCBI chr 3:160,072,141...160,118,930
Ensembl chr 3:160,072,115...160,123,961 		JBrowse link
G Pygl glycogen phosphorylase L increases expression ISO Arsenic Trioxide results in increased expression of PYGL mRNA CTD PMID:20458559 NCBI chr 6:94,433,558...94,476,219
Ensembl chr 6:94,426,346...94,476,269 		JBrowse link
G Qki QKI, KH domain containing RNA binding increases expression ISO Arsenic Trioxide results in increased expression of QKI mRNA CTD PMID:20458559 NCBI chr 1:52,935,357...53,047,338
Ensembl chr 1:52,935,382...53,047,337 		JBrowse link
G Qsox1 quiescin sulfhydryl oxidase 1 decreases expression ISO Arsenic Trioxide results in decreased expression of QSOX1 mRNA CTD PMID:19128835 NCBI chr13:70,500,060...70,537,711
Ensembl chr13:70,500,060...70,537,733 		JBrowse link
G Qtrt1 queuine tRNA-ribosyltransferase catalytic subunit 1 decreases expression ISO Arsenic Trioxide results in decreased expression of QTRT1 protein CTD PMID:19364129 NCBI chr 8:28,239,993...28,249,983
Ensembl chr 8:28,242,472...28,250,398 		JBrowse link
G R3hdm2 R3H domain containing 2 decreases expression ISO Arsenic Trioxide results in decreased expression of R3HDM2 mRNA CTD PMID:27829220 NCBI chr 7:65,097,685...65,225,863
Ensembl chr 7:65,097,923...65,225,862 		JBrowse link
G Rab11fip5 RAB11 family interacting protein 5 decreases expression ISO Arsenic Trioxide results in decreased expression of RAB11FIP5 mRNA CTD PMID:39716349 NCBI chr 4:119,428,766...119,466,277
Ensembl chr 4:119,428,766...119,466,213 		JBrowse link
G Rab13 RAB13, member RAS oncogene family increases expression ISO Arsenic Trioxide results in increased expression of RAB13 mRNA CTD PMID:20458559 NCBI chr 2:177,972,535...177,977,679
Ensembl chr 2:177,972,372...177,977,684 		JBrowse link
G Rab15 RAB15, member RAS oncogene family increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of RAB15 mRNA
Arsenic Trioxide results in decreased expression of RAB15 mRNA 		CTD PMID:20458559 PMID:22521957 NCBI chr 6:101,232,740...101,257,388
Ensembl chr 6:101,232,743...101,257,083 		JBrowse link
G Rab17 RAB17, member RAS oncogene family multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to RAB17 protein] CTD PMID:26598702 NCBI chr 9:99,001,044...99,014,340
Ensembl chr 9:99,001,045...99,014,032 		JBrowse link
G Rab1a RAB1A, member RAS oncogene family increases expression ISO Arsenic Trioxide results in increased expression of RAB1A mRNA CTD PMID:20458559 NCBI chr14:98,623,582...98,648,766
Ensembl chr14:98,623,635...98,661,582 		JBrowse link
G Rab21 RAB21, member RAS oncogene family increases expression ISO Arsenic Trioxide results in increased expression of RAB21 mRNA CTD PMID:20458559 NCBI chr 7:52,790,158...52,814,943
Ensembl chr 7:52,790,165...52,814,943 		JBrowse link
G Rab24 RAB24, member RAS oncogene family increases expression ISO Arsenic Trioxide results in increased expression of RAB24 mRNA CTD PMID:20458559 NCBI chr17:9,313,593...9,315,675
Ensembl chr17:9,313,593...9,316,575 		JBrowse link
G Rab25 RAB25, member RAS oncogene family decreases response to substance ISO RAB25 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 2:176,298,124...176,304,221
Ensembl chr 2:176,298,124...176,304,221 		JBrowse link
G Rab27b RAB27B, member RAS oncogene family decreases expression ISO Arsenic Trioxide results in decreased expression of RAB27B mRNA CTD PMID:15761015 PMID:26705709 NCBI chr18:65,870,230...66,069,597
Ensembl chr18:65,876,342...66,067,700 		JBrowse link
G Rab2a RAB2A, member RAS oncogene family decreases expression
multiple interactions
increases expression 		ISO Arsenic Trioxide results in decreased expression of RAB2A protein
[Arsenic Trioxide binds to PIN1 protein] affects the reaction [Arsenic Trioxide results in decreased expression of RAB2A protein]; Arsenic Trioxide promotes the reaction [Tretinoin results in decreased expression of RAB2A protein]; PIN1 protein affects the reaction [Arsenic Trioxide results in decreased expression of RAB2A protein]; Tretinoin promotes the reaction [Arsenic Trioxide results in decreased expression of RAB2A protein]
Arsenic Trioxide results in increased expression of RAB2 mRNA 		CTD PMID:20458559 PMID:30093655 NCBI chr 5:26,473,424...26,537,441
Ensembl chr 5:26,473,548...26,538,488 		JBrowse link
G Rab2b RAB2B, member RAS oncogene family multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to RAB2B protein] CTD PMID:26598702 NCBI chr15:27,441,860...27,462,479
Ensembl chr15:27,442,816...27,462,479 		JBrowse link
G Rab31 RAB31, member RAS oncogene family multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of RAB31 mRNA CTD PMID:15894607 NCBI chr 9:112,693,596...112,828,104
Ensembl chr 9:112,693,597...112,828,092 		JBrowse link
G Rab33a RAB33A, member RAS oncogene family increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of RAB33A mRNA
[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of RAB33A mRNA 		CTD PMID:15894607 PMID:20458559 NCBI chr  X:132,572,133...132,584,255
Ensembl chr  X:132,572,148...132,584,254 		JBrowse link
G Rab5a RAB5A, member RAS oncogene family increases expression ISO Arsenic Trioxide results in increased expression of RAB5A mRNA CTD PMID:20458559 NCBI chr 9:6,720,057...6,749,456
Ensembl chr 9:6,721,122...6,749,447 		JBrowse link
G Rab5c RAB5C, member RAS oncogene family decreases expression ISO Arsenic Trioxide results in decreased expression of RAB5C mRNA CTD PMID:39716349 NCBI chr10:86,142,872...86,166,449
Ensembl chr10:86,142,873...86,166,449 		JBrowse link
G Rab7a RAB7A, member RAS oncogene family decreases expression ISO Arsenic Trioxide results in decreased expression of RAB7A mRNA CTD PMID:15894607 NCBI chr 4:122,019,281...122,068,067
Ensembl chr 4:121,983,938...122,064,185 		JBrowse link
G Rabggta Rab geranylgeranyltransferase subunit alpha multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of RABGGTA mRNA CTD PMID:15894607 NCBI chr15:33,176,268...33,183,320
Ensembl chr15:33,176,099...33,183,271 		JBrowse link
G Rabl3 RAB, member of RAS oncogene family-like 3 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to RABL3 protein] CTD PMID:26598702 NCBI chr11:76,658,723...76,687,681
Ensembl chr11:76,658,723...76,687,940 		JBrowse link
G Rabl6 RAB, member RAS oncogene family-like 6 increases expression ISO Arsenic Trioxide results in increased expression of RABL6 mRNA CTD PMID:35676786 NCBI chr 3:28,800,802...28,826,722
Ensembl chr 3:28,800,802...28,826,722 		JBrowse link
G Rac1 Rac family small GTPase 1 multiple interactions
increases activity
decreases expression
affects localization 		ISO [ruxolitinib co-treated with Arsenic Trioxide] results in increased expression of RAC1 mRNA; [Tetradecanoylphorbol Acetate co-treated with Arsenic Trioxide] results in increased expression of RAC1 mRNA; [Tetradecanoylphorbol Acetate co-treated with Arsenic Trioxide] results in increased expression of RAC1 protein; Ascorbic Acid promotes the reaction [Arsenic Trioxide results in increased activity of RAC1 protein]
Arsenic Trioxide results in decreased expression of RAC1 mRNA; Arsenic Trioxide results in decreased expression of RAC1 protein
Arsenic Trioxide results in increased expression of and affects the localization of RAC1 protein; ATF4 protein promotes the reaction [Arsenic Trioxide results in increased expression of and affects the localization of RAC1 protein]
Arsenic Trioxide affects the localization of RAC1 protein 		CTD PMID:12239215 PMID:18424721 PMID:18922899 PMID:25419056 PMID:26238599 More... NCBI chr12:16,150,411...16,170,864
Ensembl chr12:16,128,649...16,172,109 		JBrowse link
G Rac2 Rac family small GTPase 2 decreases expression ISO Arsenic Trioxide results in decreased expression of RAC2 mRNA CTD PMID:19128835 PMID:26238599 NCBI chr 7:111,981,825...112,009,201
Ensembl chr 7:111,996,742...112,009,267 		JBrowse link
G Racgap1 Rac GTPase-activating protein 1 increases expression ISO Arsenic Trioxide results in increased expression of RACGAP1 mRNA CTD PMID:17547211 NCBI chr 7:132,629,789...132,659,738
Ensembl chr 7:132,620,595...132,659,738 		JBrowse link
G Rad17 RAD17 checkpoint clamp loader component increases expression ISO Arsenic Trioxide results in increased expression of RAD17 mRNA CTD PMID:20458559 NCBI chr 2:33,498,335...33,528,614
Ensembl chr 2:33,498,336...33,528,144 		JBrowse link
G Rad21 RAD21 cohesin complex component affects methylation ISO Arsenic Trioxide affects the methylation of RAD21 promoter CTD PMID:26046465 NCBI chr 7:85,177,715...85,204,657
Ensembl chr 7:85,177,716...85,204,657 		JBrowse link
G Rad23a RAD23 homolog A, nucleotide excision repair protein multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to RAD23A protein] CTD PMID:26598702 NCBI chr19:40,219,235...40,225,543
Ensembl chr19:40,219,636...40,225,543 		JBrowse link
G Rad23b RAD23 homolog B, nucleotide excision repair protein multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of RAD23B protein CTD PMID:15894607 NCBI chr 5:74,885,518...74,923,621
Ensembl chr 5:74,885,516...74,962,426 		JBrowse link
G Rad50 RAD50 double strand break repair protein increases expression ISO Arsenic Trioxide results in increased expression of RAD50 mRNA CTD PMID:17530438 NCBI chr10:38,310,147...38,362,100
Ensembl chr10:38,310,147...38,362,100 		JBrowse link
G Rad51c RAD51 paralog C multiple interactions
decreases expression
affects expression 		ISO Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of RAD51C mRNA]
Arsenic Trioxide affects the expression of RAD51C mRNA 		CTD PMID:27825931 PMID:29095437 NCBI chr10:72,702,299...72,728,980
Ensembl chr10:72,702,299...72,729,143 		JBrowse link
G Rad51d RAD51 paralog D increases expression ISO Arsenic Trioxide results in increased expression of RAD51D mRNA CTD PMID:20458559 NCBI chr10:68,303,350...68,322,002
Ensembl chr10:68,238,273...68,321,902 		JBrowse link
G Rad52 RAD52 homolog, DNA repair protein decreases expression ISO Arsenic Trioxide results in decreased expression of RAD52 mRNA CTD PMID:15073043 NCBI chr 4:154,778,320...154,802,002
Ensembl chr 4:154,778,320...154,800,021 		JBrowse link
G Rad54b RAD54 homolog B increases expression ISO Arsenic Trioxide results in increased expression of RAD54B mRNA CTD PMID:20458559 PMID:22521957 NCBI chr 5:29,829,465...29,901,967
Ensembl chr 5:29,855,304...29,901,964 		JBrowse link
G Rad9a RAD9 checkpoint clamp component A increases expression ISO Arsenic Trioxide results in increased expression of RAD9A mRNA CTD PMID:20862710 NCBI chr 1:210,917,970...210,983,038
Ensembl chr 1:210,917,970...210,925,161 		JBrowse link
G Raf1 Raf-1 proto-oncogene, serine/threonine kinase multiple interactions
increases expression
decreases expression 		ISO
EXP 		[Arsenic Trioxide co-treated with PD 173074] results in decreased expression of RAF1 protein; [Arsenic Trioxide co-treated with PD 173074] results in decreased expression of RAF1 protein modified form; [Arsenic Trioxide results in increased susceptibility to PD 173074] which results in decreased expression of RAF1 protein; [PD 173074 results in increased susceptibility to Arsenic Trioxide] which results in decreased expression of RAF1 protein; [PD 173074 results in increased susceptibility to Arsenic Trioxide] which results in decreased expression of RAF1 protein modified form; Arsenic Trioxide promotes the reaction [PD 173074 results in decreased expression of RAF1 protein modified form]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[Arsenic Trioxide co-treated with PD 173074] results in decreased expression of RAF1 protein modified form]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[Arsenic Trioxide co-treated with PD 173074] results in decreased expression of RAF1 protein]
Arsenic Trioxide results in increased expression of RAF1 mRNA
Arsenic Trioxide results in decreased expression of RAF1 mRNA
Phloretin inhibits the reaction [Arsenic Trioxide results in decreased expression of RAF1 mRNA] 		CTD PMID:20458559 PMID:27794399 PMID:34037972 NCBI chr 4:150,352,158...150,412,813
Ensembl chr 4:150,352,160...150,412,813 		JBrowse link
G Rala RAS like proto-oncogene A decreases response to substance
increases expression 		ISO RALA protein results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in increased expression of RALA mRNA 		CTD PMID:20458559 PMID:22330069 NCBI chr17:51,787,682...51,840,738
Ensembl chr17:51,787,699...51,840,733 		JBrowse link
G Ralbp1 ralA binding protein 1 increases expression ISO Arsenic Trioxide results in increased expression of RALBP1 mRNA CTD PMID:29633893 NCBI chr 9:112,903,289...112,940,093
Ensembl chr 9:112,903,302...112,939,659 		JBrowse link
G Ralgapa1 Ral GTPase activating protein catalytic subunit alpha 1 increases expression ISO Arsenic Trioxide results in increased expression of RALGAPA1 mRNA CTD PMID:20458559 NCBI chr 6:78,712,554...78,987,486
Ensembl chr 6:78,701,832...78,987,486 		JBrowse link
G Ralgdsl1 ral guanine nucleotide dissociation stimulator like 1 increases expression ISO Arsenic Trioxide results in increased expression of RGL1 mRNA CTD PMID:19128835 NCBI chr13:67,184,402...67,454,019
Ensembl chr13:67,184,402...67,454,019 		JBrowse link
G Ralgps1 Ral GEF with PH domain and SH3 binding motif 1 increases expression ISO Arsenic Trioxide results in increased expression of RALGPS1 mRNA CTD PMID:20458559 NCBI chr 3:36,831,029...37,067,659
Ensembl chr 3:36,831,029...37,067,659 		JBrowse link
G Raly RALY heterogeneous nuclear ribonucleoprotein decreases expression ISO Arsenic Trioxide results in decreased expression of RALY protein CTD PMID:25419056 NCBI chr 3:163,766,183...163,830,726
Ensembl chr 3:163,766,478...163,830,740 		JBrowse link
G Ramp2 receptor activity modifying protein 2 decreases expression ISO Arsenic Trioxide results in decreased expression of RAMP2 mRNA CTD PMID:20458559 NCBI chr10:86,689,148...86,690,956
Ensembl chr10:86,688,703...86,691,231 		JBrowse link
G Ranbp3l RAN binding protein 3-like increases expression ISO Arsenic Trioxide results in increased expression of RANBP3L mRNA CTD PMID:27829220 NCBI chr 2:59,785,070...59,840,338
Ensembl chr 2:59,785,450...59,840,334 		JBrowse link
G Ranbp9 RAN binding protein 9 increases expression ISO Arsenic Trioxide results in increased expression of RANBP9 mRNA CTD PMID:20458559 NCBI chr17:21,426,717...21,508,964
Ensembl chr17:21,426,777...21,508,964 		JBrowse link
G Rap1b RAP1B, member of RAS oncogene family increases expression ISO Arsenic Trioxide results in increased expression of RAP1B mRNA CTD PMID:20458559 NCBI chr 7:55,308,922...55,342,217
Ensembl chr 7:55,308,922...55,342,217 		JBrowse link
G Rap1gap2 RAP1 GTPase activating protein 2 increases expression ISO Arsenic Trioxide results in increased expression of RAP1GAP2 mRNA CTD PMID:39716349 NCBI chr10:59,753,822...59,970,946
Ensembl chr10:59,753,822...59,970,887 		JBrowse link
G Rap1gds1 Rap1 GTPase-GDP dissociation stimulator 1 multiple interactions
increases expression
decreases expression 		ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to RAP1GDS1 protein]
Arsenic Trioxide results in increased expression of RAP1GDS1 mRNA
Arsenic Trioxide results in decreased expression of RAP1GDS1 mRNA 		CTD PMID:25258189 PMID:26598702 PMID:39716349 NCBI chr 2:230,173,713...230,318,555
Ensembl chr 2:230,173,713...230,318,538 		JBrowse link
G Rap2c RAP2C, member of RAS oncogene family increases expression ISO Arsenic Trioxide results in increased expression of RAP2C mRNA CTD PMID:20458559 NCBI chr  X:135,388,881...135,401,998
Ensembl chr  X:135,388,882...135,401,998 		JBrowse link
G Rapgef3 Rap guanine nucleotide exchange factor 3 increases expression ISO Arsenic Trioxide results in increased expression of RAPGEF3 mRNA CTD PMID:35676786 NCBI chr 7:130,754,883...130,777,303
Ensembl chr 7:130,754,871...130,777,668 		JBrowse link
G Rapgef4 Rap guanine nucleotide exchange factor 4 increases expression ISO Arsenic Trioxide results in increased expression of RAPGEF4 mRNA CTD PMID:15761015 NCBI chr 3:77,217,024...77,509,933
Ensembl chr 3:77,217,039...77,509,978 		JBrowse link
G Rapgef5 Rap guanine nucleotide exchange factor 5 decreases expression ISO Arsenic Trioxide results in decreased expression of RAPGEF5 mRNA CTD PMID:26705709 NCBI chr 6:144,588,162...144,822,908
Ensembl chr 6:144,580,976...144,822,908 		JBrowse link
G Raph1 Ras association (RalGDS/AF-6) and pleckstrin homology domains 1 increases expression ISO Arsenic Trioxide results in increased expression of RAPH1 mRNA CTD PMID:20458559 NCBI chr 9:69,397,272...69,484,174
Ensembl chr 9:69,401,517...69,484,019 		JBrowse link
G Rara retinoic acid receptor, alpha multiple interactions
decreases response to substance
decreases expression
increases degradation 		ISO Arsenic Trioxide results in increased degradation of and results in decreased expression of RARA protein
4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid inhibits the reaction [Arsenic Trioxide results in increased degradation of RARA protein]; [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of RARA mRNA alternative form; [Vorinostat co-treated with Arsenic Trioxide] results in decreased expression of RARA protein mutant form; Arsenic Trioxide promotes the reaction [puerarin results in decreased expression of RARA mRNA alternative form]; Arsenic Trioxide promotes the reaction [tetraarsenic tetrasulfide results in increased degradation of [PML protein mutant form binds to RARA protein mutant form]]; Arsenic Trioxide results in increased degradation of [PML protein mutant form binds to RARA protein mutant form]; cobaltous chloride promotes the reaction [Arsenic Trioxide results in increased degradation of RARA protein mutant form]; RARA gene mutant form inhibits the reaction [Tretinoin inhibits the reaction [Arsenic Trioxide results in increased expression of HMOX1 protein]]; RARA gene mutant form inhibits the reaction [Tretinoin promotes the reaction [Arsenic Trioxide results in increased activity of CASP3 protein]]; tetraarsenic tetrasulfide promotes the reaction [Arsenic Trioxide results in increased degradation of [PML protein mutant form binds to RARA protein mutant form]]
RARA gene mutant form results in decreased susceptibility to Arsenic Trioxide
Arsenic Trioxide results in decreased expression of RARA mRNA mutant form; Arsenic Trioxide results in decreased expression of RARA protein; Arsenic Trioxide results in decreased expression of RARA protein mutant form
Arsenic Trioxide results in increased degradation of RARA protein; Arsenic Trioxide results in increased degradation of RARA protein mutant form 		CTD PMID:9834237 PMID:15688020 PMID:15748426 PMID:16330433 PMID:16891316 More... NCBI chr10:84,379,780...84,424,371
Ensembl chr10:84,389,622...84,425,160 		JBrowse link
G Rarb retinoic acid receptor, beta multiple interactions
decreases expression 		ISO Arsenic Trioxide inhibits the reaction [Tretinoin results in increased expression of RARB mRNA]
Arsenic Trioxide results in decreased expression of RARB mRNA
Arsenic Trioxide inhibits the reaction [PRAM1 protein results in decreased expression of RARB mRNA]; Arsenic Trioxide inhibits the reaction [Tretinoin results in increased expression of RARB mRNA]; Arsenic Trioxide inhibits the reaction [Tretinoin results in increased expression of RARB protein] 		CTD PMID:10673743 PMID:11133770 PMID:15688020 PMID:16184197 PMID:18941112 NCBI chr15:10,837,252...11,482,037
Ensembl chr15:11,131,358...11,482,040 		JBrowse link
G Rarg retinoic acid receptor, gamma multiple interactions ISO Arsenic Trioxide results in increased degradation of and results in decreased expression of RARG protein CTD PMID:15688020 NCBI chr 7:135,246,427...135,268,889
Ensembl chr 7:135,246,427...135,268,889 		JBrowse link
G Rars1 arginyl-tRNA synthetase 1 increases expression ISO Arsenic Trioxide results in increased expression of RARS1 protein CTD PMID:25419056 NCBI chr10:20,774,804...20,799,251
Ensembl chr10:20,774,805...20,799,251 		JBrowse link
G Rasgrf1 RAS protein-specific guanine nucleotide-releasing factor 1 increases expression ISO Arsenic Trioxide results in increased expression of RASGRF1 mRNA CTD PMID:11940349 NCBI chr 8:99,324,986...99,454,099
Ensembl chr 8:99,324,749...99,454,089 		JBrowse link
G Rasl10a RAS-like, family 10, member A decreases expression ISO Arsenic Trioxide results in decreased expression of RASL10A mRNA CTD PMID:19128835 PMID:21461292 NCBI chr14:84,169,141...84,170,519
Ensembl chr14:84,168,227...84,170,495 		JBrowse link
G Rasl11a RAS-like family 11 member A decreases expression ISO Arsenic Trioxide results in decreased expression of RASL11A mRNA CTD PMID:39716349 NCBI chr12:13,372,023...13,374,784
Ensembl chr12:13,372,023...13,376,451 		JBrowse link
G Rassf1 Ras association domain family member 1 decreases methylation
increases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased methylation of RASSF1 gene; Arsenic Trioxide results in decreased methylation of RASSF1 promoter
Arsenic Trioxide results in increased expression of RASSF1 mRNA; Arsenic Trioxide results in increased expression of RASSF1 protein
[Arsenic Trioxide results in decreased methylation of RASSF1 promoter] which results in increased expression of RASSF1 mRNA; Arsenic Trioxide promotes the reaction [Decitabine results in increased expression of RASSF1 mRNA]; Arsenic Trioxide results in increased expression of and affects the localization of RASSF1 protein; Decitabine promotes the reaction [Arsenic Trioxide results in increased expression of RASSF1 mRNA] 		CTD PMID:16613325 PMID:20079060 NCBI chr 8:117,103,665...117,114,805
Ensembl chr 8:117,103,362...117,114,805 		JBrowse link
G Rassf7 Ras association domain family member 7 decreases response to substance ISO RASSF7 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 1:205,749,173...205,753,350
Ensembl chr 1:205,747,654...205,753,360 		JBrowse link
G Rassf8 Ras association domain family member 8 increases expression ISO Arsenic Trioxide results in increased expression of RASSF8 mRNA CTD PMID:15761015 NCBI chr 4:180,447,050...180,528,792
Ensembl chr 4:180,446,846...180,528,790 		JBrowse link
G Rb1 RB transcriptional corepressor 1 decreases expression
decreases phosphorylation
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of RB1 protein modified form
Arsenic Trioxide results in decreased phosphorylation of RB1 protein
[Arsenic Trioxide results in decreased activity of CDK6 protein] which results in decreased phosphorylation of RB1 protein; Arsenic Trioxide promotes the reaction [RB1 protein binds to E2F1 protein]; Arsenic Trioxide results in increased expression of and results in increased phosphorylation of RB1 protein; TP53 protein promotes the reaction [Arsenic Trioxide results in increased expression of RB1 protein] 		CTD PMID:10850458 PMID:12480548 PMID:20953137 PMID:25335113 PMID:34042274 NCBI chr15:54,780,858...54,911,989
Ensembl chr15:54,780,858...54,911,857 		JBrowse link
G Rbbp4 RB binding protein 4, chromatin remodeling factor decreases expression ISO Arsenic Trioxide results in decreased expression of RBBP4 mRNA CTD PMID:20458559 NCBI chr 5:146,940,207...146,959,501
Ensembl chr 5:146,922,611...146,959,501 		JBrowse link
G Rbl1 RB transcriptional corepressor like 1 decreases methylation ISO Arsenic Trioxide results in decreased methylation of RBL1 promoter CTD PMID:29159499 NCBI chr 3:166,226,187...166,289,862
Ensembl chr 3:166,226,198...166,289,376 		JBrowse link
G Rbl2 RB transcriptional corepressor like 2 decreases expression ISO Arsenic Trioxide results in decreased expression of RBL2 mRNA CTD PMID:35676786 NCBI chr19:32,049,690...32,096,467
Ensembl chr19:32,049,691...32,096,411 		JBrowse link
G Rbm12 RNA binding motif protein 12 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to RBM12 protein] CTD PMID:26598702 NCBI chr 3:165,069,744...165,089,994
Ensembl chr 3:165,042,878...165,090,021 		JBrowse link
G Rbm17 RNA binding motif protein 17 increases expression ISO Arsenic Trioxide results in increased expression of RBM17 mRNA CTD PMID:20458559 NCBI chr17:71,846,941...71,863,834
Ensembl chr17:71,846,916...71,864,431 		JBrowse link
G Rbm3 RNA binding motif protein 3 increases expression ISO Arsenic Trioxide results in increased expression of RBM3 mRNA CTD PMID:39716349 NCBI chr  X:17,020,863...17,024,341
Ensembl chr  X:17,020,864...17,024,841 		JBrowse link
G Rbm38 RNA binding motif protein 38 multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of RBM38 mRNA CTD PMID:15894607 NCBI chr 3:182,219,898...182,232,723
Ensembl chr 3:182,219,899...182,232,714 		JBrowse link
G Rbm47 RNA binding motif protein 47 decreases response to substance ISO RBM47 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr14:42,407,226...42,545,304
Ensembl chr14:42,466,335...42,543,163 		JBrowse link
G Rbm6 RNA binding motif protein 6 increases expression ISO Arsenic Trioxide results in increased expression of RBM6 mRNA CTD PMID:39716349 NCBI chr 8:117,327,607...117,431,397
Ensembl chr 8:117,331,325...117,431,397 		JBrowse link
G Rbmx RNA binding motif protein, X-linked decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of RBMX mRNA; Arsenic Trioxide results in decreased expression of RBMX protein
Arsenic Trioxide results in increased expression of RBMX mRNA 		CTD PMID:12852829 PMID:20458559 PMID:25419056 NCBI chr  X:140,342,544...140,352,121
Ensembl chr  X:140,345,571...140,352,035 		JBrowse link
G Rbp1 retinol binding protein 1 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to RBP1 protein] CTD PMID:26598702 NCBI chr 8:107,904,589...107,926,109
Ensembl chr 8:107,887,417...107,983,847 		JBrowse link
G Rbp2 retinol binding protein 2 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to RBP2 protein] CTD PMID:26598702 NCBI chr 8:107,958,670...107,983,850 JBrowse link
G Rbpms RNA binding protein, mRNA processing factor increases expression ISO Arsenic Trioxide results in increased expression of RBPMS mRNA CTD PMID:20458559 NCBI chr16:64,942,159...65,098,504
Ensembl chr16:64,942,530...65,098,503 		JBrowse link
G Rchy1 ring finger and CHY zinc finger domain containing 1 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of RCHY1 mRNA
RCHY1 protein promotes the reaction [Arsenic Trioxide results in increased degradation of TP63 protein mutant form] 		CTD PMID:23271742 NCBI chr14:16,397,533...16,413,286
Ensembl chr14:16,397,494...16,413,451 		JBrowse link
G Rcl1 RNA terminal phosphate cyclase-like 1 increases expression ISO Arsenic Trioxide results in increased expression of RCL1 mRNA CTD PMID:25258189 NCBI chr 1:236,238,078...236,282,597
Ensembl chr 1:236,238,031...236,315,894 		JBrowse link
G Rcn3 reticulocalbin 3 increases expression ISO Arsenic Trioxide results in increased expression of RCN3 mRNA CTD PMID:25258189 NCBI chr 1:104,700,969...104,710,228
Ensembl chr 1:104,700,545...104,710,249 		JBrowse link
G Reg3b regenerating family member 3 beta multiple interactions ISO [Arsenic Trioxide results in increased abundance of arsenite] which results in decreased expression of REG3B mRNA CTD PMID:36791901 NCBI chr 4:112,419,776...112,423,014
Ensembl chr 4:112,419,776...112,423,014 		JBrowse link
G Reg3g regenerating family member 3 gamma multiple interactions ISO [Arsenic Trioxide results in increased abundance of arsenite] which results in decreased expression of REG3G mRNA CTD PMID:36791901 NCBI chr 4:112,482,183...112,484,738
Ensembl chr 4:112,482,183...112,484,738 		JBrowse link
G Rel REL proto-oncogene, NF-kB subunit decreases expression ISO Arsenic Trioxide results in decreased expression of REL protein CTD PMID:18349030 PMID:33634982 NCBI chr14:101,891,238...101,922,324
Ensembl chr14:101,891,243...101,921,938 		JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit affects localization
affects expression
increases expression
decreases expression
multiple interactions
decreases activity
decreases phosphorylation
increases phosphorylation
decreases response to substance 		ISO
EXP 		Arsenic Trioxide affects the localization of RELA protein
Arsenic Trioxide affects the expression of RELA protein
Arsenic Trioxide results in increased expression of RELA protein
Arsenic Trioxide results in decreased expression of RELA mRNA; Arsenic Trioxide results in decreased expression of RELA protein; Arsenic Trioxide results in decreased expression of RELA protein modified form
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of RELA protein]; 18alpha,20beta-hydroxy-11-oxo-norolean-12-en-3beta-yl-2-O-beta-D-glucopyranurosyl-alpha-D-glucopyranosiduronate magnesium tetrahydrate inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of RELA protein]; [Arsenic Trioxide co-treated with 3-(4-methylphenylsulfonyl)-2-propenenitrile co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of RELA protein; [Genistein co-treated with Arsenic Trioxide] results in decreased expression of RELA protein; Arsenic Trioxide promotes the reaction [3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [lipopolysaccharide, E coli O55-B5 affects the localization of RELA protein]]; Arsenic Trioxide results in increased expression of and results in increased phosphorylation of RELA protein; baicalin inhibits the reaction [Arsenic Trioxide results in increased expression of and results in increased phosphorylation of RELA protein]; Thioctic Acid inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of RELA protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide affects the localization of RELA protein]; [Arsenic Trioxide results in increased abundance of Arsenic] which results in increased expression of RELA protein; Apigenin inhibits the reaction [[Arsenic Trioxide results in increased abundance of Arsenic] which results in increased expression of RELA protein]; boric acid inhibits the reaction [Arsenic Trioxide results in increased expression of RELA mRNA]; boric acid inhibits the reaction [Arsenic Trioxide results in increased expression of RELA protein]; crocin inhibits the reaction [Arsenic Trioxide results in increased expression of RELA protein]; Febuxostat inhibits the reaction [Arsenic Trioxide results in increased expression of RELA protein]; Phloretin inhibits the reaction [Arsenic Trioxide affects the localization of RELA protein]; polydatin inhibits the reaction [Arsenic Trioxide results in increased expression of RELA mRNA]; trans-sodium crocetinate inhibits the reaction [Arsenic Trioxide results in increased expression of RELA protein]
3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of RELA protein]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of RELA protein]; 4-amino-1,8-naphthalimide inhibits the reaction [Arsenic Trioxide affects the localization of RELA protein]; [[Sulindac co-treated with Arsenic Trioxide] results in decreased phosphorylation of and results in decreased degradation of NFKBIA protein] which affects the localization of RELA protein; [Arsenic Trioxide binds to PIN1 protein] affects the reaction [Arsenic Trioxide results in decreased expression of RELA protein]; [Arsenic Trioxide co-treated with CSF2] results in decreased activity of RELA protein; [Arsenic Trioxide co-treated with Homoharringtonine] results in decreased expression of RELA protein; [Arsenic Trioxide co-treated with Plant Extracts] results in decreased expression of RELA protein; [Arsenic Trioxide co-treated with Tetradecanoylphorbol Acetate] results in decreased activity of and results in increased localization of RELA protein; [BIBR 1532 co-treated with Arsenic Trioxide] affects the expression of RELA mRNA; [Bortezomib co-treated with Arsenic Trioxide] results in decreased activity of RELA protein; Acetylcysteine inhibits the reaction [Arsenic Trioxide affects the localization of RELA protein]; allicin inhibits the reaction [Arsenic Trioxide results in increased expression of RELA protein]; Arsenic Trioxide inhibits the reaction [EZH2 protein binds to RELA protein]; Arsenic Trioxide inhibits the reaction [RELA protein binds to NFKB1 protein]; Arsenic Trioxide inhibits the reaction [TNF protein results in increased activity of RELA protein]; Arsenic Trioxide inhibits the reaction [TNF protein results in increased expression of RELA mRNA]; Arsenic Trioxide inhibits the reaction [TNF protein results in increased phosphorylation of RELA protein]; Arsenic Trioxide promotes the reaction [tetraarsenic tetrasulfide results in decreased expression of RELA mRNA]; Arsenic Trioxide promotes the reaction [tetraarsenic tetrasulfide results in decreased expression of RELA protein]; Arsenic Trioxide promotes the reaction [Tretinoin results in decreased expression of RELA protein]; Arsenic Trioxide results in decreased expression of and affects the localization of RELA protein; Arsenic Trioxide results in decreased phosphorylation of and affects the localization of RELA protein; Genistein promotes the reaction [Arsenic Trioxide results in decreased expression of RELA protein]; JAK1 protein inhibits the reaction [Arsenic Trioxide results in decreased expression of RELA protein]; MIR491 mRNA affects the reaction [Arsenic Trioxide results in decreased phosphorylation of and affects the localization of RELA protein]; PIN1 protein affects the reaction [Arsenic Trioxide results in decreased expression of RELA protein]; pyrazolanthrone inhibits the reaction [Arsenic Trioxide results in decreased activity of RELA protein]; RELA protein inhibits the reaction [Arsenic Trioxide inhibits the reaction [CXCL12 protein results in increased expression of CXCR4 protein]]; RELA protein inhibits the reaction [Arsenic Trioxide results in decreased expression of CXCR4 protein]; RELA protein inhibits the reaction [Arsenic Trioxide results in decreased expression of ITGAX protein]; STAT3 protein inhibits the reaction [Arsenic Trioxide results in decreased expression of RELA protein]; tetraarsenic tetrasulfide promotes the reaction [Arsenic Trioxide results in decreased expression of RELA mRNA]; tetraarsenic tetrasulfide promotes the reaction [Arsenic Trioxide results in decreased expression of RELA protein]; Tretinoin promotes the reaction [Arsenic Trioxide results in decreased expression of RELA protein]
Arsenic Trioxide results in decreased phosphorylation of RELA protein
Arsenic Trioxide results in increased expression of RELA mRNA; Arsenic Trioxide results in increased expression of RELA protein
RELA protein results in decreased susceptibility to Arsenic Trioxide 		CTD PMID:15073043 PMID:15314284 PMID:15547942 PMID:16105982 PMID:16174796 More... NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817 		JBrowse link
G Relb RELB proto-oncogene, NF-kB subunit decreases expression
multiple interactions 		ISO Arsenic Trioxide results in decreased expression of RELB mRNA; Arsenic Trioxide results in decreased expression of RELB protein
Arsenic Trioxide inhibits the reaction [Homoharringtonine results in increased expression of RELB protein] 		CTD PMID:18349030 PMID:20458559 PMID:31307525 PMID:33634982 NCBI chr 1:88,385,717...88,413,380
Ensembl chr 1:88,385,717...88,413,420 		JBrowse link
G Rep15 RAB15 effector protein decreases expression ISO Arsenic Trioxide results in decreased expression of REP15 mRNA CTD PMID:39716349 NCBI chr 4:181,682,588...181,683,661
Ensembl chr 4:181,682,588...181,683,661 		JBrowse link
G Repin1 replication initiator 1 increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of REPIN1 mRNA
[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of REPIN1 mRNA 		CTD PMID:15894607 PMID:20458559 NCBI chr 4:78,879,910...78,885,143
Ensembl chr 4:78,880,976...78,886,413 		JBrowse link
G Rere arginine-glutamic acid dipeptide repeats increases expression
increases sumoylation 		ISO Arsenic Trioxide results in increased expression of RERE mRNA
Arsenic Trioxide results in increased sumoylation of RERE protein 		CTD PMID:15761015 PMID:28318385 NCBI chr 5:166,048,770...166,380,559
Ensembl chr 5:166,048,844...166,380,558 		JBrowse link
G Rerg RAS-like, estrogen-regulated, growth-inhibitor decreases expression ISO Arsenic Trioxide results in decreased expression of RERG mRNA CTD PMID:26705709 NCBI chr 4:171,712,794...171,821,268
Ensembl chr 4:171,712,794...171,820,903 		JBrowse link
G Rest RE1-silencing transcription factor increases expression ISO Arsenic Trioxide results in increased expression of REST mRNA CTD PMID:20458559 NCBI chr14:31,213,415...31,233,451
Ensembl chr14:31,213,415...31,248,662 		JBrowse link
G Retn resistin increases expression
multiple interactions
decreases expression 		ISO Arsenic Trioxide results in increased expression of RETN mRNA
[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of and results in increased secretion of RETN protein; Arsenic Trioxide results in increased expression of and results in increased secretion of RETN protein; Fenofibrate inhibits the reaction [Arsenic Trioxide results in increased expression of and results in increased secretion of RETN protein]
Arsenic Trioxide results in decreased expression of RETN mRNA 		CTD PMID:32929351 PMID:35676786 NCBI chr12:6,508,653...6,511,115
Ensembl chr12:6,508,801...6,511,116 		JBrowse link
G Rfc2 replication factor C subunit 2 increases expression ISO Arsenic Trioxide results in increased expression of RFC2 mRNA CTD PMID:17547211 NCBI chr12:27,756,920...27,770,049
Ensembl chr12:27,756,922...27,770,025 		JBrowse link
G Rfc3 replication factor C subunit 3 decreases expression ISO Arsenic Trioxide results in decreased expression of RFC3 mRNA CTD PMID:34413873 NCBI chr12:5,836,546...5,847,331
Ensembl chr12:5,836,553...5,847,340 		JBrowse link
G Rgcc regulator of cell cycle decreases expression
increases expression 		ISO Arsenic Trioxide results in decreased expression of RGCC mRNA
Arsenic Trioxide results in increased expression of RGCC mRNA 		CTD PMID:20458559 PMID:26705709 NCBI chr15:61,071,574...61,084,408
Ensembl chr15:61,071,574...61,084,408 		JBrowse link
G Rgs11 regulator of G-protein signaling 11 increases expression ISO Arsenic Trioxide results in increased expression of RGS11 mRNA CTD PMID:20458559 NCBI chr10:15,727,279...15,735,536
Ensembl chr10:15,727,279...15,735,536 		JBrowse link
G Rgs2 regulator of G-protein signaling 2 increases expression
decreases expression 		ISO Arsenic Trioxide results in increased expression of RGS2 mRNA
Arsenic Trioxide results in decreased expression of RGS2 mRNA 		CTD PMID:12852829 PMID:20458559 PMID:21461292 PMID:24356939 PMID:25258189 NCBI chr13:58,350,063...58,352,666
Ensembl chr13:58,349,163...58,352,697 		JBrowse link
G Rhoa ras homolog family member A increases expression ISO Arsenic Trioxide results in increased expression of RHOA mRNA CTD PMID:22521957 NCBI chr 8:117,870,548...117,904,303
Ensembl chr 8:117,870,270...117,904,302 		JBrowse link
G Rhob ras homolog family member B decreases expression ISO Arsenic Trioxide results in decreased expression of RHOB mRNA CTD PMID:26238599 NCBI chr 6:37,083,030...37,085,204
Ensembl chr 6:37,075,015...37,112,772 		JBrowse link
G Rhobtb1 Rho-related BTB domain containing 1 multiple interactions
decreases expression 		ISO Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of RHOBTB1 mRNA] CTD PMID:29095437 NCBI chr20:19,326,197...19,455,182
Ensembl chr20:19,326,212...19,402,057 		JBrowse link
G Rhoc ras homolog family member C decreases expression ISO Arsenic Trioxide results in decreased expression of RHOC mRNA CTD PMID:26238599 NCBI chr 2:194,975,586...194,981,637
Ensembl chr 2:194,975,242...194,983,745 		JBrowse link
G Rhod ras homolog family member D decreases response to substance ISO RHOD protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr 1:211,138,126...211,153,953
Ensembl chr 1:211,138,126...211,152,061 		JBrowse link
G Rhof ras homolog family member F, filopodia associated decreases response to substance ISO RHOF protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 NCBI chr12:39,082,413...39,107,528
Ensembl chr12:39,091,979...39,107,528 		JBrowse link
G Rhoh ras homolog family member H increases expression ISO Arsenic Trioxide results in increased expression of RHOH mRNA CTD PMID:20458559 NCBI chr14:42,694,860...42,725,690
Ensembl chr14:42,693,413...42,749,967 		JBrowse link
G Rhoq ras homolog family member Q increases expression ISO Arsenic Trioxide results in increased expression of RHOQ mRNA CTD PMID:20458559 NCBI chr 6:13,368,499...13,403,929
Ensembl chr 1:115,757,909...115,759,467 		JBrowse link
G Rhot1 ras homolog family member T1 increases expression ISO Arsenic Trioxide results in increased expression of RHOT1 mRNA CTD PMID:20458559 NCBI chr10:65,685,687...65,760,682
Ensembl chr10:65,696,571...65,760,681 		JBrowse link
G Rimbp2 RIMS binding protein 2 decreases expression ISO Arsenic Trioxide results in decreased expression of RIMBP2 mRNA CTD PMID:26705709 NCBI chr12:33,383,646...33,582,259
Ensembl chr12:33,384,007...33,593,999 		JBrowse link
G Rims1 regulating synaptic membrane exocytosis 1 decreases expression ISO Arsenic Trioxide results in decreased expression of RIMS1 mRNA CTD PMID:26705709 NCBI chr 9:32,193,352...32,692,998
Ensembl chr 9:32,193,352...32,692,772 		JBrowse link
G Rims2 regulating synaptic membrane exocytosis 2 decreases expression ISO Arsenic Trioxide results in decreased expression of RIMS2 mRNA CTD PMID:26705709 NCBI chr 7:72,133,004...72,644,059
Ensembl chr 7:72,133,170...72,645,499 		JBrowse link
G Rinl Ras and Rab interactor-like increases expression ISO Arsenic Trioxide results in increased expression of RINL mRNA CTD PMID:39716349 NCBI chr 1:93,204,543...93,215,851
Ensembl chr 1:93,204,789...93,215,851 		JBrowse link
G Ripk1 receptor interacting serine/threonine kinase 1 increases cleavage
decreases expression
increases expression 		ISO Arsenic Trioxide results in increased cleavage of RIPK1 protein
Arsenic Trioxide results in decreased expression of RIPK1 mRNA
Arsenic Trioxide results in increased expression of RIPK1 mRNA 		CTD PMID:15314284 PMID:34108876 PMID:37230480 NCBI chr17:31,044,983...31,077,167
Ensembl chr17:31,044,994...31,077,167 		JBrowse link
G Ripor2 RHO family interacting cell polarization regulator 2 decreases expression ISO Arsenic Trioxide results in decreased expression of FAM65B mRNA CTD PMID:26705709 NCBI chr17:40,751,771...40,975,611
Ensembl chr17:40,751,771...40,975,337 		JBrowse link
G Rmdn2 regulator of microtubule dynamics 2 decreases expression ISO Arsenic Trioxide results in decreased expression of RMDN2 mRNA CTD PMID:26705709 NCBI chr 6:21,101,383...21,195,221
Ensembl chr 6:21,119,396...21,193,684 		JBrowse link
G Rmi2 RecQ mediated genome instability 2 multiple interactions ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to RMI2 protein] CTD PMID:26598702 NCBI chr10:5,336,269...5,344,202
Ensembl chr10:5,338,060...5,344,235 		JBrowse link
G Rmnd1 required for meiotic nuclear division 1 homolog increases expression ISO Arsenic Trioxide results in increased expression of RMND1 mRNA CTD PMID:22521957 NCBI chr 1:43,265,207...43,299,748
Ensembl chr 1:43,265,207...43,299,682 		JBrowse link
G Rnase2 ribonuclease A family member 2 multiple interactions ISO [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of RNASE2 mRNA CTD PMID:15894607 NCBI chr15:26,923,125...26,923,934
Ensembl chr15:26,923,134...26,923,955 		JBrowse link
G Rnaseh2a ribonuclease H2, subunit A increases expression ISO Arsenic Trioxide results in increased expression of RNASEH2A mRNA CTD PMID:17547211 NCBI chr19:40,091,206...40,100,904
Ensembl chr19:40,091,210...40,100,899 		JBrowse link
G Rnasel ribonuclease L increases expression
multiple interactions 		ISO Arsenic Trioxide results in increased expression of RNASEL mRNA
Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of RNASEL mRNA] 		CTD PMID:29095437 NCBI chr13:68,446,641...68,460,804
Ensembl chr13:68,446,882...68,459,557 		JBrowse link
G Rnaset2 ribonuclease T2 increases expression ISO Arsenic Trioxide results in increased expression of RNASET2 mRNA CTD PMID:39716349 NCBI chr 1:55,133,532...55,150,701
Ensembl chr 1:55,117,492...55,150,701 		JBrowse link
G Rnd3 Rho family GTPase 3 decreases expression ISO Arsenic Trioxide results in decreased expression of RND3 mRNA CTD PMID:26238599 NCBI chr 3:55,981,142...55,998,494
Ensembl chr 3:55,980,355...55,998,536 		JBrowse link
G Rnf128 ring finger protein 128 decreases expression ISO Arsenic Trioxide results in decreased expression of RNF128 mRNA CTD PMID:19128835 NCBI chr  X:107,968,973...108,087,037
Ensembl chr  X:107,972,348...108,087,288 		JBrowse link
G Rnf13 ring finger protein 13 increases expression ISO Arsenic Trioxide results in increased expression of RNF13 mRNA CTD PMID:20458559 NCBI chr 2:144,076,526...144,211,520
Ensembl chr 2:144,077,916...144,211,798 		JBrowse link
G Rnf130 ring finger protein 130 increases expression ISO Arsenic Trioxide results in increased expression of RNF130 mRNA CTD PMID:35676786 NCBI chr10:34,843,920...34,957,130
Ensembl chr10:34,843,915...34,960,408 		JBrowse link
G Rnf144a ring finger protein 144A multiple interactions
increases expression 		ISO Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to RNF144A protein]
Arsenic Trioxide results in increased expression of RNF144A mRNA 		CTD PMID:15761015 PMID:26598702 NCBI chr 6:48,628,241...48,748,241
Ensembl chr 6:48,631,648...48,748,179 		JBrowse link
G Rnf157 ring finger protein 157 increases expression ISO Arsenic Trioxide results in increased expression of RNF157 mRNA CTD PMID:20458559 NCBI chr10:102,070,842...102,138,738
Ensembl chr10:102,070,842...102,155,802 		JBrowse link
G Rnf167 ring finger protein 167 increases expression ISO Arsenic Trioxide results in increased expression of RNF167 mRNA CTD PMID:20458559 NCBI chr10:55,859,254...55,863,546
Ensembl chr10:55,859,297...55,863,905 		JBrowse link
G Rnf182 ring finger protein 182 decreases expression ISO Arsenic Trioxide results in decreased expression of RNF182 mRNA CTD PMID:35676786 NCBI chr17:21,232,084...21,287,329
Ensembl chr17:21,232,084...21,299,723 		JBrowse link
G Rnf220 ring finger protein 220 decreases expression ISO Arsenic Trioxide results in decreased expression of RNF220 mRNA CTD PMID:39716349 NCBI chr 5:135,975,739...136,198,017
Ensembl chr 5:135,975,739...136,197,858 		JBrowse link
G Rnf223 ring finger protein 223 increases expression ISO Arsenic Trioxide results in increased expression of RNF223 mRNA CTD PMID:39716349 NCBI chr 5:172,005,566...172,008,456
Ensembl chr 5:172,005,566...172,008,458 		JBrowse link
G Rnf24 ring finger protein 24 increases expression ISO Arsenic Trioxide results in increased expression of RNF24 mRNA CTD PMID:15761015 NCBI chr 3:138,973,492...138,987,354
Ensembl chr 3:138,973,492...139,028,177 		JBrowse link
G Rnf34 ring finger protein 34 increases expression ISO Arsenic Trioxide results in increased expression of RNF34 mRNA CTD PMID:20458559 NCBI chr12:39,364,461...39,385,391
Ensembl chr12:39,355,578...39,385,340 		JBrowse link
G Rnf4 ring finger protein 4 multiple interactions
affects localization 		ISO [[Arsenic Trioxide results in increased sumoylation of PML protein alternative form] promotes the reaction [PML protein alternative form binds to RNF4 protein]] which results in increased degradation of PML protein alternative form; [[Arsenic Trioxide results in increased sumoylation of PML protein] promotes the reaction [PML protein binds to RNF4 protein]] which results in increased degradation of PML protein; [Arsenic Trioxide results in increased sumoylation of PML protein alternative form] promotes the reaction [PML protein alternative form binds to RNF4 protein]; [Arsenic Trioxide results in increased sumoylation of PML protein] promotes the reaction [PML protein binds to RNF4 protein]; Arsenic Trioxide promotes the reaction [RNF4 protein binds to and results in increased degradation of PML protein modified form]; Ar